
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-12601-12900*
  '(".1" "210-227" "A-484954" "A-5" "A-6" "A-DUSP" "A-DUSPs" "A-E" "A-G-10"
    "A-G-20" "A-USF" "A-allele" "A-alleles" "A-and" "A-box" "A-c" "A-d" "A-e"
    "A-loop" "A-phosphorylated" "A1" "A118G" "A146T" "A146V" "A1675T"
    "A300-885A" "A375P" "A4" "A461T" "A5RT3" "A814S" "AA-PCa" "AA-induced"
    "AAAACAnnnAGCTGT" "AAH-AIS-MIA-IA" "AAUCCCA" "AB143" "AB225" "AB36" "AB67"
    "ABAE" "ABSC" "ABSCs" "ADAM10i" "ADM-DYRK1A" "ADP-ribosylation-dependent"
    "ADP-ribosyltransferase-9" "ADP‐ribose" "ADP‐ribosyl" "AE" "AEGAETT"
    "AF488-Tpo" "AFT4" "AFs" "AG1522" "AGAACTnnnAGAGCC" "AGAC" "AICD" "AJB"
    "AJI" "AJI-100" "AJI-214" "AJM" "AJPs" "AKR1C" "AKR1C-family" "AKRIC1"
    "AKT2i" "AKT308" "AKT473" "AKT7" "ALGGEN" "ALK-negative" "ALK-positive"
    "ALL-697" "ALOXs" "AM-1" "AMB" "AMPK-ULK1-dependent" "AMPK-ULK1-mediated"
    "AMPKa1" "AMPKα" "AMPKα–mutp53s" "AMZ2" "ANKRD9" "ANTS" "ANXA" "ANXA7s"
    "AP-MS" "AP1-like" "APC+" "APC-core" "APGAR" "APO-BRDU" "APOBEC3" "APTs"
    "APs" "AR-DNA" "AR-V" "AR-co-repressor" "AR-splice" "AR110" "AR599" "AR678"
    "AR75" "ARDT9" "ARE+FKHD" "ARE-LUC" "ARE-like" "ARE-luc" "ARE4-LUC"
    "ARG-197" "ARIC" "ARMS-PCR" "ARNT-PAS-B" "ARQ" "ARQ-197" "ARS" "ARTD"
    "ARTD-like" "ARTD7" "ARTD7-9" "ARTD8" "ARTD9-mediated" "ARTDs" "ARTDx"
    "ASC-J9" "ASC-J9-pretreated" "ASC-J9-treated" "ASC-J9–pretreated" "ASPS-KY"
    "ASPSKY" "AT2052" "AT9283" "ATCC" "ATCTT" "ATGGCTCCTGCACTCTTC" "ATM-IGF-1"
    "ATM-IGF-1-sCLU" "ATM-replete" "ATM·IKKγ" "ATP-competitive" "ATR-Dependent"
    "ATR-hypomorphic" "ATR-phospho-S435" "ATS" "ATTG" "AUROC" "AUROCs" "AUROC "
    "AUS" "AV-nodal" "AV-node-dependent" "AVN944" "AW" "AZ" "AZ13102909"
    "AZ909" "Aba" "Abcam" "Abdel-Wahab" "Abelson" "AcK" "Ad-CMV-β-gal" "Ad-Cre"
    "Ad-GFP" "Ad-GSK-3β-S9A" "Ad-S100A4" "Ad-S100A4-infected" "AdS" "AdS-G"
    "Adenoviral-mediated" "Adhim" "Adoo" "Adp66shcRNAi" "Adult-T-cell-Leukemia"
    "Aequorea" "Affymetrix" "Africa" "African" "African-American" "Africans"
    "Afro-Americans" "Agilent" "Ago2" "Aguayo" "AhR-independency" "Ahn" "Ai"
    "Aii-Aiii" "Aiii" "Akt*-expressing" "Akt-dependent"
    "Akt-miR-200c-E-cadherin" "Ala16Val" "Ala16Val " "Alamos" "Alb-ARKO"
    "Alb-Cre" "Albany" "Albu" "Alesci" "Alexa" "Alifano" "Alk" "Allen"
    "Alloantibody" "Allprep" "Almasi" "Alvarez" "Alzheimer" "Alzheimer's"
    "Alzheimer’s" "Amaxa" "America" "American" "Amgen" "Aminoflavone" "Amler"
    "Amoy" "Ampliseq" "Andersen" "Anderson" "Aneurysm"
    "Aneurysm-Osteoarthritis" "Annamaneni" "Annexin-A7" "AnnexinV-PE" "Aox3"
    "Apicomplexa" "Arf1" "Arg-II" "Arg194Trp" "Arg280His" "Arg399Gln"
    "Arg592–Glu947" "Arg95Ter" "Arisawa" "Armitage" "Arva" "Asia-Pacific"
    "Asian" "Asians" "Asp-Glu-Val-Asp-Gly" "Asp643Aspfs" "Asp643Aspfs*8"
    "AssayStrip" "Astellas" "AstraZeneca" "Asturias" "Athens" "Aurora"
    "Aurora-selective" "Australia" "Austria" "Autostainer" "Autotaxin" "Ave"
    "Avena" "Axel" "Axenfeld" "AxxA" "AzaHX" "AzaIMP" "Aβ" "A–E" "A–E17K"
    "A–E545K" "A–V600E" "B-C" "B-CDK1" "B-Cdk1" "B-L-100" "B-Raf-dabrafenib"
    "B-WICH" "B-a" "B-aggressive" "B-b" "B-box" "B-c" "B-dependent" "B-e" "B-f"
    "B-g" "B-h" "B-lineage" "B-lymphoma" "B-mediated" "B1" "B1-integrin" "B10"
    "B10A" "B2" "B3" "B6" "B8" "BA" "BAL1" "BALB" "BC300" "BCG823"
    "BCL-2-family" "BCL2-axes" "BCR-ABL1-negative" "BCoR" "BD" "BECN"
    "BFB-mediated" "BGC2-13" "BGJ398" "BH3-mimetic" "BH3-mimetics" "BH3-only"
    "BIBW" "BIBW-2992" "BIO" "BIRC8" "BISH" "BJ" "BJ-5ta" "BMAL"
    "BMAL1-promoter-driven" "BMDMs" "BMV" "BNF" "BO21976" "BO21977" "BO22589"
    "BO25734" "BOM1-1833" "BOND-III" "BPE" "BRA" "BRAF-melanocyte" "BRAF-mice"
    "BRAF-wildtype" "BRASTO" "BSCCs" "BSW" "BT325" "BT340" "BW" "BWA" "Ba"
    "Background" "Bak" "Bak-dependent" "Bak-independent" "Balb" "Bannayan"
    "Bannayan-Zonana" "Bannayan–Zonnana" "Barrett" "Barrett’s" "Basaloid"
    "Bastus" "Bau" "Bax" "Bax-dependent" "Bax-mediated" "Bbox" "Bcl" "Bcl-G"
    "Bcl-xl" "Begg" "Begger" "Begger's" "Beilina" "Belagouli" "Bias-reduced"
    "BilIN" "Bim-depletedCdc20" "Binet" "BioAfrica" "Bioanalyzer" "Biochem"
    "Biomax" "Biondi" "Bionetworks" "Biotech" "Blaheta" "Blk-wt-transfected"
    "Blons" "Blood–brain" "Blue-labelled" "Bmp1" "Bnipl" "Bonataike"
    "Bonferroni" "Boyden" "BrUOG" "Brazil" "Brazilian" "BrdU-incorporation"
    "Breakage-fusion-bridge" "Breslow" "Bridgewater" "Brindel" "Brinkman"
    "Broad" "Broadie" "Bromoenol" "Brugada" "Buckley" "Bulgaria" "Burk"
    "Burkitt" "C-C" "C-CS" "C-CW" "C-Cullin2-CIS" "C-E-F" "C-FW" "C-HW" "C-MY"
    "C-NHEJ" "C-NHEJ-deficient" "C-PH" "C-YH" "C-activating" "C-alpha"
    "C-change" "C-shaped" "C-to-T" "C1" "C1-like" "C11A" "C12-HSL-induced"
    "C13-HD6KD" "C135C–G172G" "C135C–G172T" "C135C–T172T" "C2" "C212" "C228T"
    "C250T" "C3" "C31cells" "C3G" "C459S" "C57" "C57BL6" "C77" "C88" "C91PL"
    "CAAT" "CAAX" "CACCCGGT" "CACCCGGTCA" "CACS" "CAIS" "CAPL" "CARS"
    "CARe-COGENT" "CAST-PCR" "CASVM" "CAY10593" "CB11" "CBFα2" "CBRs" "CBTs"
    "CCAAT-box" "CCD-18Co" "CCDS" "CCMB" "CCND" "CCdc20" "CD-H2DCFDA"
    "CD-associated" "CD-susceptibility" "CD44v" "CD74-dependent-glucose" "CD90"
    "CDA" "CDH16-Cre" "CDK-dependent" "CDK6-driven" "CDKN2a" "CDNK2A"
    "CE-TOFMS" "CEN8" "CEP17" "CEP85L" "CEs" "CFP-SelP-H" "CGI" "CG→AT"
    "CHD4-RNAi" "CHEK" "CHO-1" "CHRT" "CHX-induced" "CI95%" "CJX" "CK1δ"
    "CKAP2" "CKIδ" "CL" "CL-O" "CL387,785" "CLL-like" "CLOCK-mediated" "CLSTN2"
    "CM-H2DCFDA" "CMGC" "CMPD" "CMV-STAT1-Flag" "CMV-STAT3-Flag" "CNGs" "COM"
    "CONSORT" "CORUM" "CPAE" "CQ-treatment" "CR+PR" "CR-PC." "CR-progression"
    "CR-tumors" "CR5" "CRD42013005325" "CRE" "CRE-like" "CRPC-like" "CRPCa"
    "CRUZ" "CRYs" "CSC-like" "CSCR3" "CSIR-Senior" "CSLC" "CSLC-directed"
    "CSLCs" "CSLSc" "CSMD3" "CSNK1ε" "CSNK2α" "CSRP2" "CSS11" "CT-GFP" "CTC"
    "CTCC→TTCC" "CTCs" "CTD" "CTFFIND" "CTPP" "CVL" "CW" "CWR22RV1" "CXL"
    "CXXC" "CYP2Cs" "CYT387" "Ca" "CaMKKβ" "CaOx" "CagA-and" "Caki" "Cal-51"
    "Cal51shAhR" "Calbiochem" "CalcuSyn" "Calorimetry" "Campbell" "Canada"
    "Canbay" "Capase-8" "Carboxyl" "Carboxyl-terminal" "Carpinteria" "Carroll"
    "Cary" "Case-Control" "Casp8p41" "Castaigne" "Caucasian" "Caucasians"
    "Cd19-cre" "Cdc20-binding" "Cdc20-resistant" "Cdc42" "Cdk" "Cdk2" "Cdk2's"
    "Cdk4" "Cell-Titer-Glo" "CellMask" "CellTracker" "Cengiz" "Cervarix" "ChIP"
    "ChIP-enrichment" "ChIP-on-Chip" "ChIP-qPCR" "ChIP-sequence" "ChREBPα"
    "Chan" "Chang" "Chaqui" "Charafe" "Charpentier" "ChartMaxx" "Chaudhry"
    "Chauhdry" "Chemotherapy-naive" "Chennai" "Chi-Square" "Chi-square"
    "Chicago" "Chimerascan" "Chingford" "Chk1" "Chk1-A" "Chlorophenyl" "Choi"
    "Cholesterol-rich" "Chompret" "Chou" "Christenson" "Chun" "Chun-xiao"
    "Chung" "Cip" "Cirera" "Cirera-Salinas" "Cis" "CkII" "ClBQ" "Clara"
    "Clements" "Clinico-pathological" "Clonally-derived" "Clontech" "Cnp"
    "Cntd1" "Cochran" "Cochran-Armitage" "Cohen" "Col1a2-cre" "Col2a1-CreER"
    "Col3" "Cole" "Coles" "Colo" "Colo-rectaL" "Colombo" "Combo" "Conclusion"
    "Concomitance" "Congo" "Conradi" "Constantinescu" "Control-shRNA"
    "Coomassie" "Copy-number" "Corp" "Cossart" "Covaris" "Cowden" "Cowden’s"
    "Cox-2" "CpG-island" "Cre-T2A-YFP" "CreER" "Creighton" "Crimean" "Crk"
    "Crody" "Crohn" "Crohn's" "Crohn’s" "Crowley" "Cryo-EM" "Ct" "Cu" "Cui"
    "Cullin-Ring" "Curtis" "CyclynD1" "Cys2-His2-type" "Cyto" "Cytodyne" "Cα"
    "Cγ-cre" "Cε" "Cμ" "C‐terminal" "D-DT-associated" "D-DT-deficiency"
    "D-DT-deficient" "D-DT-dependent" "D-DT-depleted" "D-E" "D-box"
    "D-box-dependent" "D-boxes" "D-dopachrome" "D-thymidine" "D-type" "D1-like"
    "D10" "D15S116" "D15S127" "D15S202" "D15S996" "D2" "D25N" "D26N" "D3" "D4"
    "D5" "DA107" "DA360" "DA403" "DA473" "DA64" "DAB261" "DAB277" "DAB361"
    "DAB494" "DAB496" "DAB538" "DAB601" "DAB64" "DABB" "DABB-cell" "DAC1"
    "DAC2" "DADEpY" "DAF-2DA" "DBC" "DBH-HiCre" "DBZ" "DCP-LA"
    "DDP-nonresistant" "DE3" "DEAE5PW" "DEL19-CAST" "DESeq" "DEVD" "DEVD214G"
    "DEVD396" "DEVD396G" "DEVDG" "DEVN396G" "DF" "DFG-in" "DFG-out"
    "DGIIDFTSGSELLITK" "DGISPKRRRLSSSLNPSKRAP" "DGZ" "DHA" "DHA-CP6" "DHL6"
    "DHPH-1" "DIV" "DIV7" "DJ" "DJβ" "DLD1" "DLG5" "DLPs" "DMAG" "DMJ" "DMNT"
    "DMNT3A-mutated" "DMT1+IRE" "DN-ANXA7" "DNA-MATE" "DNA-binding-deficient"
    "DNA-mismatch" "DNA-protein" "DNA-staining" "DO-1" "DOI" "DOX-dependent"
    "DPB1" "DPQ" "DQ3" "DQ7" "DQA1" "DR17" "DRB1" "DRB4" "DRB5" "DRE" "DREs"
    "DRYK1A" "DSBs" "DSBs-repair" "DSEENpY" "DSMO" "DSS-risk" "DSS-treated"
    "DTIC" "DTX" "DTX3L-ARTDx" "DU145+AR" "DU145+AR+FOXA1"
    "DU145+AR+FOXA1-only" "DU145+AR-only" "DU145+AR_Q640X" "DU145+C562S"
    "DU145+G568W" "DU145-DR" "DU1450" "DUPS" "DUPS’s" "DUSP14"
    "DUSP3-depletion-associated" "DWW" "DX-MS" "DYRK1C" "DYRK4A" "DYRK4B"
    "Dako" "Dallas" "Damotte" "Danoy" "Darby" "Darier" "Darier-White"
    "Darunavir" "Davies" "Dbh" "De-regulated" "De-regulation" "Deek"
    "Deligezer" "Denkert" "Desorption" "Detroit" "Devez" "Dickkpf-1"
    "Dictyostelium" "Diego" "Dieu" "Dihydroethidium" "Diphteria" "Discussion"
    "Dmut" "Doane" "Dock180" "Dominant-negative" "Donaldson" "Dong" "Dong-Kee"
    "Doratomyces" "Dortmund" "Double-strand" "Double-variant" "Doubly-labeled"
    "Douillard" "Dox" "Drosohila" "Drosphila" "Ds" "Dublin" "Ducruit"
    "Dulbecco" "Dulbecco’s" "Duojia" "Dutch" "DxS" "Dziadziuszko" "E-adherin"
    "E-box" "E-boxes" "E-loop" "E-prostanoid" "E-supplement" "E12" "E2-Ub"
    "E2-dependant" "E2-ligases" "E2-ubiquitin" "E213-A" "E2A" "E2F1-4" "E2f"
    "E3-Ub" "E3-dependent" "E3-ligase" "E3-ligase-pIκBα" "E3-ubiquitine"
    "E336X" "E47" "E4BP4" "E746-A750" "E76K" "EACs" "EADs" "EBS-Luc" "EBS-luc"
    "ECC=50" "ECE" "ED25" "ED50" "ED75" "ED90" "EDG-family" "EDL933" "EEHVpY"
    "EEPD131" "EEPD131G" "EEPD131↓G" "EFGR" "EFHA1" "EFM" "EGF-488" "EGF-Rh"
    "EGF-like" "EGF-receptor" "EGFR-dependent" "EGFR-ligands-EGFR"
    "EGFRvII-ext" "EGFRwt" "EGM" "EGR" "EHEC" "EIA" "ELF-1" "ELISAs" "ELMO"
    "ELR" "EMAN" "EMILIA" "EMPIRE" "EMT-like" "ENA78" "ENNP2" "ENPP2"
    "ENST00000446326" "ENaC" "EORTC55971" "EPEC" "EPs" "ER+ " "ER-Golgi"
    "ER-Tracker" "ER-core" "ER-negative" "ER-stress-induced" "ER-subtype"
    "ERAD-II" "ERE-half" "ERE-like" "ERE-luc" "ERE-luciferase" "ERE-sequences"
    "EREs" "ERK-miR-200c-ZEB2" "ERMS" "ERN2" "ERS" "ERbeta2–ERbeta5"
    "ERα+SiMed25" "ERα + " "ERβ-1-mediated" "ESEfinder" "ETD" "ETF" "ETOtr"
    "ETS-activated" "ETS-associated" "ETS-dependent" "ETS-driven"
    "ETS-mediated" "ETS-repressed" "ETSs" "ETV7" "EU" "EUR" "EV71" "EVH1"
    "EWS-ETS-driven" "EWT" "EXOC1-8" "EXPERT-C" "EY" "Ectopically-expressed"
    "Edmondson" "Edmondson–Steiner" "Edmonson" "Edmonson-Steiner" "Eersel"
    "Egf" "Egger" "Egger's" "Egger’s" "Egr-1" "Egypt" "El-Din" "Elferink"
    "Elledge" "Elvidge" "EnVision + " "Encephalomyocarditis" "Enchondroma-Like"
    "Engelmann" "England" "English" "EpiTYPER" "Epithelial-to-mesenchymal"
    "ErbB" "ErbB1-4" "ErbB2-expressing" "ErbB2-targeted" "Erbb1-3" "Ercegovac"
    "Erivedge" "Erk-1" "Eskilden" "Eso" "EspG-E392R" "EspG-R" "EspI" "Ettan"
    "Eugene" "Europe" "European" "European-origin" "Europeans" "Evan" "ExoVII"
    "Exostosis-Like" "Extracellular-regulated" "Eμ-Bcl-2" "Eμ-myc" "F-HD6"
    "F-HD6DM" "F-HDAC6" "F-MSH6" "F-MT" "F-dex" "F1" "F2" "F3-FLT3-ITD"
    "F5A-HA" "FAB-M2" "FAC1" "FAIRE-qPCR" "FAIRE-seq" "FAKY397" "FBI-1on"
    "FBI-1participates" "FDG-PET" "FDRp" "FERM" "FHL" "FHRE" "FHREs" "FIGO"
    "FISH" "FK-228" "FKHD" "FKHD+ARE" "FKHD-only" "FLAG" "FLAG-12K-R-FOXA2"
    "FLAG-UVRAG-linked" "FLI-associated" "FLI-containing" "FLI-mediated"
    "FLI-repressed" "FLJ40478" "FLT3-ITD" "FLT3-ITD-A848P" "FLT3-ITD-F691L"
    "FLT3-ITD-N676K" "FLUS" "FLVCR2" "FOLFOX4" "FOP-flash" "FOPflash"
    "FOXO3-mediated" "FOXO3A-S318" "FOXO3A-Ser318" "FOXO3A-associated"
    "FOXO3A-cascade" "FOXO3A-mediated" "FOXO3A-regulator" "FT-ICR-MS" "FTK"
    "FUrD" "FV" "FV10-ASW2.1" "FV1000" "FX" "Fadok" "Family-Wise" "Fayad" "Fc"
    "Fcγ" "FcγIIIA" "FcγR" "FcγR1" "FcγR1stimulation" "FcγRI" "FcγRIIb"
    "FcγRIγ" "FcγRs" "Fernandez" "Fgrfr1" "Fifty-seven" "Figure-1B-F"
    "Figure-1H-K" "Figure-1L" "Figure-1N" "Figure-2A" "Figure-2B" "Figure-3B"
    "FigureS5A" "FinHER" "Finkel-Biskis-Jinkins" "Finland" "Finnish"
    "First-degree" "Fisheŕs" "FlagMed25" "Flp-In" "FluoroMax-3" "Fluoview" "Fn"
    "Fn-fs" "Fob1p" "Follow-up" "Fols1" "Forrest" "Forty-eight" "Forty-one"
    "Forty-seven" "Forty-six" "Four-week-old" "Francisco" "Franke" "Frankel"
    "Frater" "Fraumeni" "Freire" "Freire-de-Lima" "French" "Fridlender"
    "Fritsch" "Frizzleds" "Fucci" "Fukui" "Fulco" "FunciSNP" "Förster" "G-G-G"
    "G-MDSC" "G-agarose" "G-allele" "G-alleles" "G-quadruplex" "G0" "G1" "G1-M"
    "G1-S" "G1-arrest" "G1-checkpoint" "G1-fraction" "G12" "G12C" "G135C–G172G"
    "G135G–G172G" "G13C" "G13D" "G1–G0" "G1–G2" "G1–G3" "G2" "G272V" "G2T"
    "G464A" "G6P" "G719X" "GA" "GAL-DBD-GPS2" "GAL4-DBD-GPS2" "GAL4-DBD–tagged"
    "GAS" "GASmut" "GATA3mut" "GATK" "GBC=69.2%" "GC-MSCs-activated"
    "GC-MSCs-derived" "GC-MSCs-induced" "GC-MSCs-primed" "GCN-MSCs" "GCN≥4.0"
    "GCS" "GDC" "GDC-0425" "GDC-0575" "GEF-GAP" "GEF-independent" "GEMM"
    "GEMMs" "GFP-AMPKα2" "GFP-FAK-WT" "GFP-LC3-II" "GFP-SUMO-1" "GFP-Ubi"
    "GFP-expressing" "GFRs" "GG" "GG+GA" "GGO" "GGOs" "GGTGGC" "GGTTAG" "GGYs"
    "GI" "GI50" "GI50 " "GIBCO" "GIC50" "GILF" "GILFI" "GISTIC2" "GL"
    "GLOBOCAN" "GNCAs" "GOFmutp53" "GOLFIG" "GPR56C" "GRASP55-V5" "GRCh37"
    "GRLBD’s" "GRO-seq" "GSE13670" "GSE16837" "GSE2340021" "GSE2927222"
    "GSK-3βKO" "GSK3-NBR1-mediated" "GSK3β-KO" "GSNEpY" "GST-ARNT-PAS-B"
    "GST-CRKL-SH2" "GST-PAS-B" "GST-fusion" "GST-p21C" "GST-pull-down"
    "GST-wtp53" "GST-π" "GST–SIVA1-Δ2" "GV" "GW-627368X" "GWA" "GXSXG" "GYPB"
    "GZ" "Gab1" "Gardasil" "Gastroenterology" "Gavrilov"
    "Gehan–Breslow–Wilcoxon" "GenBank" "GeneChip" "GeneView" "Genecard"
    "Genentech" "Gene–gene" "Genini" "Genome-wide" "Genotype" "George" "Georgi"
    "GeparQuattro" "German" "Germany" "Germline " "Giemsa" "Gilak" "Gilkes"
    "Glaxo" "Gleason" "Gloucester" "GmbH" "Go6975" "Goetz" "Gonzalez" "Google"
    "Gordon" "Gordon's" "Gottlieb" "Gq" "GqR183Q" "Gr" "Grade-3" "Grade-I"
    "Grade-III" "Gram-positive" "Granta" "Granta-452" "Graziano"
    "Grb2-associated
binder-1"
    "Greek" "Grodstein" "Grotenhuis" "Group-2A" "Group-2B" "Gs-PKA" "Gsα"
    "Guagnano" "Guan" "Guangdong" "Guardino" "Guedes" "Guillermo" "Gundert"
    "Gundert-Remy" "Gurmit" "Gy" "Gyu" "Gα" "H&E" "H-C" "H-LH" "H-RAS-GTP"
    "H-bond" "H-bonds" "H-labeled" "H-methyl" "H-score" "H-thymidine" "H1"
    "H1975" "H2228" "H2DCF" "H3" "H3-Ser10" "H3-containing" "H3-positive"
    "H3.3" "H3K18Ac" "H3K27" "H3K36" "H3K56Ac" "H3K9" "H3K9Ac" "H3K9ac" "H4"
    "H4K16" "H4K16Ac" "H83D-H86D" "H9" "HA-AMPKα2" "HA-K0" "HA-K48-linked"
    "HA-NLS-PML4" "HA-YAP" "HA-tag" "HA-ubiquitin" "HA1E" "HARRT" "HBCC" "HBEC"
    "HBEC11" "HBEC7" "HBECs" "HBOC" "HBSS" "HCC-4012" "HCC-827" "HCI"
    "HCI-2509" "HCI2509" "HCT" "HCT-1116" "HCTtetK" "HCW" "HD6KO" "HDA1"
    "HDAC-corepressor" "HDAC2-1" "HDAC2-1siRNA" "HDAC6KD" "HDAC6KO"
    "HDAC6KOMEFs" "HDAC6WT" "HDF" "HDFs" "HDX-MS" "HEK293T-3xFlag-LRRK1"
    "HER2-wt" "HERACLES" "HEY-A8" "HFE-145" "HFF" "HFFs" "HG-SOC" "HGF-gene"
    "HGSCs" "HIF-1α-binding" "HIF1-regulatory" "HIV-1-1" "HIV-1-susceptible"
    "HIV2Toolbox2" "HIVToobox2" "HIVToolbox" "HIVToolbox2" "HIY" "HK" "HKe"
    "HKe-clone8" "HL-7702" "HLA*IMP" "HLAs" "HMBD" "HMOX" "HN4α" "HOMA"
    "HOMA-B" "HOP" "HOTTIP" "HOXC" "HOXD" "HOXD9" "HPC" "HPCs" "HPDP"
    "HPLC-PDA" "HPV-L1" "HR-DLBCL" "HR-HPV" "HR-HPVs" "HRE-2" "HRs" "HS606t"
    "HSC3-Inv4" "HSC3-Inv8" "HSF1-S303-Pi" "HSF1-S326-Pi" "HSF1-pS326"
    "HSPC-intrinsic" "HSV-1" "HTC116" "HTLV" "HTLV-I" "HUGO" "HULC" "HWE" "HX"
    "HYY" "Haferkamp" "Hamamatsu" "Hamdy" "Hanahan" "HapMap" "Harbottle"
    "Hardie" "Hardwidge" "Hardy-Weinberg" "Hardy–Weinberg" "Hartmann" "Harvard"
    "Hasford" "Hassall" "Hazen" "Heallen" "Hedgehog-inhibitory"
    "Hedgehog-pathway" "Hegf1" "Heidelberg" "Heidelberg-EPIC" "Helsinki"
    "Hematopoietic-derived" "Hematoxylin-eosin" "Hempel" "Hepa1c1c7"
    "Hepatocyte-specific" "HerceptTest" "Hess" "Heukamp" "Hi-Ras" "HiCre"
    "HiSeq" "High" "High-frequency" "High-grade" "High-resolution" "HindIII"
    "Hippo" "Hippo-YAP" "Hippo-deficient" "Hippo-pathway" "Hirano" "His-MBP"
    "His-MSH2" "His-PCNA" "His-SUMO1" "His-SUMO–RAD18" "His-small" "His-tag"
    "Histone" "Hmb45" "Hodgkin" "Hodgkin’s" "Hoechst" "Hoffman" "Hoffman's"
    "Hopkins" "Hotel-Dieu" "Houston" "HpaII" "Hs343T" "Hs343t" "Hs606T"
    "Hs606t" "Hsel" "Hsel-tTA" "Hsp-25" "Hsp-27" "Hsp-27tg" "Hsp-60" "Hsp70"
    "Hsp90" "Hsp90α" "Huang" "Huebert" "Huh" "HumanHap" "HumanHap610Q"
    "Humedia" "Humedia-KG" "Huntington" "Huntington’s" "Hurvitz" "Hyderabad"
    "Hypo-phosphorylated" "Hypoxhantine" "I-II" "I-TASSER" "I-associated"
    "I-specific" "I7" "IA-IIIB" "IA3-HuR" "IAP-function" "IARC-GWAS" "IASLC"
    "IAV" "IC50" "IC50s" "IC90" "ICAM" "ICC=15.7%" "ICGC" "ICI" "ID8" "ID8-IP"
    "IDHs" "IDs" "IEF" "IEFs" "IFN-I" "IFN-I-IKKε" "IFN-I-dependent"
    "IFNGR-receptor" "IFNγ-STAT1-IRF1-axis" "IFNγ-independent" "IGC"
    "IGF-1-IGF-1R" "IGF-1-mediated" "IGF-1-regulated" "IGF-1R-sCLU" "IGFRs"
    "IGS" "IGSs" "II+I" "II-III" "II4" "IIA" "III+IV" "III-IV" "IIIa" "III–IV"
    "IIS" "II–IV" "IJB" "IKBIP" "IKKs" "IKKε-independently" "IL-10Rα" "IL-10Rβ"
    "IL2Rγ-deficient" "INCB7839" "INCB8765" "INS20" "IOVs" "IP-MS" "IPG"
    "IPLab" "IQ" "IQR" "IQR=26-79" "IR+KZ-41" "IR-mimetic" "IR2" "IREs" "IRβ"
    "ISC" "ISG" "ISGs" "ISRE" "ITAM" "ITC" "ITIM" "ITSs" "IVIS" "IVS"
    "IVS2-13A" "IVS4" "Iceland" "IgA" "IgVH" "Igκ" "Igλ" "Iida" "Ikaros-like"
    "Ile105Val" "Ile105Val " "Ile19fsX59" "Ile276fsX281" "Illumina" "ImClone"
    "ImageJ" "Imaris" "Immunoglobin" "Immunohistochemisrty" "Impagnatiello"
    "In-depth" "In-house" "InWeb" "Inc" "Indiana" "Infinium" "Ingenuity-based"
    "Inhere" "Inhibin1" "Innes" "Inosine-5" "Insulin-activated" "Integragen"
    "Interval-International" "Intra-tumor" "Intron" "Inv4" "Inv8" "Invitrogen"
    "Ionisation" "Iran" "Ireland" "Irish" "Irradiation-induced"
    "Ischemia-Reperfusion" "Ito" "Iδ" "I–II" "I–III" "I–IV" "J-YT" "J774"
    "JACH" "JAGGED" "JAK1-STAT1" "JAK2WT" "JBC" "JBW" "JD" "JE" "JF-T" "JH1"
    "JH2–JH1" "JHESO" "JHL" "JKF" "JMFF" "JMJD" "JMS" "JNK-induced" "JNZ" "JO"
    "JP" "JPT" "JPT " "JQ1" "JSP" "JSmol" "JW" "JZ" "Jackson" "Jak1-2" "Jak2WT"
    "Jammu" "Janoueix" "Janoueix-Lerosey" "Japanese" "Jason" "JeM" "Jiang"
    "Jiao" "Jin" "JoMa" "JoMa-ALK-F1174L" "JoMa1-ALK" "JoMa1-ALK-F1174L"
    "JoMa1-ALK-R" "JoMa1-ALK-R1275Q" "JoMa1-ALK-derived" "JoMa1-ALK-expressing"
    "JoMa1-ALK-wt-derived" "JoMa1-NMYC-derived" "Jobin" "Johns" "Johnson"
    "Johnston" "Johnstone" "Joseph" "Juuti" "Jα" "K-ras" "K-to-R" "K13R" "K14R"
    "K18ΔK280" "K3326X" "K373" "K382" "K41A" "K48" "K48-poly-Ub" "K48only"
    "K5-Cre-PR1" "K5-CrePR1" "K6" "K63-poly-Ub" "K631M" "K63R" "K63W" "K8"
    "K845" "K847Q" "K847R" "KAAD" "KAAD-cyclopamine" "KDM" "KDMs" "KEGG"
    "KEN-box" "KHSV" "KJ" "KL-M" "KLG" "KLKs" "KMH" "KMTs" "KNN" "KOt"
    "KP-KrasA" "KPS" "KPS " "KRAS-LCS6" "KRASV12" "KRASWT" "KWL" "KZ" "KZ-41"
    "Kabuki" "Kaplan" "Kaplan-Meier" "Kaplan-Meir" "Kaplan–Meier" "Kaposi"
    "Kaposi's" "Kappa-B" "Kapłon" "Karnofsky" "Karopherin" "Karson" "Kashmir"
    "Katja" "Kato" "Kaulich" "Kawakami" "Kazakh" "Keap-1-Cul3" "Kee" "Keil"
    "Kelch-like" "Kellen" "Kellgren-Lawrence" "Kendall" "Kensler" "Khalil"
    "Ki-67" "Ki-67-antigen-positive" "Ki16452" "Kiefer" "Kikushige" "Killele"
    "Killer" "Kim" "Kinexus" "Kip" "Kirsten" "Kit-8" "Kjersem" "Knock-down"
    "Komiya" "Korea" "Korean" "Koreans" "KpnI" "Krebs" "Krejci" "Krupa"
    "Kruskal-Wallis" "Krüppel" "Kt" "Ku" "Kucukgergin" "Kurokawa" "Kurppa"
    "Kwabi-Adoo" "KxL" "Kyoto" "Kyprianou" "K→A" "L-KW" "L-MSCs"
    "L-alpha-aminobutyric" "L-arginine-starvation" "L-arginine-treatment"
    "L-glutathione" "L-type" "L1" "L10" "L10V" "L1621fs" "L243A" "L611V"
    "L858R+T790M" "L861Q" "LACZ" "LAI" "LATS-1" "LATS2-induced" "LBDs"
    "LC-MS-MS" "LC-SRM-MS" "LC3-I" "LC3I" "LC3II" "LCLs" "LEOPARD" "LF-1"
    "LINE-1" "LIPQQG" "LJ" "LKB1Δ-1083" "LL" "LM2-4175" "LMS003" "LMW-SGK1"
    "LMW-SGK1-forms" "LNA-mediated" "LNCaP+shFOXA1" "LND" "LNM" "LNP-siHDAC2"
    "LNP-siβgal478" "LOF" "LP-105" "LPA-receptors" "LPA1-3" "LPAR" "LPAR1-3"
    "LPAR4-6" "LPARs" "LPS-RS" "LPS12" "LPSs" "LQT4-13" "LQTS-susceptibility"
    "LQTS1-3" "LRAR" "LRAR1" "LRRK" "LRRK2-IN1" "LRRKs" "LSM700" "LTR-GFP"
    "LTRs" "LUBAC" "LUX-Lung" "LV-1" "LVEF" "LVFS" "LW" "LX" "LY294.002"
    "Labchip" "Lafky" "Lampang" "Landis" "Langendorff" "Large-scale"
    "Late-Hypertrophic" "Latin" "Lats1" "Lauren" "Laurent-Puig" "LckI" "Leica"
    "Lemaitre" "Lentiviral-delivered" "Leong" "Lerosey" "Leung" "Lewy" "Leydig"
    "Li" "Li-Fraumeni" "Li-Fraumeni-Like" "Lian" "Liang" "LifeAct"
    "LifeAct-Ruby" "Lin-4" "Lineweaver-Burk" "Linher" "Linher-Melville"
    "LipidMaps" "Liu" "Live-imaging" "Lmax" "Lmax " "Log-Rank" "Log-phase"
    "Long-lived" "Longer-term" "Lopez" "Lopez-Gonzalez" "Los"
    "Loss-of-function" "Loupakis" "Low" "Low-dose" "Low-grade"
    "Lox-STOP-Lox-G12D" "Ls174T-W4" "Ltd" "Luc" "Luini" "Luminex"
    "Luminex-multiplex" "Lundby" "Lupo" "Lx" "LxCxE" "Lys751Gln"
    "Lys882–Glu898" "M-1-like" "M-FISH" "M-PMV" "M-shift" "M-thick" "M1-M"
    "M1-like" "M1c" "M2-M" "M2-MΦ" "M2-like" "M5" "MAL-II" "MAPK-dependent"
    "MAPK-mediated" "MAPK-pathway" "MAPK–pathway" "MARIANNE" "MBA-MD-231"
    "MC1R-defective" "MCB" "MCF10A-ER-Src" "MCa" "MCo" "MD-MB-468"
    "MDA-MB-231+EV" "MDA-MB-231+RECK" "MDA-MB-468shAhR" "MDA-MB361"
    "MDA-MB361-LR" "MDA-MD-231" "MDACC" "MDACC-GWAS" "MDAPanc" "MDAPanc-28"
    "MDSC" "MDSCs" "ME2" "MEFS" "MELK-shRNA" "MEM" "METLIN" "MFIs"
    "MFechheimer" "MFurgerson" "MHC-I" "MID1-AREs" "MID1-association"
    "MID1-recognition" "MIFs" "MK-2006" "MK01" "MK03" "MKI" "MKN" "ML120b"
    "MLT" "MNCs" "MOG-G-CCM" "MOI" "MONC" "MONC-1" "MONC-1-ALK-F1174L"
    "MONC-1-ALK-F1174L-derived" "MOR" "MORs" "MQ" "MQA" "MRN" "MS" "MS-AFLP"
    "MS-PCR" "MSCC" "MSCCs" "MSCV" "MSFLP" "MSFLP-array" "MSH2KO" "MSH2WT"
    "MSH6KO" "MSH6WT" "MSI-H" "MSI-L" "MSI-low" "MST2" "MSigDB" "MTA1-NuRD"
    "MTDH-mediated" "MTS" "MV4" "MVG" "MYC-Neuroblastoma-related" "MZ" "MZW"
    "Macia" "Madin" "Madin-Darby" "Maffucci" "Maher" "Malvern" "Manchester"
    "Manitoba" "Manjer" "Mansuet" "Mansuet-Lupo" "Markov" "Marzec"
    "Mason-Pfizer" "Mass-spectral" "MassArray" "Massarweh" "Masson" "Masson’s"
    "Mastermind-like" "Matalka" "Matched-pair" "Matic" "Matrigels"
    "Matsubayashi" "Matteis" "Maxfield" "Mayo" "Mb" "McGraw" "MeDIP" "MeV"
    "Mean=15" "Mean=18" "Mean=19" "Mean=22" "Med25BM" "Mediator" "Meier"
    "Meier-plotter" "Meir" "Melville" "Menendez" "Merck" "Merck-Serono"
    "MesAMP" "Met-ErbB3" "Meta-regression" "MetaMorph" "MetaboAnalyst"
    "Metabochip" "Metacore" "Methylguanine-DNA-methyl-transferase"
    "Methylthiazol" "Meyenn" "MiR-122-5b" "MiR-193a-5p" "MiR-205" "MiR-224"
    "MiR-34" "MiSeq" "MicroRNA-146a" "MicroRNA-200" "MicroRNA-34" "Microbiopsy"
    "Ming-zhe" "Mir-17-5p" "Mir-193a-5p" "MirSNP" "Miskimins" "Mito-GFP"
    "Mito-dsRed" "Mito-marker" "Miyaki" "Miyauchi" "Mn" "Mn-superoxide" "Mo25α"
    "Molica" "Mono-phosphorylated" "Montero" "Montero-Ruiz" "Moore" "Morris"
    "Mortimer" "Mpl-fluorescent" "Mr" "MspI" "Munday" "Murray" "MutSig" "MutSα"
    "MutSβ" "Mutandis" "Mutant" "Muto" "Mwinyi" "My88" "MyBioSource"
    "MyBioSource’s" "MyLa" "Myc-Vps34" "MycD" "N-SH2" "N-SH2–PTP" "N-acetyl"
    "N-acyl" "N-acylation" "N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone"
    "N-ethyl-nitrosourea" "N-glycosylation" "N-linked" "N-nitroso" "N0"
    "N1406A-D1407A" "N2-like" "N214" "N396G" "N=18" "NA" "NAEPA" "NAPDH"
    "NBD-PE" "NC-Asp" "NCBI-SNP" "NCI-GWAS" "NCI-H747" "NCSD" "NCT00890825"
    "NCT00936221" "NCT01294306" "NCsiRNA" "NEBD" "NEs" "NF#1" "NF#10" "NF#3"
    "NF#4" "NF#6" "NF#6-11" "NF#7" "NF#8" "NF#9" "NF-e" "NF-κB-DNA-binding"
    "NF-κB-proximal" "NF-κB1" "NFAFc1" "NFTs" "NH" "NHGRI" "NHJE" "NHR4" "NL"
    "NLENY" "NLENY1-ES-IRES" "NLS3" "NLSs" "NM-23-H1" "NMIBC" "NMMHCIIB" "NMV"
    "NMVs" "NM_007194" "NNK" "NO-PAIN" "NOAH" "NOD-SCID" "NOTCH" "NSITE"
    "NSLCLC" "NTG" "NV" "NVP" "NVP-BGJ398" "Nagasawa" "Nagashima" "Nahrendorf"
    "Nanhai" "NanoPro" "NanoZoomer" "Nanshan" "Naphthoflavone" "Narasimha"
    "Naïve" "Nb" "NeO-Adjuvant" "Nebraska" "Nelson" "Neo-EGFL7-shRNA1"
    "Neo-adjuvant" "Neo-nonspecific-shRNA" "Nermoen" "NetPhos" "Netherlands"
    "NeuT" "Neumiester" "Neurovirology" "Newcastle" "Newcastle–Ottawa"
    "Newcomb" "Next-generation" "NextBio" "Ni-affinity" "Nibrin" "Nichols"
    "Nicolantonio" "Nigeria" "Nikon" "Ninety-eight" "NleA" "Nocodozole" "Nono"
    "Noonan" "Northampton" "Northhampton" "Notch-Delta" "Notch-associated"
    "Notch-induced" "Notch-signalling" "Notch-targeted" "Notch-targeting" "Nox"
    "Noxs" "NpGBKT" "NpGBKT7-SelP" "Nrf2" "Nrf2-Notch" "Nrf2-null" "NuRD"
    "NuSAP" "Nucleus-by-nucleus" "Néstor-Guillermo" "N = 3" "N = 4" "N = 7"
    "N‐terminal" "O-acylation" "O-linked" "OHdG" "OMM" "OMPT" "OMeG" "OPA"
    "OPC" "OPLS-DA" "OR=0.38" "OR=0.99" "OR=1.07" "OR=1.13" "OR=1.17" "OR=2.47"
    "ORIGO" "ORR" "ORRs" "ORs" "OSKM" "OSwhen" "OVCAR" "Oligomycin" "Ollier"
    "Olson" "Olympus" "On-going" "OncoCarta" "Oncology" "Oncomine"
    "One-hundred-fifty-three" "One-way" "OneStrep" "Onouchi" "Opitz" "Orbitrap"
    "OriGene" "Oris" "Orsetti" "Otho" "Ottawa" "Ovsiannikov" "Owen" "P0" "P1"
    "P2" "P2-producing" "P301L" "P53" "P53-mutated" "P7" "P7-ERα"
    "P7-phosphorylation" "P7-score" "P76-L83" "P7–P12" "P=0.02" "P=1.1×10"
    "P=2.1×10" "P=2.3×10" "P=7.6×10" "PA-Rac1-activation" "PA-Rac1-expressing"
    "PA-Rac1-induced" "PA-Rac1photoactivation" "PACS01" "PACU" "PAF-receptor"
    "PAGE" "PANDA" "PARP-C" "PARP-single-agent" "PARP1‐dependent" "PARs"
    "PAR‐binding" "PAS-B" "PB2B" "PBLs" "PC3-siARTD9" "PC9GR" "PC9GR-erlotinib"
    "PCC" "PCR-CTPP" "PCR-RFLP" "PCR-SSPs" "PCR–RFLP" "PCT" "PCs" "PD#17"
    "PD+ABT" "PDAs" "PDPK-1" "PDS" "PDS-CT" "PDSCCs" "PDZGEF" "PDZGEFs"
    "PEBP2αB" "PERK-siRNA-transfected" "PEST" "PF-00562271" "PF-271"
    "PF-431396" "PF-477736" "PHFs" "PHOSIDA" "PHW" "PI3K-III"
    "PI3K-III-mediated" "PI3KCA" "PIKCA" "PIKK" "PIKK-family" "PIKKs" "PIN20"
    "PIN20YAP1" "PINYAP20" "PIP5Kα" "PJ" "PKAc" "PKC-a" "PKC-a-evoked" "PKC-d"
    "PKC-e" "PKCλ" "PLC-β" "PLCδ" "PLR" "PML1" "PML4" "PMV" "PND-1186" "POZ"
    "PPARB" "PPARr" "PPARα-null" "PPIs" "PPMOs" "PPXY" "PR-interval"
    "PR-negative" "PR-segment" "PRC2-regulated" "PREGE" "PRLR-SF1b" "PRLRBP"
    "PROFace" "PROMO" "PROSPERO" "PROVEAN" "PSA-CS4x" "PSTSRKRP" "PTCDH4"
    "PTEN-null" "PTGS" "PTP1B·EGFR" "PTP1B·VO" "PU" "PXC" "PYCAR" "PZ" "Paneth"
    "Papanicolaou" "Paraná" "Pardanani" "Parkinson" "Parkinsonism" "Partch"
    "Pasupuleti" "PathwayStudio" "Patton" "Paxillin" "Pcam1" "Pdgfc" "Pdx1Cre"
    "Pearson" "Pearson's" "Pearsonχ" "Pecquet" "Pelletier" "Pemble" "Peng"
    "Per-KO" "Perez" "Pfizer" "Phenotype-Genotype" "Philadelphia"
    "Phosphatidylinositide" "Phosphatidylinositide-3-kinase"
    "Phosphatidylinositol-4,5-bisphosphonate" "Phosphonet" "Phosphorylation"
    "Phyre2" "PhysBinder" "Pierre" "Pillai" "Pinhel" "Pizzolato" "Pleschke"
    "Pljesa" "Pljesa-Ercegovac" "Poland" "Poly-ADP" "Poly-ADP-ribose"
    "PolyPhen" "PolyPhen-2" "Polyhistidine-tagged" "PolymiRTS" "Polη" "Polι"
    "Polκ" "Port-Wine" "Post-MI" "Post-transcriptional" "Pratt" "Primer3web"
    "Pro-inflammatory" "Profiler" "PrognoScan" "Promega" "Protein" "Proteosome"
    "Prp" "Pseudoknot" "Puig" "Pull-down" "Puri" "Pvt-1" "PxxP" "PxxSP"
    "P = 0.001" "P = 0.002" "P = 0.003" "P = 0.01" "P = 0.025" "P ≤ 0.05"
    "P = 0.02" "P≤0.006" "Q-Q" "Q-loop" "Q1" "Q3+1.5" "Q510E" "Q61H" "Q61L"
    "Q61R" "Q640X" "Q9WTI7-3" "QGL" "QOD" "QQC" "QRS" "QS" "QT" "QT-IGC"
    "QT-SNP" "QT-interval" "QTGEN" "QTSCD" "QTc" "QXX" "QZ" "Qi" "Qiagen"
    "Quantile-quantile" "Quantitative-PCR" "R&D" "R-YS" "R-phycoerythrin"
    "R-status" "R1" "R172H" "R175H" "R240A" "R38A" "R406W" "R5" "R5-tropic"
    "R519G" "R519Q" "R5L" "R5P" "R630L" "R6K" "RAD6-dependent" "RAD6–RAD18"
    "RAF-265" "RAF256" "RANs" "RAS-dependently" "RAS-effector" "RAS-system"
    "RATL" "RBO-1" "RBO-2" "RBOW" "RBW-1" "RDOR" "RE-induced" "RE9A" "REMARK"
    "REtr+c-KIT" "REtr+cKIT" "REtr-IRES-tdTomato" "REtr-c-KIT"
    "REtr-only-expressing" "RFLP" "RGD" "RIG-I-like" "RIME" "RIP3-proficient"
    "RIPA" "RJ" "RKR" "RMOT" "RNA" "RNA-DNA" "RNA-EMSA" "RNA-R"
    "RNA-expression" "RNA-induce-silencing" "RNA-protein" "RNA-pull-down"
    "RNA22" "RNAPII" "RNAi-phenotype" "ROIs" "ROS-Nrf2-Notch" "RPKM"
    "RRM2BshRNA" "RRX" "RRXS" "RSV" "RTKs" "RUNX" "RUNX1T1" "RV1" "RWP-1"
    "RXXS" "Rab1" "RabGAP" "Rac-GDP" "Rac-GTP" "Rac1" "Rac1-PAK1-axis"
    "Rac1-PAK1-link" "Rac1-PAK1-pathway" "Rac1-overexpression-mediated"
    "Rac1Q61L" "Rac1b-induced" "Rad3" "Rad3-related" "Radiation-induced"
    "Raffaghello" "Ramsden" "Ranvier" "Rap" "Rap-specific" "Rap1b-null"
    "Raritan" "Ras-like" "Rasht" "Ratchaburi" "Rautenstrauch" "Raychaudhuri"
    "Rb's" "Rb-HA" "Rb-TRIP230-ARNT" "Rb-interaction" "Rb-loss" "Rb-pSer"
    "Rbx1" "Rb’s" "Re-IP" "Re-analysis" "Re-establishing" "Re-establishment"
    "Re-expression" "Re-introduction" "Re-treating" "Re-treatment" "Rebecca"
    "Receiver-operator" "Reed-Sternberg" "Refseq" "RelA" "Remy" "Renilla"
    "Results" "Reszka" "Rev-Erbα" "Reversion-inducing" "Reznick" "Rhee" "RhoA"
    "RhoA-GTP" "RhoA-dependent" "RhoAL63" "RhoAN19" "RhoG" "Ribu5P"
    "Richardson" "Riddick" "Rieger" "Roadmap" "Roberts" "Roche" "Rockville"
    "Roman" "Romanova" "Romero" "Roock" "Rosa" "Rosai" "Rosenfeldt" "Rothman"
    "Rous" "Rouschop" "Roy" "Rs932764" "Ruiz" "Run-On" "Rupert" "Rv1" "RxRxxpS"
    "RxxL" "RxxLxxxxN" "Ryan" "S-FOXO3" "S-Y" "S-YJ" "S-acyl" "S-acylation"
    "S-acyltransferase" "S-p53" "S-transition" "S1" "S1-A" "S104" "S10A" "S10D"
    "S10F-H" "S118-ERα" "S1333" "S1348" "S1376A" "S167-ERα" "S1782" "S1981"
    "S1A-C" "S1A-D" "S1C" "S1D" "S1E" "S1G" "S1H" "S1I" "S1J" "S1K" "S1L" "S1M"
    "S1e" "S2-A" "S2-B" "S2-C" "S2-D" "S2-E" "S2-F" "S2143A" "S21A" "S2448"
    "S2448-mTOR" "S249" "S252" "S282-ERα" "S294-ERα" "S2A" "S2B" "S2C" "S2C-E"
    "S2D" "S2E" "S2F" "S2P-RNAPII" "S2–S14" "S3" "S3-B" "S3-C" "S3-D" "S31-201"
    "S318" "S380" "S3B–S3E" "S3F" "S3G" "S4-A" "S4-B" "S4-C" "S4-D" "S423"
    "S435A-mutant" "S4A" "S4B" "S4C" "S4C-F" "S4D" "S4E" "S4F" "S4G" "S4H"
    "S4I" "S4K" "S552D-phosphomimetic" "S552D-Δ45-β-Catenin"
    "S552D-Δ45-β-CateninER-myc" "S559-ERα" "S5A" "S5A-5B" "S5B-E" "S5C" "S5D"
    "S5E" "S5F" "S5H" "S5I" "S5K" "S5L" "S5M" "S6" "S6-S235"
    "S62A-Bcl-xL-transformed" "S62A-eYFP-Bcl-xL" "S62D-Bcl-xL"
    "S62D-Bcl-xL-transformed" "S62D-eYFP-Bcl-xL" "S6A" "S6A-F" "S6C" "S6G"
    "S6K" "S6K1-T389" "S6RP" "S7" "S7-E" "S7A" "S7A-7D" "S7B" "S7C" "S7D"
    "S7D-F" "S7F" "S7G" "S7I" "S7J" "S7K" "S7L" "S8" "S807" "S811" "S8A" "S8B"
    "S8D" "S8E" "S8F" "S9" "S910" "S935" "S9A" "S9A-F" "S9F" "SAINT" "SARRIO"
    "SB21807" "SBB" "SBC-2" "SBRI" "SC-791" "SCFβ-TRCP" "SCI" "SCNAs" "SCP-A1"
    "SCRs" "SD+PD" "SD=3.13" "SD=3.2" "SD=3.31" "SD=3.41" "SDB" "SDF"
    "SDF-1expression" "SDF-1α" "SDF-1α-induced" "SDF1-α" "SDF1-α-induced"
    "SDF1α" "SDP" "SDS-polyacrylamide" "SE14" "SECIS" "SELECT-1" "SENPs"
    "SERCA2a" "SERCA2b" "SF1a" "SFPN" "SGK1-antagonists" "SGK1-promoter" "SGZ"
    "SH2–JH2" "SH3-domain" "SID-SRM-MS" "SIEVE" "SIFT" "SINE" "SJK" "SJM" "SKF"
    "SKP1-CUL-1-F-box" "SKP1-CUL1-F-box" "SKP1-Cul1-Fbox" "SKS" "SKY-analysis"
    "SLB-1" "SM" "SMAD-recognition" "SMAR-1" "SMM" "SMW" "SN50" "SNA" "SNP"
    "SNP-QT" "SNP-transcript" "SNPinfo" "SNPs" "SNPs&GO" "SNVs" "SPACE-HRM"
    "SPACE-PCR" "SPIDER" "SPSS-15" "SQL" "SQTS" "SR" "SRC-family" "SROC"
    "SRP028652" "SSBR" "SSCs" "SSEA4" "STANT" "STAT" "STAT1-IRF1-X-axis"
    "STAT1-IRF2" "STAT1-dependent" "STAT1-mediated" "STAT1-signaling" "STAT1α"
    "STAT1β" "STAT3-conditionally" "STAT3-specificity" "STAT3α" "STAT3αβ"
    "STAT5a" "STGM" "STRING" "SU-DHL-16" "SUMO1–4" "SUMO­ylation" "SVM" "SVZ"
    "SW403" "SWCNT" "SWCNTs" "SX" "SYGP1" "SYTL" "SYZ" "SZ" "SZY" "Sabatel"
    "Sadoshima" "Sahra" "Sakamoto" "Sakaue" "Sakaue-Sawano" "Salinas"
    "Salvador-like" "Sameer" "Sanger" "Sangon" "Sankarnarayanan" "Sanofi"
    "Sas2p" "Sato" "Sato’s" "Savic" "Savic-Radojevic" "Scalera" "Scarff"
    "Schembri" "Schulte" "Schupfner" "Schwann" "Schwartz" "Scorpion-ARMS" "Scr"
    "Sebio" "Sec31" "Seckel" "Secondary-set" "Seedhouse" "SelP-H"
    "Self-renewal" "Selleck" "Selyunin" "Sendai" "Sensitizers" "Seok"
    "Sequenom" "Sequenom's" "Ser107" "Ser2" "Ser318" "Ser422-neighboring"
    "Ser423" "Ser435" "Serbia" "Serono" "Sertoli" "Sertoli–Leydig" "Seto"
    "Sex-determining" "Shamas" "Shamas-Din" "Shanxi" "Shao" "Shapiro" "Shariat"
    "Shen" "Shengli" "Shenzhen" "Shih" "Shim" "Shimoda" "Shimoda-Matsubayashi"
    "Sholl" "Shwachman" "Shwachman-Diamond" "SiMed25" "Sichuan" "Sidrón"
    "Sigma-Aldrich" "Simic" "Sin3a" "Sinclair" "Singaporean" "Singh"
    "Single-cell" "Single-molecule" "Single-nucleotide" "Single-nucleus"
    "Single-strand" "Sir2p" "Sir2p-like" "Sirtuin-7" "Sirtuin1" "Sirus"
    "Sixty-four" "Sixty-three" "Sixty-two" "Slattery" "SlidePath" "SlidePath's"
    "Sloan" "Smads" "SmithKline" "Snider" "Softberry" "Sokal" "Sole-Search"
    "Solute" "Solution-phase" "Sorour" "Sos" "South-east" "Spanish" "Spearman"
    "Spearman's" "Spearman’s" "SpectraMax" "Spicer" "Spiller" "Sprouty1"
    "Spry1expression" "Src" "Src-family" "Stanford" "Stat3F" "Stau" "Stau1-IP"
    "Stau1-KD-cells" "Stau1-immunoprecipitates" "Staufen1" "Steiner"
    "Sternberg" "Stieger" "Stoffel" "Stradα" "StripAssay" "Structure-based"
    "Stu" "Sturge" "Sturge-Weber" "Su-DHL-16" "Su-DHL6" "Sub-cellular" "SupF"
    "Superose" "Supp" "SureSelectXT" "Survivin-RNAi" "Survivin-RNAi-induced"
    "SurvivinC84A" "SurvivinT34A" "Sussan" "Sutton" "Sv" "Sv-C57BL" "SvJ"
    "Sweden" "Swedish" "Swiss" "SwissProt" "Syk" "SynGAP" "Synapse"
    "Szmigielska" "Szmigielska-Kapłon" "Sμ" "T-CT" "T-H" "T-JAK2" "T-ML" "T-S"
    "T-STAT3" "T-allele" "T-category" "T-classification" "T-stage" "T1" "T13"
    "T13-Cy5" "T1376" "T1890" "T1989" "T2" "T2D" "T3" "T311-ERα" "T382" "T383"
    "T389" "T389-p70S6K" "T3SS" "T4" "T468M" "T47D-ShVav1" "T5" "T7" "T7-Cy5"
    "TAA" "TAB1-dependent" "TACACA" "TAK1-TAB2" "TARKO" "TASSER" "TAT-Cre"
    "TBI" "TBK" "TBK1-myr" "TBRI" "TC+CC" "TC10a" "TCA-3" "TCCC→TTCC" "TCFα"
    "TCGA-19-2624" "TCGA’s" "TCID50" "TCRδ" "TCS2312" "TCTG" "TD" "TDM4258g"
    "TDM4370g" "TDM4374g" "TDM4450g" "TDM4788g" "TDM4997g" "TEA" "TEAD1-4"
    "TEAD2-VP16" "TEER" "TEFb" "TEGPS" "TERT-CLPTM1" "TFSEARCH" "TGFBRI1"
    "TGFIIR" "TGFRB2" "TGFβI" "TH-NMYC" "TH17" "TH3RESA" "TIQ" "TIQ-A" "TJPs"
    "TKB" "TL" "TND" "TNFRS10" "TOFMS" "TOP-GFP" "TOR1" "TP53-transcriptional"
    "TPR2B" "TRAIL+SZ" "TRANSFAC" "TRAP-14" "TRAP-6" "TRCP"
    "TRIM6-IKKε-dependent" "TRIM6-IKKε-poly-Ub" "TRIM6-ubiquitin-rich"
    "TRIP230-interaction" "TRIP230ΔRb" "TRU-origin" "TSGH" "TSH-suppressive"
    "TSZ" "TT+TC" "TTC" "TTCN" "TTCTTGGAA" "TTGTTTAC" "TWP" "TXXXS" "TZD"
    "TZDs" "Ta" "Taihang" "Taiwan" "Taiwanese" "Taiyuan" "Takanami" "Talalay"
    "Talaromyces" "Talora" "Taq" "Taqman" "Targetscan" "Tat-mediated"
    "Tax-negative" "Tax-positive" "Tax-viral-oncoprotein" "Tbc1Ds" "Tead1-4"
    "Telomerase-catalyzed" "Ten-Eleven" "Terminal-deoxynucleoitidyl" "Terrano"
    "Terry" "Tet-OFF" "Tet-Off" "Tet-on" "Tetrahymena" "Teva" "Tf" "Tf-647"
    "Tf-bound" "Tg" "Tg2576" "Th-2" "TheTrp53" "TheraScreen" "Thermo" "Thr-383"
    "Thr-387" "Thr-Pro-X-Arg" "Thr-protein" "Thr180" "Thr183" "Thr202"
    "Thr241Met" "Three-parameter" "Threonin" "Ti" "Tiacci" "Tian" "Tijhuis"
    "Time-lapse" "TissueScan" "Tjian" "Tm" "Tocris" "Tokyo" "Toll-like" "Tom"
    "Tomas" "Tomisaku" "Tomson" "Toolbox" "Topically-applied" "Toronto"
    "Toronto-replication" "TrCP1" "Tra-1–81" "Trans-endothelial" "TransFind"
    "Transcription" "Translation" "Tricho-rhino-phalangeal" "Trio-D1"
    "Trio-D1SH3" "Trio-RAC1-PAK1-axis" "Trio-Rac1-PAK1-axis"
    "Trio-Rac1-PAK1-cascade" "Trio-Rac1-PAK1–axis" "TrioGEF" "Trisenox"
    "Trojan" "Trp53" "TuJ1" "Tub-C" "Tub-c" "Tukey" "Turkish" "Tv"
    "Twenty-four" "Twenty-like" "Twenty-one" "Twenty-three" "Twist1"
    "Two-Hybrid" "Twu" "Type-I" "Tyr-1007" "Tyr1007" "Tyr1007–1008" "Tyr1162"
    "Tyr118" "Tyr182" "Tyr185" "Tyr204" "Tyr31" "Tyr37" "Tyr576" "Tyr705" "T→C"
    "U0126-treatment" "U1" "U1026-treated" "U133" "U133A" "U133A_2" "U133Plus"
    "U133Plus_2" "U19" "U29-Cy5" "U2OScells" "U373" "U42" "U42-Cy3" "U6-shRNA"
    "U76" "U78" "U937IF" "UA" "UA47-48AU" "UB" "UB-bodies" "UBP" "UBZ" "UC-II"
    "UC-III" "UC-IIa" "UC-IIb" "UDS" "UGC" "UGCs" "UICC" "UMCN" "UNMC" "USA"
    "USC" "USCS2" "USCS5" "USF1→USF2" "UTRs" "UV-B" "UV-B-RF" "UV-Induced"
    "UV-radiation" "UVA" "UVB" "UVR" "UVR-signature" "UV‐C" "UV‐C‐induced"
    "UV‐induced" "UV–DDB" "UXXC" "Ub-IKKγ-complex" "Ub-like" "UbE"
    "UbE2K-silencing" "Ubi" "Ubs" "UniProt" "Universitario" "Up-take" "Uveal"
    "V-shaped" "V1427fs" "V5" "V5-RK605AA" "V5-epitope" "V5-tagged" "V5-wtNM1"
    "V5-ΔC" "V5-ΔIQ" "V600" "V600E" "V600E-mutant" "V600K" "V617F" "VAD"
    "VAV2-GF2" "VCAM" "VCS2" "VDA" "VDG" "VE-Cad" "VE1" "VH1-Like" "VH1-like"
    "VINTAGEMI" "VM" "VP16-AR" "VPC31143" "VPMNPNL" "VQ" "VS-4718treatment"
    "VS-6063" "VSIG10" "VSV-G" "VSV-G-pseudotyped" "VUSs" "Val105Val"
    "Val16Val" "Val600Gu" "Val762Ala" "Vana" "VarScan" "Vaughn" "Vec"
    "Vectibix" "Veits" "Venn" "Ventana" "Venus" "Verastem" "Veridex" "Vermont"
    "Vernalis" "Vienna" "Vietnamese" "Vinagre" "Vineis" "Vito" "Vockel"
    "Volanis" "Voso" "Vps15-His" "Vps15-V5-His" "Vrba" "W2" "W515K" "WASP"
    "WASP-family" "WBC" "WBCs" "WCEs" "WD40-repeats" "WG" "WHR" "WKs" "WM"
    "WM1361" "WM1364" "WM793-Res#12" "WM793-Res#5" "WPD" "WPD-loop" "WQ"
    "WRC-256" "WSHU" "WSHU-NHL" "WST-1" "WSU" "WSU-NHL" "WT-ANXA7"
    "WT-ANXA7-induced" "WT-Bim" "WT-CHEK2" "WT-HA" "WT-IKKε" "WT-MCAK" "WT-Ub"
    "WTJak2" "WTs" "WY" "WZ4006" "Waals" "Wagner" "Wahab" "Wakabayashi"
    "Wallis" "Walsh" "Warburg" "Washington" "Watson" "Watson-Crick" "Weinberg"
    "Weiner" "Weiss" "Well-designed" "Well-differentiated" "Wellcome"
    "Wen-Shih" "West-Irish" "Western-blotting" "Whitehorn" "Whitney"
    "Whole-exome" "Wiedemann" "Wiedemann-Rautenstrauch" "Wiedemuth" "Wilcoxon"
    "Wilcoxon-Test" "WinROOF" "Witkiewicz" "Wnt-pathway" "Womens" "Wong"
    "Workflow" "Wright–Giemsa-stained" "Wu" "X-ray" "X-rays" "X-α-Gal"
    "X-α-gal" "X4" "X4-tropic" "XAGXG" "XF" "XJ" "XL" "XL-518" "XP-B" "XP-D"
    "XP-V" "XPA" "XPA-null" "XPAitself" "XPA‐GFP" "XPA–DNA" "XPA–PAR" "XPA–PBM"
    "XQ" "XX" "XY" "XZ" "Xq11-12" "Xq28" "Y-CC" "Y-H" "Y-W" "Y-Y" "Y-box"
    "Y118" "Y279C" "Y2H" "Y2HGold" "Y31" "Y397-pFAK" "Y654" "Y731" "Y845" "YCN"
    "YES" "YES-6" "YEW" "YFP-Tub" "YI" "YJC" "YM" "YQ" "YS" "YU-2" "YW" "YYQ"
    "YZ" "Yale" "Yamamoto" "Yang" "Yao" "Yap" "Yatabe" "Yeasmin" "Yeastmaker"
    "Yes-associated" "Yongjung" "Yoo" "Yorkie" "Yoshizawa" "Yvon" "YxxP"
    "Z-score" "Z62954982-treatment" "ZBTB7A" "ZBTB7a" "ZC" "ZEDN1" "ZJ" "ZL"
    "ZM447436" "ZM44743911" "ZRQ" "ZTL" "ZVAD" "ZWQ" "ZYW" "ZZ" "Zannini"
    "Zealand" "Zeegers" "Zeiss" "Zeng" "Zhai" "Zhang" "Zhe" "Zhejiang"
    "Zheleznyak" "Zhou" "Zhuang" "Zn" "Zn-SOD" "Zn-UBP" "ZnF" "ZnF-UBP"
    "Zonana" "Zong" "Zonnana" "Zou" "Zouiti" "a-c" "a-e" "a-f" "aCGH" "aFANCE"
    "aFANCG" "aPKCs" "aSMA" "aYAP" "aberrancies" "aberrancy"
    "aberrantly-activated" "abundanace" "accinia" "accreta" "accumbens"
    "acetyl-K" "acetyl-lysine" "acinar-predominant" "acinarpredominant" "acral"
    "acral-lentiginous" "actin-ALKF" "actin-NM1" "actin-myosin-interacting"
    "activation-loop" "activators" "active-GTP-bound" "active-site" "actives"
    "acute-phase" "acyl-biotin" "acyl-protein" "adenoidectomy"
    "adenoma-carcinoma" "adenomas" "adenoma–carcinoma" "adenoviral-delivery"
    "adenyl" "adenylyl" "adhesiveness" "adipose-derived" "adixin"
    "adjuvant-trastuzumab" "adrenocepter" "advanced-stage" "advancements"
    "afterdepolarizations" "agar" "age-and" "age-associated" "age-dependent"
    "age-sensitive" "age-specific" "aggregation-induced" "agonist-MOR"
    "agonist-liganded" "algorithm" "algorithms" "alloantigen" "alloenzyme"
    "allograft" "allografts" "alpha-OH-tamoxifen" "alpha-helices" "alpha-helix"
    "ameloblast-lineage" "amines" "amino-acid" "amino-terminal"
    "amino-terminus" "aminoacid" "aminoacids" "aminobutyrate" "amplicon"
    "amplicons" "amplificationmay" "amplifications" "ampulla"
    "analgesic-modulating" "anaphase-promoting-complex"
    "anchorage-independence" "andAtg5" "andEgfr" "andFAAP20" "andFANCG"
    "andFANCL" "andFANCM" "andMKN1" "andPml" "andPten" "andTrp53"
    "andXPAfunctions" "andk" "andp53" "androgen-ablation" "androgen-dependent"
    "androgen-deprivation" "androgen-insensitivity" "androgen-sensitivities"
    "anesthetic-relevant" "aneuploid" "aneuploidy" "aneurysms" "anions"
    "ankyrin-like" "anlage" "antagomir" "antagonises" "antibodies"
    "antibody-drug" "anticodon" "anticovulsant" "antigen" "antigens"
    "antihormone" "antimicrotubule" "antisense-treatment" "apamycin"
    "apical-basal" "apico" "apico-basal" "aplasia" "apoGR" "apoGRLBD"
    "apocrine" "apoliporptein" "apoptosis-telomerase" "apoptostis"
    "apoptotic-pro-survival" "approximately10%" "arachidonate"
    "area-under-the-curve" "arget" "arginase-II" "arisen" "arm-level"
    "arrest-associated" "arrest-specific" "arrhythmia" "arterioles" "as-of-yet"
    "asPten" "asbestos-like" "aslo" "aslog" "asparagine–glutamate"
    "aspartate-specific" "assesments" "at-risk" "atand" "ataxia-telengiectasia"
    "athanogene" "ation" "atria" "atrium" "atypia" "aureobasidin" "aureus"
    "autocleavage" "autocrine-paracrine" "autoproteolysis-inducing"
    "autoregulates" "axises" "azabenzimidazole" "azakenpaullone" "azoxymethane"
    "a–d" "a–e" "b-catenin" "barrier-protective" "basal-like" "base-base"
    "base-change" "base-line" "bead-bound" "beclin-6" "begun" "bemp1" "benzo"
    "between-study" "betweenEgfr" "betweenPml" "bi" "bi-allelic"
    "bi-directional" "bi-orientation" "bias-reduced" "bilayer" "binder-1"
    "binuclei" "bioactivities" "biofeatures" "biomass" "biospecimen"
    "birth–death" "bisphosphate" "blastocyst" "blastocysts" "bleedings"
    "blocker" "blockers" "blood-based" "blood-derived" "blood–brain" "blown"
    "blue-staining" "bodyfat" "bodyweight" "bolus" "bona" "bone-ligament"
    "bone-marrow" "bootstrap" "bothFANCB" "bothPten" "box-binding"
    "box–binding" "bp" "bp " "brachytherapy" "brainstem" "brca"
    "brca2-mediated" "break-point" "break-points" "break-repair"
    "breakage-fusion-bridge" "breakpoint" "breakpoints" "breast-ovarian"
    "breast–ovarian" "broader" "broadest" "bronchoscope" "browser" "browsers"
    "bryostatin" "bursa" "butanone" "butylhydroperoxide" "by-pass" "by-product"
    "byKras" "c-Ets-1" "c-glutamyl-cysteine-synthetase" "c-myc-HIV-1"
    "c-myc-HIV-1PR" "c-myc-HIV-PR" "c31" "cBio" "cG742T" "cGy" "cIAP" "cIAPs"
    "cN0" "cNBD" "cNLS" "cPARP" "cRNA" "cT1-2" "caSTAT3" "caSTAT5" "calcaneus"
    "calcein-AM" "calcium-and-DAG-regulated" "calvasculin" "cancer-driver"
    "cancer-microenvironment" "cancer-microenvironments"
    "cancer-predisposition" "cancerf" "cancers–and" "capillary-like" "capsid"
    "carbamoyl-phosphate" "carbaplatin" "carbonyl" "carbossi"
    "carbossi-terminal" "carboxyl-terminal" "carboxylcytosine" "cardia"
    "cardiac-restricted" "cardiac-selective" "cardiac-specific" "cardiomyoctes"
    "cargos" "carnitine" "carrier-phenotype" "carriers" "case-control"
    "case-only" "case-to-case" "case–control" "casitas" "caspase-3-like"
    "castrate-recurrent" "castration-recurrent" "catalyse"
    "catalytically-impaired" "catecholestrogens" "caval" "ccK18"
    "cdk4-transfectant" "cdk4-transfection" "cdk6-transfectant" "ceRNA"
    "ceRNAs" "cecal" "cecum" "cell-autonomous" "cell-cycle-associated"
    "cell-death-associated" "cell-extracellular-matrix" "cell-intrinsic"
    "cell-like" "cell-of-origin" "cell-permeable" "cell-protective"
    "cell-to-cell" "cell-to-substrate" "cell-type-specific" "cells" "cellulo"
    "cell–like" "centromere" "centromere-antibodies" "ceramides" "cerevisiae"
    "cesarean" "cfDNA" "changer" "channel-interacting" "chaparones"
    "charcoal-stripped" "charge-charge" "charge-reversal" "cheaper" "checkbox"
    "checkpoint-initiated" "checkpoint-sustaining" "chelates" "chemo"
    "chemo-attractive" "chemo-drugs" "chemo-radiation" "chemo-resistence"
    "chemo-sensitivities" "chemo-therapeutics" "chemoattractant"
    "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemotherapeutics-resistance" "chi-square" "chi-squared" "childhood-onset"
    "chimerism" "chloro" "choroid" "chosen" "chr22" "chromaffin" "chromatid"
    "chromatids" "chromatin-association" "chromatin-enrichment"
    "chromatin-immunoprecipitation" "chromatin-remodeling" "chromatograms"
    "chromo-some" "chromosome-CMPD" "chromosome-immunoprecipitation"
    "chronic-sun-damaged" "chronotherapy" "circadian-core" "circuitry"
    "cis-eQTLs" "cis-regulatory" "cistrome" "clade" "classic-insulin"
    "classifier" "clear-cell" "clear-cut" "clearer" "clinical-grade"
    "clinicaltrials" "clinical–pathological" "clinicians" "clinico"
    "clinico-pathologic" "clinico-pathological" "clock-cancer" "clock-gene"
    "clonally-derived" "closed-tube" "cloth-protected" "coIP" "coauthors"
    "cobas" "cobblestone-like" "cochaperone" "codon-12" "codon-anticodon"
    "codons " "coiled-coil" "cold-detergent" "colectomy" "coli"
    "colitis-associated" "collaborations" "colloid" "colonoscopy"
    "colony-formation" "colony-forming" "colorectum" "colour-coded"
    "colposcopy" "columnar-organization" "combination-induced"
    "combination-treated" "combs-like" "commonest" "community-based" "comorbid"
    "comparingBmp2" "complex-1" "complex-2" "complicon" "complicons"
    "compound-screening" "conditional-inducible" "conductance" "conformers"
    "confounder" "confounders" "congenita" "conjugate-immunohistochemistry"
    "connective-tissue" "constantsk" "constitutively-membrane"
    "contact-dependent" "contact-independent" "containing-medium" "continuum"
    "control-IPs" "control-only" "control-transfected" "controlp53"
    "copy-number" "core-binding" "core-elements" "core-glycosylation"
    "coregulators" "corneodesmosin" "corneodesmosome" "corneodesmosomes"
    "corneum" "cost-effective" "cost-effectiveness" "counter-act"
    "counter-regulation" "counter-regulatory" "counter-stain" "cov"
    "covariants" "covariate" "covariates" "coworkers" "coxsackievirus"
    "cre-loxP" "createdFANCG" "cribriform" "crizotinib-treatment"
    "cross-activation" "cross-reacted" "cross-reference" "cross-regulation"
    "cross-resistance" "cross-sectional" "cross-sections" "cross-species"
    "crossedAtg5" "cross‐complementing" "cryo-EM" "cryosurgery" "crystal-cell"
    "crystal–related" "curative-intent" "cut-off" "cyan" "cyclohexamide"
    "cyclohexamide " "cyctoskeleton" "cyto+nuc" "cytoarchitecture" "cytoband"
    "cytochome" "cytokeratin-RNA" "cytokine-synthesis" "cytology" "cytopenia"
    "cytopenias" "cytospins" "cytotechnicians" "d-f" "dCCD" "dL" "dTomato"
    "daily-endogenous" "damage-dependent" "damage-induced" "damage-inducible"
    "damage-inducing" "damage-mediated" "damage-response" "damaged+caffeine"
    "damage‐binding" "danger-associated" "dataset" "datasets" "day-times"
    "dbSNP" "dbSNP137" "ddGTP" "ddNTP" "ddNTPs" "de-convolute"
    "de-differentiated" "de-novo" "de-regulated" "de-repressor" "de-repressors"
    "decades-old" "decidua" "decidual-dependent" "decouple" "deeper" "degron"
    "dehydrogenaseand" "dehydrogenases" "delE746-A750" "deletion-mutant"
    "dendrite" "dendrocytes" "densitometer" "dentin" "deoxynucleoitidyl"
    "deoxynucleotide" "deoxynucleotidyl" "deoxyuridine" "dependend"
    "dependent-knockdown" "depolymerizer" "der" "derepress" "desaturases"
    "descendents" "desferoxamine" "desmoplasia" "detergent-insoluble"
    "detergent-soluble" "dex" "di-leucine" "di-phosphorylated"
    "diabetes-induced" "diaminobenzidine" "dichlorofluorescein" "dideoxy"
    "diet-induced" "diffusions" "difluorobenzene" "dihaloalkanes" "dihydrodiol"
    "dimethyl-malate" "dimethylmalate" "dimorphism" "dinucleotides" "dione"
    "diphosphate" "diphosphates" "diphosphatidylglycerol"
    "diphtheria-toxin-like" "diploid" "dis" "dis-adhesion" "disambiguate"
    "discovery-based" "discovery-driven" "discrepant" "disease-relevant"
    "disomy" "disruptors" "distance-dependent" "distantly-related"
    "dodecaploid" "doi" "domain-only" "dominant-negative" "dominants"
    "dopachrome" "doppler" "dosage-dependent" "dose-dependently"
    "dose-response" "dose‐dependent" "dose–response" "double-band"
    "double-blind" "double-membrane" "double-minute" "double-strand"
    "double-variant" "double‐strand" "doublings" "doubly-labeled"
    "down-expression" "down-modulation" "down-stream" "downsteam" "doxo" "dpf"
    "drawn" "driver-gene" "drivers" "drop-down" "drug-drug" "drug-selection"
    "drug-treatment" "dsDNA" "dsP21-322" "dsRBD2" "dsRBD3" "dsRBD5"
    "dual-color" "dual-compartment" "dual-specific" "dysfunction-induced"
    "dysplasia" "dysplasias" "eChIP" "eIF2-α" "eLife" "eRNA" "eRNAs" "eSNP"
    "early-HZ" "early-hypertrophic" "early-life" "early-onset" "early-response"
    "early-stage" "east-Asian" "echinoderm" "ectoderm" "ectodomain"
    "ectopically-expressed" "edatrexate" "edema" "edemas" "efect" "efficients"
    "el" "elP" "electrocautery" "electron-dense" "electron-lucent"
    "electrophysiology" "element-reporter" "elicitors" "email" "enantiomer"
    "enchondroma-like" "end-diastolic" "end-organ" "end-stage" "end-systolic"
    "endocarditis" "endoderm" "endogenously-expressed" "endogenously-produced"
    "endometria" "endometrioid" "endometrium" "endometroid" "endoscopy"
    "endothelia" "endothelial-cell-mediated" "endothelial-independent"
    "endotoxemia" "endpoint" "endpoints" "endstage" "energy-compromised"
    "energy-dependent" "enhancer" "enhancer-promoter" "enrolledPten" "enthalpy"
    "entity-dependent" "entropy" "enzyme9" "eosin" "epidemiology-approaches"
    "epigallocatechin" "epistaxis" "epithelia" "epithelial-associated"
    "epithelial-derived" "epithelial-like" "epithelial-mesenchymal"
    "epithelial-to-mesenchymal" "epithelial–mesenchymal" "epithelioid"
    "epithelium" "epitopes" "epon" "epribubin" "error-attachments" "erythema"
    "erythroblastopenia" "erythrocytes" "erythroid-cell-derived" "escN"
    "estrogen-like" "et" "ethanolamide" "ethnicities" "ethno"
    "ethno-geographic" "even-odd" "eventhough" "ever-smoking" "ever-use"
    "evolutionarily-conserved" "ex" "ex-smokers" "ex-vivo"
    "excitation-contraction" "exocrine" "exome" "exomes" "exon-9" "exon11"
    "exons" "exons " "exosome" "exostosis-like" "experiments" "expresser"
    "expressers" "extensiveness" "extra-45kDa-SGK1" "extra-LMW-SGK1"
    "extra-intestinal" "extra-low-molecular-weight-SGK1-form" "extra-vasation"
    "extracellular-signal-regulated" "eyes" "facies" "facilitators" "factorIIH"
    "factors" "fair-skinned" "false-discovery" "false-negatives"
    "false-positives" "far‐western" "fast-moving" "faster-growing" "feed-back"
    "feed-forward" "feedback-loop" "feedforward" "feet" "female-to-male"
    "femaleEgfr" "femtosecond" "fentanyl" "fiber-induced" "fibroblast-like"
    "fide" "fifths" "finding–that" "fine-needle" "fine-tuned" "fine-tuning"
    "fine‐tune" "fine‐tuning" "fingerlike" "first-generation" "first-in-class"
    "first-line" "first-stage" "five-year" "flash-frozen" "flavonoid"
    "flavonoids" "flow-chamber" "flow-cytometric" "flow-loop" "flowcytometer"
    "fluences" "flumazenil" "fluorescent-activated" "fluorodeoxyglucose"
    "fluorophores" "fluorothymidine" "follicle" "follicularis" "follow-up"
    "followed-up" "followup" "follow‐up" "fontanelle" "foot-and-mouth"
    "foramen" "force-generating" "forebears" "formers" "formylcytosine"
    "four-way" "fpkm" "frameshift" "frameshifts" "frequency-large"
    "fresh-frozen" "fromBmp2" "fromEgfr" "fromFANCG" "fromGSK-3β" "fromInk4a"
    "fromPml" "frozen" "fs" "full-ARE" "full-AREs" "full-scale" "full-text"
    "full-texts" "full-transcriptome" "full‐length" "fumarate" "fumitremorgin"
    "fundus" "fusiform" "fusiform-structure" "g-i" "gDNAs" "gadd45-interacting"
    "gain-of-function" "galeterone-liganded" "gallate" "gallbladder"
    "gamma-irradiation" "gastro" "gastro-esophageal" "gate-keeper" "gatekeeper"
    "gel-purification" "gelatin-binding" "gene-1" "gene-dense" "gene-dietary"
    "gene-disease" "gene-dosage" "gene-dose" "gene-environment" "gene-gene"
    "gene-miR34" "gene-patient" "genes" "genesN" "geneset" "genestein"
    "genetically-encoded" "gene–environment" "gene–environmental" "gene–gene"
    "gene–patient" "gene–phenotype" "genito" "genito-urinary" "genome"
    "genome-coverage" "genome-scale" "genome-wide" "genomes" "genomewide"
    "genotype-phenotype" "genotype " "germ-line" "germline" "gingiva" "glia"
    "glipizide" "glomeruli" "glutamine-ammonia" "glutamine-dependency"
    "gluteraldehyde" "glycan" "glycans" "glycerolphospholipids"
    "glycerophospholipids" "glycerophospolipid" "glycine-to-tryptophan"
    "go-or-grow" "goes" "gone" "goodness-of-fit" "grade-3" "grade-dependent"
    "granulosum" "greater" "greatest" "green-phase" "ground-glass" "groupss"
    "growth-arrest" "gyrus–SGZ" "h" "hABSC" "hABSCs" "hBMVECs" "hCD103"
    "hCD11c" "hCD19" "hCD45" "hCLU" "hCLUp" "hCLUp-Luc" "hELG1" "hGH" "hMSC"
    "hMSCs" "hNSC" "hNSCs" "hORFeome1.1" "hSCC" "hSCCs" "hTERT-immortalized"
    "hTR-U42" "habitus" "half-AREs" "half-ERE" "half-life" "half-maximal"
    "half-site" "half-sites" "half-time" "hall-mark" "hampster" "handoff"
    "haplo" "haplo-insufficient" "haplotype" "haplotypes" "head-to-head"
    "healthspan" "heart-specific" "heatmap" "heavier" "heavily-populated"
    "height-based" "helices" "helix" "hematogone" "hematogones" "hematology"
    "hematopoietic-specific" "hemi" "hemi-channel" "hemi-channels"
    "hemizygotes" "hepatectomoy" "hepatectomy" "hepatocyte-specific" "heptad"
    "herbal-derived" "herpangina" "hetero-dimer" "hetero-dimers"
    "hetero-oligomers" "heteroduplexes" "heterohexamer" "heterokeryons"
    "heterotetramers" "hexadecaploid" "hexamers" "hexanucleotide" "hexapeptide"
    "hg18" "hidden" "high-GC-content" "high-GFP-expressing" "high-affinity"
    "high-confidence" "high-content" "high-density" "high-dose"
    "high-expresser" "high-expression" "high-fidelity" "high-frequency"
    "high-grade" "high-income" "high-level" "high-miR-224" "high-order"
    "high-power" "high-priority" "high-resolution" "high-resource" "high-risk"
    "high-stage" "higher-grade" "higher-risk" "highest-resources"
    "highly-conserved" "highly-expressed" "highly-functional" "high‐affinity"
    "hindbrain" "histogeneses" "histograph" "histologies" "histology"
    "histone-2B" "histopathology" "histoscore" "histoscores" "histotypes" "hoc"
    "holo" "holo-Tf" "holocomplex" "hom" "homeostasy" "homo-dimer"
    "homogenates" "homoindel" "homolog" "homologies" "homologs" "homology-2"
    "homomultimers" "homozygotes" "hormones" "host-cell" "hot-spot" "hotspot"
    "hotspots" "hprt" "hr" "htert-RPE1" "http" "humanmutp53" "hydatidiform"
    "hydorxydeoxyguanosine" "hydroxydeoxyguanosine" "hydroxyglutarate"
    "hydroxyl" "hydroxymethylcyosine" "hydroxymethylcytosine" "hydroxysteroid"
    "hyper" "hyper-phosphorylated-Rb" "hyper-vascularization"
    "hyperandrogenism" "hyperglaecemia" "hyperinsulinaemia" "hypermethylatuon"
    "hyperoxaluria" "hyperoxia" "hypo-phosphorylated" "hypo-phosphorylates"
    "hypo-phosphorylation" "hypodiploid" "hypoglycemia" "iDCs" "iNKT"
    "iPS-IMR90" "iPlex" "iTC-200" "iTC200" "identifier" "identifiers" "ie" "ii"
    "iii" "ilent" "iliac" "iliac-pseudoarthrosis" "ill-defined" "iloperidone"
    "imFISH" "imatinib-resistant" "imidazole" "immediate-early"
    "immune-complexes" "immune-induced" "immune-mediated" "immune-related"
    "immuno-blot" "immuno-blots" "immuno-electron" "immuno-gold"
    "immuno-precipitate" "immuno-precipitation" "immuno-purifications"
    "immunoassay" "immunoassays" "immunocomplexes" "immunocytochemistry"
    "immunoglobulin" "immunogold" "immunohistochemistry" "immunohistology"
    "immunophenotype" "immunoprivilege" "immunoresponses" "immunostainer"
    "immunosurveillance" "immunotherapy" "impedance" "imporin" "imporin-α"
    "in-cell" "in-depth" "in-depth-studies" "in-frame" "in-hospital" "in-house"
    "in-situ" "in-vitro" "in-vivo" "inAtg5" "inEgfr" "inFANCB" "inFANCG"
    "inFANCL" "inFANCM" "inGSK-3β" "inPml" "inPten" "inase" "incidentalomas"
    "incompleteness" "indel" "indepth" "individual-level" "individual-matched"
    "induced-premature" "inductors" "inefficacy" "inflammation-associated"
    "inflammation-induced" "infract" "inhibiter" "inhibitis" "inhibiton"
    "inhibitor-alpha" "inhibitors" "initio" "inlslKras" "inside-out"
    "instability-high" "instability-low" "insulin-activated"
    "insulin-dependent" "insulin-like" "insulin-stimulated" "intSMYD3"
    "inter-centromere" "inter-chromosomal" "inter-correlations" "inter-focal"
    "inter-individual" "inter-kinetochore" "inter-membrane" "inter-observer"
    "inter-species" "inter-study" "interactome" "interactomes" "intercross"
    "interdomain" "intermediate-GFP-expressing" "intermediate-expressing"
    "interms" "interobserver" "interquartile" "interspecies" "interstrand"
    "interstudy" "interval-associated" "intestinal-and" "intestinal-type"
    "intra" "intra-S" "intra-observer" "intra-strand" "intra-tumor"
    "intra-tumoral" "intra-tumoural" "intra-uterine" "intra-vital"
    "intracardiac" "intramembrane" "intraobserver" "intravasate" "intron"
    "introns" "inturn" "invariant" "invasion-metastasis" "inverse-variance"
    "investigator-assessed" "involv1ed" "ionic" "ischaemia"
    "ischemia-reperfusion" "iso" "iso-osmotic" "isoalloxazine"
    "isobutylmethylxanthine" "isoenzyme" "isoenzymes" "isoforms" "isopropyl"
    "isotopologues" "isotype" "isotypes" "iv" "jejunum" "joint-preserving"
    "junction-mediated" "juxtacrine" "kappa-light-chain-enhancer"
    "karyopherin-α2" "karyotype" "karyotypes" "kd" "ketorolac" "key-regulator"
    "kg" "kg " "kinase-2" "kinetochore-MT" "kinetochore-spindle" "kinetochores"
    "kinome" "kiss-and-run" "kit-8" "knock-down" "knock-in" "knocked-down"
    "labelin" "lac" "lactone" "lambda" "lambda-phosphatase" "lamin-b1"
    "laminin-111" "laminin-332" "laminin-511" "large-bore" "large-effect"
    "large-fragment" "large-scale" "large-sized" "largeT" "laser-capture"
    "laser‐induced" "late-HZ" "late-apoptotic" "late-hypertrophic" "late-stage"
    "later-stage" "latters" "lavage" "leave-one-out" "lepidic-predominant"
    "lepidicpredominant" "let-7-MYC" "let-7a" "let-7f" "let-7g" "let-7i"
    "let7c" "let7i" "levofolinate" "levothyroxine" "libitum" "life-long"
    "lifespan" "ligament-attachment" "ligand-12" "ligand-receptor"
    "light-oxygen-voltage" "like–modifier" "lincRNA-p21" "lincRNAp21"
    "lineage-negative" "lineage-specifc" "lineage-specific" "lipoid"
    "lipopolysaccharide" "lipoproteins" "liposomes+tBid" "liposomes+tBid+Bax"
    "literature-based" "lithotripsy" "littermate" "littermates" "live-cell"
    "liver-to-body" "lnRNA" "lncRNA-p21" "lncRNAs" "lo" "lobar" "lobules"
    "loc285184" "loc285194" "loci" "log-phase" "log-term" "logit" "logrank"
    "long-chain" "long-lasting" "long-lived" "long-living" "long-range"
    "long-standing" "loss-of-function" "loss-of-heterogeneity"
    "loss-of-heterozygosity" "loss-of-phosphorylation" "loss-of-signaling"
    "low-GFP-expressing" "low-affinity" "low-density" "low-dose" "low-energy"
    "low-fidelity" "low-frequency" "low-grade" "low-income"
    "low-intermediate-GFP-expressing" "low-intermediate-expressing" "low-level"
    "low-medium-resource" "low-miR-224" "low-motility" "low-mutant" "low-pH"
    "low-pass" "low-penetrance" "low-positivity" "low-risk"
    "low-serum-containing" "low-set" "low-temperature" "lower-GFP-expressing"
    "lower-grade" "lower-risk" "lowest-energy-binding" "lslKras" "lucifer"
    "luciferase-reporter" "lumens" "luminal-like" "luminescence-based"
    "lumpectomies" "lumpectomy" "luteum" "lycogen" "lymph-node"
    "lymphadenectomy" "lymphadenopathy" "lymphoblastoid"
    "lymphoepithelioma-like" "lymphoma-like" "lymphopenia" "lymphoplasma"
    "lysine-N" "lysine-to-arginine" "lysis" "mABSC" "mABSCs" "mAb"
    "mCherry-GFP-LC3B" "mCherry-PA-Rac1Q61L" "mCitrine" "mCitrine-Rac1Q61L"
    "mCitrine-Rac1Q61L-expressing" "mK02" "mK02-miniSOG" "mKO2" "mOrange2"
    "mPCa" "mRFP" "mRNA" "mRNA-levels" "mTOR-cascade" "mTmG" "mTu3-6" "mW"
    "macrodomain" "macrodomains" "macrophage-like" "macrophage-restricted"
    "macrothrombocytopenia" "make-up" "mal-attachments" "malodialdehyde"
    "mammograms" "mammography" "mammosphere" "mammospheres" "manyEgfr"
    "marcomolecules" "mass-action" "mastectomies" "mastectomy" "materials"
    "maternal-fetal" "mating-type" "maxilla" "mcg" "mean±S" "mean±s"
    "median=6.5" "mediated-ubiquitination" "medulla" "melanin" "melanogaster"
    "melanoma-susceptible" "menometrorrhagia" "mentionedHb" "mentionedHb-egf"
    "mercaptopropionyl" "meric" "merotelic-attached" "mesenchymal-epithelial"
    "mesenchymal-like" "mesenchymal-to-amoeboid" "mesenchymal-to-epithelial"
    "mesenchyme" "mesendoderm" "mesoderm" "mesothelium" "meta-GWAS"
    "meta-regression" "meta-studies" "metabolome" "metal-mediated"
    "metaphase-anaphase" "metaphase-to-anaphase" "metastasin"
    "methanesulfonate" "methicillin" "method-COLD" "methrotrexate"
    "methyladenine" "methylcytosine" "methylnitrosamine"
    "methylthiophenothiazine" "methyltranferases" "mevalonate" "miR-100"
    "miR-101" "miR-106b~25" "miR-107" "miR-107-induced" "miR-1204" "miR-1205"
    "miR-1206" "miR-1207-3p" "miR-1208" "miR-1246" "miR-125" "miR-128"
    "miR-130a" "miR-138" "miR-140" "miR-141" "miR-143" "miR-145" "miR-146"
    "miR-146a" "miR-146b-5p" "miR-17" "miR-17-transfected" "miR-17~92"
    "miR-183" "miR-193a-5p" "miR-199a" "miR-19b" "miR-200" "miR-203" "miR-205"
    "miR-206" "miR-20a" "miR-20a-3p" "miR-210" "miR-214" "miR-222" "miR-224"
    "miR-224-binding" "miR-224-promoting" "miR-224-regulated"
    "miR-224-residing" "miR-224-transfected" "miR-23b" "miR-23b-3p" "miR-27a"
    "miR-28-mediated" "miR-301b" "miR-30b" "miR-31" "miR-3189" "miR-320"
    "miR-326" "miR-33" "miR-34" "miR-34-dependent" "miR-34-induced"
    "miR-34-mediated" "miR-34b" "miR-34c" "miR-361-3p" "miR-423" "miR-4423"
    "miR-451" "miR-4692" "miR-5001-3p" "miR-592" "miR-625" "miR-663"
    "miR-663-transfected" "miR-93" "miR-9a" "miR-NC" "miR-NC-transfected"
    "miR142-5p" "miR144" "miR153-Nrf2" "miR221" "miR27a" "miR30-based" "miR34a"
    "miR4679-1" "miRNA-130a" "miRNA-200c" "miRNA-211" "miRNA-320" "miRNA-326"
    "miRNA-gene" "miRNA-like" "miRNA-regulatory" "miRNAs" "miRNAs-regulatory"
    "miRanda" "mice" "micro-dissected" "micro-environmental"
    "micro-irradiation" "microRNA" "microRNA-107" "microRNA-200"
    "microRNA-200c" "microRNA-34" "microRNA-binding-site" "microbiota"
    "microcalorimeter" "microdomains" "microenvironment-derived" "micrograph"
    "micrographs" "micrometastases" "micropapillary-predominant"
    "micropapillarypredominant" "microsatellite" "microsatellite-unstable"
    "microtuble" "microvasculature" "microvessel" "microvessels"
    "mid-gestational" "mid-secretory" "middle-age" "midline" "midzone"
    "mini-pumps" "miniSOG" "minimotif" "minimotifs" "miniorgans" "minus-strand"
    "minutess" "mir" "mir-17" "mir-17-5p" "mir-221" "mir-222" "mir-30"
    "mir-92s" "mirRanda" "mis-localization" "mispairs" "miss-segregation"
    "missense" "mitochondria-like" "mitochondrial-dependent"
    "mitochondrial-like" "mitogen-stress" "mitomycin" "mitoses" "mitotic-phase"
    "mixed-cell" "mixed-type" "mock-treated" "model-system" "moderate-risk"
    "moderate-to-high" "modifier-1" "modifier–dependent" "molecules"
    "mono-ADP-ribosylated" "mono-ADP-ribosylation"
    "mono-ADP-ribosyltransferase" "mono-ADP-ribosyltransferases" "mono-ARTD"
    "mono-Ub" "mono-alkylating" "mono-phosphorylate" "mono-phosphorylated"
    "mono-phosphorylating" "mono-phosphorylation" "mono-ubiquitin-ligase"
    "monoamine" "monocyte-derived" "monocytopenia" "monofunctional-alkylating"
    "monolayer" "monopartite" "monophosphate" "monotherapy" "month-olds"
    "morbidities" "morpholino" "morpholinos" "morphometry" "mortem" "motile"
    "msec" "mt" "mtROS" "mtp53" "mucosa" "mucosae" "mult" "multi-center"
    "multi-cytotoxic" "multi-domain" "multi-drug" "multi-drugs"
    "multi-factorial" "multi-focal" "multi-functional" "multi-kinase"
    "multi-meric" "multi-organ" "multi-predictor" "multi-probe" "multi-protein"
    "multi-site-directly" "multi-stage" "multi-step" "multi-subunit"
    "multi-systemic" "multicenter" "multidomain" "multigene" "multimers"
    "multinucleate" "multiphoton" "multiple-family" "multiple-risk"
    "multiple-testing" "multiprotein" "multisite" "multivariant" "multivariate"
    "muscle-invasive" "muscle-specific" "mutBRAF" "mutNRAS" "mutRAS"
    "mutant-enrich" "mutant-enrichment" "mutantKRAS" "mutations"
    "mutations–specifically" "mutp" "mutp53s" "myocardium" "myocytes"
    "myofibroblast-like" "myofibroblasts" "myometrium" "myotilinopathies"
    "myotilinopathy" "myringotomy" "myristate" "myxoid" "n=10" "n=133" "n=22"
    "n=24" "n=3" "n=31" "n=36" "n=39" "n=4" "n=5" "n=58" "n=7" "nCAG" "nCLU"
    "nGGO" "nGGOs" "nLC-MS" "nab-paclitaxel" "nanoliters" "nanomaterials"
    "nanoscale" "nasi" "nasopharynx" "nc-shRNA" "ncomms5048" "near-diploid"
    "near-perfect" "near-uniform" "near-uniformity" "nearest" "necrosome"
    "neo-adjuvant" "neo-adjuvant-treated" "neo-angiogenic"
    "neo-vascularisation" "neoadjuvant" "neocortex" "neoplasias" "neovessel"
    "nephrectomies" "nephromas" "nephropathy" "networks" "neurite" "neuro"
    "neuro-pathogenic" "neuroectoderm" "neuroendocrine" "neuropathology"
    "neurospheres" "neurotrauma" "neutraceuticals" "neutropenia"
    "neutrophil-like" "neutrophilic-differentiated" "nevoid" "new-generation"
    "newer" "newly-arrived" "newly-diagnosed" "next-generation" "nick-end"
    "nine-day" "nitrites" "nitroso" "no-oscillation" "node-negative"
    "node-positive" "nonanthracycline" "noncancer" "noncardia" "noncarrier"
    "noncarriers" "nonexpresser" "nonexpressers" "nonfunctionalP53" "nonheme"
    "nonmalignant" "nonobese" "nonorgan" "nonpolysomy" "nonpregnant"
    "nonredundant" "nonresponder" "nonsense-mediated" "nonsignificant"
    "nonsmall" "normals" "novo" "nr" "nt" "nuclear-mitotic"
    "nuclear-to-cytoplasmic" "nucleases" "nucleo" "nucleosome-remodeling"
    "nutrient-deprivation" "n = 10" "n = 10" "n = 22" "n = 31" "n = 5"
    "o-dianisidine" "occludens-2" "occurrences" "octa" "oesin" "oestrogen"
    "oestrogens" "ofAtg5" "ofEgfr" "ofFANCB" "ofFANCE" "ofFANCG" "ofMSH2"
    "ofMSH2Are" "ofMSH2by" "ofPARP1" "ofPml" "ofPten" "ofXPA" "off-label"
    "off-rate" "off-rates" "off-target" "ofgsk3a" "ofp53" "ofrpL11" "ofstudies"
    "oligo-DNA" "oligomerise" "oligopyrimidine" "omentum" "omplex-1" "on-going"
    "on-off" "on-target" "onWnt4" "onc" "oncologists" "oncomiRNA" "one-fifth"
    "one-fourth" "one-sided" "one-step" "one-third" "one-way" "only-treated"
    "oocytes" "open-access" "open-label" "open-reading-frame" "ophthalmate"
    "opies" "opioid-naïve" "opioids" "opposite-increased" "opposite-polarity"
    "or15" "orAtg5" "organelle" "organelles" "organoid" "organs" "oropharynx"
    "ortho" "orthologue" "orthologues" "oscillator-types" "osteo"
    "osteo-chondrosarcoma" "osteoblasts" "osteomyelitis" "osteophyte"
    "osteophyte-like" "osteophytes" "otherwords" "ourPten" "outermembrane"
    "outside-in" "over-activated" "over-activation" "over-amplification"
    "over-dispersion" "over-enriched" "over-production" "over-representation"
    "over-treatment" "overexpressors" "overgrew" "overview" "oxidases" "oxoG"
    "oxoguanine" "oxygenase-1" "oxygens" "oxytetracycline" "p1010-Luc" "p18Bax"
    "p21-transfected" "p21Bax" "p21C-terminal" "p300-depleted" "p300-mediated"
    "p38MAPK" "p38MAPK-p53-ICAM-1" "p38aMAPK" "p46shc" "p52shc" "p53-DN"
    "p53-autonomous" "p53-deficient" "p53-null" "p53-proficient"
    "p53-regulatory" "p53-signature" "p53MT" "p53RE" "p53REs" "p73-dependent"
    "p85α" "p=0.001" "p=0.002" "p=0.003" "p=0.006" "p=0.007" "p=0.01" "p=0.018"
    "p=0.02" "p=0.025" "p=0.03" "p=0.05" "p=0.06" "p=1.01×10" "p=5.41×10"
    "p=6.65×10" "p=6.93×10" "pACT2" "pACYCDuet" "pAMPK" "pARE-Luc" "pAXL"
    "pBabe" "pBax" "pCHK1" "pCMV" "pCMV6-AV-STAT3-GFP" "pCdc2" "pECFP"
    "pECFP-C1" "pECFP-C1-S" "pECFP-C1-SelP" "pEGFP" "pEGFP-c1" "pEGFR" "pET151"
    "pET15b" "pET15b-Tub-C" "pET28a" "pEX-2-nonspecific" "pEX-5" "pEYFP"
    "pEYFP-C1" "pEZX-Luc" "pEZX-luc" "pEZX-luc-p21" "pErbB3" "pEspG"
    "pEspG-E392R" "pEspG-R" "pFAK" "pFHRE" "pFHRE-Luc" "pGADT7" "pGCMV" "pGLSP"
    "pGLSP−1076" "pGLSP−1141" "pGLSP−318" "pGLSP−676" "pGLSP−932" "pGL−954"
    "pGPU6" "pH" "pH2AX" "pH7.5" "pHER2" "pH 7.5" "pIKKβ" "pIκBα" "pLKO" "pMAL"
    "pMAL-c2X" "pMAPK" "pMET" "pN" "pNLENY" "pNLENY1-ES" "pPTEN" "pRc"
    "pS2448-mTOR" "pSMAD2" "pSTAT1" "pSTAT1-S727" "pSTAT1α" "pSTAT1α-S727"
    "pSTAT1β" "pSTAT2" "pSTAT3" "pSTAT3-S727" "pSTAT3-Y705" "pSTAT3α" "pSTAT5"
    "pSTAT6" "pSer10-histone-H3-positive" "pT" "pT288-Aurora" "pT4" "pTAF"
    "pTNM" "pTRIPZ-non" "pTRIPZ-shCLU" "pTRIPZ-shCLU-containing" "pTRIPz"
    "pTau-202" "pTau199" "pTriEx" "pTyr1007–1008" "pVSV" "pVSV-G" "pVav"
    "pVav1-Luc" "pY+1" "pY118" "pY142-VAV2" "pY147" "pY172-VAV2" "pY397"
    "pY397-FAK" "pY418-Src" "pY53" "pY589" "pY705-STAT3" "pY992"
    "pY992-peptide·VO" "pYAP" "pZ189" "pack-years" "paclitaxel-treatment"
    "pain-sensitive" "pair-loci" "paired-end" "pairwise" "palmitoyl"
    "palmostatin" "pan-Aurora" "pan-acetylation-specific" "pan-hematopoietic"
    "pan-inhibitor" "pan-kinase" "pan-specific" "pancreata"
    "pancreaticoduodenectomy" "pancreatitis" "pancreatoduodenectomies"
    "pancytopenia" "papillarypredominant" "para-aortic" "paracancer"
    "paracrine" "paracrystalline" "parallel-plate" "paralog" "parenchyma"
    "parvum" "pathCR" "patho" "patho-epidemiology" "pathologies"
    "pathophysiology" "pathways" "patient-by-patient" "patient–gene"
    "paxillin-mediated" "pc" "pcDNA" "pcDNA-GFP-STAT1" "pcDNA3-Vpr" "pcGATA3"
    "pcGATA3mut" "pca" "penentrant" "penetrance" "penetrant" "peptide-14"
    "peptides" "per-cell" "perhaps" "peri-and" "perichondrium" "perisotin"
    "peritoneum" "peroxidise" "person-years" "personalized-medicine"
    "ph-p70S6K" "phH3" "phagophore" "phagophores" "phalanges"
    "pharmacologically-induced" "phase-contrast" "phase-specific" "phenyl"
    "phoenotypes" "phopho" "phopho-proteomic" "phopsho" "phosho"
    "phosho-degron" "phosphatases" "phosphate-dependent"
    "phosphatidyl-inositol-3" "phosphatidylinositol-4,5-bisphosphonate"
    "phospho-NBR1" "phospho-PKC" "phosphoSer435" "phosphodegrons"
    "phosphogluconate" "phosphoinosital-3-kinase" "phospholipid-binding"
    "phosphomutant" "phosphomutants" "phosphopeptide" "phosphopeptides"
    "phosphoproteome" "phosphoproteomes" "phosphor-degron" "phosphor-specific"
    "phosphoresidues" "phosphorodiamidate" "phosphoryl-transfer"
    "phosphorylated-p38MAPK" "phosphorylation-dephosphorylation"
    "phosphoserines" "phosphosite" "phosphosites" "phosphotidylinositol"
    "phosphotyrosine-STAT3" "photo-activatable" "photo-activation"
    "photo-oxidation" "photodamage" "photoproduct" "photoproducts"
    "phototropin" "phototype" "physician-diagnosed" "physiologically-relevant"
    "phytosterols" "pigment-independent" "pileup" "piperidyl" "pixels"
    "placebo-controlled" "placental-derived" "placental-insufficiency-related"
    "placodes" "plamostatin" "plasmon" "plastic-adherent" "platform-based"
    "platings" "platinum-fluorouracil" "pleura" "plexiform" "ploidy"
    "plus-agarose" "plus-ends" "pmiR-RB-REPORT" "podocytopathy"
    "point-mutation" "pointes" "pole-to-pole" "poliomyelitis-like"
    "poly-ADP-ribose" "poly-C" "poly-L" "poly-Ub-activated" "poly-Ub-mediated"
    "poly-merotelic" "polyCAG" "polyGGY" "polyGGY-repeat" "polyQ" "polyT"
    "polyisoprenoid" "polymerase-1" "polymerase-nucleic" "polymorphism"
    "polymorphisms" "polyploid" "polyprotein" "polyproteins" "polysomy"
    "pooled-analysis" "poor-compliance" "poorer" "poorest" "porphyrin"
    "positive-control" "positron" "post-DNA" "post-DTB" "post-IV" "post-MI"
    "post-Nocodazole" "post-Nocodozole" "post-PCR" "post-addition"
    "post-chemotherapy" "post-entry" "post-induction" "post-infection"
    "post-injection" "post-injury" "post-irradiation" "post-knockdown"
    "post-menopausal" "post-mitotic" "post-mortem" "post-natal"
    "post-neoadjuvant" "post-polycythemia" "post-receptor" "post-recurrence"
    "post-release" "post-removal" "post-scratch" "post-stimulation"
    "post-surgery" "post-surgical" "post-synaptic" "post-test"
    "post-therapeutic" "post-therapy" "post-transcription"
    "post-transcriptional" "post-transcriptionally" "post-transfection"
    "post-translation" "post-translational" "post-translationally"
    "post-transplantation" "post-treatment" "postchemotherapy" "postmortem"
    "postpolycythemia" "posttransplant" "post‐translational" "pp130Cas"
    "pp70S6K" "pp70S6k" "ppRb" "ppaxillin" "precancer" "precipitations"
    "preimmune" "premaligmant" "premalignancy" "premature-senescent"
    "pressure-overload" "preterm" "previa" "previous-generation" "pri"
    "pri-miRNA-130a" "primary-metastatic" "primer-dependent" "primo" "priori"
    "pro-B-cell" "pro-MMPs" "pro-TAME" "pro-and" "pro-angiogenic"
    "pro-apoptosis" "pro-arrhythmia" "pro-atherogenic" "pro-cancerous"
    "pro-carcinogenic" "pro-chondrogenic" "pro-death" "pro-estrogenic"
    "pro-fibrotic" "pro-growth" "pro-inflammatory" "pro-invasive"
    "pro-longevity" "pro-metastatic" "pro-migratory" "pro-mitotic"
    "pro-oncogene" "pro-proliferative" "pro-survival" "pro-tumor" "pro-tumoral"
    "pro-tumorigenic" "proband" "probands" "probe_205112_at" "procarcinogens"
    "procaspase-3" "procollagen" "product-like" "proenzyme" "progenies"
    "progeny" "progeroid" "progesterin" "progestin" "prognosticators"
    "progression-linked" "progressors" "prokaryotes" "proliferation-competent"
    "proliferator-activated" "prolonged-mitotic" "prolonged-treatment"
    "prolymphocytes" "promiscuousness" "promots" "proof-of-concept" "propense"
    "propyl-pyrazole-triol" "prostaglandins" "prostatectomy"
    "protease-concentration-dependent" "proteasome-related" "protein-230"
    "protein-DNA" "protein-RNA" "protein-association" "protein-level"
    "protein-like" "protein-lipid" "protein-tagged-ARTD9"
    "protein-tagged-DTX3L" "proteinopathies" "proteins" "protein–liposome"
    "proteolipids" "proteome" "protien" "proto-oncoprotein" "proven"
    "pro–IL-18" "pro–IL-1β" "psCLU" "pseudo-coloured" "pseudo-dimer"
    "pseudo-kinase" "pseudoarthrosis-specific" "pseudogenes"
    "pseudokinase-mediated" "pseudosubstrate" "pseudotype" "pull-down"
    "pulldown" "pulled-down" "pulsatile" "pyrene‐induced" "pyridyl" "pyrimidin"
    "pyrimidin-2-amine" "p = 0.006" "p = 0.03" "p = 0.05" "p = 0.06"
    "p = 0.001" "p = 0.002" "p = 0.003" "p = 0.04" "p≤0.0001" "p≤0.001"
    "p≤0.01" "p≤0.05" "q21q36" "q23.1q26.1" "q3week" "qMSP" "qtl" "quadruplex"
    "quality-control" "quantitative-PCR" "quantitative-RT-PCR" "quasispecies"
    "rAd" "rVista2.0" "rabbit-derived" "racially-compatible" "rad3-related"
    "rad51-brca2" "radiation-induced" "radio-resistance" "radio-sensitization"
    "radioiodine" "radiomitigant" "radioresistance" "raft-dependent"
    "random-effect" "random-effects" "range=0.5-20.0" "rank-sum" "rapamcyin"
    "rarer" "ratio=5.856" "re-acylation" "re-aggregates" "re-aligned"
    "re-alignment" "re-aligns" "re-analyzed" "re-appearance" "re-assessement"
    "re-centers" "re-classified" "re-emerge" "re-enter" "re-entry"
    "re-equilibrated" "re-establish" "re-established" "re-evaluate"
    "re-evaluated" "re-evaluation" "re-examined" "re-expressed" "re-expressing"
    "re-expression" "re-formation" "re-formed" "re-forming" "re-hybridized"
    "re-induction" "re-introduced" "re-introducing" "re-introduction"
    "re-irradiated" "re-joining" "re-localization" "re-localized"
    "re-modelling" "re-perfusion" "re-sampling" "re-sensitization"
    "re-sensitize" "re-sensitized" "re-transformation" "re-transformed"
    "re-treatment" "re-validated" "reaction-restriction" "readout" "readouts"
    "receptor-2" "receptor-status" "receptor-tyrosine" "receptor-α"
    "recombination-associated" "red-fluorescent" "red-only" "red-phase"
    "reduction-oxidation" "refractoriness" "region-leucine" "regrew" "regrowth"
    "regualte" "regulaton" "regulators" "regulon" "regulons" "rela" "related-1"
    "remifentanil" "replacemnet" "replication-defective"
    "replicatively-competent" "repopulate" "repressive-state" "repressors"
    "requisites" "resensitise" "residuals" "resistin-like" "resp" "responder"
    "responders" "response-4" "reticulum" "retinoblastoma-interacting" "retro"
    "retroperitoneum" "retrotranslocates" "retroviral-mediated" "retrovirus"
    "revertant" "revertants" "rhBMP-2" "rhTRAIL" "ribonucleoprotein-U" "ribose"
    "riboside" "ribosomopathies" "ribosomopathy" "ribosyl" "right-sided"
    "right-tailed" "ring-like" "ring-shape" "risen" "risk-conferring"
    "risk-reducing" "ristocetin" "rmdup" "rmsds" "rotein" "rpm" "rs10174098A"
    "rs10202709G" "rs10413888" "rs10488631" "rs1050171" "rs10815160"
    "rs10850409" "rs10936599" "rs10946940" "rs11073328" "rs11187842"
    "rs11187870" "rs113420705" "rs1136410" "rs11554137" "rs11571833" "rs11651"
    "rs11651A" "rs1204038" "rs121909219" "rs121909224" "rs121909239" "rs12259"
    "rs12565776" "rs1277441" "rs12901499" "rs13034020" "rs1322650" "rs13314271"
    "rs1337080" "rs1337082" "rs143160739" "rs1432295" "rs1561876" "rs1665105"
    "rs1695" "rs174577" "rs17473423" "rs17849502" "rs17879961" "rs17884607"
    "rs1789502" "rs1800372" "rs1800629" "rs1800872" "rs1801320" "rs1801321"
    "rs1860661" "rs1873778" "rs1892356" "rs1892359" "rs1920116" "rs1937622"
    "rs20541" "rs2058613" "rs2069762" "rs207959" "rs2253017" "rs2274223"
    "rs2290692" "rs2293152" "rs2296067" "rs2304573" "rs2304573G" "rs2361634"
    "rs2720378" "rs2736100" "rs2764208" "rs2798269" "rs280521" "rs28493229"
    "rs2853669" "rs28934574" "rs28934575" "rs28934576" "rs3024505" "rs3132468"
    "rs3132468-C" "rs324011" "rs34949160" "rs35652124" "rs370052455"
    "rs3738919C" "rs3765524" "rs3765524-C" "rs3781264" "rs3796123T" "rs3825977"
    "rs3828916" "rs3828916-C" "rs3828916-G" "rs3830675" "rs3957357" "rs4263839"
    "rs428073" "rs444929" "rs4488809" "rs4728142" "rs4769793" "rs4796793"
    "rs4796793-G" "rs4796793G" "rs485411" "rs4880" "rs558702" "rs56084662"
    "rs6010620" "rs6152" "rs61764370" "rs640739" "rs6439924" "rs6721961"
    "rs6721961CA" "rs6725958C" "rs6793295" "rs6801957" "rs6983267" "rs7211777"
    "rs72689236" "rs736259" "rs744166" "rs744166-A" "rs744166C" "rs753724"
    "rs7636839" "rs795484" "rs8103453" "rs8176318" "rs9275572" "rs940739A"
    "rs940739AA" "rs940739AT" "rs940739TA" "rs962458" "rule-out" "run-in"
    "s-AML" "s-p53-antibodies" "sCLU’s" "sIBM" "salt-bridge" "sampe" "sapiens"
    "saracatinib-plus-lapatinib" "sarcomatoid" "sativa" "sc-722"
    "scar-improvement" "scar-improving" "scherichia" "scored≥8" "scores≥8"
    "score≥8" "scrRNAi" "scramble-transfected" "scratch-wound" "screenings"
    "sdRNA" "sdRNAs" "second-degree" "second-generation" "second-hit"
    "second-leading" "second-line" "second-most" "second-site" "second-stage"
    "secretome" "selectedPten" "selenocysteine" "selenocysteines"
    "selenomethionine" "selenoproteins" "self-activates" "self-activation"
    "self-aggregate" "self-antigens" "self-care" "self-digestion"
    "self-limited" "self-organization" "self-renew" "self-renewal"
    "self-reported" "self-sufficiency" "self-triggered" "self-ubiquitination"
    "selp-h" "semi" "semi-essential" "semi-quantitative" "semi-solid"
    "semiconductor-based" "senescence-like" "senescent-associated"
    "senescent-like" "sensitizer" "sequelae" "sequence-specific"
    "serine-to-alanine" "sernine" "serotype" "serotypes" "sessile" "set‐up"
    "sex-specific" "shATM" "shCLU" "shCav" "shCav-1-transfected" "shCdc20"
    "shCdc20-UMSCC-12" "shCtrl" "shCtrl-only" "shERBB2" "shFANCF" "shFOXA"
    "shFOXA1" "shFOXA1-only" "shGFP" "shJun" "shKras" "shLuc" "shMCT-1" "shNC"
    "shRIP3" "shRNA" "shRNA-DGKα1" "shRNA1" "shRNA2" "shRNAi" "shRb" "shSPAG5"
    "shScr" "shSurv" "shSurv-U87-MG" "shTUG1" "shTUG1-transfected" "shVIM"
    "shVav1" "shYAP1-2" "shake-off" "sham-irradiated" "sheet-like"
    "short-hairpin" "short-term" "showen" "showingrpL11" "shp16" "shp53"
    "shrunken" "shut-down" "si-HOTAIR" "si-HOXB7-induced" "si-NC" "siARTD"
    "siARTD8" "siARTD9" "siARTD9-mediated" "siCOP1" "siCSN5" "siCTL" "siDTX"
    "siDTX3L" "siDUSP3" "siDUSP3-1" "siDUSP3-2" "siMock" "siPLAU" "siPTEN"
    "siPVT1" "siRNA" "siRNA#1" "siRNA#1-resistant" "siRNA-Cdc20-transfected"
    "siRNA-oligos" "siSIRT1" "siSPAG5" "siSTAT1" "siSTAT3" "siScr" "siScramble"
    "siTBK1" "sialyl" "sialyl-Lewis" "sibling-pair" "side-chain" "side-effects"
    "siginificant" "signal-to-noise" "signalsome" "significance6"
    "significantly-elevated" "silico" "simulations-based" "single-base"
    "single-cell" "single-chain" "single-exponential" "single-joint"
    "single-layer" "single-marker" "single-molecule" "single-nuclei"
    "single-nucleotide" "single-nucleus" "single-phase" "single-round"
    "single-step" "single-strand" "single-target" "single‐strand" "sirtuin"
    "sister-chromatid" "site-biopsy" "site-specifically" "situ" "six-well"
    "size-exclusion" "skin-permeable" "skin-tumor" "skpI-Cdc53-F-box"
    "slow-down" "smFRET" "small-cell" "small-for-gestational-age"
    "small-molecule" "small-scale" "small-size" "smokers" "snapback" "socio"
    "socio-cultural" "socio-economic" "sodium-induced" "soft-agar" "solenoid"
    "solid-phase" "solid-predominant" "solidified-Matrigel" "solidpredominant"
    "solubility-enhancing" "solutes" "source-specific" "spatially-defined"
    "spatio" "spatio‐temporal" "specifc" "specifiers" "spectrographs"
    "spectrometer" "spectrophotomer" "sphere-forming" "spike-like"
    "spindle-assembly-checkpoint" "spindle-kinetochore" "spindle-like"
    "spinosum" "splice-site" "split-kinase" "split-reads" "squamoid"
    "squamous-cell" "ss" "ssDNA" "stabiliser" "stabilities" "stage-I+II"
    "stainings" "static-adhesion" "status-dependent" "steady-state" "stellate"
    "stem-cell" "stem-like" "stem-loop" "stemness" "step-wise" "stepwise"
    "steroid-binding" "stiffer" "stimulatesPARP1" "stimulus-recovery"
    "stone-forming" "stongest" "stop-codon" "strain-specific"
    "streptavidin-Flag–S" "stress-activated" "stress-induced"
    "stress-inducible" "stress-inducing" "stress-mediated" "stress-response"
    "stress-responsive" "stressful" "stressors" "stress–mediated"
    "structure-activity" "structure-based" "structure-forming" "suPAR" "sub-G1"
    "sub-cellular" "sub-classes" "sub-classification" "sub-clinical"
    "sub-clone" "sub-cluster" "sub-complex" "sub-complexes" "sub-confluent"
    "sub-family" "sub-group" "sub-groups" "sub-lethal" "sub-micromolar"
    "sub-network" "sub-nuclear" "sub-optimal" "sub-phenotypes" "sub-pocket"
    "sub-population" "sub-proteome" "sub-specimens" "sub-states" "sub-step"
    "sub-stoichiometric" "sub-types" "subG1" "subcentimeter" "subclass"
    "subclasses" "subcomplex" "subcutis" "subdomain" "subfamilies"
    "subfractions" "submembrane" "subpathways" "subpopulations" "subsites"
    "substate" "substrate-mimic" "substrate-recognition" "subthreshold"
    "subytpes" "succinate" "succinate-ubiquinoneoxidoreductase"
    "sucrose-non-fermenting" "sulfo-NHS-biotin" "sulfonamide"
    "sumoylation-defective" "sumoylation-for-ubiquitination"
    "sumoylation-ubiquitination" "sun-damage" "sun-sensitive" "super-activated"
    "super-activation" "super-antigen" "supernatant" "supernatants"
    "supra-physiologic" "surpress" "sutdy" "switch-like" "synapses"
    "syndrome-1" "synergise" "synergises" "synergism" "synergisms"
    "systemically-administered" "t-BHQ" "t-IGF-1R" "tTA" "ta" "tail-anchor"
    "tail-vein" "target-of-rapamycin" "target-selectivity" "targeted-capture"
    "tautomerase-independent" "tdTomato" "telengiectasia" "telomerase-DNA"
    "telomerase-dependent" "telomerase–independent" "terminally-differentiated"
    "tert" "tertile" "tertiles" "testedFAAP20" "tet-MMP3" "tet-OFF"
    "tetra-nucleotide" "tetrabromobenzotriazole" "tetracycyline"
    "tetradecanoyl" "tetraploid" "tetrazolium" "tfLC3" "thanAtg5" "thanFANCB"
    "thanp53" "thatFANCB" "thatHDAC5" "thatPml" "thatXPAandPARP1" "the136"
    "theAtg5" "theDNAdamage" "theEgfr" "theFANCB" "theFANCG" "theFANCL"
    "theFANCM" "theKras" "thePgr" "thePml" "theRPS17" "theXPA"
    "theXPA–PARinteraction" "thefive-year" "thep53" "therpL11"
    "thiazolinediones" "thioacyl" "thirty-one" "thirty-six" "thoughEgfr"
    "three-dimensional" "three-point" "three-stage" "three-year" "thrombi"
    "thrombocythemia" "thrombus" "thymic-like" "thymine–thymine" "thymocytes"
    "thymosin-like" "thymus-like" "thyroidectomy" "tightly-controlled"
    "time-course" "time-frame" "time-lapse" "time-of-flight" "time-point"
    "time-points" "time-precision" "time-scale" "timecourse" "timecourses"
    "timeframe" "timepoint" "timepoints" "tissue-divergent" "tissues" "titer"
    "titers" "titre" "toPten" "tonsillectomy" "top-score" "topology"
    "toremifene" "torsade" "touchtone" "toxin-like" "tp53" "tracheas"
    "tracheosphere" "tracheospheres" "trans-differentiate" "trans-poly"
    "trans-species" "trans-well" "transcatheter" "transcript-encoding"
    "transcription-competent" "transcription-factor-binding"
    "transcription-repressive" "transcriptional-repressive" "transcriptome"
    "transcriptomes" "transducer" "transfections" "transferase-mediated"
    "transgenes" "transition-state" "translocations" "transporter-based"
    "transwell" "transwells" "traztuzumab" "treatedPten"
    "treatment-modality-specific" "tri-phasic" "triazene" "trichrome"
    "trifluoromethyl" "trigone" "trimester" "trinucleotide" "triphosphate"
    "triphosphates" "triple-negative" "triploid" "trisomy" "trisphosphate"
    "try416" "tube-like" "tubule" "tumor-adjacent" "tumor-normal"
    "tumor-permissive" "tumor-suppressive" "tumorectomy" "tumorsphere"
    "tumorspheres" "tumour-adjacent" "tumour-associated" "tumour-cell"
    "tumour-mediated" "tumour-suppressor" "tumour–microenvironment" "ture"
    "twenty-eight" "twenty-nine" "twenty-two" "two-colour" "two-hit"
    "two-hybrid" "two-pair" "two-piece" "two-pronged" "two-sided"
    "two-single-mutant" "two-stage" "two-step" "two-step-model" "two-tailed"
    "two-thirds" "two-tiered" "two-year" "tympanostomy" "type-1" "type-16"
    "type-2" "type-5" "type-II" "ubiquinol"
    "ubiquinol-cytochromeoxidoreductase" "ubiquitin-conjugating"
    "ubiquitin-positive" "ubiquitine" "ubiqutin" "ultiple" "ultiple "
    "ultra-low" "ultrasonography" "ultrastructure" "ultrathin"
    "un-phosphorylatable" "uncoupler" "und" "under-recognition"
    "under-reporters" "under-represent" "undergoes" "undergone"
    "underperformance" "underpinnings" "undertaken" "unevenness" "univariate"
    "unmet" "untangle" "untethers" "up-regulaton" "up-regulatory" "urea"
    "urethra" "urnover" "uroepithelium" "urokinase-dependent" "urothelium"
    "users" "uteri" "utero" "uvea" "v-Ki-ras2" "v-erb-b2" "v-set" "vII" "vIII"
    "vaccines-quadrivalent" "vacuoles" "validaton" "values" "variables"
    "variants" "varieties" "vasculopathies" "vasculopathy" "vaso"
    "vaso-dilation" "vaso-obliteration" "vav-P-Bcl2" "vavBcl2" "vector-STGM"
    "vector-only" "vehicle-control" "vehicle-treated" "vehicle-treatment"
    "ventricles–SVZ" "venules" "vera" "verprolin-homologous" "vertepofin"
    "vesicle-like" "vesicle-mediated" "vibrissa" "videomicoscopy"
    "videomicroscopy" "villi" "viniferin" "viremia" "vitro" "vivo" "viz"
    "volumetry" "vsEgfr" "vsWnt4" "waist-hip" "waist-hip-ratio" "was0"
    "water-soluble" "web-based" "website" "weeker" "weight-based"
    "well-annotated" "well-characterised" "well-conducted" "well-conserved"
    "well-defined" "well-designed" "well-differentiated" "well-documented"
    "well-expressed" "well-orchestrated" "well-positioned" "well-spread"
    "well-studied" "were7–34%" "west-Ireland" "west-Irish" "whereasIL"
    "whereasIL-6" "whereasPten" "whetherPten" "whole-body" "whole-exome"
    "whole-genome" "whole-slide" "whole-transcriptome" "wide-spread"
    "wide-type" "wild-type-PAR-4" "winged-helix" "wingless-related" "wireframe"
    "withGSK-3β" "withdrawl" "withdrawn" "withgsk3a" "withoutmutp53" "withr"
    "wogonin-treatment" "workers" "workflows" "workplace-relevant" "world-wide"
    "written" "wtNM1" "www-dep" "x-y-z" "xenograph" "xenotransplant" "xiao"
    "yet-to" "yin" "z-DEVD-fmk" "z-VAD" "z-score" "zhejin1995@yahoo" "zrin"
    "zymogens" "×10" "×2" "×20–30" "×5" "×76" "×l" "× 10" "× 10" "ÜD" "Δ-1083"
    "Δ161-R175H" "Δ2" "Δ22" "Δ45-β-Catenin" "Δ45-β-CateninER-myc" "Δ5" "Δ60–89"
    "ΔC" "ΔCDK-Rb" "ΔCdk" "ΔCt" "ΔD1D2-Bim" "ΔD1D2-expressing" "ΔDBD" "ΔIQ"
    "ΔPDZ" "ΔPDZbm" "ΔRb" "ΔS1" "ΔSH3-dominant" "ΔSH3bm" "ΔTA" "ΔVpr" "ΔΨ"
    "ΨKxE" "α-granule" "α-helices" "α-helix" "α-secretase" "α-subunit"
    "α1-adrenoceptor" "α1-blockers" "α10β1" "α11β1" "α2β1" "α2β1integrin" "α3"
    "α3-knockout" "α3β1" "α4" "α5" "α5β1integrins" "α6" "α6β1" "αC–β4" "αD"
    "αD–αE" "αMHC" "αMHC-aYAP" "αSTAT3" "αV" "αv" "α–mediated" "β-148"
    "β-N-acetylglucosaminylation" "β-Naphthoflavone" "β-TRCP" "β-TRCP1"
    "β-TRIP230-Rb" "β-Y701" "β-chain" "β-heterodimer" "β-integrin"
    "β-integrin-dependent" "β-naphthoflavone" "β-oxidation" "β-secretase"
    "β-sheet" "β-strands" "β-structure" "β-subunits" "β-tubulin-III" "β1"
    "β1integrin" "β2-adrenocepter" "β2–β3" "β4–β5" "β6" "β7" "β7–β8" "β8" "βI"
    "βII" "βM" "βSTAT3" "βTRC" "β–like" "γ-aminobutyric" "γ-irradiation"
    "γ-secretases" "γ-subunit" "γ2A" "γc" "ζ-proteins" "κB" "λ-IFN"
    "λ-interferon" "λ-phosphatase" "μL" "μM–1.4" "μg" "μg " "μg " "μmol" "π–π"
    "ψKXE" "‘TTA’" "‘stemness’" "↓-P" "↓G" "−1" "−146" "−532" "−PTEN" "∧P"
    "≦20%" "≦6"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-12601-12900*
  '("Neurovirology" "CCMB" "Vockel" "occludens-2" "PF-431396" "Tocris"
    "Inhibiter" "inhibiter" "activation/phosphorylation" "treated hBMVECs"
    "TEER" "TJPs" "AJPs" "hBMVECs" "p ≤0.05" "P ≤ 0.05" "≤0.005"
    "non-receptor protein" "Miyaki" "Muto" "glycogen synthase kinase-3β"
    "hypermethylatuon" "MSFLP-array" "MSFLP" "2B-1" "2B-2" "and 2B-1"
    "and 2B-2" "sessile" "P  = 0.05" "P = 0.05" "P = 0.01" "PJ" "Manchester"
    "Therascreen" "PIKCA" "Greatest" "Nicolantonio" "traztuzumab" "ofstudies"
    "Kendall" "28/31" "and 3/31" "14/15" "adjacent normal ovarian epithelium"
    "30/30" "8q22" "neuropathology" "13/15" "a biochemical IC 50" "JQ1" "HMOX"
    "a useful biological readout" "Venn" "a robust actin cytoarchitecture"
    "cytoarchitecture" "geneset" "derepress" "monoamine" "KDM" "KDMs" "KMTs"
    "HCI2509" "HCI-2509" "HCI" "~10-fold" "≥50" "40 X" "≥24" "Innes" "Hess"
    "Jason Carroll’s" "RIME" "Carroll" "Jason" "ZNF217-" "ZNF" "Nagashima"
    "Doane" "Elvidge" "Engelmann" "Creighton" "Charafe" "Massarweh"
    "siScramble" "TCA-3" "mesoderm" "Refseq" "methyltranferases" "CtBP1/2"
    "20q13" "co-bound" "anti-hormone" "HER2 +" "mesenchymal-like" "C/" "± 200 "
    "ER+ " "HDAC1/2" "ER +" "co-precipitates" "and 3D" "Profiler" "WM"
    "azabenzimidazole" "Chaqui" "AZ13102909" "AstraZeneca" "AZ909"
    "expression/phosphorylation" "co-translational" "5HT 2"
    "cellular metastasis/invasion" "cellular invasiveness/migration" "hSCC"
    "hSCCs" "Mwinyi" "FlagMed25" "−145" "−149" "glipizide" "-enantiomer"
    "enantiomer" "anticovulsant" "factor 4α" "P ≤ 0.05" "and 2 mM" "Freire"
    "lavage" "GW-627368X" "EIA" "Fadok" "fibroproliferative sequelae"
    "COX-2/PGE 2" "/prostaglandin E2" "~60%" "~35%" "9 × 10" "10 min" "μ g/mL"
    "100 U/mL" "arterioles" "co-signaling" "venules" "SDF-1α-" "Bleedings"
    "severe bleedings" "bleedings" "fingerlike" "thrombus" "MesAMP" "SCRs"
    "Genomes" "exomes" "ristocetin" "epistaxis" "menometrorrhagia" "thrombi"
    "exchange factor-1" "RAS guanyl-releasing protein-2" "× l" "CD34 +" "SupF"
    "hELG1" "bulky DNA adducts" "siRNA#1" "F/Y" "QXX" "fide" "Polη" "RAD6"
    "anti–mouse" "mg/ml" "TGFβI" "glomerular filtration and serum nucleases"
    "KSP" "Huh7-" "Huh" "dendrocytes" "-O-methyl" "HDAC2-1siRNA" "ChREBPα"
    "PathwayStudio" "Bootstrap" "NCsiRNA" "HDAC2-1" "FK-228" "3/7"
    "non-histone" "≤ 0.01" "≤ 0.05" "3-days" "n =4" "type-2" "telengiectasia"
    "CKIδ" "Iδ" "LUBAC" "desferoxamine" "dsDNA" "a highly inducible subset"
    "heptad" "abundanace" "0.25–1" "SID-SRM-MS" "pIKKβ" "ATM +/+" "WCEs"
    "pIκBα" "DSMO" "ATM·IKKγ" "·IKKγ" "ssDNA" "oxoG" "oxoguanine" "CEs"
    "phosphotidylinositol" "Anti-rabbit" "κB" "N-acetyl" "ATM +" "NADPH/NADP +"
    "CM-H2DCFDA" "pLKO" "cell permeable exogenous dimethylmalate (DMM)"
    "dimethylmalate" "CD-H2DCFDA" "Krebs" "isotopologues" "-Glc-derived" "ME2"
    "mean ± s" "24 h" "+ 1 " "24 hr" "30 min" "2-3s" "± 0.8" "hyperoxaluria"
    "a newly developed AR degradation enhancer"
    "extracorporeal shock wave lithotripsy"
    "Extracorporeal shock wave lithotripsy" "lithotripsy" "Stieger" "NAPDH"
    "ASC-J9-treated" "ASC-J9-pretreated" "Pizzolato" "COM" "AGAACTnnnAGAGCC"
    "CDH16" "distal/collecting" "AAAACAnnnAGCTGT" "TARKO" "2.9:1" "3.1:1"
    "the newly developed AR degradation enhancer" "ARKO" "2–3:1" "CaOx" "loxP"
    "n = 3" "= 16" "= 8" "n = 7" "-methyl-" "mice/group" "24-hour" "C57/B6"
    "significantly less pathologic RNV" "Y31/Y118"
    "the quinic acid derivative KZ-41" "pathological RNV" "NV" "hyperoxia"
    "OIR17+" "#P" "IR+KZ-41" "87±18" "Cytodyne" "VCAM" "Immunoglobin"
    "a novel quinic acid derivative KZ-41" "TBI" "radiomitigant"
    "non-perfusion" "brachytherapy" "inflammatory retinal vasculopathies"
    "pathologic RNV" "OIR" "The quinic acid derivative KZ-41" "KZ-41" "KZ"
    "RNV" "C57BL6/J" "excitation/emission" "p38MAPK" "CDNK2A" "152/156" "cobas"
    "Sequenom's" "38/177" "21/177" "spectrographs" "69/177" "NCT00936221"
    "10/52" "Concomitance" "20/238" "10/480" "23/238" "52/238" "NCT00890825"
    "53/238" "46/238" "minimises" "ddNTP" "·14" "·80" "TheraScreen" "DxS"
    "iPlex" "ng/µ" "non-ATP" "inhibiton" "BECN1-" "BECN" "FV1000" "Egypt"
    "Sorour" "Özcan" "Seedhouse" "Hamdy" "Voso" "Thr241 Met" "Hyderabad"
    "Arg280His" "Arg194Trp" "280His" "Takanami" "Joseph" "El" "194Trp"
    "Deligezer" "Annamaneni" "Hasford" "Sokal" "= 1.13–2.11" "Thr241Met"
    "241Met" "the last years XPD Lys751Gln polymorphism" "Lys751Gln"
    "breakpoint" "Abelson" "751Gln" "1.10–2.69" "P = 0.05" "= 0.019" "= 0.008"
    "= 1.13" "colonic adenomas" "byKras" "tetracycyline" "shKras"
    "Lox-STOP-Lox-G12D" "KrasA" "theKras" "MSigDB" "HA1E" "EGR" "TransFind"
    "LACZ" "ΔTA" "ΔSH3bm" "-2γ" "/Broad" "mutantKRAS"
    "cell proliferation/survival" "HCTtetK" "RUNX" "5x10" "NuRD"
    "egulatory R NA- b" "rotein" "NA-" "urnover" "483-5p" "MBA-MD-231" "TrCP1"
    "inase (ERK)" "lycogen" "inase" "phosphoserines" "20 d" "interms" "IOVs"
    "indeterminate cytology" "benign cytology" "nondiagnostic cytology" "AUS"
    "60/191" "131/191" "Landis" "IOV" "Interobserver" "FNA" "p =0.002" "=8"
    "xiao" "Chun" "zhe" "WG" "ZWQ" "YYQ" "MZW" "CXL" "Loc285194" "HULC"
    "loc285194" "Vrba" "co-immunprecipitation" "mature miRNA-130a"
    "pre-miRNA-130a" "pri" "miR-130a" "RANs" "Promega" "HOXC" "lnRNA" "ceRNA"
    "Chemo" "miRNA-130a" "E-boxes" "1 + " "3 + " "pH 7.5" "E-box"
    "an UBC9 phosphomimic mt" "HA-K48R mt" "non-conjugated" "dominants"
    "non-denaturing" "mt" "mts" "non-consensus" "ΨKxE/D" "SAE1/2"
    "Neurospheres" "SUMO2/3" "enzyme9" "modifier-1" "24hrs" "K48 only" "S/T"
    "transcription/translation" "supershift" "KNN tracheal epithelium" "KNN"
    "S7D" "48 hpi" "dysplastic airway epithelium" "Rosa" "S2F"
    "proliferating EPs" "DBZ" "hABSC" "tracheas" "the tracheal epithelium"
    "SCR" "FUCCI" "the repairing tracheal epithelium" "live airway epithelium"
    "EPs" "ABSCS" "L-glutathione" "K5+" "K8+" "the initially ROS lo" "mABSC"
    "larger secondary tracheospheres" "larger tracheospheres" "-deoxyuridine"
    "deoxyuridine" "tracheospheres" "tracheosphere" "hABSCs" "mABSCs"
    "Dihydroethidium (DHE)" "the uninjured mouse tracheal epithelium"
    "Dihydroethidium" "ABSC" "ABSCs" "S7G" "S4I" "S4G" "S4C" "8+" "p38 MAPK"
    "EFM" "JMFF" "‐tuning" "double‐strand" "single‐strand" "‐tune" "‐terminal"
    "‐western" "UV‐C‐induced" "‐GFP" "multiphoton" "this experimental set‐up"
    "femtosecond" "‐up" "laser‐induced" "55‐mer" "‐salt" "full‐length" "‐mer"
    "‐affinity" "‐length" "UV‐C" "‐independent" "6‐4" "6‐4PP" "spatio‐temporal"
    "‐PBM" "PBM" "Pleschke" "‐C" "‐induced" "I/III" "nucleases" "subpathways"
    "‐complementing" "bulky helix‐distorting DNA adducts" "‐4" "‐strand"
    "‐dependent" "spatio" "‐temporal" "post‐translational" "PAR‐binding"
    "‐ribosyltransferases" "‐translational" "‐ribosyl" "ADP‐ribose" "‐ribose"
    "‐binding" "‐inducedDNAdamage" "‐green fluorescent protein" "XPAitself"
    "ofXPA" "andXPAfunctions" "factorIIH" "theXPA" "LSM 700" "10 min" "72 h"
    "phosphorylation/activity" "aslo" "UGC" "UGCs"
    "non-receptor tyrosine kinases" "underwent trastuzumab monotherapy"
    "INCB7839" "ADAM10 is" "FinHER" "adequate IHC" "p=0.02" "p ≤ 0.05"
    "ADAM10/17" "p ≤ 0.01" "INCB8765" "p≤0.0001" "p≤0.05" "ADAM10i" "p≤0.001"
    "≤0.001" "≤0.0001" "p≤0.01" "≤0.01" "≤0.05" "***p" "**p" "*p" "= 0.5"
    "p = 0.006" "touchtone" "Darier" "follicularis"
    "the cardiac sarcoplasmic reticulum" "SERCA2a" "/Ca 2+" "pointes" "torsade"
    "EADs" "afterdepolarizations" "arrhythmias" "the sarcoplasmic reticulum"
    "reticulum" "orbitrap" "Lundby" "InWeb" "The proband's" "the proband's"
    "QTc" "Schwartz" "co-existence" "monogenic LQTS" "common autosomal SNPs"
    "randomly selected genome-wide SNPs" "a left ventricular enhancer"
    "QT interval-associated SNPs" "Roadmap" "eSNP"
    "313 left ventricular biopsy" "QT-associated SNPs"
    "publicly available eQTL datasets" "genome-wide significant missense SNPs"
    "68 total genome-wide significant SNPs" "HOMA" "withr" "NHGRI"
    "the 68 QT-associated SNPs" "ARIC" "non-QT" "European-"
    "other genome-wide significant SNPs" "Metabochip" "QRS"
    "genetically elusive LQTS" "IGC" "QTSCD" "QTGEN" "msec" "SQTS"
    "fatal arrhythmia" "arrhythmia" "cardiac electrophysiology"
    "electrophysiology" "LQTS" "=23" "n=24" "=30" "=72" "=298" "4.4×10"
    "= 0.00012" "P = 0.008" "4.4 × 10" "= 0.27" "= 5×10" "capillary-like"
    "Kyprianou" "methanesulfonate" "extracellular signal-regulated kinase 1/2"
    "3 × 10" "~2.5-fold" "anti-anxiety" "using immunohistochemistry"
    "~fivefold" "GFRs" "methylthiophenothiazine" "-piperidyl" "piperidyl"
    "anti-psychotic" "100 mm 3" "25 mg/kg" "= 100" "/ mammalian"
    "cancer/stromal" "extensiveness"
    "quantitative fluorescent immunohistochemistry" "HGF/Low" "HGF/High"
    "CD68+" "slides using quantitative fluorescent immunohistochemistry"
    "pre/post" "let-7g" "miR-193a-5p" "Genecard" "MiR-193a-5p" "nanoliters"
    "platinum/taxane" "fluorescent quantitative immunohistochemistry"
    "EORTC55971" "PDS" "Quantitative fluorescent immunohistochemistry" "=58"
    "other ALK secondary C1156Y mutations co-existed" "co-existed" "Intra"
    "axises" "H2228/Vec" "H2228/HGF"
    "17-dimethylaminoethylamino-17-demethoxygeldanamycin" "heavier"
    "echinoderm" "Non-small" "ophthalmate (OPA)" "ophthalmate"
    "glycerophospolipid" "glycerolphospholipids" "LC-SRM-MS"
    "c-glutamyl-cysteine-synthetase (GCS)" "GCS" "aminobutyrate" "KRASWT"
    "aminoacids" "MetaboAnalyst" "glycerophospholipids" "Kyoto" "LipidMaps"
    "HMBD" "METLIN" "SIEVE" "non-homozygous" "JMJD" "DEVD/N396G" "G/G" "~100K"
    "~150K" "homozygous G/G SNP rs2296067" "z-DEVD-fmk" "A300-885A" "DEVD396G"
    "caspase-3-like" "~100,000" "~150,000" "rs2296067" "DEVDG"
    "Jumonji domain-2" "DMJ" "immunohistology" "RGD" "IPLab"
    "similarly variable α3" "apocrine" "Biomax" "anti-α3"
    "the mammary epithelium" "Spearman’s" "Albany" "α3β1" "p = 0.05"
    "p = 0.001" "= 0.014" "= 0.013" "non-steroidal" "α5" "= 59" "IPG" "OPC"
    "Juuti" "exogenic prostaglandins" "negative/poorly" "positive/well" "g"
    "ampulla (AC)" "pancreatic intraepithelial neoplasias" "ampulla" "LNR"
    "230 consecutive pancreatoduodenectomies" "DBC" "pancreatoduodenectomies"
    "p = 0.006" "p = 0.002" "p = 0.003" "p = 0.06" "= 62" "= 92" "Rebecca"
    "regrowth" "quantitative readouts" "typically lack inactivation/mutation"
    "inactivation/mutation" "14-day" "recruitment/assembly" "Elledge" "Zou"
    "DGISPKRRRLSSSLNPSKRAP" "UV-induced DNA photodamage" "RRX" "SX" "hprt"
    "XPA/" "UV-induced photodamage" "E/E" "UV photodamage" "adenylyl" "e/e"
    "anti-mutagenic" "melanin" "nuclear UV photodamage" "photodamage" "10 min"
    "~2-fold" "Rad3" "inBRCA1 +" "using nearest shrunken" "fromBRCA1 +"
    "distinguishBRCA1 +/+" "followup" "= 5×10-3–1×10-7" "disease/disorder"
    "= 5×10" "genes/complexes" "genes/proteins" "co-efficients" "shrunken"
    "versusBRCA1 +/+" "VUSs" "VUS" "benign polymorphisms" "using EMAN" "EMAN"
    "SPIDER" "using CTFFIND" "Weiner" "CTFFIND" "gluteraldehyde" "pH 7.5"
    "Ettan" "spectrophotomer" "Yvon" "Jobin" "Thermo" "ETD" "spectrometer"
    "Orbitrap" "pH7.5" "SpectraMax" "pACYCDuet" "pMAL" "pET151"
    "non-aggregating" "refolding/reactivation" "unfolding/inactivation" "yang"
    "yin" "apoGRLBD" "Pratt" "handoff" "decouple" "the CTD amphipathic helix"
    "V-shaped" "cryo" "Cryo" "17AAG" "monomeric GRLBD" "GRLBD’s" "F-dex" "dex"
    "cochaperones" "cochaperone" "GRLBD" "LBDs" "apoGR" "/ligand" "~1.5"
    "imFISH" "The only commercially available CTC" "Raritan" "Veridex" "PDAs"
    "Witkiewicz" "CTC" "CTCs" "pancreaticoduodenectomy" "paracancer"
    "Parenchyma" "P =  0.006" "n = 31" "non-immune" "P  = 0.007" "= 0.014"
    "P =  0.018" "macrothrombocytopenia" "membranous nephropathy"
    "diabetic nephropathy" "hypertensive nephropathy" "feedforward" "NMMHCIIB"
    "Africa" "Johnstone" "healthy human glomeruli" "glomeruli" "CORUM"
    "significantly more PPIs"
    "the identified proteins included significantly more PPIs" "IP-MS"
    "HIV-associated nephropathy (HIVAN)" "endstage"
    "a variably penetrant podocytopathy" "podocytopathy" "PPIs" "heterohexamer"
    "co-occurrence" "special microdomains" "the last transmembrane helix"
    "non-raft" "co-fractionate" "nanoscale" "Nichols" "BFPP" "H+" "phoenotypes"
    "A- and" "~2.6" "CAG/GGC" "the stable dimorphic AR-E213(G/A) SNP" "CAIS"
    "Gottlieb" "AR599" "A-alleles" "Stu" "Caucasian American" "gDNAs" "Finnish"
    "CRPCa" "Xq11-12" "antigen (PSA)" "A-allele" "G/A" "Caucasian Americans"
    "American (AA)" "=31" "G-alleles" "P = 0.03" "rs6152" "=3.2" "=19" "10-day"
    "60 mg/kg/day" "targetable pathways/molecules" "CSC/CSLC" "CSCs/CSLSc"
    "CSLC" "CSCs/CSLCs" "CSLCs" "non- CSCs" "60 mg/kg"
    "our proteomic screenings" "screenings" "co-regulates" "IC90" "Coomassie"
    "S910/S935" "phosphoresidues" "14-3-3ζ" "Beilina" "athanogene" "AP-MS"
    "LRRKs" "Z-score" "PPI" "phosphosites" "phosphosite" "LRRK1-" "LRRK"
    "to 14-3-3" "100X" "low/low" "high/high" "low/RRM2B" "high/RRM2B"
    "RRM2BshRNA" "pFHRE" "FHREs (TTGTTTAC)" "FHREs" "TTGTTTAC" "FHRE"
    "diphosphates" "HiCre" "DBH" "Lerosey" "Janoueix" "MONC-1-"
    "MONC-1-ALK-F1174L-" "MONC" "MONC-1-ALK-F1174L" "osteo"
    "JoMa1-ALK-wt-derived" "neuroendocrine" "Dbh" "/DBHHiCre" "Schulte"
    "Heukamp" "ALKF" "JoMa1-ALK-R1275Q-" "JoMa" "JoMa1-ALK-F1174L"
    "JoMa1-ALK-R1275Q" "-ALK-F1174L" "-ALK-R1275Q" "MKI" "/Th" "Alk" "NCSC"
    "YCN" "chromaffin" "adrenal medulla" "medulla" "Schwann" "glia" "JoMa1"
    "MONC-1" "NCPC" "BALB/C" "*10" "~15%" "sensitizers" "mitomycin-"
    "autophagic vacuoles" "showen" "antagonises" "NNK" "butanone" "pyridyl"
    "methylnitrosamine" "QOD" "0-10μM" "AKT2i" "AKT1/2i" "≥1μM"
    "hyperglaecemia" "unmet" "synergises" "M+" "20 p" "n=3" "anti-survival"
    "p=0.03" "IC50s" "Raffaghello" "Spicer" "granulocytic MDSCs" "MDSC" "MDSCs"
    "Fridlender" "tube-like" "indirect coculture" "1.0 × 10" "fibroblast-like"
    "iloperidone" "QT" "the intestinal epithelium" "normals" "anions" "Solute"
    "non-CD" "= 1.0E-03" "= 2.3E-02" "Infinium" "approximately 21/100,000"
    "approximately 11/100,000" "non-Caucasian" "genes/loci"
    "the International HapMap" "Singaporean" "CD-associated" "rs207959"
    "Sequenom" "/genes" "a Crohn’s" "= 3" "phospho-ERK 1/2" "= 1.0" "= 2.3"
    "p = 0.002" "/Map2 +" "phosphorylated/activated" "CTNF" "SGZ" "SVZ" "/DAPI"
    "FHL-" "hNSC" "neurospheres" "laminin (ELL)-primed hNSCs" "FHL" "SCI"
    "neurotrauma" "hNSCs" "∼35%" "WST-1" "non-autonomous" "LGC"
    "epithelial cell-like" "–b" "MKN" "cells/well" "BGC2-13" "shRNA1"
    "the more efficient shRNA1" "Korea" "15±2" "±2.9" "Balb/c"
    "Epidermal growth factor-like" "A maternal polymorphism" "endometrial ENaC"
    "ENaC" "Gordon's" "Gordon" "cell survival/death" "Bnipl" "Pdgfc" "accreta"
    "kinome" "treated and untreated HESCs" "CellMask" "day 1 decidual uteri"
    "vsEgfr" "deoxynucleotidyl" "thoughEgfr" "fromEgfr" "manyEgfr" "biomass"
    "theEgfr" "egf" "mentionedHb" "femaleEgfr" "the uterine epithelium" "uteri"
    "ofEgfr" "andEgfr" "betweenEgfr" "uterine blastocysts" "inEgfr" "oocytes"
    "luteum" "ThePgr" "Erbb" "thePgr" "Erbb1-3" "the muscular myometrium" "1-3"
    "Egf" "previa" "preterm" "blastocyst" "×2" "40X" "N = 4" "N = 7" "N = 3"
    "v-erb-b2" "Approximately 10%" "thioacyl" "C88/91" "C77/80" "C212/213"
    "chelates" "betweenPml" "ofPml" "PML4" "thePml" "thatPml" "andPml"
    "fromPml" "inPml" "Seto" "Peng" "Guan" "n = 5" "anti–FLAG" "imporin" "SIM"
    "SUMO-2/3" "or 2KR" "K45R" "ψKXE" "SENPs" "β–like" "and 2KR" "nephropathy"
    "Pathologies" "TRAF2/3:cIAP1/2" "cIAP1/2" "cIAPs" "cIAP" "Anti-human"
    "Non-canonical" "Hypoxhantine" "edatrexate" "AVN944" "non-metabolically"
    "mutRAS" "methrotrexate" "AzaIMP" "HX" "AzaHX" "GIC50" "D10" "WM1361"
    "triazene" "-methylguanine-DNA-methyl-transferase (MGMT)" "mutNRAS"
    "mutBRAF" "DTIC" "anti-tumour" "the diagnostic algorithm" "mAb:s"
    "gastric cancer algorithm" "levofolinate" "GOLFIG" "GILFI" "GILF" "Fisheŕs"
    "GCN≥4.0" "copies/cell" "= 0.0002" "= 0.0007" "P  = 0.006" "P  = 0.003"
    "P  = 0.002" "phospho- ERK1/2" "LF-1" "UV-induced UDS" "UDS" "2KA" "5KR"
    "residue/s" "KATs" "GST-p21C" "immunocomplexes" "anti-acetyl"
    "higher UV fluences" "fluences" "enzyme/s" "KAT" "SILAC" "J/m 2"
    "N-nitroso" "N-methyl-" "microdomains" "IVIS" "3×10" "cells/flank"
    "Rockville" "shCav" "μg/cm 2" "fumitremorgin" "Hoechst" "BSW" "SWCNTs"
    "SWCNT" "nanomaterials" "#12" "Non-tumorigenic" "± 0.2" "non-CSCs" "cells/"
    "non-CSC" "whose TET1 CGI" "PARP-1/PARs" "MspI"
    "heavily methylated TET1 CGI" "EpiTYPER" "MassARRAY" "HpaII" "CGI"
    "non-covalent" "5hmC" "5mC" "carboxylcytosine" "formylcytosine"
    "hydroxymethylcyosine" "methylcytosine" "hydroxymethylcytosine"
    "Non-Targeting" "24 hrs" "neoadjuvant-" "pleura" "non-receptor" "Rous"
    "HER2/hormone" "non-receptor tyrosine kinase" "=0.033" "=0.032" "= 0.008"
    "= 0.2" "= 0.11" "P= 0.006" "= 0.021" "Anti-Human" "n =36" "=65" "=124"
    "iso" "Impedance" "STGM" "stiffer" "whose mtp53" "impedance" "mtp53"
    "Chung" "making scratches/wounds" "scratches/wounds" "pBabe-Puromycin-"
    "retroviruses" "xenograph" "NeuT" "senescence-like" "*** P" "** P" "*  P"
    "24 hr" "Killele" "Vinagre" "P  = 0.001" "two-year" "= 0.004"
    "stem cell-like" "I/Intron" "nCLU" "Intron" "shCLU" "pTRIPZ"
    "IGF-1R/MAPK/Erk-1/2/Egr-1" "hCLU" "/MAPK/Erk-1/2/Egr-1" "AT2052" "Goetz"
    "SA-β-gal+" "hCLUp" "psCLU" "sCLU’s" "Ku" "secretome" "IGF-1-sCLU" "sCLU"
    "drastic pH" "Southern Brazil" "13/216" "35/291" "5/97"
    "The Brazilian founder haplotype" "hemizygotes" "proband" "probands"
    "Chompret" "HBCC" "HBOC" "southeastern Brazil" "Western Europe"
    "Northern America" "Paraná" "oligomerise" "LFL" "Li-Fraumeni-Like" "2/59"
    "70/815" "CI95%" "LFS/LFL" "southern Brazil" "p = 0.04" "n = 22" "= 11"
    "cardiac ischaemia" "ischaemia" "Noxs" "a pivotal stabiliser" "stabiliser"
    "the vascular pathologies" "Nox" "oxidases" "Evan"
    "peripheral and cerebral vasculopathies" "vasculopathies"
    "inactive procaspase-3" "BMEC" "•-" "0.1–1 µ" "survival/death"
    "vascular capillary lumens" "lumens" "18A2" "calvasculin" "CAPL"
    "metastasin" "member S100A4" "Grb2-associated
binder-1"
    "H/D" "DX-MS" "PTP1B·EGFR/pY992-peptide·VO" "SHP2/G464A"
    "·EGFR/pY992-peptide" "XAGXG" "the equatorial oxygens" "·VO" "Q-loop"
    "H-bonds" "oxygens" "imidazole" "Waals" "E-loop" "P-loop" "rmsds"
    "WPD-loop" "WPD" "rmsd" "Interdomain" "EGFR/pY992" "Gab1/pY589"
    "Paxillin/pY118" "Sprouty1/pY53" "VPMNPNL" "DSEENpY" "SFPN" "EEHVpY"
    "TEGPS" "GSNEpY" "LIPQQG" "DADEpY" "A461T" "LOF" "LEOPARD" "G-agarose"
    "anti-ERK1/2" "Blaheta" "Roman" "Haferkamp" "Axel" "JeM" "re-sensitization"
    "synergistic anti-tumor" "re-sensitize" "re-treatment" "pp70S6K" "pPTEN"
    "Re-treatment" "synergistic or additive anti-tumor" "non-response" "Caki"
    "siRNA/transfection" "5 /6" "non-responsiveness" "phosphatidyl-inositol-3"
    "XJ" "Tricho-rhino-phalangeal" "metastasise" "8q23–24.1" "follicle"
    "vibrissa" "≥ 2" "= 10" "P = 0.003" "= 0.004" "P = 0.03" "P = 0.025"
    "P = 0.002" "P = 0.001" "Schupfner" "Rupert" "Veits" "rs1050171"
    "rs1873778" "CK5/6" "Hassall" "squamoid" "transsternal lymphadenectomy"
    "tumorectomy" "All cases underwent curative hemi-" "hemi-" "Rosai" "Chan"
    "Miyauchi" "thymus-like" "CASTLE" "EnVision + "
    "phosphoinositide-3-kinase (PI3K)-induced Rac activation co-regulated"
    "co-regulated" "tibial dysplasia" "proliferation/survival" "rhBMP-2"
    "hMSCs" "other secondary sequelae" "FDRp" "NF#6" "_Lys2333del" "_6999del"
    "NF#7" "17qLOH" "#16" "iliac" "secondary clinical sequelae" "sequelae"
    "phosphoinosital-3-kinase" "Genomewide" "n=4" "#9" "=0.98" "#10"
    "bioactivities" "MIFs" "dopachrome" "Pasupuleti" "activation/stabilization"
    "mercaptopropionyl" "dichlorofluorescein"
    "the aberrant activation/stabilization" "4-iodo-6-phenylpyrimidine"
    "infection/selection" "stabilization/activation" "uptake/utilization"
    "cytokine/growth factor" "AE" "SMM" "Methylthiazol" "Spry1expression"
    "Macia" "Adoo" "Sabatel" "Huebert" "ABAE" "CPAE" "Impagnatiello" "in 1A9"
    "the human ovarian cancer cell line 1A9" "xl" "1A9" "1  ×  10" "5  ×  10"
    "p44/42" "Inv8" "Inv4" "intravasate" "*P " "4, 5-dimethylthiazol-2-yl"
    "Twenty-one" "N-glycosylation" "Constantinescu" "Albu" "Paneth" "MVG"
    "exosomes" "changer" "exosome" "Colombo" "Pecquet" "tfLC3" "mRFP"
    "ultrathin" "epon" "24hr" "Aequorea" "phototropin" "Strong co-localization"
    "the Pearson’s" "mK02" "subdomain" "WTJak2" "mKO2" "Weak co-localization"
    "strong co-localization" "mOrange2" "Approximately 8 fold more Jak2WT"
    "Jak2V617F" "JAK2WT" "Jak2WT" "miniSOG" "ERES" "pStat5" "co-precipitation"
    "2-3" "V/V" "microtuble" "centromere/kinetochores" "±0.8" "m/min"
    "R240A/L243A" "RATL" "RxxL" "ZM447436" "centromeres/kinetochores"
    "fusiform" "non-degradable" "pHH3" "Enhancer" "miR221/222"
    "phosphorylated/ acetylated" "Miranda" "regualte" "tissues/cell lines"
    "rela" "IKKs" "NF-κB1" "xenotransplant" "inhibitors/sponges" "miR-221/ 222"
    "miR-221/222" "zymogens" "Curtis" "pathologic covariates" "pSTAT3" "siPLAU"
    "Hs343t" "Hs606t" "transcriptomes" "intracardiac" "BOM1-1833" "EV"
    "subytpes" "Non-Hematopoietic" "30mins" "Nu/Nu" "p=0.006" "=0.025"
    "re-expressing" "Chauhdry" "autocleavage" "UV-" "eCFP" "Chaudhry" "SVM"
    "CASVM" "EEPD131↓G" "EEPD131" "↓G" "Alvarez" "a well-defined subset"
    "10 ng/ml" "WRE" "Δ45-β-Catenin" "siginificant" "RWP-1"
    "Δ45-β-CateninER-myc" "tetrabromobenzotriazole" "CHO-1" "LY294.002 (LY)"
    "Phosphatidylinositide" "dependend" "1 +" "anti-human" "p=0.002" "S2 A"
    "pY705-STAT3" "their respective targets pT288-Aurora" "pT288-Aurora"
    "phopho" "HCT" "ortho" "chlorophenyl" "HPNE" "Transducers" "AT9283"
    "ZM44743911" "AJI-100" "AJI-214" "AJI" "× L" "= 2.7" "= 3" "p=0.003"
    "= 0.04" "co-depletion" "co-incidence" "=22" "rs2853669" "chr5:1,295,349"
    "TTCC" "1p/19q" "G135C–G172G" "135G/C" "Krupa" "rs1801321" "rs1801320"
    "135C/C" "MFechheimer" "JMS" "MFurgerson" "exogenous K18ΔK280"
    "hexapeptide" "PHFs" "441WT " "PHF" "/G272V " "/441WT"
    "GSK3β (S9A)/441WT or GSK3β (S9A)/P301L" "/P301L" "***p " "** p "
    "441WT/AICD" "352WT/AICD" "352PHP/AICD" "441WT" "**p " "352WT" "*p "
    "352PHP" "K18ΔK280" "R5H" "Dictyostelium" "FAC1" "invariant" "lobar" "NFTs"
    "parkinsonism" "Intramembrane" "sporadic Alzheimer’s" "sporadic Alzheimer"
    "both Alzheimer’s" "mortem" "paracrystalline" "Hirano" "endometria"
    "co-transfections" "Huang" "Shih" "non-adipose tissue" "SDF-1 expression"
    "SN50" "p1010-Luc" "gastric carcinoma TSGH" "TSGH" "Chemoattractant"
    "lipoproteins" "the gastric cardia" "the typical LPSs" "LPSs"
    "gastric dysplasia" "bronchoscope" "6PG" "-positron" "positron"
    "fluorodeoxyglucose" "2DG" "TC10a" "Ds" "-Carbamoyl-aspartate" "metabolome"
    "fumarate" "OMeG" "WB" "phosphogluconate" "bisphosphate" "TOFMS" "CE"
    "oligomycin" "L858R+T790M" "PFK" "1930s" "non-responders" "5P" "mean ± S"
    "m / z" "immunoassays" "IJB" "ATCC" "Snider" "LPAR1/3" "TPA"
    "tetradecanoyl" "LRAR" "blockers" "Ki16452" "NanoPro" "LPAR" "ED50" "-OMPT"
    "OMPT" "LP-105" "LPARs" "ethanolamide" "NAEPA" "VPC31143" "LPAR1-3"
    "a multilayer squamous carcinoma epithelium"
    "organotypic three dimensional co-cultures" "co-cultures" "p = 0.03"
    "both the micro-dissected FFPE" "sdRNA" "DLD1" "miRNA-like"
    "calculated Pearson's" "≤0.0005" "P≤0.006" "non-microdissected"
    "approximately 800 bp" "≤0.006" "U19" "taqman" "*TOP" "oligopyrimidine"
    "C/D" "sdRNAs" "eukaryotic genomes" "= 0.45" "= 0.66" "P = 0.02" "20x"
    "≥60" "1q25" "Trisomy" "histotypes" "BIRC8" "PYCAR" "-1207-5p" "-1207-3p"
    "≥4-fold" "≥4" "≥ 4" "global SNP/copy number analysis" "Epithelioid"
    "sarcomatoid" "epithelioid" "11/75" "trisomy" "CNGs" "co-amplification"
    "6/26" "≥ 3" "≥ 2" "5/12" "noncancer" "patho" "0.93–1.05" "1.00–1.14"
    "=0.99" "=1.07" "IQR" "had pathologic Gleason" "Bastus" "21q22"
    "Interquartile" "= 20" "=0.06" "N=18" "ZYW" "SYZ" "Thiazolinediones"
    "thiazolinediones" "Early growth response-1" "PPRE"
    "silence/overexpression" "Thr183/Tyr185" "24 h" "caspase3/7" "Qi"
    "re-aligned" "27PolyT-AGG" "31PolyT-TTA" "PolyT" "G-quadruplex"
    "quadruplex" "-polyT" "polyT" "ExoVII" "25GGT/T7" "18GGG/T1" "21TTA/T7"
    "ddGTP" "‘TTA’" "UA47-48AU" "UA" "-AAUCCCA" "AAUCCCA" "= 0.48" "andk"
    "constantsk" "Markov" "hidden" "TTA" "Tetrahymena" "ddNTPs" "18GGG/T13"
    "18GGG" "TIRF" "U42" "Pseudoknot" "smFRET" "re-aligns" "GGTTAG"
    "re-alignment" "Transcription/Translation" "= 0.61" "= 0.098" "= 38"
    "synergisms" "Weak HIV-1-specific CD8 + T cells"
    "strong HIV-1-specific CD8 + T cells" "efect" "A-phosphorylated"
    "8000 viral clade" "clade" "m/z" "Threonin" "CD3 +" "TCID 50"
    "CD8 + T cells" "CD8 +" "incompleteness" "interstudy" "1.28–2.16"
    "0.48–3.43" "0.55–2.67" "1.34–2.68" "1.31–2.19" "1.60–2.97" "1.08–2.15"
    "1.46–3.38" "1.05–2.10" "Dziadziuszko" "1.15–2.25" "1.35–2.68" "Ottawa"
    "Newcastle" "non-Asian" "BISH" "Google" "= 57" "= 71" "= 58" "Non-Small"
    "S31-201" "product-like" "cellulo" "natural product-like" "ANTI-FLAG"
    "STAT1 α" "+1" "Terrano" "propense" "S62D-eYFP-Bcl-xL" "eventhough"
    "videomicroscopy" "a red fluorescent protein (RFP)-tagged histone-2B"
    "histone-2B" "videomicoscopy" "cyto-" "cyto" "ubiquitine" "=3" "=20"
    "uterine decidua" "myometrium" "decidua" "hydatidiform"
    "Human placental explants" "pBax-" "pBax" "primary placental explants"
    "DNA meanwhile 100 ng leptin/ml" "cPARP" "nonpregnant" "aminoacid"
    "outermembrane" "placental villi" "placental explants" "Placental explants"
    "Poly [ADP-ribose] polymerase-1" "leptin/ml"
    "BeWo cell line and human placental explants" "human placental explants"
    "trimester" "de-repressors" "n = 5" "24h" "non-responding" "pcDNA/control"
    "pcDNA/p21" "pcDNA" "anti-miR-224-" "ppRb" "weeker" "A549/DDP/p21"
    "A549/DDP/control" "∼23.5%" "pEZX-luc-p21/3" "-UTR-wt" "pEZX-luc-p21"
    "pGCMV" "pEZX" "at least three publicly available algorithms" "∼6.8-fold"
    "SPC-A1/DDP" "A549/DDP" "nonresistant" "resensitise" "Let-7i" "P =0.007"
    "=0.0032" "=0.024" "Δ  C" "=0.018" "=38" "G 0 /G 1 phase" "24 h" "μ g "
    "endoscopic biopsies" "n=5" "both normal colonic mucosa" "Ventana"
    "immunostainer" "autostainer" "non-uniform"
    "large intracytoplasmic vacuoles" "underwent neoadjuvant" "NPV"
    "the normal colonic mucosa" "non- BRAF" "VE1" "interobserver"
    "metastatic/recurrent" "chemo/radiation" "n=36" "=133" "aslog" "SAINT"
    "TASSER" "~3%" "phosphomutants" "our previous observation thatHDAC5"
    "thatHDAC5" "the mitotic midzone" "midzone" "nucleo" "phosphomutant"
    "co-repressor" "BCoR" "= 30" "nLC-MS" "mg/L" "non-eQTLs" "6p31.2" "8q24"
    "6p21" "eQTLs" "G:97%" "G:97.4%" "A:0.2%" "ZBTB7A" "rs10413888" "rs8103453"
    "biofeatures" "FunciSNP" "7p21" "3q32" "hom" "rs1860661" "3p24"
    "the previously reported SNPs" "rs13034020" "rs444929" "2p16" "6q23"
    "10p14" "5q31" "Chicago" "USC" "previously reported SNPs" "19p13.3" "MCHL"
    "Sternberg" "1 ×10" "=1.0" "= 29" "= 62" "= 8.3 × 10" "= 1.8" "=1.2 × 10"
    "1× 10" "MyLa" "Houston" "Selleck" "Diego" "Calbiochem" "LckI" "Ruiz"
    "Montero" "the global phosphoproteome" "co-signal" "non-RTKs" "MK01" "MK03"
    "phosphoproteomes" "promiscuousness" "H1975" "pEGFR" "SynGAP"
    "slightly more abundant pAXL" "pAXL" "~8-fold"
    "neurotrophic tyrosine kinase receptor related-1" "related-1"
    "pathways/networks" "co-targeting" "CL387,785" "BIBW-2992" "BIBW"
    "co-drivers" "phosphopeptides" "identification/quantification" "PC9GR"
    "anti-phosphotyrosine" "/mammalian" "NRF2-target genes polymorphisms"
    "Tijhuis" "Arisawa" "Hu" "Ala16Val" "Serbia" "1.08–2.26" "Romero" "105Ile"
    "Ile105Val" "Reszka" "alloenzyme" "dihaloalkanes" "heterozygotes"
    "0.57–1.14" "Homozygotes" "Ovsiannikov" "Dortmund" "Moore" "England"
    "Rothman" "Africans" "isoenzyme" "Harbottle" "dihydrodiol" "urothelium"
    "Remy" "Gundert" "Val16Val" "Ala16Val " "Ile105Val " "Val105Val" "105Val "
    "16Val " "1.30–2.62" "significantly older"
    "mitochondrial superoxide dismutase ( SOD2 ) (rs4880) genetic polymorphism"
    "Matic" "Komiya" "Vineis" "Terry" "Kucukgergin" "Cengiz" "Zeng" "Kellen"
    "105Val" "Sutton" "Matsubayashi" "Shimoda" "16Val" "rs4880" "−69C" "Coles"
    "rs3957357" "Watson" "Pemble" "rs1695" "Kawakami" "Simic" "Savic"
    "Ercegovac" "Pljesa" "uroepithelium" "Hempel" "Yamamoto" "Maher"
    "Wakabayashi" "Kensler" "Munday" "inductors" "Iida" "Zeegers" "Brinkman"
    "Volanis" "Cohen" "dietary nitrites" "aromatic amines" "nitrites" "amines"
    "Grotenhuis" "Ta/T1" "MIBC" "NMIBC" "Ta" "Western and Southern Europe"
    "Poland" "= 4 " "= 0.08" "= 0.02" "P  = 0.006" "P  = 0.03" "= 0.05"
    "non-cancer" "= 0.01" "= 0.04" "= 0.005" "P  = 0.001" "−617C" "HIF1α/β"
    "co-activation" "TRIP230ΔRb" "ΔRb" "Gilkes" "meric" "GST-ARNT-PAS-B"
    "Partch" "Elferink" "an essential co-activator" "Hepa1c1c7" "co-purifies"
    "Rb’s" "Sin3a/b" "Hypo-phosphorylated Rb" "procollagen" "re-perfusion"
    "Hypoxia inducible factor-1α" "its essential co-activator" "non–invasive"
    "24 h" "TP53 / Trp53" "Trp53/TP53" "TP53/Trp53" "Tyr::CreERT2 +/"
    "Trp53 LSL-R172H andTrp53" "SNVs/Mb" "non-UVR" "subcutis" "non- V600E"
    "~3.5" "mild erythema" "erythema" "UVB" "UVA" "or 15" "2 +" "~50%" "~70%"
    "non- V600" "non-melanoma" "Antihormone" "Anti-hormone" "antihormone"
    "traditional Sanger" "PR+" "Missense" "168/189" "176/189"
    "technological advancements" "Ampliseq"
    "The recent technological advancements" "advancements" "ER+" "BRA" "M1c"
    "Acral" "poorest" "V600K/R" "DDFI" "OncoCarta" "=0.66" "P =0.001" "=0.01"
    "=62" "n =39" "non-random" "Sweden"
    "such a risk-reducing contralateral mastectomy"
    "a risk-reducing contralateral mastectomy" "noncarrier" "nonanthracycline"
    "CHEK2-" "CHEK" "1.41–2.99" "1.79–3.93" "nonsignificant" "mastectomy"
    "lumpectomy" "non-carriers" "RMOT" "ORIGO" "∼1%" "noncarriers" "Dutch" "vs"
    "P =0.003" "Manjer" "tertile" "mucinous histology" "Kirsten" "v" "WHR"
    "bodyfat" "=  0.032" "= 0.032" "=  0.045" "=  0.001" "=  0.002" "=  0.041"
    "=  0.007" "=  0.006" "= 0.021" "kg/m 2" "Cα" "β7" "initio" "Y570R K883E"
    "αD" "αC" "interdomain" "RMSD" "EMPIRE" "JH1" "essential thrombocythemia"
    "homology-2" "oesin" "adixin" "zrin" "FERM" "kinase-2" "pSTAT5" "β4" "β8"
    "SKF" "24±2.37" "DIV" "RhoAL63" "RhoAN19" "Dendrites" "dendrites" "Sholl"
    "synapse" "dendrite" "accumbens" "=24" "KLG" "JD" "co-founder" "JBW"
    "habitus" "Pelletier" "PolymiRTS" "MirSNP" "mammograms" "multivariant"
    "1.1-1.8" "G-allele" "T-allele" "rs8176318" "US" "mammography" "Vermont"
    "non-variant" "clinically relevant endpoints" "Irish" "= 0.019" "= 12"
    "surpress" "a MicroCal iTC-200 microcalorimeter" "microcalorimeter" "iTC"
    "lysis" "BCA" "rpm" "Bonataike" "RIPA" "pCMV5.0-HA-" "-Myc- S" "FV"
    "at least 20 ROIs" "1/6" "/I" "ROIs" "Toolbox" "Fluoview" "Olympus" "ROI"
    "el" "pECFP-C1- s" "re-transformation" "Yeastmaker" "elP" "-Myc-"
    "pECFP-C1-S" "GIBCO" "Tian" "Shengli" "Dallas" "CRUZ" "Y2HGold" "Clontech"
    "-benzo-2,5-quinone" "ClBQ" "Chlorophenyl" "actives" "selenomethionine"
    "Eersel" "NFT" "receptor-2" "apoliporptein" "PCT" "·K" "entropy" "enthalpy"
    "Northhampton" "Ni" "pET15b" "ub-" "ub" "iTC200" "Northampton" "pEYFP-C1-"
    "pECFP-C1-" "PROFace" "ECFP" "pEYFP" "pECFP" "sapiens" "nr" "-Ade" "-His"
    "-Leu" "-Trp" "Aba" "aureobasidin" "pGADT7" "NpGBKT7-" "NpGBKT7" "NpGBKT"
    "postmortem" "butylhydroperoxide" "tert-" "tert" "Kurokawa" "CXXC" "UXXC"
    "tubule" "Apolipoprotein E receptor-2" "SECIS" "UGA" "selenocysteine" "ITC"
    "Calorimetry" "alpha 1a" "selenocysteines" "selenoproteins" "= 37" "Δ S  1"
    "= 2.1" "= 12" "± 5" "the K-ras-mutated airway epithelium"
    "K-ras-dependent pulmonary premalignancy" "anti-tumorigenic"
    "the cytologically normal bronchial airway epithelium"
    "human bronchial airway epithelium" "Schembri" "the pulmonary epithelium"
    "μmol/L" "TZDs" "TZD" "nmol/L" "ELISAs" "mirRanda" "Vana"
    "K-ras-mutated HBECs" "premalignant K-ras-mutated HBECs" "HBEC7"
    "pulmonary premalignancy" "premalignancy"
    "K-ras-mutated pulmonary epithelium" "-125a-3p" "HBEC" "HBECs"
    "cobblestone-like" "non-users" "1 × 10" "19q13" "co-amplified"
    "translocations/amplifications" "HTGTS" "KpnI" "DA107" "Pvt-1" "6-kb"
    "DAB538" "DAB601" "DAB494" "DAB361" "DAB496" "re-hybridized" "MycD"
    "HindIII" "Igλ" "Igκ" "DABB-cell" "DABB" "DA473" "Eμ-Bcl-2" "DJβ/DJβ"
    "DJβ/+" "DJβ" "haplo" "CSR-associated DSBs" "complicon" "complicons" "Sμ"
    "100–200kb" "Cμ" "IgA" "Exons" "BFB"
    "IgH V(D)J recombination-associated DSBs" "G1/S" "R&D" "Ltd" "Vernalis"
    "AJM" "Go6975" "Davies" "Cole" "Eμ-myc" "pH2AX" "phH3" "MV4" "PF-477736"
    "AR678" "SB21807" "GDC" "&D" "= 6" "pChk1" "IC 50 s" "GI 50" "ÜD" "BA"
    "cytochrome P450c17" "migration/angiogenesis" "AR-co-repressor"
    "23 consecutive GGYs" "GGYs" "MID1/α4" "polyGGY" "polyCAG" "PDPK-1"
    "phosphatase 2A" "the ventral midline" "urethra" "midline" "Opitz"
    "the secretory epithelia" "18/98" "= 0.01" "S1E" "α4" "non-genomic"
    "a facile summary readout" "WSHU" "os" "DHL6" "gain/translocation" "WSU"
    "Granta" "vavBcl2" "shp16" "MSCV" "aCGH" "UNMC" "UMCN" "co-occur" "PEST"
    "109/262" "the GISTIC algorithm" "Nebraska"
    "larger gains affecting chromosome 12q13" "12q13" "p16/" "FLIPI" "CDKN2a/b"
    "GISTIC 2" "∼45%" "= 24" "n = 10" "P = 0.001" "= 0.003" "T-ML"
    "ischemia/reperfusion" "signaling/modulators" "Fulco" "Reznick" "Pillai"
    "Sakamoto" "OHdG" "hydroxydeoxyguanosine" "ischemic/reperfusion"
    "hydorxydeoxyguanosine" "cardiomyoctes" "CIHR" "Singh" "Gurmit" "CBCF"
    "Melville" "Linher" "Katja" "Johnson" "withdrawn" "GASmut" "LKB1Δ-1083"
    "Δ-1083" "TTCTGGGAA" "TTCTTGGAA" "TTCN" "Softberry" "NSITE" "184B5"
    "PRLRBP" "SF1b" "SF1a" "ΔS1" "non-specifics" "Co-Immunoprecipitation"
    "CK1δ" "9q33.1-q33.3" "phosho" "ovarian carcinoma 2/disabled homolog 2"
    "2/disabled homolog 2" "WQ" "RJ" "RSV" "KHSV" "pNLENY" "sernine" "Vpr+"
    "pVSV" "viral genome" "NLENY1-ES-IRES" "ΔVpr" "NLENY" "Anti-Flag" "IKKα/β"
    "cells/ml" "1 × 10" "macrophage-like" "pCDNA3" "S2C" "anti-Flag"
    "nonresponder" "monolayers" "Mir" "89/295" "antagomir" "miR-17~92"
    "miR-20a" "miR-19b" "colorectcal cancer (CRC) chemoresistance"
    "colorectal cancer chemoresistance" "cells/mL" "≥20%" "≤20%" "p =0.006"
    "p=0.001" "non-restricted" "Yongjung" "Yoshizawa" "A Deek's" "Deek" "≦20%"
    "scored≥8" "scores≥8" "covariants" "RDOR" "logit" "PLRs"
    "the symmetrical SROC" "SROC" "nasopharynx" "genito" "score≥8" "≥8"
    "Brazil" "PLR" "QUADAS" "= 54" "= 26" "= 15" "= 13" "P = 0.001" "= 7"
    "inclusion/exclusion" "validaton" "DNA/chromatin" "nonredundant"
    "DNA-bound FANCD2/I" "andFANCM" "theFANCM" "inFANCM" "ofFANCE" "aFANCE"
    "ofFANCG" "theFANCL" "shFANCF" "moderately reverted cytoplasmic/nuclear"
    "bothFANCB" "fromFANCG" "thatFANCB" "andFANCG" "inFANCL" "eChIP" "inFANCG"
    "andFANCL" "inFANCB" "monoubiquitinating FANCD2/I" "theFANCB"
    "significantly more resistant thanFANCB" "ofFANCB" "thanFANCB" "theFANCG"
    "aFANCG" "createdFANCG" "UBZ" "FANCD2/I" "pancytopenia" "interstrand"
    "cytoplasmic/nuclear" "subthreshold" "VSIG10" "STANT" "multisite" "MORs"
    "-monophosphate" "monophosphate" "homozygotes" "&A" "≥7/10" "E-supplement"
    "rs1322650" "rs736259" "5-like" "≤ 3/10" "rs1892359" "rs1892356"
    "rs1937622" "=3.6" "ß=12.4" "the intronic TAOK3 SNPs" "≥ 7/10" "=1.41×10"
    "=1.55×10" "=2.6" "rs 1277441" "rs 795484" "rs428073" "One associated SNP"
    "bootstrap" "=2.77×10" "rs1277441" "p=1.01×10" "95% CI=10" "PACU" "=NS"
    "SDB" "aberrancies" "the only relevant covariate" "≤3/10" "nausea/vomiting"
    "significant co-morbidities" "intravenous fentanyl" "tympanostomy"
    "myringotomy" "flumazenil" "remifentanil" "ChartMaxx" "7/10"
    "the most significant SNPs" "adenoidectomy" "postoperative nausea/vomiting"
    "just begun" "fentanyl" "ketorolac" "2C9" "A118G" "MOR" "opioids"
    "Americans (AA)" "rs795484" "mcg/kg" "tonsillectomy" "racial/ethnic" "= 10"
    "≤ 3" "=36" "=17" "=26" "= 17" "5/30" "=12" "≤3" "=1.14" "=1.01"
    "karyotypes" "17p−" "17p" "⩽0.1" "IIIa" "3p" "5p " "5p"
    "somatic uniparental disomy" "14q" "MutSig" "renal cystic nephromas"
    "nephromas" "Leydig" "Sertoli" "Germline " "tumor/normal" "GRCh37" "mean±s"
    "HER1/3" "Chk1/2" "ERBB2/3" "Kato" "Titer" "EMT-like" "spindle-like"
    "shERBB2" "phopsho-" "phopsho" "underpinnings" "Stepwise" "gatekeeper"
    "BGJ398" "Phospho-ERK1/2" "co-dependency" "ISC" "FPN" "nonheme" "Alexa"
    "IREs" "rs2736100" "=1.17" "rs10936599" "3q26.2" "Mayo" "1.0×10" "WTCCC"
    "Wellcome" "Francisco" "at least one SNP" "rs1920116" "1×10" "=2.1"
    "=1.1×10" "~75%" "=8.3" "regulon" "NuSAP" "transport/localization" "Stau1-"
    "Stau" "htert-RPE1" "Δ2" "Dmut" "Ubi" "DTB" "APC/C-" "regulons" "Staufen1"
    "S2B" "G 1 /S" "XX" "immunoresponses" "inturn" "α/β" "latters" "formers"
    "supernatants" "MOI" "iDC" "coxsackievirus" "encephalomyocarditis"
    "fatal pulmonary edema" "herpangina" "EV71" "iDCs" "1/2 " "subcentimeter"
    "volumetry" "confounder" "fluorothymidine" "retroperitoneum"
    "aggressive subclones" "= 0.024" "= 63" "BCL" "non-tumorigenic" "ALDH1 +"
    "PIN20YAP1" "ALDH1+/CD44+" "tumorspheres" "ALDH1+" "as 1×10" "PIN20" "DOX-"
    "DOX" "Eso" "DOX+" "CATTCC" "JHESO" "PINYAP20" "non-tumorigenic Barrett’s"
    "tumorsphere" "premaligmant" "Co-transfection" "≤10%" "Adp66shcRNAi" "eIF"
    "uncoupler" "Oligomycin" "phenyl" "-chloro" "chloro" "carbonyl" "ubiquinol"
    "succinate" "mtROS" "U/ml" "oncomiRNA" "TargetScan" "231T-si221"
    "miR-23b-3p" "siPTEN" "231T cells" "rhTRAIL" "miR-23b" "Anti-mouse"
    "regulaton" "Kaposi's" "Kaposi" "ectodomain" "electrocautery" "cryosurgery"
    "SmithKline (GSK)" "SmithKline" "Glaxo" "Cervarix" "Gardasil"
    "the multifunctional HPV oncoproteins (E6 and E7) synergise" "synergise"
    "Karson" "Leong" "de-regulated" "Yeasmin" "the possible transducer"
    "juxtacrine" "Talora" "Immunohistochemisrty" "De-regulated" "socio"
    "Grade-II+" "19/128" "82/85" "109/128" "all the cervical biopsies"
    "Kashmir" "Jammu" "Chennai" "cytotechnicians" "Papanicolaou" "colposcopy"
    "III+IV" "co-infection" "85/98" "24/30" "stage-I+II" "area-under-the-curve"
    "Precancer" "CIN2/3" "±0.12" "ISCC" "the cervical epithelium"
    "simian virus 40 (SV40) largeT" "largeT" "blown" "newer" "precancer"
    "16/18" "p  = 0.007" "= 0.0004" "p  = 0.003" "= 0.005" "p = 0.001" "= 10"
    "= 4" "EnVision+" "= 0.0001" "= 30" "LBD" "AFs" "coregulators" "LXXLL"
    "ShVav1" "shVav1" "+71" "ELF-1" ".1/ELF-1" "5∼22" "25∼38" "TCFα" "NF-e"
    "143∼152" "ETF" "+165" "rVista2.0" "TRANSFAC" "pVav" "mol/L" "10 ng/mL"
    "non-hematopoietic" "adhesion/detachment" "specifc" "PE1/PE2" "-CACCCGGTCA"
    "CACCCGGTCA" "-CACCCGGT" "CACCCGGT" "homologies" "-TACACA" "TACACA" "AGAC"
    "oxytetracycline" "HRE-2" "USF/DNA" "assesments" "CG→AT" "hexanucleotide"
    "substate" "→G 1" "dis" "USF1/2" "USF1→USF2" "CACGTG" "type-1" "Tet-OFF"
    "Sussan" "Marzec" "Polymorphisms" "carriers/" "GG+GA" "Kt/V" "CACS"
    "autoregulates" "ARE-like" "-617C" "-653A" "CTPP" "rs35652124" "rs6721961"
    "=0.007" "=0.006" "more comprehensive SNPs" "Tokyo" "Sichuan" "rs28493229"
    "TFBS" "Armitage" "Cochran" "1.46–3.07" "rs1561876" "= 0.98–1.67"
    "1.07–1.80" "rs113420705" "one commonly associated SNP" "Onouchi"
    "rs2290692" "isoenzymes" "/nuclear" "transmission/disequilibrium"
    "aneurysm" "Taiwanese" "Koreans" "Tomisaku"
    "more comprehensive single nucleotide polymorphisms" "rs2069762"
    "rs2720378" "= 1.00" "= 0.98" "ta" "BJ" "HL-60/ADM" "49.53±2.43%"
    "105.36±42.94%" "pEGFP" "pCMV" "PxxSP" "DRYK1A" "DSCR" "CMGC" "= 0.006"
    "mg/mL" "phosphopeptide" "scrRNAi" "BIO" "anti-NM1" "DGIIDFTSGSELLITK" "ΔC"
    "ΔIQ" "V5-RK605AA" "wtNM1" "IQ" "ultrastructure" "MeDIP"
    "the cell permeable fluorine-conjugated UTP analogue FUrD" "FUrD" "ITSs"
    "ETSs" "IGS" "of 45S" "IGSs" "the commercial pan- GSK3β antibody 27C10"
    "27C10" "I-associated" "multiprotein" "H3K9" "co-precipitations"
    "ubiquitin/proteasome" "co-variables" "Cowden’s" "Zonana" "The Begg’s"
    "Egger’s" "Begg" "1.16–1.74" "1.12–1.50" "1.28–2.18" "1.19–1.76"
    "the studied populations covered Turkish" "Turkish" "George" "Canbay"
    "ATCTT" "rs3830675" "CNKI" "IVS4" "= 0.008" "= 0.007" "endometroid"
    "adequate PFS endpoints" "ErbBs" "Lafky" "pErbB3" "pMET" "#076"
    "immunohistochemistry (IHC)" "MyBioSource’s" "MyBioSource" "ErbB"
    "osteomyelitis" "endocarditis" "CARS" "non-infection" "endotoxemia" "Seok"
    "CSS 11" "publically available datasets" "Luminex" "1.31fold" "0.83 fold"
    "0.81 fold" "0.85fold" "orthologues" "Cnp" "Jackson" "methicillin" "C11A"
    "intercross" "BSI" "adrenocepter" "rs1800629" "S. aureus -challenged BMDMs"
    "CSS11" "C57BL/6J" "BMDMs" "A/J" "QTL" "aureus" "= 0.05" "n = 10" "= 0.019"
    "= 0.01" "= 0.04" "= 0.041" "= 0.02" "= 0.03" "p = 0.003" "= 19" "solenoid"
    "pCHK1" "Supp" "HU" "T1989" "S/TQs" "Seckel" "alpha-helices" "TOR1 (HEAT)"
    "PIKKs" "Anti-FLAG" "anti-inflammation" "histograph" "IKK α/β"
    "large-sized adenomas" "hematology" "flavonoids" "Georgi"
    "5,7-dihydroxy-8-methoxyflavone" "colorectal adenomas" "azoxymethane-"
    "azoxymethane" "pg/ml" "n =10" "/C" "∼10%" "complex-2"
    "rapamycin inhibited mTOR complex-1" "complex-1" "F5A" "mitomycin"
    "rapamcyin" "* P" "Envision+" "Δ Ψ" "μ g" "TRAIL+SZ" "shRIP3" "necrosome"
    "SZ" "TSZ" "Burk" "Kd" "plasmon" "difluorobenzene" "sulfonamide"
    "pyrimidin" "3SKC" "Malvern" "ng/" "non-radioactive" "VAD" "z" "μ g/ml"
    "/signal" "IC 50s" "Shamas" "the inactive conformers" "conformers"
    "re-equilibrated" "+CL" "−CL" "co-fractionated" "/s" "half-time"
    "liposomes+tBid" "mixing liposomes" "ANTS" "fluorophores" "liposomes"
    "liposome" "-helices" "re-localization" "±0.2" "mean±S" "co-incubation"
    "re-localized" "carboxyl" "S423/425" "mechanism/s" "WTs" "Ser423/25"
    "GSK-3β KO" "10ng/ml" "Ser 423/25" "deletion/inhibition" "−fl/fl" "LVFS"
    "LVEF" "TTC" "Indiana" "Col1a2-cre" "wks" "WKs" "hyper-" "TBRI"
    "Myofibroblasts" "Verastem" "PF-271" "~45%" "VS-4718 treatment"
    "Akt*-expressing" "*-expressing" "* remained" "VS-4718treatment"
    "*remained" "bursa" "adherent, suspended, and soft agar" "~90%" "ID8"
    "pY397" "αv" "U133 Plus" "nu/nu" "β3" "AW" "CVL" "ethno" "Taq" "AssayStrip"
    "Murray" "GGTGGC" "dideoxy" "20p" "StripAssay" "= 19" "Tomson" "Puri"
    "Donaldson" "EspGs" "Luini" "Matteis" "Alternatively EHEC EspG" "pEspG"
    "EspG-E392R:HA" "Q:HA" "late endosomes/lysosomes" "Tomas" "Sinclair"
    "Frankel" "Roberts" "espG  " "+ pEspG:HA" "Tf:TfR" "McGraw" "Maxfield"
    "the neutral extracellular pH" "peroxidise (HRP)" "holo" "peroxidise"
    "EspG:HA" "ImageJ" "the bacterial supernatant" "+pEspG:HA" "EDL933"
    "the infected cells secreted SEAP" "BFA" "escN" "espG" "EspI/NleA" "SEAP"
    "Hazen" "hGH" "Hardwidge" "Clements" "Spiller" "Selyunin" "Roy" "Cossart"
    "Shao" "Ramsden" "EPEC/EHEC" "T3SS"
    "enterohaemorrhagic Escherichia coli (EHEC)" "coli (EHEC)"
    "Enteropathogenic Escherichia coli (EPEC)" "coli (EPEC)" "EHEC" "RabGAP"
    "EspG" "Enteropathogenic and enterohaemorrhagic E  scherichia coli" "EPEC"
    "coli" "scherichia" "*** P  " "** P  " "* P  " "5 × 10" "RE-induced"
    "Transcriptome" "REtr+cKIT" "Krejci" "ZVAD" "tdTomato" "nucleus/cytoplasm"
    "Wright–Giemsa-stained cytospins" "scatter/side" "REtr+c-KIT" "Castaigne"
    "REtr-" "overgrew" "A814S" "Jiao" "A-loop" "NHR4" "re-expressed" "CD34+"
    "REtr" "Frizzleds" "hyper" "Yang" "us" "SIRT1/2" "promoter/enhancer" "CKD"
    "∧ P" "∧P" "***P" "**P" "GES" "*P" "U373" "OVCAR" "Wahab" "6/187"
    "MDS/MPNs" "CMPD" "Philadelphia" "Pardanani" "CBC" "chromatograms"
    "postpolycythemia" "+mar" "DMNT" "WBCs" "CNL" "u" "72/120" "dinucleotides"
    "GenBank" "TCTG" "combs-like" "casitas" "essential thrombocythemia (ET)"
    "vera (PV)" "thrombocythemia" "vera" "MDS/MPN" "JAK2V617F" "μ L" "Buckley"
    "specifiers" "ectoderm" "ubiqutin" "dTomato" "OSKM" "HDF" "BHQ" "HESCs"
    "progenies" "proteosome" "mesendoderm" "hESC" "hESCs" "gallate"
    "epigallocatechin" "PrognoScan" "NSLCLC" "FOPFLASH" "TOPFLASH" "-Aza-dC"
    "25/82" "7q31.1" "mutations/variants" "= 0.045" "= 0.018" "= 0.005"
    "= 0.041" "= 0.034" "Smads" "GATA3mut" "−837" "−932" "1/3" "oligo"
    "pcGATA3mut" "+40" "pcGATA3" "normal HuMedia-KG-" "−318" "−676" "−1141"
    "PhysBinder" "PROMO" "ALGGEN" "TFSEARCH" "−532" "Humedia" "BPE" "KG" "−146"
    "pGLSP" "spinosum (SS)" "KLK" "corneodesmosome" "corneodesmosin"
    "corneodesmosomes" "corneum (SC)" "corneum" "proteases/inhibitors"
    "granulosum (SG)" "spinosum" "KLKs" "granulosum" "× 10" "re-appearance"
    "S/G2/M" "Sakaue" "FGPD" "Fucci" "10.1038/ncomms5048" "doi" "Liang"
    "=0–0.08" "FI" "Förster" "NEBD" "Gy" "PIKK-family" "PIKK" "Non-genetic"
    "non-genetic" "μg " "APC/C" "=0.6" "non-oncogenic" "~19%" "6q12" "6p11.2"
    "~0.61" "Subpopulations" "CDKN2A/2B" "9p" "the deleted haplotype" "SCNAs"
    "co-existing" "vII" "non-vII" "BT340" "vIII" "BT325" "Zong" "unevenness"
    "pileup" "~0.01x" "EGFRwt" "extrachromosomal amplicons" "co-exist"
    "Carboxyl" "EGFRvII" "~20%" "GZ" "GL" "GA" "Gloucester" "America" "JACH"
    "Gonzalez" "Lopez" "Fritsch" "PDSCCs" "pN" "W/MSCCs" "W/MSCC" "PDSCC"
    "BSCCs" "retromolar trigone" "oropharynx" "trigone" "gingiva" "BSCC"
    "basaloid" "Basaloid" "= 11" "≤ 10%" "10-year" "novo" "hMSC"
    "homolog (BAMBI)" "MicroRNA-146a" "Targetscan" "miR-146b-5p"
    "anti-osteogenic" "re-examined" "HBMSC" "Sirus" "anlage" "coworkers"
    "Eskilden" "immunoprivilege" "Lian" "mesenchyme" "skeletal dysplasias"
    "dysplasias" "important TGF-β and activin ligands signal transducers"
    "miR-146a" "SSC" "SSCs" "72-hour" "anti-oncogene" "miRanda" "pGPU6"
    "siSIRT1" "70.2±1.8%" "pca" "mir" "±1.9%" "G0/G1 phases" "5×10" "Kit-8"
    "non-protein" "races/ethnicities" "Graziano" "Sebio" "bolus" "Kjersem"
    "Ryan" "rs61764370" "Vectibix" "ImClone" "PROSPERO" "LCS6" "= 0.72"
    "P = 0.003" "6-month" "non-aspirin" "PTGS" "DLG5" "localises" "rs10815160"
    "rs280521" "rs1800872" "rs3024505" "arachidonate" "ALOXs" "catalyses"
    "rs6983267" "anti-carcinogenic" "= 0.03" "= 0.01" "Guardino" "Amler"
    "Hurvitz" "Perez" "Austria" "Vienna" "TH3RESA" "MARIANNE" "Forrest" "ORR"
    "CONSORT" "BO21976" "ORRs" "TDM4450g" "EMILIA" "-MCC-DM1" "antimicrotubule"
    "ClinicalTrials" "MBC" "95% CIs" "≥2" "PHW" "ZN" "DJ" "MCB" "Manitoba"
    "biospecimen" "Pinhel" "minutess" "mastectomies" "lumpectomies"
    "Phosphonet" "Kinexus" "ERα+" "ERα + " "primary ERα+" "pS2448-mTOR"
    "approximately 10%" "p-S118-ERα" "p-T311-ERα" "p-T311-" "p-S282-ERα"
    "p-S167-ERα" "mTOR/p-S2448" "endpoint" "mTOR" "p70S6 kinase" "p-S2448"
    "n = 10" "= 7" "± 0.2" "= 0.04" "= 0.02" "= 298" "= 38" "= 0.0005"
    "= 0.0002" "= 133" "non-phosphorylated" "= 0.0032" "SDP" "BMV" "VDA" "CDA"
    "Balb/C" "S4B" "expression/secretion" "cc" "ppaxillin" "pFak" "pMAPK"
    "saracatinib/lapatinib" "the possible synergism" "CalcuSyn" "Talalay"
    "Chou" "LR" "MDA-MB361" "inhibition/silencing" "= 0.6 " "IC 50  " "mg/kg "
    "IC 50" "YW" "KOt" "NH" "anti-metastatic" "cN0" "Cox-2/PGE 2" "Adhim"
    "SC-791" "E12/E47" "T-classification" "TSCC" "flowcytometer" "= 0.024"
    "Inhere" "endothelia" "DGKα/aPKCs"
    "10 µM cell permeable PKCζ pseudosubstrate" "pseudosubstrate" "coverslips"
    "OneStrep" "coverslip" "DG" "aPKCs" "SDF-1α-induced" "ELMO"
    "stromal cell-derived factor-1α" "SDF-1α" "SDF" "SDS/PAGE" "β1 Integrin"
    "Non-silencing" "clearer" "hexamers" "Capsid"
    "almost all HIV proteins form homomultimers" "homomultimers" "browsers"
    "minimotif" "Darunavir" "_705926" "#21" "#20" "heterotetramers" "RRE" "#19"
    "Proteosome" "Karopherin" "#18" "#17" "Workflow" "#17-21" "#40375" "#1-16"
    "Workflows" "HIVtoolbox" "identifiers" "protein:ARV" "JSmol" "wireframe"
    "pulldown" "minimotifs" "checkbox" "SQL" "website" "Stanford" "ARV"
    "BioAfrica" "HDFs" "NIST" "multimers" "HIVToolbox2" "workflows"
    "HIVToolbox" "CJX" "QQC" "histogeneses" "monotherapy" "G0/G1" "promots"
    "ED" "synergism" "mor" "IC50" "inefficacy" "ovarian surface epithelium"
    "G0/G1 phase" "co-inhibition" "/G1 phase" "leukemia/lymphoma" "Genini"
    "Immunogold" "p21Bax" "p18Bax" "ΔΨ" "c-myc-HIV-1 PR" "immunogold" "Tom"
    "OMM" "c-myc-HIV-1PR" "S1e" "S1d" "COXIV" "Abcam" "D26N" "D25N" "PMV"
    "Pfizer" "PKAc" "Casp8p41" "eukaryotic initiation factor 4G" "factor 4G"
    "polyproteins" "polyprotein" "capsid" "CO-IP" "DE3" "5 × 10" "Karnofsky"
    "oncologists" "downsteam" "CBRs" "10/18" "nephrectomies" "MSKCC" "KPS "
    "S6RP" "phospho-S6RP" "clinicaltrials" "mTOR/S6" "1/18"
    "definitive dysplasia" "intraobserver" "Matalka" "colonoscopy" "Colectomy"
    "WinRooF" "regenerative mucosa" "WinROOF" "grade-3" "Grade-3" "#3"
    "sporadic adenomas" "Wong" "regenerative epithelium" "regenerative atypia"
    "atypia" "endoscopy" "IIa" "colectomy" "#8" "VM" "DUPS’s" "DUPS" "Wagner"
    "Matrigels" "non-redundant" "DUSP14" "Lmax " "Lmax" "aortic explants"
    "neovessel" "Pcam1" "aSMA" "Imaris" "μL" "blastocysts" "Aiii" "siDUSP3"
    "Nikon" "Ai" "EGM" "siCTL" "H3K36" "Gyu" "Mr" "-H1-like" "accinia" "1/200"
    "non-stimulated" "= 15" "C57BL/6 " "NA" "JKF" "EWT" "MQ" "residuals"
    "circuitry" "These residual cells repopulate" "bodyweight"
    "approximately ~50-90%" "~40%" "βSTAT3" "αSTAT3" "JAGGED" "1–3" "omentum"
    "peritoneum" "the coelomic mesothelium" "mesothelium" "repopulate"
    "‘stemness’" "CYT387" "CSC-like" "H & E" "GI50 " "non-adherent" "GI50" "MZ"
    "ARS" "myristate" "polymerization/formation" "Romanova" "genestein"
    "Zheleznyak" "SOS" "YXXP" "the phagocytic signalsome" "signalsome"
    "an heterologous FcγR/SYK" "FcγR/" "FcγR1 stimulation" "FcγR1stimulation"
    "Fernandez" "anti-FcγR1" "FcγR1" "Kiefer" "Crowley" "YxxP" "TKB" "FcγRs"
    "YXXL" "ITIM" "kd" "FcγRI" "Fc" "J774" "U937IF" "FcγR" "C57BL/6 mice" "Fcγ"
    "BW" "selected viral quasispecies" "pseudotype" "the viral genome"
    "The viral genome" "HPC" "RASF" "the previously described SNPs" "HARRT"
    "These viral quasispecies" "MFIs" "non/low" "naturally occurring SNPs"
    "expressers" "expresser" "nonexpresser" "nonexpressers" "non-expressing"
    "3T5T-containing" "the HIV-1 parental LAI" "non-GFP-expressing" "YU-2"
    "3T5T" "intra-" "and 3T5T" "AGCTTTCTACAA"
    "the previously identified C-to-T SNP" "GAGGCGTGGC"
    "Parental (wild-type) and 3T5T" "Alamos" "Los" "long-lived cell subsets"
    "HPCs" "The resultant viral quasispecies" "the HIV-1 viral genome" "HIVD"
    "a longer lifespan" "SNP-" "C/EBP" "LAI" "LTRs" "viral quasispecies"
    "quasispecies" "119X" "low/intermediate" "N-ethyl-nitrosourea" "aneuploid"
    "subsequent aneuploidy" "SurvivinT34A" "radioresistance" "Wiedemuth"
    "complex/cyclosome" "repair and NHJE in cells" "NHJE" "cs" "shATM" "S1981"
    "Giemsa-" "even hexadecaploid karyotype" "hexadecaploid" "octa-" "octa"
    "der" "Giemsa" "DSBs" "shp53/shSurv" "wt/shSurv" "DSB" "dodecaploid"
    "-shLuc" "DNA/Cyclin D1" "32n"
    "Yet further AnnexinV/propidium iodide stainings" "shSurv" "stainings"
    "hypodiploid" "triploid" "shLuc" "SBC-2" "shp53" "thymocytes"
    "dominant-negative SurvivinT34A" "polyploid" "re-aggregates" "μg "
    "non-homologous" "NL" "JF-T" "AdS" "GV" "VQ" "p85α" "Asp643Aspfs*8"
    "identifier" "CCDS" "dbSNP137" "patent foramen"
    "patent anterior fontanelle" "foramen" "fontanelle" "Rautenstrauch"
    "Wiedemann" "abnormal uterine doppler" "doppler" "APGAR" "34-year-old"
    "cesarean" "Axenfeld" "kg" "thin alae nasi" "nasi" "facies" "39-year-old"
    "×l" "-ATGGCTCCTGCACTCTTC" "ATGGCTCCTGCACTCTTC" "Mutandis" "ICGC" "Spanish"
    "cov  " "cov" "rmdup" "sampe" "BWA" "Sidrón" "HiSeq" "Invitrogen" "Covaris"
    "SureSelectXT" "Germany" "QIAGEN" "Helsinki" "Asturias" "Universitario"
    "Written" "Kabuki" "Guillermo" "Asp643Aspfs" "a recurrent mutation c" "*8"
    "_1933delTGGCA" "progeroid" "Rieger" "HYY" "fs" "Fn"
    "small-for-gestational-age" "the intronic SNP" "the intronic SNPs"
    "the FN-1 intronic polymorphism rs940739A/T" "haplotypes" "rs640739"
    "rs3738919C/A" "rs10174098A/G" "1.16–1.80" "rs940739AT" "αV (ITGAV)"
    "2q34-36" "rs940739A/T" "TAA" "Haplotype" "rs940739 A/T" "rs6725958C/A"
    "= 0.36" "= 1.14" "= 0.033" "= 1.01" "G/" "Kellgren-Lawrence" "HCW" "SBB"
    "simultaneous ectopic co-overexpression" "co-overexpression"
    "mono-ubiquitin-ligase" "pro-apoptotic STAT1-IRF1-X-axis" "DTX3L/ARTD8"
    "JAK1-STAT1:STAT1-mediated" "S10F-H" "S10A" "mono-ADP-ribosylated" "JAK1/2"
    "siARTD" "siDTX" "pSTAT1β" "-promoter-driven" "S7C" "STAT1β"
    "IFNγ-STAT1-IRF1-axis" "siARTD8" "active ARTD8" "TIQ" "DPQ" "ARTD8-"
    "siDTX3L/siARTD9" "ARTD8/DTX3L" "ARTDx" "-ADP-ribosylation" "S5D"
    "other active mono-ADP-ribosyltransferases" "ARTDs" "ARTD8/ARTD9" "S4A"
    "siMock" "subfractions" "pSTAT1α" "STAT1α/β"
    "transcriptionally active pSTAT1α" "pSTAT1" "3q21" "-3-like" "Burkitt"
    "several evolutionary conserved macrodomains" "macrodomains"
    "the active mono-ADP-ribosyltransferase ARTD8"
    "an inactive mono-ADP-ribosyltransferase" "ARTD" "Diphteria"
    "a crucial negative and positive co-regulator" "BAL1" "STAT1α"
    "clinical human mPCa’s" "mPCa" "ARTD8" "B-lymphoma" "macrodomain" "DTX"
    "Non-adherent" "non-canonical" "S9A" "S8B" "S8A" "S6A" "S5C" "S2A" "S1D"
    "mono-ADP-ribosyltransferases" "Co-expression"
    "mono-ADP-ribosyltransferase" "intramembrane" "non-p53" "Multi"
    "insulin/IGFs" "A2780/Cis" "SaOS-2/Dox" "MCF-7/Dox" "carbaplatin"
    "insulin/IGF-1" "insulin/IGF" "IGFRs" "Hodgkin’s" "insulin-like"
    "chemoresistant" "GmbH" "Amaxa" "0.3-3" "non-malignant" "KWL" "JHL" "HIY"
    "YJC" "JSP" "SJK" "never/light" "transcription factor-1" "TRU" "Clara"
    "AAH-AIS-MIA-IA" "Fukui" "pure GGO" "Korean" "cribriform" "AJCC"
    "Histopathology" "GGO" "three interstitial fibroses" "lymphoplasma"
    "fibroses" "nodular GGOs" "Nodular GGOs" "pure and mixed GGOs" "GGOs"
    "nGGOs" "nGGO" "= 0.034" "non-cancerous"
    "the histopathological re-evaluation" "replacemnet" "Oestrogen"
    "several clinicopathological and molecular subsets" "priori" "à" "deeper"
    "oestrogen-" "Slattery" "covariate" "Womens" "Campbell" "Newcomb"
    "progesterin" "T-stage" "Malmö" "progestins" "progestin" "WHI" "Grodstein"
    "MPE" "clinicopathological and molecular subsets" "HRT (CHRT)" "CHRT"
    "Mamö" "different clinicopathological and molecular subsets" "OC" "HRT"
    "non-significant" "AZ" "FTK" "RAF256" "bi" "wt/-/-" "RBO-2" "RBO-1" "RBW-1"
    "onc" "RBOW" "anti-proliferative" "MCa" "SM" "VDG" "MCo" "40/122" "arisen"
    "centromeres" "atand" "Breslow" "phototype" "10/216" "29/214" "109/229"
    "1/100" "QZ" "YQ" "TD" "Zhai" "Tyr31/Tyr118" "Tyr576/577" "SGC7901/vector"
    "Biochem" "Combo" "IFC" "NCI-N87/shRNA" "G1/G0" "SGC7901/MELK" "nc"
    "multidomain" "Bcl" "sucrose-non-fermenting" "≤ 3" "100U/ml" "S7A"
    "= 0.007" "S5A" "KJ" "phosphorylation/activation" "RSK1/2"
    "this biochemical aberrancy" "aberrancy" "kinases/activators" "ATTG"
    "stem-like" "Y-box" "mammospheres" "mammosphere" "Non-targeting" "α6" "Ko"
    "Kim" "Rhee" "Choi" "Yoo" "JE" "Ahn" "EY" "ultrasonography" "anticodon"
    "histoscore" "histoscores" "= 0.05" "± 5" "= 0.001" "= 0.035" "~ 3.2"
    "co-varieties" "Sato’s" "Sato" "Japanese" "Franke" "Zealand" "UC"
    "genotype " "Crohn’s" "95%
CI "
    "= 0.66" "= 0.03" "rs4796793" "= 0.003" "= 0.0008" "JZ" "XY" "Shim"
    "OSwhen" "AIS" "colloid" "lepidicpredominant" "solidpredominant"
    "micropapillarypredominant" "acinarpredominant" "papillarypredominant"
    "the 136" "five-year" "Zhejiang" "= 0.041" "= 0.045" "= 0.0026" "YZ" "ZL"
    "LX" "XQ" "microRNA-200c" "Akt/ERK-miR-200c- ZEB2" "miRNA-200c" "Darby"
    "Madin" "70z-Cbl" "ZEB1/2" "pTNM" "Akt/ERK- miR-200c-ZEB2" "non-silencing"
    "Akt/ERK-miR-200c-ZEB2" "ERK-miR-200c-ZEB2" "basal-like"
    "-diamino-benzidine" "2–3" "Neumiester" "the pHER2 evaluable subset"
    "PathCR" "timepoint" "pHER2" "Yale" "Denkert" "GeparQuattro" "NOAH"
    "pathCR" "BrUOG" "HER2+" "Hopkins" "Johns" "Gastroenterology" "email"
    "Guangdong" "Nanshan" "Ave" "Nanhai" "Shenzhen" "Jin" "Zhe" "YM" "XF" "ZC"
    "LW" "SJM" "ZJ" "5-aza-2" "re-expression" "cancerf" "progressors"
    "nondysplastic esophageal squamous cell mucosa"
    "normal squamous epithelium" "AUROCs" "AUROC"
    "matched normal esophageal epithelia" "EACs" "NMVs" "Barrett’s" "Barrett"
    "NMV" "AUROC " "qMSP" "AJB" "YEW" "XL" "ZRQ" "KMH" "YI" "Microsatellite"
    "multicenter" "the most frequent mutational hotspots" "Loupakis" "=11"
    "cecum" "microbiota" "interquartile" "FOLFOX4" "hotspots" "HUGO" "cecal"
    "confounders" "LINE-1" "= 51" "=13" "95% CI " "ERS" "ATS" "IASLC"
    "Integragen" "Sanofi" "Astellas" "Serono" "Merck" "Amgen" "Puig" "Pierre"
    "Blons" "Damotte" "Lemaitre" "Devez" "Ducruit" "Charpentier" "Alifano"
    "Zouiti" "Lupo" "Mansuet" "possible distinct genotypes" "Swedish"
    "mutant/wild type" "≤ 10%" "a discordant genotype" "non-mutated"
    "non-surgical" "clinicians" "/18" "1 bronchial biopsy" "Microbiopsy"
    "naïve" "L861Q/p" "INS20" "Dieu" "Yatabe" "longer PFS" "DEL19"
    "wild type/mutant" "≤20" "JW" "AMB" "histone 2AX" "naphthoflavone" "DOXO"
    "DMEM" "karyotype" "DRE" "senescent-like" "timecourses" "timecourse"
    "Cal51shAhR" "MDA-MB-468shAhR" "aminoflavone" "S1C" "BNF" "Naphthoflavone"
    "Sloan" "cBio" "hypoxia inducible factor 1α" "DREs" "CYP/SULT" "hampster"
    "SULT" "benzo" "cytochome" "-6,8-difluoro-7-methyl" "flavonoid"
    "Aminoflavone" "GI" "TNBC" "MQA" "highly polymorphic trinucleotide"
    "trinucleotide" "lipoid" "hyperandrogenism" "ng/dL" "IVS"
    "17OH-progesterone" "nCAG" "Nermoen" "Nelson" "adrenal incidentalomas"
    "incidentalomas" "virilizing CAH" "CAH" "× 10 " "JNZ" "DGZ" "stemness"
    "3KR" "CLL/lymphoma" "miR-34c" "miR-34b" "c" "TWP" "SZY" "DWW" "LJ" "Cyto"
    "Propyl-pyrazole-triol" "4,5-dimethylthiazol-2-yl" "vasogenic edema"
    "adjacent normal follicular epithelium" "Menendez" "propyl-pyrazole-triol"
    "ERα/β1" "Vito" "bilayer" "LNM" "clinicopathological/biological" "Brindel"
    "80+" "radioiodine" "levothyroxine" "thyroidectomy" "ETE" "NTG"
    "nuclear/cytoplasmic" "5-dimethylthiazol-2-yl" "I/II" "≥3" "n = 39" "= 50"
    "JP" "JO" "TND" "groupss" "titer" "viremia" "Whitehorn" "causative SNPs"
    "rs11187870" "a nonsynonymous SNP" "SNPinfo" "JPT " "rs3828916" "SR"
    "ESEfinder" "JPT" "DF" "Lampang" "Ratchaburi" "Approximately two fifths"
    "fifths" "non-DSS" "rs3132468" "Vietnamese" "rs753724" "SMW" "BD" "PXC"
    "FX" "sutdy" "ture" "penentrant" "Ti/Tv" "gain/loss" "dbSNP"
    "sporadic breast cancer genomes" "FOX" "transition/transversion" "SINE"
    "#7" "#4" "#6" "#5" "GATK" "VarScan" "multiple recurrent germline"
    "non-breast" "BRCA1+" "BRCA1 +" "12q" "= 30" "#2" "#1" "SKS" "HK"
    "cytoprotective/neuroprotective" "vitro" "edema" "infract"
    "deprivation/reperfusion" "photoproduct" "ionic" "photoproducts"
    "isoalloxazine" "neutraceuticals" "mMol/L" "μg/ml" "30 min" "QGL" "ZTL"
    "XZ" "CL" "WY" "Dulbecco’s" "labelin" "deoxynucleoitidyl" "Dulbecco"
    "retrovirus" "severe dysplasia" "dysplasia" "degron" "P  = 0.003" "= 0.018"
    "= 4" "= 5" "= 24" "= 36" "= 0.005" "= 0.006" "= 0.002" "≥5 " "BALB/c"
    "Caspase-3/7" "A/B" "YS" "CW" "A/acylatransferase" "lactone" "Bromoenol"
    "acylation/deacylation" "plamostatin" "O-acylation" "GXSXG"
    "deacylation/acylation" "APTs" "palmitoyl" "HPDP" "S-acylation" "μg"
    "revertants" "polyisoprenoid" "1/2" "Palmostatin" "palmostatin" "MAFP"
    "trifluoromethyl" "PLA/AT" "A/acyltransferase" "× 10" "μg/mL"
    "co-precipitated" "pretest" "TaqMan" "cfDNA" "Amoy" "1/1000" "1/10" "bp "
    "Zhou" "snapback" "IgVH" "Aguayo" "Kapłon" "Szmigielska" "Frater"
    "microvasculature" "Hodgkin" "immunosurveillance" "adverse prognosticators"
    "prognosticators" "lipopolysaccharide" "Fayad" "Molica" "Biondi"
    "bulky lymphadenopathy" "B/C" "lymphadenopathy" "WBC" "Tukey" "hoc"
    "microvessels" "34/35" "21/35" "36/51" "prolymphocytes" "49/51" "5/51"
    "7/51" "non-PC" "ELR" "whereasIL" "Binet" "morphometry" "Microvessel" "PCs"
    "microvessel" "= 0.0205" "= 0.0010" "= 0.0001" "= 0.0504" "= 0.0004" "Th-2"
    "neuroectoderm" "GqR183Q" "Sturge" "vertepofin" "fundus" "porphyrin" "Dox"
    "pTRIPz" "soft agar" "pYAP" "uveal" "OCM1" "phosphodegrons" "Gs"
    "two homologous transcription co-activators" "uvea" "choroid" "Gq/11"
    "Uveal" "YAP/TAZ" "~5%" "UBLD" "mono-Ub" "UbE" "co-localize" "CCHFV"
    "Congo" "Crimean" "non-covalently" "WCE" "PPMOs" "PPMO"
    "phosphorodiamidate" "ISRE" "CoIP" "Bbox" "Co-immunoprecipitation"
    "EMCV viral titers" "titers" "EMCV" "Encephalomyocarditis" "IAV" "TBK-1-"
    "TBK" "2CARD" "Sendai" "synthetizes" "ISG" "ISGs" "non-targeting"
    "Toll-like" "Zn" "MSH2KO" "4KQ" "K845/K847Q" "K845/K847R"
    "acetylation/ubiquitination" "4KR" "approximately 1 hr" "ofMSH2Are" "DAC2"
    "K63R" "MSH6WT" "MSH6KO" "F-HD6DM" "ofMSH2" "C13-HD6KD" "HDAC6WT" "HDAC6KO"
    "coIP" "Superose" "DEAE5PW" "BC300" "NEs" "DAC1" "antigen (PCNA)"
    "heteroduplexes" "mispairs" "UBP" "ZnF" "HDA1" "MutSα" "Drosphila"
    "re-entry" "aYAP" "αMHC" "Drosohila" "Sadoshima" "withdrawl"
    "the trabecular myocardium" "Olson" "Heallen" "YES/SRC" "apoptostis"
    "cyctoskeleton" "chaparones" "Gα s" "Gα" "submembrane" "Mst1/2" "Lats1/2"
    "TEA" "yorkie" "Yorkie" "Duojia" "perisotin" "Hippo/YAP" "Nigeria" "Otho"
    "Sankarnarayanan" "Shen" "polymorphism/genotypes" "Bau" "Taiwan" "Twu"
    "Liu" "involvement/effect" "Polymorphism (SNP)" "Polymorphism"
    "50-years-old" "Pro/Pro" "Pro/" "non-dysplastic" "FOM" "buccal mucosa"
    "Gilak" "Rasht" "northern Iran" "Northern Iran" "Iran" "stongest" "eQTL"
    "rs7636839" "ECR" "rs4488809" "=1.00" "=1.13" "squamous epithelia"
    "most Northern Europeans" "Eastern Europeans" "=1.27×10" "=0.38" "K3326X"
    "_257del" "Iceland" "brca" "penetrant" "=2.47" "bps" "rs56084662"
    "Western and Eastern Europe" "Europe" "Finland" "13q13.1" "and 3q28"
    "22q12.1" "rs13314271" "rs17879961" "rs11571833" "Toronto" "Heidelberg"
    "Harvard" "genomewide" "HumanHap" "IARC" "MDACC" "Anderson" "12q13.33"
    "9p21" "at 5p15.33" "commonest" "15q25.1" "5p15.33" "6p21.33" "3q28"
    "1000 genomes" "~10%" "non-smokers" "=7" "=4" "1000 Genomes"
    "amplificationmay" "cheaper" "Hoffman's" "Hoffman"
    "2,6,6-tetramethylpiperidine-1-oxyl" "/or" "were7–34%" "HerceptTest"
    "185-kD" "The gastric mucosae" "mucosae" "andMKN1"
    "the oxidative product malodialdehyde" "Langendorff" "malodialdehyde" "Tg"
    "Heat shock protein-27tg" "Nahrendorf" "Gr1−" "Gr" "lo"
    "at least two subpopulations" "cytospins" "cardiac myocytes" "myocytes"
    "an allogeneic LC B10" "syngeneic B10" "-triphosphate" "deoxynucleotide"
    "titre" "alloantibody" "Alloantibody" "CD8+T cells" "posttransplant"
    "CD8+ T cells" "=0.0004" "n=10" "35±10.37" "Immunocytochemistry"
    "cardiac biopsies" "Cardiac allograft vasculopathy (CAV)"
    "vasculopathy (CAV)" "vasculopathy" "allograft" "C57BL/6" "CD8+" "CD3+"
    "CD14+" "Hsp-27tg" "allografts" "B10" "littermate" "-ethyl-" "anti–rabbit"
    "=10" "the 21-gene mutational prognostic classifier"
    "a synonymous polymorphism" "chr22:27413951" "Arg95Ter" "T/T" "C/C"
    "strong co-occurrences" "MetaCore" "ERN2" "GYPB" "_007194" "Walsh" "chr22"
    "only one SNP" "hg18" "co-occurrences" "AEGAETT" "PREGE" "RKR" "cNLS"
    "Zannini" "NLS3" "PSTSRKRP" "monopartite" "karyopherin-α2" "NLSs" "Synapse"
    "Bionetworks" "PHOSIDA" "NetPhos" "UniProt"
    "our published computational algorithm" "Non-silent" "Metacore" "adenyl"
    "DAVID" "non-silent" "genesN" "334 unique tumor sample IDs" "IDs"
    "polymorphism (SNP)" "WUSM" "Washington" "HGSCs" "Exome" "1100delC"
    "Weinberg" "Hanahan" "TCGA’s" "TCGA" "development/recurrence" "BRCA1/2"
    "EOC" "= 15" "= 6" "Exon 11" "Colo" "HERACLES" "/CEP17" "chemoradiotherapy"
    "rectal biopsy" "Conradi" "signals/nucleus" "CEP17" "GCN" "disomy" "1+"
    "gastro" "ISH" "SISH" "situ" "= 0.024" "= 0.018" "= 0.001" "= 0.033" "2+"
    "polyQ" "re-formation" "interaction/colocalization" "myotilinopathy"
    "myotilinopathies" "GSK3A/B" "UB" "lambda" "anti-phospho-NBR1"
    "co-affinity" "azakenpaullone" "ZZ" "Parkinson" "HMERF" "proteinopathies"
    "sIBM" "+ 0.2" "β 1" "blocker" "co-localized" "NS/NSFs" "Masson’s" "H&E"
    "Col3" "HS/HSFs" "Biotech" "Sangon" "Co-immunofluorescence" "trichrome"
    "Masson" "IL-10Rβ" "IL-10Rα" "myofibroblasts" "alpha-smooth muscle" "-β1"
    "anti-fibrotic" "phosphoproteome" "β1integrin" "α5β1integrins"
    "β1 integrins" "desmoplasia" "β1 integrin" "monolayer" "stellate"
    "chemoattractant" "around 6-times" "SNA" "C31 cells" "α10β1" "α3"
    "transwells" "α2β1integrin" "α2β1 integrin" "glycan" "transducers"
    "adhesiveness" "glycans" "α2β1" "x" "sialyl" "MDAPanc" "Non-invasive"
    "100 U/mL" "β1" "riboside (NR)" "riboside" "overexpressors" "myocardium"
    "pulsatile" "NOTCH" "H3K18Ac" "genotoxic stressors" "+/min"
    "long-chain fatty acyl" "acyl" "kappa-light-chain-enhancer"
    "severe hypoglycemia" "CNS" "HFD" "T2D" "SEER" "viniferin"
    "forkhead box O3a" "coactivator 1α" "Huntington’s" "Huntington"
    "cardiac pathologies" "129/Sv" "lymphopenia" "hypoglycemia" "SvJ"
    "this sexual dimorphism" "dimorphism" "mono-ADP-ribosylation" "DMH/LH"
    "BRASTO" "Sirtuins" "prokaryotes" "H4K16Ac" "Sir2p" "ilent" "Johnston"
    "Mortimer" "healthspan" "insulin/insulin-like growth factor-1" "IIS"
    "$1 trillion" "age-associated pathologies" "forebears" "/NADH"
    "stem/progenitor" "co-activator" "H3K9Ac" "Shariat" "nonorgan" "und"
    "Gavrilov" "Riddick" "95%Cl" "Almasi" "tertiles" "immunoassay"
    "prostatectomy" "pT" "GS" "suPAR" "Gleason" "nonmalignant" "= 5" "= 0.035"
    "Leung" "classical ERE" "retro" "the main constitutive active AR subtype"
    "chosen" "hetero" "the pure antiestrogen ICI" "ICI" "EREs" "9-day" "AR110"
    "carbossi" "RV1" "AR75" "Rv1" "CWR22RV1" "17beta-diol" "8beta-VE2"
    "topology" "ERbeta5" "ERE" "disruptors" "homeostasy" "16p" "20q"
    "breakpoints" "16p12.2" "20q13.2" "Richardson" "Scarff" "SBRI"
    "the latter representing ~80%" "~80%" "IDC" "primo" "French" "T/N"
    "aneuploidy" "Orsetti" "Sameer" "MAP9/ASAP"
    "cyclin D:Cdk4/6 complexes strictly mono-phosphorylate Rb" "ΔCDK-Rb"
    "Mono-Phosphorylation" "constitutively mono-phosphorylating Rb"
    "switch-like" "cyclin E/A:Cdk2's" "cyclin E/A:Cdk2" "LxCxE"
    "mono-phosphorylate" "shRNAi" "Scr" "shRb" "PBLs" "tetraploid" "non-Rb"
    "Rb-deleted MEFS" "mono-phosphorylation" "depolymerizer" "MEFS" "/D3 +"
    "homozygous LoxP cyclin D1 f/f" "f/f" "LoxP"
    "Cyclin D:Cdk4/6 complexes exclusively mono-phosphorylate Rb"
    "our hands E1a, E2F1, E2F2, and E2F3 all bound T373 mono-phosphorylated Rb"
    "IEFs" "Cyclin D:Cdk4/6" "+FBS" "mono-phosphorylating"
    "asynchronously cycling primary HFFs" "only mono-phosphorylated Rb" "HFF"
    "15xCdk" "9xCdk" "Rb 6xCdk" "di-phosphorylated" "Rb 3xCdk" "Rb 2xCdk"
    "∼7.0" "1xCdk" "ΔCdk" "A-box" "active Rb" "HFFs"
    "progressive hypo-phosphorylated Rb" "Un" "active mono-phosphorylated Rb"
    "IEF" "hypo-phosphorylated Rb" "the putative hypo-phosphorylated Rb"
    "inactive hyper-phosphorylated Rb" "Rb's" "A'/B" "Shapiro" "Kaulich"
    "Narasimha" "mono-phosphorylated" "Mono-phosphorylated" "cyclin D:Cdk4/6"
    "non-functional" "3 +" "non-phosphorylatable" "anti-autophagy" "Perhaps"
    "inlslKras" "heterozygote" "G12D/+" "Pdx1Cre" "non-responder" "responder"
    "andp53" "R172H/+" "thep53" "Rosenfeldt" "orAtg5" "TheAtg5" "andAtg5"
    "exocrine" "ofAtg5" "theAtg5" "L/+" "lslKras" "L/L" "GEMM"
    "benign liver adenomas" "adenomas" "HCQ" "CQ" "~6%" "non-metastatic"
    "FKHD+ARE" "Heatmap" "_Q640X" "Q640X" "co-occupancy" "ARE+FKHD" "FAIRE"
    "DU145+AR+FOXA1" "DU145+AR" "shFOXA1" "shFOXA" "shCtrl" "co-occupied"
    "FXBS" "ARBS" "FKHD" "cistrome" "ΔCt" "Tet-On" "ribosomopathy" "broader"
    "morpholinos" "MNCs" "smaller heads/eyes" "edemas" "hindbrain"
    "densitometer" "morpholino" "representative electron micrographs" "±5"
    "dpf" "introns" "LCLs" "lymphoblastoid" "shScr" "NI" "immuno" "gone"
    "siScr" "si" "in 1B" "erythrocytes" "erythroblastopenia" "MDS" "congenita"
    "Shwachman" "a pure red cell aplasia" "aplasia" "cytopenia"
    "ribosomopathies" "LC3II" "non-mutant" "pathophysiology" "calcaneus"
    "phalanges" "Ranvier" "exostosis-like" "Exostosis-Like" "COLX" "∼50%"
    "mTmG" "enchondroma-like" "CreER" "Enchondroma-Like" "v/v" "phospho-ERK1/2"
    "RPKM" "HZ" "PZ" "perichondrium" "MHE" "Maffucci" "Ollier" "Thr202/Tyr204"
    "fl/fl" "= 6" "Stoffel" "goes" "Meyenn" "Belagouli" "libitum" "12K-R"
    "12K-R-FOXA2" "FLAG-12K-R-FOXA2" "carnitine" "LC-MS/MS" "broadest"
    "sirtuins" "orthologue" "endoderm" "Sirtuin" "co-activators" "mucosa"
    "PPARB" "TGFIIR" "CkII" "Nono" "silico" "BMAL" "Rev-Erb α" "lac" "IR2"
    "Roche" "conductance" "II4" "A5RT3" "clock/cancer" "non-parametric"
    "STRING" "KEGG" "GeneView" "Rev-Erbα" "classifier" "HKe" "HTC116"
    "chronotherapy" "day-times" "elicitors" "= 24" "= 5" "Non-transformed"
    "hydroxyl" "eukaryotic initiation factor 2α" "factor 2α" "βM" "ARE4"
    "postchemotherapy" "wildtype" "CRPC" "CRE-like" "Keil" "TUNEL" "Co-IP"
    "light chain 3B" "methyladenine"
    "scattered double-membrane structures containing recognizable cellular organelles"
    "diffusions" "Tm" "p" "Rouschop" "30 min" "4-week-old" "Thr 180 /Tyr 182"
    "IL-32-treated M2-M Φ" "solutes" "M2-M Φ" "lucifer" "-isopropyl"
    "isopropyl" "LL" "PxxP" "AxxA" "anti-inflammatory" "M1-like"
    "Thr180/Tyr182" "pcDNA3" "organelles" "organelle" "neutral pH"
    "Prostaglandins" "diphosphatidylglycerol" "Christenson" "helices"
    "mevalonate" "proteolipids" "retrotranslocates" "sensitizer" "-Sensitizers"
    "Sensitizers" "-Anti-apoptotic" "ceramides" "non-enzymatic"
    "Anti-apoptotic" "SCFβ-TRCP" "D-box" "the observed synergistic anti-cancer"
    "interactome" "C91PL" "HTLV" "ΔD1D2-Bim" "D-boxes" "TRCP" "0–2"
    "G1/S phase" "Nocodozole" "oligos"
    "N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone" "shGFP" "shCdc20"
    "Tet-on" "-tail-mimetic" "re-introducing" "non-transformed" "anti-cancer"
    "associated SNPs" "*02:01" "*03:01" "Morris" "iNKT" "an important antigen"
    "DQ7" "rs10946940" "rs2764208" "DRB5" "DRB4" "DPB1" "DR17/DQ2" "HLA*IMP"
    "serotype" "*IMP" "most significant SNP" "rs9275572"
    "the most significant unaccounted SNP" "rs558702"
    "the most significant SNP" "6p21-22" "most highly significant SNPs"
    "non-significance" "rs17849502" "PROVEAN"
    "the significantly associated SNPs" "two significantly associated SNPs"
    "15q14" "rs12259" "mult" "the next most-significant SNP" "Non-HLA"
    "non-HLA" "Raychaudhuri" "disambiguate" "OMIM" "serotypes" "Bonferroni"
    "stepwise" "= 298" "= 0.05" "= 7" "= 0.96" "non-synonymous" "cytopenias"
    "Kikushige" "subpopulations" "isotypes" "relapsed/refractory" "chimerism"
    "antigen" "alloantigen" "platings" "CLP" "utero" "Whitney" "Cd" "hCD45"
    "sublethally irradiated nonobese diabetic/severe" "diabetic/severe"
    "nonobese" "hematogone" "MiSeq" "++" "co-occurring" "VAF" "FACS" "CD90"
    "monocytopenia" "neutropenia" "hematogones" "Tiacci" "EMH" "immunoglobulin"
    "continuum" "= 0.006" "= 0.02" "Hartmann" "rs11554137" "coauthors"
    "PolyPhen" "CIMP" "2HG" "Bulgaria" "chemo-" "&GO" "PolyPhen-2" "algorithms"
    "D15S996" "D15S127" "D15S202" "D15S116" "IDHs" "KPS"
    "intact tissues/organs" "kinases/phosphatases" "MLT" "non-targeted"
    "triphosphates" "magnitude/nature" "non-irradiated" "doublings"
    "immunoprecipitation/immunoblotting" "Eugene" "CellTracker" "hemi" "MeV"
    "cGy" "AG1522" "localise" "stressful" "post-therapeutic pathologies"
    "prostaglandins" "catalyse" "biological endpoints" "endpoints" "chromatid"
    "Nagasawa" "radiation-induced non-targeted" "progeny" "/G 1 phase"
    "miR4679-1" "activation/repression" "ChIP-seq/microarray" " RNAPII"
    "readout" "JBC" "Arva" "indepth" "intragenic eRNAs" "Tjian" "Pre"
    "bound p53REs" "SYTL" "bidirectional eRNAs" "eRNA"
    "three distal p53 enhancers" "intronic p53 enhancers" "DR5/Killer"
    "TNFRS10" "IKBIP" "non-overlapping" "active RNAPII" "promoter-bound RNAPII"
    "Oncomine" "p53 TAD1" "heatmap" "RNAPII" "browser" "MFI" "fpkm"
    "seven different available global ChIP datasets" "∼3%" "risen" "DO-1"
    "microarray/ChIP-seq" "DESeq" "eRNAs" "DOI" "Allen" "eLife" "seq" "= 19"
    "p53 +/+" "p53REs" "hydroxyglutarate" "3+" "Andersen" "95%C" "=0.005"
    "immunophenotype" "3/113" "a weak cytoplasmic/nuclear" "ph-p70S6K" "TGFRB2"
    "=0.0097" "100x" "=0.0005" "BilIN" "Clinico" "exome" "Gallbladder"
    "104/153" "=0.0019" "IDH1/2" "118/153" "GBC" "gallbladder" "exon 11"
    "non-invasive" "p =0.003" "=50" "=0.05" "=69" "=15" "=6" "=39"
    "GC anatomic subsites" "subsites" "discrepant" "Kazakh" "rs2274223"
    "- trend=0.04" "205111_at" "-trend=0.04" "=0.02" "=0.51" "=0.03"
    "205111_s_at" "214159_at" "205112_at" "_s_at" "Cary" "covariates" "HRs"
    "Meir" "Lauren" "Wilcoxon" "rs3765524" "GWAS" "percent positive pixels"
    "SlidePath's" "pixels" "epithelia" "NDPI" "Nanozoomer" "Ireland" "Dublin"
    "Leica" "SlidePath" "Bridgewater" "Hamamatsu" "NanoZoomer"
    "-diaminobenzidine" "diaminobenzidine" "Autostainer" "DAKO" "Aldrich"
    "Carpinteria" "Corp" "Dako" "pH" "GNCAs" "&E" "algorithm" "cRNA" "ie"
    "U133Plus_2" "U133Plus" "_2" "U133A" "Bioanalyzer" "Qiagen" "Allprep"
    "predominantly (>50%) tumor, and tissue RNA quality/quantity"
    "quality/quantity" "°C" "NCI" "UGI" "Taihang" "Taiyuan" "Shanxi"
    "genome-wide significance6" "10q23" "=0.04" "_at" "_205112"
    "non-significantly" "U133" "GNCA" "GeneChip" "Germline" "acral" "UV" "NCSD"
    "MUPs" "lymphadenectomy (LND)" "LND" "lymphadenectomy" "MUP" "95 % CI"
    "anti-tumor" "pc" "tumor microenvironment/metabolism" "DLPs"
    "histopathology" "APs" "regrew" "ourPten" "treatedPten" "10uM"
    "histological analysis ofPten pc−/−" "whetherPten" "InPten" "pc−/−"
    "enrolledPten" "GEMMs" "Western Blot analysis ofPten Lx/Lx andPten Lx/Lx"
    "bothPten" "whereasPten" "ofPten"
    "significant and dose dependent inPten +/− ( xref ) as well asPten Lx/Lx"
    "asPten" "inPten" "toPten" "Lx/Lx" "andPten" "selectedPten" "ribose"
    "proto" "Caspase 3/7" "neuro" "co-regulation" "mild/moderate" "miR34a"
    "ROS/H 2 O 2" "gene-miR34" "otherwords" "pseudogenes" "ceRNAs" "titrate"
    "chronic oxidative neurodegenerative pathologies" "LBVAD" "iv" "iii"
    "Ad-CMV-β-gal" "caspase 3/7" "miR153/Nrf2/ARE" "∼25%" "stressors" "Alesci"
    "Zhang" "Nrf2/ARE" "∼40%" "PQ/H 2 O 2" "anti-miR153" "Patton" "Broadie"
    "∼1.6" "ii" "miR142-5p" "142-5p" "27a" "Parkinsonism" "haplotype"
    "prolonged/chronic" "untethers" "BBB" "neocortex" "Lewy" "miR153" "PQ"
    "∼30%" "30 min" "nitroso" "phytosterols" "penetrance" "cardia" "noncardia"
    "Australia" "Canada" "Danoy" "German" "Crohn's" "times/week" "≥average"
    "TC+CC" "Crohn" "17q21" "GG" "rs2293152" "CC" "rs744166" "transducer"
    "= 0.007" "= 0.002" "≥5" "extra-low-molecular-weight-SGK1-form"
    "triphosphate" "SwissProt" "exon11"
    "various experimentally proven relations" "proven relations"
    "extra-45kDa-SGK1" "ANXA7s" "ANXA7-" "ANXA" "the entire exon11" "LMW"
    "Ser318/321" "10q-locus" "NCBI" "underperformance" "hepatectomoy"
    "hepatectomy" "comorbid" "neoadjuvant" "undergone" "HLAs" "antigens" "b"
    "let7i" "UTRs" "respiratory epithelium" "Apicomplexa" "let-7i" "parvum"
    "sirtuin" "Δ Ct" "intestinal jejunum" "jejunum" "explants" "CD16+"
    "heterokeryons" "transcription/replication" "APOBEC3" "refractoriness" "nt"
    "vivo" "Ex" "M2- like" "p24/1×10" "Renilla" "FOPflash"
    "a transcriptional co-activator" "CD3-CD14+" "CD" "supernatant" "HIV-1-1"
    "HAART" "5/6" "LTR" "TEFb" "trisphosphate" "subsets" "Trojan" "osteoblasts"
    "FGFR1/ CEN8" "Guagnano" "predicting chemoresistance" "chemoresistance"
    "diploid" "CEN8" "nonpolysomy" "polysomy" "responders"
    "a histological subtype/s" "NVP" "8p12" "rarer" "= 4" "= 0.2" "= 19" "urea"
    "a modest concentration 0.5 mmol/L" "Crody" "VINTAGEMI"
    "up-regulation/activation" "mmol/L" "omplex-1" "the m ammalian t arget o"
    "apamycin" "o" "arget" "Scalera" "vaso" "semi" "nonsmall" "paralog"
    "transcatheter" "pg/mL" "resp" "Steiner" "Edmonson" "Spearman's" "Spearman"
    "24/39" "26/39" "27/39" "PPXY" "Edmondson" "= 4" "= 0.001" "702/1699"
    "4/209" "Douillard" "Vaughn" "Guedes" "=0.5" "Latin" "amplicons" "amplicon"
    "146/372" "12/13" "Athens" "Greek" "microsatellite" "ploidy" "PI3KCA"
    "Roock" "oncology" "exons " "immunotherapy" "QS" "cytology" "ECOG"
    "Oncology" "a less aggressive subtype" "PFS" "codons " "multigene"
    "fluorouracil/leucovorin" "Chimerascan" "SIFT" "brainstem" "nevoid"
    "dentin" "miniorgans" "placodes" "Kurppa" "AM-1" "Teva" "Trisenox"
    "the SMO antagonists KAAD-cyclopamine" "SMO antagonists KAAD-cyclopamine"
    "antagonists KAAD-cyclopamine" "Genentech" "Erivedge" "KAAD-cyclopamine"
    "KAAD" "hotspot" "previously established morphological subtypes"
    "plexiform" "Sanger" "SNVs" "transcriptome" "maxilla" "-d" "d" "RhoG"
    "CAAX" "Trio-Rac1-PAK1-axis" "Trio-Rac1-PAK1-cascade" "Trio-RAC1-PAK1-axis"
    "Trio-Rac1-PAK1–axis" "DHPH-1" "ΔSH3-dominant" "Trio-D1SH3" "timeframe"
    "30min" "un" "H83D-H86D" "Venus" "readouts" "begun" "TrioGEF" "Tet-" "tet-"
    "non-polar" "CAY10593" "LifeAct" "PIP5Kα-" "PIP5Kα" "apico" "cNBD"
    "Ras-like" "PDZGEFs" "phosphatidic acid inhibitis" "inhibitis" "PDZGEF"
    "100 U/ml" "collaborations" "Pearson's" "Pearson" "Inc" "OriGene"
    "TissueScan" "Immunohistochemistry" "shMCT-1" "cytoband" "MOCK" "binuclei"
    "−PTEN" "cyclohexamide" "dehydrogenaseand" "cyclohexamide " "ultiple"
    "RhoA" "opies" "ultiple " "100 U/ml" "=0.001" "pFAK" "CHX" "pY397-FAK"
    "co-localizes" "pY172-VAV2" "significantly fewer micrometastases"
    "micrometastases" "shVIM" "pY142-VAV2" "greatest" "g/mL" "co-IP"
    "co-stained" "caspase-3/7" "lifespan" "melanogaster" "Owen" "vacuoles"
    "Miskimins" "Zhuang" "Sahra" "WRC-256" "IRβ" "copper/zinc" "Mn" "Cu/Zn"
    "hyperinsulinaemia" "GLOBOCAN" "5.0×10" "co-regulator" "Kee" "Dong" "chemo"
    "The soft agar" "co-overexpressed" "luc" "FBI-1 on" "FBI-1on"
    "cytoplasmic/nucleus" "immunocytochemistry" "ARQ" "Luc" "co-regulators"
    "Cui" "et" "Rb" "Krüppel" "POZ" "co-repressors" "anti-FLAG"
    "co-transfected" "Hardie" "ofp53" "GOFmutp53" "wt" "ECAR" "OXPHOS"
    "thanp53" "isobutylmethylxanthine" "R172H/H" "longer migration/invasion"
    "-Δ161" "Δ161" "6xHis" "nucleus-localized mutp53 E336X"
    "the nucleus-localized mutp53 E336X" "hemagglutinnin" "AMPKα2" "mutp53-"
    "mutp" "energy stress-induced pAMPK" "pAMPK" "controlp53" "non-GOF"
    "sub-confluent culture condition two mutp53s" "E336X" "Detroit"
    "retroviral vector pBabe" "pBabe" "interactomes" "mutp53" "wtp53"
    "marcomolecules" "Warburg" "HNSCC" "mutp53s" "migration/invasion"
    "non-classical" "90m 2" "undergoes" "neurite" "cargos" "subclasses"
    "non-specifically" "subclass" "preimmune" "micrograph" "micrographs"
    "villi" "CBTs" "proteome" "holocomplex" "cerevisiae" "homogenates"
    "non-specific" "anti-rabbit" "anti-mouse" "only articles written" "English"
    "written" "ORs" "Arg399Gln" "399Gln" "Val762Ala" "762Ala" "MassArray"
    "Taqman" "Caucasians"
    "both auto-poly(ADP-ribosyl)ation and trans-poly(ADP-ribosyl)ation"
    "a commonly occurring PARP-1 polymorphism"
    "approximately 1,066 single-nucleotide polymorphisms" "Begger's" "Egger's"
    "Egger" "Begger" "RFLP" "1.09–1.25" "0.95–1.11" "HWE" "colorectum" "ation"
    "1q41–42" "DSBR" "SSBR" "ribosyl" "diphosphate" "descendents" "Asian"
    "rs1136410" "polymerase-1" "95% CI " "PCC" "p53−/−" "p53+/+" "subG1"
    "centromere" "HCT116 p53−/−" "multinucleate" "mitoses" "ss" "24.439±2.815%"
    "agar" "shSPAG5" "shNC" "siSPAG5" "=0.0002" "chromatids" "Chang" "PLNM"
    "tetrazolium" "Transwell" "PANDA" "intSMYD3" "bona" "HOTTIP" "HOXD"
    "protien" "bp" "H3K27" "HOXD9" "IHC" "SPC-A1/shTUG1" "shTUG1"
    "co-transfection" "isotype" "p53RE" "g/ml" "doxo" "≤60" "=96" "Meier"
    "Kaplan" "non-tumor" "7.1-kb" "∼20%" "Khalil" "non-coding" "Univariate"
    "Non-specific" "=0.003" "=0.002" "non-small" "American" "Sos" "T/C" "mg/kg"
    "MTS" "∼70%" "coculture" "∼60%" "Doratomyces" "Talaromyces" "EU" "ELISA"
    "=10 " "=0.0047" "=0.0504" "significantly shorter long-term DFS"
    "a significantly worse 5-year" "=0.0466" "5-year" "Swiss" "Weiss" "ex"
    "=0.3890" "=0.0763" "=0.0854" "histological subtype" "=0.0367" "12/17"
    "57/110" "=127" "DFS" "=0.0205" "=0.0204" "pack-years" "IIA" "T-category"
    "41/329" "REMARK" "8p11.23" "Multivariate" "UICC" "clinico"
    "possible adduct" "non-exposed" "rs28934575" "homoindel" "FIGO"
    "rs121909239" "rs121909224" "Cowden" "Zonnana" "Bannayan" "frameshifts"
    "toremifene" "Noonan" "polymorphism" "drawn" "frozen" "FFPE" "minimise"
    "histologies" "adduct" "exposure/treatment" "frameshift" "germline"
    "Fraumeni" "Li" "codon" "codons"
    "menstrual, proliferative and secretory endometrium" "⩽0.05" "endometrioid"
    "oxidise" "intra" "interspecies" "4-OH-tamoxifen" "alpha-OH-tamoxifen"
    "adducts" "oestrogen" "exogenous oestrogens" "oestrogens" "indel"
    "endometrium" "the associated SNP" "Jiang" "missense" "Yao" "95% CI"
    "univariate" "95%CI" "genotypes" "viz" "pairwise" "exons" "Forty-one"
    "older" "BMI" "CNV" "USA" "rs3825977" "the last intron" "intron"
    "radiographic OA" "osteophyte" "JSN" "osteophytes" "Chingford"
    "idiopathic generalized OA (GOA)" "OA (GOA)" "aneurysms" "OA" "AOS"
    "Aneurysm" "= 0.002" "ENPP2/autotaxin" "LPA1-3" "subset"
    "multiple soft tissue sarcoma subtypes" "immunohistochemistry" "histology"
    "shJun" "organoid" "subtypes" "ASPSKY" "USCS5" "USCS2"
    "amplification/overexpression" "KY" "c-Jun -amplified subclones"
    "subclones" "Naïve" "pyrophosphatase/phophodiesterase" "ENPP2"
    "ENPP2/Autotaxin" "LPS12" "Illumina" "transwell" "Oris" "non-amplified"
    "Affymetrix" "timepoints" "1p32" "pure WDLPS" "~30%" "WDLPS"
    "differentiated/dedifferentiated" "myxoid" "subtype" "subfamilies" "DDLPS"
    "proenzyme" "facilitators" "epithelium" "datasets" "TGFß" "dataset"
    "NextBio" "Boyden" "parenchyma" "=5" "transgenes" "pancreata" "tTA" "Hsel"
    "multivariate" "logrank" "poorer" "=18" "Wallis" "biopsy" "pancreatitis"
    "H-score" "paracrine" "untangle"
    "many premalignant pancreatic intraepithelial neoplasias" "neoplasias"
    "co-conspirator" "biopsies" "PDA" "polymorphisms" "genotype" "Netherlands"
    "13q14.13" "Brugada" "Ito" "desaturases" "13q12.11" "1p13.2" "11q12"
    "no genome-wide SNPs" "Genome-wide SNPs" "enhancers" "Genome" "enhancer"
    "proven" "=2.3" "rs2253017" "EUR" "nearest" "overview" "genomes"
    "The genome-wide significant SNPs" "*IQR"
    "all available tissues/experiments" "× 10" "rs174577" "SNP" "Hapmap"
    "Genotype" "All genome-wide top SNPs" "rs2798269" "P-duration"
    "2.3 Million imputed autosomal SNPs" "CEU" "HapMap" "atria" "Americans"
    "African" "Asians" "Europeans" "GWA" "atrium"
    "genome-wide significant SNPs" "EFHA1" "SNPs" "×10" "European" "DMAG"
    "CMML" "ITD" "ITDs" "multi" "severe pathologies" "pathologies" "subcomplex"
    "Vps15-V5-His" "eosin (HE)" "lobules" "eosin" "littermates"
    "WIPI2-associated phagophores" "dCCD" "phagophore" "revertant" "HBSS"
    "phagophores" "co-localization" "KO" "HA" "cyan" "Tg2576" "DHA"
    "both soluble and fibrillary Aβ" "Aβ-degrading enzyme expression/activity"
    "expression/activity" "co-treated" "co-treatment" "Co-treatment"
    "oligomeric Aβ" "hrs" "hr" "AUUUA" "-UTR" "UTR" "ECE" "neuronal synapses"
    "synapses" "Alzheimer's" "anti-apoptotic" "Bryostatin" "bryostatin" "Cε"
    "AD" "neurotoxic Aβ" "strongest" "Aβ" "Alzheimer’s" "Alzheimer"
    "WASP-family" "WASP" "undertaken" "mCitrine" "PA-Rac1photoactivation"
    "MetaMorph" "LSM700" "Zeiss" "Rac1Q61L" "445-nm" "Rac1 T17N" "sheet-like"
    "motile" "helix" "Jα" "sativa" "Avena" "Wu"
    "the dominant negative (DN) Rac1T17N"
    "the constitutively active (CA) Rac1Q61L" "pre-"
    "genotoxic catecholestrogens" "catecholestrogens" "procarcinogens"
    "17β-HSD" "dione" "Salinas" "Cirera" "perhaps" "co-regulatory" "biotin"
    "AP" "AKR1C-family" "greater" "non-transfected" "17β-HSD1" "Ct"
    "transfectants" "transfectant" "genome" "D-type" "homologs" "pre"
    "17β-HSD2" "dehydrogenases" "hydroxysteroid" "AKR" "homolog"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-12601-12900*
  '(("CSIR" . SPARSER::PROTEIN)
    ("the increased tyrosine phosphorylated forms" . SPARSER::FORM)
    ("Src and Rac" . SPARSER::COLLECTION)
    ("p-Y-β-catenin" . SPARSER::COLLECTION) ("PYK2/FAK" . SPARSER::COLLECTION)
    ("VE-cadherin/VE-PTP" . SPARSER::COLLECTION) ("zonula" . SPARSER::PROTEIN)
    ("RelA/p65" . SPARSER::COLLECTION) ("IKK-RelA/p65" . SPARSER::COLLECTION)
    ("highly redox sensitive kinase" . SPARSER::KINASE)
    ("respective phosphatases VE-PTP and SHP2" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-3" . SPARSER::COLLECTION)
    ("occludin and tricellulin" . SPARSER::COLLECTION)
    ("tricellulin" . SPARSER::PROTEIN) ("occludin" . SPARSER::PROTEIN)
    ("p120-catenin and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and VE-cadherin" . SPARSER::COLLECTION)
    ("SHP2 and VE-PTP" . SPARSER::COLLECTION)
    ("VE-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("monoclonal VE-cadherin antibody" . SPARSER::ANTIBODY)
    ("VE-cadherin-associated β-catenin as well as VE-Cadherin [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("VE-cadherin-associated β-catenin" . SPARSER::PROTEIN)
    ("VE-PTPs" . SPARSER::COLLECTION)
    ("their respective tyrosine" . SPARSER::AMINO-ACID)
    ("VE-cadherin complex (VE-PTP and SHP2) and their impact on tyrosine phosphorylation of VE-cadherin"
     . SPARSER::COLLECTION)
    ("PYK2 and tyrosine" . SPARSER::COLLECTION)
    ("β-catenin [ xref ] and VE-cadherin [ xref ]" . SPARSER::COLLECTION)
    ("β-catenin or plakoglobin" . SPARSER::COLLECTION)
    ("vinculin, α-actinin, ZO-1 and actin" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VE-cadherin and catenin" . SPARSER::COLLECTION)
    ("adherens junction proteins (AJPs) and tight junction proteins (TJPs)"
     . SPARSER::COLLECTION)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("junctional proteins" . SPARSER::PROTEIN)
    ("VE-PTP and SHP2" . SPARSER::COLLECTION)
    ("VE-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("NOX2 and NOX4" . SPARSER::COLLECTION) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("MMP-3" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("Proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("PYK-2" . SPARSER::PROTEIN) ("VE-Cadherin" . SPARSER::PROTEIN)
    ("protein-G" . SPARSER::PROTEIN) ("NaF 1 " . SPARSER::PROTEIN)
    ("p-Y" . SPARSER::PROTEIN) ("α-actinin" . SPARSER::PROTEIN)
    ("vascular endothelial-cadherin" . SPARSER::PROTEIN)
    ("VE-PTP" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("PYK2" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN) ("-azacytidine" . SPARSER::DRUG)
    ("MSI and SSAs" . SPARSER::COLLECTION) ("Conductin" . SPARSER::PROTEIN)
    ("adenomatous polyposis coli ( APC ) gene" . SPARSER::GENE)
    ("messenger RNA and microRNA" . SPARSER::COLLECTION)
    ("TCF7L2 , FBXW7 and SOX7" . SPARSER::COLLECTION)
    ("MSI and SSA" . SPARSER::COLLECTION)
    ("APC and b-catenin" . SPARSER::COLLECTION)
    ("b-catenin" . SPARSER::PROTEIN-PAIR)
    ("contained all the SSAs" . SPARSER::PROTEIN)
    ("serrated-MSI" . SPARSER::COLLECTION)
    ("TAs and MSSs" . SPARSER::COLLECTION)
    ("5 MSSs (41.7%) and 1 TA (12.5%)" . SPARSER::COLLECTION)
    ("subsets" . SPARSER::PROTEIN)
    ("appeared altered differentially" . SPARSER::PROTEIN)
    ("TA, SSA, MSS and MSI" . SPARSER::COLLECTION)
    ("MSS and MSI" . SPARSER::COLLECTION)
    ("MSIs and SSAs" . SPARSER::COLLECTION)
    ("MSSs and TAs" . SPARSER::COLLECTION) ("MSIs" . SPARSER::PROTEIN)
    ("MSSs" . SPARSER::PROTEIN) ("MSI and MSS" . SPARSER::COLLECTION)
    ("SSAs and MSI" . SPARSER::COLLECTION) ("Mismatch" . SPARSER::PROTEIN)
    ("Serrated" . SPARSER::PROTEIN) ("APC and β-catenin" . SPARSER::COLLECTION)
    ("TAs and MSS" . SPARSER::COLLECTION)
    ("MSI and MLH1" . SPARSER::COLLECTION) ("TAs" . SPARSER::PROTEIN)
    ("MSI or MSS" . SPARSER::COLLECTION) ("SSAs" . SPARSER::PROTEIN)
    ("AFLP" . SPARSER::PROTEIN) ("SSA and MSI" . SPARSER::COLLECTION)
    ("SSA" . SPARSER::PROTEIN) ("SOX7" . SPARSER::PROTEIN)
    ("FAM123B" . SPARSER::PROTEIN) ("FZD10" . SPARSER::PROTEIN)
    ("LRP5" . SPARSER::PROTEIN) ("trastuzumab and mTOR" . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("RAS/RAF/MAPK" . SPARSER::COLLECTION) ("AKT/PI3K" . SPARSER::COLLECTION)
    ("G–H1047R and c" . SPARSER::COLLECTION)
    ("ZSTK474 or sirolimus" . SPARSER::COLLECTION)
    ("EGFR and PIKCA" . SPARSER::COLLECTION) ("Sirolimus" . SPARSER::DRUG)
    ("EGFR, KRAS, PI3K, BRAF and AKT" . SPARSER::COLLECTION)
    ("sirolimus (Rapamycin) and ZSTK474" . SPARSER::COLLECTION)
    ("EGFR/PI3K/mTOR" . SPARSER::COLLECTION) ("Tarceva" . SPARSER::DRUG)
    ("EGFR, BRAF, AKT and PI3K" . SPARSER::COLLECTION)
    ("IGF and HER3" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("a dual EGFR and HER2 small molecule" . SPARSER::MOLECULE)
    ("HER2, and lapatinib" . SPARSER::COLLECTION)
    ("cetuximab (Erbitux™) in colorectal cancer (CRC) and vemurafenib (Zelboraf™) in skin melanoma"
     . SPARSER::COLLECTION)
    ("Zelboraf" . SPARSER::DRUG) ("Iressa" . SPARSER::DRUG)
    ("PI3K-PTEN-AKT-mTOR" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("Epidermal Growth Factor Receptors (HER)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF, AKT or PIK3CA" . SPARSER::COLLECTION)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("the PI3K inhibitor ZSTK474 or the MTOR inhibitor sirolimus"
     . SPARSER::COLLECTION)
    ("ZSTK474 and sirolimus" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("EGFR, BRAF, AKT, and PI3K" . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("PI3K/Akt/MTOR" . SPARSER::COLLECTION)
    ("G–H" . SPARSER::PROTEIN) ("A–V" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor Receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF- κ B, p50, and p65" . SPARSER::COLLECTION)
    ("p50-RelA" . SPARSER::COLLECTION)
    ("proteins and components of the RNA-induced silencing complex"
     . SPARSER::COMPONENT)
    ("molecule and regulator" . SPARSER::COLLECTION)
    ("proteins and components" . SPARSER::COLLECTION)
    ("NF- κ B, p50 and p65" . SPARSER::COLLECTION)
    ("p50, and p65" . SPARSER::COLLECTION)
    ("NF- κ B and CBP" . SPARSER::COLLECTION)
    ("CREB-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kappaB" . SPARSER::PROTEIN)
    ("primary human fetal astrocytes" . SPARSER::PROTEIN)
    ("a neuropathology-associated gene" . SPARSER::GENE)
    ("astrocyte elevated gene-1 or metadherin" . SPARSER::COLLECTION)
    ("AEG-1/MTDH" . SPARSER::COLLECTION) ("MTDH" . SPARSER::PROTEIN)
    ("the active transcription factor complex" . SPARSER::BIO-COMPLEX)
    ("active dimers" . SPARSER::DIMER)
    ("p50, p52, p65, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("the most common histological type" . TYPE)
    ("p50 and metadherin" . SPARSER::COLLECTION)
    ("p50, p65, and metadherin" . SPARSER::COLLECTION)
    ("metadherin" . SPARSER::PROTEIN) ("Metadherin" . SPARSER::PROTEIN)
    ("CRM1" . SPARSER::PROTEIN) ("exportin1" . SPARSER::PROTEIN)
    ("ACT-1" . SPARSER::PROTEIN) ("single-pass" . SPARSER::PROTEIN-FAMILY)
    ("astrocyte elevated gene-1" . SPARSER::PROTEIN)
    ("AEG-1" . SPARSER::PROTEIN) ("IKK β" . SPARSER::PROTEIN)
    ("I- κ B" . SPARSER::PROTEIN) ("I- κ Bs" . SPARSER::PROTEIN)
    ("irinotecan and temozolomide" . SPARSER::COLLECTION)
    ("more soluble derivatives" . SPARSER::DERIVATIVE)
    ("assay global histone" . SPARSER::PROTEIN)
    ("the repressive NuRD complex" . SPARSER::BIO-COMPLEX)
    ("the associated complex" . SPARSER::BIO-COMPLEX)
    ("NURF" . SPARSER::PROTEIN)
    ("its associated LSD1 subunit" . SPARSER::FRAGMENT)
    ("Sin3A" . SPARSER::PROTEIN) ("NcoR/SMRT" . SPARSER::COLLECTION)
    ("NcoR" . SPARSER::PROTEIN) ("R2L2" . SPARSER::PROTEIN)
    ("LSD1 and LSD1" . SPARSER::COLLECTION) ("phalloidin" . SPARSER::MOLECULE)
    ("RUNX2 , IGFBP3 , CDH1 , and HMOX1" . SPARSER::COLLECTION)
    ("NKX2.2 , CAV1 , GSTM4 , E2F1 , and IGF1" . SPARSER::COLLECTION)
    ("HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("previously identified EWS/FLI direct target genes" . SPARSER::GENE)
    ("using GSEA" . SPARSER::PROTEIN)
    ("retroviral-mediated shRNA" . SPARSER::PROTEIN)
    ("a specific and reversible noncompetitive inhibitor" . SPARSER::INHIBITOR)
    ("LOX and TGFBR2" . SPARSER::COLLECTION) ("LOX" . SPARSER::PROTEIN)
    ("Tranylcypromine" . SPARSER::DRUG) ("tranylcypromine" . SPARSER::DRUG)
    ("a translocation-derived fusion oncoprotein and aberrant transcription factor"
     . SPARSER::COLLECTION)
    ("aberrant transcription factor" . SPARSER::PROTEIN)
    ("histone lysine methyltransferases (KMTs) and demethylases (KDMs)"
     . SPARSER::COLLECTION)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("EWS/ETS" . SPARSER::COLLECTION) ("EWS/ERG" . SPARSER::COLLECTION)
    ("EWS/FLI" . SPARSER::COLLECTION) ("FLI" . SPARSER::PROTEIN)
    ("EWS/ETS family" . SPARSER::COLLECTION) ("EWS" . SPARSER::PROTEIN)
    ("CYP3A4" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("Co-REST" . SPARSER::PROTEIN) ("HMOX1 protein" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("GSTM4" . SPARSER::PROTEIN)
    ("NKX2.2" . SPARSER::PROTEIN) ("4 –1" . SPARSER::PROTEIN)
    ("RPL19" . SPARSER::PROTEIN) ("FLI-1" . SPARSER::PROTEIN)
    ("CHD4" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("EF-2" . SPARSER::PROTEIN) ("GATA3, FOXA1, and ERα" . SPARSER::COLLECTION)
    ("ZNF217-ER" . SPARSER::COLLECTION) ("subset" . SPARSER::PROTEIN)
    ("ERα or ER-regulated genes" . SPARSER::COLLECTION)
    ("GATA3-FOXA1" . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("three-dimensional chromatin" . SPARSER::PROTEIN)
    ("ERα and FOXA1" . SPARSER::COLLECTION)
    ("TFF1, ERBB3, SLC22A5, and LRIG1" . SPARSER::COLLECTION)
    ("the differential FOXA1" . SPARSER::PROTEIN) ("a special class" . CLASS)
    ("multiple intrinsic subtypes" . SPARSER::PROTEIN)
    ("basal cohorts" . SPARSER::MOLECULE) ("/ERBB2" . SPARSER::COLLECTION)
    ("ERα precipitated both ZNF217 and the ZNF217-binding partner CtBP2 (see Additional file xref )"
     . SPARSER::COLLECTION)
    ("ERα precipitated both ZNF217" . SPARSER::PROTEIN)
    ("ERα and 108 proteins" . SPARSER::COLLECTION)
    ("ZNF217 and co-bound" . SPARSER::COLLECTION)
    ("CAV2, ELF5, ID2, TGFB2, LRIG1, FOXO3, CXCL12, and CD44"
     . SPARSER::COLLECTION)
    ("ZNF217-ERα" . SPARSER::COLLECTION)
    ("the known estrogen responsive ERα-target genes LRIG1 [ xref ] and SLC22A5 [ xref ]"
     . SPARSER::COLLECTION)
    ("AXIN1 and IGFBP4" . SPARSER::COLLECTION)
    ("ZNF217 and ERα" . SPARSER::COLLECTION)
    ("ERα, FOXA1, and GATA3" . SPARSER::COLLECTION)
    ("GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("ERα, GATA3, and FOXA1" . SPARSER::COLLECTION)
    ("FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("ZNF217 and alternative breast cancer transcription regulators"
     . SPARSER::COLLECTION)
    ("TCF7L2, NR2F2, ERα, GATA3, and FOXA1" . SPARSER::COLLECTION)
    ("ERα, and AP-1" . SPARSER::COLLECTION)
    ("-TGA(G/C)TCA(T/C)-3" . SPARSER::PROTEIN) ("-TGA" . SPARSER::COLLECTION)
    ("HOMER" . SPARSER::PROTEIN-FAMILY)
    ("TGFβ, WNT, and ER" . SPARSER::COLLECTION)
    ("nucleosomes" . SPARSER::BIO-COMPLEX) ("the predominant class" . CLASS)
    ("the repressive histone" . SPARSER::PROTEIN)
    ("TFF1 and the previously identified ZNF217 regulatory target"
     . SPARSER::COLLECTION)
    ("the previously identified ZNF217 regulatory target"
     . SPARSER::TARGET-PROTEIN)
    ("genome-wide chromatin mapping" . SPARSER::PROTEIN)
    ("RNA-" . SPARSER::RNA) ("G9a and EZH2" . SPARSER::COLLECTION)
    ("Jarid1b/Plu-1" . SPARSER::COLLECTION)
    ("CtBP and ZNF217" . SPARSER::COLLECTION) ("CtBP" . SPARSER::PROTEIN)
    ("ZNF217 and ERalpha" . SPARSER::COLLECTION)
    ("ZNF217-ERalpha" . SPARSER::COLLECTION)
    ("ERalpha co-precipitates ZNF217 and its binding partner CtBP2"
     . SPARSER::COLLECTION)
    ("FOXA1, GATA3 and ERalpha" . SPARSER::COLLECTION)
    ("ELF5" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("IGFBP4" . SPARSER::PROTEIN) ("SLC22A5" . SPARSER::PROTEIN)
    ("LRIG1" . SPARSER::PROTEIN) ("NR2F2" . SPARSER::PROTEIN)
    ("Lys9" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("Jarid1b" . SPARSER::PROTEIN) ("CtBP1" . SPARSER::PROTEIN)
    ("CtBP2" . SPARSER::PROTEIN) ("C 2 H 2" . SPARSER::MOLECULE)
    ("ZNF217" . SPARSER::PROTEIN) ("BRAF, NRAS, and NF1" . SPARSER::COLLECTION)
    ("RAS-GTPase activating protein" . SPARSER::COLLECTION)
    ("NRAS subset" . SPARSER::PROTEIN)
    ("PTEN and CDKN2A" . SPARSER::COLLECTION)
    ("TBK1-PDK1" . SPARSER::COLLECTION)
    ("CCL5, IL-6, and IL-8" . SPARSER::COLLECTION)
    ("the exocyst complex and subsequent interaction with AKT1 and AKT2"
     . SPARSER::COLLECTION)
    ("RAF/MEK" . SPARSER::COLLECTION)
    ("Nod1, TNFRSF25, and TRAF3" . SPARSER::COLLECTION)
    ("AZD6244 and TBK1" . SPARSER::COLLECTION)
    ("Bim-EL, Mcl-1, and Bmf" . SPARSER::COLLECTION) ("Bmf" . SPARSER::PROTEIN)
    ("AZD6244 and AZ909 alone elicited an increase in apoptosis"
     . SPARSER::COLLECTION)
    ("PDK1 and IKKε" . SPARSER::COLLECTION)
    ("previously published azabenzimidazole derivatives" . SPARSER::DERIVATIVE)
    ("a promiscuous inhibitor" . SPARSER::INHIBITOR)
    ("BX795 and AZD6244" . SPARSER::COLLECTION)
    ("TBK1 and an IC 50" . SPARSER::COLLECTION)
    ("TBK1 and PDK1" . SPARSER::COLLECTION)
    ("an ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("a heterooctameric complex" . SPARSER::BIO-COMPLEX)
    ("WM1366 TR and WM1361A TR" . SPARSER::COLLECTION)
    ("TBK1-myristoylated" . SPARSER::COLLECTION)
    ("myristoylated" . SPARSER::PROTEIN)
    ("phosphomimetic mutants" . SPARSER::MUTANT)
    ("the atypical IκB kinase family" . SPARSER::PROTEIN-FAMILY)
    ("NRAS and mutant" . SPARSER::COLLECTION)
    ("TBK1 and MEK" . SPARSER::COLLECTION) ("RalB" . SPARSER::PROTEIN)
    ("RalA" . SPARSER::PROTEIN) ("MEK-ERK1/2" . SPARSER::COLLECTION)
    ("taxanes, and platinum" . SPARSER::COLLECTION)
    ("RAF and PI3K" . SPARSER::COLLECTION) ("RalGEF/Ral" . SPARSER::COLLECTION)
    ("RalGEFs" . SPARSER::PROTEIN) ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARAF" . SPARSER::PROTEIN) ("RAFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFRSF25" . SPARSER::PROTEIN) ("Nod1" . SPARSER::PROTEIN)
    ("Bim-EL" . SPARSER::PROTEIN) ("BX795" . SPARSER::DRUG)
    ("-receptors" . SPARSER::COLLECTION) ("antidepressant" . SPARSER::DRUG)
    ("caffeine or other reagents" . SPARSER::COLLECTION)
    ("an antimetastatic reagent" . SPARSER::MOLECULE)
    ("CASK and cellular metastasis/invasion" . SPARSER::COLLECTION)
    ("CASK , HTR2C , and β-catenin" . SPARSER::COLLECTION)
    ("VELI-3 or MALS-3" . SPARSER::COLLECTION)
    ("significantly ( P < 0.05) more human genomic DNA" . SPARSER::DNA)
    ("Lin-7C/CASK/CTNNB1" . SPARSER::COLLECTION)
    ("Mirtazapine" . SPARSER::DRUG) ("Lin-7C and CASK" . SPARSER::COLLECTION)
    ("CASK" . SPARSER::PROTEIN) ("Lin-7C and CTNNB1" . SPARSER::COLLECTION)
    ("mirtazapine and quetiapine" . SPARSER::COLLECTION)
    ("the mirtazapine- and quetiapine-treated cells ( xref )"
     . SPARSER::COLLECTION)
    ("IPA, apomorphine, caffeine, and risperidone" . SPARSER::COLLECTION)
    ("mirtazapine-" . SPARSER::DRUG)
    ("five pharmaceutical reagents" . SPARSER::MOLECULE)
    ("VELI3 or MALS-3" . SPARSER::COLLECTION)
    ("Lin-7C/β-catenin" . SPARSER::COLLECTION)
    ("apomorphine, caffeine, risperidone, quetiapine, and mirtazapine"
     . SPARSER::COLLECTION)
    ("mirtazapine" . SPARSER::DRUG) ("quetiapine" . SPARSER::DRUG)
    ("risperidone" . SPARSER::DRUG) ("apomorphine" . SPARSER::DRUG)
    ("C -3" . SPARSER::PROTEIN) ("A -3" . SPARSER::PROTEIN)
    ("AC -3" . SPARSER::PROTEIN) ("AG -3" . SPARSER::PROTEIN)
    ("Lin-2" . SPARSER::PROTEIN) ("VELI-3" . SPARSER::PROTEIN)
    ("calcium/calmodulin-dependent serine protein kinase" . SPARSER::PROTEIN)
    ("5-hydroxytryptamine receptor 2C" . SPARSER::PROTEIN)
    ("MALS-3" . SPARSER::PROTEIN) ("VELI3" . SPARSER::PROTEIN)
    ("HTR2C" . SPARSER::PROTEIN) ("Lin-7C" . SPARSER::PROTEIN)
    ("TRAP220/Med1" . SPARSER::COLLECTION) ("Med25-ERα" . SPARSER::COLLECTION)
    ("a
pivotal cofactor"
     . SPARSER::MOLECULE)
    ("ERα and HNF4α" . SPARSER::COLLECTION)
    ("HNF4α-luciferase" . SPARSER::COLLECTION)
    ("a classical hormone
nuclear receptor"
     . SPARSER::RECEPTOR)
    ("CAR, PXR,
GR, HNF4α, and ERα"
     . SPARSER::COLLECTION)
    ("drug
metabolizing enzymes as well as other xenobiotics and endogenous compounds"
     . SPARSER::COLLECTION)
    ("enzymes as well as other xenobiotics" . SPARSER::COLLECTION)
    ("HNF4α and CAR" . SPARSER::COLLECTION)
    ("Exogenous ligand" . SPARSER::LIGAND)
    ("Med25 and the nuclear receptors ERα, HNF4α, and CAR"
     . SPARSER::COLLECTION)
    ("ERα, HNF4α, and CAR" . SPARSER::COLLECTION)
    ("siRNA and Med25" . SPARSER::COLLECTION)
    ("Med25 and
ERα"
     . SPARSER::COLLECTION)
    ("Med25 or ERα" . SPARSER::COLLECTION)
    ("Med25 or Med25" . SPARSER::COLLECTION)
    ("ERα, E2 or vehicle EtOH" . SPARSER::COLLECTION)
    ("a
3XERE-luciferase"
     . SPARSER::COLLECTION)
    ("Med25
and ERα"
     . SPARSER::COLLECTION)
    ("E2 or vehicle EtOH" . SPARSER::COLLECTION)
    ("Med25 and ERα" . SPARSER::COLLECTION)
    ("ERE’s" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("antidiabetic drugs such as tolbutamide and glipizide"
     . SPARSER::COLLECTION)
    ("most nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("the principal CYP2C enzyme" . SPARSER::ENZYME)
    ("tolbutamide" . SPARSER::DRUG) ("anticoagulant" . SPARSER::DRUG)
    ("phenytoin" . SPARSER::DRUG) ("proteins or mRNAs" . SPARSER::COLLECTION)
    ("environmental chemicals" . SPARSER::MOLECULE) ("Cs" . SPARSER::PROTEIN)
    ("CYP2C8" . SPARSER::PROTEIN)
    ("xenobiotics and environmental toxins" . SPARSER::COLLECTION)
    ("receptor (CAR)" . SPARSER::RECEPTOR)
    ("other xenobiotics and endogenous compounds" . SPARSER::COLLECTION)
    ("CYP2C" . SPARSER::PROTEIN) ("Med1" . SPARSER::PROTEIN)
    ("TRAP220" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Med 1" . SPARSER::PROTEIN)
    ("a
3"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA
polymerase II"
     . SPARSER::PROTEIN)
    ("pG5" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phenol Red" . SPARSER::DRUG) ("Med25" . SPARSER::PROTEIN)
    ("pregnane X receptor" . SPARSER::PROTEIN)
    ("TGF- β 1, and HGF" . SPARSER::COLLECTION)
    ("hydroxyproline" . SPARSER::MOLECULE) ("exogenous HGF" . SPARSER::PROTEIN)
    ("Lima" . SPARSER::PROTEIN) ("PGE 2 and HGF" . SPARSER::COLLECTION)
    ("peroxisome proliferator-activated receptors (PPAR)" . SPARSER::PROTEIN)
    ("PGE synthase1 as well as PGD synthase [ xref ]" . SPARSER::COLLECTION)
    ("PGD" . SPARSER::PROTEIN) ("PGE" . SPARSER::PROTEIN)
    ("STAT, c-fos, c-Jun, and AP-1" . SPARSER::COLLECTION)
    ("human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("proinflammatory eicosanoids, thromboxane B 2 , and leukotriene C 4"
     . SPARSER::COLLECTION)
    ("eicosanoids, thromboxane B 2 , and leukotriene C 4"
     . SPARSER::COLLECTION)
    ("eicosanoids" . SPARSER::MOLECULE) ("PGs" . SPARSER::MOLECULE)
    ("regenerative mediators" . SPARSER::PROTEIN)
    ("antifibrotic mediators" . SPARSER::PROTEIN)
    ("NS-398, AH-6809, or PHA-665752" . SPARSER::COLLECTION)
    ("LPS-treated macrophages" . SPARSER::PROTEIN)
    ("10  μ M NS-398 and 10  μ M AH-6809 (Figures xref and xref )"
     . SPARSER::COLLECTION)
    ("Neither NS-398 nor indomethacin" . SPARSER::COLLECTION)
    ("HGF and TGF- β" . SPARSER::COLLECTION)
    ("COX-2-specific siRNA or a negative control siRNA" . SPARSER::COLLECTION)
    ("using anti-HGF α -chain antibody" . SPARSER::ANTIBODY)
    ("NS-398 or AH-6809" . SPARSER::COLLECTION) ("/EP2" . SPARSER::COLLECTION)
    ("GW" . SPARSER::PROTEIN) ("EP1, EP2, EP3, and EP4" . SPARSER::COLLECTION)
    ("EP2 and EP4" . SPARSER::COLLECTION) ("EP1" . SPARSER::PROTEIN)
    ("using COX-2-specific siRNA" . SPARSER::PROTEIN)
    ("10 and 50  μ M NS-398 and 10  μ M indomethacin ( xref )"
     . SPARSER::COLLECTION)
    ("NS-398 (1, 10, and 50  μ M) and indomethacin (10  μ M) completely inhibited apoptotic cell-induced HGF mRNA (Figures xref and xref )"
     . SPARSER::COLLECTION)
    ("indomethacin (10  μ M) completely inhibited apoptotic cell-induced HGF mRNA"
     . SPARSER::PROTEIN)
    ("NS-398 or indomethacin" . SPARSER::COLLECTION)
    ("using pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("NS-398, indomethacin, and siRNAs" . SPARSER::COLLECTION)
    ("PGE 2 and 15d-PGJ 2" . SPARSER::COLLECTION)
    ("1  μ M NS-398 or 10  μ M indomethacin ( xref )" . SPARSER::COLLECTION)
    ("Indomethacin" . SPARSER::DRUG)
    ("the highly selective COX-2 inhibitor NS-398 (1~50  μ M) or the nonselective COX inhibitor indomethacin (10  μ M)"
     . SPARSER::COLLECTION)
    ("the nonselective COX inhibitor indomethacin" . SPARSER::DRUG)
    ("actinomycin D or cycloheximide" . SPARSER::COLLECTION)
    ("COX-2 or COX-1" . SPARSER::COLLECTION)
    ("UV-irradiated neutrophils" . SPARSER::PROTEIN)
    ("aged apoptotic human neutrophils" . SPARSER::PROTEIN)
    ("using total RNA" . SPARSER::RNA) ("HGF and COX-2" . SPARSER::COLLECTION)
    ("HGF and COX-2/PGE 2" . SPARSER::COLLECTION)
    ("HGF [ xref ] and COX-2" . SPARSER::COLLECTION)
    ("indomethacin" . SPARSER::DRUG)
    ("TNF- α , IL-1 β , and IL-8" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("the major eicosanoid" . SPARSER::MOLECULE)
    ("COX-1 or COX-2" . SPARSER::COLLECTION) ("eicosanoid" . SPARSER::MOLECULE)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("VEGF, HGF, and PGE 2" . SPARSER::COLLECTION)
    ("TGF- β , IL-10, and PGE 2" . SPARSER::COLLECTION)
    ("Both NS-398 and COX-2-siRNA" . SPARSER::COLLECTION)
    ("COX-2-siRNA" . SPARSER::COLLECTION)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION) ("synthase1" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN)
    ("activating transcription factor 2" . SPARSER::PROTEIN)
    ("ELK-1" . SPARSER::PROTEIN) ("leukotriene C 4" . SPARSER::MOLECULE)
    ("thromboxane B 2" . SPARSER::MOLECULE) ("α -chain" . SPARSER::PROTEIN)
    ("EP4 receptor" . SPARSER::PROTEIN) ("EP2 receptor" . SPARSER::PROTEIN)
    ("EP4" . SPARSER::PROTEIN) ("EP3" . SPARSER::PROTEIN)
    ("LSM5" . SPARSER::PROTEIN) ("CA-3" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("15d-PGJ 2" . SPARSER::MOLECULE)
    ("TGF- β 1" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("AH-6809" . SPARSER::DRUG) ("PGH 2" . SPARSER::MOLECULE)
    ("HGF receptor" . SPARSER::PROTEIN) ("EP2" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("monomeric collagen" . SPARSER::PROTEIN)
    ("CalDAG-GEFI/P2Y12" . SPARSER::COLLECTION)
    ("thrombin or collagen" . SPARSER::COLLECTION)
    ("exogenous ADP" . SPARSER::PROTEIN)
    ("ICAM-1 ( xref ) and neutrophils" . SPARSER::COLLECTION)
    ("RasGRP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("defective kindlin-3" . SPARSER::PROTEIN)
    ("only four candidate genes" . SPARSER::GENE)
    ("only one normal allele" . SPARSER::ALLELE)
    ("PKC and ADP" . SPARSER::COLLECTION)
    ("anti-CD11b/CD18" . SPARSER::COLLECTION)
    ("ICAM-1 and anti-CD3" . SPARSER::COLLECTION)
    ("β2-integrin" . SPARSER::COLLECTION)
    ("Rap1 and Rac1" . SPARSER::COLLECTION)
    ("ADP ( xref ) and TRAP-6 (not depicted)" . SPARSER::COLLECTION)
    ("a single mutated allele" . SPARSER::ALLELE)
    ("fibrillar collagen" . SPARSER::PROTEIN)
    ("the EGFP and the wild-type form" . SPARSER::COLLECTION)
    ("soluble fibrinogen" . SPARSER::PROTEIN)
    ("ADP or TRAP-6" . SPARSER::COLLECTION)
    ("soluble and immobilized fibrinogen" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN) ("the mutated form" . SPARSER::FORM)
    ("ADP and TRAP-6" . SPARSER::COLLECTION)
    ("a small neutral amino acid" . SPARSER::AMINO-ACID)
    ("proteins and GEFs" . SPARSER::COLLECTION) ("Sos-2" . SPARSER::PROTEIN)
    ("normal ITGA2B and ITGB3" . SPARSER::COLLECTION)
    ("ITGA2B and ITGB3" . SPARSER::COLLECTION)
    ("a nonsynonymous c" . SPARSER::PROTEIN) ("PRP" . SPARSER::PROTEIN)
    ("Thrombin" . SPARSER::PROTEIN) ("thrombin" . SPARSER::PROTEIN)
    ("serotonin and PAI-1" . SPARSER::COLLECTION)
    ("granulophysin" . SPARSER::PROTEIN) ("mepacrine" . SPARSER::DRUG)
    ("serotonin" . SPARSER::MOLECULE)
    ("αIIbβ3 and GPIbα" . SPARSER::COLLECTION)
    ("ADP or epinephrine" . SPARSER::COLLECTION) ("TRAP" . SPARSER::PROTEIN)
    ("the most predominant small GTPases" . SPARSER::GTPASE)
    ("potentially safe therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("functional CalDAG-GEFI" . SPARSER::PROTEIN)
    ("calcium- and DAG-regulated guanine exchange factor-1 (CalDAG-GEFI)"
     . SPARSER::COLLECTION)
    ("calcium-" . SPARSER::CALCIUM) ("C5a" . SPARSER::PROTEIN)
    ("U3" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("PAK-1" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-Phosphate Dehydrogenase" . SPARSER::PROTEIN)
    ("URP2" . SPARSER::PROTEIN) ("N-Ethylmaleimide" . SPARSER::MOLECULE)
    ("L-Arg" . SPARSER::PROTEIN) ("plasma)" . SPARSER::PROTEIN)
    ("CD62P" . SPARSER::PROTEIN) ("CD42a" . SPARSER::PROTEIN)
    ("CD42d" . SPARSER::PROTEIN) ("CD42b" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("PAR-1" . SPARSER::PROTEIN)
    ("Rap1b" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("CALDAG-GEFI" . SPARSER::PROTEIN) ("P2Y12" . SPARSER::PROTEIN)
    ("GTPγs" . SPARSER::PROTEIN) ("Ha-Ras" . SPARSER::PROTEIN)
    ("Ha-ras" . SPARSER::PROTEIN) ("ITGB3" . SPARSER::PROTEIN)
    ("ITGA2B" . SPARSER::PROTEIN) ("FERMT3" . SPARSER::PROTEIN)
    ("fermitin family member 3" . SPARSER::PROTEIN) ("SCR2" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("PAC-1" . SPARSER::PROTEIN)
    ("GPIbα" . SPARSER::PROTEIN) ("thrombin receptor" . SPARSER::PROTEIN)
    ("Ras-like GTPase" . SPARSER::PROTEIN) ("kindlin-3" . SPARSER::PROTEIN)
    ("αIIbβ3" . SPARSER::PROTEIN) ("CalDAG-GEFI" . SPARSER::PROTEIN)
    ("RAS guanyl-releasing protein" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("RASGRP2" . SPARSER::PROTEIN)
    ("SIVA1 and hELG1" . SPARSER::COLLECTION)
    ("the replicative polymerases" . SPARSER::PROTEIN)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("C1orf124/Spartan/DVC1" . SPARSER::COLLECTION)
    ("Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Claspin" . SPARSER::PROTEIN)
    ("RAD18 and SIVA1" . SPARSER::COLLECTION)
    ("PCNA or RAD18" . SPARSER::COLLECTION)
    ("RAD18–SIVA1–PCNA" . SPARSER::COLLECTION)
    ("RAD18–PCNA" . SPARSER::COLLECTION) ("GST-SIVA1" . SPARSER::COLLECTION)
    ("using GST-fused SIVA1 and His-small ubiquitin-like modifier (SUMO)–fused RAD18 recombinant proteins"
     . SPARSER::PROTEIN)
    ("SIVA1 and His-small" . SPARSER::COLLECTION)
    ("–fused" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("SIVA1 and RAD18" . SPARSER::COLLECTION)
    ("Substrate" . SPARSER::SUBSTRATE) ("RAD18 and RAD6" . SPARSER::COLLECTION)
    ("RAD18 or RAD6" . SPARSER::COLLECTION)
    ("USP1 and UAF1" . SPARSER::COLLECTION)
    ("SIVA1 and USP1" . SPARSER::COLLECTION)
    ("both the RAD18–RAD6 ubiquitin ligase complex and the USP1–UAF1 deubiquitinase complex"
     . SPARSER::COLLECTION)
    ("RAD18–RAD6" . SPARSER::COLLECTION)
    ("SIVA1 and Polη" . SPARSER::COLLECTION)
    ("exogenous SIVA1 or SIVA1 mutants" . SPARSER::MUTANT)
    ("SIVA1 or SIVA1" . SPARSER::COLLECTION)
    ("siRNA or SIVA1" . SPARSER::COLLECTION)
    ("siRNA#1-resistant wild-type SIVA1 or its point mutants"
     . SPARSER::COLLECTION)
    ("genotoxin" . SPARSER::MOLECULE)
    ("mitomycin C (MMC) and hydroxyurea (HU)" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG) ("MMC" . SPARSER::PROTEIN)
    ("Many PCNA-associated proteins" . SPARSER::PROTEIN)
    ("purified recombinant wild-type SIVA1 and the other mutants"
     . SPARSER::COLLECTION)
    ("SIVA1-" . SPARSER::PROTEIN)
    ("PCNA and several other proteins" . SPARSER::COLLECTION)
    ("recombinant maltose-binding protein (MBP)–tagged PCNA and GST-tagged SIVA1"
     . SPARSER::COLLECTION)
    ("maltose" . SPARSER::MOLECULE) ("PCNA and SIVA1" . SPARSER::COLLECTION)
    ("SIVA1–PCNA" . SPARSER::COLLECTION)
    ("SIVA1 and PCNA" . SPARSER::COLLECTION) ("Morc3" . SPARSER::PROTEIN)
    ("SIVA1 and Myc-tagged" . SPARSER::COLLECTION)
    ("a major SIVA1-associated protein" . SPARSER::PROTEIN)
    ("PCNA–protein" . SPARSER::COLLECTION)
    ("intracellular ligand" . SPARSER::LIGAND)
    ("USP1 or UAF1" . SPARSER::COLLECTION) ("USP1–UAF1" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("PCNA and TLS polymerases" . SPARSER::COLLECTION)
    ("the E2 ubiquitin-conjugating enzyme RAD6 and the E3 ubiquitin ligase RAD18 ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("RAD6" . SPARSER::PROTEIN) ("cis-syn" . SPARSER::COLLECTION)
    ("syn" . SPARSER::PROTEIN) ("RAD18 and PCNA" . SPARSER::COLLECTION)
    ("RAD6–RAD18" . SPARSER::PROTEIN-PAIR) ("pEF1" . SPARSER::PROTEIN)
    ("RAD6B" . SPARSER::PROTEIN) ("RAD6A" . SPARSER::PROTEIN)
    ("DVC1" . SPARSER::PROTEIN) ("C1orf124" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("M/L" . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN) ("1 A" . SPARSER::PROTEIN)
    ("PAF15" . SPARSER::PROTEIN) ("CD27" . SPARSER::PROTEIN)
    ("UAF1" . SPARSER::PROTEIN) ("USP1" . SPARSER::PROTEIN)
    ("Cdt2" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("SIVA1" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN)
    ("only one disease-specific HDAC isoform" . SPARSER::ISOFORM)
    ("lipogenic enzymes" . SPARSER::ENZYME)
    ("KLF11 , BTG2 and TP53I3" . SPARSER::COLLECTION)
    ("SKP2 and TGFβI" . SPARSER::COLLECTION)
    ("polo-like kinase 1 (PLK1) and kinesin spindle protein (KSP) ( xref )"
     . SPARSER::COLLECTION)
    ("protein (KSP)" . SPARSER::PROTEIN)
    ("at least 21 siRNAs" . SPARSER::PROTEIN)
    ("only one HDAC2 target protein" . SPARSER::PROTEIN)
    ("LNP-siβgal478" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("uridine or guanosine" . SPARSER::COLLECTION)
    ("nucleosides" . SPARSER::MOLECULE) ("uridine" . SPARSER::PROTEIN)
    ("systemic siRNA" . SPARSER::PROTEIN)
    ("p53, c-Myc and pRB" . SPARSER::COLLECTION)
    ("SKP2 and p27" . SPARSER::COLLECTION)
    ("CDK2, CDK4, CDK6, Cyclin D1 and Cyclin E" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("TP53I3, BTG2, KLF11 and TAGLN" . SPARSER::COLLECTION)
    ("TAGLN" . SPARSER::PROTEIN)
    ("HDAC1, HDAC3, HDAC4, HDAC5 and HDAC8" . SPARSER::COLLECTION)
    ("only HDAC2 protein" . SPARSER::PROTEIN)
    ("cationic lipids" . SPARSER::LIPID) ("-2, or -3" . SPARSER::COLLECTION)
    ("HDAC2-1" . SPARSER::COLLECTION)
    ("CDK6, BCL-2, and PPARγ" . SPARSER::COLLECTION)
    ("nanoparticles (LNP)" . SPARSER::MOLECULE) ("LNP" . SPARSER::PROTEIN)
    ("COP1 or CSN5" . SPARSER::COLLECTION)
    ("a novel cinnamic hydroxamic acid HDACi" . SPARSER::MOLECULE)
    ("Panobinostat" . SPARSER::DRUG)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Romidepsin" . SPARSER::DRUG) ("FK" . SPARSER::MOLECULE)
    ("Vorinostat" . SPARSER::DRUG) ("HDACi" . SPARSER::MOLECULE)
    ("class IIb (HDAC6, 10) and class IV (HDAC11)" . SPARSER::COLLECTION)
    ("other regulators of glycolysis (ChREBPα, GLUT4) and lipogenesis (SREBP1C, FAS)"
     . SPARSER::COLLECTION)
    ("ChREBP" . SPARSER::PROTEIN) ("CDK6 and BCL-2" . SPARSER::COLLECTION)
    ("MC1568" . SPARSER::DRUG) ("Flt3L" . SPARSER::PROTEIN)
    ("RPS6KA3" . SPARSER::PROTEIN) ("KLF11" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("COP1" . SPARSER::PROTEIN)
    ("LBH589" . SPARSER::DRUG) ("HDAC11" . SPARSER::PROTEIN)
    ("SREBP1C" . SPARSER::PROTEIN) ("Histone deacetylase 2" . SPARSER::PROTEIN)
    ("IκBα-β-TrCP-ubiquitin ligase" . SPARSER::COLLECTION)
    ("progressive ataxia" . SPARSER::PROTEIN)
    ("RelA and CDK9" . SPARSER::COLLECTION)
    ("The immediate-early genes" . SPARSER::GENE)
    ("CDK9/CCNT1" . SPARSER::COLLECTION)
    ("CDK-9 and cyclin T1" . SPARSER::COLLECTION)
    ("the ribosomal S6 kinases, PKAc and MSK-1" . SPARSER::COLLECTION)
    ("S6 kinases, PKAc and MSK-1" . SPARSER::COLLECTION)
    ("Ub-IKKγ" . SPARSER::COLLECTION) ("SID-SRM" . SPARSER::COLLECTION)
    ("the IKK-α and -β kinases" . SPARSER::COLLECTION)
    ("TRAF6 and the LUBAC E3 ligases" . SPARSER::COLLECTION)
    ("IKKγ-ATM" . SPARSER::COLLECTION)
    ("a reducing agent (dithiothreitol) or a ferric ion chelator (desferoxamine)"
     . SPARSER::COLLECTION)
    ("a ferric ion chelator" . SPARSER::MOLECULE)
    ("dithiothreitol" . SPARSER::PROTEIN) ("Nibrin" . SPARSER::PROTEIN)
    ("p-IκBα" . SPARSER::COLLECTION)
    ("ubiquitin and complex" . SPARSER::COLLECTION)
    ("CDK9 and phospho-Ser 2" . SPARSER::COLLECTION)
    ("anti-RelA, CDK9 or phospho-Ser 2 Pol II Abs" . SPARSER::PROTEIN)
    ("anti-RelA, CDK9 or phospho-Ser 2" . SPARSER::COLLECTION)
    ("Gro-β and IκBα-containing chromatin" . SPARSER::COLLECTION)
    ("IL-8, Gro-β and IκBα-containing chromatin" . SPARSER::COLLECTION)
    ("CDK9 and RNA" . SPARSER::COLLECTION)
    ("immediate-early gene promoters" . SPARSER::PROMOTER)
    ("RelA and co-activators" . SPARSER::COLLECTION)
    ("phospho-Ser 276 RelA immediate-early genes" . SPARSER::GENE)
    ("shRNA or ATM" . SPARSER::COLLECTION)
    ("Gro-β and IL-8" . SPARSER::COLLECTION)
    ("ATM-shRNA" . SPARSER::COLLECTION)
    ("these immediate-early genes" . SPARSER::GENE)
    ("IL-8 and Gro-β" . SPARSER::COLLECTION) ("ROS-" . SPARSER::PROTEIN)
    ("mitogen-stress related kinase-1 (MSK1) and catalytic subunit"
     . SPARSER::COLLECTION)
    ("redundant ribosomal S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("RelA and phospho-Ser 276" . SPARSER::COLLECTION)
    ("RelA +/+ and RelA −/− MEFs" . SPARSER::COLLECTION)
    ("A western blot" . SPARSER::PROTEIN)
    ("a proteotypic peptide" . SPARSER::PEPTIDE) ("β-TrCP-" . SPARSER::PROTEIN)
    ("NF-κB2/p100 western blot" . SPARSER::PROTEIN)
    ("NF-κB2/p100-β-TrCP" . SPARSER::COLLECTION) ("shRNA-" . SPARSER::PROTEIN)
    ("NF-κB2/p100" . SPARSER::COLLECTION)
    ("β-TrCP and IκBα" . SPARSER::COLLECTION)
    ("MEFs and ATM" . SPARSER::COLLECTION)
    ("shRNA and ATM" . SPARSER::COLLECTION)
    ("a prototypic peptide" . SPARSER::PEPTIDE)
    ("SID" . SPARSER::PROTEIN-FAMILY) ("ATM-NF-κB" . SPARSER::COLLECTION)
    ("IKK-associated ATM" . SPARSER::PROTEIN)
    ("·Ub-IKKγ" . SPARSER::COLLECTION) ("pATM and IKKγ" . SPARSER::COLLECTION)
    ("a traditional drug" . SPARSER::DRUG)
    ("ROS and 8-oxoG" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("Lamin B and β-tubulin" . SPARSER::COLLECTION)
    ("chemokine/cytokine" . SPARSER::COLLECTION)
    ("the IKK complex and subsequent NF-κB-dependent gene expression"
     . SPARSER::COLLECTION)
    ("DAMPs" . SPARSER::DAMP) ("PAMP" . SPARSER::PROTEIN)
    ("immediate-early cytokine genes" . SPARSER::GENE)
    ("the Ribosomal S6 Kinase family" . SPARSER::PROTEIN-FAMILY)
    ("inactive RelA·p50 heterodimer" . SPARSER::HETERODIMER)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("NF-κB-dependent immediate-early cytokine genes" . SPARSER::GENE)
    ("ribosmal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("IgG2" . SPARSER::BIO-COMPLEX) ("CCNT1" . SPARSER::PROTEIN)
    ("CDK-9" . SPARSER::PROTEIN) ("MSK-1" . SPARSER::PROTEIN)
    ("hnRNP-U" . SPARSER::PROTEIN) ("CUL-1" . SPARSER::PROTEIN)
    ("IKK-α" . SPARSER::PROTEIN) ("NADPH-oxidase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY) ("VP-16" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("Glu-C" . SPARSER::PROTEIN)
    ("Gro-β" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("kinase-like" . SPARSER::PROTEIN-FAMILY)
    ("some functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hyperactive MDM2" . SPARSER::PROTEIN) ("Exogenous DMM" . SPARSER::DRUG)
    ("further stabilized p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oxaloacetate" . SPARSER::MOLECULE)
    ("the few progression-linked enzymes" . SPARSER::ENZYME)
    ("exogenous pyruvate" . SPARSER::PROTEIN)
    ("the principal redox" . SPARSER::PROTEIN)
    ("Mitochondrial complex I" . SPARSER::PROTEIN)
    ("exogenous NAC" . SPARSER::PROTEIN)
    ("DMM and cisplatin" . SPARSER::COLLECTION)
    ("E-cadherin and mucin-1" . SPARSER::COLLECTION)
    ("mucin-1 and vimentin" . SPARSER::COLLECTION)
    ("selectively increases ROS" . SPARSER::PROTEIN)
    ("exogenous NAC or GSH" . SPARSER::COLLECTION)
    ("DMM and NAC or GSH" . SPARSER::COLLECTION)
    ("NAC or GSH" . SPARSER::COLLECTION)
    ("Both exogenous NAC and GSH" . SPARSER::COLLECTION)
    ("NAC and GSH" . SPARSER::COLLECTION)
    ("first measured mitochondrial ROS" . SPARSER::PROTEIN)
    ("MitoSOX" . SPARSER::DRUG)
    ("Antioxidants N-acetyl-cysteine (NAC) and glutathione (GSH)"
     . SPARSER::COLLECTION)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG)
    ("Antioxidants" . SPARSER::DRUG) ("a cell permeable form" . SPARSER::FORM)
    ("AKT and PDK1" . SPARSER::COLLECTION)
    ("exogenous cell permeable malate" . SPARSER::MOLECULE)
    ("exogenous malate" . SPARSER::MOLECULE) ("-malate" . SPARSER::MOLECULE)
    ("mitochondrial malate" . SPARSER::MOLECULE) ("pERK" . SPARSER::PROTEIN)
    ("AMPK and PTEN" . SPARSER::COLLECTION)
    ("PTEN and PDK1" . SPARSER::COLLECTION) ("p-PTEN" . SPARSER::COLLECTION)
    ("PDK1 and p-PDK1" . SPARSER::COLLECTION)
    ("PDK1 and PTEN" . SPARSER::COLLECTION)
    ("Exogenous N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("-lactate" . SPARSER::LACTATE) ("Seahorse" . SPARSER::PROTEIN)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("Citrate" . SPARSER::PROTEIN) ("-citrate" . SPARSER::COLLECTION)
    ("tracer" . SPARSER::MOLECULE) ("Pyruvate" . SPARSER::PROTEIN)
    ("pyruvate, glucose and glutamine" . SPARSER::COLLECTION)
    ("Hams/F12" . SPARSER::COLLECTION) ("Hams" . SPARSER::PROTEIN)
    ("essential amino acids such as Val" . SPARSER::AMINO-ACID)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("phosphatidylcholine (PC)" . SPARSER::MOLECULE)
    ("both the fatty acyl" . SPARSER::PROTEIN) ("glycerol" . SPARSER::PROTEIN)
    ("the 13 C 6 -Glc-derived fatty acyl" . SPARSER::PROTEIN)
    ("-Gln" . SPARSER::COLLECTION) ("-Glc" . SPARSER::MOLECULE)
    ("Glc" . SPARSER::MOLECULE) ("SIRM" . SPARSER::PROTEIN)
    ("pyruvate and CO 2" . SPARSER::COLLECTION)
    ("NADH or NADPH" . SPARSER::COLLECTION)
    ("EGFR, PTEN and MYC" . SPARSER::COLLECTION)
    ("EGFR , KRAS , LKB1 and PTEN" . SPARSER::COLLECTION)
    ("DMM" . SPARSER::DRUG) ("/NADPH" . SPARSER::COLLECTION)
    ("Mitochondrial malic enzyme 2" . SPARSER::PROTEIN)
    ("CO 2 and pyruvate" . SPARSER::COLLECTION)
    ("NAD + or NADP +" . SPARSER::COLLECTION)
    ("dinucleotide" . SPARSER::MOLECULE) ("ME" . SPARSER::PROTEIN)
    ("mucin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("p-PDK1" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE) ("malic enzyme 2" . SPARSER::PROTEIN)
    ("PH1 and PH2" . SPARSER::COLLECTION) ("thiazide" . SPARSER::MOLECULE)
    ("calcium and precipitation" . SPARSER::COLLECTION)
    ("AGT1 or AGT2" . SPARSER::COLLECTION)
    ("hepatocytes and NADPH oxidase" . SPARSER::COLLECTION)
    ("CDH16-Cre" . SPARSER::PROTEIN-PAIR) ("CDH" . SPARSER::PROTEIN)
    ("Kap-Cre" . SPARSER::COLLECTION) ("Kap" . SPARSER::PROTEIN)
    ("systemic AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ACTB-Cre" . SPARSER::COLLECTION) ("loxP" . SPARSER::PROTEIN)
    ("androgen/AR" . SPARSER::COLLECTION)
    ("androgen and its receptor" . SPARSER::COLLECTION)
    ("testosterone ( xref ) or urinary excretion" . SPARSER::COLLECTION)
    ("citrate and uric acid" . SPARSER::COLLECTION)
    ("Calcium" . SPARSER::CALCIUM) ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatic glycolate oxidase and kidney epithelial NADPH oxidase subunit p22-PHOX"
     . SPARSER::COLLECTION)
    ("kidney proximal or distal epithelial AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cre-loxP" . SPARSER::COLLECTION) ("glyoxylate" . SPARSER::MOLECULE)
    ("Males" . SPARSER::MOLECULE) ("PH2" . SPARSER::PROTEIN)
    ("PH1" . SPARSER::PROTEIN) ("SLC26A6" . SPARSER::PROTEIN)
    ("B-i" . SPARSER::PROTEIN) ("AGT2" . SPARSER::PROTEIN)
    ("alanine-glyoxylate aminotransferase 2" . SPARSER::PROTEIN)
    ("AGT1" . SPARSER::PROTEIN)
    ("alanine-glyoxylate aminotransferase" . SPARSER::PROTEIN)
    ("pAX2" . SPARSER::PROTEIN) ("uric acid" . SPARSER::MOLECULE)
    ("p22-PHOX" . SPARSER::PROTEIN) ("glycolate oxidase" . SPARSER::PROTEIN)
    ("the optic disc and significantly reduced neovascular tufting"
     . SPARSER::COLLECTION)
    ("focal adhesion kinases (FAK) and scaffolding protein"
     . SPARSER::COLLECTION)
    ("kinases (FAK)" . SPARSER::PROTEIN)
    ("cytoskeletal protein effectors" . SPARSER::EFFECTOR)
    ("p53 and ICAM-1" . SPARSER::COLLECTION)
    ("the optic disc" . SPARSER::BIO-COMPLEX) ("disc" . SPARSER::BIO-COMPLEX)
    ("the central retina" . SPARSER::DRUG) ("Normoxia" . SPARSER::PROTEIN)
    ("the retinal vasculature" . SPARSER::PROTEIN)
    ("selectin" . SPARSER::PROTEIN-FAMILY) ("PECAM" . SPARSER::PROTEIN)
    ("ICAM" . SPARSER::PROTEIN-FAMILY) ("melphalan" . SPARSER::DRUG)
    ("subsequent tissue ischemia" . SPARSER::PROTEIN)
    ("a subsequent growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The ischemic retina" . SPARSER::DRUG)
    ("quinic acid derivatives" . SPARSER::DERIVATIVE)
    ("reducing both the retinal ischemia" . SPARSER::PROTEIN)
    ("RECs" . SPARSER::PROTEIN) ("Resultant ischemia" . SPARSER::PROTEIN)
    ("subsequent hypoxia" . SPARSER::PROTEIN) ("REC" . SPARSER::PROTEIN)
    ("E-selectin" . SPARSER::PROTEIN) ("P17" . SPARSER::PROTEIN)
    ("P110" . SPARSER::PROTEIN) ("bh 2" . SPARSER::MOLECULE)
    ("SB202190" . SPARSER::DRUG) ("Alpha-tubulin" . SPARSER::PROTEIN)
    ("TP53 and CDNK2A" . SPARSER::COLLECTION) ("using ARMS" . SPARSER::PROTEIN)
    ("ARMS or Sanger" . SPARSER::COLLECTION)
    ("HRAS , NRAS and BRAF" . SPARSER::COLLECTION) ("IVD" . SPARSER::PROTEIN)
    ("EGFR TKI's" . SPARSER::PROTEIN)
    ("TP53 , PIK3CA and CDNK2A" . SPARSER::COLLECTION)
    ("HRAS and NRAS and codon" . SPARSER::COLLECTION)
    ("NRAS and codon" . SPARSER::COLLECTION) ("OPA " . SPARSER::MOLECULE)
    ("PPA" . SPARSER::PROTEIN) ("The resultant fragment" . SPARSER::FRAGMENT)
    ("cobimetinib (GDC-0973, XL-518) and trametinib" . SPARSER::COLLECTION)
    ("cobimetinib" . SPARSER::DRUG) ("one-sided p " . SPARSER::PROTEIN)
    ("Selumetinib" . SPARSER::DRUG)
    ("gefitinib, erlotinib and afatinib, and ALK" . SPARSER::COLLECTION)
    ("afatinib, and ALK" . SPARSER::COLLECTION)
    ("Caucasian NSCLC ADC" . SPARSER::PROTEIN)
    ("Caucasian ADC" . SPARSER::PROTEIN)
    ("relevant biomarkers" . SPARSER::MOLECULE) ("GDC-0973" . SPARSER::DRUG)
    ("ARRY-142886" . SPARSER::DRUG) ("EEF2K-EEF2" . SPARSER::COLLECTION)
    ("proteins or organelles" . SPARSER::COLLECTION)
    ("C2-ceramide, temozolomide, and arsenic trioxide" . SPARSER::COLLECTION)
    ("doxorubicin or MK-2206" . SPARSER::COLLECTION)
    ("using DCFDA" . SPARSER::DRUG) ("DCFDA" . SPARSER::DRUG)
    ("AMPKα and ULK1" . SPARSER::COLLECTION)
    ("AMPKα or ULK1" . SPARSER::COLLECTION)
    ("AMPK and its downstream target ULK1" . SPARSER::COLLECTION)
    ("PRKAA1 and PRKAA2" . SPARSER::COLLECTION)
    ("siRNA and ULK1" . SPARSER::COLLECTION)
    ("ULK1 and LC3" . SPARSER::COLLECTION)
    ("MK-2206 and nutrient" . SPARSER::COLLECTION)
    ("BECN1 or ATG7" . SPARSER::COLLECTION)
    ("ATG5, BECN1, or ATG7" . SPARSER::COLLECTION)
    ("ATG5, BECN1, and ATG7" . SPARSER::COLLECTION)
    ("ATG5-" . SPARSER::PROTEIN) ("ATG5 and ATG7" . SPARSER::COLLECTION)
    ("BECN1 and ATG7" . SPARSER::COLLECTION)
    ("E64d and pepstatin" . SPARSER::COLLECTION) ("pepstatin" . SPARSER::DRUG)
    ("using multiple siRNAs" . SPARSER::PROTEIN)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("AMPK or ULK1" . SPARSER::COLLECTION)
    ("AMPK-ULK1" . SPARSER::COLLECTION) ("ANXA5" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("C2-ceramide" . SPARSER::MOLECULE) ("PRKAA2" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN) ("BECN1" . SPARSER::PROTEIN)
    ("E64d" . SPARSER::MOLECULE) ("Eef2k" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 13" . SPARSER::PROTEIN)
    ("SAPK4" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("MAPK13" . SPARSER::PROTEIN) ("polypeptide 1" . SPARSER::PROTEIN)
    ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("MK-2206" . SPARSER::MOLECULE)
    ("eukaryotic translation elongation factor 2" . SPARSER::PROTEIN)
    ("EEF2" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor-2 kinase" . SPARSER::PROTEIN)
    ("EEF2K" . SPARSER::PROTEIN) ("Lys/Lys" . SPARSER::COLLECTION)
    ("Afro-Americans" . SPARSER::PROTEIN-PAIR) ("Afro" . SPARSER::PROTEIN)
    ("variant XPD 751Gln allele and the risk" . SPARSER::COLLECTION)
    ("heterozygous + homozygous variant genotypes" . SPARSER::PROTEIN)
    ("Lys/Gln" . SPARSER::COLLECTION)
    ("ACA, and Sokal and Hasford" . SPARSER::COLLECTION)
    ("Gln, His, and Trp" . SPARSER::COLLECTION) ("SSB" . SPARSER::PROTEIN)
    ("the XRCC1 194Trp and 399Gln alleles and CML risk" . SPARSER::COLLECTION)
    ("XRCC1 Arg194Trp and Arg399Gln polymorphisms" . SPARSER::COLLECTION)
    ("imatinib, dasatinib, or nilotinib" . SPARSER::COLLECTION)
    ("the variant heterozygous and homozygous genotypes" . SPARSER::PROTEIN)
    ("XRCC1 and XRCC3" . SPARSER::COLLECTION)
    ("variant homozygous genotypes" . SPARSER::PROTEIN)
    ("acute myeloid and lymphoblastic leukemia" . SPARSER::COLLECTION)
    ("acute myeloid" . SPARSER::PROTEIN)
    ("both variants RAD51 135C and XRCC3 241Met alleles" . SPARSER::COLLECTION)
    ("Qin" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("DNA polymerase beta, DNA ligase III, and poly ADP-ribose polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("bulky adducts and thymidine dimers" . SPARSER::DIMER)
    ("group D ( XPD )" . SPARSER::PROTEIN)
    ("XRCC1 or XRCC3" . SPARSER::COLLECTION)
    ("DNA polymerase beta" . SPARSER::PROTEIN) ("group D" . SPARSER::PROTEIN)
    ("XRCC3" . SPARSER::PROTEIN) ("X-ray repair" . SPARSER::PROTEIN)
    ("RASSF1 and AKT" . SPARSER::COLLECTION)
    ("EGFR and RAS" . SPARSER::COLLECTION) ("MAPK/PI3K" . SPARSER::COLLECTION)
    ("TEAD2 and E2F1" . SPARSER::COLLECTION)
    ("YAP1, KRAS and EMT" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("Yap1 or Renilla" . SPARSER::COLLECTION)
    ("Fn1, Cdh2, Snai1, Snai2, Zeb1, and Ocln" . SPARSER::COLLECTION)
    ("Fn1" . SPARSER::PROTEIN) ("Ocln" . SPARSER::PROTEIN)
    ("KP-KrasA" . SPARSER::PROTEIN-PAIR)
    ("Kras and mutant" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("KP" . SPARSER::PROTEIN)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Lox" . SPARSER::PROTEIN)
    ("AR-FOS" . SPARSER::COLLECTION) ("YAP1-FOS" . SPARSER::COLLECTION)
    ("YAP1 and FOS" . SPARSER::COLLECTION)
    ("VIM and Slug" . SPARSER::COLLECTION)
    ("YAP1 and JUN" . SPARSER::COLLECTION)
    ("complexes (FOS)" . SPARSER::BIO-COMPLEX)
    ("YAP1 or control (anti-GFP) immune complexes" . SPARSER::COLLECTION)
    ("FOS and YAP1" . SPARSER::COLLECTION)
    ("EMT transcriptional regulators nor FOS" . SPARSER::COLLECTION)
    ("FOS, Slug, or Snail" . SPARSER::COLLECTION)
    ("Slug or Snail" . SPARSER::COLLECTION)
    ("Slug and Snail" . SPARSER::COLLECTION)
    ("Vimentin ( VIM )" . SPARSER::PROTEIN)
    ("E-cadherin ( CDH1 ) and Occludin ( OCLN ) ( xref )"
     . SPARSER::COLLECTION)
    ("Occludin ( OCLN )" . SPARSER::PROTEIN)
    ("mesenchymal genes" . SPARSER::GENE) ("OCLN" . SPARSER::PROTEIN)
    ("Occludin" . SPARSER::PROTEIN) ("VIM" . SPARSER::PROTEIN)
    ("YAP1 or KRAS" . SPARSER::COLLECTION) ("KRAS-MAPK" . SPARSER::COLLECTION)
    ("family and ATF" . SPARSER::COLLECTION)
    ("protein (SP)" . SPARSER::PROTEIN)
    ("c-MYC, HIF, and E2F" . SPARSER::COLLECTION)
    ("KRAS G13D and YAP1" . SPARSER::COLLECTION)
    ("YAP1 and KRAS" . SPARSER::COLLECTION)
    ("KRAS or YAP1" . SPARSER::COLLECTION)
    ("previously described YAP1 domain-specific mutants" . SPARSER::MUTANT)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("MEK or PI3K" . SPARSER::COLLECTION)
    ("the PI3K inhibitor GDC-0941 or the MEK inhibitor AZD-6244 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("ERK, MEK, or AKT" . SPARSER::COLLECTION)
    ("either KRAS G13D or YAP1" . SPARSER::COLLECTION)
    ("c-MYC and PIK3CA" . SPARSER::COLLECTION)
    ("MAPK or PI3K" . SPARSER::COLLECTION)
    ("YAP1 and WWTR1" . SPARSER::COLLECTION) ("CCSB" . SPARSER::PROTEIN)
    ("the ERBB4 internal cytoplasmic fragment" . SPARSER::FRAGMENT)
    ("Activator" . SPARSER::ACTIVATOR) ("Hpo" . SPARSER::PROTEIN)
    ("an essential oncogene" . SPARSER::ONCOGENE)
    ("FOS and JUN" . SPARSER::COLLECTION)
    ("Mitogen-Activated Protein Kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS , BRAF , and EGFR" . SPARSER::COLLECTION)
    ("KRAS and YAP1" . SPARSER::COLLECTION) ("RASSF1" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("early growth response protein" . SPARSER::PROTEIN)
    ("AZD-6244" . SPARSER::DRUG) ("Ras-binding" . SPARSER::PROTEIN)
    ("GDC-0941" . SPARSER::DRUG) ("Yap1" . SPARSER::PROTEIN)
    ("TBX5" . SPARSER::PROTEIN)
    ("Ral Guanine nucleotide Exchange Factor" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSF1 and HuR" . SPARSER::COLLECTION)
    ("HIF1 and Cyclin D" . SPARSER::COLLECTION) ("nanog" . SPARSER::PROTEIN)
    ("HSF1 and mTOR" . SPARSER::COLLECTION)
    ("HSF1 and mTORC1" . SPARSER::COLLECTION)
    ("p21 and microRNAs" . SPARSER::COLLECTION)
    ("the basic components" . SPARSER::COMPONENT)
    ("possible miRNA target" . SPARSER::TARGET-PROTEIN)
    ("HuR and miRNA" . SPARSER::COLLECTION) ("HSF1-" . SPARSER::PROTEIN)
    ("HuR and let-7" . SPARSER::COLLECTION)
    ("HSF1 and lincRNA-p21" . SPARSER::COLLECTION)
    ("HuR and β - catenin" . SPARSER::COLLECTION)
    ("an essential activator" . SPARSER::ACTIVATOR) ("hsf1" . SPARSER::PROTEIN)
    ("phospho-T389 p70 S6 kinase and its mRNA RPS6KB1" . SPARSER::COLLECTION)
    ("HSF1, HuR and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and HuR" . SPARSER::COLLECTION)
    ("HuR and the CTNNB1 mRNA ( xref , xref )" . SPARSER::COLLECTION)
    ("many mRNAs or long non-coding RNA" . SPARSER::COLLECTION)
    ("TTR-RBPs" . SPARSER::COLLECTION) ("uracil" . SPARSER::DRUG)
    ("TTR-RBP" . SPARSER::COLLECTION) ("RBP" . SPARSER::PROTEIN)
    ("TTR" . SPARSER::PROTEIN)
    ("the β-catenin gene ( CTNNB1) and stimulation" . SPARSER::COLLECTION)
    ("a powerful transcription factor" . SPARSER::PROTEIN)
    ("HSF1-EGFP" . SPARSER::COLLECTION)
    ("doxycyclin-inducible lentiviral vector constructs expressing either shRNA"
     . SPARSER::PROTEIN)
    ("doxycyclin" . SPARSER::MOLECULE)
    ("HSF1 and β-catenin" . SPARSER::COLLECTION)
    ("activated HSF1 accompanied elevated β-catenin" . SPARSER::PROTEIN)
    ("the stem cell self-renewal factor β-catenin" . SPARSER::PROTEIN)
    ("a primary substrate of mTORC1 and these data" . SPARSER::COLLECTION)
    ("/CD24" . SPARSER::COLLECTION) ("CD44 and CD24" . SPARSER::COLLECTION)
    ("Dsh" . SPARSER::PROTEIN) ("TrCP" . SPARSER::PROTEIN)
    ("LEF1 and TCF1" . SPARSER::COLLECTION)
    ("p70 S6kinase (S6K) and 4E-BP ( xref )" . SPARSER::COLLECTION)
    ("raptor and LST8" . SPARSER::COLLECTION)
    ("HSF1-MTA1" . SPARSER::COLLECTION)
    ("activator and inhibitor of gene expression" . SPARSER::INHIBITOR)
    ("activator and inhibitor" . SPARSER::COLLECTION)
    ("receptors, HER2 and HER3" . SPARSER::COLLECTION)
    ("HuR and β-catenin" . SPARSER::COLLECTION)
    ("the stem cell renewal factor β-catenin" . SPARSER::PROTEIN)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("(beta" . SPARSER::PROTEIN) ("IA3" . SPARSER::DRUG)
    ("β - catenin" . SPARSER::PROTEIN) ("p70 S6K" . SPARSER::PROTEIN)
    ("RPS6KB1" . SPARSER::PROTEIN) ("elavL1" . SPARSER::PROTEIN)
    ("β -catenin" . SPARSER::PROTEIN) ("P70 S6K" . SPARSER::PROTEIN)
    ("LRP-5" . SPARSER::PROTEIN) ("TCF1" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("4E-BP" . SPARSER::PROTEIN) ("LST8" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN) ("Factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β–catenin" . SPARSER::PROTEIN) ("adult sporadic PTCs" . SPARSER::PROTEIN)
    ("PTCs" . SPARSER::PROTEIN) ("RET/PTC" . SPARSER::COLLECTION)
    ("PPV and NPV" . SPARSER::COLLECTION) ("PPVs" . SPARSER::MOLECULE)
    ("BRAF V600E and cytology" . SPARSER::COLLECTION)
    ("PAX8" . SPARSER::PROTEIN) ("Yan" . SPARSER::PROTEIN)
    ("MZM" . SPARSER::DRUG) ("a tumor-suppressive lncRNA" . SPARSER::RNA)
    ("GAS5 [ xref ] and HULC [ xref ]" . SPARSER::COLLECTION)
    ("particular miRNAs, and miRNAs" . SPARSER::COLLECTION)
    ("miRNAs, and miRNAs" . SPARSER::COLLECTION)
    ("PRC2 and LSD1" . SPARSER::COLLECTION)
    ("LSD1/CoREST/REST" . SPARSER::COLLECTION) ("CoREST" . SPARSER::PROTEIN)
    ("HOTAIR and c-Myc" . SPARSER::COLLECTION)
    ("HOTAIR and Ago2" . SPARSER::COLLECTION)
    ("Ago2 and miRNA-130a" . SPARSER::COLLECTION)
    ("siRNA or miRNA-mediated gene" . SPARSER::COLLECTION)
    ("a vital component" . SPARSER::COMPONENT)
    ("HOTAIR and miR-130a" . SPARSER::COLLECTION)
    ("HOTAIR or HOTAIR" . SPARSER::COLLECTION)
    ("si-NC or si-HOTAIR" . SPARSER::COLLECTION)
    ("si-HOTAIR" . SPARSER::PROTEIN-PAIR)
    ("c-Myc and the labeled wild-type HOTAIR oligonucleotides"
     . SPARSER::COLLECTION)
    ("c-Myc and Max" . SPARSER::COLLECTION) ("-c-Myc" . SPARSER::COLLECTION)
    ("HOXC11 and HOXC12" . SPARSER::COLLECTION)
    ("miRNA and lncRNA" . SPARSER::COLLECTION)
    ("c-Myc and HOTAIR" . SPARSER::COLLECTION)
    ("response element (RE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HOTAIR and miRNA-130a" . SPARSER::COLLECTION)
    ("HOTAIR, c-Myc and miRNA-130a" . SPARSER::COLLECTION)
    ("HOTAIR or miRNA-130a" . SPARSER::COLLECTION)
    ("HOTAIR and miRNAs" . SPARSER::COLLECTION)
    ("an oncogene and negative prognostic factor" . SPARSER::COLLECTION)
    ("pri-miRNA" . SPARSER::RNA) ("Ago 2" . SPARSER::PROTEIN)
    ("HOXC12" . SPARSER::PROTEIN) ("HOXC11" . SPARSER::PROTEIN)
    ("the Food and Drug Administration breakthrough therapy designation"
     . SPARSER::COLLECTION)
    ("palbociclib" . SPARSER::DRUG)
    ("interphase CDKs (CDK2, 4, 6) and cyclins (cyclin D, E)"
     . SPARSER::COLLECTION)
    ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("promyelocytic leukemia (PML)" . SPARSER::PROTEIN)
    ("UBC9 and the phosphorylated UBC9" . SPARSER::COLLECTION)
    ("only CDK1 kinase" . SPARSER::KINASE)
    ("SUMO1 and ubiquitin" . SPARSER::COLLECTION)
    ("myc-UBC9 wt and S71A mt" . SPARSER::COLLECTION)
    ("UBC9 wt or S71D mt" . SPARSER::COLLECTION)
    ("Myc-UBC9 wt and S71A mt" . SPARSER::COLLECTION)
    ("Myc-UBC9" . SPARSER::COLLECTION)
    ("CDK6 complex and UBC9 or RB1" . SPARSER::COLLECTION)
    ("UBC9 or RB1" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("cyclin B1/CDK1 complex and UBC9 or histone H1 as" . SPARSER::COLLECTION)
    ("UBC9 or histone" . SPARSER::COLLECTION)
    ("cyclin B1/CDK1" . SPARSER::COLLECTION)
    ("cyclin B1-CDK1" . SPARSER::COLLECTION)
    ("using HA and GFP antibodies" . SPARSER::ANTIBODY)
    ("HA and GFP" . SPARSER::COLLECTION)
    ("cyclin D-CDK6" . SPARSER::COLLECTION)
    ("an N-terminal lobe and a C-terminal lobe" . SPARSER::COLLECTION)
    ("Flag-CDK6 wt and K147R mt" . SPARSER::COLLECTION)
    ("CDK6 wt and all K-R mts" . SPARSER::COLLECTION)
    ("wt and K-R" . SPARSER::COLLECTION) ("arginines" . SPARSER::AMINO-ACID)
    ("CDK2 and CDK4" . SPARSER::COLLECTION)
    ("SUMO1 and control shRNA" . SPARSER::COLLECTION)
    ("Flag-CDK6 wt and K216R mt ( xref )" . SPARSER::COLLECTION)
    ("cyclin D1 and pRB" . SPARSER::COLLECTION)
    ("Flag-CDK6 wt and K216R mt" . SPARSER::COLLECTION)
    ("using YFP antibodies" . SPARSER::ANTIBODY)
    ("Flag-CDK4" . SPARSER::COLLECTION) ("CDK6 and GFP" . SPARSER::COLLECTION)
    ("YFP-SUMO3" . SPARSER::COLLECTION) ("YFP-SUMO1" . SPARSER::COLLECTION)
    ("Flag-UBC9" . SPARSER::COLLECTION) ("UBC9 and CDK6" . SPARSER::COLLECTION)
    ("UBC9-CDK6" . SPARSER::COLLECTION)
    ("SUMO1 or control shRNA" . SPARSER::COLLECTION)
    ("myc-UBC9" . SPARSER::COLLECTION) ("Flag-CDK6" . SPARSER::COLLECTION)
    ("SUMO1 and another CDK6 antibody" . SPARSER::COLLECTION)
    ("SAE1/SAE2" . SPARSER::COLLECTION)
    ("ATP, SAE1/2, UBC9 and CDK6" . SPARSER::COLLECTION)
    ("SUMO1 or CDK6" . SPARSER::COLLECTION)
    ("SUMO1 and CDK6" . SPARSER::COLLECTION)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("proteins and CDK6" . SPARSER::COLLECTION) ("His-" . SPARSER::AMINO-ACID)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("UBC9 and SUMO1-conjugated proteins" . SPARSER::COLLECTION)
    ("SEA1, UBC9 and SUMO1-conjugated proteins" . SPARSER::COLLECTION)
    ("sulfate (SDS)" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("sumoylation-defective microphthalmia-associated transcription factor (MITF)"
     . SPARSER::PROTEIN)
    ("reptin" . SPARSER::PROTEIN) ("CDK1-cyclin" . SPARSER::COLLECTION)
    ("CDK2-cyclin E" . SPARSER::COLLECTION)
    ("CDK4/6-cyclin D" . SPARSER::COLLECTION)
    ("CDK2, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("enzyme (E2) and ligase (E3) and the conjugated ubiquitin"
     . SPARSER::COLLECTION)
    ("ligase (E3) and the conjugated ubiquitin" . SPARSER::COLLECTION)
    ("only 50% amino acids" . SPARSER::AMINO-ACID)
    ("SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("SUMO1-CDK6" . SPARSER::COLLECTION) ("Ro-3306" . SPARSER::DRUG)
    ("Ubc9" . SPARSER::PROTEIN) ("cyclin E1" . SPARSER::PROTEIN)
    ("Cyclin-B" . SPARSER::PROTEIN-FAMILY) ("UBC5" . SPARSER::PROTEIN)
    ("UBC13" . SPARSER::PROTEIN) ("Sea2" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("RanGap1" . SPARSER::PROTEIN) ("RBL2" . SPARSER::PROTEIN)
    ("RBL1" . SPARSER::PROTEIN) ("SEA1" . SPARSER::PROTEIN)
    ("SAE2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("KAI1" . SPARSER::PROTEIN) ("cullin 1" . SPARSER::PROTEIN)
    ("SAE1" . SPARSER::PROTEIN) ("SUMO3" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("SUMO4" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("Cigarette" . SPARSER::DRUG)
    ("environmental oxidants" . SPARSER::MOLECULE)
    ("mammalian proliferative neuronal SCs" . SPARSER::PROTEIN)
    ("oxidants and anti-oxidants" . SPARSER::COLLECTION)
    ("mammalian quiescent hematopoietic SCs" . SPARSER::PROTEIN)
    ("Nrf2-Notch1" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("::Nrf2" . SPARSER::BIO-COMPLEX)
    ("Adenoviral Cre-GFP" . SPARSER::COLLECTION)
    ("Cre-GFP" . SPARSER::COLLECTION) ("Nrf2 and Notch1" . SPARSER::COLLECTION)
    ("Notch1, Delta1, Jagged1, Hes1, and HeyL" . SPARSER::COLLECTION)
    ("ROS-Nrf2" . SPARSER::COLLECTION) ("Polidocanol" . SPARSER::DRUG)
    ("Wt and K5" . SPARSER::COLLECTION) ("Notch1 (NICD)" . SPARSER::PROTEIN)
    ("K5-NICD" . SPARSER::COLLECTION) ("MUC5Ac" . SPARSER::PROTEIN)
    ("PIgR" . SPARSER::PROTEIN) ("Hey1 and HeyL" . SPARSER::COLLECTION)
    ("HeyL" . SPARSER::PROTEIN) ("ligand and receptor" . SPARSER::COLLECTION)
    ("Wt and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and its repressor protein Keap1" . SPARSER::COLLECTION)
    ("ROX" . SPARSER::PROTEIN) ("Wt" . SPARSER::PROTEIN)
    ("hpi" . SPARSER::PROTEIN) ("polidocanol" . SPARSER::DRUG)
    ("DPI and Apocynin" . SPARSER::COLLECTION)
    ("NOX/DUOX" . SPARSER::COLLECTION) ("Apocynin" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("DUOX" . SPARSER::PROTEIN)
    ("NOX" . SPARSER::PROTEIN) ("H 2 O 2 and NAC" . SPARSER::COLLECTION)
    ("exogenous ROS" . SPARSER::PROTEIN)
    ("p63 and Keratin 5" . SPARSER::COLLECTION)
    ("DHE and Mitosox" . SPARSER::COLLECTION) ("Mitosox" . SPARSER::DRUG)
    ("ethynyl" . SPARSER::MOLECULE) ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("Redox" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("tracheobronchial" . SPARSER::PROTEIN) ("SCs" . SPARSER::PROTEIN)
    ("γ tubulin" . SPARSER::PROTEIN) ("anti-oxidants" . SPARSER::DRUG)
    ("Ru486" . SPARSER::DRUG) ("PR1" . SPARSER::PROTEIN)
    ("Jagged 1" . SPARSER::PROTEIN) ("RU486" . SPARSER::DRUG)
    ("CC10" . SPARSER::PROTEIN) ("MUC5" . SPARSER::PROTEIN)
    ("Polymeric Immunoglobulin receptor" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("basic Helix-Loop-Helix" . SPARSER::PROTEIN)
    ("Notch 2" . SPARSER::PROTEIN) ("Jagged2" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN)
    ("Quinone Oxidoreductase" . SPARSER::PROTEIN)
    ("atypical Protein Kinase" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("1K" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("Keratin 5" . SPARSER::PROTEIN)
    ("2’,7’-dichlorodihydrofluorescein diacetate" . SPARSER::DRUG)
    ("Nuclear factor erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("SV" . SPARSER::MOLECULE) ("OP" . SPARSER::MOLECULE)
    ("PARP1 and the DNA glycosylases Ogg1 and Neil1" . SPARSER::COLLECTION)
    ("Ogg1 and Neil1" . SPARSER::COLLECTION)
    ("XPA and NER" . SPARSER::COLLECTION) ("cellular NER" . SPARSER::PROTEIN)
    ("XPA–PARP1–SIRT1" . SPARSER::COLLECTION)
    ("PARP1 and SIRT1" . SPARSER::COLLECTION)
    ("XPA and DDB2" . SPARSER::COLLECTION)
    ("approximately 20 amino acids" . SPARSER::AMINO-ACID)
    ("PBM" . SPARSER::PROTEIN) ("PFA" . SPARSER::MOLECULE)
    ("dimeric XPA" . SPARSER::PROTEIN) ("PARP1–XPA" . SPARSER::COLLECTION)
    ("NAD + and an activator oligonucleotide" . SPARSER::COLLECTION)
    ("a strong PARP1 activator" . SPARSER::ACTIVATOR)
    ("PARP1 and XPA" . SPARSER::COLLECTION)
    ("the duplex oligonucleotide" . SPARSER::MOLECULE)
    ("WRN and p53" . SPARSER::COLLECTION) ("WRN" . SPARSER::PROTEIN)
    ("XPA and PARP1" . SPARSER::COLLECTION)
    ("several highly conserved basic amino acids" . SPARSER::AMINO-ACID)
    ("XPA–PBM" . SPARSER::PROTEIN-PAIR)
    ("four highly conserved basic amino acids" . SPARSER::AMINO-ACID)
    ("three basic amino acids and one hydrophobic amino acid"
     . SPARSER::COLLECTION)
    ("three basic amino acids" . SPARSER::AMINO-ACID)
    ("XPA–DDB2/TFIIH" . SPARSER::COLLECTION)
    ("basic and hydrophobic amino acids" . SPARSER::AMINO-ACID)
    ("the clinically relevant pharmacological PARP inhibitor ABT888"
     . SPARSER::DRUG)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("mer" . SPARSER::PROTEIN) ("UV‐C light" . SPARSER::PROTEIN)
    ("XPG, and DNA" . SPARSER::COLLECTION) ("/XPF" . SPARSER::COLLECTION)
    ("XPF" . SPARSER::PROTEIN) ("helicases" . SPARSER::PROTEIN)
    ("XPC and the UV–DDB complex (DDB1‐DDB2‐containing E3‐ubiquitin ligase complex)"
     . SPARSER::COLLECTION)
    ("CSA/CSB" . SPARSER::COLLECTION) ("DDB" . SPARSER::DRUG)
    ("CSB" . SPARSER::PROTEIN)
    ("UV‐light‐induced cyclobutane pyrimidine dimers" . SPARSER::DIMER)
    ("Glu, Asp and Lys" . SPARSER::COLLECTION)
    ("biopolymer" . SPARSER::MOLECULE) ("paraformaldehyde" . SPARSER::DRUG)
    ("pyrimidone" . SPARSER::MOLECULE)
    ("which overlaps theDNAdamage‐binding protein" . SPARSER::PROTEIN)
    ("specific basic amino acids" . SPARSER::AMINO-ACID)
    ("TFIIH" . SPARSER::PROTEIN)
    ("a complex and reversible post‐translational modification that controls protein function"
     . SPARSER::COLLECTION)
    ("H2a" . SPARSER::PROTEIN) ("Neil1" . SPARSER::PROTEIN)
    ("Ogg1" . SPARSER::PROTEIN) ("ABT888" . SPARSER::DRUG)
    ("PJ34" . SPARSER::DRUG) ("DDB1" . SPARSER::PROTEIN)
    ("diphtheria toxin" . SPARSER::PROTEIN)
    ("IL-6 and IL-11" . SPARSER::COLLECTION)
    ("AURKA-STAT3" . SPARSER::COLLECTION)
    ("proteins, BCL2 and MCL1" . SPARSER::COLLECTION)
    ("Adeno-AURKA" . SPARSER::COLLECTION)
    ("exogenous AURKA" . SPARSER::PROTEIN) ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and cytokines" . SPARSER::COLLECTION)
    ("cytokines, growth factors, and pro-survival" . SPARSER::COLLECTION)
    ("alisertib" . SPARSER::DRUG)
    ("β-catenin, and NF-κB" . SPARSER::COLLECTION)
    ("AURKA-JAK2" . SPARSER::COLLECTION)
    ("AZD1480 or siRNA" . SPARSER::COLLECTION)
    ("BCL2 and MCL1" . SPARSER::COLLECTION) ("FLO-1" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("AZD1480" . SPARSER::DRUG)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("a prognostic and predictive biomarker" . SPARSER::MOLECULE)
    ("a potential prognostic and predictive biomarker" . SPARSER::MOLECULE)
    ("ADAMs and other metalloproteinases [ xref ]" . SPARSER::COLLECTION)
    ("HB-EGF and BTC" . SPARSER::COLLECTION)
    ("epigen and neuregulin" . SPARSER::COLLECTION)
    ("epigen" . SPARSER::PROTEIN)
    ("betacellulin and heregulin" . SPARSER::COLLECTION)
    ("pertuzumab and lapatinib" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("ADAM10 and ADAM17" . SPARSER::COLLECTION)
    ("Ki67 and poorer" . SPARSER::COLLECTION)
    ("ADAM10 or ADAM17" . SPARSER::COLLECTION)
    ("ADAM10, ADAM17 and ADAM10/17" . SPARSER::COLLECTION)
    ("exogenous betacellulin" . SPARSER::PROTEIN)
    ("EGFR, HER2, and HER4" . SPARSER::COLLECTION)
    ("neuregulins" . SPARSER::PROTEIN)
    ("EGFR, HER4, and HER2" . SPARSER::COLLECTION) ("dmso" . SPARSER::MOLECULE)
    ("EGFR and HER4 receptors and their preferential dimerization partner HER2 (figures xref left and right panels, xref )"
     . SPARSER::COLLECTION)
    ("their preferential dimerization partner HER2" . SPARSER::PROTEIN)
    ("EGFR and HER4" . SPARSER::COLLECTION) ("AKT/PKB" . SPARSER::COLLECTION)
    ("ADAM17 and ADAM10" . SPARSER::COLLECTION)
    ("EGF and betacellulin" . SPARSER::COLLECTION)
    ("Notch receptor and its ligand Delta 1 [ xref ]" . SPARSER::COLLECTION)
    ("Ephrins [ xref ], N-cadherin [ xref ], E-cadherin [ xref ], Notch receptor and its ligand Delta 1 [ xref ]"
     . SPARSER::COLLECTION)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("disintegrin" . SPARSER::PROTEIN) ("ADAMs" . SPARSER::PROTEIN)
    ("heregulin and betacellulin" . SPARSER::COLLECTION)
    ("betacellulin" . SPARSER::PROTEIN)
    ("EGFR, HER2, HER3, and HER4" . SPARSER::COLLECTION)
    ("a therapeutic target and a potential biomarker" . SPARSER::COLLECTION)
    ("naïve and trastuzumab" . SPARSER::COLLECTION)
    ("ADAM9" . SPARSER::PROTEIN) ("IRS 2" . SPARSER::PROTEIN)
    ("Delta 1" . SPARSER::PROTEIN) ("ADAM17" . SPARSER::PROTEIN)
    ("Kr" . SPARSER::PROTEIN-FAMILY)
    ("the Mendelian Timothy syndrome gene (LQT8) CACNA1C" . SPARSER::PROTEIN)
    ("ATP2A2 , PLN , PRKCA and SRL and SLC8A1" . SPARSER::COLLECTION)
    ("SRL and SLC8A1" . SPARSER::COLLECTION) ("Trpm7" . SPARSER::PROTEIN)
    ("Mg 2+ and Ca 2+" . SPARSER::COLLECTION) ("melastatin" . SPARSER::PROTEIN)
    ("LQT8" . SPARSER::PROTEIN) ("the 5 Mendelian LQTS genes" . SPARSER::GENE)
    ("phospholamban" . SPARSER::PROTEIN) ("sarcalumenin" . SPARSER::PROTEIN)
    ("the Mendelian LQTS genes" . SPARSER::GENE)
    ("KCNQ1 , KCNH2 , CACNA1C , CAV3 and SNTA1" . SPARSER::COLLECTION)
    ("Mendelian LQTS genes" . SPARSER::GENE) ("PRKCA" . SPARSER::PROTEIN)
    ("the Mendelian genes" . SPARSER::GENE)
    ("the first 12 known Mendelian LQTS genes" . SPARSER::GENE)
    ("DAPPLE" . SPARSER::PROTEIN)
    ("known myocardial repolarization proteins" . SPARSER::PROTEIN)
    ("the 13 amino-acid altering variants" . SPARSER::VARIANT)
    ("ESP" . SPARSER::PROTEIN)
    ("the canonical LQTS1-3 causative genes" . SPARSER::GENE)
    ("ATP2A2 , CAV1 , CAV2 , SLC8A1 , SRL , and TRPM7" . SPARSER::COLLECTION)
    ("SRL" . SPARSER::PROTEIN)
    ("previously unrecognized Mendelian LQTS genes" . SPARSER::GENE)
    ("cation" . SPARSER::MOLECULE) ("at least one gene" . SPARSER::GENE)
    ("eQTL" . SPARSER::PROTEIN) ("glucose and HOMA-B" . SPARSER::COLLECTION)
    ("FEN1-FADS2" . SPARSER::COLLECTION) ("triglycerides" . SPARSER::MOLECULE)
    ("SCN5A-SCN10A" . SPARSER::COLLECTION) ("PLN" . SPARSER::PROTEIN)
    ("principal components" . SPARSER::COMPONENT)
    ("further annotated QT-associated genes" . SPARSER::GENE)
    ("LQT1" . SPARSER::PROTEIN)
    ("Mendelian LQTS families" . SPARSER::PROTEIN-FAMILY)
    ("KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNJ2" . SPARSER::COLLECTION)
    ("ion channels or channel-interacting proteins" . SPARSER::COLLECTION)
    ("channel-interacting proteins" . SPARSER::PROTEIN)
    ("SCD" . SPARSER::PROTEIN) ("SCN4B" . SPARSER::PROTEIN)
    ("AKAP9" . SPARSER::PROTEIN) ("ANK2" . SPARSER::PROTEIN)
    ("KCNE2" . SPARSER::PROTEIN) ("TRPC1" . SPARSER::PROTEIN)
    ("Serca2" . SPARSER::PROTEIN) ("NCX1" . SPARSER::PROTEIN)
    ("beta subunit" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("caveolin 1" . SPARSER::PROTEIN) ("SERCA2" . SPARSER::PROTEIN)
    ("SNTA1" . SPARSER::PROTEIN) ("CAV3" . SPARSER::PROTEIN)
    ("CACNA1C" . SPARSER::PROTEIN) ("SGOL2" . SPARSER::PROTEIN)
    ("ETF1" . SPARSER::PROTEIN) ("ATXN1" . SPARSER::PROTEIN)
    ("TRPM7" . SPARSER::PROTEIN) ("SLC8A1" . SPARSER::PROTEIN)
    ("CAV2" . SPARSER::PROTEIN) ("TCEA3" . SPARSER::PROTEIN)
    ("LIG3" . SPARSER::PROTEIN) ("FADS1" . SPARSER::PROTEIN)
    ("CNOT1" . SPARSER::PROTEIN) ("ATP1B1" . SPARSER::PROTEIN)
    ("n-3" . SPARSER::PROTEIN)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("RR 1" . SPARSER::PROTEIN) ("RR 2" . SPARSER::PROTEIN)
    ("ATP2A2" . SPARSER::PROTEIN) ("FEN1" . SPARSER::PROTEIN)
    ("LQT4" . SPARSER::PROTEIN) ("LQT3" . SPARSER::PROTEIN)
    ("LQT2" . SPARSER::PROTEIN) ("KCNJ2" . SPARSER::PROTEIN)
    ("KCNE1" . SPARSER::PROTEIN) ("KCNH2" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("VEGF, and HIF" . SPARSER::COLLECTION) ("Quinazoline" . SPARSER::MOLECULE)
    ("PCNA and PARP" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("VEGFR-2 and doxazosin" . SPARSER::COLLECTION)
    ("Akt, PDK1, and mTOR" . SPARSER::COLLECTION)
    ("Akt/PDK1/mTOR" . SPARSER::COLLECTION)
    ("p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("doxazosin and rapamycin" . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("wortmannin and rapamycin" . SPARSER::COLLECTION)
    ("an essential downstream component" . SPARSER::COMPONENT)
    ("Akt- and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("adrenoceptor" . SPARSER::PROTEIN) ("quinazoline" . SPARSER::MOLECULE)
    ("piperazine" . SPARSER::DRUG)
    ("VEGF receptor 1 (VEGFR-1) and VEGFR-2" . SPARSER::COLLECTION)
    ("molecules and growth factors" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION) ("doxazosin" . SPARSER::DRUG)
    ("Doxazosin" . SPARSER::DRUG)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("kappa light polypeptide gene" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("which anchors Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anchors" . SPARSER::ANCHOR) ("VEGFR-1 and VEGFR-2" . SPARSER::COLLECTION)
    ("Bcl-2, survivin, c-Myc, COX-2, ICAM-1, and XIAP" . SPARSER::COLLECTION)
    ("FAK/mTOR" . SPARSER::COLLECTION)
    ("PDK1, Akt, and mTOR" . SPARSER::COLLECTION)
    ("VEGF and hypoxia-inducible factor" . SPARSER::COLLECTION)
    ("XIAP" . SPARSER::PROTEIN) ("Bax and p53" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin dependent kinase 4" . SPARSER::COLLECTION)
    ("p16 and p27" . SPARSER::COLLECTION)
    ("cell-cycle-associated proteins" . SPARSER::PROTEIN)
    ("the cell-death-associated proteins PARP, caspase-9, and caspase-3"
     . SPARSER::COLLECTION)
    ("PARP, caspase-9, and caspase-3" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("PCNA and Ki-67" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA) and Ki-67"
     . SPARSER::COLLECTION)
    ("Hematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("a pivotal downstream target" . SPARSER::TARGET-PROTEIN)
    ("VEGF, integrins, and growth factor" . SPARSER::COLLECTION)
    ("hydrochloride" . SPARSER::MOLECULE)
    ("VEGFR-2/PI3K/mTOR" . SPARSER::COLLECTION)
    ("thioridazine" . SPARSER::DRUG) ("phenothiazine" . SPARSER::DRUG)
    ("Thioridazine" . SPARSER::DRUG) ("PECAM-1" . SPARSER::PROTEIN)
    ("VEGFR-1" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("exhibiting high HGF (protein/gene) and low MET gene high c-Met protein"
     . SPARSER::COLLECTION)
    ("c-Met and HGF" . SPARSER::COLLECTION) ("longer PFI" . SPARSER::PROTEIN)
    ("HGF/c-Met" . SPARSER::COLLECTION) ("prognostic microRNAs" . SPARSER::RNA)
    ("actionable molecular targets" . SPARSER::TARGET-PROTEIN)
    ("High c-Met/Low HGF and Low HGF/Low c-Met" . SPARSER::COLLECTION)
    ("High HGF/High c-Met, High HGF/Low c-Met, High c-Met/Low HGF and Low HGF/Low c-Met"
     . SPARSER::COLLECTION)
    ("pre- and post-NACT" . SPARSER::COLLECTION)
    ("cellular masks" . SPARSER::PROTEIN)
    ("pre and post-NACT" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION)
    ("HGF and concomitantly repressed MET" . SPARSER::COLLECTION)
    ("TUBB" . SPARSER::PROTEIN) ("PFI" . SPARSER::PROTEIN)
    ("pre-NACT" . SPARSER::COLLECTION)
    ("NACT and PDS-CT" . SPARSER::COLLECTION)
    ("Gene and microRNA" . SPARSER::COLLECTION) ("PBK" . SPARSER::PROTEIN)
    ("DROSHA and DICER" . SPARSER::COLLECTION) ("DROSHA" . SPARSER::PROTEIN)
    ("a correspondent drug inhibitor" . SPARSER::INHIBITOR)
    ("miR-221, let7c and miR-193a-5p" . SPARSER::COLLECTION)
    ("miR-27a" . SPARSER::PROTEIN-PAIR)
    ("twenty-two underwent NACT" . SPARSER::PROTEIN)
    ("gene and microRNA" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and its receptor c-Met"
     . SPARSER::COLLECTION)
    ("microRNA and gene" . SPARSER::COLLECTION)
    ("HGF and c-Met" . SPARSER::COLLECTION)
    ("HGF and MET" . SPARSER::COLLECTION)
    ("microRNAs and genes" . SPARSER::COLLECTION) ("NACT" . SPARSER::PROTEIN)
    ("micro-RNAs" . SPARSER::MICRO-RNA) ("H-10" . SPARSER::PROTEIN)
    ("triethylene glycol" . SPARSER::MOLECULE) ("GNAI1" . SPARSER::PROTEIN)
    ("ID4" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("KIF11" . SPARSER::PROTEIN) ("CHEK1" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("ganetespib" . SPARSER::DRUG)
    ("HGF-MET" . SPARSER::COLLECTION) ("MET or EGFR" . SPARSER::COLLECTION)
    ("alectinib, HGF or EGFR" . SPARSER::COLLECTION)
    ("STAT3 and ALK" . SPARSER::COLLECTION)
    ("MET and EGFR" . SPARSER::COLLECTION)
    ("ALK, EGFR, and MET" . SPARSER::COLLECTION)
    ("MET (HGF) and EGFR (EGF, HB-EGF, and TGF-α)" . SPARSER::COLLECTION)
    ("HGF, TGF-α, or HGF" . SPARSER::COLLECTION)
    ("HGF, TGF-α, and HGF" . SPARSER::COLLECTION)
    ("MET, ALK, and ROS1" . SPARSER::COLLECTION)
    ("alectinib and 17-DMAG" . SPARSER::COLLECTION)
    ("EGFR or downstream AKT and ERK1/2" . SPARSER::COLLECTION)
    ("EGFR and its downstream molecules" . SPARSER::COLLECTION)
    ("MET, AKT, and ERK1/2" . SPARSER::COLLECTION)
    ("ALK and STAT3" . SPARSER::COLLECTION)
    ("AKT, ERK1/2, and STAT3" . SPARSER::COLLECTION)
    ("ERK1/2, and STAT3" . SPARSER::COLLECTION)
    ("ALK and MET" . SPARSER::COLLECTION)
    ("endogenously-produced HGF" . SPARSER::PROTEIN)
    ("endogenously-expressed HGF" . SPARSER::PROTEIN)
    ("HGF or EGFR" . SPARSER::COLLECTION)
    ("EGF, HB-EGF, and TGF-α" . SPARSER::COLLECTION)
    ("HGF and EGFR" . SPARSER::COLLECTION) ("ALK-TKI" . SPARSER::COLLECTION)
    ("ins" . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("ALK, MET, and ROS1" . SPARSER::COLLECTION) ("Crizotinib" . SPARSER::DRUG)
    ("ALK, MET, EGFR, and AKT" . SPARSER::COLLECTION)
    ("EGFR ligands and HGF" . SPARSER::COLLECTION)
    ("alectinib" . SPARSER::DRUG) ("Alectinib" . SPARSER::DRUG)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A20" . SPARSER::PROTEIN)
    ("17-Allylamino 17-demethoxygeldanamycin" . SPARSER::DRUG)
    ("Heat shock protein 90" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN)
    ("a lowered intracellular asparagine" . SPARSER::AMINO-ACID)
    ("exogenous glutamine" . SPARSER::AMINO-ACID)
    ("glutamine and glutamate" . SPARSER::COLLECTION)
    ("a major anaplerotic substrate" . SPARSER::SUBSTRATE)
    ("Glutamine" . SPARSER::AMINO-ACID)
    ("cellular metabolites" . SPARSER::PROTEIN)
    ("Oncogene" . SPARSER::ONCOGENE)
    ("external glutamine" . SPARSER::AMINO-ACID)
    ("GLS1 and GLUD1" . SPARSER::COLLECTION)
    ("glutaminase (GLS1) and glutamate dehydrogenase (GLUD1)"
     . SPARSER::COLLECTION)
    ("glutamine-ammonia ligase (GLUL), glutaminase (GLS1) and glutamate dehydrogenase (GLUD1)"
     . SPARSER::COLLECTION)
    ("ligase (GLUL)" . SPARSER::LIGASE) ("GLUL" . SPARSER::PROTEIN)
    ("synthetase (GS)" . SPARSER::PROTEIN)
    ("c-glutamyl-2" . SPARSER::COLLECTION) ("OPA" . SPARSER::MOLECULE)
    ("ophthalmic" . SPARSER::DRUG) ("GSH and GSSG" . SPARSER::COLLECTION)
    ("SRM" . SPARSER::PROTEIN) ("an essential coenzyme" . SPARSER::MOLECULE)
    ("coenzyme" . SPARSER::MOLECULE)
    ("glutamine, asparagine, and proline" . SPARSER::COLLECTION)
    ("ammonia" . SPARSER::MOLECULE)
    ("PI and phosphatidylserine (PS)" . SPARSER::COLLECTION)
    ("PI and phosphatidylserine" . SPARSER::COLLECTION)
    ("phosphatidylinositols" . SPARSER::PROTEIN)
    ("phosphatidylcholines" . SPARSER::MOLECULE)
    ("specific unique metabolites" . SPARSER::PROTEIN)
    ("aspartic acid (D), valine (V), or cysteine (C)" . SPARSER::COLLECTION)
    ("mutated forms" . SPARSER::FORM) ("oxidized glutathione" . SPARSER::DRUG)
    ("alpha-ketoglutarate" . SPARSER::DRUG) ("GLUD1" . SPARSER::PROTEIN)
    ("GLS1" . SPARSER::PROTEIN) ("only cleavable JMJD2C" . SPARSER::PROTEIN)
    ("Chemotherapeutic drugs" . SPARSER::DRUG)
    ("state and H3K9" . SPARSER::COLLECTION)
    ("mRNA and H3K9" . SPARSER::COLLECTION)
    ("the cleavable form" . SPARSER::FORM)
    ("homozygous G/G genotype" . SPARSER::PROTEIN)
    ("the heterozygous state (G/A, 48.1%) and homozygous state (G/G, 32.1%)"
     . SPARSER::COLLECTION)
    ("full-length JMJD2C or N-terminal cleavage JMJD2C (fragment 1-396 amino acid)"
     . SPARSER::COLLECTION)
    ("fmk" . SPARSER::PROTEIN) ("TNF-α/CHX" . SPARSER::COLLECTION)
    ("TNF-α or CHX" . SPARSER::COLLECTION)
    ("/cycloheximide (CHX)" . SPARSER::COLLECTION)
    ("/cycloheximide" . SPARSER::COLLECTION)
    ("KDM4C and GASC1" . SPARSER::COLLECTION) ("PHD" . SPARSER::PROTEIN)
    ("JmjN" . SPARSER::PROTEIN-FAMILY) ("basal γ-H2AX" . SPARSER::PROTEIN)
    ("c-1" . SPARSER::PROTEIN) ("N214" . SPARSER::PROTEIN)
    ("GATA-1" . SPARSER::PROTEIN) ("JMJD2" . SPARSER::PROTEIN)
    ("Jumonji domain" . SPARSER::PROTEIN) ("GASC1" . SPARSER::PROTEIN)
    ("KDM4C" . SPARSER::PROTEIN)
    ("histone lysine demethylase" . SPARSER::PROTEIN)
    ("JMJD2C" . SPARSER::PROTEIN) ("COX2 and hormone" . SPARSER::COLLECTION)
    ("the commercial TMA" . SPARSER::MOLECULE)
    ("Rac1/PAK1" . SPARSER::COLLECTION)
    ("A formidable barrier" . SPARSER::PROTEIN)
    ("the most appropriate integrins" . SPARSER::PROTEIN)
    ("αvβ3 and αvβ5" . SPARSER::COLLECTION) ("cilengitide" . SPARSER::DRUG)
    ("ER, PR or nodal" . SPARSER::COLLECTION)
    ("the commercial TMAs" . SPARSER::MOLECULE)
    ("TMA and AMC" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bank" . SPARSER::PROTEIN)
    ("a smaller TMA" . SPARSER::MOLECULE) ("ILC" . SPARSER::PROTEIN)
    ("the only integrin β subunit" . SPARSER::FRAGMENT)
    ("antiserum" . SPARSER::PROTEIN)
    ("α3 integrin ( ITGA3 ) and COX2 ( PTGS2 )" . SPARSER::COLLECTION)
    ("both non-steroidal anti-inflammatory drugs (NSAIDs) and agents"
     . SPARSER::COLLECTION)
    ("selectively target COX2" . SPARSER::PROTEIN)
    ("valdecoxib" . SPARSER::DRUG) ("rofecoxib" . SPARSER::DRUG)
    ("laminins" . SPARSER::PROTEIN-FAMILY) ("lactating" . SPARSER::MOLECULE)
    ("18 α subunits and 8 β subunits" . SPARSER::COLLECTION)
    ("24 distinct integrins" . SPARSER::PROTEIN)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("bidirectional signaling receptors" . SPARSER::RECEPTOR)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("COX2 and α3" . SPARSER::COLLECTION)
    ("subunit or COX2" . SPARSER::COLLECTION)
    ("COX2/PTGS2" . SPARSER::COLLECTION)
    ("von-Willebrand Factor" . SPARSER::PROTEIN) ("LAMA5" . SPARSER::PROTEIN)
    ("ITGA3" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("EP, ARS, OPC and IPG" . SPARSER::COLLECTION)
    ("EP, ARS, and OPC" . SPARSER::COLLECTION)
    ("EP and IPG" . SPARSER::COLLECTION) ("Histopathologic type" . TYPE)
    ("the intestinal subtype" . SPARSER::PROTEIN)
    ("the intestinal and pancreatobiliary subtypes" . SPARSER::PROTEIN)
    ("intestinal and pancreatobiliary types" . TYPE)
    ("the intestinal differentiation type" . TYPE)
    ("PC and DBC" . SPARSER::COLLECTION)
    ("AC, DBC and PC" . SPARSER::COLLECTION)
    ("AC (p = 0.011) and PC (p = 0.043)" . SPARSER::COLLECTION)
    ("strong COX-2" . SPARSER::PROTEIN)
    ("pancreatobiliary or intestinal type" . TYPE)
    ("COX-2 and LNR" . SPARSER::COLLECTION) ("pancreatobiliary type" . TYPE)
    ("histopathologic type" . TYPE) ("MEK/CDK4" . SPARSER::COLLECTION)
    ("PI3K/MEK" . SPARSER::COLLECTION)
    ("Ral-GDS and other small G-proteins" . SPARSER::COLLECTION)
    ("selumetinib and trametinib" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG) ("selumetinib" . SPARSER::DRUG)
    ("calcein" . SPARSER::MOLECULE) ("MEK and PI3K/AKT" . SPARSER::COLLECTION)
    ("Rad51 and GSK3β" . SPARSER::COLLECTION)
    ("Axl, c-MET, and c-KIT" . SPARSER::COLLECTION)
    ("an orally available tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("Amuvatinib" . SPARSER::DRUG) ("Axl/Gas6" . SPARSER::COLLECTION)
    ("EGFR/ERBB2/ERBB3" . SPARSER::COLLECTION)
    ("Axl, ERBB2, c-MET, EGFR and Ephrins" . SPARSER::COLLECTION)
    ("Ephrins" . SPARSER::PROTEIN) ("CRAF" . SPARSER::PROTEIN)
    ("BRAF/MEK" . SPARSER::COLLECTION)
    ("a paradigm whereby kinase inhibitors" . SPARSER::INHIBITOR)
    ("Axl, AKT and MAPK" . SPARSER::COLLECTION)
    ("Axl and AKT" . SPARSER::COLLECTION)
    ("c-KIT and the Axl ligand Gas6" . SPARSER::COLLECTION)
    ("c-KIT, Axl, PDGFRα and Rad51" . SPARSER::COLLECTION)
    ("Axl" . SPARSER::PROTEIN) ("amuvatinib" . SPARSER::DRUG)
    ("ephrin A4" . SPARSER::PROTEIN) ("MEK-162" . SPARSER::DRUG)
    ("XPA and possibly other DNA repair proteins" . SPARSER::COLLECTION)
    ("possibly other DNA repair proteins" . SPARSER::PROTEIN)
    ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the phosphomimetic S435D ATR mutant" . SPARSER::MUTANT)
    ("our data mechanistically link ATR and XPA" . SPARSER::COLLECTION)
    ("MSH-MC1R-cAMP" . SPARSER::COLLECTION)
    ("mechanistically link PKA" . SPARSER::PROTEIN)
    ("XPA and ATR" . SPARSER::COLLECTION) ("PKA-ATR" . SPARSER::COLLECTION)
    ("RX" . SPARSER::PROTEIN)
    ("ATR ( xref ) or wild-type XPA (XPA-WT)" . SPARSER::COLLECTION)
    ("ATR-Chk1" . SPARSER::COLLECTION)
    ("UV-damaged chromatin" . SPARSER::PROTEIN)
    ("ATR and XPA" . SPARSER::COLLECTION)
    ("XPA-associated ATR" . SPARSER::PROTEIN)
    ("DNA repair-relevant proteins" . SPARSER::PROTEIN)
    ("XPA-ATR" . SPARSER::COLLECTION) ("XPA-chromatin" . SPARSER::COLLECTION)
    ("XPA and MC1R" . SPARSER::COLLECTION)
    ("neither wild-type XPA nor FLAG-tagged XPA" . SPARSER::COLLECTION)
    ("chromatin-XPA" . SPARSER::COLLECTION) ("MC1R/cAMP" . SPARSER::COLLECTION)
    ("the skin UV-associated melanocytic cAMP" . SPARSER::PROTEIN)
    ("ASIP" . SPARSER::PROTEIN) ("forskolin or MSH" . SPARSER::COLLECTION)
    ("-PP" . SPARSER::COLLECTION) ("melanocytic NER" . SPARSER::PROTEIN)
    ("forskolin or the phosphodiesterase inhibitor rolipram"
     . SPARSER::COLLECTION)
    ("either MSH (MC1R agonist), forskolin or the phosphodiesterase inhibitor rolipram"
     . SPARSER::COLLECTION)
    ("CPDs" . SPARSER::PROTEIN) ("rolipram" . SPARSER::DRUG)
    ("Topically-applied forskolin" . SPARSER::PROTEIN)
    ("a skin-permeable adenylyl cyclase activator" . SPARSER::ACTIVATOR)
    ("forskolin" . SPARSER::PROTEIN)
    ("UV-induced cyclobutane pyrimidine dimers (CPD)" . SPARSER::DIMER)
    ("dimers (CPD)" . SPARSER::DIMER) ("cyclobutane" . SPARSER::MOLECULE)
    ("Mc1r or tyrosinase" . SPARSER::COLLECTION) ("Mc1r" . SPARSER::PROTEIN)
    ("K14-Scf" . SPARSER::COLLECTION) ("tyrosinase" . SPARSER::PROTEIN)
    ("Scf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MC1R-cAMP-PKA" . SPARSER::COLLECTION)
    ("many other NER and damage response proteins ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("ERCC4 (XP-F) and ERCC5 (XP-G)" . SPARSER::COLLECTION)
    ("XPA, ERCC1, ERCC3 (XP-B), XPC, ERCC2 (XP-D), DDB2 (XP-E), ERCC4 (XP-F) and ERCC5 (XP-G)"
     . SPARSER::COLLECTION)
    ("XPC" . SPARSER::PROTEIN) ("kinase (PKA)" . SPARSER::KINASE)
    ("hormone (MSH)" . SPARSER::MOLECULE) ("MSH" . SPARSER::PROTEIN)
    ("UV-damaged DNA" . SPARSER::DNA) ("ATR-XPA" . SPARSER::COLLECTION)
    ("group A (XPA)" . SPARSER::PROTEIN)
    ("a melanocytic transmembrane receptor" . SPARSER::RECEPTOR)
    ("XP-A" . SPARSER::PROTEIN) ("p-PKA" . SPARSER::PROTEIN)
    ("agouti signaling protein" . SPARSER::PROTEIN) ("XP-G" . SPARSER::PROTEIN)
    ("ERCC5" . SPARSER::PROTEIN) ("XP-F" . SPARSER::PROTEIN)
    ("ERCC4" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("ERCC3" . SPARSER::PROTEIN) ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("MC1R" . SPARSER::PROTEIN) ("melanocortin 1 receptor" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("allele, and tumor" . SPARSER::COLLECTION)
    ("IFNβ or IFNγ" . SPARSER::COLLECTION)
    ("IFIT1 , IFIT2 , IFIT3 , HERC5 , and USP18" . SPARSER::COLLECTION)
    ("functional BRCA1" . SPARSER::PROTEIN)
    ("previously reported radiation-responsive genes" . SPARSER::GENE)
    ("the most highly predictive genes" . SPARSER::GENE)
    ("UBD" . SPARSER::PROTEIN) ("IFNG" . SPARSER::PROTEIN)
    ("GENESIS" . SPARSER::PROTEIN)
    ("the most consistent predictive genes" . SPARSER::GENE)
    ("acini" . SPARSER::PROTEIN) ("zinc-binding" . SPARSER::PROTEIN)
    ("an 1863 amino-acid protein" . SPARSER::PROTEIN)
    ("pathogenic variants" . SPARSER::VARIANT) ("HERC5" . SPARSER::PROTEIN)
    ("IGHG1" . SPARSER::PROTEIN) ("IFI44L" . SPARSER::PROTEIN)
    ("HLA-DMB" . SPARSER::PROTEIN) ("MX2" . SPARSER::PROTEIN)
    ("USP18" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("TNS4" . SPARSER::PROTEIN) ("MX1" . SPARSER::PROTEIN)
    ("IFIT2" . SPARSER::PROTEIN) ("TBX21" . SPARSER::PROTEIN)
    ("SOX4" . SPARSER::PROTEIN) ("SERPINF1" . SPARSER::PROTEIN)
    ("PLA2G4A" . SPARSER::PROTEIN) ("IFNA5" . SPARSER::PROTEIN)
    ("IFNA4" . SPARSER::PROTEIN) ("IFIT3" . SPARSER::PROTEIN)
    ("CXCR3" . SPARSER::PROTEIN) ("Cryo-EM" . SPARSER::PROTEIN-PAIR)
    ("Electron" . SPARSER::MOLECULE) ("cryo" . SPARSER::PROTEIN)
    ("Hsp90-Hsp70-GR" . SPARSER::COLLECTION) ("LTQ" . SPARSER::MOLECULE)
    ("TCEP" . SPARSER::MOLECULE) ("TFA" . SPARSER::PROTEIN)
    ("2µM Hsp40 and 5mM ATP/ MgCl 2" . SPARSER::COLLECTION)
    ("Solution" . SPARSER::MOLECULE) ("Deuterium" . SPARSER::MOLECULE)
    ("DTT" . SPARSER::MOLECULE) ("KCl" . SPARSER::MOLECULE)
    ("HEPES" . SPARSER::MOLECULE) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nonfunctional misfolded states" . SPARSER::BIO-STATE)
    ("Hsp70 and the refolding/reactivation" . SPARSER::COLLECTION)
    ("bacterial Hsp90 and Hsp70" . SPARSER::COLLECTION)
    ("Hsp90 and nucleotide exchange factors" . SPARSER::COLLECTION)
    ("GrpE" . SPARSER::PROTEIN) ("Hsp70-Hsp90" . SPARSER::COLLECTION)
    ("GR or two Hsp70s" . SPARSER::COLLECTION)
    ("Hsp90:Hsp70" . SPARSER::BIO-COMPLEX)
    ("ligand, and chaperones" . SPARSER::COLLECTION)
    ("around Hsp90 and p23" . SPARSER::COLLECTION)
    ("Hsp90 and p23" . SPARSER::COLLECTION) ("Chaperones" . SPARSER::PROTEIN)
    ("Hsp70, HOP, and GR" . SPARSER::COLLECTION)
    ("Hsp70 and HOP" . SPARSER::COLLECTION)
    ("Hsp90 and HOP" . SPARSER::COLLECTION)
    ("that Hsp90’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bag-1 and Hsp90" . SPARSER::COLLECTION)
    ("Hop and p23" . SPARSER::COLLECTION) ("Hop" . SPARSER::PROTEIN)
    ("Bag-1, or Hsp90" . SPARSER::COLLECTION)
    ("a traditional Hsp70 exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("directly contrast Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chaperone" . SPARSER::PROTEIN) ("Hsp70:Hsp90" . SPARSER::BIO-COMPLEX)
    ("SBD" . SPARSER::PROTEIN) ("TPR2A, TPR2B and DP2" . SPARSER::COLLECTION)
    ("only one monomer" . SPARSER::MONOMER) ("Hsp90-HOP" . SPARSER::COLLECTION)
    ("Hsp70 and the apo HOP" . SPARSER::COLLECTION)
    ("one Hsp90 dimer and one copy" . SPARSER::COLLECTION)
    ("Hsp90:HOP:Hsp70:GR" . SPARSER::BIO-COMPLEX) ("obs" . SPARSER::PROTEIN)
    ("previously inactive" . SPARSER::INACTIVE)
    ("a stalled inactive intermediate complex" . SPARSER::BIO-COMPLEX)
    ("Hsp70, Hsp90 and HOP" . SPARSER::COLLECTION)
    ("Hsp90:GR" . SPARSER::BIO-COMPLEX) ("p23 and Hsp90" . SPARSER::COLLECTION)
    ("mutant or 17AAG" . SPARSER::COLLECTION)
    ("Hsp90:Hsp70:HOP:GRLBD" . SPARSER::COLLECTION)
    ("GRLBD" . SPARSER::PROTEIN)
    ("dimeric Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsp90 and cochaperones" . SPARSER::COLLECTION)
    ("Hsp70:GRLBD" . SPARSER::PROTEIN-PAIR)
    ("dimer and GRLBD" . SPARSER::COLLECTION)
    ("Hsp90 and either HOP or p23" . SPARSER::COLLECTION)
    ("HOP or p23" . SPARSER::COLLECTION)
    ("Hsp70 and Hsp40" . SPARSER::COLLECTION) ("HDX" . SPARSER::PROTEIN)
    ("Hsp40 and F-dex and ligand" . SPARSER::COLLECTION)
    ("AMPPNP or ADP" . SPARSER::COLLECTION) ("AMPPNP" . SPARSER::MOLECULE)
    ("the F602S mutant ( xref ), a trend" . SPARSER::MUTANT)
    ("conformation and ligand" . SPARSER::COLLECTION)
    ("p23 and HOP" . SPARSER::COLLECTION)
    ("Hsp70 and Hsp90" . SPARSER::COLLECTION)
    ("Hsp90 and three specific cochaperones" . SPARSER::COLLECTION)
    ("Hsp70, Hsp90 and three specific cochaperones" . SPARSER::COLLECTION)
    ("Hsp90 and GRLBD" . SPARSER::COLLECTION)
    ("its ligand binding competent state" . SPARSER::BIO-STATE)
    ("Hsp90:HOP" . SPARSER::BIO-COMPLEX) ("cryo-EM" . SPARSER::COLLECTION)
    ("Hsp40 and Hsp70" . SPARSER::COLLECTION)
    ("Hsp40, Hsp70, Hsp90, HOP, and p23" . SPARSER::COLLECTION)
    ("Glucocorticoid Receptor (GR)" . SPARSER::PROTEIN)
    ("an NTD-dimerized closed conformation" . SPARSER::BIO-CONFORMATION)
    ("apo" . SPARSER::PROTEIN) ("most canonical chaperones" . SPARSER::PROTEIN)
    ("a ubiquitous ATP-dependent molecular chaperone" . SPARSER::PROTEIN)
    ("Hsp90 and Hsp70" . SPARSER::COLLECTION)
    ("GR:Hsp70:Hsp90:HOP" . SPARSER::BIO-COMPLEX)
    ("the two chaperone’s" . SPARSER::PROTEIN)
    ("Hsp90 and the HOP and p23 cochaperones" . SPARSER::COLLECTION)
    ("HOP and p23" . SPARSER::COLLECTION) ("cochaperones" . SPARSER::PROTEIN)
    ("HOP" . SPARSER::PROTEIN)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("YDJ1" . SPARSER::PROTEIN) ("Hsp70s" . SPARSER::PROTEIN)
    ("ATP dependent" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("Bag-1" . SPARSER::PROTEIN) ("DP2" . SPARSER::PROTEIN)
    ("TPR2" . SPARSER::PROTEIN) ("TPR2A" . SPARSER::PROTEIN)
    ("Ydj1" . SPARSER::PROTEIN) ("Hsp40" . SPARSER::PROTEIN)
    ("Glucocorticoid Receptor" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("Hsp70" . SPARSER::PROTEIN)
    ("LMC" . SPARSER::PROTEIN) ("Cav-1 and FASN" . SPARSER::COLLECTION)
    ("FASN and Cav-1" . SPARSER::COLLECTION) ("FASN" . SPARSER::PROTEIN)
    ("an adverse prognostic biomarker" . SPARSER::MOLECULE)
    ("CAFs, PAFs, and NFs" . SPARSER::COLLECTION) ("NFs" . SPARSER::PROTEIN)
    ("PAFs" . SPARSER::PROTEIN-FAMILY) ("Stromal Cav-1" . SPARSER::PROTEIN)
    ("TGF-β1 and SNCG" . SPARSER::COLLECTION) ("SNCG" . SPARSER::PROTEIN)
    ("Cav-1, Cav-2, and Cav-3" . SPARSER::COLLECTION)
    ("Cav" . SPARSER::PROTEIN) ("Caveolins" . SPARSER::PROTEIN-FAMILY)
    ("stromal Cav-1" . SPARSER::PROTEIN)
    ("a strong prognosis biomarker" . SPARSER::MOLECULE)
    ("stromal caveolin-1" . SPARSER::PROTEIN) ("Cav-3" . SPARSER::PROTEIN)
    ("Cav-2" . SPARSER::PROTEIN) ("Stat3 and MAPK1" . SPARSER::COLLECTION)
    ("an accessory gene" . SPARSER::GENE)
    ("a regulatory light chain" . SPARSER::PROTEIN) ("IIs" . SPARSER::PROTEIN)
    ("MYH10 and MYH14" . SPARSER::COLLECTION) ("myosins" . SPARSER::PROTEIN)
    ("integrin, radixin, moesin and talin" . SPARSER::COLLECTION)
    ("talin" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("Myh9" . SPARSER::PROTEIN)
    ("renal medicine" . SPARSER::DRUG) ("shRNA-2" . SPARSER::COLLECTION)
    ("cytoskeletal regulators" . SPARSER::REGULATOR)
    ("amino acid and nucleotide" . SPARSER::COLLECTION)
    ("a meaningful functional complex" . SPARSER::BIO-COMPLEX)
    ("APOL1 and MYH9" . SPARSER::COLLECTION) ("adriamycin" . SPARSER::DRUG)
    ("sentinels" . SPARSER::DRUG) ("proteinuria" . SPARSER::PROTEIN)
    ("two regulatory light" . SPARSER::PROTEIN)
    ("two essential light" . SPARSER::PROTEIN)
    ("the predominant mammalian force-generating ATPase" . SPARSER::PROTEIN)
    ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("NMMHCIIA-enriched actin-myosin-interacting proteins" . SPARSER::PROTEIN)
    ("non-muscle myosin heavy chain IIA (NMMHCIIA)" . SPARSER::PROTEIN)
    ("the predominant force-generating ATPase" . SPARSER::PROTEIN)
    ("NMMHCIIA" . SPARSER::PROTEIN) ("MYL12B" . SPARSER::PROTEIN)
    ("MYH14" . SPARSER::PROTEIN) ("MYH10" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("HCO 3" . SPARSER::MOLECULE) ("APOL1" . SPARSER::PROTEIN)
    ("non-muscle myosin heavy chain IIA" . SPARSER::PROTEIN)
    ("MYH9" . SPARSER::PROTEIN)
    ("rhodopsin and secretin" . SPARSER::COLLECTION)
    ("secretin" . SPARSER::DRUG) ("rhodopsin" . SPARSER::PROTEIN)
    ("Calpeptin" . SPARSER::MOLECULE) ("Arginine" . SPARSER::AMINO-ACID)
    ("collagen III treated cell conditioned media" . SPARSER::PROTEIN)
    ("Gpr56" . SPARSER::PROTEIN) ("Gpr" . SPARSER::PROTEIN)
    ("GPR56 probably needs lipid" . SPARSER::LIPID) ("Lipid" . SPARSER::LIPID)
    ("amphipathic lipids" . SPARSER::LIPID) ("Fractions" . SPARSER::COMPONENT)
    ("the reported disease-associated GPR56 mutant alleles" . SPARSER::ALLELE)
    ("-GPR56" . SPARSER::COLLECTION) ("GPS" . SPARSER::PROTEIN)
    ("noncanonical seven transmembrane spanning (7TM) receptors"
     . SPARSER::RECEPTOR)
    ("EMR2" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("A–L" . SPARSER::PROTEIN) ("Membrane-bound" . SPARSER::PROTEIN)
    ("Monoclonal Antibody" . SPARSER::DRUG) ("H11" . SPARSER::PROTEIN)
    ("B subunit" . SPARSER::PROTEIN) ("Streptavidin–agarose" . SPARSER::DRUG)
    ("MC-1" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("GPR56" . SPARSER::PROTEIN) ("antiandrogens" . SPARSER::DRUG)
    ("the E213-G allele and risk" . SPARSER::COLLECTION)
    ("a polymorphic variant or SNP" . SPARSER::COLLECTION)
    ("unrelated healthy AA" . SPARSER::MOLECULE)
    ("variant or SNP" . SPARSER::COLLECTION)
    ("AA-families" . SPARSER::MOLECULE)
    ("commercial siRNA-oligos" . SPARSER::PROTEIN-PAIR)
    ("siRNA-oligos" . SPARSER::PROTEIN-PAIR)
    ("AA and CA" . SPARSER::COLLECTION)
    ("17 (52.9%) AA-patients" . SPARSER::MOLECULE)
    ("AA-patients" . SPARSER::MOLECULE) ("AAs or CAs" . SPARSER::COLLECTION)
    ("GAG" . SPARSER::PROTEIN) ("AAs and CAs" . SPARSER::COLLECTION)
    ("castration-recurrent PCa" . SPARSER::PROTEIN)
    ("Functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen-AR" . SPARSER::COLLECTION)
    ("testosterone (T) and dihydrotestosterone (DHT)" . SPARSER::COLLECTION)
    ("anti-androgens or non-androgenic ligands" . SPARSER::COLLECTION)
    ("hypersensitive receptor" . SPARSER::RECEPTOR)
    ("oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("highly repetitive DNA" . SPARSER::DNA) ("GGC" . SPARSER::PROTEIN)
    ("a biologically more aggressive PCa" . SPARSER::PROTEIN)
    ("healthy unrelated AA" . SPARSER::MOLECULE)
    ("sporadic PCa" . SPARSER::PROTEIN) ("AAs" . SPARSER::MOLECULE)
    ("Androgen receptor (AR)" . SPARSER::PROTEIN)
    ("Glycine)" . SPARSER::PROTEIN) ("Cos-7" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("Androgen receptor" . SPARSER::PROTEIN)
    ("an attractive candidate molecule" . SPARSER::MOLECULE)
    ("other downstream mediators and upstream activators"
     . SPARSER::COLLECTION)
    ("K-Ras and JNK" . SPARSER::COLLECTION)
    ("K-Ras as well as JNK" . SPARSER::COLLECTION)
    ("Tgfbr2" . SPARSER::PROTEIN)
    ("systemically-administered JNK inhibitor" . SPARSER::INHIBITOR)
    ("Nodal/Activin" . SPARSER::COLLECTION) ("Activin" . SPARSER::PROTEIN)
    ("Nodal" . SPARSER::PROTEIN)
    ("a mutated (G12D) K-Ras allele" . SPARSER::ALLELE)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("Sox2 and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("a practical therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("molecules and signaling pathways" . SPARSER::COLLECTION)
    ("collagen-I" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("PSN-1" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("the synaptic vesicle endocytosis protein Endophilin A"
     . SPARSER::PROTEIN)
    ("kinase (GAK)" . SPARSER::KINASE)
    ("neurosecretory protein VGF" . SPARSER::PROTEIN)
    ("VGF" . SPARSER::PROTEIN) ("chromogranin" . SPARSER::PROTEIN)
    ("tubulins" . SPARSER::PROTEIN)
    ("Hsp90 (identified via AP-MS) and BAG proteins (identified using protein microarray)"
     . SPARSER::COLLECTION)
    ("ANK and LRR" . SPARSER::COLLECTION)
    ("the respective proteins" . SPARSER::PROTEIN)
    ("ANK, COR or kinase" . SPARSER::COLLECTION) ("ANK" . SPARSER::PROTEIN)
    ("ankyrin and leucine-rich repeat" . SPARSER::COLLECTION)
    ("Hsc70, BAG5 and Hsp90" . SPARSER::COLLECTION)
    ("LRRK2-14-3-3" . SPARSER::COLLECTION)
    ("SH-SY5Y-eGFP-LRRK2" . SPARSER::COLLECTION)
    ("eGFP-LRRK1" . SPARSER::COLLECTION) ("Rh" . SPARSER::MOLECULE)
    ("rhodamine" . SPARSER::PROTEIN) ("LRRK2-IN-1" . SPARSER::COLLECTION)
    ("IN-1" . SPARSER::PROTEIN) ("LRRK1 and vice-versa" . SPARSER::COLLECTION)
    ("LRR" . SPARSER::PROTEIN) ("LRRK1 as well as LRRK2" . SPARSER::COLLECTION)
    ("Hsc70, Hsp90 and BAG5" . SPARSER::COLLECTION)
    ("Hsc70, BAG5 and HSP90" . SPARSER::COLLECTION)
    ("LRRK1:EGF-R and LRRK2:14-3-3" . SPARSER::COLLECTION)
    ("LRRK2:14-3-3" . SPARSER::BIO-COMPLEX)
    ("LRRK1:EGF-R" . SPARSER::BIO-COMPLEX) ("LRRK1:BAG" . SPARSER::BIO-COMPLEX)
    ("LRRK2:BAG" . SPARSER::BIO-COMPLEX) ("BAGs" . SPARSER::PROTEIN-FAMILY)
    ("BAG" . SPARSER::PROTEIN-FAMILY)
    ("3xFlag-tagged LRRK1 or LRRK2" . SPARSER::COLLECTION)
    ("LRRK1 or LRRK2" . SPARSER::COLLECTION)
    ("the unique interacting proteins" . SPARSER::PROTEIN)
    ("LRRK1 and 14-3-3" . SPARSER::COLLECTION)
    ("LRRK2 ( xref ) and 16 shared proteins ( xref )" . SPARSER::COLLECTION)
    ("3xFlag-tagged eGFP" . SPARSER::PROTEIN) ("eGFP" . SPARSER::PROTEIN)
    ("Protein-protein" . SPARSER::COLLECTION) ("ankyrin" . SPARSER::PROTEIN)
    ("COR" . SPARSER::PROTEIN-FAMILY) ("ROCO" . SPARSER::PROTEIN-FAMILY)
    ("LRRK1 and LRRK2" . SPARSER::COLLECTION) ("-LRRK2" . SPARSER::COLLECTION)
    ("SH-SY5Y-LRRK1" . SPARSER::COLLECTION) ("LRRK1-" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("Endophilin A" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG)
    ("early endosome antigen 1" . SPARSER::PROTEIN) ("BAG5" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("14-3-3 zeta" . SPARSER::PROTEIN)
    ("beta)" . SPARSER::PROTEIN) ("armadillo-like" . SPARSER::PROTEIN-FAMILY)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("EGF-R" . SPARSER::PROTEIN)
    ("LRRK1" . SPARSER::PROTEIN) ("LRRK2" . SPARSER::PROTEIN)
    ("FOXO3 and p53" . SPARSER::COLLECTION)
    ("RRM2B and FOXO" . SPARSER::COLLECTION) ("S3b" . SPARSER::PROTEIN)
    ("exhibited strong p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO3/RRM2B" . SPARSER::COLLECTION)
    ("RRM2B and nuclear FOXO3" . SPARSER::COLLECTION)
    ("RRM2B and FOXO3" . SPARSER::COLLECTION)
    ("RRM2B or FOXO3" . SPARSER::COLLECTION)
    ("EGFP-FOXO3" . SPARSER::COLLECTION)
    ("RRM2B (the −964 site) and p27" . SPARSER::COLLECTION)
    ("oligos" . SPARSER::PROTEIN) ("RRM2B and MnSOD" . SPARSER::COLLECTION)
    ("Mut" . SPARSER::PROTEIN) ("RRM2B-luciferase" . SPARSER::COLLECTION)
    ("FOXO3 (WT)" . SPARSER::PROTEIN) ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("the only RR subunit" . SPARSER::FRAGMENT)
    ("ataxia telangiectasia-mutated (ATM) and RRM2B" . SPARSER::COLLECTION)
    ("RRM2B and RRM1" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION)
    ("RRM1, RRM2, and RRM2B" . SPARSER::COLLECTION)
    ("p53R2" . SPARSER::PROTEIN) ("deoxyribonucleoside" . SPARSER::MOLECULE)
    ("ribonucleoside" . SPARSER::MOLECULE)
    ("FOXO3 and RRM2B" . SPARSER::COLLECTION)
    ("RRM2B and/or FOXO3" . SPARSER::COLLECTION)
    ("Ribonucleotide" . SPARSER::MOLECULE) ("β-ACTIN" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("tag 1" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("Forkhead box O 3" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN) ("RRM1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("RRM2B" . SPARSER::PROTEIN)
    ("ALK or Myc" . SPARSER::COLLECTION) ("Myc and MYCN" . SPARSER::COLLECTION)
    ("NMP" . SPARSER::MOLECULE)
    ("the conditional actin-ALKF 1174L" . SPARSER::PROTEIN-PAIR)
    ("actin-ALKF" . SPARSER::PROTEIN-PAIR) ("DBH" . SPARSER::PROTEIN)
    ("the two most frequent ALK" . SPARSER::PROTEIN)
    ("ALK-tyrosine kinase" . SPARSER::COLLECTION)
    ("Myc/Mycn" . SPARSER::COLLECTION) ("/Phox2b" . SPARSER::COLLECTION)
    ("Mycn/β-actin" . SPARSER::COLLECTION)
    ("Myc and Mycn" . SPARSER::COLLECTION)
    ("d-JoMa1-ALK" . SPARSER::COLLECTION)
    ("Myc, Sox2, Sox9, Notch1, Notch2, Snai2, Bmp1/2, Twist1/2, Hmga2, nestin, and vimentin"
     . SPARSER::COLLECTION)
    ("Ncam1, and Uchl1" . SPARSER::COLLECTION) ("Uchl1" . SPARSER::PROTEIN)
    ("Mycn" . SPARSER::PROTEIN) ("synaptophysin" . SPARSER::PROTEIN)
    ("Chromogranin" . SPARSER::PROTEIN)
    ("Gata" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JoMa1-NMYC" . SPARSER::COLLECTION) ("NMYC" . SPARSER::PROTEIN)
    ("AKT, ERK and Stat3" . SPARSER::COLLECTION) ("Ptprc" . SPARSER::PROTEIN)
    ("WB" . SPARSER::PROTEIN) ("JoMa1-Migr" . SPARSER::COLLECTION)
    ("JoMa1-ALK-wt" . SPARSER::COLLECTION) ("Migr" . SPARSER::PROTEIN)
    ("-ALK-wt" . SPARSER::COLLECTION)
    ("Ngfr, Sox9, Snai1, and Snai2" . SPARSER::COLLECTION)
    ("Ngfr" . SPARSER::PROTEIN) ("unfavorable NB" . SPARSER::PROTEIN)
    ("a highly malignant Phox2b" . SPARSER::PROTEIN)
    ("/nestin" . SPARSER::COLLECTION)
    ("the mesechymal/stem marker CD44 and the neural stem/progenitor cell marker nestin"
     . SPARSER::COLLECTION)
    ("the sympathoadrenal marker Phox2b" . SPARSER::PROTEIN)
    ("the neuronal marker Ncam1" . SPARSER::PROTEIN)
    ("the neural stem/progenitor cell marker nestin" . SPARSER::PROTEIN)
    ("Ncam1" . SPARSER::PROTEIN) ("nestin" . SPARSER::PROTEIN)
    ("NCP" . SPARSER::PROTEIN) ("JoMa1" . SPARSER::PROTEIN)
    ("progressive and resistant NB" . SPARSER::PROTEIN)
    ("these migratory NC derivatives" . SPARSER::DERIVATIVE)
    ("ALK and Myc" . SPARSER::COLLECTION) ("JoMa1-ALK" . SPARSER::COLLECTION)
    ("Myc-ER" . SPARSER::COLLECTION) ("ALK-wt" . SPARSER::COLLECTION)
    ("NB" . SPARSER::PROTEIN) ("TAE684" . SPARSER::DRUG)
    ("Gata3" . SPARSER::PROTEIN) ("Phox2a" . SPARSER::PROTEIN)
    ("Notch2" . SPARSER::PROTEIN) ("CD99" . SPARSER::PROTEIN)
    ("Snai2" . SPARSER::PROTEIN) ("Phox2b" . SPARSER::PROTEIN)
    ("Sox10" . SPARSER::PROTEIN) ("v-Myc" . SPARSER::PROTEIN)
    ("cytometry and CCK-8" . SPARSER::COLLECTION)
    ("epirubicin-" . SPARSER::DRUG) ("JNK or TGF-β" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins Bad and Bim" . SPARSER::COLLECTION)
    ("exogenous Bad and Bim" . SPARSER::COLLECTION)
    ("epirubicin and cisplatin" . SPARSER::COLLECTION)
    ("Atg5 and Atg7" . SPARSER::COLLECTION)
    ("the essential autophagy genes Atg5 or Atg7" . SPARSER::COLLECTION)
    ("these pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("some pro-apoptotic genes" . SPARSER::GENE)
    ("LC3 and SQSTM1/p62" . SPARSER::COLLECTION)
    ("CQ or 3-MA" . SPARSER::COLLECTION) ("hydrolases" . SPARSER::PROTEIN)
    ("HCCs" . SPARSER::PROTEIN) ("Bad and Bim" . SPARSER::COLLECTION)
    ("glucose and hypoxia (LH)" . SPARSER::COLLECTION)
    ("glucose and hypoxia" . SPARSER::COLLECTION)
    ("hypoxia and nutrient" . SPARSER::COLLECTION)
    ("Hypoxia and nutrient" . SPARSER::COLLECTION) ("PMD2" . SPARSER::MOLECULE)
    ("MK2206 and chloroquine" . SPARSER::COLLECTION) ("-1-" . SPARSER::PROTEIN)
    ("urethane" . SPARSER::MOLECULE) ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("erlotinib or lapatinib" . SPARSER::COLLECTION)
    ("KRAS/EGFR" . SPARSER::COLLECTION)
    ("MK2206 or chloroquine" . SPARSER::COLLECTION)
    ("gefitinib and chloroquine, MK2206 and chloroquine, gefitinib and MK2206, or gefitinib, MK2206, and chloroquine"
     . SPARSER::COLLECTION)
    ("chloroquine, MK2206 and chloroquine, gefitinib and MK2206, or gefitinib, MK2206, and chloroquine"
     . SPARSER::COLLECTION)
    ("chloroquine, gefitinib and MK2206, or gefitinib, MK2206, and chloroquine"
     . SPARSER::COLLECTION)
    ("MK2206, or gefitinib, MK2206, and chloroquine" . SPARSER::COLLECTION)
    ("gefitinib, MK2206, and chloroquine" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN)
    ("gefitinib and chloroquine" . SPARSER::COLLECTION)
    ("chloroquine and gefitinib" . SPARSER::COLLECTION)
    ("gefitinib, and 20μM" . SPARSER::COLLECTION)
    ("LC3 and PARP" . SPARSER::COLLECTION)
    ("a pharmacologic inhibitor chloroquine" . SPARSER::PROTEIN)
    ("pro- or anti-survival" . SPARSER::COLLECTION)
    ("Isoform" . SPARSER::ISOFORM)
    ("AKT1 siRNA (p=0.013) and AKT2 siRNA (p<0.01)" . SPARSER::COLLECTION)
    ("Gefitinib or MK2206" . SPARSER::COLLECTION)
    ("pAKT and pEGFR" . SPARSER::COLLECTION)
    ("gefitinib or MK2206" . SPARSER::COLLECTION)
    ("gefitinib (0.1 μM for HCC-827 and PC-9 or 1 μM for A549 and H1975) and/or MK2206 (1 μM)"
     . SPARSER::COLLECTION)
    ("MK2206 and gefitinib" . SPARSER::COLLECTION)
    ("gefitinib and MK2206" . SPARSER::COLLECTION)
    ("an EGFR TKI (gefitinib) as well as the AKT inhibitor MK2206"
     . SPARSER::COLLECTION)
    ("hypoxia and growth-factor" . SPARSER::COLLECTION)
    ("subcellular components" . SPARSER::COMPONENT)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) and AKT [ xref ]"
     . SPARSER::COLLECTION)
    ("gefitinib and AKT" . SPARSER::COLLECTION) ("Foxn1" . SPARSER::PROTEIN)
    ("AZD5363" . SPARSER::DRUG) ("AKT 1" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT3" . SPARSER::PROTEIN) ("phospho-inositide" . SPARSER::MOLECULE)
    ("MSC-neutrophils" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("MSCs-neutrophils" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("Ren" . SPARSER::PROTEIN) ("anti-CD3/anti-CD28" . SPARSER::COLLECTION)
    ("Akt and NF κ B" . SPARSER::COLLECTION)
    ("pro-inflammatory and pro-angiogenic mediators" . SPARSER::PROTEIN)
    ("Further studies using inhibitors" . SPARSER::INHIBITOR)
    ("CREB and p27" . SPARSER::COLLECTION)
    ("Mac-1 (data not shown) and OSM" . SPARSER::COLLECTION)
    ("Mac-1–ICAM-1" . SPARSER::COLLECTION) ("Mac-1" . SPARSER::PROTEIN)
    ("a pro-tumoral N2 type" . TYPE) ("MMP-9 and VEGF" . SPARSER::COLLECTION)
    ("naive bone marrow neutrophils (NN) and granulocytic MDSCs (G-MDSC)"
     . SPARSER::COLLECTION)
    ("naive bone marrow neutrophils (NN)" . SPARSER::PROTEIN)
    ("neutrophils (NN)" . SPARSER::PROTEIN)
    ("tumor-associated neutrophils (TAN)" . SPARSER::PROTEIN)
    ("N1–N2" . SPARSER::COLLECTION)
    ("MSCs and neutrophils" . SPARSER::COLLECTION)
    ("IL-6–STAT3" . SPARSER::COLLECTION)
    ("neutrophils, and α -SMA and vimentin" . SPARSER::COLLECTION)
    ("α -SMA and vimentin" . SPARSER::COLLECTION)
    ("neutrophils and supernatants" . SPARSER::COLLECTION)
    ("IL-6RA or IgG" . SPARSER::COLLECTION)
    ("IL-8, CCL2, and TNF α" . SPARSER::COLLECTION)
    ("IL-6, IL-8, and MCP-1" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("U0126 or WP1066" . SPARSER::COLLECTION)
    ("IL-8, TNF α , and CCL2" . SPARSER::COLLECTION)
    ("WP1066 and U0126" . SPARSER::COLLECTION)
    ("STAT3–ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2 and STAT3" . SPARSER::COLLECTION)
    ("the STAT3 inhibitor WP1066 (10  μ M) or ERK1/2-specific inhibitor U0126 (10  μ M)"
     . SPARSER::COLLECTION)
    ("IL-8, CCL2, TNF α , and OSM" . SPARSER::COLLECTION)
    ("RPMI" . SPARSER::PROTEIN) ("apoptotic neutrophils" . SPARSER::PROTEIN)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("CD29, CD44, and CD90" . SPARSER::COLLECTION)
    ("CD14, CD34, CD45, CD71, and HLA-DR" . SPARSER::COLLECTION)
    ("GC-MSCs-activated neutrophils" . SPARSER::PROTEIN)
    ("IL-6–IL-6R" . SPARSER::COLLECTION)
    ("IL-8, CCL2, TNF α , and oncostatin M" . SPARSER::COLLECTION)
    ("the tumor-derived MSCs and tumor-infiltrating neutrophils"
     . SPARSER::COLLECTION)
    ("-smooth muscle" . SPARSER::COLLECTION)
    ("extracellular matrix proteins and their proteases" . SPARSER::COLLECTION)
    ("hyaluronan" . SPARSER::MOLECULE)
    ("IL-6–STAT3–ERK1/2" . SPARSER::COLLECTION)
    ("normal MSCs" . SPARSER::PROTEIN)
    ("GC-MSCs-derived IL-6" . SPARSER::PROTEIN)
    ("STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("GC-MSCs-primed neutrophils" . SPARSER::PROTEIN)
    ("IL-8, TNF α , CCL2, and oncostatin M" . SPARSER::COLLECTION)
    ("OSM" . SPARSER::PROTEIN)
    ("neutrophils and gastric cancer-derived MSCs (GC-MSCs)"
     . SPARSER::COLLECTION)
    ("gastric cancer-derived MSCs" . SPARSER::PROTEIN)
    ("GC-MSCs" . SPARSER::COLLECTION)
    ("essential component" . SPARSER::COMPONENT) ("MSCs" . SPARSER::PROTEIN)
    ("a 15 " . SPARSER::PROTEIN) ("CD45RO" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("NF κ B" . SPARSER::PROTEIN) ("IFN- β" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("CD71" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("α -SMA" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("CXCL5" . SPARSER::PROTEIN) ("oncostatin M" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("SLCO3A1 and QT" . SPARSER::COLLECTION)
    ("a key pro-inflammatory transcription factor and controls many genes"
     . SPARSER::COLLECTION)
    ("a key pro-inflammatory transcription factor" . SPARSER::PROTEIN)
    ("multispecific transport proteins" . SPARSER::PROTEIN)
    ("Solute carrier organic anion transporters" . SPARSER::PROTEIN)
    ("SLCOs/OATPs" . SPARSER::COLLECTION)
    ("OATPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OATPD, OATP-D, OATP3A1, FLJ40478, and SLC21A11" . SPARSER::COLLECTION)
    ("OATPD" . SPARSER::PROTEIN) ("p38 and AKT" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("P38 and AKT" . SPARSER::COLLECTION)
    ("The positive internal control TNFSF15" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG) ("ATG16L1 and IRGM" . SPARSER::COLLECTION)
    ("IRGM" . SPARSER::PROTEIN) ("disease-associated NOD2" . SPARSER::PROTEIN)
    ("initially named NOD2 and later renamed CARD15" . SPARSER::COLLECTION)
    ("Nicotine" . SPARSER::DRUG) ("P65, ERK, and JNK" . SPARSER::COLLECTION)
    ("only one gene" . SPARSER::GENE)
    ("solute carrier family" . SPARSER::PROTEIN)
    ("solute carrier organic anion transporter family member 3A1"
     . SPARSER::PROTEIN)
    ("SLC21A11" . SPARSER::PROTEIN) ("OATP3A1" . SPARSER::PROTEIN)
    ("OATP-D" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL23R" . SPARSER::PROTEIN) ("CARD15" . SPARSER::PROTEIN)
    ("P65" . SPARSER::PROTEIN) ("SLCO3A1" . SPARSER::PROTEIN)
    ("TNFSF15" . SPARSER::PROTEIN) ("MVD and TAM" . SPARSER::COLLECTION)
    ("types or organs" . SPARSER::COLLECTION) ("immature type" . TYPE)
    ("a mature and immature type" . TYPE) ("immature CAF type" . TYPE)
    ("FSP1, PDGFRα or PDGFRβ" . SPARSER::COLLECTION)
    ("FSP1, FAP, PDGFRα, and PDGFRβ" . SPARSER::COLLECTION)
    ("matrix metalloproteinase or cathepsins" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("immature CAFs" . SPARSER::PROTEIN)
    ("CAFs" . SPARSER::PROTEIN)
    ("increased tumor associated macrophages" . SPARSER::PROTEIN)
    ("fibroblast activation protein (FAP)" . SPARSER::PROTEIN)
    ("CD68" . SPARSER::PROTEIN) ("FSP-1" . SPARSER::PROTEIN)
    ("stromal cell-derived factor 1" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("fibroblast activation protein" . SPARSER::PROTEIN)
    ("bone morphogenetic proteins, leukemia inhibitory factor, and Notch-Delta ligands"
     . SPARSER::LIGAND)
    ("Various external cues" . SPARSER::PROTEIN-FAMILY)
    ("proteins, leukemia inhibitory factor, and Notch-Delta"
     . SPARSER::COLLECTION)
    ("Delta" . SPARSER::PROTEIN)
    ("EGF- and FGF2-primed hNSCs" . SPARSER::COLLECTION)
    ("Hb9-" . SPARSER::PROTEIN) ("CNTF" . SPARSER::PROTEIN)
    ("FGF2 and heparin" . SPARSER::COLLECTION)
    ("Akt-GSK3β" . SPARSER::COLLECTION) ("Akt/GSK3β" . SPARSER::COLLECTION)
    ("FGF2 and EGF" . SPARSER::COLLECTION)
    ("MAPK and PLC-γ" . SPARSER::COLLECTION)
    ("/Akt/glycogen synthase" . SPARSER::COLLECTION)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("0.5 µM Stattic ( xref ) or 0.25 uM Niclosamide ( xref )"
     . SPARSER::COLLECTION)
    ("mature astrocytes" . SPARSER::PROTEIN) ("Astrocytes" . SPARSER::PROTEIN)
    ("0.5 µM Stattic or 0.25 µM Niclosamide" . SPARSER::COLLECTION)
    ("a phosphor-specific antibody" . SPARSER::PROTEIN)
    ("STAT3 and GAPDH" . SPARSER::COLLECTION)
    ("Our newly developed STAT3 inhibitor" . SPARSER::INHIBITOR)
    ("Stattic-" . SPARSER::DRUG) ("/MAP2" . SPARSER::COLLECTION)
    ("FHL-primed control cells expressed both Hb9 and MAP2"
     . SPARSER::COLLECTION)
    ("Hb9 and MAP2" . SPARSER::COLLECTION)
    ("Stattic (0.5uM) or Niclosamide (0.25 uM)" . SPARSER::COLLECTION)
    ("Hb9/GAPDH" . SPARSER::COLLECTION)
    ("Stattic or Niclosamide" . SPARSER::COLLECTION)
    ("Stattic (0.5 or 2.5 µM) and Niclosamide (0.25 µM)" . SPARSER::COLLECTION)
    ("both ELL- and FHL-primed hNSCs" . SPARSER::COLLECTION)
    ("ELL or FHL" . SPARSER::COLLECTION)
    ("both ELL- and FHL-primed hNSCs ( xref )" . SPARSER::COLLECTION)
    ("ELL and FHL" . SPARSER::COLLECTION)
    ("ELL- and FHL-primed hNSCs" . SPARSER::COLLECTION)
    ("ELL-" . SPARSER::PROTEIN) ("EGF or FGF2" . SPARSER::COLLECTION)
    ("pSTAT3-Y705/total STAT3 or pSTAT3-S727/total STAT3"
     . SPARSER::COLLECTION)
    ("FGF2/Heparin/Laminin (FHL)" . SPARSER::COLLECTION)
    ("EGF/LIF/Laminin" . SPARSER::COLLECTION)
    ("FGF2/Heparin/Laminin" . SPARSER::COLLECTION)
    ("Laminin" . SPARSER::PROTEIN) ("FGF2 or EGF" . SPARSER::COLLECTION)
    ("growth factors, EGF and FGF2" . SPARSER::COLLECTION)
    ("PI3K/Akt/GSK3B" . SPARSER::COLLECTION)
    ("STAT1, STAT5, JAK1, JAK2 and Src" . SPARSER::COLLECTION)
    ("Jun/Jun" . SPARSER::COLLECTION) ("c-Myc/Max" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN)
    ("the commercially available STAT3 inhibitors" . SPARSER::INHIBITOR)
    ("leukemia inhibitory factor (LIF) and laminin (ELL)-primed hNSCs"
     . SPARSER::COLLECTION)
    ("GABA) neuronal subtypes" . SPARSER::PROTEIN)
    ("heparin and laminin" . SPARSER::COLLECTION) ("ELL" . SPARSER::PROTEIN)
    ("pro-inflammatory interleukin" . SPARSER::PROTEIN)
    ("JAK1-STAT3" . SPARSER::COLLECTION)
    ("nearby astrocytes" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN)
    ("Stattic and Niclosamide" . SPARSER::COLLECTION)
    ("Hb9" . SPARSER::PROTEIN) ("Niclosamide" . SPARSER::DRUG)
    ("Stattic" . SPARSER::DRUG) ("Id3" . SPARSER::PROTEIN)
    ("hes5" . SPARSER::PROTEIN) ("Notch 1" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("Ngn2" . SPARSER::PROTEIN) ("PLC-γ" . SPARSER::PROTEIN-FAMILY)
    ("bis-tris" . SPARSER::MOLECULE) ("Alpha-" . SPARSER::PROTEIN)
    ("HJC0149" . SPARSER::DRUG) ("GABA)" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("HB9" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("the EMT-associated transcription suppressor Snail" . SPARSER::PROTEIN)
    ("AKT, and vascular endothelial" . SPARSER::COLLECTION)
    ("EGFR, and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN)
    ("SNAIL, SLUG, Twist1, and Twist2" . SPARSER::COLLECTION)
    ("several EMT-associated proteins" . SPARSER::PROTEIN)
    ("casein" . SPARSER::PROTEIN) ("TrkB" . SPARSER::PROTEIN)
    ("Snail, Slug, and ZEB1" . SPARSER::COLLECTION)
    ("Snail and vimentin" . SPARSER::COLLECTION) ("BCG" . SPARSER::DRUG)
    ("the mesenchymal markers vimentin and Snail" . SPARSER::COLLECTION)
    ("the typical EMT" . SPARSER::PROTEIN)
    ("epithelial tight junction" . SPARSER::PROTEIN)
    ("EGFR and AKT" . SPARSER::COLLECTION) ("adherin" . SPARSER::PROTEIN)
    ("the mesenchymal markers vimentin ( r  = 0.620, P <0.05) and Snail ( r  = 0.492, P <0.05)"
     . SPARSER::COLLECTION)
    ("the mesenchymal markers vimentin" . SPARSER::PROTEIN)
    ("–c" . SPARSER::COLLECTION) ("–d" . SPARSER::COLLECTION)
    ("vimentin, Snail, and E-cadherin" . SPARSER::COLLECTION)
    ("MKN28-NC and MKN28-EGFL7" . SPARSER::COLLECTION)
    ("poly-HEMA and anoikis" . SPARSER::COLLECTION) ("HEMA" . SPARSER::PROTEIN)
    ("Anoikis" . SPARSER::PROTEIN)
    ("MKN28-EGFL7 and MKN28-NC" . SPARSER::COLLECTION)
    ("BGC-NC" . SPARSER::COLLECTION) ("BGC" . SPARSER::PROTEIN)
    ("pEX-2-EGFL7" . SPARSER::COLLECTION) ("EGFR−AKT" . SPARSER::COLLECTION)
    ("-cadherin" . SPARSER::COLLECTION) ("statin" . SPARSER::MOLECULE)
    ("EGFL7−EGFR−AKT−Snail" . SPARSER::COLLECTION)
    ("EGFR−AKT−Snail" . SPARSER::COLLECTION)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("vimentin and Snail" . SPARSER::COLLECTION)
    ("the mesenchymal marker vimentin and the EMT-associated transcription repressor Snail"
     . SPARSER::COLLECTION)
    ("the EMT-associated transcription repressor Snail" . SPARSER::PROTEIN)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("Sonic hedgehog" . SPARSER::PROTEIN) ("Snai1" . SPARSER::PROTEIN)
    ("Tyrphostin AG1478" . SPARSER::DRUG) ("EGFL7" . SPARSER::PROTEIN)
    ("TOB1 and MIG6" . SPARSER::COLLECTION)
    ("the continued progression of pregnancy" . SPARSER::PROTEIN)
    ("progressive nature of pregnancy" . SPARSER::PROTEIN)
    ("MEKK" . SPARSER::PROTEIN) ("WNK" . SPARSER::PROTEIN-FAMILY)
    ("AKT1S1 or WNK1" . SPARSER::COLLECTION) ("GSK3b" . SPARSER::PROTEIN)
    ("CTNNB" . SPARSER::PROTEIN)
    ("MAPK and downstream effectors (P38a, RSK1/2/3, HSP27, JUN, CREB)"
     . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("HCK" . SPARSER::PROTEIN)
    ("predominant EGFR ligands" . SPARSER::LIGAND)
    ("Hbegf and Areg" . SPARSER::COLLECTION) ("Hbegf" . SPARSER::PROTEIN)
    ("PGR" . SPARSER::PROTEIN) ("AMP (EPC)" . SPARSER::AMP)
    ("Egfr and Wnt4" . SPARSER::COLLECTION) ("Xaf1" . SPARSER::PROTEIN)
    ("Dapk1" . SPARSER::PROTEIN) ("Zeb1" . SPARSER::PROTEIN)
    ("Dcc" . SPARSER::PROTEIN) ("Perp" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("Egfr and Bmp2" . SPARSER::COLLECTION)
    ("Aox1" . SPARSER::PROTEIN) ("Scarb1" . SPARSER::PROTEIN)
    ("Cyp39a1" . SPARSER::PROTEIN) ("Tcerg1" . SPARSER::PROTEIN)
    ("Lsm2" . SPARSER::PROTEIN) ("Aox" . SPARSER::PROTEIN)
    ("Fasn" . SPARSER::PROTEIN) ("Hmgcr" . SPARSER::PROTEIN)
    ("Apoe" . SPARSER::PROTEIN) ("Egfr-Wnt4" . SPARSER::COLLECTION)
    ("Egfr-Bmp2" . SPARSER::COLLECTION)
    ("an additional 1,923 unique genes" . SPARSER::GENE)
    ("the predominant regulator" . SPARSER::REGULATOR)
    ("Egfr , Wnt4 and Bmp2" . SPARSER::COLLECTION) ("Dact1" . SPARSER::PROTEIN)
    ("Sfrp4" . SPARSER::PROTEIN)
    ("receptors, Bmp2 , Bmpr2 and Acvr1" . SPARSER::COLLECTION)
    ("Bmp2 and Acvr1" . SPARSER::COLLECTION) ("Acvr1" . SPARSER::PROTEIN)
    ("Bmpr2" . SPARSER::PROTEIN)
    ("growth factor and kinase" . SPARSER::COLLECTION)
    ("Bak1" . SPARSER::PROTEIN) ("Mcm2" . SPARSER::PROTEIN)
    ("Ccnd3" . SPARSER::PROTEIN) ("E2f8" . SPARSER::PROTEIN)
    ("E2f3" . SPARSER::PROTEIN) ("Igf1" . SPARSER::PROTEIN)
    ("Fgf7" . SPARSER::PROTEIN) ("Mcm" . SPARSER::PROTEIN)
    ("the predominant ligand" . SPARSER::LIGAND)
    ("the only Erbb receptor" . SPARSER::RECEPTOR)
    ("decidual markers IGFBP1 and PRL" . SPARSER::COLLECTION)
    ("cJUN" . SPARSER::PROTEIN)
    ("either treatment type or EGFR status" . SPARSER::COLLECTION)
    ("HESCs" . SPARSER::PROTEIN)
    ("IGFBP1 ( xref ) and EGFR ( xref )" . SPARSER::COLLECTION)
    ("IGFBP1 and EGFR" . SPARSER::COLLECTION)
    ("classic decidual markers IGFBP1 and PRL" . SPARSER::COLLECTION)
    ("IGFBP1 and PRL" . SPARSER::COLLECTION) ("HESC" . SPARSER::PROTEIN)
    ("EGFR and WNT4" . SPARSER::COLLECTION)
    ("Bmp2 or Wnt4" . SPARSER::COLLECTION)
    ("Bmp2 and 1,305 genes" . SPARSER::COLLECTION)
    ("BMP2 and WNT4" . SPARSER::COLLECTION)
    ("Bmp2 , Wnt4 , Ptgs2 , Id1 , Fkbp5 and Fst" . SPARSER::COLLECTION)
    ("Ptgs2" . SPARSER::PROTEIN) ("Fst" . SPARSER::PROTEIN)
    ("Erbb2 or Erbb3" . SPARSER::COLLECTION)
    ("Ihh , Ptch , Gli1 or COUP-TFII" . SPARSER::COLLECTION)
    ("P4 and E2" . SPARSER::COLLECTION)
    ("Ihh , Il13ra2 , and Areg" . SPARSER::COLLECTION)
    ("acute P4 target genes Ihh , Il13ra2 , Cyp26a1 and Areg"
     . SPARSER::COLLECTION)
    ("Ihh , Il13ra2 , Cyp26a1 and Areg" . SPARSER::COLLECTION)
    ("Cyp26a1" . SPARSER::PROTEIN) ("Il13ra2" . SPARSER::PROTEIN)
    ("Cyp" . SPARSER::PROTEIN) ("EGF and E2" . SPARSER::COLLECTION)
    ("gonadotropins" . SPARSER::PROTEIN) ("Erbb2" . SPARSER::PROTEIN)
    ("d/d" . SPARSER::COLLECTION)
    ("the epidermal growth factor receptor ( Egfr/Erbb1 ) and v-erb-b2 erythroblastic leukemia viral oncogene homolog 2–4 ( Her2 , Erbb3 and Erbb4 , respectively)"
     . SPARSER::COLLECTION)
    ("Erbb3 and Erbb4" . SPARSER::COLLECTION) ("Erbb4" . SPARSER::PROTEIN)
    ("Egfr/Erbb1" . SPARSER::COLLECTION)
    ("Areg , Egf and Tgfa" . SPARSER::COLLECTION) ("Tgfa" . SPARSER::PROTEIN)
    ("Areg" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("Nr2f2" . SPARSER::PROTEIN) ("ovalbumin" . SPARSER::PROTEIN)
    ("Pgr" . SPARSER::PROTEIN)
    ("the predominant hormone of pregnancy" . SPARSER::PROTEIN)
    ("progesterone and estrogen" . SPARSER::COLLECTION)
    ("effective pharmaceutical therapeutics" . SPARSER::THERAPEUTICS)
    ("WNK1 and AKT1S1" . SPARSER::COLLECTION)
    ("boneless morphogenic protein" . SPARSER::PROTEIN)
    ("Bmp2 and Wnt4" . SPARSER::COLLECTION) ("Bmp2" . SPARSER::PROTEIN)
    ("Bmp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MMTV" . SPARSER::PROTEIN)
    ("Phospho-Kinase" . SPARSER::PROTEIN) ("mm 3" . SPARSER::PROTEIN)
    ("MIG6" . SPARSER::PROTEIN)
    ("epithelial sodium channel" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("AMPKa2" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("P38a" . SPARSER::PROTEIN)
    ("Hk2" . SPARSER::PROTEIN) ("Nup160" . SPARSER::PROTEIN)
    ("Nup155" . SPARSER::PROTEIN) ("Wnt6" . SPARSER::PROTEIN)
    ("Birc6" . SPARSER::PROTEIN) ("Birc5" . SPARSER::PROTEIN)
    ("Mcm7" . SPARSER::PROTEIN) ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRAS40" . SPARSER::PROTEIN) ("phospho-kinase" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN) ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("WNT4" . SPARSER::PROTEIN) ("Fkbp5" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erbb1" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("COUP-TFII" . SPARSER::PROTEIN) ("AKT1S1" . SPARSER::PROTEIN)
    ("WNK1" . SPARSER::PROTEIN) ("Wnt4" . SPARSER::PROTEIN)
    ("Erbb3" . SPARSER::PROTEIN) ("PMLs" . SPARSER::PROTEIN)
    ("HIF-1a and c-Myc" . SPARSER::COLLECTION)
    ("PKC, GSK-3β, CK2, and JNK" . SPARSER::COLLECTION)
    ("NF-κB and histone" . SPARSER::COLLECTION)
    ("SFN and ROS" . SPARSER::COLLECTION) ("cellular ROS" . SPARSER::PROTEIN)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("PML and Nrf2" . SPARSER::COLLECTION)
    ("PML and PML" . SPARSER::COLLECTION)
    ("Nrf2 and nuclear forms" . SPARSER::COLLECTION)
    ("Keap1 and forms" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::MOLECULE) ("-acetyl" . SPARSER::MOLECULE)
    ("Sdhaf1 and Sdhaf2" . SPARSER::COLLECTION)
    ("Sdha-d" . SPARSER::COLLECTION) ("Sdha" . SPARSER::PROTEIN)
    ("-ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("the NQO1 ( xref ) and HO-1 promoters ( xref )" . SPARSER::COLLECTION)
    ("Exogenous overexpressed Nrf2" . SPARSER::PROTEIN)
    ("significantly more Nrf2 inPml −/− MEFs" . SPARSER::PROTEIN)
    ("subcellular fractionation inPml +/+ andPml −/− MEFs" . SPARSER::PROTEIN)
    ("Nrf2 and its target NQO1" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("specific cysteines of PML" . SPARSER::PROTEIN)
    ("oxidative stress inducers" . SPARSER::MOLECULE)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN) ("glucoraphanin" . SPARSER::DRUG)
    ("isothiocyanate" . SPARSER::MOLECULE) ("Sulforaphane" . SPARSER::PROTEIN)
    ("antioxidative enzymes" . SPARSER::ENZYME)
    ("chaperones, transporters, and anti-inflammatory" . SPARSER::COLLECTION)
    ("antioxidative genes" . SPARSER::GENE)
    ("sulforaphane (SFN)" . SPARSER::DRUG) ("SFN" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein (PML)" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("anti–β" . SPARSER::PROTEIN) ("RNF4" . SPARSER::PROTEIN)
    ("E3 ubiquitin ligase RNF4" . SPARSER::PROTEIN)
    ("Sdhaf2" . SPARSER::PROTEIN) ("Sdhaf1" . SPARSER::PROTEIN)
    ("As 2 O 3" . SPARSER::DRUG)
    ("NAD(P)H dehydrogenase [quinone] 1" . SPARSER::PROTEIN)
    ("cullin 3" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2–related factor 2" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2–related factor 2" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("cyclin D1 and pS2" . SPARSER::COLLECTION)
    ("GPS2 and SMRT" . SPARSER::COLLECTION)
    ("ERE-reporter" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("GPS2-N-CoR/SMRT" . SPARSER::COLLECTION)
    ("N-CoR/SMRT" . SPARSER::COLLECTION) ("SP3 or SP3" . SPARSER::COLLECTION)
    ("an activator or a repressor" . SPARSER::COLLECTION)
    ("SUMO-1–fused" . SPARSER::COLLECTION)
    ("retinoic acid (RA)" . SPARSER::MOLECULE)
    ("the protein's" . SPARSER::PROTEIN)
    ("a heterodimeric receptor" . SPARSER::RECEPTOR)
    ("Daxx, and NEMO" . SPARSER::COLLECTION) ("Daxx" . SPARSER::PROTEIN)
    ("SUMO and GPS2" . SPARSER::COLLECTION)
    ("SUMO or SUMO-bearing proteins" . SPARSER::COLLECTION)
    ("LXRβ or LRH-1" . SPARSER::COLLECTION)
    ("GPS2 and SUMO" . SPARSER::COLLECTION)
    ("the SMRT repressive complex" . SPARSER::BIO-COMPLEX)
    ("Myc-tagged SMRT and Flag-tagged HDAC3" . SPARSER::COLLECTION)
    ("anti-Myc, Flag, or HA" . SPARSER::COLLECTION)
    ("SMRT and HDAC3" . SPARSER::COLLECTION)
    ("a transcription-repressive complex" . SPARSER::BIO-COMPLEX)
    ("GPS2 or mutant" . SPARSER::COLLECTION)
    ("2KR and Myc-tagged" . SPARSER::COLLECTION)
    ("Flag-tagged TBL1 and HA-tagged wild-type GPS2 or its mutant 2KR"
     . SPARSER::COLLECTION)
    ("HA-tagged wild-type GPS2 or its mutant 2KR" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("HA-tagged wild-type GPS2 or its mutants K45R" . SPARSER::COLLECTION)
    ("K45R" . SPARSER::PROTEIN) ("CV-1" . SPARSER::PROTEIN)
    ("mut, SENP2, or SENP3" . SPARSER::COLLECTION)
    ("SENP2, SENP3, or SENP1" . SPARSER::COLLECTION)
    ("SENP2, or SENP3" . SPARSER::COLLECTION)
    ("Flag-SENP1" . SPARSER::COLLECTION) ("GAL4-UAS-luc" . SPARSER::COLLECTION)
    ("GAL" . SPARSER::PROTEIN)
    ("HA-tagged GPS2 and GFP-tagged SUMO1" . SPARSER::COLLECTION)
    ("GPS2-SUMO" . SPARSER::COLLECTION)
    ("GPS2 and green fluorescent protein" . SPARSER::COLLECTION)
    ("GFP-SUMO-1" . SPARSER::PROTEIN-PAIR)
    ("GPS2 and Myc-tagged" . SPARSER::COLLECTION)
    ("GPS2 and TBL1" . SPARSER::COLLECTION)
    ("N-CoR and TBL1" . SPARSER::COLLECTION)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("SUMO-protein" . SPARSER::COLLECTION)
    ("SUMO-2 and -3" . SPARSER::COLLECTION)
    ("cyclinA1–CDK2" . SPARSER::COLLECTION)
    ("several nuclear receptors and orphan receptors" . SPARSER::COLLECTION)
    ("LXR, FXR, LRH-1, HNF4α, and SHP" . SPARSER::COLLECTION)
    ("active and important" . SPARSER::COLLECTION)
    ("lipid, and cholesterol" . SPARSER::COLLECTION) ("FXR" . SPARSER::PROTEIN)
    ("TRAF2/Ubc13" . SPARSER::COLLECTION)
    ("GPS2 and other proteins" . SPARSER::COLLECTION)
    ("protein and p300" . SPARSER::COLLECTION)
    ("SMRT and GPS2" . SPARSER::COLLECTION) ("transducin" . SPARSER::PROTEIN)
    ("SMRT/N-CoR" . SPARSER::COLLECTION) ("a 37-kDa" . SPARSER::COLLECTION)
    ("SUMO-2 or -3" . SPARSER::COLLECTION) ("SUMO" . SPARSER::PROTEIN)
    ("SMRT" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("SP3" . SPARSER::PROTEIN) ("CRABP-II" . SPARSER::PROTEIN)
    ("Histone H3K" . SPARSER::PROTEIN) ("LXRβ" . SPARSER::PROTEIN)
    ("SENP3" . SPARSER::PROTEIN) ("SENP2" . SPARSER::PROTEIN)
    ("SENP1" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("SUMO-4" . SPARSER::PROTEIN)
    ("cyclinA1" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("LRH-1" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("TBL1" . SPARSER::PROTEIN) ("K45" . SPARSER::PROTEIN)
    ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-protein pathway suppressor 2" . SPARSER::PROTEIN)
    ("SUMO-1" . SPARSER::PROTEIN)
    ("p53 and ornithine decarboxylase" . SPARSER::COLLECTION)
    ("ODC" . SPARSER::PROTEIN)
    ("βTrCP or another E3 ubiquitin ligase" . SPARSER::COLLECTION)
    ("a currently unidentified E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("TRAF3:TRAF2" . SPARSER::BIO-COMPLEX)
    ("the Smac mimetic GT13072" . SPARSER::DRUG)
    ("NIK and NIK" . SPARSER::COLLECTION)
    ("exogenous cIAP1 or cIAP2" . SPARSER::COLLECTION)
    ("the natural ligand LIGHT or a LTβR" . SPARSER::COLLECTION)
    ("the only E3 ubiquitin ligases" . SPARSER::LIGASE)
    ("MG132 or bortezomib" . SPARSER::COLLECTION) ("Velcade" . SPARSER::DRUG)
    ("bortezomib" . SPARSER::DRUG) ("MG132 and CHX" . SPARSER::COLLECTION)
    ("basal NIK" . SPARSER::PROTEIN) ("-phosphatase" . SPARSER::PHOSPHATASE)
    ("LIGHT" . SPARSER::PROTEIN) ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("which releases NIK" . SPARSER::PROTEIN) ("LT" . SPARSER::PROTEIN)
    ("both cIAP1 ( Birc2 ) and cIAP2 ( Birc3 )" . SPARSER::COLLECTION)
    ("Birc3" . SPARSER::PROTEIN)
    ("TRAF2, TRAF3, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("cIAP1 or cIAP2" . SPARSER::COLLECTION)
    ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("TNFSF14" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("lymphotoxin-β" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("GT13072" . SPARSER::DRUG) ("cIAP2" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("IG and OE" . SPARSER::COLLECTION)
    ("IG" . SPARSER::MOLECULE) ("Inosine" . SPARSER::MOLECULE)
    ("Guanosine" . SPARSER::MOLECULE) ("Methylguanine" . SPARSER::MOLECULE)
    ("Dacarbazine" . SPARSER::DRUG) ("RAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF/RAS" . SPARSER::COLLECTION)
    ("both DHFR and the pro-survival transcription factor MITF"
     . SPARSER::COLLECTION)
    ("E2F and Chk1" . SPARSER::COLLECTION) ("MTX" . SPARSER::DRUG)
    ("Historically antifolate drugs such as methotrexate or edatrexate"
     . SPARSER::COLLECTION)
    ("Historically antifolate drugs" . SPARSER::DRUG)
    ("BRAF and RAS" . SPARSER::COLLECTION)
    ("IL8 and VEGF" . SPARSER::COLLECTION)
    ("BRAF or RAS" . SPARSER::COLLECTION)
    ("pyrimethamine and methrotrexate" . SPARSER::COLLECTION)
    ("pyrimethamine" . SPARSER::DRUG)
    ("dehydrogenase (IMPDH)" . SPARSER::PROTEIN)
    ("Thymidine" . SPARSER::PROTEIN)
    ("HGPRT and thymidine kinase" . SPARSER::COLLECTION)
    ("aminopterin" . SPARSER::DRUG)
    ("thymidine kinase (TK1) and APRT" . SPARSER::COLLECTION)
    ("APRT" . SPARSER::PROTEIN)
    ("-guanosine monophosphate (GMP) or guanosine (GR)" . SPARSER::COLLECTION)
    ("-guanosine monophosphate" . SPARSER::MOLECULE)
    ("guanosine" . SPARSER::MOLECULE)
    ("hypoxanthine-guanine phosphoribosyl–transferase (HGPRT)"
     . SPARSER::PROTEIN)
    ("hypoxanthine (HX)" . SPARSER::DRUG) ("HGPRT" . SPARSER::PROTEIN)
    ("hypoxanthine" . SPARSER::DRUG) ("Hypoxanthine" . SPARSER::DRUG)
    ("lomeguatrib" . SPARSER::DRUG) ("CHK-1 and CHK-2" . SPARSER::COLLECTION)
    ("meG" . SPARSER::DRUG) ("carmustine or cisplatin" . SPARSER::COLLECTION)
    ("cisplatin and DTIC" . SPARSER::COLLECTION)
    ("TMZ and carmustine" . SPARSER::COLLECTION)
    ("methylguanine" . SPARSER::MOLECULE)
    ("multi-drug resistance phenotype-associated proteins" . SPARSER::PROTEIN)
    ("Temozolomide" . SPARSER::DRUG) ("a toxic DNA" . SPARSER::DNA)
    ("MTIC" . SPARSER::DRUG) ("prodrug" . SPARSER::DRUG)
    ("paclitaxel and vinblastine" . SPARSER::COLLECTION)
    ("vinblastine" . SPARSER::DRUG)
    ("the chloro-ethylating agents carmustine or the bifunctional alkylating agents like cisplatin [ xref ]"
     . SPARSER::COLLECTION)
    ("the monofunctional-alkylating agents dacarbazine (DTIC) and temozolomide (TMZ)"
     . SPARSER::COLLECTION)
    ("dacarbazine (DTIC)" . SPARSER::DRUG) ("carmustine" . SPARSER::DRUG)
    ("Ral-GDS or PI3-kinase" . SPARSER::COLLECTION)
    ("antifolate" . SPARSER::MOLECULE)
    ("dacarbazine (DTIC) and temozolomide (TMZ)" . SPARSER::COLLECTION)
    ("Hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("BETA-ACTIN" . SPARSER::PROTEIN) ("O6" . SPARSER::PROTEIN)
    ("IMPDH2" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("guanosine monophosphate" . SPARSER::MOLECULE)
    ("hypoxanthine-guanine phosphoribosyl–transferase" . SPARSER::PROTEIN)
    ("CHK-2" . SPARSER::PROTEIN) ("CHK-1" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN)
    ("methyl-transferase" . SPARSER::PROTEIN) ("O  6" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN) ("Ral-GDS" . SPARSER::PROTEIN)
    ("Ras/Raf/MAPK/ERK" . SPARSER::COLLECTION)
    ("neither the combination cytotoxic drug nor the administration"
     . SPARSER::COLLECTION)
    ("oxaliplatin or single capecitabine" . SPARSER::COLLECTION)
    ("aldesleukin" . SPARSER::PROTEIN) ("a fully human mAb" . SPARSER::DRUG)
    ("The two therapeutic Abs" . SPARSER::PROTEIN)
    ("the EGFR disomic line CW-2" . SPARSER::PROTEIN)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("chemorefractory patient cohorts" . SPARSER::MOLECULE)
    ("c–d" . SPARSER::COLLECTION)
    ("the chemorefractory patient cohort" . SPARSER::MOLECULE)
    ("KRAS-" . SPARSER::PROTEIN) ("Secondary aims" . SPARSER::PROTEIN)
    ("a combined chemorefractory patient cohort" . SPARSER::MOLECULE)
    ("EGFR-targeting monoclonal antibodies" . SPARSER::ANTIBODY)
    ("chemorefractory CRC" . SPARSER::PROTEIN)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("The chemorefractory patient cohort" . SPARSER::MOLECULE)
    ("chemorefractory metastatic CRC" . SPARSER::PROTEIN)
    ("pERK1/2" . SPARSER::PROTEIN) ("B-1" . SPARSER::PROTEIN)
    ("CW-2" . SPARSER::PROTEIN) ("RFC" . SPARSER::PROTEIN)
    ("XPG" . SPARSER::PROTEIN) ("XPA" . SPARSER::PROTEIN)
    ("aphidicolin and araC" . SPARSER::COLLECTION) ("araC" . SPARSER::DRUG)
    ("aphidicolin" . SPARSER::PROTEIN) ("2KR, or 5KR" . SPARSER::COLLECTION)
    ("wt or mutants" . SPARSER::COLLECTION)
    ("RFP-PCNA 2KR and RFP-PCNA 5KR" . SPARSER::COLLECTION)
    ("soluble PCNA" . SPARSER::PROTEIN) ("soluble form" . SPARSER::FORM)
    ("the soluble form" . SPARSER::FORM)
    ("the soluble fraction" . SPARSER::COMPONENT) ("max" . SPARSER::PROTEIN)
    ("the wt and the mutant proteins" . SPARSER::COLLECTION)
    ("the 2KR or the 5KR mutant" . SPARSER::COLLECTION)
    ("CBP, or p300" . SPARSER::COLLECTION)
    ("wt , 2KR or 5KR" . SPARSER::COLLECTION)
    ("2KR and 5KR" . SPARSER::COLLECTION) ("defective PCNA" . SPARSER::PROTEIN)
    ("wt , or his-PCNA" . SPARSER::COLLECTION) ("dUTP" . SPARSER::MOLECULE)
    ("wt and PCNA" . SPARSER::COLLECTION)
    ("wt or mutant" . SPARSER::COLLECTION) ("RFP-" . SPARSER::PROTEIN)
    ("GFP-H2B" . SPARSER::COLLECTION) ("wt and mutant" . SPARSER::COLLECTION)
    ("2KR or 5KR" . SPARSER::COLLECTION) ("RFP-PCNA" . SPARSER::COLLECTION)
    ("CBP or p300" . SPARSER::COLLECTION) ("KATs" . SPARSER::PROTEIN)
    ("anti-PCNA and anti-acetyl" . SPARSER::COLLECTION)
    ("meiotic" . SPARSER::DRUG) ("Polyubiquitination" . SPARSER::PROTEIN)
    ("a homotrimeric protein" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("NER" . SPARSER::PROTEIN) ("MTH2" . SPARSER::PROTEIN)
    ("S6E" . SPARSER::PROTEIN-FAMILY) ("S6D" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("HDAC-1" . SPARSER::PROTEIN)
    ("2KR" . SPARSER::PROTEIN) ("p125" . SPARSER::PROTEIN)
    ("P300" . SPARSER::PROTEIN) ("KAT3A" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN) ("KAT3B" . SPARSER::PROTEIN)
    ("ERK8" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN)
    ("Cav-1 and low-density lipoprotein receptor-related protein 6"
     . SPARSER::COLLECTION)
    ("RNA and proteins" . SPARSER::COLLECTION)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("Cav-1 and p53" . SPARSER::COLLECTION)
    ("FTC, and SP" . SPARSER::COLLECTION)
    ("p53 and Cav-1" . SPARSER::COLLECTION)
    ("MYC , CCND1, IL6, and FN1" . SPARSER::COLLECTION)
    ("GSN" . SPARSER::PROTEIN) ("NSP" . SPARSER::PROTEIN)
    ("the key biomarkers" . SPARSER::MOLECULE)
    ("Cav-1-p53" . SPARSER::COLLECTION) ("anoikis" . SPARSER::PROTEIN)
    ("a plasma membrane-associated protein caveolin-1" . SPARSER::PROTEIN)
    ("notably carbon nanotubes" . SPARSER::MOLECULE)
    ("nanotubes" . SPARSER::MOLECULE) ("P30" . SPARSER::DRUG)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 6" . SPARSER::PROTEIN)
    ("insulin-like growth factor I" . SPARSER::PROTEIN)
    ("CD 133" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("p19ARF and p53" . SPARSER::COLLECTION)
    ("two potent competitive PARP inhibitors" . SPARSER::INHIBITOR)
    ("Chemical" . SPARSER::MOLECULE)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("possible cofactors" . SPARSER::PROTEIN) ("CpGs" . SPARSER::PROTEIN)
    ("the repressive chromatin" . SPARSER::PROTEIN) ("POL" . SPARSER::PROTEIN)
    ("H3K4 and H3K9" . SPARSER::COLLECTION)
    ("Glucosyltransferase" . SPARSER::PROTEIN)
    ("bisulfite" . SPARSER::MOLECULE)
    ("PARP-1 and/or PARP-2" . SPARSER::COLLECTION) ("PARG" . SPARSER::PROTEIN)
    ("PJ-34 and 1μM" . SPARSER::COLLECTION)
    ("PJ-34 and ABT-888" . SPARSER::COLLECTION)
    ("DNA and histone methylation [ xref , xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("azacytidine" . SPARSER::DRUG) ("glucosyltransferase" . SPARSER::PROTEIN)
    ("JURKAT" . SPARSER::PROTEIN) ("nucleosome" . SPARSER::BIO-COMPLEX)
    ("KDM5B and KDM4D" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("histones and DNA" . SPARSER::COLLECTION)
    ("its highly homologous protein PARP-2/ARTD2" . SPARSER::COLLECTION)
    ("PARP-2/ARTD2" . SPARSER::COLLECTION)
    ("polymer (PAR)" . SPARSER::MOLECULE)
    ("developmental regulators" . SPARSER::REGULATOR)
    ("TET1 and TET2" . SPARSER::COLLECTION)
    ("TET1, TET2 and TET3" . SPARSER::COLLECTION) ("TET" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("LMNB1" . SPARSER::PROTEIN)
    ("β-glucuronidase" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("demethylase activity" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("PJ-34" . SPARSER::DRUG)
    ("ALC1" . SPARSER::PROTEIN) ("Dnmt1" . SPARSER::PROTEIN)
    ("KDM4D" . SPARSER::PROTEIN) ("KDM5B" . SPARSER::PROTEIN)
    ("PARP-2" . SPARSER::PROTEIN) ("TET3" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN) ("TET1" . SPARSER::PROTEIN)
    ("p53 and EGFR" . SPARSER::COLLECTION)
    ("receptor-Src-HER2" . SPARSER::COLLECTION)
    ("EpoR/Jak2" . SPARSER::COLLECTION) ("EpoR" . SPARSER::PROTEIN)
    ("p110 α (PI3K catalytic subunit) and pAkt" . SPARSER::COLLECTION)
    ("PTEN and Src" . SPARSER::COLLECTION)
    ("Src and PTEN" . SPARSER::COLLECTION)
    ("PTEN or mTOR" . SPARSER::COLLECTION)
    ("MAPK and p27" . SPARSER::COLLECTION) ("/pAkt" . SPARSER::COLLECTION)
    ("p110 α (22.9% P= 0.11) or pAkt (28.4% P= 0.2)" . SPARSER::COLLECTION)
    ("-IGF1R" . SPARSER::COLLECTION)
    ("a common upstream regulator of the Ras/MAPK ( xref ) and PI3K pathways ( xref ) inducing malignant transformation"
     . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("integrins and growth factors" . SPARSER::COLLECTION)
    ("hepatocyte growth factor/scatter factor receptor" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("HER1 (EGFR)" . SPARSER::PROTEIN)
    ("EGFR and p27" . SPARSER::COLLECTION)
    ("active Src and several proteins" . SPARSER::COLLECTION)
    ("p110 α" . SPARSER::PROTEIN) ("group C" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("scatter factor receptor" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("shRNA and STGM" . SPARSER::COLLECTION) ("ACEA" . SPARSER::PROTEIN)
    ("polylysine" . SPARSER::MOLECULE) ("spiked" . SPARSER::PROTEIN)
    ("a 3 µ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-ras and c-MYC" . SPARSER::COLLECTION)
    ("Myc and Ras" . SPARSER::COLLECTION)
    ("RAS family and c-MYC" . SPARSER::COLLECTION)
    ("MYC and RAS" . SPARSER::COLLECTION)
    ("ERK, AKT, and p38 kinases as well as their phosphorylated or activated forms"
     . SPARSER::COLLECTION)
    ("ERK, AKT, and p38" . SPARSER::COLLECTION)
    ("oncognic RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LnCaP and DU145" . SPARSER::COLLECTION)
    ("ERBB2 ( PBP-ERBB2 ) or a mutated form" . SPARSER::COLLECTION)
    ("a mutated form" . SPARSER::FORM) ("PBP-RAS" . SPARSER::COLLECTION)
    ("PBP-ERBB2" . SPARSER::COLLECTION)
    ("PBP-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PBP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERBB2 and RAS" . SPARSER::COLLECTION)
    ("ERBB2 or RAS" . SPARSER::COLLECTION) ("Raf/ERK" . SPARSER::COLLECTION)
    ("RalGEF" . SPARSER::PROTEIN)
    ("three monomeric GTPases, H-RAS, N-RAS, and K-RAS" . SPARSER::COLLECTION)
    ("GTPases, H-RAS, N-RAS, and K-RAS" . SPARSER::COLLECTION)
    ("The principal downstream effector" . SPARSER::EFFECTOR)
    ("phosphoinositide-3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("ERBB2 or HER2 or NEU" . SPARSER::COLLECTION)
    ("HER2 or NEU" . SPARSER::COLLECTION) ("NEU" . SPARSER::PROTEIN)
    ("ERBB2 or H-RAS" . SPARSER::COLLECTION) ("LnCaP" . SPARSER::PROTEIN)
    ("ERBB2/RAS" . SPARSER::COLLECTION)
    ("the ERBB2 oncogene or the RAS oncogene" . SPARSER::COLLECTION)
    ("the aggressive forms" . SPARSER::FORM)
    ("all the blood-based biomarkers" . SPARSER::MOLECULE)
    ("MYC protein" . SPARSER::PROTEIN) ("Kras2" . SPARSER::PROTEIN)
    ("ERRB2" . SPARSER::PROTEIN) ("c- MYC" . SPARSER::PROTEIN)
    ("hormone-sensitive" . SPARSER::PROTEIN)
    ("an aggressive subtype" . SPARSER::PROTEIN)
    ("the mutated promoter" . SPARSER::PROMOTER)
    ("mutated TERT promoter" . SPARSER::PROMOTER)
    ("new prognostic biomarkers" . SPARSER::MOLECULE)
    ("the mutated TERT promoter" . SPARSER::PROMOTER)
    ("hypoxia and TMZ" . SPARSER::COLLECTION)
    ("Hypoxia and TMZ" . SPARSER::COLLECTION)
    ("mutated promoters" . SPARSER::PROMOTER) ("Ets/TCF" . SPARSER::COLLECTION)
    ("TMZ" . SPARSER::DRUG)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("IGF-1 and TGF-β" . SPARSER::COLLECTION)
    ("extracellular sCLU" . SPARSER::PROTEIN)
    ("Hsp90 or Hsp72" . SPARSER::COLLECTION)
    ("sCLU-shRNA" . SPARSER::COLLECTION) ("shRNA-sCLU" . SPARSER::COLLECTION)
    ("an extracellular chaperone" . SPARSER::PROTEIN)
    ("IGF-1/IGF-1R-sCLU" . SPARSER::COLLECTION)
    ("IGF-1/IGF-1R/MAPK/ERK-1/2/Egr-1" . SPARSER::COLLECTION)
    ("Src and Erk-1/2" . SPARSER::COLLECTION)
    ("Erk-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t-IGF-1R" . SPARSER::PROTEIN-PAIR) ("functional ATM" . SPARSER::PROTEIN)
    ("IGF-1/IGF-1R" . SPARSER::COLLECTION)
    ("P-Erk/t-Erk" . SPARSER::COLLECTION) ("DDRs" . SPARSER::PROTEIN)
    ("IGF-1-sCLU" . SPARSER::PROTEIN) ("p-Erk-1/t-Erk" . SPARSER::COLLECTION)
    ("oxygen (O 2 ) and no significant difference" . SPARSER::COLLECTION)
    ("CLU" . SPARSER::PROTEIN) ("apolipoprotein" . SPARSER::MOLECULE)
    ("p53, p21 and p16" . SPARSER::COLLECTION)
    ("Secretory Clusterin" . SPARSER::PROTEIN) ("Clusterin" . SPARSER::PROTEIN)
    ("IGF-1 and sCLU" . SPARSER::COLLECTION) ("sCLU" . SPARSER::PROTEIN)
    ("IGF-1R-sCLU" . SPARSER::PROTEIN-PAIR)
    ("ATM-IGF-1" . SPARSER::PROTEIN-PAIR) ("Src/MAPK" . SPARSER::COLLECTION)
    ("ATM/IGF-1/IGF-1R/Src/Erk1-2/Egr-1" . SPARSER::COLLECTION)
    ("extracellular chaperone" . SPARSER::PROTEIN)
    ("Secretory clusterin" . SPARSER::PROTEIN)
    ("ATM-related kinase (ATR) and Ku-dependent DNA protein kinase (DNA-PK)"
     . SPARSER::COLLECTION)
    ("kinase (ATR)" . SPARSER::KINASE) ("Ataxia" . SPARSER::PROTEIN)
    ("secretory proteins" . SPARSER::PROTEIN)
    ("Ras, c-myc, or BRAF" . SPARSER::COLLECTION)
    ("ATM-IGF-1-sCLU" . SPARSER::PROTEIN-PAIR)
    ("IGF-1R/MAPK/Egr-1" . SPARSER::COLLECTION) ("AAI" . SPARSER::PROTEIN)
    ("a known pro-survival extracellular chaperone" . SPARSER::PROTEIN)
    ("secretory clusterin" . SPARSER::PROTEIN) ("OGX-011" . SPARSER::DRUG)
    ("OGX011" . SPARSER::DRUG) ("Hsp27" . SPARSER::PROTEIN)
    ("Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-Erk-1" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("P18" . SPARSER::PROTEIN)
    ("P13" . SPARSER::PROTEIN) ("Erk-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CGK733" . SPARSER::DRUG) ("AG1024" . SPARSER::DRUG)
    ("paediatric p" . SPARSER::PROTEIN)
    ("virtually all ACC and CPT" . SPARSER::COLLECTION)
    ("ACC and CPT" . SPARSER::COLLECTION) ("allele (LOH)" . SPARSER::ALLELE)
    ("Brazilian BC cohorts" . SPARSER::MOLECULE)
    ("any suspicious FHC" . SPARSER::PROTEIN)
    ("the single most prevalent cancer-associated founder alleles"
     . SPARSER::ALLELE)
    ("the Brazilian founder allele" . SPARSER::ALLELE)
    ("zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only mutant alleles" . SPARSER::ALLELE)
    ("BRCA1, BRCA2 and CHEK2" . SPARSER::COLLECTION) ("SD " . SPARSER::PROTEIN)
    ("CPT" . SPARSER::PROTEIN) ("State" . SPARSER::BIO-STATE)
    ("all Brazilian p" . SPARSER::PROTEIN) ("alkaline" . SPARSER::PROTEIN)
    ("a conditional mutant" . SPARSER::MUTANT)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 , BRCA2 and TP53" . SPARSER::COLLECTION) ("FHC" . SPARSER::PROTEIN)
    ("The Brazilian founder p" . SPARSER::PROTEIN)
    ("Brazilian LFS/LFL families" . SPARSER::PROTEIN-FAMILY)
    ("RC1" . SPARSER::PROTEIN) ("PKC and NADPH oxidase" . SPARSER::COLLECTION)
    ("NADPH oxidase and PKC-" . SPARSER::COLLECTION)
    ("diabetic mice retinas" . SPARSER::DRUG) ("retinas" . SPARSER::DRUG)
    ("retina" . SPARSER::DRUG) ("vascular Nox5" . SPARSER::PROTEIN)
    ("particular Nox2" . SPARSER::PROTEIN)
    ("a polyphenolic antioxidant" . SPARSER::PROTEIN)
    ("apocynin and resveratrol" . SPARSER::COLLECTION)
    ("p22-phox and Nox1" . SPARSER::COLLECTION) ("MAPK-" . SPARSER::PROTEIN)
    ("Nox1, Nox2, Nox4 and Nox5" . SPARSER::COLLECTION)
    ("Nox5" . SPARSER::PROTEIN) ("Nox1" . SPARSER::PROTEIN)
    ("subunits, p22-phox, p47-phox, p40-phox and p67-phox"
     . SPARSER::COLLECTION)
    ("vascular NADPH oxidase" . SPARSER::PROTEIN)
    ("prooxidant" . SPARSER::MOLECULE)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION) ("d" . SPARSER::PROTEIN)
    ("PKC and/or NADPH oxidase" . SPARSER::COLLECTION)
    ("the cerebral barrier" . SPARSER::PROTEIN)
    ("Blue-labelled albumin and sodium fluorescein" . SPARSER::COLLECTION)
    ("Blue-labelled albumin" . SPARSER::PROTEIN)
    ("fluorescein" . SPARSER::MOLECULE) ("cerebral barrier" . SPARSER::PROTEIN)
    ("NADPH oxidase and PKC" . SPARSER::COLLECTION)
    ("p22-phox and Nox2" . SPARSER::COLLECTION)
    ("complex I, cyclooxygenase or xanthine" . SPARSER::COLLECTION)
    ("xanthine" . SPARSER::MOLECULE) ("PKC-d" . SPARSER::COLLECTION)
    ("particular superoxide anion" . SPARSER::MOLECULE)
    ("Bad, Bax and Bid" . SPARSER::COLLECTION)
    ("Bcl-2 and bcl-XL" . SPARSER::COLLECTION)
    ("human cerebral barrier" . SPARSER::PROTEIN)
    ("Nox2 and p22-phox" . SPARSER::COLLECTION) ("Nox2" . SPARSER::PROTEIN)
    ("PKC-" . SPARSER::PROTEIN) ("MnTBAP" . SPARSER::DRUG)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("bEnd3" . SPARSER::PROTEIN)
    ("Nox4" . SPARSER::PROTEIN) ("p67-phox" . SPARSER::PROTEIN)
    ("p40-phox" . SPARSER::PROTEIN) ("p47-phox" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("shp-1" . SPARSER::PROTEIN)
    ("l-NAME" . SPARSER::MOLECULE) ("LY333531" . SPARSER::DRUG)
    ("TNF-a" . SPARSER::PROTEIN) ("bcl-XL" . SPARSER::PROTEIN)
    ("p22-phox" . SPARSER::PROTEIN) ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("human esophageal squamous cells S100A4" . SPARSER::PROTEIN)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("S100A4 and VEGF" . SPARSER::COLLECTION)
    ("CRC, and VEGF" . SPARSER::COLLECTION)
    ("myosin and actin" . SPARSER::COLLECTION)
    ("VEGF and E-cadherin" . SPARSER::COLLECTION)
    ("LY294002 and rapamycin" . SPARSER::COLLECTION)
    ("Ad-S100A4-infected SW480" . SPARSER::PROTEIN)
    ("migrated SW480" . SPARSER::PROTEIN)
    ("the serine/threonine kinase p70 S6 kinase (p70S6K) and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("phosphatidylinositol-3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR/p70S6K" . SPARSER::COLLECTION)
    ("LY294002 or rapamycin" . SPARSER::COLLECTION)
    ("mTOR/p70S6K" . SPARSER::COLLECTION)
    ("Akt, mTOR and p70S6K" . SPARSER::COLLECTION)
    ("eukaryotic translation initiation factor 4E binding protein 1"
     . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pEL-98" . SPARSER::PROTEIN) ("FSP1" . SPARSER::PROTEIN)
    ("p9Ka" . SPARSER::PROTEIN) ("Mts1" . SPARSER::PROTEIN)
    ("S100A4" . SPARSER::PROTEIN) ("member S" . SPARSER::PROTEIN)
    ("LS-associated
SHP2 mutants"
     . SPARSER::MUTANT)
    ("growth factor receptors and scaffolding proteins" . SPARSER::COLLECTION)
    ("SHP2 and PTP1B" . SPARSER::COLLECTION)
    ("both p NPP- and pTyr-containing peptide substrates"
     . SPARSER::COLLECTION)
    ("NPP-" . SPARSER::PROTEIN)
    ("some haploinsufficient alleles" . SPARSER::ALLELE)
    ("Y279C/C459S" . SPARSER::PROTEIN) ("EGF or HGF" . SPARSER::COLLECTION)
    ("SHP2–Gab1" . SPARSER::COLLECTION)
    ("the GOF E76K
mutant as well as the LS SHP2 mutants"
     . SPARSER::COLLECTION)
    ("SHP2/Gab1" . SPARSER::COLLECTION) ("SHP2 and Gab1" . SPARSER::COLLECTION)
    ("the closed SHP2 conformation
and increase"
     . SPARSER::COLLECTION)
    ("the six other LS-associated SHP2 mutants" . SPARSER::MUTANT)
    ("deuterium" . SPARSER::MOLECULE)
    ("the LS SHP2 mutant PTP domain binary
complexes"
     . SPARSER::BIO-COMPLEX)
    ("The LS-Associated SHP2 Mutants" . SPARSER::MUTANT)
    ("the LS-associated
SHP2 mutants"
     . SPARSER::MUTANT)
    ("precisely position pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("water, which
interacts with the apical oxygen and one"
     . SPARSER::COLLECTION)
    ("the apical oxygen" . SPARSER::MOLECULE)
    ("the nucleophilic water" . SPARSER::MOLECULE)
    ("PTP
and PTP1B"
     . SPARSER::COLLECTION)
    ("vanadate" . SPARSER::MOLECULE) ("VO" . SPARSER::MOLECULE)
    ("the LS-Associated
SHP2 Mutants"
     . SPARSER::MUTANT)
    ("amide" . SPARSER::MOLECULE) ("guanidinium" . SPARSER::MOLECULE)
    ("the mutant and wild-type
structures"
     . SPARSER::COLLECTION)
    ("wild-type SHP2 and LS
SHP2 mutant Y279C"
     . SPARSER::COLLECTION)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("more physiologically relevant substrates" . SPARSER::SUBSTRATE)
    ("aryl" . SPARSER::PROTEIN)
    ("both a
small molecule chromogenic substrate p NPP and pTyr-containing
peptides"
     . SPARSER::COLLECTION)
    ("both a
small molecule chromogenic substrate p NPP"
     . SPARSER::PROTEIN)
    ("NPP" . SPARSER::PROTEIN)
    ("immunoprecipitated enzymes and/or
substrates"
     . SPARSER::COLLECTION)
    ("LS-Associated SHP2 Mutants" . SPARSER::MUTANT)
    ("LS-associated SHP2 mutants" . SPARSER::MUTANT)
    ("the most recurrent LS-associated SHP2 mutant Y279C" . SPARSER::PROTEIN)
    ("the LS-associated SHP2 mutants" . SPARSER::MUTANT)
    ("deafness" . SPARSER::PROTEIN)
    ("protein tyrosine kinases (PTKs) and protein tyrosine
phosphatases (PTPs)"
     . SPARSER::COLLECTION)
    ("PTKs and PTPs" . SPARSER::COLLECTION)
    ("all reported LS-associated SHP2 mutants" . SPARSER::MUTANT)
    ("this enzyme’s" . SPARSER::ENZYME)
    ("growth
factor receptors and adaptor proteins"
     . SPARSER::COLLECTION)
    ("RAS-ERK1/2" . SPARSER::COLLECTION) ("RAF1" . SPARSER::PROTEIN)
    ("SOS1" . SPARSER::PROTEIN)
    ("epidermal growth
factor"
     . SPARSER::PROTEIN)
    ("scaffolding
protein"
     . SPARSER::PROTEIN)
    ("B–D" . SPARSER::PROTEIN)
    ("oxygen
atom"
     . SPARSER::MOLECULE)
    ("E-P" . SPARSER::PROTEIN)
    ("glutamic
acid"
     . SPARSER::AMINO-ACID)
    ("Sprouty1" . SPARSER::PROTEIN) ("mM 3" . SPARSER::PROTEIN)
    ("p -nitrophenyl" . SPARSER::MOLECULE)
    ("extracellular
signal-regulated kinase 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein
tyrosine phosphatase"
     . SPARSER::PROTEIN)
    ("growth
factor"
     . SPARSER::GROWTH-FACTOR)
    ("protein tyrosine
phosphatase"
     . SPARSER::PROTEIN)
    ("AH and RAB" . SPARSER::COLLECTION) ("RAB" . SPARSER::PROTEIN)
    ("cdk-cyclin" . SPARSER::COLLECTION)
    ("temsirolimus or everolimus" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("Cdk2 and cyclin" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("Akt and p70S6k" . SPARSER::COLLECTION)
    ("pAkt and pp70S6k" . SPARSER::COLLECTION)
    ("pAkt and pp70S6K" . SPARSER::COLLECTION)
    ("cdk1, cdk2, cdk4 and cyclin E" . SPARSER::COLLECTION)
    ("p27, p53 and p73" . SPARSER::COLLECTION)
    ("cdk1 and cdk2" . SPARSER::COLLECTION)
    ("phosphorylated Akt (pAkt) and p70S6 kinase (pp70S6K)"
     . SPARSER::COLLECTION)
    ("-inhibitors" . SPARSER::INHIBITOR)
    ("temsirolimus (Torisel®) and everolimus (Afinitor®)"
     . SPARSER::COLLECTION)
    ("Torisel" . SPARSER::DRUG)
    ("a pivotal key regulator" . SPARSER::REGULATOR)
    ("cdk2/cyclin" . SPARSER::COLLECTION)
    ("cdk2 and cyclin" . SPARSER::COLLECTION)
    ("Akt and p70S6K" . SPARSER::COLLECTION)
    ("everolimus and VPA" . SPARSER::COLLECTION)
    ("valproic acid (VPA)" . SPARSER::MOLECULE)
    ("-inhibitor" . SPARSER::INHIBITOR) ("VPA" . SPARSER::PROTEIN)
    ("Y28" . SPARSER::PROTEIN) ("PKBα" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p19" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("Valproic acid" . SPARSER::MOLECULE)
    ("S6k" . SPARSER::PROTEIN) ("1-1 " . SPARSER::PROTEIN)
    ("cdk2" . SPARSER::PROTEIN) ("valproic acid" . SPARSER::MOLECULE)
    ("JH and WL" . SPARSER::COLLECTION) ("WL" . SPARSER::MOLECULE)
    ("PS and GZ" . SPARSER::COLLECTION) ("Smooth muscle" . SPARSER::PROTEIN)
    ("gene or protein" . SPARSER::COLLECTION)
    ("TRPS1 and EMT" . SPARSER::COLLECTION)
    ("further research using larger patient cohort" . SPARSER::MOLECULE)
    ("ER and PR" . SPARSER::COLLECTION)
    ("receptor or HER-2" . SPARSER::COLLECTION)
    ("E-cadherin (P = 0.002) and β-catenin (P = 0.003)" . SPARSER::COLLECTION)
    ("E-cadherin and other epithelial genes [ xref ]" . SPARSER::COLLECTION)
    ("osteocalcin" . SPARSER::PROTEIN) ("Ikaros" . SPARSER::PROTEIN)
    ("rhino" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("Trichorhinophalangeal syndrome type 1 ( TRPS1 ) gene" . SPARSER::GENE)
    ("GATA" . SPARSER::PROTEIN)
    ("Insulin-like growth factor II" . SPARSER::PROTEIN)
    ("IGF-II" . SPARSER::PROTEIN)
    ("insulin-like growth factor II" . SPARSER::PROTEIN)
    ("EGFR-2" . SPARSER::PROTEIN) ("E-5" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("IMP3" . SPARSER::PROTEIN)
    ("AH" . SPARSER::MOLECULE)
    ("colony stimulating factor-1 (CSF1) and the RET receptor"
     . SPARSER::COLLECTION)
    ("PDGFR- α , c-KIT, FLT3, colony stimulating factor-1 (CSF1) and the RET receptor"
     . SPARSER::COLLECTION)
    ("VEGFR1–3" . SPARSER::COLLECTION) ("Sunitinib" . SPARSER::DRUG)
    ("inhibitors and EGFR-inhibitors" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG) ("DNA-extraction" . SPARSER::DNA)
    ("thymic tumor type" . TYPE) ("Imatinib" . SPARSER::DRUG)
    ("inapplicable DNA" . SPARSER::DNA)
    ("KIT, PDGFR-α, EGFR and KRAS" . SPARSER::COLLECTION)
    ("calcitonin, thyroglobulin and TTF-1" . SPARSER::COLLECTION)
    ("CD117, EGFR, COX-2 and Ki67" . SPARSER::COLLECTION)
    ("EGFR, KIT and PDGFR-α" . SPARSER::COLLECTION)
    ("KIT and KRAS" . SPARSER::COLLECTION)
    ("CD5, CD117 and CK5/6" . SPARSER::COLLECTION)
    ("thyroglobulin, calcitonin and TTF-1" . SPARSER::COLLECTION)
    ("calcitonin" . SPARSER::PROTEIN)
    ("KRAS , EGFR , PDGFR-α and KIT" . SPARSER::COLLECTION)
    ("CD117, EGFR and COX-2" . SPARSER::COLLECTION) ("CSF1" . SPARSER::PROTEIN)
    ("colony stimulating factor-1" . SPARSER::PROTEIN)
    ("PDGFR- α" . SPARSER::PROTEIN) ("A - F" . SPARSER::PROTEIN)
    ("K-2" . SPARSER::PROTEIN) ("CK 5" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("PDGFR-α" . SPARSER::PROTEIN) ("MEK and PI3K" . SPARSER::COLLECTION)
    ("KITLG and RAC2" . SPARSER::COLLECTION) ("mast cell" . SPARSER::PROTEIN)
    ("Ras/Mek/Erk" . SPARSER::COLLECTION)
    ("multiple cell type-specific conditional mutants" . SPARSER::MUTANT)
    ("Ras/Erk" . SPARSER::COLLECTION)
    ("EGFR or other receptor tyrosine kinase inhibitors" . SPARSER::COLLECTION)
    ("EREG/EGFR" . SPARSER::COLLECTION) ("normal KRAS" . SPARSER::PROTEIN)
    ("recombinant human bone morphogenic protein (BMP)-2" . SPARSER::PROTEIN)
    ("rhBMP-2" . SPARSER::COLLECTION)
    ("EGFR , EREG and KITLG (SCF)" . SPARSER::COLLECTION)
    ("EGFR , EREG and KITLG" . SPARSER::COLLECTION)
    ("stem cell factor (SCF)" . SPARSER::PROTEIN) ("KITLG" . SPARSER::PROTEIN)
    ("fluorescent-activated flow cytometry" . SPARSER::PROTEIN)
    ("Nf1" . SPARSER::PROTEIN)
    ("the second-most statistically significant gene (FDRp=1.09e–27) and the second-most"
     . SPARSER::COLLECTION)
    ("epiregulin" . SPARSER::PROTEIN) ("EREG" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN)
    ("bisphosphonates" . SPARSER::MOLECULE)
    ("NF1 and neurofibromin" . SPARSER::COLLECTION)
    ("specific cancer-associated genes" . SPARSER::GENE)
    ("BMP2" . SPARSER::PROTEIN) ("RAC2" . SPARSER::PROTEIN)
    ("KIT ligand" . SPARSER::PROTEIN) ("e −5" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("dual targeting MIF/D-DT small molecule inhibitors" . SPARSER::INHIBITOR)
    ("small molecule targeting of MIF's" . SPARSER::MOLECULE)
    ("MIF and D-DTs" . SPARSER::COLLECTION)
    ("MIF-associated protein oxidoreductase activity" . SPARSER::PROTEIN)
    ("cysteines" . SPARSER::AMINO-ACID) ("oxidoreductase" . SPARSER::PROTEIN)
    ("cytokines and growth factors, MIF and D-DT" . SPARSER::COLLECTION)
    ("growth factors, MIF and D-DT" . SPARSER::COLLECTION)
    ("vestigial" . SPARSER::PROTEIN-FAMILY)
    ("aberrant AMPK" . SPARSER::PROTEIN)
    ("D-DT and their shared cell surface receptor" . SPARSER::COLLECTION)
    ("MIF, D-DT and their shared cell surface receptor" . SPARSER::COLLECTION)
    ("NAC and MPG" . SPARSER::COLLECTION)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC) and N-(2-mercaptopropionyl) glycine (MPG)"
     . SPARSER::COLLECTION)
    ("aberrantly expressed/activated p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycine (MPG)" . SPARSER::AMINO-ACID) ("MPG" . SPARSER::PROTEIN)
    ("proteins, lipids and DNA" . SPARSER::COLLECTION)
    ("ATP/AMP" . SPARSER::PROTEIN-PAIR)
    ("AMPKα ( xref ) and a small molecule AMPK inhibitor"
     . SPARSER::COLLECTION)
    ("-IPP" . SPARSER::COLLECTION) ("IPP" . SPARSER::PROTEIN)
    ("wildtype and p53" . SPARSER::COLLECTION)
    ("p53, p21 or MDM2" . SPARSER::COLLECTION)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("Lentiviral-delivered MIF and D-DT shRNA" . SPARSER::PROTEIN)
    ("only moderate p21 mRNA" . SPARSER::PROTEIN)
    ("MIF and/or D-DT" . SPARSER::COLLECTION)
    ("p21 and Mdm2" . SPARSER::COLLECTION)
    ("validating efficient siRNA" . SPARSER::PROTEIN)
    ("p21 and MDM2" . SPARSER::COLLECTION) ("Hudson" . SPARSER::PROTEIN)
    ("Wildtype" . SPARSER::PROTEIN) ("MIF/D-DT" . SPARSER::COLLECTION)
    ("MIF or D-DT" . SPARSER::COLLECTION)
    ("MIF and D-DT" . SPARSER::COLLECTION) ("MIF" . SPARSER::PROTEIN)
    ("D-DTs" . SPARSER::PROTEIN) ("oxidoreductase activity" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("H2DCFDA" . SPARSER::DRUG)
    ("NM-23" . SPARSER::PROTEIN) ("CSN5" . SPARSER::PROTEIN)
    ("COP9 signalosome subunit 5" . SPARSER::PROTEIN)
    ("MIF-2" . SPARSER::PROTEIN) ("D-DT" . SPARSER::PROTEIN)
    ("D-dopachrome tautomerase" . SPARSER::PROTEIN)
    ("Macrophage migration inhibitory factor" . SPARSER::PROTEIN)
    ("Embryonal subtype" . SPARSER::PROTEIN)
    ("an inhibitor of motility and invasion" . SPARSER::COLLECTION)
    ("Spry1 , PTEN and programmed cell death 4" . SPARSER::COLLECTION)
    ("family and caspase" . SPARSER::COLLECTION)
    ("prolactin" . SPARSER::PROTEIN) ("Pokemon-" . SPARSER::PROTEIN)
    ("phytoestrogen" . SPARSER::DRUG)
    ("apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("ERK and AKT" . SPARSER::COLLECTION) ("Geneticin" . SPARSER::MOLECULE)
    ("Bcl-2 and Bcl-xl" . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("Urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("Fibroblast growth factor1" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDCD4" . SPARSER::PROTEIN) ("programmed cell death 4" . SPARSER::PROTEIN)
    ("full - length" . SPARSER::PROTEIN) ("Spry1" . SPARSER::PROTEIN)
    ("HHH" . SPARSER::PROTEIN) ("EMT and MMPs" . SPARSER::COLLECTION)
    ("Snail and Twist1" . SPARSER::COLLECTION)
    ("ERK1/2/SHP2" . SPARSER::COLLECTION)
    ("ERK1/2 and SHP2" . SPARSER::COLLECTION)
    ("EMT-associated E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("a significantly higher SHP2" . SPARSER::PROTEIN)
    ("ERK1/2-Snail/Twist1" . SPARSER::COLLECTION)
    ("matrix and stromal proteins" . SPARSER::COLLECTION)
    ("growth factors, cytokines, and extracellular-matrix"
     . SPARSER::COLLECTION)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("PTK and PTP" . SPARSER::COLLECTION)
    ("protein tyrosine kinase (PTK) and protein tyrosine phosphatase (PTP)"
     . SPARSER::COLLECTION)
    ("tyrosine kinase (PTK)" . SPARSER::PROTEIN)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP2-ERK1/2-Snail/Twist1" . SPARSER::COLLECTION)
    ("effectors, Snail and Twist1" . SPARSER::COLLECTION)
    ("Snail/Twist1" . SPARSER::COLLECTION) ("FR180204" . SPARSER::DRUG)
    ("p44" . SPARSER::PROTEIN) ("50 kD" . SPARSER::PROTEIN)
    ("C-3" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("tyrosine-protein phosphatase non-receptor type 11" . SPARSER::PROTEIN)
    ("src-homology" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("Src-homology" . SPARSER::PROTEIN)
    ("ruxolitinib" . SPARSER::DRUG) ("exosomal Mpl" . SPARSER::PROTEIN)
    ("the degradative arm" . SPARSER::PROTEIN)
    ("at least one component" . SPARSER::COMPONENT)
    ("JAK2V617F" . SPARSER::PROTEIN) ("the receptor’s" . SPARSER::RECEPTOR)
    ("Jak2 and Mpl" . SPARSER::COLLECTION)
    ("Jak2 and its cognate receptor ( xref )" . SPARSER::COLLECTION)
    ("Aberrant Mpl" . SPARSER::PROTEIN)
    ("the immature Mpl glycoproteins" . SPARSER::PROTEIN)
    ("immature core-glycosylated CFTR" . SPARSER::PROTEIN)
    ("CFTR" . SPARSER::PROTEIN) ("Mpl and Sec31" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("surface immature Mpl" . SPARSER::PROTEIN)
    ("LC3, LAMP1 and Rab11" . SPARSER::COLLECTION)
    ("Syntaxin 5 or Grasp55" . SPARSER::COLLECTION)
    ("light-EM" . SPARSER::COLLECTION) ("HA-STX5" . SPARSER::COLLECTION)
    ("immature form" . SPARSER::FORM) ("the mature Mpl form" . SPARSER::FORM)
    ("Methylamine" . SPARSER::DRUG)
    ("the immature 74 kDa form" . SPARSER::FORM)
    ("the mature 84 kDa Mpl form" . SPARSER::FORM)
    ("ionophore" . SPARSER::MOLECULE) ("monensin" . SPARSER::DRUG)
    ("Monensin" . SPARSER::DRUG) ("mature Mpl" . SPARSER::PROTEIN)
    ("the surface-biotinylated 84 kDa mature form" . SPARSER::FORM)
    ("ionomycin" . SPARSER::DRUG) ("ionophores" . SPARSER::MOLECULE)
    ("Akt or Erk" . SPARSER::COLLECTION)
    ("the fluorescent ligand" . SPARSER::LIGAND)
    ("Jak2, Stat1, Stat5, Akt and Erk" . SPARSER::COLLECTION)
    ("Jak-Stat" . SPARSER::COLLECTION)
    ("mature Mpl fusion protein" . SPARSER::PROTEIN)
    ("new Mpl" . SPARSER::PROTEIN)
    ("the larger Mpl mK02 fusion protein" . SPARSER::PROTEIN)
    ("The newly-arrived Mpl" . SPARSER::PROTEIN)
    ("only mutant Jak2" . SPARSER::PROTEIN)
    ("immature and mature Mpl glycoprotein" . SPARSER::PROTEIN)
    ("the 74 kDa immature form" . SPARSER::FORM)
    ("NHS-biotin" . SPARSER::COLLECTION) ("NHS" . SPARSER::PROTEIN)
    ("red-fluorescent LC3" . SPARSER::PROTEIN)
    ("mRFP-GFP" . SPARSER::COLLECTION) ("Shu" . SPARSER::PROTEIN)
    ("DAB and oxygen" . SPARSER::COLLECTION)
    ("glutaraldehyde" . SPARSER::MOLECULE)
    ("fluorescent proteins" . SPARSER::PROTEIN)
    ("transitional ER" . SPARSER::PROTEIN)
    ("Golgin-97 (Golgi) or EEA1 (early endosome)" . SPARSER::COLLECTION)
    ("Sec 31a (marker of ER exit sites) and Rab11" . SPARSER::COLLECTION)
    ("Mpl and antibodies" . SPARSER::COLLECTION) ("Sec 31a" . SPARSER::PROTEIN)
    ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("Mpl-Jak2" . SPARSER::COLLECTION) ("citrine" . SPARSER::PROTEIN)
    ("Mpl and Jak2" . SPARSER::COLLECTION)
    ("Mpl and Mpl" . SPARSER::COLLECTION)
    ("mature:immature Mpl" . SPARSER::PROTEIN)
    ("the mature form" . SPARSER::FORM)
    ("wildtype and mutant" . SPARSER::COLLECTION)
    ("normal platelets" . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("JAK2 and mutant" . SPARSER::COLLECTION)
    ("the immature form" . SPARSER::FORM) ("Erythroid" . SPARSER::PROTEIN)
    ("immature Mpl glycoprotein" . SPARSER::PROTEIN)
    ("GRASP" . SPARSER::PROTEIN) ("normal Jak2" . SPARSER::PROTEIN)
    ("either an activating form of JAK2 (V617F and others) or mutations in the ER resident protein"
     . SPARSER::COLLECTION)
    ("Jak2 and Tyk2" . SPARSER::COLLECTION)
    ("an immature form" . SPARSER::FORM)
    ("Thrombopoietin (Tpo) and its receptor" . SPARSER::COLLECTION)
    ("the principal regulators" . SPARSER::REGULATOR)
    ("Tpo" . SPARSER::PROTEIN) ("Thrombopoietin" . SPARSER::PROTEIN)
    ("immature Mpl" . SPARSER::PROTEIN)
    ("both immature and mature Mpl" . SPARSER::PROTEIN)
    ("light and electron" . SPARSER::COLLECTION)
    ("LC3 and LAMP1" . SPARSER::COLLECTION) ("Sec31a" . SPARSER::PROTEIN)
    ("Jak2, Mpl and Jak2" . SPARSER::COLLECTION) ("Mpl" . SPARSER::PROTEIN)
    ("JAK2 or calreticulin" . SPARSER::COLLECTION)
    ("calreticulin" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG) ("Sulfo-NHS" . SPARSER::DRUG)
    ("LAMP-1" . SPARSER::PROTEIN) ("CD107a" . SPARSER::PROTEIN)
    ("golgin-97" . SPARSER::PROTEIN) ("Sec31A" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin K" . SPARSER::PROTEIN) ("Grasp55" . SPARSER::PROTEIN)
    ("STX5" . SPARSER::PROTEIN) ("Syntaxin 5" . SPARSER::PROTEIN)
    ("GRASP55" . SPARSER::PROTEIN) ("ATG12" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("CD9" . SPARSER::PROTEIN)
    ("Na+/H+" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("Golgin-97" . SPARSER::PROTEIN) ("ERGIC-53" . SPARSER::PROTEIN)
    ("CD235a" . SPARSER::PROTEIN)
    ("thrombopoietin receptor" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("phosphomimetic MCAK S621D" . SPARSER::PROTEIN)
    ("the nonphosphorylatable protein" . SPARSER::PROTEIN)
    ("which targets MCAK" . SPARSER::PROTEIN) ("mal" . SPARSER::PROTEIN)
    ("neither MCAK S621A nor MCAK S621D" . SPARSER::COLLECTION)
    ("the phosphomimetic MCAK variant S621D" . SPARSER::PROTEIN)
    ("tubulin and Hec1" . SPARSER::COLLECTION)
    ("INCENP and ACA" . SPARSER::COLLECTION)
    ("fresh medium containing MG132" . SPARSER::PROTEIN)
    ("Eg5" . SPARSER::PROTEIN)
    ("EGFP-tagged MCAK and its variants" . SPARSER::COLLECTION)
    ("polymer" . SPARSER::MOLECULE) ("polymerized tubulin" . SPARSER::PROTEIN)
    ("MCAK S621A or MCAK S621D (Figure xref , upper panel)"
     . SPARSER::COLLECTION)
    ("MCAK S621A and MCAK S621D" . SPARSER::COLLECTION)
    ("Both MCAK S621A and MCAK S621D" . SPARSER::COLLECTION)
    ("MCAK and variants" . SPARSER::COLLECTION)
    ("MCAK S621A or MCAK S621D and myc-tagged ubiquitin" . SPARSER::COLLECTION)
    ("MCAK S621D and myc-tagged ubiquitin" . SPARSER::COLLECTION)
    ("the phosphomimetic variant" . SPARSER::VARIANT)
    ("Mitotic proteins" . SPARSER::PROTEIN)
    ("a degradation competent conformation" . SPARSER::BIO-CONFORMATION)
    ("the phosphomimetic MCAK S621D" . SPARSER::PROTEIN)
    ("mitotic cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("almost no phosphorylated MCAK" . SPARSER::PROTEIN)
    ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("Cdc20 or Cdh1" . SPARSER::COLLECTION)
    ("CHX and protein" . SPARSER::COLLECTION)
    ("securin and cyclin B1" . SPARSER::COLLECTION)
    ("securin" . SPARSER::PROTEIN) ("GST-MCAK" . SPARSER::COLLECTION)
    ("individually mutated each serine/threonine" . SPARSER::COLLECTION)
    ("cyclin B1 or control siRNA (Figure xref , 1 st row, lanes 4, 5 and 6)"
     . SPARSER::COLLECTION)
    ("Plk1 and Flag-tagged MCAK co-precipitated" . SPARSER::COLLECTION)
    ("centrosomes and the centromeres/kinetochores" . SPARSER::COLLECTION)
    ("MCAK and Plk1" . SPARSER::COLLECTION)
    ("Plk1 and MCAK" . SPARSER::COLLECTION) ("sororin" . SPARSER::PROTEIN)
    ("Plks" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1 (Cdk1) and Polo-like kinase"
     . SPARSER::COLLECTION)
    ("MCAK/Kif2c" . SPARSER::COLLECTION) ("Kif2a" . SPARSER::PROTEIN)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Microtubule-associated motor proteins" . SPARSER::PROTEIN)
    ("the MCAK's" . SPARSER::PROTEIN) ("mitotic key kinases" . SPARSER::KINASE)
    ("MCAK" . SPARSER::PROTEIN) ("Hec1" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("Emi1" . SPARSER::PROTEIN)
    ("BI 2536" . SPARSER::DRUG) ("P25" . SPARSER::PROTEIN)
    ("Kif2c" . SPARSER::PROTEIN) ("Kif2b" . SPARSER::PROTEIN)
    ("kinesin-13" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin" . SPARSER::PROTEIN)
    ("duo" . SPARSER::PROTEIN)
    ("miR-200c, p65, JNK2, HSF1 and IL-6" . SPARSER::COLLECTION)
    ("miR-301a" . SPARSER::COLLECTION)
    ("p27Kip1, RECK, c-Kit, TIMP3 and PTEN" . SPARSER::COLLECTION)
    ("miR-221/ 222" . SPARSER::PROTEIN) ("NF-κB-STAT3" . SPARSER::COLLECTION)
    ("miR-221/222-" . SPARSER::PROTEIN)
    ("RelA or STAT3 and miR-221" . SPARSER::COLLECTION)
    ("STAT3 and miR-221" . SPARSER::COLLECTION)
    ("PDLIM2 and miR-221" . SPARSER::COLLECTION)
    ("RelA, and STAT3" . SPARSER::COLLECTION)
    ("miR-221/222-NF-κB-STAT3" . SPARSER::COLLECTION)
    ("miR-221/222" . SPARSER::PROTEIN)
    ("miR-221/222-NF-κB" . SPARSER::PROTEIN-PAIR)
    ("miRNA-NF-κB" . SPARSER::COLLECTION)
    ("RelA, RelB, NIK, p100, c-Myc, SKP2 and miR-221/222"
     . SPARSER::COLLECTION)
    ("NIK" . SPARSER::PROTEIN)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("STAT3 and RelA" . SPARSER::COLLECTION)
    ("PDLIM2-STAT3" . SPARSER::COLLECTION) ("pdlim2" . SPARSER::PROTEIN)
    ("SOCS1 and PDLIM2" . SPARSER::COLLECTION)
    ("RelB or IKKβ" . SPARSER::COLLECTION)
    ("the promoter or coding region" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("IL-1β or TNFα" . SPARSER::COLLECTION)
    ("RelA or RelB" . SPARSER::COLLECTION) ("RelB/p52" . SPARSER::COLLECTION)
    ("IL-1β and/or TNFα" . SPARSER::COLLECTION) ("IL-1β-" . SPARSER::PROTEIN)
    ("RelA and RelB" . SPARSER::COLLECTION)
    ("RelA/NF-κB" . SPARSER::COLLECTION)
    ("miR-221 and 222 inhibitors" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("RelA, RelB, and c-Rel" . SPARSER::COLLECTION)
    ("RelA/p50" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("NF-κB and signal transducer and activator of transcription 3"
     . SPARSER::COLLECTION)
    ("RelA, STAT3 and PDLIM2" . SPARSER::COLLECTION)
    ("RelA and STAT3" . SPARSER::COLLECTION) ("RelA" . SPARSER::PROTEIN)
    ("NF-κB and STAT3" . SPARSER::COLLECTION) ("HSF1" . SPARSER::PROTEIN)
    ("301a" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("Bay-117082" . SPARSER::DRUG) ("DLD-1" . SPARSER::PROTEIN)
    ("PDZ and LIM domain 2" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("PDLIM2" . SPARSER::PROTEIN)
    ("a frequently inactivated MSG" . SPARSER::PROTEIN)
    ("uPA-RECK" . SPARSER::COLLECTION) ("plasminogen" . SPARSER::PROTEIN)
    ("uPA, uPAR and plasminogen activator" . SPARSER::COLLECTION)
    ("RECK, STAT3 and microRNAs" . SPARSER::COLLECTION)
    ("uPAR and the primary activators" . SPARSER::COLLECTION)
    ("hypoxia and cytokines" . SPARSER::COLLECTION)
    ("STAT3 and HIF1a" . SPARSER::COLLECTION)
    ("HDAC or DNA" . SPARSER::COLLECTION)
    ("ER, PR, or HER2" . SPARSER::COLLECTION)
    ("STAT3 and RECK" . SPARSER::COLLECTION)
    ("IL-6RA and gp130" . SPARSER::COLLECTION)
    ("β1-integrin and GAL-1" . SPARSER::COLLECTION)
    ("conventional western blot" . SPARSER::PROTEIN)
    ("IL-8, β1-integrin, and galectin-1" . SPARSER::COLLECTION)
    ("extracellular cytokines or proteases" . SPARSER::COLLECTION)
    ("directly binding other membrane proteins" . SPARSER::PROTEIN)
    ("cytokines or proteases" . SPARSER::COLLECTION) ("GPI" . SPARSER::PROTEIN)
    ("VEGF and PLAU" . SPARSER::COLLECTION) ("NOD" . SPARSER::PROTEIN)
    ("a well-documented protein" . SPARSER::PROTEIN)
    ("RECK or EV" . SPARSER::COLLECTION)
    ("55 known pro- or anti-angiogenic factors" . SPARSER::COLLECTION)
    ("significantly less VEGF" . SPARSER::PROTEIN)
    ("VEGF and HIF-1α" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and IL-10" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-9 and MT1-MMP" . SPARSER::COLLECTION) ("MMP2-" . SPARSER::PROTEIN)
    ("MMP-2, MMP-9 and MT1-MMP" . SPARSER::COLLECTION)
    ("BOM1-1833 cells (an in vivo selected and highly bone metastatic cell line) ( xref ) re-expressing RECK"
     . SPARSER::PROTEIN)
    ("significantly less CD34" . SPARSER::PROTEIN)
    ("RECK-expressing metastatic foci" . SPARSER::PROTEIN)
    ("CD34 and VEGF" . SPARSER::COLLECTION)
    ("metastatic foci" . SPARSER::PROTEIN) ("BLI" . SPARSER::PROTEIN)
    ("other larger patient cohorts" . SPARSER::MOLECULE)
    ("the basal subtype" . SPARSER::PROTEIN) ("MSG" . SPARSER::PROTEIN)
    ("MSGs" . SPARSER::PROTEIN) ("robust mediators" . SPARSER::PROTEIN)
    ("previously unknown trigger" . SPARSER::PROTEIN)
    ("RECK" . SPARSER::PROTEIN) ("Galectin-1" . SPARSER::PROTEIN)
    ("BS 3" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("HIF1a" . SPARSER::PROTEIN) ("NM23" . SPARSER::PROTEIN)
    ("IL-6RA" . SPARSER::PROTEIN) ("GAL-1" . SPARSER::PROTEIN)
    ("galectin-1" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("caspase-8/PAR-4" . SPARSER::COLLECTION) ("TNFα-" . SPARSER::PROTEIN)
    ("the pleiotropic cytokine TNFα" . SPARSER::PROTEIN)
    ("phospho-serine/phospho-threonine" . SPARSER::COLLECTION)
    ("Bap31, RIP-1, osteopontin and CYLD" . SPARSER::COLLECTION)
    ("CYLD" . SPARSER::PROTEIN) ("-P 2 -P" . SPARSER::COLLECTION)
    ("-P 3" . SPARSER::COLLECTION) ("Caspases" . SPARSER::PROTEIN)
    ("caspase-3 and PAR-4" . SPARSER::COLLECTION)
    ("caspase-8 and PAR-4" . SPARSER::COLLECTION)
    ("PAR-4 and caspase-8" . SPARSER::COLLECTION)
    ("sh-caspase-8" . SPARSER::COLLECTION) ("TNFα/CHX" . SPARSER::COLLECTION)
    ("TNFα and cycloheximide" . SPARSER::COLLECTION)
    ("DISC" . SPARSER::BIO-COMPLEX) ("Flp" . SPARSER::PROTEIN)
    ("SAC and leucine" . SPARSER::COLLECTION)
    ("PAR-4 and PAR-4" . SPARSER::COLLECTION)
    ("PAR-4 and PARP-1" . SPARSER::COLLECTION)
    ("pan-specific caspase inhibitor" . SPARSER::INHIBITOR)
    ("PKCζ and PKCλ/τ" . SPARSER::COLLECTION)
    ("kinase and WT1" . SPARSER::COLLECTION)
    ("tumor 1 (WT1) protein and DLK/ZIP kinase" . SPARSER::COLLECTION)
    ("the atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DLK/ZIP" . SPARSER::COLLECTION) ("ZIP" . SPARSER::PROTEIN)
    ("DLK" . SPARSER::PROTEIN) ("Hras" . SPARSER::PROTEIN)
    ("hormone-" . SPARSER::MOLECULE)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("caspase-1" . SPARSER::PROTEIN)
    ("14-3-3 sigma" . SPARSER::PROTEIN) ("RIP-1" . SPARSER::PROTEIN)
    ("Bap31" . SPARSER::PROTEIN) ("p28" . SPARSER::PROTEIN)
    ("P 2 -P" . SPARSER::PROTEIN) ("P 4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Z-IETD-FMK" . SPARSER::DRUG) ("Caspase-1" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("Par-4" . SPARSER::PROTEIN) ("PAR-4" . SPARSER::PROTEIN)
    ("-β-Catenin" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("PI3K and WNT" . SPARSER::COLLECTION)
    ("phosphomimetic S552D-β-Catenin mutants" . SPARSER::MUTANT)
    ("our approach directly links PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("synergizes" . SPARSER::PROTEIN) ("PTEN and APC" . SPARSER::COLLECTION)
    ("c-MYC and Cyclin-D1" . SPARSER::COLLECTION)
    ("c-MYC, Cyclin-D1 and LEF-1" . SPARSER::COLLECTION)
    ("anti-β-Catenin" . SPARSER::COLLECTION)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a phosphomimetic aspartate" . SPARSER::PROTEIN)
    ("basal β-Catenin" . SPARSER::PROTEIN)
    ("β-Catenin, GFP and phospho-AKT" . SPARSER::COLLECTION)
    ("ER-myc" . SPARSER::COLLECTION) ("TBB" . SPARSER::PROTEIN)
    ("CdC37" . SPARSER::PROTEIN) ("Cyclin-D1" . SPARSER::PROTEIN)
    ("SW480 and RWP-1" . SPARSER::COLLECTION)
    ("LiCl [ xref ] and wnt3a-conditioned medium [ xref ]"
     . SPARSER::COLLECTION)
    ("CHO" . SPARSER::PROTEIN) ("Rac1 and JNK" . SPARSER::COLLECTION)
    ("WNT and PI3K" . SPARSER::COLLECTION)
    ("APC or β-Catenin" . SPARSER::COLLECTION)
    ("S552D-phosphomimetic β-Catenin mutants" . SPARSER::MUTANT)
    ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("D11" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("GSK3-β" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("4-hydroxy-tamoxifen" . SPARSER::DRUG)
    ("myc-tagged" . SPARSER::PROTEIN) ("S1 B" . SPARSER::PROTEIN)
    ("Casein kinase 2" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("Cyclin-D" . SPARSER::PROTEIN) ("wnt3a" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN)
    ("Aurora-selective inhibitors" . SPARSER::INHIBITOR)
    ("JAK2-" . SPARSER::PROTEIN)
    ("JAK2 and Aurora kinases" . SPARSER::COLLECTION)
    ("kinases, Alisertib and Ruxolitinib" . SPARSER::COLLECTION)
    ("multi kinase inhibitors such as AT9283 and CEP-701 that block"
     . SPARSER::COLLECTION)
    ("mm3" . SPARSER::PROTEIN) ("VX-680 and Alisertib" . SPARSER::COLLECTION)
    ("dual inhibitors" . SPARSER::INHIBITOR)
    ("highly potent small-molecule dual inhibitors" . SPARSER::INHIBITOR)
    ("Alisertib (24.5 %) and Ruxolitinib (48.6%)" . SPARSER::COLLECTION)
    ("Alisertib (49%) and Ruxolitinib (23.7%)" . SPARSER::COLLECTION)
    ("neither Alisertib nor Ruxolitinib" . SPARSER::COLLECTION)
    ("Alisertib (0.03 μM) and Ruxolitinib (0.4 μM)" . SPARSER::COLLECTION)
    ("Ruxolitinib (20 μM) or the combination" . SPARSER::COLLECTION)
    ("A kinase inhibitor Alisertib and the JAK2 inhibitor Ruxolitinib"
     . SPARSER::COLLECTION)
    ("A inhibitor Alisertib and the JAK2 inhibitor Ruxolitinib"
     . SPARSER::COLLECTION)
    ("JAK2 and Aurora + JAK2" . SPARSER::COLLECTION)
    ("B and JAK2" . SPARSER::PROTEIN)
    ("B and JAK2 in intact human cancer cells" . SPARSER::PROTEIN)
    ("JAK1/JAK2" . SPARSER::COLLECTION)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR) ("Transducers" . SPARSER::PROTEIN)
    ("JAK1, JAK2, JAK3, and TYK2" . SPARSER::COLLECTION)
    ("vorinostat [ xref ] and nilotinib [ xref ]" . SPARSER::COLLECTION)
    ("cisplatin [ xref ], temozolomide [ xref ], taxanes [ xref ], vorinostat [ xref ] and nilotinib [ xref ]"
     . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG)
    ("MLN8054 and MLN8237" . SPARSER::COLLECTION)
    ("Hesperadin" . SPARSER::DRUG)
    ("new anticancer drugs and intense efforts" . SPARSER::COLLECTION)
    ("dual Aurora A/JAK2 inhibitors" . SPARSER::INHIBITOR)
    ("these dual inhibitors" . SPARSER::INHIBITOR)
    ("Alisertib and Ruxolitinib" . SPARSER::COLLECTION)
    ("Ruxolitinib" . SPARSER::DRUG) ("Alisertib" . SPARSER::DRUG)
    ("beta-cyclodextrin" . SPARSER::MOLECULE) ("F-2" . SPARSER::PROTEIN)
    ("JAk2" . SPARSER::PROTEIN) ("CEP-701" . SPARSER::DRUG)
    ("P-Erk" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("MLN8054" . SPARSER::DRUG) ("MK-0457" . SPARSER::DRUG)
    ("VX-680" . SPARSER::DRUG)
    ("telomerase activity or hTERT" . SPARSER::COLLECTION)
    ("promoter and patient" . SPARSER::COLLECTION)
    ("Housekeeping gene" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("the homologous recombination repair gene" . SPARSER::GENE)
    ("135G/C heterozygous variant" . SPARSER::VARIANT)
    ("p  " . SPARSER::PROTEIN) ("DNA and DNA" . SPARSER::COLLECTION)
    ("The 135C/C homozygous variant" . SPARSER::VARIANT)
    ("C–T" . SPARSER::PROTEIN) ("G–G" . SPARSER::PROTEIN)
    ("RAD51 C" . SPARSER::PROTEIN) ("C–G" . SPARSER::PROTEIN)
    ("Fe65, Tip60, and caspases" . SPARSER::COLLECTION)
    ("exogenous c31/APP/352PHP tau or AICD/352PHP tau" . SPARSER::PROTEIN)
    ("tau or AICD/352PHP" . SPARSER::COLLECTION)
    ("tau mutants R406W and R5H" . SPARSER::COLLECTION)
    ("Tau mutants P301L and K18ΔK280" . SPARSER::COLLECTION)
    ("paired helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("GSK3β [ xref , xref ] or tau mutants" . SPARSER::COLLECTION)
    ("GSK3β or another kinase" . SPARSER::COLLECTION)
    ("exogenous constitutively active GSK3β (S9A) and tau"
     . SPARSER::COLLECTION)
    ("GSK3β (S9A) and tau (Figure  xref )" . SPARSER::COLLECTION)
    ("exogenous constitutively active GSK3β" . SPARSER::PROTEIN)
    ("tau and its mutants" . SPARSER::COLLECTION)
    ("actin and tau" . SPARSER::COLLECTION)
    ("tau and actin" . SPARSER::COLLECTION) ("R5H " . SPARSER::PROTEIN)
    ("tau-actin" . SPARSER::COLLECTION) ("Tau and actin" . SPARSER::COLLECTION)
    ("tau and state" . SPARSER::COLLECTION)
    ("oligomers and higher order polymers" . SPARSER::COLLECTION)
    ("paired helical filaments (PHF)" . SPARSER::PROTEIN-FAMILY)
    ("pTau" . SPARSER::PROTEIN)
    ("All FTDP-17 mutant tau proteins as well as WT tau isoforms"
     . SPARSER::COLLECTION)
    ("forms " . SPARSER::FORM) ("tau " . SPARSER::PROTEIN)
    ("GSK3β and the phosphorylation state" . SPARSER::COLLECTION)
    ("GFP/GSK3β" . SPARSER::COLLECTION)
    ("GSK3β (S9A)/R5H tau or GSK3β (S9A)/R406W tau" . SPARSER::PROTEIN)
    ("tau or GSK3β" . SPARSER::COLLECTION) ("/R5H" . SPARSER::COLLECTION)
    ("GSK3β (S9A)/G272V tau and GSK3β (S9A)/P301L tau" . SPARSER::PROTEIN)
    ("tau and GSK3β" . SPARSER::COLLECTION)
    ("GSK3β (S9A) and tau" . SPARSER::COLLECTION) ("R5H" . SPARSER::PROTEIN)
    ("isoform or 352PHP" . SPARSER::COLLECTION)
    ("441WT alone + GSK3β" . SPARSER::PROTEIN)
    ("the c-terminal 31 amino acids of APP (c31)" . SPARSER::PROTEIN)
    ("GSK3β and tau" . SPARSER::COLLECTION)
    ("K18 or K18ΔK280" . SPARSER::COLLECTION)
    ("tau and mutant" . SPARSER::COLLECTION)
    ("tau and Hirano" . SPARSER::COLLECTION)
    ("K18, or K18ΔK280" . SPARSER::COLLECTION)
    ("tau, 352PHP, and FTDP-17" . SPARSER::COLLECTION)
    ("K18 and K18ΔK280" . SPARSER::COLLECTION) ("ΔK280" . SPARSER::PROTEIN)
    ("nearly all tau isoforms and mutants" . SPARSER::COLLECTION)
    ("isoforms and mutants" . SPARSER::COLLECTION) ("PHP" . SPARSER::PROTEIN)
    ("protein (CT)" . SPARSER::PROTEIN)
    ("transforming growth factor-β3" . SPARSER::COLLECTION)
    ("FAC" . SPARSER::PROTEIN) ("actin-associated proteins" . SPARSER::PROTEIN)
    ("FTLD-tau" . SPARSER::COLLECTION)
    ("amyloid precursor protein (APP)" . SPARSER::PROTEIN)
    ("alpha tubulin" . SPARSER::PROTEIN) ("DE-" . SPARSER::MOLECULE)
    ("Tip60" . SPARSER::PROTEIN) ("Fe65" . SPARSER::PROTEIN)
    ("microtubule associated protein tau" . SPARSER::PROTEIN)
    ("FTDP-17" . SPARSER::PROTEIN) ("PSEN2" . SPARSER::PROTEIN)
    ("PSEN1" . SPARSER::PROTEIN) ("presenilin 1" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("YL and MZ" . SPARSER::COLLECTION) ("YL, and MZ" . SPARSER::COLLECTION)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("AKT and BCL-2" . SPARSER::COLLECTION)
    ("p53 and BCL-2" . SPARSER::COLLECTION)
    ("leukemia-2" . SPARSER::COLLECTION)
    ("PTEN and the mutant (Figure  xref A)" . SPARSER::COLLECTION)
    ("a particular miRNA" . SPARSER::PROTEIN)
    ("EC and a novel target" . SPARSER::COLLECTION)
    ("miR-205 directly targets PTEN" . SPARSER::PROTEIN)
    ("PKB/AKT" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("either potent oncogenes or tumor suppressor genes
[ xref ]"
     . SPARSER::COLLECTION)
    ("either potent oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("Protein kinase B" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("NF-κB and p38" . SPARSER::COLLECTION)
    ("p50 and p38" . SPARSER::COLLECTION)
    ("matrix-metalloproteases" . SPARSER::COLLECTION)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("resistin and TLR4" . SPARSER::COLLECTION)
    ("TNFα, IL-6, adiponectin, leptin, visfatin, and resistin"
     . SPARSER::COLLECTION)
    ("visfatin" . SPARSER::PROTEIN) ("adiponectin" . SPARSER::PROTEIN)
    ("Adipocytokines" . SPARSER::PROTEIN-FAMILY)
    ("p50 and DAPI" . SPARSER::COLLECTION)
    ("PDTC, or siRNA" . SPARSER::COLLECTION)
    ("p65 or p50" . SPARSER::COLLECTION) ("PDTC" . SPARSER::DRUG)
    ("MAPK and SDF-1expression" . SPARSER::COLLECTION)
    ("SDF-1 and promoter" . SPARSER::COLLECTION)
    ("MAPK and p38" . SPARSER::COLLECTION) ("JNK-" . SPARSER::PROTEIN)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PD98059 or SP600125" . SPARSER::COLLECTION)
    ("GRO, ENA78, GCP-2 or IL-8" . SPARSER::COLLECTION)
    ("NF-κB and p50" . SPARSER::COLLECTION)
    ("CXCR4 and CXCR7" . SPARSER::COLLECTION)
    ("resistin and any known receptor" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION)
    ("IL-8, IL-1β, and tumor necrosis factor" . SPARSER::COLLECTION)
    ("resistin and resistin-like" . SPARSER::COLLECTION)
    ("CRP" . SPARSER::PROTEIN) ("Too much body fat" . SPARSER::PROTEIN)
    ("resistin and SDF-1" . SPARSER::COLLECTION)
    ("Resistin" . SPARSER::PROTEIN) ("resistin" . SPARSER::PROTEIN)
    ("Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine receptor"
     . SPARSER::PROTEIN)
    ("C-N" . SPARSER::PROTEIN) ("H-R" . SPARSER::PROTEIN)
    ("C-H" . SPARSER::PROTEIN) ("IκBβ" . SPARSER::PROTEIN)
    ("GCP-2" . SPARSER::PROTEIN) ("D-8" . SPARSER::PROTEIN)
    ("CXCR7" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("phosphofructokinase and pyruvate" . SPARSER::COLLECTION)
    ("as well-defined biomarkers" . SPARSER::MOLECULE)
    ("FBP, DHAP, LA, 6PG, and NC-Asp" . SPARSER::COLLECTION)
    ("EGFR, gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("TXNIP or mutp53" . SPARSER::COLLECTION)
    ("RHOA/ROCK" . SPARSER::COLLECTION)
    ("activated RHOA and its downstream effector ROCK" . SPARSER::COLLECTION)
    ("RHOA" . SPARSER::PROTEIN)
    ("tumor-associated mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TXNIP" . SPARSER::PROTEIN) ("EGFR-PI3K/AKT" . SPARSER::COLLECTION)
    ("AS160 (Akt substrate of 160 kDa) and Tbc1Ds" . SPARSER::COLLECTION)
    ("Tbc" . SPARSER::BIO-COMPLEX) ("TC10" . SPARSER::PROTEIN)
    ("EGFRs" . SPARSER::PROTEIN) ("GLUT" . SPARSER::PROTEIN)
    ("EGFR, gefitinib, and erlotinib" . SPARSER::COLLECTION)
    ("the key metabolites" . SPARSER::PROTEIN)
    ("functional GLUT3" . SPARSER::PROTEIN) ("pyrimidines" . SPARSER::DRUG)
    ("Carbamoyl" . SPARSER::MOLECULE) ("Pyrimidine" . SPARSER::DRUG)
    ("conversely oxidative glutathione (GSSG)" . SPARSER::DRUG)
    ("reductive glutathione (GSH)" . SPARSER::DRUG)
    ("reductive nicotinamide adenine dinucleotide (NADH)" . SPARSER::MOLECULE)
    ("amino acids such as proline (Pro)" . SPARSER::AMINO-ACID)
    ("acetyl-CoA and citrate" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE) ("citrate" . SPARSER::PROTEIN)
    ("GLUT1 (glucose transporter 1, SLC2A1 ) and GLUT3 (glucose transporter 3, SLC2A3 )"
     . SPARSER::COLLECTION)
    ("Transporter" . SPARSER::PROTEIN)
    ("Lactate dehydrogenase A (LDHA)" . SPARSER::PROTEIN)
    ("p-PDHA1" . SPARSER::COLLECTION) ("p-LDHA" . SPARSER::COLLECTION)
    ("MYC-regulated glutaminase (GLS) and glycogen synthase (GYS)"
     . SPARSER::COLLECTION)
    ("glutaminase (GLS)" . SPARSER::PROTEIN) ("p-GYS" . SPARSER::COLLECTION)
    ("GYS" . SPARSER::PROTEIN) ("GLS" . SPARSER::PROTEIN)
    ("glutaminase" . SPARSER::PROTEIN) ("GLUT1 and HK2" . SPARSER::COLLECTION)
    ("EGFR, AKT, and ERK" . SPARSER::COLLECTION)
    ("EGFR, AKT, ERK, and c-Myc" . SPARSER::COLLECTION)
    ("The MYC-regulated genes GLUT1 (glucose transporter 1) and HK2 (Hexokinase 2)"
     . SPARSER::COLLECTION)
    ("Western blot (WB)" . SPARSER::PROTEIN)
    ("MYC, and β-actin" . SPARSER::COLLECTION)
    ("DMSO or gefitinib" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION) ("Enzymes" . SPARSER::ENZYME)
    ("pyruvate (PA)" . SPARSER::PROTEIN) ("ribulose" . SPARSER::MOLECULE)
    ("Glucose" . SPARSER::PROTEIN) ("lactate (LA)" . SPARSER::MOLECULE)
    ("PEP" . SPARSER::DRUG) ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("DHAP" . SPARSER::MOLECULE)
    ("dihydroxyacetone" . SPARSER::MOLECULE) ("FBP" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("methanol" . SPARSER::MOLECULE)
    ("Pentose" . SPARSER::MOLECULE) ("PC-9 and H1975" . SPARSER::COLLECTION)
    ("delE" . SPARSER::PROTEIN) ("PC-9" . SPARSER::PROTEIN)
    ("Lactate" . SPARSER::LACTATE) ("key metabolites" . SPARSER::PROTEIN)
    ("PKM2, and LDHA" . SPARSER::COLLECTION)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A (LDHA)" . SPARSER::PROTEIN)
    ("MYC, K-RAS, and BRAF" . SPARSER::COLLECTION) ("FH" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN) ("carbamoyl" . SPARSER::MOLECULE)
    ("pentose" . SPARSER::MOLECULE) ("BCR-ABL" . SPARSER::PROTEIN)
    ("Mutp53" . SPARSER::PROTEIN)
    ("thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("AS160" . SPARSER::PROTEIN) ("SGLT1" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("SLC2A3" . SPARSER::PROTEIN) ("SLC2A1" . SPARSER::PROTEIN)
    ("pyruvate kinase muscle isozyme" . SPARSER::PROTEIN)
    ("Hexokinase 2" . SPARSER::PROTEIN)
    ("hexokinase activity" . SPARSER::PROTEIN) ("G3P" . SPARSER::PROTEIN)
    ("D -glucose" . SPARSER::MOLECULE) ("Ribonuclease A" . SPARSER::PROTEIN)
    ("PDHA1" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("d -glucose" . SPARSER::MOLECULE) ("Myc/Max" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("fumarate hydratase" . SPARSER::PROTEIN)
    ("GLUT3" . SPARSER::PROTEIN) ("lower LPA-concentrations" . SPARSER::LPA)
    ("LPA-concentrations" . SPARSER::LPA) ("ERK and Akt" . SPARSER::COLLECTION)
    ("LPAR1 or LPAR3" . SPARSER::COLLECTION)
    ("PKC or EGFR" . SPARSER::COLLECTION)
    ("Akt, ERK, and p38" . SPARSER::COLLECTION)
    ("EGFR and Akt" . SPARSER::COLLECTION)
    ("Akt, ERK or p38" . SPARSER::COLLECTION)
    ("EGFR, Akt and ERK" . SPARSER::COLLECTION)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("EGFR, ERK, and Akt" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN)
    ("cetuximab or gefitinib" . SPARSER::COLLECTION)
    ("gefitinib and cetuximab" . SPARSER::COLLECTION)
    ("EGFR (at Tyr 1173) as well as the downstream signalling molecules ERK, Akt, and p38"
     . SPARSER::COLLECTION)
    ("ERK, Akt, and p38" . SPARSER::COLLECTION)
    ("the EGFR tyrosine kinase inhibitor gefitinib or the EGFR antibody cetuximab"
     . SPARSER::COLLECTION)
    ("the p38 kinase and the PI3 kinase" . SPARSER::COLLECTION)
    ("the MEK/ERK kinase, the p38 kinase and the PI3 kinase"
     . SPARSER::COLLECTION)
    ("PD98059, SB203580, and LY294002" . SPARSER::COLLECTION)
    ("LPAR1 and LPAR2" . SPARSER::COLLECTION)
    ("the phosphospecific antibody" . SPARSER::PROTEIN)
    ("a phosphospecific ERK antibody" . SPARSER::ANTIBODY)
    ("Akt and p38" . SPARSER::COLLECTION)
    ("EGFR, Akt, ERK and p38" . SPARSER::COLLECTION)
    ("LPAR1 and LPAR3" . SPARSER::COLLECTION)
    ("mainly target LPAR1 and/or LPAR3" . SPARSER::COLLECTION)
    ("mainly target LPAR1" . SPARSER::PROTEIN)
    ("Very few commercially available LPAR inhibitors" . SPARSER::INHIBITOR)
    ("EGFR, Akt, and ERK" . SPARSER::COLLECTION)
    ("EGFR, Akt, or ERK" . SPARSER::COLLECTION)
    ("LPAR2 and LPAR3" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY) ("LPAR1-3" . SPARSER::COLLECTION)
    ("EDG" . SPARSER::PROTEIN)
    ("at least six different LPA receptors" . SPARSER::RECEPTOR)
    ("PGE 2 nor NT" . SPARSER::COLLECTION)
    ("receptors, and autotaxin" . SPARSER::COLLECTION)
    ("at least six different receptors" . SPARSER::RECEPTOR)
    ("lysophospholipase" . SPARSER::PROTEIN)
    ("GPCRs and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("specific heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("locally active substances" . SPARSER::SUBSTANCE)
    ("EGF and HGF" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("receptor (EGFR )" . SPARSER::RECEPTOR)
    ("growth factors, and Met" . SPARSER::COLLECTION)
    ("Many biologically active substances" . SPARSER::SUBSTANCE)
    ("Protein and mRNA" . SPARSER::COLLECTION) ("P2Y5" . SPARSER::PROTEIN)
    ("LPAR 1" . SPARSER::PROTEIN) ("LPAR6" . SPARSER::PROTEIN)
    ("LPAR5" . SPARSER::PROTEIN) ("LPAR4" . SPARSER::PROTEIN)
    ("LPAR2" . SPARSER::PROTEIN) ("Anti-ERK" . SPARSER::PROTEIN)
    ("Ki16425" . SPARSER::MOLECULE) ("Prostaglandin E2" . SPARSER::MOLECULE)
    ("GM6001" . SPARSER::DRUG)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LPAR3" . SPARSER::PROTEIN) ("LPAR1" . SPARSER::PROTEIN)
    ("Lysophosphatidic acid" . SPARSER::LPA)
    ("U6 or snoRNA" . SPARSER::COLLECTION)
    ("snRNA or U19" . SPARSER::COLLECTION)
    ("mutant p53 and the GAS5 -derived snoRNAs" . SPARSER::COLLECTION)
    ("p53 and the GAS5 -derived snoRNAs" . SPARSER::COLLECTION)
    ("the GAS5 gene hosts ten intronic snoRNAs and a lncRNA"
     . SPARSER::COLLECTION)
    ("the GAS5 gene hosts ten intronic snoRNAs" . SPARSER::RNA)
    ("U44 or snoRNA" . SPARSER::COLLECTION)
    ("both snoRNA U44 (Pearson Correlation = 0.69; R 2 linear = 0.47) and snoRNA U47 (Pearson Correlation = 0.67; R 2 linear = 0.45)"
     . SPARSER::COLLECTION)
    ("snoRNA U44 (P≤0.0005) and snoRNA U47 (P≤0.0005)" . SPARSER::COLLECTION)
    ("RNA and gene" . SPARSER::COLLECTION)
    ("both snoRNA U44 (Pearson Correlation = 0.73; R 2 linear = 0.53; P = 0.001) and snoRNA U47 (Pearson Correlation = 0.66; R 2 linear = 0.43; P = 0.02)"
     . SPARSER::COLLECTION)
    ("both snoRNA U44 (Pearson Correlation = 0.64; R 2 linear = 0.41; P = 0.02) and snoRNA U47 (Pearson Correlation = 0.69; R 2 linear = 0.49; P = 0.01)"
     . SPARSER::COLLECTION)
    ("U6 and U19" . SPARSER::COLLECTION)
    ("the GAS5 -derived snoRNAs U44 (P<0.01) and U47 (P<0.01)"
     . SPARSER::COLLECTION)
    ("snRNA" . SPARSER::RNA) ("U44 and U47" . SPARSER::COLLECTION)
    ("GAS5 and/or its snoRNAs" . SPARSER::COLLECTION)
    ("U44, U76 and U78" . SPARSER::COLLECTION)
    ("androgen/androgen receptor" . SPARSER::COLLECTION)
    ("ribosomal RNA" . SPARSER::RNA)
    ("their snoRNAs and 5*-end sequences xref" . SPARSER::COLLECTION)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("Mapping" . SPARSER::PROTEIN)
    ("ten intronic C/D box snoRNAs and two mature long non-coding RNAs (lncRNAs) isoforms that originate"
     . SPARSER::COLLECTION)
    ("two mature long non-coding RNAs (lncRNAs) isoforms" . SPARSER::ISOFORM)
    ("ten intronic C/D box snoRNAs" . SPARSER::RNA)
    ("mature snoRNAs" . SPARSER::RNA)
    ("miRNAs and snoRNAs" . SPARSER::COLLECTION)
    ("snoRNAs and their host genes" . SPARSER::COLLECTION)
    ("termed C/D box snoRNAs and H/ACA box snoRNAs" . SPARSER::COLLECTION)
    ("snoRNAs, termed C/D box snoRNAs and H/ACA box snoRNAs"
     . SPARSER::COLLECTION)
    ("form small nucleolar ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("snoRNPs" . SPARSER::BIO-COMPLEX) ("ribosomal RNAs" . SPARSER::RNA)
    ("snRNAs" . SPARSER::PROTEIN) ("ncRNAs" . SPARSER::RNA)
    ("p53 and the GAS5 snoRNAs" . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA)
    ("The growth arrest-specific transcript 5 gene" . SPARSER::GENE)
    ("snoRNAs" . SPARSER::RNA) ("Nutlin3" . SPARSER::DRUG)
    ("small nucleolar RNA" . SPARSER::RNA) ("U47" . SPARSER::PROTEIN)
    ("U44" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("guide RNAs" . SPARSER::RNA) ("small nucleolar RNAs" . SPARSER::RNA)
    ("GAS5" . SPARSER::PROTEIN)
    ("BCL2L1, BCL2, ICEBERG and BIRC8" . SPARSER::COLLECTION)
    ("C-MYC and N-MYC" . SPARSER::COLLECTION)
    ("at least 6 miRNAs" . SPARSER::PROTEIN)
    ("CDK1, CDK2, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("ICEBERG and BIRC8" . SPARSER::COLLECTION)
    ("LTB, BCL2L14 , and PYCAR" . SPARSER::COLLECTION)
    ("BIRC7 and BIRC2" . SPARSER::COLLECTION)
    ("LTB , BIRC7, BCL2L14, PYCAR , and BIRC2" . SPARSER::COLLECTION)
    ("ICEBERG, CASP5 , and BIRC8" . SPARSER::COLLECTION)
    ("BCL2L1, BCL2, ICEBERG , and BIRC8" . SPARSER::COLLECTION)
    ("CASP5 and TNF" . SPARSER::COLLECTION)
    ("LTB, BCL2L14, PYCAR, FASLG , and TNFRSF1B" . SPARSER::COLLECTION)
    ("BCL2L1, BCL2, ICEBERG, CASP5, TNF , and BIRC8" . SPARSER::COLLECTION)
    ("ICEBERG" . SPARSER::PROTEIN) ("BBC3 and TNFRSF21" . SPARSER::COLLECTION)
    ("LTB, BCL2L14, PYCARD , and FASLG" . SPARSER::COLLECTION)
    ("BIRC7, BCL2A1 , and BIRC2" . SPARSER::COLLECTION)
    ("seven genes that were upregulated ( LTB, BIRC7, BCL2L14, PYCARD, BCL2A1, FASLG , and BIRC2 ) and three genes that were downregulated ( NFKB1, BBC3 , and TNFRSF21)"
     . SPARSER::COLLECTION)
    ("LTB, BIRC7, BCL2L14, PYCARD, BCL2A1, FASLG , and BIRC2"
     . SPARSER::COLLECTION)
    ("NFKB1, BBC3 , and TNFRSF21" . SPARSER::COLLECTION)
    ("FASLG" . SPARSER::PROTEIN) ("PYCARD" . SPARSER::PROTEIN)
    ("LTB" . SPARSER::PROTEIN) ("PVT1 , and anti-" . SPARSER::COLLECTION)
    ("miRNA , and non-transfected" . SPARSER::COLLECTION)
    ("miRNA and non-transfected" . SPARSER::COLLECTION)
    ("C-MYC and si" . SPARSER::COLLECTION)
    ("C -MYC and PVT1" . SPARSER::COLLECTION) ("MPMs" . SPARSER::MOLECULE)
    ("MYC, PVT1 , and miRNAs" . SPARSER::COLLECTION)
    ("at least six microRNAs" . SPARSER::RNA)
    ("three major histologic subtypes" . SPARSER::PROTEIN)
    ("asbestos" . SPARSER::MOLECULE) ("CNG" . SPARSER::PROTEIN)
    ("C - MYC and PVT1" . SPARSER::COLLECTION)
    ("C-MYC and PVT1" . SPARSER::COLLECTION) ("N-MYC" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CASP5" . SPARSER::PROTEIN) ("BCL2L1" . SPARSER::PROTEIN)
    ("TNFRSF1B" . SPARSER::PROTEIN) ("TNFRSF21" . SPARSER::PROTEIN)
    ("BIRC2" . SPARSER::PROTEIN) ("BCL2A1" . SPARSER::PROTEIN)
    ("BCL2L14" . SPARSER::PROTEIN) ("BIRC7" . SPARSER::PROTEIN)
    ("C -MYC" . SPARSER::PROTEIN) ("C - MYC" . SPARSER::PROTEIN)
    ("PVT1" . SPARSER::PROTEIN)
    ("testosterone and estradiol" . SPARSER::COLLECTION)
    ("the six polymorphic AR genetic variants" . SPARSER::VARIANT)
    ("– 1" . SPARSER::PROTEIN) ("which causes DNA" . SPARSER::DNA)
    ("TMPRSS2 and ERG" . SPARSER::COLLECTION)
    ("the androgen-regulated promoter TMPRSS2 and the ETS transcription factor family member ERG ( xref )"
     . SPARSER::COLLECTION)
    ("a unique molecular subtype" . SPARSER::PROTEIN)
    ("TMPRSS2:ERG" . SPARSER::BIO-COMPLEX)
    ("androgen receptor ( AR )" . SPARSER::PROTEIN) ("BPC3" . SPARSER::PROTEIN)
    ("the antidiabetic drug" . SPARSER::DRUG)
    ("Egr-1 and PDK1" . SPARSER::COLLECTION)
    ("exogenous PDK1" . SPARSER::PROTEIN)
    ("of a number of downstream signal cascades that are involved in suppression of apoptosis"
     . SPARSER::REGULATOR)
    ("a kinase and master regulator" . SPARSER::COLLECTION)
    ("p65 and p53" . SPARSER::COLLECTION)
    ("nuclear factor-κB (NF-κB) and p53" . SPARSER::COLLECTION)
    ("Egr-1, nuclear factor-κB (NF-κB) and p53" . SPARSER::COLLECTION)
    ("AMPKα and SAPK/JNK" . SPARSER::COLLECTION)
    ("a heterotrimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("Stress-activated protein kinase/c-Jun" . SPARSER::COLLECTION)
    ("antidiabetic drugs" . SPARSER::DRUG)
    ("rosiglitazone, ciglitazone, and pioglitazone" . SPARSER::COLLECTION)
    ("response elements (PPRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("PPRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Egr-1 and Egr-1" . SPARSER::COLLECTION)
    ("ciglitazone and metformin" . SPARSER::COLLECTION)
    ("AMPKα and c-Jun" . SPARSER::COLLECTION) ("Ciglitazone" . SPARSER::DRUG)
    ("ciglitazone" . SPARSER::DRUG) ("Egr-1 and PPARγ" . SPARSER::COLLECTION)
    ("blot and siRNA/transfection" . SPARSER::COLLECTION)
    ("Peroxisome proliferator-activated receptors gamma (PPARγ) ligands"
     . SPARSER::LIGAND)
    ("Peroxisome" . SPARSER::PROTEIN)
    ("Phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2- yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("2–4 " . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("Early growth response" . SPARSER::PROTEIN)
    ("Stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GW9662" . SPARSER::DRUG)
    ("phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("TEL" . SPARSER::PROTEIN) ("POT1/TPP1" . SPARSER::COLLECTION)
    ("the dimeric telomerase complex" . SPARSER::BIO-COMPLEX)
    ("many disease-associated alleles" . SPARSER::ALLELE)
    ("these shorter Exo VII" . SPARSER::PROTEIN) ("Exo" . SPARSER::PROTEIN)
    ("‘AGG’" . SPARSER::MOLECULE) ("AGG" . SPARSER::MOLECULE)
    ("dGTP and ddTTP" . SPARSER::COLLECTION) ("‘GGT’" . SPARSER::PROTEIN)
    ("GGT" . SPARSER::PROTEIN) ("ddTTP" . SPARSER::MOLECULE)
    ("dGTP" . SPARSER::DGTP) ("U29 and U42" . SPARSER::COLLECTION)
    ("DNA-primer" . SPARSER::DNA)
    ("a catalytically active telomerase complex" . SPARSER::BIO-COMPLEX)
    ("Doubly-labeled hTR molecules" . SPARSER::MOLECULE)
    ("well-fit" . SPARSER::PROTEIN-FAMILY) ("dNTPs" . SPARSER::MOLECULE)
    ("‘GGG’" . SPARSER::MOLECULE) ("GGG" . SPARSER::MOLECULE)
    ("POT1-TPP1" . SPARSER::COLLECTION)
    ("polymerases and reverse transcriptases" . SPARSER::COLLECTION)
    ("polymerases" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION) ("nuclease" . SPARSER::PROTEIN)
    ("hTR" . SPARSER::RNA) ("glucose oxidase" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN) ("C-5" . SPARSER::PROTEIN)
    ("U29" . SPARSER::PROTEIN) ("TPP1" . SPARSER::PROTEIN)
    ("POT1" . SPARSER::PROTEIN)
    ("reverse transcriptases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("genes or gene" . SPARSER::COLLECTION)
    ("viral escape variants" . SPARSER::VARIANT)
    ("adequate dNTP" . SPARSER::MOLECULE) ("dNTP" . SPARSER::MOLECULE)
    ("host kinases and virally-encoded substrate proteins"
     . SPARSER::COLLECTION)
    ("promoting transcriptional elongation" . SPARSER::PROTEIN)
    ("viral CDK orthologs" . SPARSER::PROTEIN)
    ("nuclear and cytoplasmic cell-associated p21" . SPARSER::PROTEIN)
    ("The cell-intrinsic CDK inhibitor p21" . SPARSER::PROTEIN)
    ("waf-1/cip1" . SPARSER::COLLECTION)
    ("the three-dimensional conformation" . SPARSER::BIO-CONFORMATION)
    ("subtilisin" . SPARSER::PROTEIN) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("this viral variant" . SPARSER::VARIANT)
    ("a GFP-encoding R5-tropic HIV-1 variant" . SPARSER::VARIANT)
    ("Alanine" . SPARSER::AMINO-ACID) ("palm" . SPARSER::PROTEIN)
    ("MS 2 and MS 3" . SPARSER::COLLECTION)
    ("p51 and p66" . SPARSER::COLLECTION)
    ("CDK2/Cyclin A" . SPARSER::COLLECTION)
    ("rabbit-derived antibodies" . SPARSER::ANTIBODY)
    ("CDK7 or CDK9" . SPARSER::COLLECTION) ("HPO" . SPARSER::PROTEIN)
    ("CDK2/cyclin E" . SPARSER::COLLECTION)
    ("CDK2/cyclin" . SPARSER::COLLECTION)
    ("basic amino acids" . SPARSER::AMINO-ACID)
    ("CDK1 and CDK4" . SPARSER::COLLECTION)
    ("CDK2 and CDK7" . SPARSER::COLLECTION)
    ("Roscovitine and Olomoucine" . SPARSER::COLLECTION)
    ("viral co-receptors" . SPARSER::PROTEIN)
    ("strong-stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antibodies and IL-2" . SPARSER::COLLECTION)
    ("Roscovitine or Olomoucine" . SPARSER::COLLECTION)
    ("CD3/CD8" . SPARSER::COLLECTION) ("Olomoucine" . SPARSER::DRUG)
    ("Roscovitine" . SPARSER::DRUG)
    ("reverse transcriptase (RT)" . SPARSER::PROTEIN)
    ("CDK9 ( xref ) and CDK2 ( xref ; xref )" . SPARSER::COLLECTION)
    ("cell-intrinsic inhibitors" . SPARSER::INHIBITOR)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("waf-1/cip-1" . SPARSER::COLLECTION) ("CDKI" . SPARSER::DRUG)
    ("APOBEC3G, TRIM5α and BST2" . SPARSER::COLLECTION)
    ("two geographically distinct cohorts" . SPARSER::MOLECULE)
    ("a cell-intrinsic CDK inhibitor" . SPARSER::INHIBITOR)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral reverse transcriptase" . SPARSER::PROTEIN)
    ("Lamin B1" . SPARSER::PROTEIN) ("lysyl endopeptidase" . SPARSER::PROTEIN)
    ("18h" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("bispecific antibody" . SPARSER::DRUG)
    ("polymerase II" . SPARSER::PROTEIN) ("MS 3" . SPARSER::PROTEIN)
    ("Lys-C" . SPARSER::PROTEIN) ("p66" . SPARSER::PROTEIN)
    ("p51" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("CDK7" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Polymerase II" . SPARSER::PROTEIN) ("cip-1" . SPARSER::PROTEIN)
    ("waf-1" . SPARSER::PROTEIN) ("TRIM5α" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("types and numbers" . SPARSER::COLLECTION)
    ("CGN or MET" . SPARSER::COLLECTION) ("CGN" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("all histological subtypes" . SPARSER::PROTEIN)
    ("Ras-Rac/Rho" . SPARSER::COLLECTION)
    ("HGF/scatter factor" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("the mesenchymal-epithelial transition (MET) gene" . SPARSER::GENE)
    ("HGF Receptor" . SPARSER::PROTEIN)
    ("Scatter Factor Receptor" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor Receptor" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("Proto-Oncogene" . SPARSER::PROTO-ONCOGENE)
    ("scatter factor" . SPARSER::PROTEIN)
    ("STAT1 or STAT5" . SPARSER::COLLECTION)
    ("STAT1 or STAT3" . SPARSER::COLLECTION)
    ("IL-6 or IFN- α" . SPARSER::COLLECTION)
    ("GFP-STAT1" . SPARSER::COLLECTION) ("STAT1-Flag" . SPARSER::COLLECTION)
    ("IFN- α or IFN- γ" . SPARSER::COLLECTION) ("Benzofurans" . SPARSER::DRUG)
    ("STAT3-STAT3" . SPARSER::COLLECTION) ("STAT-GFP" . SPARSER::COLLECTION)
    ("STAT3-GFP" . SPARSER::COLLECTION) ("STAT3-Flag" . SPARSER::COLLECTION)
    ("STAT3 or STAT1" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("STAT1 (–14.24) and STAT5 (–15.1)" . SPARSER::COLLECTION)
    ("STAT1 and STAT5" . SPARSER::COLLECTION)
    ("the benzofuran and isopropyl ester moieties" . SPARSER::COLLECTION)
    ("benzofuran and Lys591" . SPARSER::COLLECTION)
    ("ester and Thr620" . SPARSER::COLLECTION) ("ether" . SPARSER::MOLECULE)
    ("the homologous STAT1 protein" . SPARSER::PROTEIN)
    ("benzofuran" . SPARSER::DRUG) ("BG1" . SPARSER::PROTEIN)
    ("curcumin, cucurbitacin, honokiol, guggulsterone, resveratrol, berbamine, and flavopiridol"
     . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG) ("berbamine" . SPARSER::DRUG)
    ("guggulsterone" . SPARSER::DRUG) ("honokiol" . SPARSER::DRUG)
    ("cucurbitacin" . SPARSER::MOLECULE) ("complementing" . SPARSER::PROTEIN)
    ("both protein and target DNA" . SPARSER::COLLECTION)
    ("primarily STAT3 inhibitors" . SPARSER::INHIBITOR)
    ("stattic and fludarabine" . SPARSER::COLLECTION)
    ("fludarabine" . SPARSER::DRUG) ("stattic" . SPARSER::DRUG)
    ("STAT3 and STAT1" . SPARSER::COLLECTION)
    ("The amidosalicylic acid S3I-201" . SPARSER::MOLECULE)
    ("oligopeptides" . SPARSER::MOLECULE) ("Molecules" . SPARSER::MOLECULE)
    ("JAK or Src" . SPARSER::COLLECTION) ("ml –1" . SPARSER::PROTEIN)
    ("Interferon gamma" . SPARSER::PROTEIN)
    ("Transcription Factor" . SPARSER::PROTEIN) ("BP-1" . SPARSER::PROTEIN)
    ("FLLL32" . SPARSER::DRUG) ("I-M" . SPARSER::PROTEIN)
    ("STA-21" . SPARSER::DRUG) ("IFN- α" . SPARSER::PROTEIN)
    ("TGF α" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("protein inhibitor of activated STAT3" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("SET9" . SPARSER::PROTEIN)
    ("S3I-201" . SPARSER::MOLECULE) ("mitochondrial Bax" . SPARSER::PROTEIN)
    ("the phosphodefective Bcl-xL mutant" . SPARSER::MUTANT)
    ("the phosphomimetic S62D mutant" . SPARSER::MUTANT)
    ("the phosphodefective S62A Bcl-xL mutant" . SPARSER::MUTANT)
    ("Polo-like or Jun" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-263" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-263 and taxanes" . SPARSER::COLLECTION)
    ("ABT-263 and taxanes" . SPARSER::COLLECTION)
    ("a mitotic arrested state" . SPARSER::BIO-STATE)
    ("the only anti-apoptotic Bcl-2 homologue" . SPARSER::PROTEIN)
    ("Puma, Hrk and Bad" . SPARSER::COLLECTION)
    ("the weak fraction" . SPARSER::COMPONENT)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("S62A-Bcl-xL or S62D-Bcl-xL" . SPARSER::COLLECTION)
    ("Bax and S62A variant" . SPARSER::COLLECTION)
    ("ABT-737 (1  μ M) significantly decreased BRET" . SPARSER::PROTEIN)
    ("eYFP-Bcl-xL" . SPARSER::COLLECTION)
    ("N-terminal Luciferase-fused Bax and N-terminal eYFP-fused S62-Bcl-xL variants"
     . SPARSER::COLLECTION)
    ("eYFP-fused" . SPARSER::COLLECTION)
    ("Luciferase-fused" . SPARSER::COLLECTION) ("BRET" . SPARSER::PROTEIN)
    ("eventhough Bax and/or Bak" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax and/or Bak" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("the orally bivalent Bcl-2/Bcl-xL inhibitor ABT-263" . SPARSER::DRUG)
    ("the bivalent Bcl-2/Bcl-xL inhibitor" . SPARSER::INHIBITOR)
    ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION)
    ("prosurvival Bcl-2 homologues" . SPARSER::PROTEIN)
    ("the most prominent prosurvival protein" . SPARSER::PROTEIN)
    ("Bcl-xL, Bcl-2 or Mcl-1, and Cdc20" . SPARSER::COLLECTION)
    ("Mcl-1, and Cdc20" . SPARSER::COLLECTION)
    ("Bad, Puma or Hrk" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL or Bcl-w" . SPARSER::COLLECTION)
    ("Puma or Hrk" . SPARSER::COLLECTION) ("Hrk" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Mcl-1 protein" . SPARSER::COLLECTION)
    ("Cal" . SPARSER::PROTEIN) ("mitotic protein" . SPARSER::PROTEIN)
    ("directly target Cdc20" . SPARSER::PROTEIN)
    ("a strong caspase" . SPARSER::PROTEIN)
    ("Cdc20 or paclitaxel" . SPARSER::COLLECTION)
    ("diverse subtypes" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Bcl-w or ABT-199" . SPARSER::COLLECTION)
    ("Bcl-w or ABT-199" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL or Mcl-1" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG) ("poisons" . SPARSER::MOLECULE)
    ("antimitotic" . SPARSER::MOLECULE)
    ("The phospho-mimetic S62D-Bcl-xL mutant" . SPARSER::MUTANT)
    ("efficient caspase" . SPARSER::PROTEIN) ("caspase-" . SPARSER::PROTEIN)
    ("Antimitotic" . SPARSER::MOLECULE) ("ABT-737-" . SPARSER::DRUG)
    ("LEU2" . SPARSER::PROTEIN) ("GAL1" . SPARSER::PROTEIN)
    ("ura3" . SPARSER::PROTEIN) ("leu2" . SPARSER::PROTEIN)
    ("MitoTracker Red" . SPARSER::MOLECULE) ("ABT737" . SPARSER::DRUG)
    ("CDC20" . SPARSER::PROTEIN) ("Q-VD-Oph" . SPARSER::DRUG)
    ("Cdc-20" . SPARSER::PROTEIN) ("Polo-like" . SPARSER::PROTEIN)
    ("Mcl-1 protein" . SPARSER::PROTEIN) ("Q-VD-OPh" . SPARSER::DRUG)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("ABT-199" . SPARSER::DRUG) ("BCL-2, BAX and p53" . SPARSER::COLLECTION)
    ("BID, BIM or PUMA" . SPARSER::COLLECTION)
    ("NOXA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("BCL-2 or BCL-xL" . SPARSER::COLLECTION)
    ("the soluble inactive state" . SPARSER::BIO-STATE)
    ("proteins, BAX, BIM, and BAD" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION)
    ("more pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BAX, BAK, and BOK" . SPARSER::COLLECTION) ("BOK" . SPARSER::PROTEIN)
    ("Antagonist" . SPARSER::MOLECULE)
    ("cytokeratin 7, vimentin and HLA-G" . SPARSER::COLLECTION)
    ("BCL-2 and BAX" . SPARSER::COLLECTION)
    ("exogenous leptin" . SPARSER::PROTEIN)
    ("form and cPARP" . SPARSER::COLLECTION)
    ("Caspase-3 and Poly [ADP-ribose] polymerase 1" . SPARSER::COLLECTION)
    ("cPARP-1" . SPARSER::COLLECTION)
    ("hCG, cAMP and 17β-estradiol" . SPARSER::COLLECTION)
    ("hCG" . SPARSER::PROTEIN)
    ("leptin and its functional receptors" . SPARSER::COLLECTION)
    ("pleiotropic peptide" . SPARSER::PEPTIDE)
    ("BAX or BAK" . SPARSER::COLLECTION) ("BAX and BAK" . SPARSER::COLLECTION)
    ("hetero-oligomers" . SPARSER::PROTEIN-PAIR) ("BAK" . SPARSER::PROTEIN)
    ("MDM2, and p53" . SPARSER::COLLECTION) ("BCL-2/BAX" . SPARSER::COLLECTION)
    ("BAX and BID" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("BAX" . SPARSER::PROTEIN) ("Caspase-3 and DNA" . SPARSER::COLLECTION)
    ("BCL-xL" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("HLA-G" . SPARSER::PROTEIN) ("p89" . SPARSER::PROTEIN)
    ("1–4 µ" . SPARSER::PROTEIN) ("βgal" . SPARSER::PROTEIN)
    ("pGL2" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("Poly [ADP-ribose] polymerase 1" . SPARSER::PROTEIN)
    ("p53AIP1" . SPARSER::PROTEIN)
    ("p53-regulated apoptosis-inducing protein 1" . SPARSER::PROTEIN)
    ("Poly [ADP-ribose] polymerase" . SPARSER::PROTEIN)
    ("miRNAs/p21" . SPARSER::COLLECTION)
    ("the largest miRNA gene" . SPARSER::GENE)
    ("miRNAs and p21" . SPARSER::COLLECTION)
    ("Bcl-xL and survivin" . SPARSER::COLLECTION)
    ("caspase-3, caspase-9 or PARP" . SPARSER::COLLECTION)
    ("dsRNAs" . SPARSER::RNA)
    ("specifically p21 Waf1/CIP1" . SPARSER::COLLECTION)
    ("Waf1/CIP1" . SPARSER::COLLECTION) ("cyclin-CDK4" . SPARSER::COLLECTION)
    ("cyclin-CDK2" . SPARSER::COLLECTION)
    ("PHLPP1 and PHLPP2 or RKIP" . SPARSER::COLLECTION)
    ("PHLPP2 or RKIP" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("HDAC1, HDAC3, and histone" . SPARSER::COLLECTION)
    ("acetylase" . SPARSER::PROTEIN)
    ("CDC42, CDH1, PAK2 and BCL-2" . SPARSER::COLLECTION)
    ("PAK4 and MMP9" . SPARSER::COLLECTION)
    ("docetaxel, gemcitabine or vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG) ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("CDKs and cyclin" . SPARSER::COLLECTION)
    ("cyclinD1, cyclinA and cyclinE" . SPARSER::COLLECTION)
    ("cdk1, ppRb, pRb, E2F1, cyclinD1, cyclinA and cyclinE"
     . SPARSER::COLLECTION)
    ("p-cdk1" . SPARSER::COLLECTION) ("cyclinA" . SPARSER::PROTEIN)
    ("p21WAF1/CIP1" . SPARSER::COLLECTION) ("siRNA/p21" . SPARSER::COLLECTION)
    ("pcDNA/p21" . SPARSER::COLLECTION) ("pEZX-luc" . SPARSER::PROTEIN-PAIR)
    ("miR-NC" . SPARSER::PROTEIN-PAIR) ("pGCMV/miR-NC" . SPARSER::COLLECTION)
    ("anti-miR-NC" . SPARSER::COLLECTION)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("DDP-nonresistant" . SPARSER::PROTEIN-PAIR)
    ("endogenous tiny noncoding RNAs" . SPARSER::RNA)
    ("-pRb" . SPARSER::COLLECTION) ("DDP" . SPARSER::PROTEIN)
    ("oncogenes and tumour suppressors" . SPARSER::COLLECTION)
    ("Waf1" . SPARSER::PROTEIN) ("PHLPP2" . SPARSER::PROTEIN)
    ("PHLPP1" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("API-5" . SPARSER::PROTEIN) ("cdk1" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("cdc2" . SPARSER::PROTEIN)
    ("pcDNA 3" . SPARSER::PROTEIN) ("RAB14" . SPARSER::PROTEIN)
    ("plk1" . SPARSER::PROTEIN)
    ("cis -diamminedichloroplatinum" . SPARSER::DRUG)
    ("MLH1 and PMS2" . SPARSER::COLLECTION)
    ("abundant extracellular mucin" . SPARSER::PROTEIN)
    ("dim" . SPARSER::PROTEIN-FAMILY)
    ("abundant
extracellular mucin"
     . SPARSER::PROTEIN)
    ("PPV" . SPARSER::MOLECULE)
    ("occasional non- BRAF mutant" . SPARSER::MUTANT)
    ("cohort revealed non-specific BRAF V600E" . SPARSER::PROTEIN)
    ("mutation-specific BRAFV600E monoclonal antibodies" . SPARSER::ANTIBODY)
    ("a prognostic and
predictive biomarker"
     . SPARSER::MOLECULE)
    ("HDAC3 and MEF2D" . SPARSER::COLLECTION)
    ("unique HDAC5" . SPARSER::PROTEIN)
    ("NCOR1 and TBL1X" . SPARSER::COLLECTION)
    ("MEF2D, NCOR1, TBL1X, and HDAC3" . SPARSER::COLLECTION)
    ("BAZ1B and BAZ2A" . SPARSER::COLLECTION)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("conformation and protein" . SPARSER::COLLECTION)
    ("proteins and protein" . SPARSER::COLLECTION)
    ("MEF2C and MEF2D" . SPARSER::COLLECTION) ("CaMK2D" . SPARSER::PROTEIN)
    ("cs" . SPARSER::PROTEIN) ("HDAC5-EGFP" . SPARSER::COLLECTION)
    ("histone deacetylases evolutionarily predate histones" . SPARSER::PROTEIN)
    ("predate" . SPARSER::DRUG) ("Lysine" . SPARSER::AMINO-ACID)
    ("structural homology" . SPARSER::PROTEIN)
    ("antiviral therapeutics" . SPARSER::THERAPEUTICS)
    ("PRM" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("beclin" . SPARSER::PROTEIN) ("BAZ2A" . SPARSER::PROTEIN)
    ("BAZ1B" . SPARSER::PROTEIN) ("CaMK2" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("GPS2" . SPARSER::PROTEIN)
    ("TBL1XR1" . SPARSER::PROTEIN) ("TBL1X" . SPARSER::PROTEIN)
    ("NCOR2" . SPARSER::PROTEIN) ("NCOR1" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("CAMK2D" . SPARSER::PROTEIN)
    ("MEF2D" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("PD1" . SPARSER::PROTEIN) ("MS 2" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("14–3–3" . SPARSER::PROTEIN) ("bcl-6" . SPARSER::PROTEIN)
    ("HDAC 11" . SPARSER::PROTEIN) ("eQTLs" . SPARSER::PROTEIN)
    ("IL13 , REL and GATA3" . SPARSER::COLLECTION) ("MCHL" . SPARSER::PROTEIN)
    ("previously published subtype" . SPARSER::PROTEIN)
    ("6p21-p22" . SPARSER::PROTEIN-PAIR) ("p22" . SPARSER::PROTEIN)
    ("associated variants" . SPARSER::VARIANT)
    ("cis-eQTLs" . SPARSER::PROTEIN-PAIR)
    ("genotype and TCF3" . SPARSER::COLLECTION) ("DNAse" . SPARSER::PROTEIN)
    ("ARL4A-ETV1" . SPARSER::COLLECTION) ("ARL" . SPARSER::PROTEIN)
    ("histologic subtype (MCHL)" . SPARSER::PROTEIN)
    ("genotypic variants" . SPARSER::VARIANT)
    ("HBS1L-MYB" . SPARSER::COLLECTION) ("MYB" . SPARSER::PROTEIN)
    ("EOMES" . SPARSER::PROTEIN)
    ("different HL histological subtypes" . SPARSER::PROTEIN)
    ("REL , GATA3 and IL13" . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("HRS" . SPARSER::PROTEIN) ("HLA and non-HLA" . SPARSER::COLLECTION)
    ("H2A.Z" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("ABF-1" . SPARSER::PROTEIN) ("Oct-2" . SPARSER::PROTEIN)
    ("ZBTB7" . SPARSER::PROTEIN) ("G-G" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("HBS1L" . SPARSER::PROTEIN)
    ("IL13" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("p31" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("other dual-specific inhibitors" . SPARSER::INHIBITOR)
    ("dasatinib and other clinical-grade dual-specificity Bcr-Abl and Src family kinase inhibitors"
     . SPARSER::COLLECTION)
    ("Bcr-Abl and Src" . SPARSER::COLLECTION)
    ("dasatinib and NF-κB" . SPARSER::COLLECTION)
    ("Blk and Fyn" . SPARSER::COLLECTION)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("Bcr-Abl and the Src family kinases" . SPARSER::COLLECTION)
    ("Sprycel" . SPARSER::DRUG) ("Chemicals" . SPARSER::MOLECULE)
    ("Lck" . SPARSER::PROTEIN)
    ("the activating tyrosine (Y388) and not" . SPARSER::COLLECTION)
    ("Blk-wt" . SPARSER::COLLECTION) ("exogenous IL-3" . SPARSER::PROTEIN)
    ("blasticidin-" . SPARSER::MOLECULE) ("blasticidin" . SPARSER::MOLECULE)
    ("childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN) ("PB2" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN)
    ("nearly 40 different kinase" . SPARSER::KINASE)
    ("SRC, FYN, and EGFR" . SPARSER::COLLECTION)
    ("both an upstream activator and a downstream mediator"
     . SPARSER::COLLECTION)
    ("MEK/Erk" . SPARSER::COLLECTION) ("mTOR/AKT" . SPARSER::COLLECTION)
    ("MET or IRS2" . SPARSER::COLLECTION)
    ("erlotinib or afatinib" . SPARSER::COLLECTION)
    ("MET, ROR1, and Gab1/2" . SPARSER::COLLECTION)
    ("peptides and proteins" . SPARSER::COLLECTION)
    ("increased tyrosine phosphorylated MET" . SPARSER::PROTEIN)
    ("pre- and post-EGFR-TKI" . SPARSER::COLLECTION)
    ("Src or MET" . SPARSER::COLLECTION)
    ("83 unique pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("158, 153, 157, and 109 unique pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("189 unique proteins" . SPARSER::PROTEIN)
    ("279 unique pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("afatinib (10 mg/kg) or dasatinib (15 mg/kg)" . SPARSER::COLLECTION)
    ("afatinib and WZ4002" . SPARSER::COLLECTION)
    ("erlotinib and dasatinib" . SPARSER::COLLECTION)
    ("LYN and FRK" . SPARSER::COLLECTION)
    ("kinases or kinase" . SPARSER::COLLECTION)
    ("SRC, LYN, FYN, and FRK" . SPARSER::COLLECTION) ("FRK" . SPARSER::PROTEIN)
    ("LYN" . SPARSER::PROTEIN) ("SRC and FYN" . SPARSER::COLLECTION)
    ("another irreversible EGFR-TKI" . SPARSER::PROTEIN)
    ("afatinib or dasatinib" . SPARSER::COLLECTION)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("dasatinib and afatinib" . SPARSER::COLLECTION)
    ("EGFR, MET, ERBB3, SHC1, CBL, and STAT3" . SPARSER::COLLECTION)
    ("c-SRC" . SPARSER::COLLECTION) ("FYN" . SPARSER::PROTEIN)
    ("CSK, PKCD, MAPK3, PIK3R2, SYK, TNK2, EPHB2, EPHA4, FAK, and PTK2B"
     . SPARSER::COLLECTION)
    ("PKCD" . SPARSER::PROTEIN) ("CSK" . SPARSER::PROTEIN)
    ("Afatinib" . SPARSER::DRUG) ("IGF1 and Gas6" . SPARSER::COLLECTION)
    ("HGF and IGF" . SPARSER::COLLECTION) ("key RTK" . SPARSER::PROTEIN)
    ("exogenous ligands" . SPARSER::LIGAND)
    ("MK01, SHC1, GAB1, EGFR, and ERBB3" . SPARSER::COLLECTION)
    ("peptides and pathways" . SPARSER::COLLECTION)
    ("45 more abundant unique pTyr peptides" . SPARSER::PEPTIDE)
    ("proteins and proteins" . SPARSER::COLLECTION)
    ("MET, IRS2, or AXL" . SPARSER::COLLECTION)
    ("MET-TKI" . SPARSER::COLLECTION) ("MET and AXL" . SPARSER::COLLECTION)
    ("Gab1 and Gab2" . SPARSER::COLLECTION)
    ("ROR1 or neurotrophic tyrosine kinase receptor related-1 (pTyr-789, ~13-fold; pTyr-828, ~34-fold)"
     . SPARSER::COLLECTION)
    ("nearly 11-fold more MET pTyr peptides" . SPARSER::PEPTIDE)
    ("77 unique pTyr peptides" . SPARSER::PEPTIDE)
    ("110 unique pTyr peptides" . SPARSER::PEPTIDE)
    ("EGFR and MET" . SPARSER::COLLECTION)
    ("265 unique phosphoproteins" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("tryptic peptides" . SPARSER::PEPTIDE)
    ("pAkt and pErk" . SPARSER::COLLECTION) ("pErk" . SPARSER::PROTEIN)
    ("RTKs and non-RTKs" . SPARSER::COLLECTION)
    ("rapamycin (mTOR) inhibitor PI-103 ( xref ) and HKI-272"
     . SPARSER::COLLECTION)
    ("irreversible EGFR-TKI" . SPARSER::PROTEIN)
    ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("afatinib and dasatinib" . SPARSER::COLLECTION)
    ("Dasatinib" . SPARSER::DRUG) ("Akt and Erk" . SPARSER::COLLECTION)
    ("neither erlotinib nor afatinib" . SPARSER::COLLECTION)
    ("MET, IGF, and AXL" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("tyrosine-phosphorylated peptides and mass-spectrometry-based identification/quantification"
     . SPARSER::COLLECTION)
    ("reversible EGFR-TKI" . SPARSER::PROTEIN)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION) ("DDR2" . SPARSER::PROTEIN)
    ("YES1" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("EPHA4" . SPARSER::PROTEIN) ("EPHB2" . SPARSER::PROTEIN)
    ("PIK3R2" . SPARSER::PROTEIN) ("MAPK3" . SPARSER::PROTEIN)
    ("Gas6" . SPARSER::PROTEIN) ("GAS6" . SPARSER::PROTEIN)
    ("PTK6" . SPARSER::PROTEIN)
    ("Ras-related protein Rab-7a" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE) ("Gab2" . SPARSER::PROTEIN)
    ("Gab1" . SPARSER::PROTEIN) ("ROR1" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("CL-387,785" . SPARSER::DRUG)
    ("WZ4002" . SPARSER::DRUG) ("HKI-272" . SPARSER::DRUG)
    ("PF00299804" . SPARSER::DRUG)
    ("NRF2 and NRF2-target genes polymorphisms" . SPARSER::COLLECTION)
    ("genotype, GSTT1 and SOD2" . SPARSER::COLLECTION)
    ("NRF2 variants and GSTM1 and GSTP1 Ile105Val genetic polymorphisms"
     . SPARSER::COLLECTION)
    ("GSTM1 and GSTP1" . SPARSER::COLLECTION)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE)
    ("at least one GSTA1 −69T allele" . SPARSER::ALLELE)
    ("at least one GSTP1 105Ile allele" . SPARSER::ALLELE)
    ("toxic metabolites" . SPARSER::PROTEIN)
    ("GSTT1 and GSTP1" . SPARSER::COLLECTION)
    ("at least one GSTP1 105Val allele" . SPARSER::ALLELE)
    ("Cao" . SPARSER::MOLECULE) ("heterozygotes" . SPARSER::PROTEIN)
    ("fewer GSTT1 null genotypes" . SPARSER::PROTEIN)
    ("particular genotype" . SPARSER::PROTEIN)
    ("NRF2, SOD2 and GSTs" . SPARSER::COLLECTION) ("GSTs" . SPARSER::PROTEIN)
    ("NRF2 transcription factor and NRF2-modulated antioxidant"
     . SPARSER::COLLECTION)
    ("arylamines and PAHs" . SPARSER::COLLECTION)
    ("arylamines" . SPARSER::MOLECULE) ("GSTT1 and SOD2" . SPARSER::COLLECTION)
    ("GSTP1 and GSTT1" . SPARSER::COLLECTION)
    ("SOD2 Ala16Val + Val16Val genotype (OR 0.55, 95 % CI 0.32–0.96; P  = 0.04) and GSTP1 Ile105Val + Val105Val and GSTT1"
     . SPARSER::COLLECTION)
    ("15 double genotypes and 18 triple genotypes" . SPARSER::COLLECTION)
    ("18 triple genotypes" . SPARSER::PROTEIN)
    ("at least one minor GSTP1 105Val allele" . SPARSER::ALLELE)
    ("NRF2 and NRF2 target genes and BC risk" . SPARSER::COLLECTION)
    ("NRF2 and NRF2" . SPARSER::COLLECTION)
    ("GSTT1 null genotype" . SPARSER::PROTEIN) ("Hua" . SPARSER::PROTEIN)
    ("GSTM1 (Fryer et al. xref ) and GSTT1 (Pemble et al. xref )"
     . SPARSER::COLLECTION)
    ("gene and enzyme" . SPARSER::COLLECTION)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("GSTM1 and GSTT1" . SPARSER::COLLECTION)
    ("isothiocyanates" . SPARSER::MOLECULE)
    ("NRF2 or NFE2L2" . SPARSER::COLLECTION) ("PAHs" . SPARSER::PROTEIN)
    ("at least one 16Val allele" . SPARSER::ALLELE)
    ("GSTM1 null genotype" . SPARSER::PROTEIN)
    ("GSTA1, GSTP1, SOD2 and NRF2" . SPARSER::COLLECTION)
    ("NRF2 and five NRF2-regulated genes" . SPARSER::COLLECTION)
    ("various antioxidant and metabolic genes" . SPARSER::COLLECTION)
    ("GSTP1  " . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("GSTP1" . SPARSER::PROTEIN)
    ("GSTA1" . SPARSER::PROTEIN) ("GSTT1" . SPARSER::PROTEIN)
    ("GSTM1" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("Avastin" . SPARSER::DRUG)
    ("neither HIF1α nor HIF2α" . SPARSER::COLLECTION)
    ("hypo-phosphorylated Rb" . SPARSER::PROTEIN)
    ("TRIP230-HIF1" . SPARSER::COLLECTION)
    ("ARNT, HIF1α, TRIP230 and Rb" . SPARSER::COLLECTION)
    ("Rb, hypoxia and CoCl 2" . SPARSER::COLLECTION)
    ("CXCR4 and PLOD2" . SPARSER::COLLECTION)
    ("Rb and HIF" . SPARSER::COLLECTION)
    ("PLOD2 and CXCR4" . SPARSER::COLLECTION) ("multi" . SPARSER::PROTEIN)
    ("ARNT-TRIP230" . SPARSER::COLLECTION)
    ("EPO and VEGF" . SPARSER::COLLECTION)
    ("a transcriptionally competent mutant" . SPARSER::MUTANT)
    ("Rb" . SPARSER::PROTEIN) ("Rb-pSer" . SPARSER::PROTEIN-PAIR)
    ("ARNT and multiple co-activators" . SPARSER::COLLECTION)
    ("NCoA" . SPARSER::PROTEIN) ("ARNT and Rb" . SPARSER::COLLECTION)
    ("Immuno-blot" . SPARSER::COLLECTION)
    ("a multimeric complex" . SPARSER::BIO-COMPLEX)
    ("ARNT, TRIP230 and Rb" . SPARSER::COLLECTION)
    ("siRNA or Rb" . SPARSER::COLLECTION) ("severe hypoxia" . SPARSER::PROTEIN)
    ("a complete complement" . SPARSER::PROTEIN) ("Immuno" . SPARSER::PROTEIN)
    ("hypoxia and PLOD2" . SPARSER::COLLECTION) ("immuno" . SPARSER::PROTEIN)
    ("ARNT and TRIP230" . SPARSER::COLLECTION)
    ("immuno-blot" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION)
    ("ARNT or HIF1α" . SPARSER::COLLECTION)
    ("TRIP230 and Rb" . SPARSER::COLLECTION)
    ("HIF1α and ARNT" . SPARSER::COLLECTION)
    ("HIF1α or HIF2α" . SPARSER::COLLECTION)
    ("the VEGF promoter and EPO enhancer under normoxic conditions ( xref )"
     . SPARSER::COLLECTION)
    ("HIF1α, ARNT, TRIP230 and Rb" . SPARSER::COLLECTION)
    ("TRIP230 or a control rabbit IgG" . SPARSER::COLLECTION)
    ("HIF1α, ARNT, TRIP230 or a control rabbit IgG" . SPARSER::COLLECTION)
    ("VEGF and EPO" . SPARSER::COLLECTION)
    ("the VEGF promoter and EPO enhancer" . SPARSER::COLLECTION)
    ("Rb-associated Repressor Proteins" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN) ("Repressor" . SPARSER::REPRESSOR)
    ("CXCR4, VEGF and PLOD2" . SPARSER::COLLECTION)
    ("CXCR4 or VEGF" . SPARSER::COLLECTION)
    ("MCF7 and LNCaP" . SPARSER::COLLECTION)
    ("siRNAs and mRNA" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("AHR and HIF1α" . SPARSER::COLLECTION)
    ("AHR" . SPARSER::PROTEIN) ("TR and ARNT" . SPARSER::COLLECTION)
    ("aryl hydrocarbon receptor and HIF1α" . SPARSER::COLLECTION)
    ("TRIP230 and ARNT" . SPARSER::COLLECTION)
    ("its hypo-phosphorylated form" . SPARSER::FORM)
    ("receptor (TR)" . SPARSER::RECEPTOR)
    ("TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCR4 and procollagen" . SPARSER::COLLECTION)
    ("Brm/Brg-1" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("Brm" . SPARSER::PROTEIN) ("new vasculature" . SPARSER::PROTEIN)
    ("ARNT or HIF1β" . SPARSER::COLLECTION)
    ("HIF1α-ARNT/HIF1β" . SPARSER::COLLECTION) ("Protein-G" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("a 20 µ" . SPARSER::PROTEIN)
    ("2–4 µ" . SPARSER::PROTEIN) ("ARNT Protein" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC3" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("Sin3" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("PLOD2" . SPARSER::PROTEIN) ("lysyl hydroxylase 2" . SPARSER::PROTEIN)
    ("Brg-1" . SPARSER::PROTEIN) ("HIF1β" . SPARSER::PROTEIN)
    ("TRIP230" . SPARSER::PROTEIN) ("sunscreens" . SPARSER::DRUG)
    ("neonatal macrophages" . SPARSER::PROTEIN)
    ("RAC1, STK19 and PPP6C" . SPARSER::COLLECTION)
    ("mutant and TP53/Trp53" . SPARSER::COLLECTION)
    ("::Braf" . SPARSER::BIO-COMPLEX)
    ("Two conditional-inducible mouse alleles" . SPARSER::ALLELE)
    ("LSL" . SPARSER::PROTEIN)
    ("significantly more somatic single nucleotide variants (SNVs; median 6.16 [range 0.26-40.69] vs. 0.19 SNVs/Mb [range 0.02–2.16]; xref ; xref ) and a significantly higher proportion"
     . SPARSER::COLLECTION)
    ("significantly more somatic single nucleotide variants"
     . SPARSER::VARIANT)
    ("pyrimidine" . SPARSER::DRUG)
    ("melanoma oncogenes and tumour suppressors ( MITF, BRAF, CCND1, CDKN2A ; xref ; xref )  xref"
     . SPARSER::COLLECTION)
    ("Sunscreen" . SPARSER::DRUG)
    ("S100 and Hmb45/MelanA" . SPARSER::COLLECTION)
    ("MelanA" . SPARSER::PROTEIN) ("UVR and non-UVR" . SPARSER::COLLECTION)
    ("SPF" . SPARSER::PROTEIN) ("sunscreen" . SPARSER::DRUG)
    ("UVR" . SPARSER::PROTEIN-FAMILY) ("ki67" . SPARSER::PROTEIN)
    ("HMB45" . SPARSER::DRUG) ("A-1" . SPARSER::PROTEIN)
    ("PPP6C" . SPARSER::PROTEIN) ("STK19" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("p14 ARF" . SPARSER::PROTEIN)
    ("Hmb45" . SPARSER::DRUG) ("S100" . SPARSER::PROTEIN)
    ("raloxifene" . SPARSER::PROTEIN)
    ("tamoxifen and anastrozole" . SPARSER::COLLECTION)
    ("anastrozole" . SPARSER::DRUG) ("Aromatase" . SPARSER::PROTEIN)
    ("modulators and aromatase" . SPARSER::COLLECTION)
    ("a dual EGFR/ErbB2 reversible tyrosine kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("MAPK/Erk1/2" . SPARSER::COLLECTION)
    ("TP53 and PIK3CA" . SPARSER::COLLECTION)
    ("PIK3CA and TP53" . SPARSER::COLLECTION) ("Hot" . SPARSER::PROTEIN)
    ("FBX" . SPARSER::PROTEIN) ("ERBB2, ER, and PR" . SPARSER::COLLECTION)
    ("a heterodimeric enzyme" . SPARSER::ENZYME)
    ("Immunohistochemical staining revealed different states"
     . SPARSER::BIO-STATE)
    ("Progesterone" . SPARSER::PROTEIN)
    ("ABL1, AKT1, ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, FBXW7, FGFR1, FGFR2, FGFR3, FLT3, GNAS, HNF1A, HRAS, IDH1, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, and VHL"
     . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN) ("RET" . SPARSER::PROTEIN)
    ("GNAS" . SPARSER::PROTEIN) ("menopausal states" . SPARSER::BIO-STATE)
    ("personalized drugs or combination therapies" . SPARSER::COLLECTION)
    ("various histologic types" . TYPE)
    ("PIK3CA, and TP53" . SPARSER::COLLECTION) ("Ion" . SPARSER::MOLECULE)
    ("chr3" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("S1–3" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("HIPK1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("v-erb" . SPARSER::PROTEIN)
    ("the complete genes or exons" . SPARSER::COLLECTION)
    ("the BRAF (35.1 months, P =0.03) or NRAS -mutant" . SPARSER::COLLECTION)
    ("Acral lentiginous and demoplastic melanoma subtypes" . SPARSER::PROTEIN)
    ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF -mutant or BRAF/NRAS wild-type disease ( xref )"
     . SPARSER::COLLECTION)
    ("KRAS mutant or RAS/RAF wild-type disease ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("RAS/RAF" . SPARSER::COLLECTION)
    ("mutant BRAF and the downstream kinase MEK (MAPK inhibitors)"
     . SPARSER::COLLECTION)
    ("a historical cohort" . SPARSER::MOLECULE)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("X11" . SPARSER::PROTEIN)
    ("BRCA1-" . SPARSER::PROTEIN) ("TP53 and BRCA1" . SPARSER::COLLECTION)
    ("CHEK2-" . SPARSER::PROTEIN) ("CMF" . SPARSER::PROTEIN)
    ("both the adjuvant chemotherapy group (HR 4.54, 95% CI 2.41–8.65) and the group"
     . SPARSER::COLLECTION)
    ("Types" . TYPE)
    ("the RMOT cohort (<1%) and ORIGO cohort (37% data not shown in tables)"
     . SPARSER::COLLECTION)
    ("platinum or anthracyclines" . SPARSER::COLLECTION)
    ("CHEK2 and adjuvant" . SPARSER::COLLECTION)
    ("One Dutch hereditary non- BRCA1/2 breast cancer patient cohort ( n =1220) and two Dutch cohorts"
     . SPARSER::COLLECTION)
    ("One Dutch hereditary non- BRCA1/2 breast cancer patient cohort"
     . SPARSER::MOLECULE)
    ("HR 1" . SPARSER::PROTEIN-FAMILY) ("HR 2" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN)
    ("cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("the here studied cohort" . SPARSER::MOLECULE)
    ("mucinous tumour type" . TYPE)
    ("the here examined cohort" . SPARSER::MOLECULE)
    ("sporadic CRC" . SPARSER::PROTEIN)
    ("v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) oncogene"
     . SPARSER::ONCOGENE)
    ("494 incident CRC" . SPARSER::PROTEIN)
    ("v-Raf murine sarcoma viral oncogene homolog B1" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN)
    ("preformed homodimeric receptors" . SPARSER::PROTEIN)
    ("heterodimeric receptors" . SPARSER::PROTEIN)
    ("JAK2 and JAK1" . SPARSER::COLLECTION)
    ("particular JAK1" . SPARSER::PROTEIN)
    ("the bulky phenylalanine" . SPARSER::AMINO-ACID)
    ("β3–αC" . SPARSER::COLLECTION) ("DFG" . SPARSER::PROTEIN)
    ("phosphoryl" . SPARSER::MOLECULE) ("Abl" . SPARSER::PROTEIN)
    ("the autoinhibitory state" . SPARSER::BIO-STATE)
    ("Epo" . SPARSER::PROTEIN) ("asparagine–arginine" . SPARSER::COLLECTION)
    ("asparagine" . SPARSER::AMINO-ACID)
    ("the actual disease mutant" . SPARSER::MUTANT) ("αC" . SPARSER::PROTEIN)
    ("αC–β4" . SPARSER::PROTEIN-PAIR) ("β4" . SPARSER::PROTEIN)
    ("β4–β5" . SPARSER::PROTEIN-PAIR) ("salt" . SPARSER::MOLECULE)
    ("β3" . SPARSER::PROTEIN) ("β2–β3" . SPARSER::COLLECTION)
    ("lobe" . SPARSER::PROTEIN)
    ("explicit solvent molecules" . SPARSER::MOLECULE)
    ("JH" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("homodimeric receptor-JAK2" . SPARSER::COLLECTION)
    ("heterodimeric receptor-JAK" . SPARSER::COLLECTION)
    ("receptor-JAK2" . SPARSER::COLLECTION)
    ("receptor-JAK" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("JAK1–3" . SPARSER::COLLECTION)
    ("erythropoietin and growth hormone" . SPARSER::COLLECTION)
    ("Na +" . SPARSER::MOLECULE) ("R K" . SPARSER::PROTEIN)
    ("protein kinase domains" . SPARSER::PROTEIN-FAMILY)
    ("cytokine-receptor" . SPARSER::PROTEIN) ("band 4 .1" . SPARSER::PROTEIN)
    ("BDNF or SKF81297" . SPARSER::COLLECTION)
    ("PBS or the D1-like agonist SKF81297" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("GFP and MAP2" . SPARSER::COLLECTION)
    ("GTPase-GFP" . SPARSER::COLLECTION)
    ("dominant-negative (DN) Rac1 (Rac1N17) or RhoA (RhoAN19) or constitutively active (CA) Rac1 (Rac1L61) or RhoA (RhoAL63)"
     . SPARSER::COLLECTION)
    ("constitutively active (CA) Rac1 (Rac1L61) or RhoA (RhoAL63)"
     . SPARSER::COLLECTION)
    ("dominant-negative (DN) Rac1" . SPARSER::PROTEIN) ("soma" . SPARSER::DRUG)
    ("PSD-95 and synapsin I" . SPARSER::COLLECTION)
    ("the post-synaptic marker PSD-95 and the pre-synaptic marker synapsin I"
     . SPARSER::COLLECTION)
    ("the post-synaptic marker PSD-95" . SPARSER::PROTEIN)
    ("Rac1/Cdc42" . SPARSER::COLLECTION) ("stimulants" . SPARSER::DRUG)
    ("the D1 class (D1 and D5) and the D2 class (D2, D3 and D4)"
     . SPARSER::COLLECTION)
    ("NAc" . SPARSER::MOLECULE) ("Cocaine" . SPARSER::DRUG)
    ("Rac1 and RhoA" . SPARSER::COLLECTION) ("cocaine" . SPARSER::DRUG)
    ("Rac1, RhoA and Cdc42" . SPARSER::COLLECTION) ("Dopamine" . SPARSER::DRUG)
    ("Rho kinase" . SPARSER::PROTEIN) ("synapsin I" . SPARSER::PROTEIN)
    ("PSD-95" . SPARSER::PROTEIN)
    ("post-synaptic density protein" . SPARSER::PROTEIN)
    ("Synapsin-I" . SPARSER::PROTEIN) ("γ-actin" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("SCH23390" . SPARSER::DRUG)
    ("SKF81297" . SPARSER::DRUG) ("JN" . SPARSER::PROTEIN)
    ("appropriate cohorts" . SPARSER::MOLECULE)
    ("a more aggressive breast cancer genotype" . SPARSER::PROTEIN)
    ("estrogen, which will be altered by body habitus as well as the societal acceptance"
     . SPARSER::COLLECTION)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("the homozygous (TT) rs8176318 variant" . SPARSER::VARIANT)
    ("hetero TG or homozygous GG alleles" . SPARSER::COLLECTION)
    ("homozygous GG alleles" . SPARSER::ALLELE)
    ("the homozygous (TT) mutant genotype" . SPARSER::PROTEIN)
    ("respective subtypes" . SPARSER::PROTEIN)
    ("previously described estrogen responsive genes GREB1 [ xref ] and TFF1 [ xref ]"
     . SPARSER::COLLECTION)
    ("previously described estrogen responsive genes GREB1" . SPARSER::PROTEIN)
    ("fulvestrant" . SPARSER::DRUG)
    ("our mutant and wild-type luciferase reporters" . SPARSER::COLLECTION)
    ("homozygous wild-type (TG and GG) alleles" . SPARSER::ALLELE)
    ("TG and GG" . SPARSER::COLLECTION) ("BRCA1-3" . SPARSER::COLLECTION)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("the homozygous TT variant" . SPARSER::VARIANT)
    ("BRCA1- 3" . SPARSER::COLLECTION) ("Trefoil factor 1" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("anti-estrogen" . SPARSER::DRUG)
    ("a 20 " . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN) ("β-Estradiol" . SPARSER::MOLECULE)
    ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1-1" . SPARSER::PROTEIN)
    ("A new interactive protein" . SPARSER::PROTEIN)
    ("The interactive protein" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("Tris" . SPARSER::MOLECULE) ("ASW" . SPARSER::PROTEIN)
    ("CFP and YFP" . SPARSER::COLLECTION) ("CFP/YFP" . SPARSER::COLLECTION)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NpGBKT7-SelP" . SPARSER::PROTEIN-PAIR) ("-Myc" . SPARSER::COLLECTION)
    ("TGCs" . SPARSER::PROTEIN) ("TGAs" . SPARSER::PROTEIN)
    ("-goat" . SPARSER::COLLECTION)
    ("Myc and HA monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Myc and HA" . SPARSER::COLLECTION) ("TX" . SPARSER::PROTEIN)
    ("antibiotic" . SPARSER::DRUG) ("pACT" . SPARSER::PROTEIN)
    ("stabilizer" . SPARSER::MOLECULE)
    ("phosphatases and protein" . SPARSER::COLLECTION)
    ("selenate" . SPARSER::MOLECULE) ("van" . SPARSER::PROTEIN)
    ("paclitaxel and epothilone" . SPARSER::COLLECTION)
    ("epothilone" . SPARSER::MOLECULE)
    ("the smallest isoform" . SPARSER::ISOFORM)
    ("two globular protein subunits" . SPARSER::FRAGMENT)
    ("MTs" . SPARSER::PROTEIN) ("MOG" . SPARSER::PROTEIN)
    ("−1 and Δ S  1" . SPARSER::COLLECTION) ("cal" . SPARSER::PROTEIN)
    ("M −1 and K  2" . SPARSER::COLLECTION)
    ("around 10 kDa" . SPARSER::PROTEIN) ("polyacrylamide" . SPARSER::DRUG)
    ("-IMAC" . SPARSER::COLLECTION) ("IMAC" . SPARSER::PROTEIN)
    ("YFP-" . SPARSER::PROTEIN) ("CFP-" . SPARSER::PROTEIN)
    ("Sel" . SPARSER::MOLECULE) ("cationic molecules" . SPARSER::MOLECULE)
    ("polyamines and calcium [ xref ]" . SPARSER::COLLECTION)
    ("several cationic molecules" . SPARSER::MOLECULE)
    ("polyamines" . SPARSER::MOLECULE) ("CFP-SelP" . SPARSER::COLLECTION)
    ("the enhanced cyan fluorescence protein (CFP) and yellow fluorescence protein (YFP)"
     . SPARSER::COLLECTION)
    ("protein (YFP)" . SPARSER::PROTEIN) ("protein (CFP)" . SPARSER::PROTEIN)
    ("Gold" . SPARSER::MOLECULE) ("Gal" . SPARSER::PROTEIN)
    ("Ade" . SPARSER::PROTEIN) ("TGC" . SPARSER::PROTEIN)
    ("selp" . SPARSER::PROTEIN) ("selenoprotein" . SPARSER::PROTEIN)
    ("Tubulin" . SPARSER::PROTEIN)
    ("the interactive protein" . SPARSER::PROTEIN)
    ("a multi-functional protein" . SPARSER::PROTEIN)
    ("megalin" . SPARSER::PROTEIN) ("Megalin" . SPARSER::PROTEIN)
    ("UGA" . SPARSER::PROTEIN)
    ("a traditional stop codon (UGA)" . SPARSER::PROTEIN)
    ("codon (UGA)" . SPARSER::PROTEIN)
    ("SelP and tubulin" . SPARSER::COLLECTION)
    ("interactive proteins" . SPARSER::PROTEIN)
    ("selenium" . SPARSER::MOLECULE) ("SelP" . SPARSER::PROTEIN)
    ("Se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Selenium" . SPARSER::MOLECULE)
    ("microtubule associated protein Tau" . SPARSER::PROTEIN)
    ("E-1" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("Trp-Leu" . SPARSER::MOLECULE) ("t -BHP" . SPARSER::MOLECULE)
    ("tert -butyl hydroperoxide" . SPARSER::MOLECULE)
    ("S  2" . SPARSER::MOLECULE) ("K  2" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("K  1" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("pCDNA3" . SPARSER::PROTEIN)
    ("B-6" . SPARSER::PROTEIN) ("A-4" . SPARSER::PROTEIN)
    ("B-4" . SPARSER::PROTEIN) ("E. coli )" . SPARSER::PROTEIN)
    ("AH109" . SPARSER::DRUG) ("amyloid-beta peptide" . SPARSER::PROTEIN)
    ("TrxR1" . SPARSER::PROTEIN) ("two domains" . SPARSER::PROTEIN)
    ("lipoprotein receptor" . SPARSER::PROTEIN) ("apoER2" . SPARSER::PROTEIN)
    ("Apolipoprotein E receptor" . SPARSER::PROTEIN)
    ("selenoprotein P" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("smoke (ECS)" . SPARSER::MOLECULE) ("Pioglitazone" . SPARSER::DRUG)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("VEGF or CXCL1" . SPARSER::COLLECTION)
    ("hsa-miR-125a-3p" . SPARSER::COLLECTION) ("hsa" . SPARSER::PROTEIN)
    ("K-ras and HBEC7" . SPARSER::COLLECTION)
    ("PEA3, and chromatin" . SPARSER::COLLECTION)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-ras- and/or K-ras/P53-mutated HBECs" . SPARSER::COLLECTION)
    ("VEGF and CXCL1" . SPARSER::COLLECTION) ("K-ras-" . SPARSER::PROTEIN)
    ("miR-125a-3p" . SPARSER::COLLECTION)
    ("two mature isoforms" . SPARSER::ISOFORM)
    ("pre-miR-125a" . SPARSER::COLLECTION)
    ("MiR-125a-3p" . SPARSER::COLLECTION)
    ("a possible biomarker" . SPARSER::MOLECULE)
    ("pioglitazone and miR-125a" . SPARSER::COLLECTION)
    ("pioglitazone" . SPARSER::DRUG) ("K-ras/P53" . SPARSER::COLLECTION)
    ("CXCL1 and vascular endothelial" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("miR-125a-5p" . SPARSER::MOLECULE) ("MiR-125a" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("PEA3" . SPARSER::PROTEIN)
    ("miR-125a" . SPARSER::PROTEIN) ("IgH/cyclinD1" . SPARSER::COLLECTION)
    ("pre-GC" . SPARSER::COLLECTION)
    ("activated c-myc genes or c-myc genes" . SPARSER::COLLECTION)
    ("proximal 12/23 RSSs" . SPARSER::PROTEIN)
    ("dicentric derivatives" . SPARSER::DERIVATIVE)
    ("no strong cryptic RSSs" . SPARSER::PROTEIN)
    ("strong cryptic RSSs" . SPARSER::PROTEIN)
    ("DAB and DA" . SPARSER::COLLECTION) ("DA or DAB" . SPARSER::COLLECTION)
    ("Southern blot" . SPARSER::PROTEIN)
    ("c-myc and IgH" . SPARSER::COLLECTION) ("c-myc-" . SPARSER::PROTEIN)
    ("MycA" . SPARSER::PROTEIN) ("SHM or CSR" . SPARSER::COLLECTION)
    ("DA, AB, and DAB" . SPARSER::COLLECTION)
    ("15 expressed surface IgM and either Igκ (13 tumors) or Igλ (2 tumors)"
     . SPARSER::COLLECTION)
    ("a productive V(D)J exon" . SPARSER::PROTEIN)
    ("DA and AB" . SPARSER::COLLECTION)
    ("DSB frequency around oncogenes" . SPARSER::ONCOGENE)
    ("large centric chromosome 12 fragments" . SPARSER::FRAGMENT)
    ("the Bcl11b haplo-insufficient T-cell tumor suppressor"
     . SPARSER::SUPPRESSOR)
    ("Bcl11b" . SPARSER::PROTEIN) ("RSSs" . SPARSER::PROTEIN)
    ("Cryptic" . SPARSER::PROTEIN)
    ("cytidine deaminase (AID)" . SPARSER::PROTEIN) ("AID" . SPARSER::PROTEIN)
    ("SHM" . SPARSER::DRUG) ("IgM" . SPARSER::PROTEIN)
    ("classical non-homologous DNA" . SPARSER::DNA) ("RSS" . SPARSER::PROTEIN)
    ("receptors (TCR)" . SPARSER::RECEPTOR)
    ("The B-cell antigen receptor (BCR) and its secreted antibody form"
     . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("IgL" . SPARSER::PROTEIN)
    ("Ig" . SPARSER::MOLECULE) ("DA and DAB" . SPARSER::COLLECTION)
    ("IgH/c-myc" . SPARSER::COLLECTION) ("IgH" . SPARSER::PROTEIN)
    ("DA or AB" . SPARSER::COLLECTION) ("cyclinD1" . SPARSER::PROTEIN)
    ("Myc3" . SPARSER::PROTEIN) ("CD43" . SPARSER::PROTEIN)
    ("1-8" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia-mutated" . SPARSER::PROTEIN)
    ("CB, KS and AJM" . SPARSER::COLLECTION)
    ("Chk1 or the small molecule kinase inhibitor UCN-01"
     . SPARSER::COLLECTION)
    ("siRNA and the small molecule Go6975" . SPARSER::COLLECTION)
    ("unrepairable DNA" . SPARSER::DNA)
    ("the c-myc and l-myc oncogenes" . SPARSER::COLLECTION)
    ("l-myc" . SPARSER::COLLECTION) ("CDKs" . SPARSER::PROTEIN)
    ("either siRNA or small molecules" . SPARSER::COLLECTION)
    ("Fanconi’s" . SPARSER::PROTEIN-FAMILY)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("a cytotoxic chemotherapeutic drug" . SPARSER::DRUG)
    ("cytotoxic chemotherapeutic drugs" . SPARSER::DRUG)
    ("irinotecan and gemcitabine" . SPARSER::COLLECTION)
    ("Chk1, cyclin B1 and pCdc2" . SPARSER::COLLECTION)
    ("MV" . SPARSER::PROTEIN) ("G1:S:G2/M" . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN)
    ("Chk1 siRNA or the kinase inhibitor UCN-01" . SPARSER::COLLECTION)
    ("gemcitabine, irinotecan and cisplatin" . SPARSER::COLLECTION)
    ("Chk1 and cyclin B1" . SPARSER::COLLECTION) ("zVAD-FMK" . SPARSER::DRUG)
    ("UCN-01" . SPARSER::DRUG) ("MK-8776" . SPARSER::DRUG)
    ("LY2603618" . SPARSER::DRUG) ("AK and ÜD" . SPARSER::COLLECTION)
    ("MRS" . SPARSER::PROTEIN) ("AIK" . SPARSER::PROTEIN)
    ("EK" . SPARSER::PROTEIN) ("gene and marker" . SPARSER::COLLECTION)
    ("a strong negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("the MID1 protein complex and the subsequent downregulation of the AR protein [ xref ]"
     . SPARSER::COLLECTION)
    ("AKT and AR" . SPARSER::COLLECTION)
    ("PI3K/PDPK1/AKT" . SPARSER::COLLECTION)
    ("the pro-metastatic metalloproteinase MMP14" . SPARSER::PROTEIN)
    ("MID1-AR" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("around AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("PMEPA1 and AR" . SPARSER::COLLECTION)
    ("a translational inducer" . SPARSER::PROTEIN)
    ("a positive translational regulator" . SPARSER::REGULATOR)
    ("MID1/alpha4" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION) ("PP2a" . SPARSER::PROTEIN)
    ("MIDAS" . SPARSER::PROTEIN) ("HuR and poly-C" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN) ("RBPs" . SPARSER::PROTEIN)
    ("the non-malignant benign parts" . SPARSER::COMPONENT)
    ("the 105 kb distal promoter" . SPARSER::PROMOTER)
    ("MID1, α4 or non-silencing" . SPARSER::COLLECTION)
    ("actinomycinD" . SPARSER::MOLECULE) ("AR-mRNA" . SPARSER::COLLECTION)
    ("MID1 or α4" . SPARSER::COLLECTION) ("del1313TGAC" . SPARSER::PROTEIN)
    ("MID1 or mutant" . SPARSER::COLLECTION)
    ("FLAG-MID1" . SPARSER::COLLECTION) ("protein-" . SPARSER::PROTEIN)
    ("thymosin" . SPARSER::PROTEIN) ("MID1-FLAG" . SPARSER::COLLECTION)
    ("MID1-protein" . SPARSER::COLLECTION)
    ("MID1 complex-associated mRNAs" . SPARSER::PROTEIN)
    ("mTOR/PP2A" . SPARSER::COLLECTION) ("PDPK-1" . SPARSER::COLLECTION)
    ("PDPK" . SPARSER::PROTEIN)
    ("microtubules and targets specific mRNAs" . SPARSER::COLLECTION)
    ("active polyribosomes" . SPARSER::BIO-COMPLEX)
    ("polyribosomes" . SPARSER::BIO-COMPLEX)
    ("mTOR/Raptor" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("the microtubule-associated transcription factor GLI3" . SPARSER::PROTEIN)
    ("microtubule-associated PP2A" . SPARSER::PROTEIN)
    ("the principal phosphatase" . SPARSER::PHOSPHATASE)
    ("lyase" . SPARSER::PROTEIN)
    ("a cellular master regulator and an important player"
     . SPARSER::COLLECTION)
    ("MID1 and its binding partner alpha4 (α4)" . SPARSER::COLLECTION)
    ("These urogenital malformations" . SPARSER::PROTEIN)
    ("MID1 and androgen" . SPARSER::COLLECTION)
    ("malformations" . SPARSER::PROTEIN)
    ("a microtubule-associated ubiquitin E3 ligase" . SPARSER::LIGASE)
    ("the key regulator and oncogenic driver" . SPARSER::COLLECTION)
    ("AR and PI3K" . SPARSER::COLLECTION)
    ("the key transcription factor" . SPARSER::PROTEIN)
    ("PCa and a promising target" . SPARSER::COLLECTION)
    ("NFκB-" . SPARSER::PROTEIN) ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR-protein" . SPARSER::COLLECTION)
    ("The microtubule-associated MID1 protein complex" . SPARSER::BIO-COMPLEX)
    ("protein-mRNA" . SPARSER::COLLECTION)
    ("AR and MID1" . SPARSER::COLLECTION) ("MID1 and AR" . SPARSER::COLLECTION)
    ("TMSL8" . SPARSER::PROTEIN) ("PFDN5" . SPARSER::PROTEIN)
    ("ARE2" . SPARSER::PROTEIN) ("ARE1" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("FBS 1" . SPARSER::PROTEIN)
    ("PDPK1" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN) ("PMEPA1" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("PCBP1" . SPARSER::PROTEIN)
    ("PCBP2" . SPARSER::PROTEIN) ("abiraterone acetate" . SPARSER::DRUG)
    ("phosphatase 2" . SPARSER::PROTEIN) ("alpha4" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN) ("MID1" . SPARSER::PROTEIN)
    ("CDK4, CDKN2a/p16, RB, and CCND3" . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG)
    ("phosphorylated RB and the drug" . SPARSER::COLLECTION)
    ("CDK4 and CDKN2A" . SPARSER::COLLECTION)
    ("BCL2 and p21" . SPARSER::COLLECTION)
    ("CDK4, CDKN2A, and RB" . SPARSER::COLLECTION)
    ("CDKN2A, RB1, and CDK4" . SPARSER::COLLECTION)
    ("CDKN2A or RB" . SPARSER::COLLECTION)
    ("a sizeable fraction" . SPARSER::COMPONENT)
    ("kinase and BCL2" . SPARSER::COLLECTION) ("ABT" . SPARSER::MOLECULE)
    ("ABT-737 and PD-0332991" . SPARSER::COLLECTION)
    ("BH3 mimetic drugs" . SPARSER::DRUG)
    ("CDK4, CDK6, and RB1" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN)
    ("CDK4, Cyclin D3, or shp16" . SPARSER::COLLECTION)
    ("CDK4 or mutant" . SPARSER::COLLECTION)
    ("p16 or Rb1" . SPARSER::COLLECTION) ("Rb1" . SPARSER::PROTEIN)
    ("CDK4/CCND3" . SPARSER::COLLECTION)
    ("CDK4 and CCND3" . SPARSER::COLLECTION)
    ("CDKN2A, RB, and CDK4" . SPARSER::COLLECTION)
    ("CCND1 and CCND2" . SPARSER::COLLECTION)
    ("RB and CDKN2A" . SPARSER::COLLECTION)
    ("p16 or RB1" . SPARSER::COLLECTION)
    ("EZH2 and CREBBP" . SPARSER::COLLECTION)
    ("CDK4 and BCL2" . SPARSER::COLLECTION) ("Cyclin D2" . SPARSER::PROTEIN)
    ("l -Glutamine" . SPARSER::MOLECULE) ("P-RB" . SPARSER::PROTEIN)
    ("P-Rb" . SPARSER::PROTEIN) ("PD-0332991" . SPARSER::DRUG)
    ("Cyclin D3" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("CCND3" . SPARSER::PROTEIN) ("1 −4" . SPARSER::PROTEIN)
    ("CDKN2" . SPARSER::PROTEIN)
    ("cardiac aging, and targeting Sirt1" . SPARSER::PROTEIN)
    ("AMPK-Sirt1" . SPARSER::COLLECTION) ("angiotensin" . SPARSER::PROTEIN)
    ("Telmisartan" . SPARSER::DRUG) ("Resveratrol" . SPARSER::PROTEIN)
    ("skeletal myoblasts" . SPARSER::PROTEIN)
    ("phospho-AMPK and MnSOD" . SPARSER::COLLECTION)
    ("the Sirt1’s" . SPARSER::PROTEIN)
    ("Sirt1 and its associated molecules" . SPARSER::COLLECTION)
    ("its associated molecules" . SPARSER::MOLECULE)
    ("Sirt1 and MnSOD" . SPARSER::COLLECTION)
    ("FoxO1 and p53" . SPARSER::COLLECTION)
    ("AMPK, Sirt1 and MnSOD" . SPARSER::COLLECTION)
    ("Nampt and Sirt1" . SPARSER::COLLECTION)
    ("AMPK and Nampt" . SPARSER::COLLECTION)
    ("MnSOD, Trx1 and Bcl-xL" . SPARSER::COLLECTION)
    ("Trx1" . SPARSER::PROTEIN) ("Trx" . SPARSER::PROTEIN)
    ("ray" . SPARSER::PROTEIN)
    ("Sirt1 and the associated molecules" . SPARSER::COLLECTION)
    ("the associated molecules" . SPARSER::MOLECULE)
    ("ischemia or ischemic/reperfusion" . SPARSER::COLLECTION)
    ("antioxidants and downregulation of proapoptotic molecules"
     . SPARSER::COLLECTION)
    ("elegans, and metazoan" . SPARSER::COLLECTION)
    ("antioxidants and up-regulation of proapoptotic molecules"
     . SPARSER::COLLECTION)
    ("AMPK-Nampt-Sirt1" . SPARSER::COLLECTION) ("Nampt" . SPARSER::PROTEIN)
    ("Sirt1 and other (associated) downstream molecules" . SPARSER::COLLECTION)
    ("compound C" . SPARSER::MOLECULE) ("Compound C" . SPARSER::MOLECULE)
    ("FoxO1" . SPARSER::PROTEIN) ("thioredoxin1" . SPARSER::PROTEIN)
    ("inducer or suppressor" . SPARSER::COLLECTION)
    ("methylsulfonylmethane (MSM)" . SPARSER::DRUG)
    ("STAT5B/insulin-like growth factor receptor" . SPARSER::COLLECTION)
    ("STAT3/VEGF" . SPARSER::COLLECTION) ("MSM" . SPARSER::DRUG)
    ("methylsulfonylmethane" . SPARSER::DRUG)
    ("PRL, ERα, and STAT3" . SPARSER::COLLECTION)
    ("ER and STAT3" . SPARSER::COLLECTION)
    ("STATs and HIF1α" . SPARSER::COLLECTION)
    ("HIF1α and STAT3" . SPARSER::COLLECTION)
    ("RAS-MAPK" . SPARSER::COLLECTION)
    ("MAPK, and ERK1/2" . SPARSER::COLLECTION)
    ("STATs and other signaling components" . SPARSER::COLLECTION)
    ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("particular STAT5A" . SPARSER::PROTEIN)
    ("IL-6 or IL-3" . SPARSER::COLLECTION)
    ("IL6Rα and GP130" . SPARSER::COLLECTION)
    ("PRL and other cytokines" . SPARSER::COLLECTION)
    ("chemical and siRNA-mediated" . SPARSER::COLLECTION)
    ("cyclin D1
[ xref , xref ] and β-casein
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("potentially several other isoforms" . SPARSER::ISOFORM)
    ("heterodimeric PRLR" . SPARSER::PROTEIN)
    ("LF, SF1a, and SF1b" . SPARSER::COLLECTION) ("SF1b" . SPARSER::PROTEIN)
    ("AMPK and protein" . SPARSER::COLLECTION)
    ("β-catenin and β-tubulin" . SPARSER::COLLECTION)
    ("LKB1 and β-catenin" . SPARSER::COLLECTION)
    ("IgG, STAT3 and STAT5A" . SPARSER::COLLECTION)
    ("STAT3 and/or STAT5A" . SPARSER::COLLECTION)
    ("the distal LKB1 promoter" . SPARSER::PROMOTER)
    ("JAK2 or STAT3" . SPARSER::COLLECTION)
    ("JAK2, STAT3, and STAT5A" . SPARSER::COLLECTION)
    ("JAK2, STAT3, or STAT5A" . SPARSER::COLLECTION)
    ("STAT3 or STAT5A" . SPARSER::COLLECTION)
    ("STAT3 (TTCTGGGAA)" . SPARSER::PROTEIN)
    ("promoter (TTCTTGGAA)" . SPARSER::PROMOTER) ("PRE" . SPARSER::PROTEIN)
    ("GAA" . SPARSER::PROTEIN) ("PRL and cytokine" . SPARSER::COLLECTION)
    ("STATs, and STAT" . SPARSER::COLLECTION)
    ("PRLR-SF1b" . SPARSER::PROTEIN-PAIR)
    ("approximately 85–90 kDa" . SPARSER::PROTEIN)
    ("the monoclonal anti-human PRLR antibody" . SPARSER::ANTIBODY)
    ("intermediate, and short forms (ΔS1, IF, SF1a and SF1b, respectively) and the PRLR binding protein (reviewed in
[ xref ])"
     . SPARSER::COLLECTION)
    ("intermediate, and short forms" . SPARSER::FORM)
    ("delta" . SPARSER::PROTEIN) ("LKB1-AMPK-ACC" . SPARSER::COLLECTION)
    ("actin and calnexin" . SPARSER::COLLECTION)
    ("calnexin" . SPARSER::PROTEIN)
    ("PRL or other cytokines" . SPARSER::COLLECTION)
    ("long form (LF)" . SPARSER::PROTEIN)
    ("specifically targets STAT3" . SPARSER::PROTEIN)
    ("STAT (PIAS)" . SPARSER::PROTEIN)
    ("SHP-1 and Protein" . SPARSER::COLLECTION)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("Suppressors" . SPARSER::SUPPRESSOR)
    ("interleukin (IL)" . SPARSER::PROTEIN)
    ("STAT1, STAT3, STAT5A, and STAT5B" . SPARSER::COLLECTION)
    ("PRL and IL-6" . SPARSER::COLLECTION)
    ("receptor (PRLR)" . SPARSER::RECEPTOR) ("PRLR" . SPARSER::PROTEIN)
    ("STAT3 and STAT5A" . SPARSER::COLLECTION)
    ("siRNAs or inhibitors" . SPARSER::COLLECTION)
    ("STAT3, and STAT5A" . SPARSER::COLLECTION)
    ("Prolactin (PRL) and Signal transducer" . SPARSER::COLLECTION)
    ("PRL" . SPARSER::PROTEIN) ("Prolactin" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("EGR-1" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN) ("GP130" . SPARSER::PROTEIN)
    ("IL6Rα" . SPARSER::PROTEIN) ("IL-6 receptor" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("OCT-1" . SPARSER::PROTEIN)
    ("octamer-binding transcription factor 1" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1 alpha" . SPARSER::PROTEIN)
    ("β catenin" . SPARSER::PROTEIN) ("pcDNA3" . SPARSER::PROTEIN)
    ("PD098059" . SPARSER::DRUG) ("WP1066" . SPARSER::DRUG)
    ("in Chinese hamster" . SPARSER::PROTEIN) ("PDK4" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("β-casein" . SPARSER::PROTEIN)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("STAT5B" . SPARSER::PROTEIN) ("Interleukin 6" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("long form" . SPARSER::PROTEIN)
    ("Akt inhibitors or Fbw7/CKI inhibitors" . SPARSER::COLLECTION)
    ("Fbw7/CKI" . SPARSER::COLLECTION) ("CKI" . SPARSER::PROTEIN)
    ("DAB2IP and NF1" . SPARSER::COLLECTION)
    ("RasGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurofibromin" . SPARSER::PROTEIN)
    ("Cyclin E, c-Myc, c-Jun, Mcl-1, mTOR and Notch-1" . SPARSER::COLLECTION)
    ("Ras and TRAF" . SPARSER::COLLECTION)
    ("Fbw7 and DAB2IP" . SPARSER::COLLECTION)
    ("DAB2IP and Fbw7" . SPARSER::COLLECTION)
    ("Fbw7 and substrate" . SPARSER::COLLECTION)
    ("Cullin-1 and DAB2IP" . SPARSER::COLLECTION)
    ("Rbx1 and Skp1" . SPARSER::COLLECTION)
    ("Cullin-1 and an associated F-box protein" . SPARSER::COLLECTION)
    ("an associated F-box protein" . SPARSER::PROTEIN)
    ("Cullin-1 and Cullin-4A" . SPARSER::COLLECTION)
    ("Cullin-2, Cullin-3, or Cullin-5" . SPARSER::COLLECTION)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("RasGAP" . SPARSER::PROTEIN)
    ("the phospho-mimetic mutant" . SPARSER::MUTANT)
    ("RAS-ERK" . SPARSER::COLLECTION) ("TRAF2 and Ras" . SPARSER::COLLECTION)
    ("DAB2IP and Ras" . SPARSER::COLLECTION)
    ("DAB2IP and TRAF2" . SPARSER::COLLECTION)
    ("TRAF2 and ASK1" . SPARSER::COLLECTION)
    ("RAS, ERK and Akt" . SPARSER::COLLECTION)
    ("any Akt or similar kinases" . SPARSER::COLLECTION)
    ("SGK and ribosomal S6 kinase (S6K)" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("SGK" . SPARSER::PROTEIN) ("EZH2 or promoter" . SPARSER::COLLECTION)
    ("Ras and TRAF2" . SPARSER::COLLECTION)
    ("H-Ras and R-Ras" . SPARSER::COLLECTION)
    ("Ras-Raf-ERK" . SPARSER::COLLECTION) ("ASK1-JNK" . SPARSER::COLLECTION)
    ("DAB2IP and its effector molecules H-Ras and TRAF2" . SPARSER::COLLECTION)
    ("H-Ras and TRAF2" . SPARSER::COLLECTION)
    ("DOC-2/DAB2" . SPARSER::COLLECTION) ("gag-pol" . SPARSER::PROTEIN)
    ("HA-Ras" . SPARSER::PROTEIN) ("Cullin 5" . SPARSER::PROTEIN)
    ("Cullin 4" . SPARSER::PROTEIN) ("Cullin 3" . SPARSER::PROTEIN)
    ("Cullin 2" . SPARSER::PROTEIN) ("Cullin 1" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("Cullin-5" . SPARSER::PROTEIN)
    ("Cullin-3" . SPARSER::PROTEIN) ("Cullin-2" . SPARSER::PROTEIN)
    ("Cullin-4A" . SPARSER::PROTEIN) ("Cullin-1" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("R-Ras" . SPARSER::PROTEIN)
    ("RAS GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-GTPase activating protein" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("DAB2IP" . SPARSER::PROTEIN)
    ("DAB2" . SPARSER::PROTEIN) ("DOC-2" . SPARSER::PROTEIN)
    ("disabled homolog 2" . SPARSER::PROTEIN)
    ("YL and RJ" . SPARSER::COLLECTION) ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("NEMO" . SPARSER::PROTEIN) ("Several viral proteins" . SPARSER::PROTEIN)
    ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAK1-TAB2" . SPARSER::PROTEIN-PAIR)
    ("TRIM5/tetherin" . SPARSER::COLLECTION)
    ("NF-κB and AP-1-dependent genes [ xref , xref ]" . SPARSER::COLLECTION)
    ("TRIM5 and tetherin" . SPARSER::COLLECTION)
    ("the relatively abundant virion-associated Vpr protein"
     . SPARSER::PROTEIN)
    ("TAK1 and NF-κB" . SPARSER::COLLECTION) ("vGPCR" . SPARSER::PROTEIN)
    ("virion-associated Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proviral DNA" . SPARSER::DNA) ("the HIV-Luc proviral DNA" . SPARSER::DNA)
    ("TAK1, TRAF6 or TAB3" . SPARSER::COLLECTION)
    ("TAK1, TRAF6, or TAB3" . SPARSER::COLLECTION)
    ("NF-κB-" . SPARSER::PROTEIN) ("whose promoters" . SPARSER::PROMOTER)
    ("NF-κB or AP-1" . SPARSER::COLLECTION)
    ("Vpr or TAK1" . SPARSER::COLLECTION)
    ("IKKβ and MKK7" . SPARSER::COLLECTION)
    ("TAK1 and TRAF6" . SPARSER::COLLECTION)
    ("auto-polyubiquitination" . SPARSER::PROTEIN)
    ("Vpr and TAB3" . SPARSER::COLLECTION)
    ("TRAF6 and TRAF2" . SPARSER::COLLECTION)
    ("TRAF6 or TRAF2" . SPARSER::COLLECTION)
    ("TRAF2- or TRAF6-specific shRNA" . SPARSER::COLLECTION)
    ("TRAF2-" . SPARSER::PROTEIN) ("Vpr and TAK1" . SPARSER::COLLECTION)
    ("anti-Myc or anti-Flag" . SPARSER::COLLECTION)
    ("Flag-Vpr" . SPARSER::COLLECTION) ("Myc-TAK1" . SPARSER::COLLECTION)
    ("THP-1 (Figure  xref C) and THP-1" . SPARSER::COLLECTION)
    ("HIV-1 VLP (Vpr+) or HIV-1 VLP (Vpr-)" . SPARSER::COLLECTION)
    ("Vpr-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pcDNA3-Vpr" . SPARSER::PROTEIN-PAIR) ("pLP1" . SPARSER::PROTEIN)
    ("VLP" . SPARSER::PROTEIN) ("AZT" . SPARSER::DRUG)
    ("total endogenous TAK1 and its phosphorylated form" . SPARSER::COLLECTION)
    ("PP1 and PP2A" . SPARSER::COLLECTION)
    ("the HIV-1 virion-associated Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral gp41 protein" . SPARSER::PROTEIN)
    ("TNFα, IL-1β, and TGFβ" . SPARSER::COLLECTION)
    ("TRAF2 or TRAF6" . SPARSER::COLLECTION)
    ("c-Jun N-terminal kinase (JNK) and p38 MAPK" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("MKK" . SPARSER::PROTEIN-FAMILY)
    ("TAB2 or TAB3" . SPARSER::COLLECTION)
    ("the receptor proximal complex" . SPARSER::BIO-COMPLEX)
    ("TAB2, and TAB3" . SPARSER::COLLECTION) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("nuclear factor-κB (NF-κB) and activator protein 1 (AP-1)"
     . SPARSER::COLLECTION)
    ("IL-6, IL-8, and CCL5" . SPARSER::COLLECTION)
    ("the viral pre-integration complex (PIC)" . SPARSER::BIO-COMPLEX)
    ("complex (PIC)" . SPARSER::BIO-COMPLEX)
    ("viral Gag protein" . SPARSER::PROTEIN)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("HIV-1 virion-associated Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor-β-activated kinase" . SPARSER::KINASE)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("tetradecanoylphorbol acetate" . SPARSER::DRUG) ("NL4" . SPARSER::PROTEIN)
    ("Tax protein" . SPARSER::PROTEIN) ("B-E" . SPARSER::PROTEIN)
    ("ICP0" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("Calyculin A" . SPARSER::MOLECULE)
    ("TAB2" . SPARSER::PROTEIN) ("TAK1 binding protein 1" . SPARSER::PROTEIN)
    ("MAP3K" . SPARSER::PROTEIN) ("MAPK kinase kinase" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("Gag protein" . SPARSER::PROTEIN)
    ("TAB3" . SPARSER::PROTEIN)
    ("MDM2 and a tumor suppressor PTEN" . SPARSER::COLLECTION)
    ("TSC" . SPARSER::PROTEIN) ("AKT/PI3K/HIF-1α" . SPARSER::COLLECTION)
    ("Significantly higher miR-17-5" . SPARSER::PROTEIN)
    ("fluorouracil, irinotecan and oxaliplatin" . SPARSER::COLLECTION)
    ("miRNA, antagomir or antisense" . SPARSER::COLLECTION)
    ("PTEN/AKT/PI3K" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("Oxaliplatin, Irinotecan, and Fluorouracil" . SPARSER::COLLECTION)
    ("Irinotecan" . SPARSER::DRUG) ("Oxaliplatin" . SPARSER::DRUG)
    ("mature miR-17-5" . SPARSER::PROTEIN)
    ("leucovorin and oxaliplatin" . SPARSER::COLLECTION)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("a few predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("irinotecan and oxaliplatin" . SPARSER::COLLECTION)
    ("miR-7" . SPARSER::PROTEIN)
    ("healthy controls display s-p53 antibodies" . SPARSER::ANTIBODY)
    ("type, histology, age, or degree" . SPARSER::COLLECTION)
    ("western-blot" . SPARSER::PROTEIN)
    ("s-p53-antibody" . SPARSER::COLLECTION) ("verge" . SPARSER::PROTEIN)
    ("PLRs" . SPARSER::PROTEIN) ("autoantibody" . SPARSER::PROTEIN)
    ("protein and anti-p53" . SPARSER::COLLECTION)
    ("auto-antibodies" . SPARSER::ANTIBODY) ("DOR" . SPARSER::PROTEIN)
    ("DORs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NLR" . SPARSER::PROTEIN)
    ("s-p53" . SPARSER::COLLECTION) ("S14" . SPARSER::PROTEIN)
    ("FANCB and FANCL" . SPARSER::COLLECTION)
    ("FANC" . SPARSER::PROTEIN-FAMILY) ("FANCC-FANCG" . SPARSER::COLLECTION)
    ("a much more robust substrate" . SPARSER::SUBSTRATE)
    ("FANCF and FANCM" . SPARSER::COLLECTION)
    ("FANCL and FANCB" . SPARSER::COLLECTION)
    ("isogenic single and double mutants" . SPARSER::MUTANT)
    ("FANCG and FANCM" . SPARSER::COLLECTION) ("ICL" . SPARSER::PROTEIN)
    ("FANCD2 or FANCI" . SPARSER::COLLECTION)
    ("FANCM and FANCF" . SPARSER::COLLECTION)
    ("FANCG and FANCE" . SPARSER::COLLECTION)
    ("FANCE and FANCF" . SPARSER::COLLECTION)
    ("FANCG and FANCF" . SPARSER::COLLECTION)
    ("FANCG or FANCF" . SPARSER::COLLECTION)
    ("FANCM/FAAP24" . SPARSER::COLLECTION)
    ("FANCB or FANCL" . SPARSER::COLLECTION)
    ("FANCA-FANCG" . SPARSER::COLLECTION) ("psoralen-" . SPARSER::DRUG)
    ("psoralen" . SPARSER::DRUG)
    ("damage-induced chromatin" . SPARSER::PROTEIN)
    ("Ube2t" . SPARSER::PROTEIN)
    ("ligases, or multi-subunit" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("HECT" . SPARSER::PROTEIN)
    ("Chromatin and DNA" . SPARSER::COLLECTION)
    ("FANCG and FANCL" . SPARSER::COLLECTION)
    ("FANCL and FAAP100" . SPARSER::COLLECTION)
    ("SFB-tagged FANCL and/or FAAP100" . SPARSER::COLLECTION)
    ("SFB" . SPARSER::PROTEIN)
    ("soluble protein fractions" . SPARSER::COMPONENT)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("mitomycin C or cisplatin" . SPARSER::COLLECTION)
    ("four isogenic HCT116 knockout mutants" . SPARSER::MUTANT)
    ("FANCL or FANCB" . SPARSER::COLLECTION)
    ("FANCG or FAAP20" . SPARSER::COLLECTION)
    ("FANCG and FAAP20" . SPARSER::COLLECTION) ("Mutants" . SPARSER::MUTANT)
    ("Component" . SPARSER::COMPONENT) ("FANCM" . SPARSER::PROTEIN)
    ("FANCC, FANCE, and FANCF" . SPARSER::COLLECTION)
    ("FANCB and FAAP100" . SPARSER::COLLECTION)
    ("FANCB-FANCL-FAAP100" . SPARSER::COLLECTION)
    ("a possible scaffold" . SPARSER::SCAFFOLD) ("TPR" . SPARSER::PROTEIN)
    ("FANCA, FANCG, and FAAP20" . SPARSER::COLLECTION)
    ("FANCL and FAAP20" . SPARSER::COLLECTION)
    ("seven FA proteins (A, B, C, E, F, G, and L) and two FA"
     . SPARSER::COLLECTION)
    ("FAAP20 and FAAP100" . SPARSER::COLLECTION)
    ("classical FA genes" . SPARSER::GENE)
    ("FANCL, FANCB, and FAAP100" . SPARSER::COLLECTION)
    ("chromatin and DNA" . SPARSER::COLLECTION)
    ("FANCC-FANCE-FANCF" . SPARSER::COLLECTION)
    ("FANCA-FANCG-FAAP20" . SPARSER::COLLECTION) ("FANCF" . SPARSER::PROTEIN)
    ("FANCE" . SPARSER::PROTEIN) ("FANCC" . SPARSER::PROTEIN)
    ("FANCG" . SPARSER::PROTEIN) ("FANCA" . SPARSER::PROTEIN)
    ("FANCB" . SPARSER::PROTEIN) ("FANCL" . SPARSER::PROTEIN)
    ("M 2" . SPARSER::MOLECULE) ("H2A" . SPARSER::PROTEIN)
    ("FAAP24" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("B-L" . SPARSER::PROTEIN) ("A-G" . SPARSER::PROTEIN)
    ("FAAP20" . SPARSER::PROTEIN) ("FAAP100" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("the MOR and/or other signaling proteins" . SPARSER::COLLECTION)
    ("each racial cohort" . SPARSER::MOLECULE)
    ("88.2 mcg/kg intraoperative morphine" . SPARSER::MOLECULE)
    ("naloxone" . SPARSER::DRUG)
    ("WD repeat and SOCS box containing 2 ( WSB2 ) and kinase suppressor of ras 2 ( KSR2 )"
     . SPARSER::COLLECTION)
    ("ß-arrestin" . SPARSER::COLLECTION)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("threonines" . SPARSER::AMINO-ACID) ("MOR and TAO3" . SPARSER::COLLECTION)
    ("MOR" . SPARSER::PROTEIN) ("Opioid" . SPARSER::PROTEIN)
    ("ERK1/ERK2" . SPARSER::COLLECTION) ("TAO" . SPARSER::DRUG)
    ("the large and diverse Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methyltransferase like 21A and cyclic adenosine" . SPARSER::COLLECTION)
    ("rs 2952768-associated minor variants" . SPARSER::VARIANT)
    ("A subsequent independent replication cohort" . SPARSER::MOLECULE)
    ("TAOK3 and morphine" . SPARSER::COLLECTION)
    ("Asparagine" . SPARSER::AMINO-ACID)
    ("postoperative morphine" . SPARSER::MOLECULE)
    ("Oxycodone" . SPARSER::DRUG) ("Anesthetic" . SPARSER::DRUG)
    ("received no preoperative acetaminophen" . SPARSER::DRUG)
    ("propofol" . SPARSER::DRUG) ("oxycodone" . SPARSER::DRUG)
    ("the smaller replication cohort" . SPARSER::MOLECULE)
    ("AA and EC" . SPARSER::COLLECTION) ("oxyhemoglobin" . SPARSER::MOLECULE)
    ("severe OSA" . SPARSER::PROTEIN) ("OSA" . SPARSER::PROTEIN)
    ("ketamine" . SPARSER::DRUG)
    ("the final retrospective discovery and replication cohorts"
     . SPARSER::MOLECULE)
    ("AIMS" . SPARSER::PROTEIN) ("retrospective cohorts" . SPARSER::MOLECULE)
    ("naïve" . SPARSER::PROTEIN) ("anesthetic" . SPARSER::DRUG)
    ("CYP2C9" . SPARSER::PROTEIN) ("warfarin" . SPARSER::DRUG)
    ("epoxide" . SPARSER::MOLECULE)
    ("an effective postoperative analgesic" . SPARSER::DRUG)
    ("EC and AA" . SPARSER::COLLECTION) ("Morphine" . SPARSER::MOLECULE)
    ("opioid-naïve" . SPARSER::COLLECTION) ("morphine" . SPARSER::MOLECULE)
    ("opioid" . SPARSER::PROTEIN) ("KSR2" . SPARSER::PROTEIN)
    ("kinase suppressor of ras 2" . SPARSER::PROTEIN)
    ("WSB2" . SPARSER::PROTEIN)
    ("WD repeat and SOCS box containing 2" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methyltransferase like 21A" . SPARSER::PROTEIN)
    ("CDC5L" . SPARSER::PROTEIN) ("TMEM117" . SPARSER::PROTEIN)
    ("transmembrane protein 117" . SPARSER::PROTEIN)
    ("SUDS3" . SPARSER::PROTEIN) ("PEBP1" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine binding protein 1" . SPARSER::PROTEIN)
    ("CYP4F2" . SPARSER::PROTEIN) ("4F2" . SPARSER::PROTEIN)
    ("VKORC1" . SPARSER::PROTEIN) ("subunit 1" . SPARSER::PROTEIN)
    ("OPRM1" . SPARSER::PROTEIN) ("opioid receptor" . SPARSER::PROTEIN)
    ("TAO3" . SPARSER::PROTEIN) ("TAOK3" . SPARSER::PROTEIN)
    ("mature 3p miRNAs" . SPARSER::PROTEIN)
    ("the 3p mature miRNAs" . SPARSER::PROTEIN)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("mature miRNAs" . SPARSER::PROTEIN) ("miRNA-seq" . SPARSER::COLLECTION)
    ("PTEN , ATM and WT1" . SPARSER::COLLECTION)
    ("ALK , MYCN  and REL" . SPARSER::COLLECTION)
    ("PTEN and SUFU" . SPARSER::COLLECTION)
    ("TP53 and MAP2K4" . SPARSER::COLLECTION) ("SUFU" . SPARSER::PROTEIN)
    ("REL" . SPARSER::PROTEIN) ("MYCN  " . SPARSER::PROTEIN)
    ("Oncogenes" . SPARSER::ONCOGENE) ("allele " . SPARSER::ALLELE)
    ("the 5p mature miRNA" . SPARSER::PROTEIN)
    ("the 3p mature miRNA" . SPARSER::PROTEIN) ("DICER" . SPARSER::PROTEIN)
    ("a unique variant" . SPARSER::VARIANT) ("qter" . SPARSER::DRUG)
    ("DICER1, TP53  and NRAS" . SPARSER::COLLECTION) ("IIIb" . SPARSER::DRUG)
    ("RNase" . SPARSER::PROTEIN) ("Kit 2" . SPARSER::PROTEIN)
    ("DICER1 " . SPARSER::PROTEIN) ("Ago2" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("pre-miRNAs" . SPARSER::RNA) ("pre-miRNA" . SPARSER::RNA)
    ("TP53  " . SPARSER::PROTEIN) ("SLX4" . SPARSER::PROTEIN)
    ("BTBD12" . SPARSER::PROTEIN) ("DICER1" . SPARSER::PROTEIN)
    ("a vital upstream regulator" . SPARSER::REGULATOR)
    ("mut or HER2" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("HER2-wt" . SPARSER::COLLECTION)
    ("AG1478 or Erlotinib" . SPARSER::COLLECTION)
    ("ATM, ATR and Chk1" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION)
    ("ATM and Chk2" . SPARSER::COLLECTION) ("mut-HER2" . SPARSER::COLLECTION)
    ("HER2-mut" . SPARSER::COLLECTION) ("HER2-" . SPARSER::PROTEIN)
    ("HER3 and HER4" . SPARSER::COLLECTION)
    ("HER3- and HER4-shRNA" . SPARSER::COLLECTION)
    ("HER4-shRNA" . SPARSER::COLLECTION) ("HER3-" . SPARSER::PROTEIN)
    ("DNA-content" . SPARSER::DNA) ("HER2-shRNA" . SPARSER::COLLECTION)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("HER3 and/or HER4" . SPARSER::COLLECTION)
    ("HER2, HER3 and/or HER4" . SPARSER::COLLECTION)
    ("Chk2 (downstream target of ATM) and Chk1 (downstream target of ATR)"
     . SPARSER::COLLECTION)
    ("Cdc2/Cyclin" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("HER1/2/3" . SPARSER::COLLECTION) ("HER2 and HER3" . SPARSER::COLLECTION)
    ("HER1 and HER3" . SPARSER::COLLECTION)
    ("HER1, HER2 and HER3" . SPARSER::COLLECTION)
    ("Herceptin and HER1" . SPARSER::COLLECTION)
    ("ERBB or EGFR" . SPARSER::COLLECTION)
    ("ligand and HER3" . SPARSER::COLLECTION)
    ("HER1, HER3 and HER4" . SPARSER::COLLECTION)
    ("HER1 and HER2" . SPARSER::COLLECTION)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("their respective downstream targets" . SPARSER::TARGET-PROTEIN)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("HER3 or HER4" . SPARSER::COLLECTION) ("ATM/ATR" . SPARSER::COLLECTION)
    ("HER1, HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("AZD6244" . SPARSER::DRUG) ("PLX4032" . SPARSER::DRUG)
    ("CP724714" . SPARSER::DRUG) ("CI1033" . SPARSER::DRUG)
    ("inhibitors and mechanisms" . SPARSER::COLLECTION)
    ("FGFR-ERBB" . SPARSER::COLLECTION)
    ("inhibitors and antibodies" . SPARSER::COLLECTION)
    ("FGFR and ERBB" . SPARSER::COLLECTION) ("FGFR/ERBB" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("FGFR and EGFR" . SPARSER::COLLECTION)
    ("dual ERBB/FGFR inhibitors" . SPARSER::INHIBITOR)
    ("ERBB/FGFR" . SPARSER::COLLECTION)
    ("cancer makes FGFRs attractive therapeutic targets"
     . SPARSER::TARGET-PROTEIN)
    ("exogeneous NRG1 or NRG2" . SPARSER::COLLECTION)
    ("NRG1 or NRG2" . SPARSER::COLLECTION)
    ("the principal ligands" . SPARSER::LIGAND)
    ("FGFR1 or FGFR2" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("EGF, HBEGF, AREG, and TGFA" . SPARSER::COLLECTION)
    ("HBEGF" . SPARSER::PROTEIN)
    ("NRG1, NRG2, NRG4, and BTC" . SPARSER::COLLECTION)
    ("BTC" . SPARSER::PROTEIN) ("ERBB2 and/or ERBB3" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN) ("shRNA and drug" . SPARSER::COLLECTION)
    ("ERBB and ERBB" . SPARSER::COLLECTION)
    ("AZD8931 and lapatinib" . SPARSER::COLLECTION)
    ("AZD8931 or lapatinib" . SPARSER::COLLECTION)
    ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 or ERBB3" . SPARSER::COLLECTION)
    ("ERBB2/ERBB3" . SPARSER::COLLECTION)
    ("EGFR, ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("p-ERBB3" . SPARSER::COLLECTION) ("p-ERBB2" . SPARSER::COLLECTION)
    ("p-FGFR" . SPARSER::COLLECTION) ("p-FRS2" . SPARSER::COLLECTION)
    ("Strong phospho-EGFR" . SPARSER::PROTEIN) ("p-MET" . SPARSER::COLLECTION)
    ("the mesenchymal markers N-cadherin and fibronectin"
     . SPARSER::COLLECTION)
    ("N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("PLAU, PLAUR, SNAIL and SLUG" . SPARSER::COLLECTION)
    ("SLUG" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("PLAU" . SPARSER::PROTEIN)
    ("42 membrane receptor tyrosine kinases (RTKs) and mRNA"
     . SPARSER::COLLECTION)
    ("ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("Hepatocyte Growth Factor (HGF)" . SPARSER::PROTEIN)
    ("orally bioavailable inhibitor" . SPARSER::INHIBITOR)
    ("FGFR1/2/3" . SPARSER::COLLECTION) ("FGFR3-TACC3" . SPARSER::COLLECTION)
    ("FGFR1-TACC1" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("FGFR1, FGFR2, FGFR3 and FGFR4" . SPARSER::COLLECTION)
    ("The Fibroblast Growth Factors (FGFs) and their cognate receptors (FGFRs)"
     . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN) ("ERBB" . SPARSER::PROTEIN)
    ("ponatinib" . SPARSER::DRUG) ("anti-ERBB2" . SPARSER::DRUG)
    ("e2" . SPARSER::MOLECULE) ("H12" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("s 5a" . SPARSER::PROTEIN)
    ("NRG4" . SPARSER::PROTEIN) ("NRG2" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("AZD8931" . SPARSER::DRUG)
    ("FRS2" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("AZD4547" . SPARSER::DRUG)
    ("TACC3" . SPARSER::PROTEIN) ("TACC1" . SPARSER::PROTEIN)
    ("FGFR4" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factors" . SPARSER::PROTEIN-FAMILY)
    ("Fibroblast Growth Factor" . SPARSER::PROTEIN-FAMILY)
    ("FRDA" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("frataxin" . SPARSER::PROTEIN) ("SIRT3 and IRP1" . SPARSER::COLLECTION)
    ("proteins and DNA" . SPARSER::COLLECTION)
    ("SIRT3 and TfR1" . SPARSER::COLLECTION)
    ("deferoxamine (DFO)" . SPARSER::MOLECULE) ("chelator" . SPARSER::MOLECULE)
    ("DFO" . SPARSER::MOLECULE) ("deferoxamine" . SPARSER::MOLECULE)
    ("exogenous iron" . SPARSER::MOLECULE)
    ("TfR1 and FTL" . SPARSER::COLLECTION)
    ("FTL and DMT1+IRE" . SPARSER::COLLECTION)
    ("divalent metal transporter 1 (DMT1) (+ IRE) mRNA" . SPARSER::PROTEIN)
    ("-IRE" . SPARSER::COLLECTION) ("FTL" . SPARSER::PROTEIN)
    ("TfR1 and ferritins" . SPARSER::COLLECTION)
    ("ferritin" . SPARSER::PROTEIN) ("ferritins" . SPARSER::PROTEIN)
    ("catalase and NAC" . SPARSER::COLLECTION)
    ("IRE/IRP" . SPARSER::COLLECTION) ("IRP" . SPARSER::PROTEIN)
    ("IRE" . SPARSER::PROTEIN) ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("lentiviral short hairpin RNAs" . SPARSER::RNA)
    ("IDH2 and MnSOD" . SPARSER::COLLECTION)
    ("iron and TfR1" . SPARSER::COLLECTION)
    ("a membrane-associated glycoprotein" . SPARSER::PROTEIN)
    ("mitochondrial SIRT3" . SPARSER::PROTEIN) ("IRPs" . SPARSER::PROTEIN)
    ("Hif1α" . SPARSER::PROTEIN) ("DMT1" . SPARSER::PROTEIN)
    ("FPN1" . SPARSER::PROTEIN) ("ferroportin-1" . SPARSER::PROTEIN)
    ("ferritin light chain" . SPARSER::PROTEIN)
    ("iron-sulfur cluster" . SPARSER::MOLECULE) ("Glut1" . SPARSER::PROTEIN)
    ("IRP2" . SPARSER::PROTEIN) ("TfR1" . SPARSER::PROTEIN)
    ("IRP1" . SPARSER::PROTEIN)
    ("the pulmonary fibrosis risk allele" . SPARSER::ALLELE)
    ("The colorectal cancer risk allele" . SPARSER::ALLELE)
    ("the 34th exon" . SPARSER::PROTEIN) ("PIP" . SPARSER::PROTEIN)
    ("RTEL1-PCNA" . SPARSER::COLLECTION)
    ("TERC and five additional genes" . SPARSER::COLLECTION)
    ("Alleles" . SPARSER::ALLELE)
    ("TERC , TERT, EGFR , CCDC26 , CDKN2B , PHLDB1 , and RTEL1"
     . SPARSER::COLLECTION)
    ("TERC , TERT and RTEL1" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("TERT and RTEL1" . SPARSER::COLLECTION)
    ("TERC and TERT" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("PHLDB1" . SPARSER::PROTEIN) ("CCDC26" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA) ("RTEL1" . SPARSER::PROTEIN)
    ("important cell cycle regulators such as cyclins, mitotic kinases and organizers"
     . SPARSER::COLLECTION)
    ("mitotic kinases" . SPARSER::KINASE)
    ("the cytoskeleton-associated protein" . SPARSER::PROTEIN)
    ("TMAP" . SPARSER::PROTEIN) ("–Pr55 Gag" . SPARSER::COLLECTION)
    ("SMD" . SPARSER::DRUG)
    ("the first N-terminal 88 amino acids of Stau1" . SPARSER::PROTEIN)
    ("relevant mRNAs" . SPARSER::PROTEIN)
    ("the multifunctional RNA-binding protein Stau1" . SPARSER::PROTEIN)
    ("JUB" . SPARSER::PROTEIN) ("Ajuba" . SPARSER::PROTEIN)
    ("control-IPs" . SPARSER::PROTEIN) ("Stau1-IPs" . SPARSER::COLLECTION)
    ("IPs" . SPARSER::PROTEIN) ("antibody and anti-HA" . SPARSER::COLLECTION)
    ("RNPs" . SPARSER::PROTEIN) ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("mitotic Stau1 55 -bound mRNAs" . SPARSER::PROTEIN)
    ("targeted Stau1 or a non-targeted (NT) shRNA" . SPARSER::COLLECTION)
    ("the first 88 N-terminal amino acids of Stau1" . SPARSER::PROTEIN)
    ("HA-Cdh1" . SPARSER::COLLECTION) ("HA-Cdc20" . SPARSER::COLLECTION)
    ("Cdc20 and APC/C" . SPARSER::COLLECTION) ("Cdh1-" . SPARSER::PROTEIN)
    ("Cdh1 and APC/C" . SPARSER::COLLECTION) ("/Cdc20" . SPARSER::COLLECTION)
    ("/Cdh1" . SPARSER::COLLECTION) ("FLAG-Cdc20" . SPARSER::COLLECTION)
    ("FLAG-Cdh1" . SPARSER::COLLECTION) ("FLAG-YFP" . SPARSER::COLLECTION)
    ("APC/C Cdc20 and/or APC/C Cdh1" . SPARSER::COLLECTION)
    ("Cdh1 or Cdc20" . SPARSER::COLLECTION)
    ("GFP-Ubiquitin" . SPARSER::COLLECTION) ("-HA" . SPARSER::COLLECTION)
    ("-FLAG" . SPARSER::COLLECTION)
    ("endogenous Stau1 55 and Stau1" . SPARSER::COLLECTION)
    ("the mitotic markers cyclin B1" . SPARSER::PROTEIN)
    ("Cdc20 and Cdh1" . SPARSER::COLLECTION) ("KEN" . SPARSER::PROTEIN)
    ("subunits, Cdc20 and Cdh1" . SPARSER::COLLECTION)
    ("Stau1-bound mRNAs and the cis" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("55 kDa (Stau1 55 ) and 63 kDa (Stau1 63 )" . SPARSER::COLLECTION)
    ("proteins and non-coding" . SPARSER::COLLECTION)
    ("Staufen" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("Pr55 Gag" . SPARSER::PROTEIN) ("UPF1" . SPARSER::PROTEIN)
    ("MOBKL2B" . SPARSER::PROTEIN) ("SPBC24" . SPARSER::PROTEIN)
    ("RPL22" . SPARSER::PROTEIN) ("N -ethylmaleimide" . SPARSER::MOLECULE)
    ("RO-3306" . SPARSER::DRUG) ("cyclin B1" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Cul1" . SPARSER::PROTEIN)
    ("messenger RNAs" . SPARSER::RNA) ("Stau1" . SPARSER::PROTEIN)
    ("Western blot and flow cytometry" . SPARSER::PROTEIN)
    ("HP" . SPARSER::PROTEIN)
    ("a potential broad antiviral molecular target" . SPARSER::TARGET-PROTEIN)
    ("IL-12 and IFN" . SPARSER::COLLECTION)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6, TNF-α, and IFN-β" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Ser and Thr" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, Maf, and ATF" . SPARSER::COLLECTION)
    ("MAPK and EV71" . SPARSER::COLLECTION)
    ("MEK3, MEK6 and p38" . SPARSER::COLLECTION)
    ("JNK and Thr180/Tyr182" . SPARSER::COLLECTION)
    ("Thr and Tyr" . SPARSER::COLLECTION)
    ("dual kinases MAP2Ks (e.g., MEK3 and MEK6, etc.) and several MAP3Ks"
     . SPARSER::COLLECTION)
    ("dual kinases MAP2Ks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK3 and MEK6" . SPARSER::COLLECTION)
    ("MTK1, MLK2/MST, MLK3, ASK1 and TAK1" . SPARSER::COLLECTION)
    ("JNK1/2 and EV71" . SPARSER::COLLECTION)
    ("MEK4, MEK7 and JNK1/2" . SPARSER::COLLECTION)
    ("MEK4 and MEK7" . SPARSER::COLLECTION)
    ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("jnk1, jnk2 and jnk3" . SPARSER::COLLECTION) ("jnk2" . SPARSER::PROTEIN)
    ("jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-2, IL-6, IL-10, IL-12 p40, TNF-α and IFN-β" . SPARSER::COLLECTION)
    ("IL-2, IL-12 p40, IL-12 p70, IFN-α and IFN-β" . SPARSER::COLLECTION)
    ("IL-2, IL-6, IL-10, IL-12 p40, IL-12 p70, TNF-α, IFN-α and IFN-β"
     . SPARSER::COLLECTION)
    ("IL-2, IL-6, IL-10, IL-12, TNF-α,IFN-α and IFN-β" . SPARSER::COLLECTION)
    ("JNK1/2 or p38" . SPARSER::COLLECTION)
    ("total and phosphorylated c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("SP600125 or SB203580" . SPARSER::COLLECTION)
    ("total and phosphorylated JNK1/2 and p38 MAPK" . SPARSER::PROTEIN)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("MAPK, SP600125 and SB203580" . SPARSER::COLLECTION)
    ("IL-2, IL-6, IL-12, TNF-α, and IFN-β" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("CD80 and CD11c" . SPARSER::COLLECTION)
    ("CD3 and CD83" . SPARSER::COLLECTION)
    ("GM-CSF and IL-4" . SPARSER::COLLECTION)
    ("granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4"
     . SPARSER::COLLECTION)
    ("ERK1/2, JNKs and p38 MAPKs" . SPARSER::COLLECTION)
    ("NLK" . SPARSER::PROTEIN) ("IL-6, IL-10 and TNF-α" . SPARSER::COLLECTION)
    ("SP600125 and SB203580" . SPARSER::COLLECTION)
    ("MAPK, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("IFN-β and IL-12 p40" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("IL-2, IL-6, IL-10, and TNF-α" . SPARSER::COLLECTION)
    ("JNK1/2 and p38" . SPARSER::COLLECTION)
    ("c-Jun NH 2 -terminal kinase/stress-activated kinase (JNK/SAPK) and the p38 mitogen-activated protein kinase (p38 MAPK)"
     . SPARSER::COLLECTION)
    ("JNK/SAPK" . SPARSER::COLLECTION) ("ATF2" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN) ("MLK3" . SPARSER::PROTEIN)
    ("MLK2" . SPARSER::PROTEIN) ("MTK1" . SPARSER::PROTEIN)
    ("MAP3Ks" . SPARSER::PROTEIN-FAMILY) ("MEK6" . SPARSER::PROTEIN)
    ("MEK7" . SPARSER::PROTEIN) ("MAP2Ks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFN-α" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("VP1 protein" . SPARSER::PROTEIN) ("JNK3" . SPARSER::PROTEIN)
    ("MEK4" . SPARSER::PROTEIN) ("IL-12 p70" . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE) ("OAZ1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("RPL27" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("p38 MAPKs" . SPARSER::PROTEIN) ("Nemo-like kinase" . SPARSER::PROTEIN)
    ("ERK7" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("ERK3" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("IL-12 p40" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE)
    ("BRAF, NRAS, and PIK3CA" . SPARSER::COLLECTION)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("quantitative 3D" . SPARSER::PROTEIN-FAMILY) ("FDG" . SPARSER::PROTEIN)
    ("the indolent and aggressive forms" . SPARSER::FORM)
    ("Ras, Raf, and MAPK" . SPARSER::COLLECTION)
    ("a major inducer" . SPARSER::PROTEIN)
    ("the BCL family ( xref ) and SOX9" . SPARSER::COLLECTION)
    ("INK4a/ARF" . SPARSER::COLLECTION) ("albumin-cre" . SPARSER::COLLECTION)
    ("TLR4 and TGF-β" . SPARSER::COLLECTION)
    ("YAP1 and IGF2BP3" . SPARSER::COLLECTION)
    ("its sequence-specific DNA binding partner Tead2" . SPARSER::PROTEIN)
    ("YAP1 and its target SOX9" . SPARSER::COLLECTION)
    ("YAP1, SOX9 and Ki67" . SPARSER::COLLECTION) ("ALDH-" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("ALDH1-" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN) ("TEAD-YAP1" . SPARSER::COLLECTION)
    ("ALDH1 and CD44" . SPARSER::COLLECTION)
    ("ALDH1 and OCT4" . SPARSER::COLLECTION)
    ("exogenous YAP1 S127A" . SPARSER::PROTEIN)
    ("YAP1 and Tead2" . SPARSER::COLLECTION) ("Tead2" . SPARSER::PROTEIN)
    ("YAP1 and TEAD" . SPARSER::COLLECTION)
    ("conditional alleles" . SPARSER::ALLELE)
    ("SOX9 and CTGF" . SPARSER::COLLECTION) ("KATO-TN" . SPARSER::COLLECTION)
    ("PIN" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("YAP1-SOX9" . SPARSER::COLLECTION) ("YAP1 and SOX9" . SPARSER::COLLECTION)
    ("LRP6 and TCF4" . SPARSER::COLLECTION)
    ("exogenous SOX9 and Slug" . SPARSER::COLLECTION)
    ("SOX9 and Slug" . SPARSER::COLLECTION) ("MaSC" . SPARSER::PROTEIN)
    ("group (HMG)" . SPARSER::MOLECULE)
    ("its relevant transcriptional targets" . SPARSER::TARGET-PROTEIN)
    ("YAP1 and TAZ" . SPARSER::COLLECTION)
    ("its transcriptional coactivator Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("YAP1 or SOX9" . SPARSER::COLLECTION)
    ("exogenous YAP1" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("IGF2BP3" . SPARSER::PROTEIN)
    ("vitamin A" . SPARSER::MOLECULE) ("TEAD2" . SPARSER::PROTEIN)
    ("SOX-9" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("CRIF1 or p66shc" . SPARSER::COLLECTION)
    ("Increased mitochondrial ROS" . SPARSER::PROTEIN)
    ("Rotenone" . SPARSER::PROTEIN) ("TMRE" . SPARSER::MOLECULE)
    ("MitoSox" . SPARSER::DRUG)
    ("UQCRC2 (Complex III) and COX4 (Complex IV)" . SPARSER::COLLECTION)
    ("NDUFA9 (Complex I), UQCRC2 (Complex III) and COX4 (Complex IV)"
     . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN) ("shc" . SPARSER::PROTEIN)
    ("shcA" . SPARSER::PROTEIN) ("hydrazine (CCCP)" . SPARSER::DRUG)
    ("CCCP" . SPARSER::MOLECULE) ("hydrazine" . SPARSER::DRUG)
    ("large mitoribosomal subunits" . SPARSER::PROTEIN)
    ("ETC" . SPARSER::PROTEIN) ("Electrons" . SPARSER::MOLECULE)
    ("complex I and complex" . SPARSER::COLLECTION)
    ("oxLDL" . SPARSER::MOLECULE)
    ("vascular cell adhesion molecule-1 and endoplasmic reticulum stress proteins"
     . SPARSER::COLLECTION)
    ("increased mitochondrial ROS" . SPARSER::PROTEIN)
    ("subunits, and CRIF1" . SPARSER::COLLECTION)
    ("gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CR6" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN) ("CH 2" . SPARSER::MOLECULE)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("ATP5A1" . SPARSER::PROTEIN)
    ("COX4" . SPARSER::PROTEIN) ("UQCRC2" . SPARSER::PROTEIN)
    ("NDUFA9" . SPARSER::PROTEIN) ("Crif1" . SPARSER::PROTEIN)
    ("MS-1" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("p46" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("NADH dehydrogenase" . SPARSER::PROTEIN) ("p66shc" . SPARSER::PROTEIN)
    ("CRIF1" . SPARSER::PROTEIN) ("MiRNAs" . SPARSER::PROTEIN)
    ("miR-221 and PTEN" . SPARSER::COLLECTION)
    ("another PTEN possible regulator" . SPARSER::REGULATOR)
    ("the western blot" . SPARSER::PROTEIN)
    ("N-cadherin, fibronectin and vimentin" . SPARSER::COLLECTION)
    ("receptor (DR)" . SPARSER::RECEPTOR) ("cFLIP" . SPARSER::PROTEIN)
    ("DcR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-221 or targeting PTEN" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE) ("miR-21" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("M15" . SPARSER::DRUG) ("DcR2" . SPARSER::PROTEIN)
    ("TRAIL-R4" . SPARSER::PROTEIN) ("decoy receptor" . SPARSER::PROTEIN)
    ("TRAIL-R3" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN) ("receptors-" . SPARSER::PROTEIN)
    ("Notch-1, Notch-2 and Notch-3" . SPARSER::COLLECTION)
    ("either small interfering RNAs (siRNAs) or endogenous or artificial microRNAs"
     . SPARSER::COLLECTION)
    ("enzymes and γ-secretase" . SPARSER::COLLECTION)
    ("paralogue" . SPARSER::PROTEIN)
    ("dominant-negative fragments" . SPARSER::FRAGMENT)
    ("Mastermind" . SPARSER::PROTEIN-FAMILY) ("ADAM" . SPARSER::PROTEIN)
    ("Wingless" . SPARSER::PROTEIN)
    ("the traditional antineoplastic drugs" . SPARSER::DRUG)
    ("Notch-3 and Notch-1" . SPARSER::COLLECTION)
    ("PI3kinase-PKB/Akt" . SPARSER::COLLECTION)
    ("these viral oncogenes" . SPARSER::ONCOGENE)
    ("the developmental state" . SPARSER::BIO-STATE)
    ("E6 and E7 viral oncogenes" . SPARSER::ONCOGENE)
    ("E6 and E7" . SPARSER::COLLECTION) ("LBC" . SPARSER::PROTEIN)
    ("Pap" . SPARSER::MOLECULE) ("nuc" . SPARSER::PROTEIN)
    ("87.5% cytoplasmic Notch-3 (p = 0.005) and 91.7% nuclear Notch-3 (p = 0.01)"
     . SPARSER::COLLECTION)
    ("80kDa" . SPARSER::PROTEIN) ("viral oncoproteins" . SPARSER::PROTEIN)
    ("E6/E7" . SPARSER::COLLECTION) ("RBPjk" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN)
    ("Delta1, Jagged-1, and Jagged-2" . SPARSER::COLLECTION)
    ("Notch-1, Notch-2, Notch-3, and Notch-4" . SPARSER::COLLECTION)
    ("HPV infection particularly HPV type" . TYPE)
    ("predictable biomarkers" . SPARSER::MOLECULE)
    ("Notch-1 and Notch-3" . SPARSER::COLLECTION)
    ("γ-secretase" . SPARSER::PROTEIN) ("PI3kinase" . SPARSER::PROTEIN)
    ("H-K" . SPARSER::PROTEIN) ("B-F" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("CIN3" . SPARSER::PROTEIN)
    ("CIN2" . SPARSER::PROTEIN) ("CIN1" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("HES-1" . SPARSER::PROTEIN)
    ("CBF1" . SPARSER::PROTEIN) ("Jagged-2" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN) ("Delta1" . SPARSER::PROTEIN)
    ("Notch-4" . SPARSER::PROTEIN) ("Notch-2" . SPARSER::PROTEIN)
    ("Notch-3" . SPARSER::PROTEIN) ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("Tamoxifen and ICI 182,780" . SPARSER::COLLECTION)
    ("a steroidal type II ER antagonist" . SPARSER::MOLECULE)
    ("The biological ligand" . SPARSER::LIGAND)
    ("Vav1 and ER" . SPARSER::COLLECTION)
    ("a hematopoietic-specific protein" . SPARSER::PROTEIN)
    ("DMSO group and a 9.45% reduction in E 2 group" . SPARSER::COLLECTION)
    ("Vav1, and T47D-Ctrl" . SPARSER::COLLECTION) ("vav" . SPARSER::PROTEIN)
    ("c-Myb/ELF-1" . SPARSER::COLLECTION)
    ("anti-c-Myb (upper panels) or anti-ELF-1(lower panels) antibodies"
     . SPARSER::COLLECTION)
    ("c-Myb and/or ELF-1" . SPARSER::COLLECTION)
    ("E 2 or Tamoxifen" . SPARSER::COLLECTION)
    ("The wild type vav 1 promoter (WT) and the truncated mutants (D1, D2, D3)"
     . SPARSER::COLLECTION)
    ("promoter (WT)" . SPARSER::PROMOTER)
    ("DMSO and E 2" . SPARSER::COLLECTION)
    ("no perfect ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the vav 1 proximal promoter" . SPARSER::PROMOTER)
    ("E 2 and PPT" . SPARSER::COLLECTION)
    ("DMSO, E 2 , PPT, or DPN" . SPARSER::COLLECTION)
    ("-ER" . SPARSER::COLLECTION)
    ("ICI 182,780 and Tamoxifen" . SPARSER::COLLECTION)
    ("E 2 or DMSO" . SPARSER::COLLECTION)
    ("cell lines Western blot" . SPARSER::PROTEIN)
    ("Calponin" . SPARSER::PROTEIN) ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("c-Myb and ELF-1" . SPARSER::COLLECTION)
    ("no recognizable estrogen response element (ERE)"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("selective estrogen receptor modulator (SERM)" . SPARSER::DRUG)
    ("SERM" . SPARSER::DRUG)
    ("a typical estrogen receptor (ER) ligand" . SPARSER::MOLECULE)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("ELF-1" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("vav 1" . SPARSER::PROTEIN)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("E 2" . SPARSER::MOLECULE) ("SERPINS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p300 and CBP" . SPARSER::COLLECTION) ("acetylases" . SPARSER::PROTEIN)
    ("the basal transcription complex [ xref ] and guide recruitment of the hSET1A histone methylase complex to chromatin"
     . SPARSER::COLLECTION)
    ("methylase" . SPARSER::PROTEIN) ("USF2 and YY1" . SPARSER::COLLECTION)
    ("SMAD4 and SMAD2/3" . SPARSER::COLLECTION) ("MAD" . SPARSER::PROTEIN)
    ("TGF-β1-" . SPARSER::PROTEIN)
    ("the rat PAI-1 proximal promoter" . SPARSER::PROMOTER)
    ("TGGCCTACACC-3" . SPARSER::COLLECTION)
    ("GCCTACACC-3" . SPARSER::COLLECTION) ("TCCCAG-3" . SPARSER::COLLECTION)
    ("USF-PE2" . SPARSER::COLLECTION) ("-activator" . SPARSER::ACTIVATOR)
    ("Keratinocytes" . SPARSER::PROTEIN)
    ("the PE2 (human) and HRE-2 (rat) PAI-1 target" . SPARSER::COLLECTION)
    ("trio" . SPARSER::PROTEIN)
    ("PAI-1 and the uPA receptor (PLAUR) ( xref )" . SPARSER::COLLECTION)
    ("receptor (PLAUR)" . SPARSER::RECEPTOR)
    ("northern blot" . SPARSER::PROTEIN) ("PLAUR" . SPARSER::PROTEIN)
    ("Rank" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("tPA" . SPARSER::PROTEIN) ("FBS-" . SPARSER::PROTEIN)
    ("c-MYC and cyclin D 1" . SPARSER::COLLECTION)
    ("Certain growth suppressive genes" . SPARSER::GENE)
    ("SERPIN" . SPARSER::PROTEIN)
    ("Matricellular (i.e., anchored) PAI-1" . SPARSER::PROTEIN)
    ("Jak/Stat" . SPARSER::COLLECTION) ("TGF-β1 and p53" . SPARSER::COLLECTION)
    ("cyclin B 1 and CDK1" . SPARSER::COLLECTION)
    ("p27 and p53" . SPARSER::COLLECTION)
    ("APC, p27, BRCA2, p53 and TGF-β1" . SPARSER::COLLECTION)
    ("bHLH-LZ" . SPARSER::COLLECTION) ("bHLH" . SPARSER::PROTEIN)
    ("PAI-1 and PAI-2" . SPARSER::COLLECTION) ("USF" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("HIF2α" . SPARSER::PROTEIN)
    ("hSET1A" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("Id1" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("TFE3" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("MMP-12" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("SERPINB2" . SPARSER::PROTEIN) ("SERPINB1" . SPARSER::PROTEIN)
    ("AT3" . SPARSER::PROTEIN) ("TEF3" . SPARSER::PROTEIN)
    ("PF1" . SPARSER::PROTEIN) ("CUB domain" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("cyclin B 1" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("Upstream stimulatory factor-1" . SPARSER::PROTEIN)
    ("PAI-2" . SPARSER::PROTEIN) ("PE2" . SPARSER::PROTEIN)
    ("USF2" . SPARSER::PROTEIN) ("USF1" . SPARSER::PROTEIN)
    ("cyclin D 1" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN) ("ApoE" . SPARSER::PROTEIN)
    ("the resultant peroxynitrite" . SPARSER::MOLECULE)
    ("peroxynitrite" . SPARSER::MOLECULE) ("vasodilator" . SPARSER::PROTEIN)
    ("systolic and diastolic BP" . SPARSER::PROTEIN)
    ("genotype (GG+GA) and genotype AA" . SPARSER::COLLECTION)
    ("homocysteine and troponin" . SPARSER::COLLECTION)
    ("diastolic BP, and albumin" . SPARSER::COLLECTION)
    ("BP, and albumin" . SPARSER::COLLECTION)
    ("β2-microglobulin, CACS and troponin" . SPARSER::COLLECTION)
    ("troponin" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("MZF1 and ARE-like" . SPARSER::COLLECTION) ("bleomycin" . SPARSER::DRUG)
    ("hydroxytoluene" . SPARSER::MOLECULE)
    ("homology (ECH)" . SPARSER::PROTEIN)
    ("systolic BP and diastolic BP" . SPARSER::COLLECTION)
    ("diastolic BP" . SPARSER::PROTEIN) ("systolic BP" . SPARSER::PROTEIN)
    ("diastolic BP and albumin" . SPARSER::COLLECTION)
    ("Systolic BP" . SPARSER::PROTEIN) ("BP and albumin" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("Troponin T" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("high-density lipoprotein" . SPARSER::PROTEIN) ("MZF1" . SPARSER::PROTEIN)
    ("myeloid zinc finger 1" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("erythroid 2" . SPARSER::PROTEIN) ("β2-microglobulin" . SPARSER::PROTEIN)
    ("cyclosporine" . SPARSER::DRUG)
    ("cytarabine and cladribine" . SPARSER::COLLECTION)
    ("cladribine" . SPARSER::PROTEIN) ("cytarabine" . SPARSER::MOLECULE)
    ("CTP" . SPARSER::PROTEIN) ("AA and AC" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION)
    ("CASP3 and NFATc2" . SPARSER::COLLECTION)
    ("FAM167A-BLK" . SPARSER::COLLECTION) ("BLK" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("4 risk alleles and 5" . SPARSER::COLLECTION)
    ("allele and rs1561876" . SPARSER::COLLECTION)
    ("CASP3 rs2720378 GC or CC genotype" . SPARSER::COLLECTION)
    ("IL-2 rs2069762 AC or CC genotype and STIM1 rs1561876 AA genotype"
     . SPARSER::COLLECTION)
    ("genotype and STIM1" . SPARSER::COLLECTION) ("CART" . SPARSER::PROTEIN)
    ("ITPKC and CASP3" . SPARSER::COLLECTION) ("calmodulin" . SPARSER::PROTEIN)
    ("Calcineurin" . SPARSER::PROTEIN) ("molecule (STIM)" . SPARSER::MOLECULE)
    ("STIM" . SPARSER::PROTEIN)
    ("diacylglycerol and inositol 1,4,5-triphosphate" . SPARSER::COLLECTION)
    ("ITPKC" . SPARSER::PROTEIN)
    ("rs2720378 GC or CC genotype" . SPARSER::COLLECTION)
    ("genotype and rs1561876" . SPARSER::COLLECTION)
    ("rs2720378 GC + CC genotypes (OR = 1.39, 95% CI = 1.07–1.80, P = 0.014) or rs2069762 AC + CC genotypes (OR = 1.28, 95% CI = 0.98–1.67, P = 0.066)"
     . SPARSER::COLLECTION)
    ("/NFAT" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("calcineurin inhibitor" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("TGFB2" . SPARSER::PROTEIN)
    ("Transforming growth factor-beta" . SPARSER::PROTEIN)
    ("FCGR2A" . SPARSER::PROTEIN) ("HLA-E" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("NFATc1" . SPARSER::PROTEIN)
    ("STIM2" . SPARSER::PROTEIN) ("STIM1" . SPARSER::PROTEIN)
    ("NFATc2" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("Inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("geminin" . SPARSER::PROTEIN) ("p53 and IRF1" . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN)
    ("cyclin D1 and a repressor" . SPARSER::COLLECTION)
    ("cyclins and CKIs" . SPARSER::COLLECTION) ("CKIs" . SPARSER::PROTEIN)
    ("cyclin D1 and p21" . SPARSER::COLLECTION) ("DREAM" . SPARSER::PROTEIN)
    ("HL-60/ADM" . SPARSER::PROTEIN) ("HL60/ADM" . SPARSER::COLLECTION)
    ("HL-60/ADM-DYRK1A" . SPARSER::PROTEIN-PAIR)
    ("DYRK1A and c-Myc" . SPARSER::COLLECTION)
    ("DYRK1A and pEGFP" . SPARSER::COLLECTION)
    ("Serine or Threonine" . SPARSER::COLLECTION)
    ("Fbw7 and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and DYRK1A" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK2" . SPARSER::COLLECTION) ("ADM" . SPARSER::PROTEIN)
    ("REST" . SPARSER::PROTEIN) ("DS" . SPARSER::PROTEIN)
    ("a strong candidate gene" . SPARSER::GENE)
    ("DYRK1A and DYRK2" . SPARSER::COLLECTION) ("NFATc" . SPARSER::PROTEIN)
    ("DYRK1A, DYRK1B, DYRK1C, DYRK2, DYRK3, DYRK4A, and DYRK4B"
     . SPARSER::COLLECTION)
    ("DYRK" . SPARSER::PROTEIN) ("AP4" . SPARSER::PROTEIN)
    ("CRY2" . SPARSER::PROTEIN) ("LIN52" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("PH 4" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("DYRK4" . SPARSER::PROTEIN)
    ("DYRK3" . SPARSER::PROTEIN) ("DYRK2" . SPARSER::PROTEIN)
    ("DYRK1B" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN)
    ("the multiprotein complex that contains GSK3β and its substrate NM1"
     . SPARSER::COLLECTION)
    ("nascent rRNA" . SPARSER::PROTEIN) ("EDD/hHyd" . SPARSER::COLLECTION)
    ("hHyd" . SPARSER::PROTEIN) ("EDD" . SPARSER::PROTEIN)
    ("SNF2h, WSTF or PCAF" . SPARSER::COLLECTION)
    ("UBR5 and Fbxw8" . SPARSER::COLLECTION)
    ("ligases, UBR5 and F-box/WD repeat-containing protein 8"
     . SPARSER::COLLECTION)
    ("MG132-treated GSK3β +/+ MEFs" . SPARSER::PROTEIN)
    ("possible E3 ligases" . SPARSER::LIGASE)
    ("anti-NM1 antibodies and the co-immunoprecipitated protein fractions"
     . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::PROTEIN-PAIR)
    ("BIO-treated GSK3β +/+ MEFs" . SPARSER::PROTEIN)
    ("oxime" . SPARSER::MOLECULE)
    ("MG132-treated GSK3β −/− MEFs" . SPARSER::PROTEIN)
    ("MG132-treated GSK3β +/+ MEFs and GSK3β −/− MEFs" . SPARSER::PROTEIN)
    ("MEFs or GSK3β" . SPARSER::COLLECTION)
    ("a V5-tagged NM1 mutant" . SPARSER::MUTANT) ("RK" . SPARSER::PROTEIN)
    ("SNF2h, PCAF, and WSTF" . SPARSER::COLLECTION)
    ("dense chromatin" . SPARSER::PROTEIN) ("NORs" . SPARSER::PROTEIN)
    ("fibrillar component (FC) and granular component (GC)"
     . SPARSER::COLLECTION)
    ("granular component (GC)" . SPARSER::COMPONENT)
    ("fibrillar component (FC)" . SPARSER::COMPONENT)
    ("three typical components" . SPARSER::COMPONENT) ("DFCs" . SPARSER::DRUG)
    ("nucleolin and UBF" . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN)
    ("actin and certain components" . SPARSER::COLLECTION)
    ("promoter, 18S and IGSs" . SPARSER::COLLECTION)
    ("promoter, 18S and IGSs co-precipitated" . SPARSER::COLLECTION)
    ("GSK3β (CGR11) and non-specific rabbit IgGs" . SPARSER::COLLECTION)
    ("UBF, and antibodies" . SPARSER::COLLECTION)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methylcytidine" . SPARSER::MOLECULE) ("UTP" . SPARSER::MOLECULE)
    ("pre-rRNA" . SPARSER::COLLECTION)
    ("the CGR11 antibody and the DNA" . SPARSER::COLLECTION)
    ("28S rDNA and the IGSs (intergenic sequences)" . SPARSER::COLLECTION)
    ("MEFs and GSK3β" . SPARSER::COLLECTION)
    ("CGR11 and 27C10" . SPARSER::COLLECTION)
    ("preferentially target active GSK3β" . SPARSER::PROTEIN)
    ("the first nine N-terminal amino acids of the protein ( xref )"
     . SPARSER::PROTEIN)
    ("transcription-competent polymerase" . SPARSER::PROTEIN)
    ("TAF" . SPARSER::PROTEIN) ("GSK3β and pol" . SPARSER::COLLECTION)
    ("the active gene" . SPARSER::GENE)
    ("chromatin and the pol I-associated actin" . SPARSER::COLLECTION)
    ("the subunits WSTF and the ATPase SNF2h" . SPARSER::COLLECTION)
    ("upstream binding factor (UBF)" . SPARSER::PROTEIN)
    ("UBF" . SPARSER::PROTEIN) ("SL1" . SPARSER::PROTEIN)
    ("-rRNA" . SPARSER::COLLECTION) ("rRNAs" . SPARSER::RNA)
    ("essential regulator" . SPARSER::REGULATOR)
    ("the rDNA chromatin and transcription activation" . SPARSER::COLLECTION)
    ("WSTF and SNF2h" . SPARSER::COLLECTION) ("SNF2h" . SPARSER::PROTEIN)
    ("WSTF" . SPARSER::PROTEIN) ("WICH" . SPARSER::PROTEIN)
    ("actin and myosin" . SPARSER::COLLECTION) ("1c" . SPARSER::PROTEIN)
    ("PCAF" . SPARSER::PROTEIN) ("Texas-Red" . SPARSER::DRUG)
    ("RPA194" . SPARSER::PROTEIN) ("Serine residue" . SPARSER::MOLECULE)
    ("PO3" . SPARSER::PROTEIN) ("Fbxw8" . SPARSER::PROTEIN)
    ("F-box/WD repeat-containing protein 8" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSH2B" . SPARSER::PROTEIN) ("CGR11" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN)
    ("upstream binding factor" . SPARSER::PROTEIN) ("TIF1A" . SPARSER::PROTEIN)
    ("SNF2" . SPARSER::PROTEIN) ("UBR5" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE)
    ("phosphoinositol-3-kinase/AKT" . SPARSER::COLLECTION)
    ("heterozygous (+/−) genotype" . SPARSER::PROTEIN)
    ("gene and risk" . SPARSER::COLLECTION)
    ("PTEN IVS4 (−/−) genotype and the (−) allele" . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("a dual phosphatase" . SPARSER::PHOSPHATASE)
    ("The 403 amino-acid PTEN protein" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("ErbBs" . SPARSER::PROTEIN) ("MET and ErbB3" . SPARSER::COLLECTION)
    ("ErbB3-neuregulin" . SPARSER::COLLECTION)
    ("the ErbB2-targeted antibody" . SPARSER::PROTEIN)
    ("commercial antibody reagents" . SPARSER::MOLECULE)
    ("ErbB1 or ErbB2" . SPARSER::COLLECTION)
    ("therapeutic antibodies (pertuzumab, cetuximab, matuzumab) or kinase inhibitors (erlotinib, gefitinib, lapatinib or CI-1033)"
     . SPARSER::COLLECTION)
    ("erlotinib, gefitinib, lapatinib or CI-1033" . SPARSER::COLLECTION)
    ("histological types" . TYPE) ("family and MET" . SPARSER::COLLECTION)
    ("MET/Ron" . SPARSER::COLLECTION) ("Ron" . SPARSER::PROTEIN)
    ("ErbB3, pErbB3, MET and pMET" . SPARSER::COLLECTION)
    ("ErbB1, ErbB2, ErbB3 and MET" . SPARSER::COLLECTION)
    ("HTR" . SPARSER::PROTEIN) ("ErbB4 and MET" . SPARSER::COLLECTION)
    ("available commercial antibodies" . SPARSER::ANTIBODY)
    ("ErbB3 and MET" . SPARSER::COLLECTION)
    ("commercial antibodies" . SPARSER::ANTIBODY)
    ("ErbB3, ErbB4 and MET" . SPARSER::COLLECTION)
    ("ErbB3-MET" . SPARSER::COLLECTION)
    ("ErbB3 (Her3) and ErbB4 (Her4)" . SPARSER::COLLECTION)
    ("ErbB1 and ErbB2" . SPARSER::COLLECTION)
    ("ErbB1 (EGFR) and ErbB2 (Her2)" . SPARSER::COLLECTION)
    ("a therapeutic monoclonal antibody" . SPARSER::DRUG)
    ("bevacizumab" . SPARSER::DRUG)
    ("aggressive platinum and taxane-based chemotherapy regimens"
     . SPARSER::COLLECTION)
    ("aggressive platinum" . SPARSER::MOLECULE) ("CI-1033" . SPARSER::DRUG)
    ("ErbB3" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("GM-CSF, IL-1β, IL-6, and TNFα" . SPARSER::COLLECTION)
    ("membrane protein or protein" . SPARSER::COLLECTION)
    ("TLR2 and NOD2" . SPARSER::COLLECTION) ("enterotoxin" . SPARSER::PROTEIN)
    ("TLR2" . SPARSER::PROTEIN) ("TNFα/NF-κB" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN)
    ("human neutrophils () and human macrophages ()" . SPARSER::COLLECTION)
    ("neutrophils and macrophages" . SPARSER::COLLECTION)
    ("TNFα-TNF" . SPARSER::COLLECTION)
    ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("antimicrobial effectors" . SPARSER::EFFECTOR) ("Pre" . SPARSER::PROTEIN)
    ("IL-6 RNA (p = 0.0078) and TNF-α RNA (p = 0.048)" . SPARSER::COLLECTION)
    ("macrophages or BMDMs" . SPARSER::COLLECTION)
    ("IL-6 (p = 0.015) and TNF-α (p = 0.018)" . SPARSER::COLLECTION)
    ("significantly more GM-CSF (p = 0.041) and IL-6 (p = 0.01)"
     . SPARSER::COLLECTION)
    ("significantly more GM-CSF" . SPARSER::PROTEIN)
    ("macrophages and BMDMs" . SPARSER::COLLECTION)
    ("more inflammatory cytokines" . SPARSER::PROTEIN)
    ("Neutrophils and macrophages" . SPARSER::COLLECTION)
    ("Neutrophils" . SPARSER::PROTEIN)
    ("Dusp3 (p<0.05) and Psme3 (p<0.05)" . SPARSER::COLLECTION)
    ("NF-κB and both Dusp3 and Psme3 ( xref )" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("IκBα-p65-p50" . SPARSER::COLLECTION)
    ("Dusp3 or Psme3" . SPARSER::COLLECTION)
    ("Dusp3 , or Psme3" . SPARSER::COLLECTION)
    ("Dusp3 (p<0.01) and Psme3 (p<0.01)" . SPARSER::COLLECTION)
    ("LTA" . SPARSER::PROTEIN) ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("staphylococcal" . SPARSER::PROTEIN)
    ("Eif1 , Cnp , Fam134c , Cntd1 , Psme3 , Dusp3 , Mpp2 , Slc4a1 , Slc25a39 , Dcaf7 , and Gna13"
     . SPARSER::COLLECTION)
    ("Gna13" . SPARSER::PROTEIN) ("Mpp2" . SPARSER::PROTEIN)
    ("Eif1" . SPARSER::PROTEIN)
    ("Quantitative Trait Loci (QTL) mapping" . SPARSER::PROTEIN)
    ("Dusp3 , Psme3 , and Dcaf7" . SPARSER::COLLECTION)
    ("Dusp3 and Psme3" . SPARSER::COLLECTION)
    ("Dcaf7, Dusp3, and Psme3" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::PROTEIN)
    ("Dcaf7 , Dusp3 , Fam134c , Psme3 , and Slc4a1" . SPARSER::COLLECTION)
    ("Slc4a1" . SPARSER::PROTEIN) ("Psme3" . SPARSER::PROTEIN)
    ("Dcaf7" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("member C" . SPARSER::PROTEIN) ("NOD2" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("Slc25a39" . SPARSER::PROTEIN) ("autosomal recessive" . SPARSER::PROTEIN)
    ("IL17A" . SPARSER::PROTEIN) ("Fam134c" . SPARSER::PROTEIN)
    ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATR or S1333D-ATR" . SPARSER::COLLECTION)
    ("ATR and MCM2" . SPARSER::COLLECTION) ("Substrates" . SPARSER::SUBSTRATE)
    ("ATR, S1333A-ATR or S1333D-ATR" . SPARSER::COLLECTION)
    ("FLAG-HA" . SPARSER::COLLECTION)
    ("one conditional ATR allele and the second allele" . SPARSER::COLLECTION)
    ("one conditional ATR allele" . SPARSER::ALLELE)
    ("neomycin" . SPARSER::DRUG) ("flox" . SPARSER::PROTEIN)
    ("arginine and lysine" . SPARSER::COLLECTION)
    ("a 3A-ATR" . SPARSER::COLLECTION) ("16A-ATR" . SPARSER::COLLECTION)
    ("an inactive dimer" . SPARSER::DIMER) ("ATR-ATRIP" . SPARSER::COLLECTION)
    ("RAD9-HUS1-RAD1" . SPARSER::COLLECTION) ("ATRIP" . SPARSER::PROTEIN)
    ("serine or threonine" . SPARSER::COLLECTION) ("TQ" . SPARSER::DRUG)
    ("FATC" . SPARSER::PROTEIN-FAMILY) ("PRD" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN) ("TRRAP" . SPARSER::PROTEIN)
    ("ATM and Rad3-related" . SPARSER::COLLECTION)
    ("glycine, arginine, or lysine" . SPARSER::COLLECTION)
    ("ATR, ATM, and DNA-PK" . SPARSER::COLLECTION)
    ("Aspartic Acid" . SPARSER::AMINO-ACID) ("a 3A" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("Kinase Activity" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN)
    ("single-stranded DNA binding protein" . SPARSER::PROTEIN)
    ("RAD1" . SPARSER::PROTEIN) ("HUS1" . SPARSER::PROTEIN)
    ("RAD9" . SPARSER::PROTEIN) ("Protein phosphatase 2" . SPARSER::PROTEIN)
    ("Elongation factor" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("TOPBP1" . SPARSER::PROTEIN)
    ("NF- κ B and cytokines" . SPARSER::COLLECTION)
    ("inducers or Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and NF- κ B" . SPARSER::COLLECTION)
    ("a favorable redox" . SPARSER::PROTEIN)
    ("K-Ras, B-Raf and Myc" . SPARSER::COLLECTION)
    ("antioxidant and detoxification enzymes" . SPARSER::COLLECTION)
    ("several pro-inflammatory genes" . SPARSER::GENE)
    ("TNF- α , IL-1 β and IL-6" . SPARSER::COLLECTION)
    ("NF- κ B, STAT3 and AP-1" . SPARSER::COLLECTION)
    ("Keap1 and Nrf2" . SPARSER::COLLECTION)
    ("Keap1 and Nrf2 or ubiquitin" . SPARSER::COLLECTION)
    ("Nrf2 or ubiquitin" . SPARSER::COLLECTION)
    ("a more extensively ubiquitinated-Keap1 protein" . SPARSER::PROTEIN)
    ("JNK and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("JNK, AKT and PI3K" . SPARSER::COLLECTION)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("multiple inflammation-associated proliferational genes" . SPARSER::GENE)
    ("MAPK-PI3K-Akt" . SPARSER::COLLECTION)
    ("IKK and I κ B" . SPARSER::COLLECTION)
    ("IL-1 β and IL-6" . SPARSER::COLLECTION)
    ("the conditional media" . SPARSER::PROTEIN) ("BrdU-" . SPARSER::DRUG)
    ("IOD" . SPARSER::MOLECULE) ("Media" . SPARSER::PROTEIN)
    ("BrdU and proliferating cell nuclear antigen (PCNA)"
     . SPARSER::COLLECTION)
    ("BrdU and proliferating cell nuclear antigen" . SPARSER::COLLECTION)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("NF- κ B and Nrf2" . SPARSER::COLLECTION)
    ("DSS and wogonin" . SPARSER::COLLECTION) ("CAC" . SPARSER::PROTEIN)
    ("inflammation-associated CRC" . SPARSER::PROTEIN)
    ("AOM/DSS" . SPARSER::COLLECTION) ("AOM" . SPARSER::PROTEIN)
    ("several inflammation-associated mediators" . SPARSER::PROTEIN)
    ("synthase and cyclooxygenases" . SPARSER::COLLECTION)
    ("genistein" . SPARSER::PROTEIN) ("fisetin" . SPARSER::DRUG)
    ("luteolin" . SPARSER::DRUG)
    ("–NF-E2-related factor 2" . SPARSER::COLLECTION)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("thioredoxin" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("colitis-associated colon cancer" . SPARSER::PROTEIN)
    ("I κ B and IKK α/β" . SPARSER::COLLECTION)
    ("prototypical pro-inflammatory cytokines IL-6 and IL-1 β"
     . SPARSER::COLLECTION)
    ("THP-1" . SPARSER::PROTEIN) ("IL-6 and IL-1 β" . SPARSER::COLLECTION)
    ("sulfate" . SPARSER::MOLECULE) ("Wogonin" . SPARSER::DRUG)
    ("anti-neoplastic and anti-inflammatory activities" . SPARSER::COLLECTION)
    ("methoxyflavone" . SPARSER::MOLECULE) ("wogonin" . SPARSER::DRUG)
    ("The transcriptional factors nuclear factor- κ B (NF- κ B) and NF-E2-related factor 2 (Nrf2)"
     . SPARSER::COLLECTION)
    ("β -Actin" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("BTB-Kelch protein" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("factor- κ B" . SPARSER::PROTEIN)
    ("chemotherapeutic agent mitomycin C and mTOR inhibitor rapamycin"
     . SPARSER::DRUG)
    ("Mitomycin C and rapamycin" . SPARSER::COLLECTION)
    ("S6K1–Bad–Bak" . SPARSER::COLLECTION)
    ("pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("Akt/PKB and S6K1" . SPARSER::COLLECTION)
    ("JNK and S6K1" . SPARSER::COLLECTION)
    ("the pro-apoptotic molecule Bad" . SPARSER::PROTEIN)
    ("its downstream effector S6K1 and the binding protein"
     . SPARSER::COLLECTION)
    ("phosphoinositide-3-kinase and mTOR" . SPARSER::COLLECTION)
    ("everolimus and mitomycin C" . SPARSER::COLLECTION)
    ("sham group and the single treatment group ( xref )"
     . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H&E) and CEA (used as a tumor marker)"
     . SPARSER::COLLECTION)
    ("CEA" . SPARSER::PROTEIN) ("Hematoxylin" . SPARSER::MOLECULE)
    ("siRNA or Bad" . SPARSER::COLLECTION) ("p-S6K1" . SPARSER::COLLECTION)
    ("F5A" . SPARSER::PROTEIN) ("F5A-HA" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("S6K1/Bad" . SPARSER::COLLECTION)
    ("either mitomycin C or the combination-induced apoptosis (PARP cleavage, hallmark of apoptosis)"
     . SPARSER::COLLECTION)
    ("a novel S6K1-specific inhibitor and a useful tool" . SPARSER::COLLECTION)
    ("Cellular cytochrome c" . SPARSER::PROTEIN)
    ("mitomycin C (2  μ g/ml) and/or rapamycin (5  μ g/ml)"
     . SPARSER::COLLECTION)
    ("mitomycin C (5  μ g/ml) and/or rapamycin (10  μ g/ml)"
     . SPARSER::COLLECTION)
    ("pro-apoptotic member Bax or Bak" . SPARSER::COLLECTION)
    ("Bad and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-xL or Bcl-2" . SPARSER::COLLECTION)
    ("mitochondrial Bad" . SPARSER::PROTEIN)
    ("a dual pathway kinase" . SPARSER::KINASE)
    ("Akt and S6K1" . SPARSER::COLLECTION)
    ("JNK and Akt" . SPARSER::COLLECTION)
    ("caspases and PARP" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("mitomycin C (5  μ g/ml) and/or rapamycin (2.5–10  μ g/ml)"
     . SPARSER::COLLECTION)
    ("mitomycin C and mTOR" . SPARSER::COLLECTION)
    ("crosslinker" . SPARSER::PROTEIN) ("DeltaCT-HA" . SPARSER::COLLECTION)
    ("mitomycin C and rapamycin inactivated p70 S6 ribosomal kinase"
     . SPARSER::KINASE)
    ("mitomycin C and rapamycin" . SPARSER::COLLECTION)
    ("chemotherapeutic agent mitomycin C" . SPARSER::DRUG)
    ("terminal transferase" . SPARSER::PROTEIN) ("CX-1" . SPARSER::PROTEIN)
    ("COX-IV" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("dabrafenib and vemurafenib" . SPARSER::COLLECTION)
    ("RIP3-associated pathological states" . SPARSER::BIO-STATE)
    ("RIP3 or B-Raf" . SPARSER::COLLECTION)
    ("RIP3 and Raf" . SPARSER::COLLECTION)
    ("RIP1 and RIP3" . SPARSER::COLLECTION)
    ("RIP1, RIP3 and B-Raf" . SPARSER::COLLECTION)
    ("RIP3-mediated pathological states" . SPARSER::BIO-STATE)
    ("only two RIP3 inhibitors" . SPARSER::INHIBITOR)
    ("GSK" . SPARSER::PROTEIN)
    ("multiple pathological states" . SPARSER::BIO-STATE)
    ("disulfide" . SPARSER::MOLECULE) ("aminotransferase" . SPARSER::PROTEIN)
    ("necrostatin-1 or RIP1" . SPARSER::COLLECTION)
    ("vemurafenib or GDC0879" . SPARSER::COLLECTION)
    ("dabrafenib, vemurafenib or GDC-0879" . SPARSER::COLLECTION)
    ("dabrafenib, vemurafenib and GDC-0879" . SPARSER::COLLECTION)
    ("RIP3 and other protein kinases" . SPARSER::COLLECTION)
    ("RIP1, RIP3 and MLKL" . SPARSER::COLLECTION)
    ("RIP1/RIP3" . SPARSER::COLLECTION)
    ("RIP3 and RIP1 or MLKL" . SPARSER::COLLECTION)
    ("RIP1 or MLKL" . SPARSER::COLLECTION)
    ("TRAIL and Fas ligand" . SPARSER::COLLECTION)
    ("TRAIL or Fas ligand" . SPARSER::COLLECTION)
    ("iodide (PI)" . SPARSER::PROTEIN) ("RIP1-" . SPARSER::PROTEIN)
    ("amine" . SPARSER::MOLECULE) ("SKC" . SPARSER::PROTEIN)
    ("dabrafenib and B-Raf" . SPARSER::COLLECTION)
    ("dabrafenib and RIP3" . SPARSER::COLLECTION)
    ("dabrafenib, AZ628, regorafenib, PLX4720, vemurafenib and sorafenib"
     . SPARSER::COLLECTION)
    ("GDC-0879 and SB590885" . SPARSER::COLLECTION)
    ("necrostatin-1 and SU11248" . SPARSER::COLLECTION)
    ("regorafenib" . SPARSER::DRUG)
    ("10 commercially available protein kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("RIP3 and RIP1" . SPARSER::COLLECTION)
    ("RIP1 and B-Raf" . SPARSER::COLLECTION)
    ("B-Raf/B-Raf" . SPARSER::COLLECTION)
    ("to be run" . SPARSER::PROTEIN-FAMILY)
    ("be run" . SPARSER::PROTEIN-FAMILY) ("MBP" . SPARSER::PROTEIN)
    ("glutathione S -transferase (GST)" . SPARSER::PROTEIN)
    ("ATP-competitively" . SPARSER::ATP)
    ("TNF α , TRAIL or Fas ligand" . SPARSER::COLLECTION)
    ("caspase-8 or FADD" . SPARSER::COLLECTION)
    ("analgesic and antipyretic" . SPARSER::COLLECTION)
    ("antipyretic" . SPARSER::DRUG) ("analgesic" . SPARSER::DRUG)
    ("Acetaminophen" . SPARSER::DRUG) ("FADD" . SPARSER::PROTEIN)
    ("the necroptic kinases" . SPARSER::KINASE)
    ("functional caspase-8" . SPARSER::PROTEIN)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("acetaminophen" . SPARSER::DRUG) ("protein (MLKL)" . SPARSER::PROTEIN)
    ("RIP3 and MLKL" . SPARSER::COLLECTION) ("MLKL" . SPARSER::PROTEIN)
    ("RIP1, RIP2 and RIP5" . SPARSER::COLLECTION)
    ("6 B-Raf" . SPARSER::COLLECTION) ("protein (RIP)" . SPARSER::PROTEIN)
    ("P20" . SPARSER::PROTEIN) ("EF1 α" . SPARSER::PROTEIN)
    ("GDC0879" . SPARSER::DRUG) ("SB590885" . SPARSER::DRUG)
    ("GDC-0879" . SPARSER::DRUG) ("AZ628" . SPARSER::DRUG)
    ("SU11248" . SPARSER::DRUG) ("necrostatin-1" . SPARSER::MOLECULE)
    ("myelin basic protein" . SPARSER::PROTEIN)
    ("keratin-18" . SPARSER::PROTEIN)
    ("mixed lineage kinase domain-like" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("RIP5" . SPARSER::PROTEIN) ("RIP2" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("6 B" . SPARSER::PROTEIN)
    ("RIP3" . SPARSER::PROTEIN) ("‘run'" . SPARSER::PROTEIN-FAMILY)
    ("tBid or BimL" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("exclusively monomeric membrane-bound Bax" . SPARSER::PROTEIN)
    ("oligomer" . SPARSER::MOLECULE) ("Bax and tBid" . SPARSER::COLLECTION)
    ("liposomes and the liposomes" . SPARSER::COLLECTION)
    ("DAC and tBid" . SPARSER::COLLECTION)
    ("stably membrane-bound Bax" . SPARSER::PROTEIN)
    ("protein–liposome" . SPARSER::PROTEIN-PAIR) ("BimL" . SPARSER::PROTEIN)
    ("Bax or Bcl-XL" . SPARSER::COLLECTION)
    ("A single-exponential fit" . SPARSER::PROTEIN-FAMILY)
    ("DAC and liposomes" . SPARSER::COLLECTION) ("NBD" . SPARSER::PROTEIN)
    ("external tBid" . SPARSER::PROTEIN)
    ("the fluorescent molecules" . SPARSER::MOLECULE)
    ("mixing liposomes" . SPARSER::PROTEIN) ("soluble Bax" . SPARSER::PROTEIN)
    ("Bax and M mCherry" . SPARSER::COLLECTION)
    ("underwent MOMP" . SPARSER::PROTEIN) ("tBid or Bax" . SPARSER::COLLECTION)
    ("a fluorescent Smac-mCherry fusion protein" . SPARSER::PROTEIN)
    ("Smac-mCherry" . SPARSER::COLLECTION) ("bak" . SPARSER::PROTEIN)
    ("pre" . SPARSER::PROTEIN) ("Mitochondria" . SPARSER::PROTEIN)
    ("Bax and Bcl-XL" . SPARSER::COLLECTION)
    ("tBid or Bax, and mitochondria or liposomes" . SPARSER::COLLECTION)
    ("Bax, and mitochondria or liposomes" . SPARSER::COLLECTION)
    ("carbonate" . SPARSER::MOLECULE) ("cBid" . SPARSER::PROTEIN-FAMILY)
    ("Bcl-2 or Bcl-XL" . SPARSER::COLLECTION)
    ("‘runs'" . SPARSER::PROTEIN-FAMILY)
    ("mitochondria or liposomes" . SPARSER::COLLECTION)
    ("tBid and Bax" . SPARSER::COLLECTION)
    ("Smac/Diablo" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("M − P" . SPARSER::PROTEIN) ("CL-2" . SPARSER::PROTEIN)
    ("TbC1" . SPARSER::PROTEIN) ("Mtch2" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::REGULATOR) ("KOs" . SPARSER::PROTEIN)
    ("sham and MI" . SPARSER::COLLECTION)
    ("SMAD-3 and GSK-3β" . SPARSER::COLLECTION)
    ("TGF-β-SMAD-3" . SPARSER::COLLECTION)
    ("GSK-3β and SMAD-3" . SPARSER::COLLECTION)
    ("MEFs and GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3β-KO" . SPARSER::COLLECTION) ("Pre-KO" . SPARSER::PROTEIN-PAIR)
    ("Col-KO and Per-KO" . SPARSER::COLLECTION) ("KO" . SPARSER::PROTEIN)
    ("GSK3β-KO" . SPARSER::PROTEIN-PAIR) ("Postn-Cre" . SPARSER::COLLECTION)
    ("Periostin" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("periostin" . SPARSER::PROTEIN) ("Postn" . SPARSER::PROTEIN)
    ("SMAD-2 and SMAD-3" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("TGFBRI" . SPARSER::PROTEIN)
    ("Virtually every form" . SPARSER::FORM)
    ("TGF-β1-SMAD-3" . SPARSER::COLLECTION) ("KLF5" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("SIS3" . SPARSER::MOLECULE)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRPC6" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 4" . SPARSER::PROTEIN)
    ("SMAD-7" . SPARSER::PROTEIN) ("SMAD-6" . SPARSER::PROTEIN)
    ("SMAD-4" . SPARSER::PROTEIN) ("R-SMADs" . SPARSER::PROTEIN-FAMILY)
    ("R-SMAD" . SPARSER::PROTEIN-FAMILY) ("SMAD-2" . SPARSER::PROTEIN)
    ("ALK5" . SPARSER::PROTEIN) ("SMAD-3" . SPARSER::PROTEIN)
    ("KRAS, BRAF, and PIK3CA" . SPARSER::COLLECTION)
    ("PI3K and FAK" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("KRAS G12D and BRAF G464E" . SPARSER::COLLECTION)
    ("PI3K and RAS" . SPARSER::COLLECTION)
    ("integrin and FAK" . SPARSER::COLLECTION)
    ("matrix-integrin" . SPARSER::COLLECTION)
    ("integrins and matrix" . SPARSER::COLLECTION)
    ("CTRL and Akt*-expressing" . SPARSER::COLLECTION)
    ("FAK-β5" . SPARSER::COLLECTION)
    ("αvβ3 or β1 integrin" . SPARSER::COLLECTION)
    ("two independent lentiviral shRNAs" . SPARSER::RNA)
    ("FAK and β5" . SPARSER::COLLECTION)
    ("FAK, OPN, and β5" . SPARSER::COLLECTION)
    ("FAK, OPN and αvβ5" . SPARSER::COLLECTION)
    ("GFP-FAK" . SPARSER::COLLECTION) ("GFP-FAK-KD" . SPARSER::COLLECTION)
    ("-KD" . SPARSER::COLLECTION)
    ("VS-4718-treated sensitive HEY" . SPARSER::PROTEIN-FAMILY)
    ("annexin V and 7-AAD" . SPARSER::COLLECTION) ("AAD" . SPARSER::MOLECULE)
    ("FAK, and OPN" . SPARSER::COLLECTION)
    ("OPN and a downstream target" . SPARSER::COLLECTION)
    ("β5, αv, and β1 integrin" . SPARSER::COLLECTION)
    ("β5, αv, β3, and β1 integrin" . SPARSER::COLLECTION)
    ("integrin, and OPN" . SPARSER::COLLECTION)
    ("proteins and integrin" . SPARSER::COLLECTION)
    ("a potential diagnostic blood biomarker" . SPARSER::MOLECULE)
    ("fibronectin, vitronectin, and osteopontin" . SPARSER::COLLECTION)
    ("vitronectin" . SPARSER::PROTEIN)
    ("growth factors and soluble matrix proteins" . SPARSER::COLLECTION)
    ("soluble matrix proteins" . SPARSER::PROTEIN)
    ("integrin and OPN" . SPARSER::COLLECTION) ("PND" . SPARSER::PROTEIN)
    ("integrin, and FAK" . SPARSER::COLLECTION)
    ("integrin, and osteopontin" . SPARSER::COLLECTION)
    ("OPN" . SPARSER::PROTEIN) ("VS-4718" . SPARSER::DRUG)
    ("Formalin" . SPARSER::MOLECULE)
    ("at least 1% mutated alleles" . SPARSER::ALLELE)
    ("aberrant melting" . SPARSER::DRUG)
    ("an aberrant melting" . SPARSER::DRUG)
    ("exons 20 and 21 abnormal melting" . SPARSER::DRUG)
    ("any aberrant melting" . SPARSER::DRUG)
    ("tyrosine kinase and EGFRvIII" . SPARSER::COLLECTION)
    ("TKIs" . SPARSER::PROTEIN) ("HRMA" . SPARSER::PROTEIN)
    ("anti-EGFR monoclonal antibodies and no predictive biomarker"
     . SPARSER::COLLECTION)
    ("no predictive biomarker" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U87" . SPARSER::PROTEIN) ("Px2" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("GP5" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and ion channel" . SPARSER::COLLECTION)
    ("the major apical anion exchanger DRA" . SPARSER::PROTEIN)
    ("DRA" . SPARSER::PROTEIN) ("Rabs and ARFs" . SPARSER::COLLECTION)
    ("EspG" . SPARSER::PROTEIN) ("EspGs" . SPARSER::PROTEIN)
    ("lipids and proteins" . SPARSER::COLLECTION)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("ARF or Rab" . SPARSER::COLLECTION)
    ("Consistently neither mutant" . SPARSER::MUTANT)
    ("pEspG:HA" . SPARSER::BIO-COMPLEX) ("Rab11–GFP" . SPARSER::COLLECTION)
    ("ARFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TfR and EGFR" . SPARSER::COLLECTION)
    ("TfR and β1 integrin" . SPARSER::COLLECTION)
    ("the bacterial outer membrane adhesin intimin" . SPARSER::PROTEIN)
    ("intimin" . SPARSER::PROTEIN) ("adhesin" . SPARSER::PROTEIN)
    ("clathrin and dynamin" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN)
    ("the only T3SS effector" . SPARSER::EFFECTOR) ("Iron" . SPARSER::MOLECULE)
    ("iron" . SPARSER::MOLECULE)
    ("transferrin receptor (TfR) and VAMP3" . SPARSER::COLLECTION)
    ("trans-complemented" . SPARSER::COLLECTION) ("TGN" . SPARSER::PROTEIN)
    ("BFA" . SPARSER::MOLECULE)
    ("wild type EHEC strain EDL933" . SPARSER::PROTEIN)
    ("EDL" . SPARSER::PROTEIN) ("SEAP" . SPARSER::PROTEIN-FAMILY)
    ("alkaline phosphatase (SEAP)" . SPARSER::PROTEIN-FAMILY)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VirA and EspG" . SPARSER::COLLECTION)
    ("RACK1 (Clements et al ., xref ) and tubulin (Hardwidge et al ., xref )"
     . SPARSER::COLLECTION)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VirA" . SPARSER::PROTEIN)
    ("TfR" . SPARSER::PROTEIN) ("transferrin" . SPARSER::PROTEIN)
    ("or 2 " . SPARSER::MOLECULE) ("B12" . SPARSER::PROTEIN)
    ("phenol Red" . SPARSER::DRUG) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("anion exchanger" . SPARSER::PROTEIN) ("ATG16L1" . SPARSER::PROTEIN)
    ("mAtg9" . SPARSER::PROTEIN) ("Rab 35" . SPARSER::PROTEIN)
    ("Rab 11" . SPARSER::PROTEIN) ("ARF6" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("TGN46" . SPARSER::PROTEIN)
    ("VAMP3" . SPARSER::PROTEIN) ("Rab11a" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE) ("ARF1" . SPARSER::PROTEIN)
    ("Rab1" . SPARSER::PROTEIN) ("RACK1" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("transferrin receptor" . SPARSER::PROTEIN)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("REtr or c-KIT" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION) ("endonuclease" . SPARSER::PROTEIN)
    ("ATM, OGG1 and BRCA2" . SPARSER::COLLECTION)
    ("imatinib, nilotinib and dasatinib" . SPARSER::COLLECTION)
    ("ABL" . SPARSER::PROTEIN) ("BCR" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG) ("nilotinib" . SPARSER::DRUG)
    ("REtr- and c-KIT" . SPARSER::COLLECTION) ("SCF-" . SPARSER::PROTEIN)
    ("KU55933 and KU60019" . SPARSER::COLLECTION)
    ("OGG1 , ATM and BRCA2" . SPARSER::COLLECTION)
    ("REtr or REtr and c-KIT" . SPARSER::COLLECTION)
    ("REtr and c-KIT" . SPARSER::COLLECTION) ("daunorubicin" . SPARSER::DRUG)
    ("imatinib" . SPARSER::DRUG)
    ("c-KIT and phosphatidylinositol" . SPARSER::COLLECTION)
    ("-kinase" . SPARSER::KINASE)
    ("AVEN, BCL2, BCLXL and MCL1" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("BCLXL" . SPARSER::PROTEIN) ("AVEN" . SPARSER::PROTEIN)
    ("REtr- and REtr+c-KIT" . SPARSER::COLLECTION) ("REtr-" . SPARSER::PROTEIN)
    ("REtr and REtr+c-KIT" . SPARSER::COLLECTION) ("REtr" . SPARSER::PROTEIN)
    ("REtr-c-KIT" . SPARSER::PROTEIN-PAIR) ("CD38−" . SPARSER::PROTEIN)
    ("c-KIT(D816V) and c-KIT(A814S)" . SPARSER::COLLECTION)
    ("CD11c and CD13" . SPARSER::COLLECTION) ("FAB" . SPARSER::PROTEIN)
    ("a chemotherapeutic drug" . SPARSER::DRUG) ("AraC" . SPARSER::DRUG)
    ("STAT3 (caSTAT3) or STAT5 (caSTAT5)" . SPARSER::COLLECTION)
    ("c-KIT and REtr" . SPARSER::COLLECTION)
    ("mutated c-KIT and a truncated variant" . SPARSER::COLLECTION)
    ("NHR3 and NHR4" . SPARSER::COLLECTION)
    ("RUNX1/ETO (RE)" . SPARSER::COLLECTION)
    ("AML1 , CBFα2 or PEBP2αB" . SPARSER::COLLECTION)
    ("MTG8 or RUNX1T1" . SPARSER::COLLECTION) ("CBF" . SPARSER::PROTEIN)
    ("RUNX1/ETO" . SPARSER::COLLECTION) ("ETO" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("KU60019" . SPARSER::DRUG)
    ("KU55933" . SPARSER::DRUG) ("OGG1" . SPARSER::PROTEIN)
    ("Ly294002" . SPARSER::MOLECULE) ("ZVAD-fmk" . SPARSER::DRUG)
    ("Grb2-associated binder 2" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcription factor 5" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("CD15" . SPARSER::DRUG) ("CD13" . SPARSER::PROTEIN)
    ("γ-tubulin" . SPARSER::PROTEIN) ("-3 " . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("C-KIT" . SPARSER::PROTEIN) ("NHR3" . SPARSER::PROTEIN)
    ("N-CoR" . SPARSER::PROTEIN) ("MTG8" . SPARSER::PROTEIN)
    ("PEBP2" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("SIRT1 or SIRT2" . SPARSER::COLLECTION)
    ("siRNA and SIRT1/2" . SPARSER::COLLECTION) ("-Wnt" . SPARSER::COLLECTION)
    ("β-catenin, c-Jun, and Dvls" . SPARSER::COLLECTION)
    ("Dvls" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FZD7 and SIRT1" . SPARSER::COLLECTION)
    ("SIRT1-FZD7" . SPARSER::COLLECTION)
    ("Mei and colleagues" . SPARSER::COLLECTION) ("LSCs" . SPARSER::PROTEIN)
    ("Mei" . SPARSER::MOLECULE) ("wherein Wnt proteins" . SPARSER::PROTEIN)
    ("β-catenin or FZD7" . SPARSER::COLLECTION)
    ("β-catenin, c-Jun, and Dvl1" . SPARSER::COLLECTION)
    ("β-catenin or c-Jun" . SPARSER::COLLECTION)
    ("significantly less β-catenin and c-Jun" . SPARSER::COLLECTION)
    ("β-catenin, c-Jun, or Dvl1" . SPARSER::COLLECTION)
    ("Dvl1" . SPARSER::PROTEIN) ("c-Jun and Dvl1" . SPARSER::COLLECTION)
    ("CCAAT" . SPARSER::PROTEIN) ("SP1" . SPARSER::PROTEIN)
    ("human genome sequence AC069148.6" . SPARSER::PROTEIN)
    ("SIRT-1 and SIRT-2" . SPARSER::COLLECTION)
    ("SIRT-2" . SPARSER::COLLECTION) ("VII" . SPARSER::PROTEIN)
    ("Fzd7" . SPARSER::PROTEIN) ("Fzd" . SPARSER::PROTEIN-FAMILY)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION) ("cambinol" . SPARSER::DRUG)
    ("FZD1 and FZD8" . SPARSER::COLLECTION)
    ("FZD3, FZD4 and FZD7" . SPARSER::COLLECTION)
    ("SIRT1 and Wnt" . SPARSER::COLLECTION)
    ("SIRT1 and FZD7" . SPARSER::COLLECTION)
    ("β-catenin/TCF4" . SPARSER::COLLECTION) ("FZDs" . SPARSER::PROTEIN-FAMILY)
    ("FZD/LRP5/6" . SPARSER::COLLECTION)
    ("histones, coactivators, enzymes and chromatin" . SPARSER::COLLECTION)
    ("β-catenin and c-Jun" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT2, and siRNA" . SPARSER::COLLECTION)
    ("SIRT2, and siRNA" . SPARSER::COLLECTION)
    ("sirtuins and components" . SPARSER::COLLECTION)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("FZD" . SPARSER::PROTEIN-FAMILY) ("Protein A" . SPARSER::PROTEIN)
    ("C-4" . SPARSER::PROTEIN) ("Wnt receptor" . SPARSER::PROTEIN)
    ("Frizzled 1" . SPARSER::PROTEIN) ("SIRT-1" . SPARSER::PROTEIN)
    ("FZD6" . SPARSER::PROTEIN) ("Sirtuin1" . SPARSER::PROTEIN)
    ("FZD4" . SPARSER::PROTEIN) ("FZD3" . SPARSER::PROTEIN)
    ("FZD8" . SPARSER::PROTEIN) ("FZD1" . SPARSER::PROTEIN)
    ("SFRP1" . SPARSER::PROTEIN)
    ("secreted frizzled related protein 1" . SPARSER::PROTEIN)
    ("LRP5/6" . SPARSER::PROTEIN) ("Sirtuin-1" . SPARSER::PROTEIN)
    ("FZD7" . SPARSER::PROTEIN)
    ("biochemical hallmark proteins" . SPARSER::PROTEIN)
    ("Atg7, Beclin 1 and LC3" . SPARSER::COLLECTION)
    ("HDACs, HDAC1, -2, and -3" . SPARSER::COLLECTION)
    ("Atg 7, Beclin 1 and LC3II" . SPARSER::COLLECTION)
    ("siRNA-p21-HDAC4" . SPARSER::COLLECTION)
    ("Atg7, Beclin 1 and LC3-II" . SPARSER::COLLECTION)
    ("fluorescent antibodies" . SPARSER::ANTIBODY)
    ("the anti-apoptotic protein Bcl-2 and the pro-apoptotic protein Bax"
     . SPARSER::COLLECTION)
    ("NC-siRNA" . SPARSER::COLLECTION) ("NAC" . SPARSER::PROTEIN)
    ("-HDAC4" . SPARSER::COLLECTION) ("p21WAF1/Cip1" . SPARSER::COLLECTION)
    ("Cip" . SPARSER::PROTEIN) ("HDAC4-siRNA" . SPARSER::COLLECTION)
    ("HDAC4 and siRNA" . SPARSER::COLLECTION)
    ("inhibitor 1" . SPARSER::PROTEIN) ("Atg 7" . SPARSER::PROTEIN)
    ("N -acetylcysteine" . SPARSER::DRUG) ("H 2 DCFDA" . SPARSER::DRUG)
    ("53BP1" . SPARSER::PROTEIN) ("Histone deacetylase 4" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("DNMT3A, FLT3, and NPM1" . SPARSER::COLLECTION)
    ("Methyltransferase inhibitors and JAK2 inhibitors" . SPARSER::COLLECTION)
    ("Methyltransferase" . SPARSER::PROTEIN)
    ("our relative larger cohort" . SPARSER::MOLECULE)
    ("classic MPNs" . SPARSER::PROTEIN) ("the usual types" . TYPE)
    ("MPNs or MDS/MPNs" . SPARSER::COLLECTION)
    ("CMPD/MDS" . SPARSER::COLLECTION) ("CMML" . SPARSER::PROTEIN)
    ("ITDs" . SPARSER::PROTEIN) ("PV and MF group" . SPARSER::COLLECTION)
    ("adult Chinese classic MPNs" . SPARSER::PROTEIN) ("c" . SPARSER::PROTEIN)
    ("PLT" . SPARSER::PROTEIN) ("PV and ET group" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3A, and DNMT3B" . SPARSER::COLLECTION)
    ("cytosine" . SPARSER::NUCLEOBASE) ("DNMTs" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("a haploinsufficient tumor suppressor gene" . SPARSER::PROTEIN)
    ("a multifunctional phosphoprotein" . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN) ("nucleophosmin" . SPARSER::PROTEIN)
    ("dehydrogenase (IDH)" . SPARSER::PROTEIN)
    ("proto-oncogene (CBL)" . SPARSER::PROTEIN) ("MPL" . SPARSER::PROTEIN)
    ("the classical forms" . SPARSER::FORM)
    ("the three nonleukemic forms" . SPARSER::FORM) ("PV" . SPARSER::PROTEIN)
    ("hemoglobin, or platelet" . SPARSER::COLLECTION)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("the 120 classic MPNs" . SPARSER::PROTEIN)
    ("NPM1, and DNMT3A" . SPARSER::COLLECTION) ("MPNs" . SPARSER::PROTEIN)
    ("NMP1" . SPARSER::PROTEIN) ("G-3" . SPARSER::PROTEIN)
    ("ddH2" . SPARSER::PROTEIN) ("DNMT3B" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("IKZF1" . SPARSER::PROTEIN)
    ("IKAROS family zinc finger 1" . SPARSER::PROTEIN)
    ("ASXL1" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("TET oncogene family member 2" . SPARSER::PROTEIN)
    ("antioxidant and detoxification genes" . SPARSER::COLLECTION)
    ("key chaperones and subunits" . SPARSER::COLLECTION)
    ("chaperones and subunits" . SPARSER::COLLECTION)
    ("at least 32 subunits" . SPARSER::FRAGMENT)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("antioxidant and proteasome-related genes" . SPARSER::COLLECTION)
    ("hESC" . SPARSER::PROTEIN)
    ("strong mesendoderm inducers" . SPARSER::MOLECULE)
    ("hESCs" . SPARSER::PROTEIN)
    ("ubiqutin-transduced hESCs" . SPARSER::PROTEIN)
    ("Epoxomicin" . SPARSER::DRUG) ("Lactacystin" . SPARSER::DRUG)
    ("an essential molecular chaperone" . SPARSER::PROTEIN)
    ("various proteasome subunits and related chaperones"
     . SPARSER::COLLECTION)
    ("POMP , PSMA4 , PSMB6 , PSMB7, PSMB8 and PSMD11" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN)
    ("first identified possible proteasome complex subunits"
     . SPARSER::FRAGMENT)
    ("lactacystin and epoxomicin" . SPARSER::COLLECTION)
    ("epoxomicin" . SPARSER::DRUG) ("lactacystin" . SPARSER::DRUG)
    ("BHQ" . SPARSER::PROTEIN)
    ("OCT4, NANOG and alkaline phosphatase" . SPARSER::COLLECTION)
    ("OCT4, SOX2, KLF4 and C-MYC" . SPARSER::COLLECTION)
    ("SSEA" . SPARSER::PROTEIN)
    ("t-BHQ and sulforaphane" . SPARSER::COLLECTION)
    ("t-BHQ" . SPARSER::COLLECTION) ("sulforaphane" . SPARSER::PROTEIN)
    ("NANOG , SOX2 and TERT" . SPARSER::COLLECTION)
    ("hINs" . SPARSER::PROTEIN-FAMILY) ("HO-1 and NQO-1" . SPARSER::COLLECTION)
    ("iPS" . SPARSER::PROTEIN)
    ("immunoproteasomal subunits" . SPARSER::PROTEIN)
    ("antioxidant and ubiquitin/proteasome-related" . SPARSER::COLLECTION)
    ("GCLM" . SPARSER::PROTEIN) ("Nrf2-KEAP1" . SPARSER::COLLECTION)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("CNC-bZip" . SPARSER::COLLECTION) ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CNC" . SPARSER::PROTEIN) ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("protein (POMP)" . SPARSER::PROTEIN) ("POMP" . SPARSER::PROTEIN)
    ("OCT4 and NANOG" . SPARSER::COLLECTION)
    ("a key pluripotency gene and a regulator of proteasome activity in human embryonic stem cells (hESCs)"
     . SPARSER::COLLECTION)
    ("MSX1" . SPARSER::PROTEIN) ("HAND1" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN) ("OTX2" . SPARSER::PROTEIN)
    ("PAX6" . SPARSER::PROTEIN) ("PSMD11" . SPARSER::PROTEIN)
    ("PSMB8" . SPARSER::PROTEIN) ("PSMB7" . SPARSER::PROTEIN)
    ("PSMB6" . SPARSER::PROTEIN) ("PSMA4" . SPARSER::PROTEIN)
    ("C-MYC" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("Kelch-Like ECH-Associated Protein 1" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("tert -Butylhydroquinone" . SPARSER::DRUG)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("chymotrypsin-like" . SPARSER::PROTEIN)
    ("Chymotrypsin-like" . SPARSER::PROTEIN) ("NeuroD1" . SPARSER::PROTEIN)
    ("Tra-1" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("pRK5" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("Amino Acid" . SPARSER::AMINO-ACID) ("PSMB5" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("Heme oxygenase 1" . SPARSER::PROTEIN)
    ("NQO-1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("Nuclear factor, erythroid 2" . SPARSER::PROTEIN)
    ("the major phytochemical" . SPARSER::DRUG)
    ("phytochemical" . SPARSER::DRUG) ("a strong inducer" . SPARSER::PROTEIN)
    ("AXIN2 and BTRCP" . SPARSER::COLLECTION)
    ("BTRCP [ xref ] and HIC1 [ xref ]" . SPARSER::COLLECTION)
    ("AXIN2 [ xref ], BTRCP [ xref ] and HIC1 [ xref ]" . SPARSER::COLLECTION)
    ("BTRCP" . SPARSER::PROTEIN) ("siRNA-" . SPARSER::PROTEIN)
    ("LEF/TCF" . SPARSER::COLLECTION)
    ("c-MYC and cyclin D1" . SPARSER::COLLECTION)
    ("a clinically relevant regulator" . SPARSER::REGULATOR)
    ("HBP1 and β-catenin" . SPARSER::COLLECTION)
    ("AXIN2/βTrCP" . SPARSER::COLLECTION)
    ("cyclin D1 and c-MYC" . SPARSER::COLLECTION)
    ("early diagnostic and new effective therapeutic targets"
     . SPARSER::TARGET-PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("mRNA/protein" . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("N-acetylcysteine" . SPARSER::DRUG) ("HIC1" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN) ("HBP1" . SPARSER::PROTEIN)
    ("HMG-box transcription factor 1" . SPARSER::PROTEIN)
    ("keratinocytes and SPINK5" . SPARSER::COLLECTION)
    ("STAT4, c-Ets-1, c-Ets-2, Elk-1, Pax-5 and p53" . SPARSER::COLLECTION)
    ("c-Ets-1" . SPARSER::PROTEIN-PAIR) ("mut" . SPARSER::PROTEIN)
    ("SRY" . SPARSER::PROTEIN) ("pGL" . SPARSER::PROTEIN)
    ("KLK" . SPARSER::GENE) ("protease-SPINK5" . SPARSER::COLLECTION)
    ("cytoplasmic desmosomal plaque proteins" . SPARSER::PROTEIN)
    ("transmembrane desmoglein-1" . SPARSER::PROTEIN)
    ("desmocollin-1" . SPARSER::COLLECTION) ("plakoglobin" . SPARSER::PROTEIN)
    ("desmocollin" . SPARSER::PROTEIN) ("kallikreins" . SPARSER::PROTEIN)
    ("Y chromosome" . SPARSER::PROTEIN) ("a3d" . SPARSER::PROTEIN)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("Pax-5" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("c-Ets-2" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("Mg 2+" . SPARSER::MOLECULE)
    ("pGL4" . SPARSER::PROTEIN) ("and −1" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("KLK15" . SPARSER::PROTEIN) ("KLK1" . SPARSER::PROTEIN)
    ("tissue kallikrein" . SPARSER::PROTEIN)
    ("desmoglein-1" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("SPINK5" . SPARSER::PROTEIN)
    ("Serine protease inhibitor" . SPARSER::PROTEIN)
    ("inhibitor of Chk1 or Wee1 (MK-1775) and irradiation"
     . SPARSER::COLLECTION)
    ("Chk1 or Wee1" . SPARSER::COLLECTION)
    ("Chk1 and p-Chk1" . SPARSER::COLLECTION) ("p-Chk1" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("siRNA and MK-1775" . SPARSER::COLLECTION)
    ("Cdt1 and Geminin" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("radiosensitizer" . SPARSER::DRUG) ("18 h" . SPARSER::PROTEIN)
    ("MK-1775" . SPARSER::DRUG) ("PF-00477736" . SPARSER::DRUG)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nat" . SPARSER::PROTEIN)
    ("its essential co-factor" . SPARSER::MOLECULE)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("Myt1 and Cdc25C" . SPARSER::COLLECTION)
    ("IR, and 30 min" . SPARSER::COLLECTION) ("caffeine" . SPARSER::MOLECULE)
    ("MDC1-mCherry" . SPARSER::COLLECTION)
    ("an essential pro-mitotic enzyme" . SPARSER::ENZYME)
    ("an average around six foci" . SPARSER::PROTEIN)
    ("MDC1-GFP" . SPARSER::COLLECTION)
    ("the nocodazole-induced mitotic trap" . SPARSER::PROTEIN)
    ("foci or MDC1" . SPARSER::COLLECTION)
    ("essential mediators" . SPARSER::PROTEIN)
    ("pro-mitotic enzymes" . SPARSER::ENZYME)
    ("the pro-mitotic kinases polo-like kinase-1" . SPARSER::PROTEIN)
    ("CDK1-Cyclin B1" . SPARSER::COLLECTION)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("a 37 " . SPARSER::PROTEIN) ("pH3" . SPARSER::MOLECULE)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Mdc1" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("RO3306" . SPARSER::DRUG) ("BI2536" . SPARSER::DRUG)
    ("Myt1" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("polo-like kinase-1" . SPARSER::PROTEIN) ("/Arf" . SPARSER::COLLECTION)
    ("EGFR , MET , and PDGFRA" . SPARSER::COLLECTION)
    ("RB , TP53 and PTEN" . SPARSER::COLLECTION)
    ("erlotinib, lapatinib, afatinib and neratinib" . SPARSER::COLLECTION)
    ("afatinib and neratinib" . SPARSER::COLLECTION)
    ("neratinib" . SPARSER::DRUG) ("afatinib" . SPARSER::DRUG)
    ("EGFRvIII and EGFRvII" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFRvII-" . SPARSER::PROTEIN)
    ("EGFRvII and EGFRvIII" . SPARSER::COLLECTION)
    ("supplemental IL-3" . SPARSER::PROTEIN)
    ("EGFRvII and the previously characterized EGFRvIII" . SPARSER::COLLECTION)
    ("the previously characterized EGFRvIII" . SPARSER::PROTEIN)
    ("driving oncogenic variant" . SPARSER::VARIANT)
    ("EGFRvII" . SPARSER::PROTEIN) ("EGFRvII-ext" . SPARSER::PROTEIN-PAIR)
    ("ext" . SPARSER::PROTEIN) ("an unambiguous solution" . SPARSER::MOLECULE)
    ("SCNA" . SPARSER::PROTEIN)
    ("both wild-type EGFR as well as EGFRvIII" . SPARSER::COLLECTION)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("only 2 alleles" . SPARSER::ALLELE) ("SNS" . SPARSER::PROTEIN)
    ("yet functionally cooperative variants" . SPARSER::VARIANT)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("both EGFRvIII (deletion of exons 2–7) and EGFRvII (deletion of exons 14–15)"
     . SPARSER::COLLECTION)
    ("at least one aberrant EGFR variant" . SPARSER::VARIANT)
    ("EGFR , PDGFRA and MET" . SPARSER::COLLECTION)
    ("EGFRvIII and Carboxyl-terminal" . SPARSER::COLLECTION)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("the classical subtype" . SPARSER::PROTEIN)
    ("kinases (RTK)" . SPARSER::PROTEIN)
    ("EGFR , PDGFRA , and MET" . SPARSER::COLLECTION)
    ("multiple EGFR mutational variants" . SPARSER::VARIANT)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("p19Arf" . SPARSER::PROTEIN)
    ("p16Ink4a" . SPARSER::PROTEIN) ("K24" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("Braf V600E and p300" . SPARSER::COLLECTION)
    ("Braf/MAPK" . SPARSER::COLLECTION) ("Akt and ERK2" . SPARSER::COLLECTION)
    ("Braf and HDAC" . SPARSER::COLLECTION)
    ("B-raf inhibitors and vorinostat or romidepsin" . SPARSER::COLLECTION)
    ("Sorafenib and vorinostat" . SPARSER::COLLECTION)
    ("vorinostat or romidepsin" . SPARSER::COLLECTION)
    ("vorinostat (Merck) and romidepsin (Gloucester Pharmaceuticals)"
     . SPARSER::COLLECTION)
    ("romidepsin" . SPARSER::DRUG)
    ("simultaneously targeting Braf and nuclear p300" . SPARSER::COLLECTION)
    ("MEK1/2 inhibitors or small molecule inhibitors" . SPARSER::COLLECTION)
    ("p300, and Braf" . SPARSER::COLLECTION)
    ("high Braf and high cytoplasmic p300" . SPARSER::COLLECTION)
    ("high Braf and low nuclear p300" . SPARSER::COLLECTION)
    ("low Braf and high nuclear p300" . SPARSER::COLLECTION)
    ("IRS" . SPARSER::PROTEIN) ("p300 and Braf" . SPARSER::COLLECTION)
    ("mitogen activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK1/2)"
     . SPARSER::COLLECTION)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN) ("HAT" . SPARSER::PROTEIN)
    ("Braf and MEK1/2" . SPARSER::COLLECTION) ("ipilimumab" . SPARSER::DRUG)
    ("BrafV" . SPARSER::PROTEIN) ("dacarbazine" . SPARSER::DRUG)
    ("Braf and nuclear p300" . SPARSER::COLLECTION)
    ("Braf and cytoplasmic p300" . SPARSER::COLLECTION)
    ("Braf and p300" . SPARSER::COLLECTION) ("Braf" . SPARSER::PROTEIN)
    ("salt inducible kinase 2" . SPARSER::PROTEIN) ("B-raf" . SPARSER::PROTEIN)
    ("IRS 6" . SPARSER::PROTEIN) ("IRS 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTLA-4" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("LPK" . SPARSER::PROTEIN)
    ("a normally functioning cadherin-catenin complex" . SPARSER::BIO-COMPLEX)
    ("Catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("well-differentiated SCCs" . SPARSER::PROTEIN)
    ("cadherins and catenins" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDSCC and W/MSCC" . SPARSER::COLLECTION)
    ("PDSCC and BSCC" . SPARSER::COLLECTION)
    ("PDSCC or W/MSCC" . SPARSER::COLLECTION) ("PDSCC" . SPARSER::PROTEIN)
    ("SCCs (PDSCC)" . SPARSER::PROTEIN) ("SCCs" . SPARSER::PROTEIN)
    ("an aggressive variant" . SPARSER::VARIANT)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-βs and activin" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("the bone morphogenic proteins (BMPs) and their receptors"
     . SPARSER::COLLECTION)
    ("the bone morphogenic proteins" . SPARSER::PROTEIN)
    ("BMPs" . SPARSER::PROTEIN) ("Bcl-XL and STAT3" . SPARSER::COLLECTION)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("SMAD2, SMAD3, SMAD4, TGFB-induced factor homeobox 1 (TGIF1), BMP and activin membrane-bound inhibitor homolog (BAMBI) and activin"
     . SPARSER::COLLECTION)
    ("BMP and activin" . SPARSER::COLLECTION)
    ("ACVR1C/ACVR1B/ACVRL1" . SPARSER::COLLECTION) ("BAMBI" . SPARSER::PROTEIN)
    ("TGFB" . SPARSER::PROTEIN) ("RUNX2 and ALP" . SPARSER::COLLECTION)
    ("SMAD2/SMAD3" . SPARSER::COLLECTION)
    ("SMAD2, SMAD3 and SMAD4" . SPARSER::COLLECTION)
    ("chondrogenic media" . SPARSER::PROTEIN)
    ("osteogenic and chondrogenic media" . SPARSER::PROTEIN)
    ("Only 7 miRs" . SPARSER::PROTEIN) ("osteogenic media" . SPARSER::PROTEIN)
    ("RUNX2 and Type I" . SPARSER::COLLECTION)
    ("namely SOX9 and type II collagen" . SPARSER::PROTEIN)
    ("SOX9 and type II" . SPARSER::COLLECTION)
    ("Collagen and Osteonectin" . SPARSER::COLLECTION)
    ("Osteonectin" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("ALP" . SPARSER::PROTEIN)
    ("CD63, ALCAM and Nucleostemin" . SPARSER::COLLECTION)
    ("CD63 and ALCAM" . SPARSER::COLLECTION)
    ("ALCAM and putative stem cell marker Nucleostemin" . SPARSER::COLLECTION)
    ("stromal antigens CD63, ALCAM and putative stem cell marker Nucleostemin"
     . SPARSER::COLLECTION)
    ("Nucleostemin" . SPARSER::PROTEIN) ("ALCAM" . SPARSER::PROTEIN)
    ("chondrogenic related genes" . SPARSER::GENE) ("OSX" . SPARSER::PROTEIN)
    ("Wnt and TGF-β" . SPARSER::COLLECTION)
    ("RUNX2 and Osterix" . SPARSER::COLLECTION) ("Osterix" . SPARSER::PROTEIN)
    ("complex (RICS)" . SPARSER::BIO-COMPLEX) ("RICS" . SPARSER::PROTEIN)
    ("mesenchymal cell condensation" . SPARSER::PROTEIN-FAMILY)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("TGF-β and activin" . SPARSER::COLLECTION) ("activin" . SPARSER::PROTEIN)
    ("SMAD6" . SPARSER::PROTEIN) ("SMAD- 1" . SPARSER::PROTEIN)
    ("receptor-activated SMADs" . SPARSER::PROTEIN-FAMILY)
    ("TGF-βs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl-XL" . SPARSER::PROTEIN)
    ("ACVRL1" . SPARSER::PROTEIN) ("ACVR1B" . SPARSER::PROTEIN)
    ("ACVR1C" . SPARSER::PROTEIN) ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor type" . SPARSER::PROTEIN) ("TGIF1" . SPARSER::PROTEIN)
    ("homeobox 1" . SPARSER::PROTEIN) ("Type X" . SPARSER::PROTEIN)
    ("TGF- β3" . SPARSER::PROTEIN) ("b-5" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("TGF-β3" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("histone deacetylase 5" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("SIRT1 and miR-221" . SPARSER::COLLECTION)
    ("β-catenin and survivin" . SPARSER::COLLECTION)
    ("promoter or tumor" . SPARSER::COLLECTION)
    ("p27, TRPS1, PTEN, ARHI, TIMP3, HECTD2 and RAB1A" . SPARSER::COLLECTION)
    ("ARHI" . SPARSER::PROTEIN) ("SIRT1-3" . SPARSER::COLLECTION)
    ("mRNA-3" . SPARSER::COLLECTION) ("sirt1" . SPARSER::PROTEIN)
    ("miR-221 and miR-222 inhibitors" . SPARSER::COLLECTION)
    ("the miR-221 inhibitor and miR-222 inhibitor" . SPARSER::COLLECTION)
    ("miR-221 inhibitor and miR-222 inhibitor" . SPARSER::COLLECTION)
    ("miR-221 inhibitor or miR-222 inhibitor" . SPARSER::COLLECTION)
    ("pEX" . SPARSER::PROTEIN)
    ("mir-221 inhibitor and mir-222 inhibitor" . SPARSER::COLLECTION)
    ("gene or suppressor" . SPARSER::COLLECTION) ("PCas" . SPARSER::PROTEIN)
    ("LNCap" . SPARSER::PROTEIN)
    ("miR-221 or miR-222 inhibitor" . SPARSER::COLLECTION)
    ("RAB1A" . SPARSER::PROTEIN) ("HECTD2" . SPARSER::PROTEIN)
    ("TIMP3" . SPARSER::PROTEIN) ("TRPS1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("MiR-221" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("Allele" . SPARSER::ALLELE) ("PRISMA" . SPARSER::DRUG)
    ("a negative predictive biomarker" . SPARSER::MOLECULE)
    ("Nordic FLOX" . SPARSER::PROTEIN) ("FLOX" . SPARSER::PROTEIN)
    ("genotype and log-rank" . SPARSER::COLLECTION)
    ("met" . SPARSER::AMINO-ACID)
    ("cetuximab (Erbitux, ImClone , LLC) and panitumumab (Vectibix, Amgen )"
     . SPARSER::COLLECTION)
    ("Erbitux" . SPARSER::DRUG) ("LCS6" . SPARSER::PROTEIN)
    ("KRAS-LCS6" . SPARSER::COLLECTION) ("Monoclonal antibody" . SPARSER::DRUG)
    ("Nan" . SPARSER::PROTEIN) ("CTNNB1 or β-catenin" . SPARSER::COLLECTION)
    ("WNT/cadherin-associated protein" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFκB-derived pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("p50/p50" . SPARSER::COLLECTION) ("homodimer" . SPARSER::HOMODIMER)
    ("enteric" . SPARSER::PROTEIN) ("Luminal" . SPARSER::DRUG)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("COX-2 and the COX-2-derived PGE 2" . SPARSER::COLLECTION)
    ("MYC and NSAIDs" . SPARSER::COLLECTION) ("NAN" . SPARSER::PROTEIN)
    ("DLG" . SPARSER::PROTEIN) ("TERT-CLPTM1L" . SPARSER::COLLECTION)
    ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("a prospective cohort" . SPARSER::MOLECULE)
    ("NSAIDs and NR1I2 or NR1H2" . SPARSER::COLLECTION)
    ("NR1I2 or NR1H2" . SPARSER::COLLECTION)
    ("PXR and LXR" . SPARSER::COLLECTION) ("LXR" . SPARSER::PROTEIN)
    ("PXR" . SPARSER::PROTEIN) ("xenobiotic" . SPARSER::MOLECULE)
    ("NSAID and the marker polymorphisms TYK2 rs280521" . SPARSER::COLLECTION)
    ("colon cancer, and NSAID" . SPARSER::COLLECTION)
    ("the receptor-associated kinases" . SPARSER::KINASE)
    ("STAT6 , TYK2 and JAK2" . SPARSER::COLLECTION)
    ("IKBKB" . SPARSER::PROTEIN)
    ("NSAIDs and transcription factor" . SPARSER::COLLECTION)
    ("IL1B, LEP and IL6" . SPARSER::COLLECTION)
    ("The pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1B, IL-6, IL-8 and TNF- α" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN)
    ("prospective cohorts" . SPARSER::MOLECULE)
    ("PTGS1, PTGS2 , ALOXs , PLA2G1B, ABCB1, ABCC2 and SLC22A4"
     . SPARSER::COLLECTION)
    ("PGE 2 and leukotriene" . SPARSER::COLLECTION)
    ("ABCB1 , ABCC2 and SLC22A4" . SPARSER::COLLECTION)
    ("the essential fatty acid AA" . SPARSER::MOLECULE)
    ("PGE 2 , PGI 2 and PGJ 2" . SPARSER::COLLECTION)
    ("PPARD and PPARG" . SPARSER::COLLECTION)
    ("NSAIDs and PPARD or PPARG" . SPARSER::COLLECTION)
    ("PPARD or PPARG" . SPARSER::COLLECTION) ("PPARG" . SPARSER::PROTEIN)
    ("PPARs" . SPARSER::PROTEIN) ("ALOX15 and ALOX5AP" . SPARSER::COLLECTION)
    ("FLAP" . SPARSER::PROTEIN) ("leukotriene" . SPARSER::MOLECULE)
    ("leukotrienes" . SPARSER::PROTEIN)
    ("lipoxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTGS2 and NSAID" . SPARSER::COLLECTION)
    ("the pro-carcinogenic prostaglandin E 2" . SPARSER::MOLECULE)
    ("NSAIDs and PTGS1 and PTGS2" . SPARSER::COLLECTION)
    ("PTGS1 and PTGS2" . SPARSER::COLLECTION)
    ("the wildtype and the variant alleles" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("large well-characterised prospective cohorts" . SPARSER::MOLECULE)
    ("NSAIDs and PTGS-2" . SPARSER::COLLECTION) ("wildtype" . SPARSER::PROTEIN)
    ("MYC (encoding a transcription factor involved in cell cycle progression, apoptosis and cellular transformation) and NSAIDs"
     . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN)
    ("Nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("ASA" . SPARSER::PROTEIN) ("NSAIDs" . SPARSER::DRUG)
    ("transcription factor 7-like 2" . SPARSER::PROTEIN)
    ("PIN3" . SPARSER::PROTEIN) ("CLPTM1L" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("CYP2" . SPARSER::PROTEIN)
    ("UGT1A6" . SPARSER::PROTEIN) ("NR1H2" . SPARSER::PROTEIN)
    ("NR1I2" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("MAPK14" . SPARSER::PROTEIN)
    ("MAPK12" . SPARSER::PROTEIN) ("MAPK1" . SPARSER::PROTEIN)
    ("MAP3K10" . SPARSER::PROTEIN) ("SMAD7" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("IL-1B" . SPARSER::PROTEIN) ("SLC22A4" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("PLA2G1B" . SPARSER::PROTEIN)
    ("PGJ 2" . SPARSER::MOLECULE) ("PGI 2" . SPARSER::PROTEIN)
    ("arachidonate 5-lipoxygenase-activating protein" . SPARSER::PROTEIN)
    ("ALOX5AP" . SPARSER::PROTEIN) ("ALOX15" . SPARSER::PROTEIN)
    ("ALOX5" . SPARSER::PROTEIN) ("LTB 4" . SPARSER::PROTEIN)
    ("PTGS1" . SPARSER::PROTEIN) ("thromboxane A 2" . SPARSER::MOLECULE)
    ("COX-1" . SPARSER::PROTEIN) ("PTGS-2" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("LG" . SPARSER::MOLECULE)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("RESA" . SPARSER::PROTEIN)
    ("local and central HER2" . SPARSER::PROTEIN)
    ("confirmatory HER2" . SPARSER::PROTEIN)
    ("trastuzumab (27.1% versus 17.9%) or a taxane (40.0% versus 32.8%)"
     . SPARSER::COLLECTION)
    ("previously untreated MBC received either trastuzumab" . SPARSER::DRUG)
    ("TDM" . SPARSER::PROTEIN) ("T-DM1 or capecitabine" . SPARSER::COLLECTION)
    ("MCC" . SPARSER::PROTEIN) ("maytansine" . SPARSER::DRUG)
    ("trastuzumab, trastuzumab and pertuzumab, or lapatinib"
     . SPARSER::COLLECTION)
    ("pertuzumab, or lapatinib" . SPARSER::COLLECTION)
    ("mRNA " . SPARSER::PROTEIN)
    ("docetaxel (HT) or trastuzumab emtansine (T-DM1)" . SPARSER::COLLECTION)
    ("PDL-1" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("T-DM1 " . SPARSER::PROTEIN) ("T-DM1" . SPARSER::PROTEIN)
    ("LCM" . SPARSER::PROTEIN-FAMILY)
    ("the v-akt murine thymoma viral oncogene homolog gene" . SPARSER::GENE)
    ("v-akt" . SPARSER::COLLECTION)
    ("the provincial laboratory and frozen fragments" . SPARSER::FRAGMENT)
    ("ER/PR" . SPARSER::COLLECTION) ("ER " . SPARSER::PROTEIN)
    ("total or phosphorylated p70S6K" . SPARSER::PROTEIN)
    ("letrozole" . SPARSER::DRUG)
    ("tamoxifen and aromatase" . SPARSER::COLLECTION)
    ("Previously reported studies included cohorts" . SPARSER::MOLECULE)
    ("ERα-" . SPARSER::PROTEIN) ("MBTB" . SPARSER::PROTEIN)
    ("previously published cohorts" . SPARSER::MOLECULE)
    ("irrelevant antibodies" . SPARSER::ANTIBODY)
    ("using DSP and co-immunoprecipitation (co-IP) undertaken"
     . SPARSER::COLLECTION)
    ("rh-mTOR" . SPARSER::PROTEIN) ("rh" . SPARSER::MOLECULE)
    ("FRAP/mTOR" . SPARSER::COLLECTION) ("FRAP" . SPARSER::PROTEIN)
    ("mTOR and its downstream target p70S6K" . SPARSER::COLLECTION)
    ("p-S2448" . SPARSER::PROTEIN) ("p-S2448-mTOR" . SPARSER::COLLECTION)
    ("RFS " . SPARSER::PROTEIN)
    ("Previously constructed TMAs" . SPARSER::MOLECULE)
    ("mTOR and pS2448-mTOR" . SPARSER::COLLECTION)
    ("p70-S6kinase" . SPARSER::COLLECTION)
    ("new ‘endocrine’" . SPARSER::PROTEIN) ("‘endocrine’" . SPARSER::PROTEIN)
    ("intact estrogen" . SPARSER::MOLECULE)
    ("mTOR and its down stream target p70S6 kinase" . SPARSER::COLLECTION)
    ("ERα, p-S167-ERα and p-S282-ERα" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-ER" . SPARSER::PROTEIN) ("AZD 8055" . SPARSER::DRUG)
    ("Na3VO4" . SPARSER::MOLECULE) ("estradiol-17β" . SPARSER::MOLECULE)
    ("FKBP12-rapamycin complex-associated protein" . SPARSER::PROTEIN)
    ("PF-4708671" . SPARSER::DRUG) ("AZD8055" . SPARSER::DRUG)
    ("S6kinase" . SPARSER::PROTEIN-FAMILY) ("ERα " . SPARSER::PROTEIN)
    ("p-S" . SPARSER::PROTEIN) ("RB and SDP" . SPARSER::COLLECTION)
    ("RB, BMV, and SDP" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("LF" . SPARSER::PROTEIN)
    ("phosphorylated HER2 or both HER2 and EGFR [ xref ]"
     . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("pAkt and pMAPK" . SPARSER::COLLECTION)
    ("HER2 or EGFR" . SPARSER::COLLECTION)
    ("lapatinib and cetuximab" . SPARSER::COLLECTION)
    ("PI3K/HER2" . SPARSER::COLLECTION) ("EGFR or Src" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN)
    ("the increased autocatalytic T798M variant" . SPARSER::VARIANT)
    ("cetuximab and trastuzumab" . SPARSER::COLLECTION)
    ("Rexer" . SPARSER::DRUG) ("EGFR, MAPK, and Src" . SPARSER::COLLECTION)
    ("Cetuximab" . SPARSER::DRUG)
    ("lapatinib or cetuximab" . SPARSER::COLLECTION)
    ("cetuximab and lapatinib" . SPARSER::COLLECTION)
    ("Src and EGFR" . SPARSER::COLLECTION)
    ("the wild-type EGFR or the mutant Tyr845Phe (Y845F) variant"
     . SPARSER::COLLECTION)
    ("FAK, paxillin, and p130Cas" . SPARSER::COLLECTION)
    ("phospho-Akt and phospho-MAPK" . SPARSER::COLLECTION)
    ("EGFR/Src" . SPARSER::COLLECTION)
    ("EGF and transforming growth factor" . SPARSER::COLLECTION)
    ("HER3/EGFR" . SPARSER::COLLECTION) ("HER2/EGFR" . SPARSER::COLLECTION)
    ("EGFR and Src" . SPARSER::COLLECTION) ("HER2/Src" . SPARSER::COLLECTION)
    ("Src, Akt, and MAPK" . SPARSER::COLLECTION)
    ("HER2, Akt, MAPK, Src, paxillin, and p130Cas" . SPARSER::COLLECTION)
    ("HER2, EGFR, Akt, MAPK, Src, FAK, paxillin, and p130Cas"
     . SPARSER::COLLECTION)
    ("Alu" . SPARSER::PROTEIN)
    ("neither saracatinib nor lapatinib" . SPARSER::COLLECTION)
    ("pSrc" . SPARSER::PROTEIN) ("Akt and MAPK" . SPARSER::COLLECTION)
    ("HER2, Akt, and MAPK" . SPARSER::COLLECTION)
    ("saracatinib and lapatinib" . SPARSER::COLLECTION)
    ("Src and HER2" . SPARSER::COLLECTION)
    ("the anti-HER2 drugs trastuzumab [ xref ] and lapatinib [ xref ]"
     . SPARSER::COLLECTION)
    ("focal adhesion kinase (FAK), paxillin, RhoA, and other molecules"
     . SPARSER::COLLECTION)
    ("insulin-like growth factor-1 receptor, and c-Met" . SPARSER::COLLECTION)
    ("TKs" . SPARSER::PROTEIN)
    ("other RTKs or intracellular signaling effectors" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR) ("Lapatinib" . SPARSER::DRUG)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("emtansine" . SPARSER::DRUG) ("TK" . SPARSER::PROTEIN)
    ("/Akt" . SPARSER::COLLECTION) ("HER3 and EGFR" . SPARSER::COLLECTION)
    ("a transmembrane receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER" . SPARSER::PROTEIN) ("EGFR/HER2" . SPARSER::COLLECTION)
    ("Saracatinib" . SPARSER::DRUG) ("saracatinib" . SPARSER::DRUG)
    ("Adenosine triphosphate" . SPARSER::MOLECULE)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 4" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("Crk-associated substrate" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("AZD0530" . SPARSER::DRUG)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("p95" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("KS, SS, NH, and KOt" . SPARSER::COLLECTION)
    ("both higher Cox-2 and lower CDH-1" . SPARSER::COLLECTION)
    ("functional E-cadherin" . SPARSER::PROTEIN)
    ("NS-398 [ xref , xref ] and celecoxib [ xref ]" . SPARSER::COLLECTION)
    ("celecoxib, NS-398, nimesulide, and meloxicam" . SPARSER::COLLECTION)
    ("meloxicam" . SPARSER::DRUG) ("nimesulide" . SPARSER::DRUG)
    ("ZEB1 and Slug" . SPARSER::COLLECTION)
    ("ligand (RANKL)" . SPARSER::MOLECULE) ("RANKL" . SPARSER::PROTEIN)
    ("ZEB1 and Snail" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("a principal effector" . SPARSER::EFFECTOR)
    ("celecoxib or Cox-2" . SPARSER::COLLECTION)
    ("Cox-2/Snail" . SPARSER::COLLECTION)
    ("Cox-2 and E-cadherin" . SPARSER::COLLECTION)
    ("at least two Cox-2 inhibitors" . SPARSER::INHIBITOR)
    ("etodolac, celecoxib, and NS-398" . SPARSER::COLLECTION)
    ("etodolac" . SPARSER::DRUG)
    ("lower E-cadherin and higher Cox-2" . SPARSER::COLLECTION)
    ("the Cox-2 inhibitors compared to DMSO treatment" . SPARSER::INHIBITOR)
    ("CDH-1 and Cox-2" . SPARSER::COLLECTION)
    ("CDH-1 and its transcriptional repressors" . SPARSER::COLLECTION)
    ("CDH-1, and HSC-4" . SPARSER::COLLECTION)
    ("neither Cox-2 nor CDH-1" . SPARSER::COLLECTION)
    ("Cox-2 and CDH-1" . SPARSER::COLLECTION) ("FAP" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and growth factors" . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE) ("/ZEB2" . SPARSER::COLLECTION)
    ("DeltaEF1/ZEB1" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN)
    ("cell adhesion and gain mesenchymal traits" . SPARSER::PROTEIN)
    ("E-cadherin and Cox-2" . SPARSER::COLLECTION)
    ("CDH-1 and its repressors" . SPARSER::COLLECTION)
    ("E-cadherin (CDH-1) and its transcriptional repressors (SIP1, Snail, Twist)"
     . SPARSER::COLLECTION)
    ("HSC-2 and HSC-4" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("celecoxib" . SPARSER::DRUG) ("HSC-2" . SPARSER::PROTEIN)
    ("-2 " . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("SIP-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E-Cadherin" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("ZFHX1B" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("Cox2" . SPARSER::PROTEIN) ("HT-1080" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("Smad interacting protein 1" . SPARSER::PROTEIN)
    ("DeltaEF1" . SPARSER::PROTEIN) ("HSC-4" . SPARSER::PROTEIN)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDH-1" . SPARSER::PROTEIN)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("chemokines and growth factors" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DGKα or aPKCs" . SPARSER::COLLECTION)
    ("particular PKCι" . SPARSER::PROTEIN) ("EGF-" . SPARSER::PROTEIN)
    ("whose receptor" . SPARSER::RECEPTOR)
    ("OST-DGKα induced elongation" . SPARSER::PROTEIN)
    ("aPKC/Rac" . SPARSER::COLLECTION) ("Elongation" . SPARSER::PROTEIN)
    ("aPKC" . SPARSER::PROTEIN) ("MMP-9 and β1 integrin" . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE) ("PS-PKCζ" . SPARSER::COLLECTION)
    ("siRNA-DGKα" . SPARSER::COLLECTION) ("siRNA-CTRL" . SPARSER::COLLECTION)
    ("DGK" . SPARSER::PROTEIN) ("myc–DGKα" . SPARSER::COLLECTION)
    ("myc-DGKα" . SPARSER::COLLECTION)
    ("currently available antibodies" . SPARSER::ANTIBODY)
    ("HGF, EGF and VEGF" . SPARSER::COLLECTION)
    ("shRNA-DGKα2" . SPARSER::COLLECTION) ("shRNA-CTRL" . SPARSER::COLLECTION)
    ("CTRL" . SPARSER::PROTEIN) ("shRNA-DGKα1" . SPARSER::COLLECTION)
    ("DGKα and aPKCs" . SPARSER::COLLECTION)
    ("RhoGDI and Rac1" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("growth factors, estrogen and tyrosine kinase" . SPARSER::COLLECTION)
    ("DG" . SPARSER::PROTEIN) ("DGKs" . SPARSER::PROTEIN)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("atypical PKC" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("pMT2" . SPARSER::PROTEIN)
    ("RAB11FIP1" . SPARSER::PROTEIN) ("PKCι" . SPARSER::PROTEIN)
    ("PI3Kβ" . SPARSER::PROTEIN) ("DOCK180" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("DGKα" . SPARSER::PROTEIN) ("Diacylglycerol kinase" . SPARSER::PROTEIN)
    ("ARVs" . SPARSER::PROTEIN)
    ("Many scientists model highly complex proteins" . SPARSER::PROTEIN)
    ("peptides or compounds" . SPARSER::COLLECTION)
    ("p6, and Vpu" . SPARSER::COLLECTION)
    ("Env, GP120, GP41, Capsid, and Vif" . SPARSER::COLLECTION)
    ("trimers" . SPARSER::TRIMER) ("Env" . SPARSER::PROTEIN)
    ("Subtype" . SPARSER::PROTEIN) ("Atazanavir" . SPARSER::DRUG)
    ("the beneficial and primary DRMs" . SPARSER::PROTEIN)
    ("PSSM" . SPARSER::PROTEIN) ("specific viral subtypes" . SPARSER::PROTEIN)
    ("flap" . SPARSER::PROTEIN) ("prothymosin" . SPARSER::PROTEIN)
    ("Response Element (RRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TBP and p53" . SPARSER::COLLECTION) ("p53 and TBP" . SPARSER::COLLECTION)
    ("Cyclin T1 and CDK9" . SPARSER::COLLECTION)
    ("Several previously unknown examples" . SPARSER::EXAMPLE)
    ("∼30 different proteins and multiple types and sites"
     . SPARSER::COLLECTION)
    ("types and sites" . SPARSER::COLLECTION)
    ("Rev, Vif, and Vpr" . SPARSER::COLLECTION) ("Saquinavir" . SPARSER::DRUG)
    ("ID" . SPARSER::PROTEIN) ("the selected ARV drugs" . SPARSER::DRUG)
    ("all ARV drugs" . SPARSER::DRUG) ("PDB" . SPARSER::MOLECULE)
    ("three synchronized interactive protein" . SPARSER::PROTEIN)
    ("HIV:ARV complexes" . SPARSER::BIO-COMPLEX) ("ARV" . SPARSER::PROTEIN)
    ("protein or drug" . SPARSER::COLLECTION)
    ("protein:ARV" . SPARSER::PROTEIN-PAIR)
    ("protease and reverse transcriptase" . SPARSER::COLLECTION)
    ("Our refactored database contained 671 unique DRMs" . SPARSER::PROTEIN)
    ("antiretroviral (ARV) drugs" . SPARSER::DRUG)
    ("Integrase" . SPARSER::PROTEIN) ("Bank" . SPARSER::PROTEIN)
    ("most drug therapies specifically target HIV proteins" . SPARSER::PROTEIN)
    ("almost all HIV proteins" . SPARSER::PROTEIN) ("DRMs" . SPARSER::PROTEIN)
    ("Class M" . SPARSER::PROTEIN) ("GP41" . SPARSER::PROTEIN)
    ("GP120" . SPARSER::DRUG) ("RNA binding protein" . SPARSER::PROTEIN)
    ("Sam68" . SPARSER::PROTEIN) ("Exportin 1" . SPARSER::PROTEIN)
    ("NLP1" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Cyclin T" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("Cyclin T1" . SPARSER::PROTEIN)
    ("SSH" . SPARSER::MOLECULE) ("YY" . SPARSER::MOLECULE)
    ("Extracellular-regulated protein kinase" . SPARSER::KINASE)
    ("platinum-" . SPARSER::MOLECULE)
    ("G protein-coupled receptors (GPCRs) use multifunctional adaptor proteins"
     . SPARSER::PROTEIN)
    ("P70S6K, 4EBP1, AKT, and MAPK" . SPARSER::COLLECTION)
    ("PAF or EGF" . SPARSER::COLLECTION)
    ("WEB2086 and EGFR" . SPARSER::COLLECTION)
    ("PAF/PAFR" . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies and EGFR" . SPARSER::COLLECTION)
    ("AG1478 and/or WEB2086" . SPARSER::COLLECTION)
    ("AG1478 and WEB2086" . SPARSER::COLLECTION)
    ("EGFR and β-arrestin2" . SPARSER::COLLECTION)
    ("AG1478 or WEB2086" . SPARSER::COLLECTION)
    ("P70S6K, 4EBP1, AKT and MAPK" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION) ("PAF and EGF" . SPARSER::COLLECTION)
    ("PAF (from 0.1 to 1000 nM) or EGF (from 0.1 to 20 ng/ml)"
     . SPARSER::COLLECTION)
    ("eukaryotic initiation factor 4E-binding protein 1 (4EBP1) and ribosomal protein S6 kinase (P70S6K)"
     . SPARSER::COLLECTION)
    ("P70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("selected proteins and their activated forms" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("WEB2086 or AG1478" . SPARSER::COLLECTION)
    ("the PAFR antagonist WEB2086 and the EGFR inhibitor AG1478"
     . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and transforming growth factor (TGF)"
     . SPARSER::COLLECTION)
    ("monoclonal antibodies or tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies or tyrosine kinase" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("matuzumab" . SPARSER::DRUG)
    ("PAFR and/or EGFR" . SPARSER::COLLECTION)
    ("mTOR, AKT, and MAPK" . SPARSER::COLLECTION)
    ("WEB2086 and AG1478" . SPARSER::COLLECTION)
    ("PAFR and EGFR" . SPARSER::COLLECTION)
    ("EGFR and PAFR" . SPARSER::COLLECTION) ("PAF" . SPARSER::PROTEIN-FAMILY)
    ("PAFR" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("β-arrestin" . SPARSER::PROTEIN) ("β-arrestins" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("β-arrestin2" . SPARSER::PROTEIN)
    ("CCK8" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("WEB2086" . SPARSER::DRUG)
    ("platelet-activating factor receptor" . SPARSER::PROTEIN)
    ("isolated mitochondria and flow cytometry" . SPARSER::COLLECTION)
    ("MH" . SPARSER::MOLECULE) ("KS" . SPARSER::PROTEIN)
    ("EM" . SPARSER::PROTEIN) ("IK" . SPARSER::PROTEIN)
    ("Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("AKIP-1" . SPARSER::COLLECTION) ("oxidase" . SPARSER::PROTEIN)
    ("Subunit" . SPARSER::FRAGMENT) ("COX" . SPARSER::PROTEIN)
    ("Adenine" . SPARSER::NUCLEOBASE)
    ("Hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p73 and BCA3" . SPARSER::COLLECTION)
    ("proteins, p73 and AIF" . SPARSER::COLLECTION)
    ("cytochrome c and AIF" . SPARSER::COLLECTION)
    ("p21, Bax and p53" . SPARSER::COLLECTION)
    ("caspase-activated DNase (ICAD)" . SPARSER::PROTEIN)
    ("PARP and inhibitor" . SPARSER::COLLECTION) ("ICAD" . SPARSER::PROTEIN)
    ("cytochrome c and APAF-1" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN)
    ("NC and their fragments" . SPARSER::COLLECTION)
    ("mitochondria-enriched subcellular fractions" . SPARSER::COMPONENT)
    ("anti- and pro-apoptotic proteins" . SPARSER::COLLECTION)
    ("Bcl-2 and caspase 8" . SPARSER::COLLECTION)
    ("PR " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PR and BCA3" . SPARSER::COLLECTION)
    ("Bax and an acetylated form" . SPARSER::COLLECTION)
    ("p53, Bax and an acetylated form" . SPARSER::COLLECTION)
    ("pGL3-bax-luc" . SPARSER::COLLECTION)
    ("Tom22 and VDAC" . SPARSER::COLLECTION)
    ("Bak or Bid" . SPARSER::COLLECTION) ("Calpain" . SPARSER::PROTEIN)
    ("residual calpain" . SPARSER::PROTEIN) ("Ritonavir" . SPARSER::DRUG)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("selected anti- and pro-apoptotic Bcl-2 family proteins"
     . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("HIV-1 PR(D25N) and BCA3" . SPARSER::COLLECTION)
    ("Bak and Mito-marker" . SPARSER::COLLECTION) ("COXIV" . SPARSER::PROTEIN)
    ("IMM" . SPARSER::PROTEIN) ("PR/BCA3" . SPARSER::COLLECTION)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both HIV-1 PR and HIV-1 PRO" . SPARSER::COLLECTION)
    ("c-myc-HIV-1 PR (D25N) or c-myc-HIV-1 PRO (D25N)" . SPARSER::COLLECTION)
    ("c-myc and HA" . SPARSER::COLLECTION)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("/BCA3" . SPARSER::COLLECTION)
    ("PR, and N-terminally" . SPARSER::COLLECTION)
    ("ritonavir" . SPARSER::DRUG) ("PRO" . SPARSER::AMINO-ACID)
    ("c-myc/HA" . SPARSER::COLLECTION)
    ("the BCA3 and HIV-1 PR(D25N) proteins" . SPARSER::COLLECTION)
    ("both BCA3 and HIV-1 PR(D25N)" . SPARSER::COLLECTION)
    ("BCA3 and HIV-1 PR(D25N)" . SPARSER::COLLECTION)
    ("iodixanol" . SPARSER::DRUG)
    ("Both BCA3 and HIV-1 PR(D25N) proteins" . SPARSER::COLLECTION)
    ("ER-GFP" . SPARSER::COLLECTION) ("dsRed" . SPARSER::PROTEIN)
    ("Mito" . SPARSER::DRUG) ("BCA3 and HIV PR" . SPARSER::COLLECTION)
    ("Co-expressed BCA3 and HIV-1 PR co-localized" . SPARSER::COLLECTION)
    ("HA-BCA3" . SPARSER::COLLECTION)
    ("PR17(D26N) and PR12(D26N)" . SPARSER::COLLECTION)
    ("PRs" . SPARSER::PROTEIN)
    ("pro-apoptotic mitochondrial proteins" . SPARSER::PROTEIN)
    ("-polymerase" . SPARSER::COLLECTION) ("anion" . SPARSER::MOLECULE)
    ("Breast carcinoma-associated protein 3" . SPARSER::PROTEIN)
    ("protein or AKIP1" . SPARSER::COLLECTION) ("AKIP" . SPARSER::PROTEIN)
    ("pro-apoptotic protein Bid" . SPARSER::PROTEIN)
    ("Casp" . SPARSER::PROTEIN)
    ("PABPC1 [ xref ] and a subunit" . SPARSER::COLLECTION)
    ("eIF3d" . SPARSER::PROTEIN) ("retroviral proteases" . SPARSER::PROTEIN)
    ("mature proteins" . SPARSER::PROTEIN)
    ("viral PR, reverse transcriptase and integrase" . SPARSER::COLLECTION)
    ("matrix, capsid and nucleocapsid" . SPARSER::COLLECTION)
    ("PR, reverse transcriptase and integrase" . SPARSER::COLLECTION)
    ("integrase" . SPARSER::PROTEIN)
    ("the virus-encoded aspartic PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic Bax protein" . SPARSER::PROTEIN) ("bax" . SPARSER::PROTEIN)
    ("breast carcinoma-associated protein 3" . SPARSER::PROTEIN)
    ("Tom22, VDAC and ANT" . SPARSER::COLLECTION)
    ("AIF and Hsp60" . SPARSER::COLLECTION) ("VDAC" . SPARSER::PROTEIN)
    ("protease (PR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Voltage-dependent" . SPARSER::PROTEIN)
    ("A-kinase interacting protein 1" . SPARSER::PROTEIN)
    ("TWEEN 20" . SPARSER::MOLECULE) ("JC-1" . SPARSER::MOLECULE)
    ("l 35" . SPARSER::PROTEIN) ("calpain inhibitor" . SPARSER::PROTEIN)
    ("Protein-A" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("HSPD1" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("COX IV" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("S 5" . SPARSER::MOLECULE) ("caspase-activated DNase" . SPARSER::PROTEIN)
    ("APAF-1" . SPARSER::PROTEIN) ("Caspase 8" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("annexin-V" . SPARSER::PROTEIN) ("S1b" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("Casp-9" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("A-kinase" . SPARSER::PROTEIN)
    ("proline-rich protein" . SPARSER::PROTEIN) ("p41" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("PABPC1" . SPARSER::PROTEIN)
    ("factor 4" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("Gag polyprotein" . SPARSER::PROTEIN)
    ("Gag-Pol polyprotein" . SPARSER::PROTEIN) ("BCA3" . SPARSER::PROTEIN)
    ("Hsp60" . SPARSER::PROTEIN) ("Tom22" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SL, YK, and JG" . SPARSER::COLLECTION)
    ("SL and YK" . SPARSER::COLLECTION)
    ("SL, YK, LS, and JG" . SPARSER::COLLECTION) ("JG" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN) ("Partial" . SPARSER::PROTEIN)
    ("DCR" . SPARSER::PROTEIN)
    ("predictive efficacy biomarkers" . SPARSER::MOLECULE)
    ("RAS/MEK/ERK" . SPARSER::COLLECTION)
    ("phospho-4EBP1 and phospho-S6RP" . SPARSER::COLLECTION)
    ("mTOR or AKT" . SPARSER::COLLECTION) ("larger cohort" . SPARSER::MOLECULE)
    ("p90rsk" . SPARSER::PROTEIN-FAMILY) ("rsk" . SPARSER::PROTEIN)
    ("temsirolimus" . SPARSER::DRUG) ("Cho" . SPARSER::PROTEIN)
    ("phospho-mTOR or phospho-S6RP" . SPARSER::COLLECTION)
    ("phospho-mTOR, phospho-S6RP or phospho-4EBP1" . SPARSER::COLLECTION)
    ("4EBP1 and S6RP" . SPARSER::COLLECTION)
    ("phospho-AKT, phospho-mTOR, phospho-S6RP and phospho-4EBP1"
     . SPARSER::COLLECTION)
    ("mTOR-associated molecules" . SPARSER::MOLECULE)
    ("CR, PR and SD" . SPARSER::COLLECTION)
    ("interferon-alpha or interleukin-2" . SPARSER::COLLECTION)
    ("gemcitabine and fluorouracil" . SPARSER::COLLECTION)
    ("sorafenib, sunitinib or axitinib" . SPARSER::COLLECTION)
    ("axitinib" . SPARSER::DRUG) ("Ib" . SPARSER::DRUG)
    ("the informed consent form" . SPARSER::FORM) ("Dec" . SPARSER::PROTEIN)
    ("mTOR signaling-associated molecules" . SPARSER::MOLECULE)
    ("mTOR-associated signaling molecules" . SPARSER::MOLECULE)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("AKT, mTOR, S6RP and 4EBP1" . SPARSER::COLLECTION)
    ("p70S6K1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E (eIF4E) binding protein-1 (4EBP1) and p70 ribosomal protein S6 kinase"
     . SPARSER::COLLECTION)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("phospho-mTOR and phospho-S6RP" . SPARSER::COLLECTION)
    ("phosphorylated mTOR, S6RP and/or 4EBP1" . SPARSER::COLLECTION)
    ("phospho-4EBP1 and phospho-AKT" . SPARSER::COLLECTION)
    ("CBR" . SPARSER::PROTEIN)
    ("these mTOR-associated molecules" . SPARSER::MOLECULE)
    ("1b" . SPARSER::PROTEIN) ("VEGFR" . SPARSER::PROTEIN)
    ("everolimus" . SPARSER::DRUG) ("Everolimus" . SPARSER::MOLECULE)
    ("interferon-alpha" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("anti-VEGF" . SPARSER::DRUG) ("RAD001" . SPARSER::DRUG)
    ("JI and ST" . SPARSER::COLLECTION) ("JI" . SPARSER::PROTEIN)
    ("SF" . SPARSER::PROTEIN) ("SK" . SPARSER::PROTEIN)
    ("intense p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one part" . SPARSER::COMPONENT) ("IIb" . SPARSER::DRUG)
    ("47.11" . SPARSER::PROTEIN) ("TM" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN)
    ("a particular DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP10/MKP5" . SPARSER::COLLECTION) ("ERK and p38" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN) ("Ca2+ and DAG" . SPARSER::COLLECTION)
    ("lipids and DAG" . SPARSER::COLLECTION)
    ("calcium (Ca2+) and diacylglycerol (DAG)" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("the angiogenic growth factor b-FGF" . SPARSER::DRUG)
    ("VEGFC" . SPARSER::PROTEIN) ("DUSP23/VHZ" . SPARSER::COLLECTION)
    ("DUSP1/MKP1" . SPARSER::COLLECTION) ("VHZ" . SPARSER::PROTEIN)
    ("the atypical dual specificity phosphatase DUSP3" . SPARSER::PROTEIN)
    ("STYX [ xref ], DUSP14 [ xref ] and laforin [ xref ]"
     . SPARSER::COLLECTION)
    ("19 A-DUSPs" . SPARSER::COLLECTION) ("laforin" . SPARSER::PROTEIN)
    ("STYX" . SPARSER::PROTEIN)
    ("autologous serum complemented" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN)
    ("Acta2 (aSMA) and Pdgfrb (CD140b)" . SPARSER::COLLECTION)
    ("Acta2" . SPARSER::PROTEIN) ("Cd144" . SPARSER::PROTEIN)
    ("Cdh5" . SPARSER::PROTEIN) ("Pdgfrb" . SPARSER::PROTEIN)
    ("Acta" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Heparin" . SPARSER::PROTEIN)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PLCγ/PKC" . SPARSER::COLLECTION)
    ("AnnexinV-PI" . SPARSER::COLLECTION) ("PI3k/Akt" . SPARSER::COLLECTION)
    ("phospho-c-Jun (Ser63) and c-Jun antibodies" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("using phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("siRNAs or siCTL" . SPARSER::COLLECTION)
    ("ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("MAPKs and EGFR" . SPARSER::COLLECTION)
    ("A representative western blot" . SPARSER::PROTEIN)
    ("Biii" . SPARSER::PROTEIN) ("Aii" . SPARSER::PROTEIN)
    ("EBM" . SPARSER::PROTEIN) ("cpm" . SPARSER::PROTEIN)
    ("anti-DUSP3 or anti-Von Willebrand Factor" . SPARSER::COLLECTION)
    ("vWF" . SPARSER::PROTEIN) ("study DUSP3’s" . SPARSER::PROTEIN)
    ("demethylase" . SPARSER::PROTEIN)
    ("ERK1/2 and JNK1/2" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("pTyr and pThr" . SPARSER::COLLECTION)
    ("DUSP3/Dusp3" . SPARSER::COLLECTION)
    ("the atypical DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the typical DUSPs or MAPK specific phosphatases" . SPARSER::PHOSPHATASE)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("DUSPs or MAPK" . SPARSER::COLLECTION)
    ("Dual-specificity phosphatases (DUSPs) or Vaccinia -H1-like (VH1-Like) enzymes"
     . SPARSER::COLLECTION)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transplanted b-FGF containing Matrigel and LLC xenograft tumors"
     . SPARSER::COLLECTION)
    ("FITC-dextran" . SPARSER::MOLECULE) ("dextran" . SPARSER::DEXTRAN)
    ("ERK1/2, JNK1/2 and EGFR" . SPARSER::COLLECTION)
    ("complex and contradictory roles in tumorigenesis" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION) ("Dusp3" . SPARSER::PROTEIN)
    ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VHR" . SPARSER::PROTEIN)
    ("ND2" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("basic-Fibroblast growth factor" . SPARSER::PROTEIN)
    ("MKP5" . SPARSER::PROTEIN) ("DUSP10" . SPARSER::PROTEIN)
    ("DUSP2" . SPARSER::PROTEIN) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("DUSP23" . SPARSER::PROTEIN) ("MKP1" . SPARSER::PROTEIN)
    ("DUSP1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("19 A" . SPARSER::PROTEIN) ("CD140b" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-2" . SPARSER::PROTEIN) ("3-1" . SPARSER::PROTEIN)
    ("Von Willebrand Factor" . SPARSER::PROTEIN) ("KDM2A" . SPARSER::PROTEIN)
    ("p-Thr" . SPARSER::PROTEIN) ("b-FGF" . SPARSER::DRUG)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H 1 R" . SPARSER::PROTEIN)
    ("DUSP3" . SPARSER::PROTEIN) ("OM and MQ" . SPARSER::COLLECTION)
    ("a symptomatic state" . SPARSER::BIO-STATE)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("LIF and IL-6" . SPARSER::COLLECTION) ("Oct4-NANOG" . SPARSER::COLLECTION)
    ("multidrug resistant genes and concomitant chemoresistance"
     . SPARSER::COLLECTION)
    ("IL-6 and G-CSF" . SPARSER::COLLECTION)
    ("cisplatin or paclitaxel" . SPARSER::COLLECTION)
    ("CD117 and EpCAM" . SPARSER::COLLECTION)
    ("CD117, Oct4 and CA125" . SPARSER::COLLECTION)
    ("the embryonic stem cell marker Oct4 and the ovarian cancer marker CA125"
     . SPARSER::COLLECTION)
    ("the CSC marker CD117 (c-kit), the embryonic stem cell marker Oct4 and the ovarian cancer marker CA125"
     . SPARSER::COLLECTION)
    ("the ovarian cancer marker CA125" . SPARSER::DRUG)
    ("paclitaxel (1 ng/ml for HEY cells and 4-6 ng/ml for ascites tumor cells) and 1 μM concentration"
     . SPARSER::COLLECTION)
    ("paclitaxel and CYT387" . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION)
    ("Oct4 and EpCAM" . SPARSER::COLLECTION)
    ("CD117 and CD44" . SPARSER::COLLECTION)
    ("EpCAM and the embryonic stem cells markers Oct4" . SPARSER::COLLECTION)
    ("cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("JAK2 and downstream STAT3" . SPARSER::COLLECTION)
    ("phosphorylated JAK2 (Tyr-1007/1008) and downstream STAT3 (Tyr-705)"
     . SPARSER::COLLECTION)
    ("total JAK2 (T-JAK2) and STAT3 (T-STAT3)" . SPARSER::COLLECTION)
    ("JAK2 (Tyr1007/1008) and STAT3 (Tyr-705)" . SPARSER::COLLECTION)
    ("CD117, Oct4 and JAGGED" . SPARSER::COLLECTION)
    ("EpCAM, CD44 and NANOG" . SPARSER::COLLECTION)
    ("CD117 and the embryonic stem cell markers Oct4 and NANOG"
     . SPARSER::COLLECTION)
    ("CSC markers EpCAM, CD117 and the embryonic stem cell markers Oct4 and NANOG"
     . SPARSER::COLLECTION)
    ("Oct4 and NANOG" . SPARSER::COLLECTION)
    ("EpCAM and CD117" . SPARSER::COLLECTION)
    ("NANOG and Oct4" . SPARSER::COLLECTION) ("EpCAM" . SPARSER::PROTEIN)
    ("Paclitaxel" . SPARSER::DRUG)
    ("very few control cells displayed ERCC1" . SPARSER::PROTEIN)
    ("ERCC1 and β-tubulin" . SPARSER::COLLECTION)
    ("ERCC1 and β-tubulin-III" . SPARSER::COLLECTION)
    ("LIF" . SPARSER::PROTEIN) ("GCSF" . SPARSER::PROTEIN)
    ("glutathione and metallothionein" . SPARSER::COLLECTION)
    ("metallothionein" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION) ("CYT" . SPARSER::MOLECULE)
    ("HEY" . SPARSER::PROTEIN-FAMILY) ("N-cadherin" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("cytokeratin 7" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("CA125" . SPARSER::DRUG)
    ("DLD" . SPARSER::PROTEIN) ("sRBCs" . SPARSER::PROTEIN)
    ("src" . SPARSER::PROTEIN) ("Phorbol" . SPARSER::DRUG)
    ("CBL and SYK" . SPARSER::COLLECTION)
    ("SHP-1 or PTKs" . SPARSER::COLLECTION)
    ("Stat1 and Jak1" . SPARSER::COLLECTION)
    ("Tyk2 and Stat2" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("PTPs" . SPARSER::PROTEIN)
    ("kinases and/or phosphatases" . SPARSER::COLLECTION)
    ("PTP" . SPARSER::PROTEIN) ("Tau" . SPARSER::PROTEIN)
    ("receptor and serine" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP1 and PMA" . SPARSER::COLLECTION)
    ("proto-oncoprotein" . SPARSER::PROTEIN-PAIR)
    ("a given intact protein can" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("granulocyte-macrophage colony stimulating factor and erythropoietin receptor"
     . SPARSER::COLLECTION)
    ("receptor and mitogen" . SPARSER::COLLECTION)
    ("Syk kinase and the γ-subunit" . SPARSER::COLLECTION)
    ("COS" . SPARSER::MOLECULE) ("SYK" . SPARSER::PROTEIN)
    ("GF109203X or activator" . SPARSER::COLLECTION)
    ("PMA or PMA " . SPARSER::COLLECTION) ("SRBC" . SPARSER::PROTEIN)
    ("PMA " . SPARSER::PROTEIN) ("kinases, Syk and Src" . SPARSER::COLLECTION)
    ("anti-CBL and anti-CRKL" . SPARSER::COLLECTION)
    ("PKC and SHP1" . SPARSER::COLLECTION)
    ("CBL and Syk" . SPARSER::COLLECTION)
    ("tyrosine kinase, Src and Syk" . SPARSER::COLLECTION)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("a typical PKCζ" . SPARSER::PROTEIN)
    ("at least 11 isoforms" . SPARSER::ISOFORM)
    ("homology and cofactor" . SPARSER::COLLECTION) ("DAG" . SPARSER::DAG)
    ("serine/threonine" . SPARSER::COLLECTION) ("phorbol" . SPARSER::DRUG)
    ("kinases and adaptor proteins" . SPARSER::COLLECTION)
    ("Nck, Grb2, Crk, CrkL, Syk, Fyn, and Lyn" . SPARSER::COLLECTION)
    ("Lyn" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("CrkL" . SPARSER::PROTEIN) ("Nck" . SPARSER::PROTEIN)
    ("Syk/Zap-70" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Syk" . SPARSER::PROTEIN)
    ("the associated FcγRI gamma subunit" . SPARSER::PROTEIN)
    ("monomeric IgG (CD64) and FcγRIIIA (CD16)" . SPARSER::COLLECTION)
    ("monomeric IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor, and Fc" . SPARSER::COLLECTION)
    ("IgE and IgG" . SPARSER::COLLECTION) ("IgE" . SPARSER::PROTEIN)
    ("IRs" . SPARSER::PROTEIN) ("RI" . SPARSER::MOLECULE)
    ("the phosphorylation state of CBL, the activation state of Rac and the negative regulation of ITAM signaling"
     . SPARSER::COLLECTION)
    ("CBL-CRKL" . SPARSER::COLLECTION) ("CRKL" . SPARSER::PROTEIN)
    ("PMA" . SPARSER::PROTEIN) ("CBL" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("Stat2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase activity" . SPARSER::PROTEIN)
    ("small G-protein" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PKC δ" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("PI-3 kinase" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("PI-3Kinase" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol" . SPARSER::MOLECULE) ("c-CBL" . SPARSER::PROTEIN)
    ("Zap-70" . SPARSER::PROTEIN) ("FcγRIIA" . SPARSER::PROTEIN)
    ("gamma subunit" . SPARSER::PROTEIN) ("FcγRIIIA" . SPARSER::PROTEIN)
    ("CD64" . SPARSER::PROTEIN) ("Fc receptor" . SPARSER::PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("GF109203X" . SPARSER::DRUG)
    ("SS, MN and BW" . SPARSER::COLLECTION) ("MN" . SPARSER::PROTEIN)
    ("VP" . SPARSER::PROTEIN) ("Bovine serum albumin" . SPARSER::PROTEIN)
    ("appropriate cis" . SPARSER::PROTEIN)
    ("the 3T5T double-variant LTR-containing viral genotype"
     . SPARSER::PROTEIN)
    ("a 3T5T LTR-containing proviral DNA" . SPARSER::DNA)
    ("the viral promoter" . SPARSER::PROMOTER)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("The memory CD4 + T-cell" . SPARSER::PROTEIN)
    ("a resting memory state" . SPARSER::BIO-STATE)
    ("their promonocytic state" . SPARSER::BIO-STATE)
    ("viral genes" . SPARSER::GENE)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("these particular cytokines" . SPARSER::PROTEIN)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("pEGFP-N1" . SPARSER::COLLECTION) ("YU-2" . SPARSER::COLLECTION)
    ("continuous highly active" . SPARSER::ACTIVE) ("Los" . SPARSER::MOLECULE)
    ("conB" . SPARSER::PROTEIN)
    ("viral regulatory proteins" . SPARSER::PROTEIN)
    ("Perivascular macrophages" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("monocyte-macrophage" . SPARSER::PROTEIN) ("TF-1" . SPARSER::PROTEIN)
    ("EBP" . SPARSER::PROTEIN) ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("T-G" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("l -glutamine" . SPARSER::MOLECULE) ("p50" . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("BK" . SPARSER::PROTEIN) ("GATA1-Sur" . SPARSER::COLLECTION)
    ("K14-Survivin" . SPARSER::COLLECTION) ("Sur" . SPARSER::PROTEIN)
    ("particular Survivin’s" . SPARSER::PROTEIN)
    ("particular Survivin" . SPARSER::PROTEIN)
    ("mitotic regulators" . SPARSER::REGULATOR)
    ("smac/DIABLO" . SPARSER::COLLECTION) ("AIF" . SPARSER::PROTEIN)
    ("DIABLO" . SPARSER::PROTEIN) ("residual γH2AX foci" . SPARSER::PROTEIN)
    ("an intact CPC" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("defective CPC" . SPARSER::PROTEIN)
    ("DNA-PK and ATM" . SPARSER::COLLECTION)
    ("the mitotic SAC" . SPARSER::PROTEIN) ("cyclosome" . SPARSER::PROTEIN)
    ("mitotic SAC proteins" . SPARSER::PROTEIN)
    ("CENP-E, Bub1, BubR1, Bub3, Mad1, Mad2 and Mps1" . SPARSER::COLLECTION)
    ("Mad2" . SPARSER::PROTEIN) ("Mad" . SPARSER::PROTEIN)
    ("CS and ATM" . SPARSER::COLLECTION) ("p53 and p21" . SPARSER::COLLECTION)
    ("ATM, CHK2 and DNA-PK" . SPARSER::COLLECTION)
    ("DNA-sensor" . SPARSER::DNA) ("γH2AX/ATM-foci" . SPARSER::COLLECTION)
    ("γH2AX/ATM" . SPARSER::COLLECTION) ("tetra-" . SPARSER::MOLECULE)
    ("der(10)dup(10)(q23.1q26.1)t" . SPARSER::PROTEIN)
    ("pter" . SPARSER::PROTEIN) ("SKY" . SPARSER::PROTEIN)
    ("DAPI" . SPARSER::DRUG)
    ("significantly less (p < 0.01) p21 waf/cip" . SPARSER::COLLECTION)
    ("DNA-damages" . SPARSER::DNA)
    ("anti-tubulin and anti-centromere-antibodies" . SPARSER::COLLECTION)
    ("ACA" . SPARSER::PROTEIN) ("Cyclin D1 and p21" . SPARSER::COLLECTION)
    ("DNA-synthesis" . SPARSER::DNA) ("p53/p21" . SPARSER::COLLECTION)
    ("Cyclin D1 and Cyclin E" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Survivin and p53" . SPARSER::COLLECTION)
    ("subsequent p21 waf/cip" . SPARSER::COLLECTION)
    ("antisense or dominant-negative SurvivinT34A" . SPARSER::COLLECTION)
    ("an even greater fraction" . SPARSER::COMPONENT)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("actin-myosin" . SPARSER::COLLECTION) ("MGCRacGAP" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("complex (CPC)" . SPARSER::BIO-COMPLEX)
    ("around centromeres" . SPARSER::PROTEIN) ("CPC" . SPARSER::PROTEIN)
    ("INCENP" . SPARSER::PROTEIN) ("Borealin" . SPARSER::PROTEIN)
    ("proteins (CPP)" . SPARSER::PROTEIN) ("CPP" . SPARSER::MOLECULE)
    ("activated caspases [ xref , xref ] and smac/Diablo [ xref ]"
     . SPARSER::COLLECTION)
    ("smac/Diablo" . SPARSER::COLLECTION) ("Diablo" . SPARSER::PROTEIN)
    ("smac" . SPARSER::PROTEIN)
    ("only one baculoviral IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIR" . SPARSER::PROTEIN) ("birc5" . SPARSER::PROTEIN)
    ("IAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM and DNA-PK" . SPARSER::COLLECTION) ("waf/cip" . SPARSER::COLLECTION)
    ("cip" . SPARSER::PROTEIN) ("waf" . SPARSER::PROTEIN)
    ("γH2AX-foci" . SPARSER::COLLECTION) ("DDR" . SPARSER::PROTEIN)
    ("stably knockdown Survivin" . SPARSER::PROTEIN)
    ("SBC-2" . SPARSER::COLLECTION) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Survivin" . SPARSER::PROTEIN) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("p53 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α-Tubulin" . SPARSER::PROTEIN)
    ("− 3" . SPARSER::PROTEIN) ("murine leukemia virus" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("Aurora-B" . SPARSER::PROTEIN) ("Mps1" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("CENP-E" . SPARSER::PROTEIN)
    ("Nu7026" . SPARSER::DRUG) ("S15" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("inner centromere protein" . SPARSER::PROTEIN)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("CB and CL-O" . SPARSER::COLLECTION) ("DAP" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN) ("Akt/mTor" . SPARSER::COLLECTION)
    ("the mature protein" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN)
    ("whose clinical features fit" . SPARSER::PROTEIN-FAMILY)
    ("PIK3R1 and ZNF276" . SPARSER::COLLECTION)
    ("-AAATCTTTGCCCCCAAAACT-3" . SPARSER::COLLECTION)
    ("PRISM" . SPARSER::PROTEIN) ("Variants" . SPARSER::VARIANT)
    ("a homozygous variant" . SPARSER::VARIANT)
    ("a heterozygous variant" . SPARSER::VARIANT) ("BAM" . SPARSER::PROTEIN)
    ("alae" . SPARSER::PROTEIN-FAMILY) ("ZNF276" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("DMS" . SPARSER::DRUG) ("HSL" . SPARSER::PROTEIN)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN)
    ("the major fibronectin receptor" . SPARSER::PROTEIN)
    ("Fibronectin and Fn-fs" . SPARSER::COLLECTION)
    ("Fibronectin" . SPARSER::PROTEIN) ("TGA or TAA" . SPARSER::COLLECTION)
    ("heparin-" . SPARSER::PROTEIN) ("heparin" . SPARSER::PROTEIN)
    ("prothrombin" . SPARSER::PROTEIN) ("FTO" . SPARSER::PROTEIN)
    ("oxalate" . SPARSER::MOLECULE) ("TA" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("FN-1 and ITGAV" . SPARSER::COLLECTION)
    ("osteoarthritic chondrocytes" . SPARSER::PROTEIN)
    ("the more promiscuous alpha integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Integrin" . SPARSER::PROTEIN)
    ("at least 24 different heterodimers" . SPARSER::HETERODIMER)
    ("the insoluble form" . SPARSER::FORM) ("The soluble form" . SPARSER::FORM)
    ("a multifunctional glycoprotein" . SPARSER::PROTEIN)
    ("TGA and TAA" . SPARSER::COLLECTION) ("TGA" . SPARSER::PROTEIN)
    ("FN-1 and the integrin αV gene ( ITGAV )" . SPARSER::COLLECTION)
    ("gene ( ITGAV )" . SPARSER::GENE) ("ITGAV" . SPARSER::PROTEIN)
    ("the FN ( FN-1 ) and integrin genes" . SPARSER::COLLECTION)
    ("α5β1, αvβ3, and αvβ5" . SPARSER::COLLECTION) ("FN" . SPARSER::PROTEIN)
    ("fibronectin receptor" . SPARSER::PROTEIN) ("BANK1" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FN-1" . SPARSER::PROTEIN) ("αvβ5" . SPARSER::PROTEIN)
    ("αvβ3" . SPARSER::PROTEIN) ("POH" . SPARSER::DRUG)
    ("STAT1 or the macrodomains" . SPARSER::COLLECTION)
    ("aggressive PCa" . SPARSER::PROTEIN)
    ("classical therapeutic drugs" . SPARSER::DRUG)
    ("inhibitors and drugs" . SPARSER::COLLECTION)
    ("STAT1-" . SPARSER::PROTEIN) ("DTX3L and/or ARTD8" . SPARSER::COLLECTION)
    ("DTX3L/ARTD9" . SPARSER::COLLECTION)
    ("the E3 ubiquitin ligase DTX3L and the macrodomain-containing mono-ADP-ribosyltransferases ARTD8 and ARTD9"
     . SPARSER::COLLECTION)
    ("STAT1:STAT3" . SPARSER::BIO-COMPLEX)
    ("DTX3L, STAT1 and STAT3" . SPARSER::COLLECTION)
    ("ARTD9 and IRF1" . SPARSER::COLLECTION)
    ("IFNγ/IRF1" . SPARSER::COLLECTION)
    ("DTX3L or STAT1" . SPARSER::COLLECTION)
    ("DTX3L and STAT1" . SPARSER::COLLECTION)
    ("STAT1 or both STAT1 and DTX3L" . SPARSER::COLLECTION)
    ("STAT1 and DTX3L" . SPARSER::COLLECTION)
    ("ARTD9 or ARTD8" . SPARSER::COLLECTION)
    ("ARTD9 and STAT1α/β" . SPARSER::COLLECTION)
    ("PTPN1 and PTPN2" . SPARSER::COLLECTION)
    ("IFNγ/JAK1" . SPARSER::COLLECTION)
    ("their shared bidirectional promoter" . SPARSER::PROMOTER)
    ("its own bidirectional promoter" . SPARSER::PROMOTER)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("DTX3L, ARTD9 and STAT1β" . SPARSER::COLLECTION)
    ("-promoter" . SPARSER::PROMOTER) ("STAT1 and ARTD8" . SPARSER::COLLECTION)
    ("ARTD9 or DTX3L" . SPARSER::COLLECTION)
    ("ARTD9/STAT1" . SPARSER::COLLECTION) ("DTX3L/STAT1" . SPARSER::COLLECTION)
    ("the antagonistic isoform" . SPARSER::ISOFORM)
    ("p21 and IRF1" . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("STAT1-IRF2" . SPARSER::PROTEIN-PAIR)
    ("ARTD1 and ARTD8 or ARTD9" . SPARSER::COLLECTION)
    ("Olaparib and Veliparib" . SPARSER::COLLECTION)
    ("Veliparib" . SPARSER::DRUG) ("ARTD9 and ARTD1" . SPARSER::COLLECTION)
    ("IFNγ-STAT1-IRF1" . SPARSER::COLLECTION)
    ("IFNγ and/or docetaxel" . SPARSER::COLLECTION)
    ("DTX3L and ARTD8 or ARTD9" . SPARSER::COLLECTION)
    ("ARTD9 and active" . SPARSER::COLLECTION)
    ("ARTD9 and other ARTDs" . SPARSER::COLLECTION)
    ("strong complexes" . SPARSER::BIO-COMPLEX)
    ("ARTD9/DTX3L" . SPARSER::COLLECTION)
    ("DTX3L or ARTD9" . SPARSER::COLLECTION)
    ("DTX3L, ARTD8 or ARTD9" . SPARSER::COLLECTION)
    ("protein and complex" . SPARSER::COLLECTION)
    ("docetaxel-resistant residual cell lines PC3-DR" . SPARSER::MOLECULE)
    ("IL6/STAT3" . SPARSER::COLLECTION)
    ("ARTD9 and DTX3L" . SPARSER::COLLECTION)
    ("DTX3L, ARTD8, ARTD9, STAT1, pSTAT1, STAT2, pSTAT2, STAT3α, STAT3αβ, pSTAT3α, STAT5, pSTAT5, STAT6 and pSTAT6"
     . SPARSER::COLLECTION)
    ("DTX3L, ARTD8 and ARTD9, STAT1 and pSTAT1" . SPARSER::COLLECTION)
    ("ARTD9, STAT1 and pSTAT1" . SPARSER::COLLECTION)
    ("The DTX3L gene and all three genes" . SPARSER::COLLECTION)
    ("the same evolutionary conserved gene" . SPARSER::GENE)
    ("DTX3L and macrodomain-containing mono-ADP-ribosyltransferases"
     . SPARSER::COLLECTION)
    ("the same bidirectional IFNγ-responsive promoter" . SPARSER::PROMOTER)
    ("IFNγ-STAT1-IRF1-p53" . SPARSER::COLLECTION) ("PARPs" . SPARSER::MOLECULE)
    ("aspartate" . SPARSER::PROTEIN)
    ("also known as B-aggressive lymphoma protein (BAL1) and PARP9"
     . SPARSER::COLLECTION)
    ("CXCR4, ERK1/2 and c-Myc" . SPARSER::COLLECTION)
    ("STAT1-AKT1-clusterin" . SPARSER::COLLECTION)
    ("clusterin" . SPARSER::PROTEIN) ("multidrug" . SPARSER::PROTEIN)
    ("doxorubicin, docetaxel or anthracyclines" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE) ("kinases (JAK)" . SPARSER::PROTEIN)
    ("receptor and Janus" . SPARSER::COLLECTION)
    ("IFNγ/STAT1" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("constitutively expressed STAT1 and IFN-stimulated genes"
     . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION) ("Docetaxel" . SPARSER::DRUG)
    ("PCa (CRPC)" . SPARSER::PROTEIN)
    ("ARTD9 and/or DTX3L" . SPARSER::COLLECTION)
    ("STAT1, DTX3L and ARTD-like" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("DTX3L and ARTD9" . SPARSER::COLLECTION)
    ("DTX3L, ARTD9 and ARTD8" . SPARSER::COLLECTION)
    ("DTX3L, ARTD8 and ARTD9" . SPARSER::COLLECTION)
    ("STAT1 and/or IRF1" . SPARSER::COLLECTION)
    ("DTX3L, ARTD8, ARTD9 and STAT1" . SPARSER::COLLECTION)
    ("The Deltex (DTX)-3-like E3 ubiquitin ligase (DTX3L), also known as B-lymphoma and BAL-associated protein (BBAP)"
     . SPARSER::COLLECTION)
    ("BAL-associated protein (BBAP)" . SPARSER::PROTEIN)
    ("BBAP" . SPARSER::PROTEIN) ("BAL" . SPARSER::PROTEIN)
    ("Deltex" . SPARSER::PROTEIN-FAMILY) ("IFNGR1" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("I-T" . SPARSER::PROTEIN)
    ("H-Y" . SPARSER::PROTEIN) ("F-H" . SPARSER::PROTEIN)
    ("PTPN2" . SPARSER::PROTEIN) ("PTPN1" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("IRF2" . SPARSER::PROTEIN)
    ("PARP10" . SPARSER::PROTEIN) ("ARTD10" . SPARSER::PROTEIN)
    ("PARP2" . SPARSER::PROTEIN) ("ARTD2" . SPARSER::PROTEIN)
    ("ARTD1" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("IRF1" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("PARP14" . SPARSER::PROTEIN)
    ("ARTD9" . SPARSER::PROTEIN) ("DTX3L" . SPARSER::PROTEIN)
    ("hyperglycemia" . SPARSER::PROTEIN) ("Sirt7/INSR" . SPARSER::COLLECTION)
    ("seven times more INSR [ xref ] and 10 times more IGF receptors [ xref ]"
     . SPARSER::COLLECTION)
    ("ellipticine" . SPARSER::DRUG) ("methotrexate" . SPARSER::DRUG)
    ("IGF-1 and IGF-1R" . SPARSER::COLLECTION)
    ("IL-3 and TNF-α" . SPARSER::COLLECTION)
    ("the predominant substrate" . SPARSER::SUBSTRATE)
    ("IGF-1 and integrins" . SPARSER::COLLECTION)
    ("IGF/IRS-2" . SPARSER::COLLECTION) ("Adriamycin" . SPARSER::DRUG)
    ("hTERT" . SPARSER::PROTEIN) ("drosophila" . SPARSER::PROTEIN)
    ("Pgp, GST-π and topoisomerase" . SPARSER::COLLECTION)
    ("Pgp" . SPARSER::PROTEIN) ("IRS-4, IGF-1 and IGF-2" . SPARSER::COLLECTION)
    ("INSR and slightly upregulated IRS-1" . SPARSER::COLLECTION)
    ("IGF-1 and Sirt7" . SPARSER::COLLECTION)
    ("Sirt7 and INSR" . SPARSER::COLLECTION)
    ("IGF-1/IGF-INSR" . SPARSER::COLLECTION) ("IGF-INSR" . SPARSER::COLLECTION)
    ("INSR, IRS-1, IRS-2, IRS-4, IGF-1 and IGF-2" . SPARSER::COLLECTION)
    ("MRP1 and BCRP" . SPARSER::COLLECTION) ("Cis" . SPARSER::PROTEIN)
    ("Sirt7 and P-glycoprotein" . SPARSER::COLLECTION)
    ("mdr1, BCRP, and MRP-1" . SPARSER::COLLECTION)
    ("etoposide and carbaplatin" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("active rRNA genes" . SPARSER::GENE)
    ("particular IGFBP2 and IGFBP5" . SPARSER::COLLECTION)
    ("IGFBP2 and IGFBP5" . SPARSER::COLLECTION)
    ("IGFs, IGF-1R and IGF-2R" . SPARSER::COLLECTION)
    ("INSR and IGFRs" . SPARSER::COLLECTION)
    ("lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("The insulin receptor (INSR) and the IGF-1R" . SPARSER::COLLECTION)
    ("insulin receptor (INSR)" . SPARSER::PROTEIN)
    ("IGF-1, IGF-2 and IGFR" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("INSR and IRS-1" . SPARSER::COLLECTION)
    ("IGF-1 and IGF-2" . SPARSER::COLLECTION)
    ("FITC-insulin" . SPARSER::MOLECULE) ("BCRP" . SPARSER::PROTEIN)
    ("Doxorubicin or Cisplatin" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("Aims" . SPARSER::PROTEIN)
    ("IGFs" . SPARSER::PROTEIN) ("intercalating agent" . SPARSER::DRUG)
    ("TNF-α" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("p-glycoprotein" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("mdr1" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("ABCC1" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("IGF-1-R" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("RNA polymerase I" . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("IGFBP2" . SPARSER::PROTEIN)
    ("INSR-B" . SPARSER::PROTEIN) ("INSR-A" . SPARSER::PROTEIN)
    ("IGF-2R" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("growth-factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRP-1" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("IRS-4" . SPARSER::PROTEIN) ("IRS-2" . SPARSER::PROTEIN)
    ("Sirt7" . SPARSER::PROTEIN) ("CTL" . SPARSER::PROTEIN)
    ("opacity" . SPARSER::PROTEIN-FAMILY)
    ("the largest cohort" . SPARSER::MOLECULE) ("all radiologic types" . TYPE)
    ("light or non-smokers" . SPARSER::COLLECTION)
    ("Thyroid" . SPARSER::PROTEIN)
    ("acinar predominant subtypes" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("EML4-ALK" . SPARSER::COLLECTION)
    ("the papillary predominant subtype" . SPARSER::PROTEIN)
    ("the lepidic subtype" . SPARSER::PROTEIN)
    ("the solid subtype" . SPARSER::PROTEIN)
    ("ALK- and EGFR" . SPARSER::COLLECTION) ("ALK-" . SPARSER::PROTEIN)
    ("Subtypes" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4 ( EML4 ) and ALK gene"
     . SPARSER::COLLECTION)
    ("crizotinib" . SPARSER::DRUG) ("SPN" . SPARSER::PROTEIN)
    ("EGFR and ALK" . SPARSER::COLLECTION)
    ("EGFR and K-ras" . SPARSER::COLLECTION)
    ("opacities" . SPARSER::PROTEIN-FAMILY)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("Hormone" . SPARSER::MOLECULE) ("p 21, p27 and p53" . SPARSER::COLLECTION)
    ("cyclin D1 and p53" . SPARSER::COLLECTION)
    ("MSI or p 53" . SPARSER::COLLECTION)
    ("BRAF-wildtype" . SPARSER::PROTEIN-PAIR) ("serrated" . SPARSER::PROTEIN)
    ("continous combined estrogen" . SPARSER::MOLECULE)
    ("betacatenin" . SPARSER::PROTEIN)
    ("beta-catenin-, p 53 and cyclin D1, and microsatellite"
     . SPARSER::COLLECTION)
    ("cyclin D1, and microsatellite" . SPARSER::COLLECTION)
    ("beta-catenin-" . SPARSER::PROTEIN) ("TNM-stage" . SPARSER::MOLECULE)
    ("cohort-" . SPARSER::MOLECULE)
    ("beta-catenin, cyclin D1, p53 and mismatch" . SPARSER::COLLECTION)
    ("progestins" . SPARSER::DRUG)
    ("the longest duration group" . SPARSER::MOLECULE)
    ("incident CRC" . SPARSER::PROTEIN) ("ERT" . SPARSER::PROTEIN)
    ("p 21" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("p 53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-catenin" . SPARSER::PROTEIN)
    ("phospho-Erk and phospho-Mek" . SPARSER::COLLECTION)
    ("neither vemurafenib nor RAF265" . SPARSER::COLLECTION)
    ("mitomycin C, oxaliplatin, paclitaxel, etoposide, or 5-fluorouracil"
     . SPARSER::COLLECTION)
    ("RAF265 and vemurafenib" . SPARSER::COLLECTION)
    ("Erk 1/2 and AKT" . SPARSER::COLLECTION) ("perifosine" . SPARSER::PROTEIN)
    ("namely B-Raf V600E and p110α H1047R" . SPARSER::COLLECTION)
    ("namely B-Raf V600E" . SPARSER::PROTEIN)
    ("vemurafenib and RAF265" . SPARSER::COLLECTION)
    ("Sorafenib" . SPARSER::DRUG) ("BRAF-" . SPARSER::PROTEIN)
    ("a topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("Raf/Mek/Erk" . SPARSER::COLLECTION) ("Complementing" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN)
    ("oncogenically mutant BRAF" . SPARSER::PROTEIN)
    ("Mek and Erk" . SPARSER::COLLECTION)
    ("the deleted alleles" . SPARSER::ALLELE) ("genotypes" . SPARSER::PROTEIN)
    ("RBO" . SPARSER::PROTEIN) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("single alleles (Figure  xref A) and the generation"
     . SPARSER::COLLECTION)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("KRAS , APC , and TP53" . SPARSER::COLLECTION)
    ("namely V600E mutant B-Raf" . SPARSER::PROTEIN)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Dabrafenib" . SPARSER::DRUG)
    ("Mek 1/2 and Erk 1/2" . SPARSER::COLLECTION)
    ("genotype" . SPARSER::PROTEIN) ("phospho-protein" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-I" . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("PI-103" . SPARSER::DRUG) ("EGFR antibody" . SPARSER::PROTEIN)
    ("PUMA protein" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("Erk 1/2" . SPARSER::PROTEIN)
    ("Mek 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3 kinase" . SPARSER::PROTEIN) ("RAF265" . SPARSER::DRUG)
    ("mitomycin C" . SPARSER::DRUG) ("B-Raf" . SPARSER::PROTEIN)
    ("PP, and MCa" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("LM" . SPARSER::MOLECULE) ("MCS" . SPARSER::PROTEIN)
    ("NCCN" . SPARSER::MOLECULE)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("CyclinD1 and cKIT" . SPARSER::COLLECTION)
    ("CSD or acral" . SPARSER::COLLECTION)
    ("BRAF/cKIT/CyclinD1" . SPARSER::COLLECTION)
    ("CyclinD1 or cKIT" . SPARSER::COLLECTION)
    ("centromeres" . SPARSER::PROTEIN) ("BRAF and MEK" . SPARSER::COLLECTION)
    ("the proliferation-controlling CyclinD1 (CCND1) or cKIT genes"
     . SPARSER::COLLECTION)
    ("the correspondent proteins" . SPARSER::PROTEIN)
    ("CSD" . SPARSER::PROTEIN) ("CyclinD1 or CDK4" . SPARSER::COLLECTION)
    ("CDK4/cyclin D1" . SPARSER::COLLECTION)
    ("NRAS, BRAF, MEK1/2, and ERK1/2" . SPARSER::COLLECTION)
    ("cKIT and CyclinD1" . SPARSER::COLLECTION) ("MPM" . SPARSER::MOLECULE)
    ("cKIT" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("p190RhoGEF" . SPARSER::PROTEIN)
    ("RhoGEF" . SPARSER::PROTEIN) ("Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("The FAK inhibitor and MELK inhibitor" . SPARSER::COLLECTION)
    ("5-FU, and MELK" . SPARSER::COLLECTION)
    ("MELK-siRNA" . SPARSER::COLLECTION) ("nc" . SPARSER::PROTEIN)
    ("Gastrin" . SPARSER::PROTEIN) ("CDS" . SPARSER::PROTEIN)
    ("nc-shRNA" . SPARSER::PROTEIN-PAIR) ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("FCM" . SPARSER::MOLECULE) ("pL" . SPARSER::PROTEIN)
    ("MELK-shRNA" . SPARSER::PROTEIN-PAIR)
    ("MELK and chemoresistance" . SPARSER::COLLECTION)
    ("the immortalized normal gastric epithelial cell line GES-1"
     . SPARSER::PROTEIN)
    ("Maternal embryonic leucine zipper kinase (MELK)" . SPARSER::PROTEIN)
    ("sucrose" . SPARSER::MOLECULE) ("FAK and paxillin" . SPARSER::COLLECTION)
    ("FAK/paxillin" . SPARSER::COLLECTION) ("gastrin" . SPARSER::PROTEIN)
    ("FAK/Paxillin" . SPARSER::COLLECTION) ("MELK" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("p190" . SPARSER::PROTEIN) ("p120RasGAP" . SPARSER::PROTEIN)
    ("Dock180" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("OTSSP167" . SPARSER::DRUG) ("S3-A" . SPARSER::PROTEIN)
    ("S1-B" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("NH2" . SPARSER::MOLECULE) ("Src kinase" . SPARSER::PROTEIN)
    ("B-Myb" . SPARSER::PROTEIN) ("ZPR9" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN) ("CDC25B" . SPARSER::PROTEIN)
    ("KIAA0175" . SPARSER::PROTEIN) ("MPK38" . SPARSER::PROTEIN)
    ("pEg3" . SPARSER::PROTEIN) ("SNF1" . SPARSER::PROTEIN-FAMILY)
    ("Maternal embryonic leucine zipper kinase" . SPARSER::PROTEIN)
    ("BSA" . SPARSER::PROTEIN) ("FW" . SPARSER::MOLECULE)
    ("SOX2, NANOG, CCND1 and ITGA6" . SPARSER::COLLECTION)
    ("the stem cell-associated genes" . SPARSER::GENE)
    ("NANOG and ITGA6" . SPARSER::COLLECTION)
    ("luciferase and GFP" . SPARSER::COLLECTION) ("MDA" . SPARSER::DRUG)
    ("CD44 , MET , and EGFR" . SPARSER::COLLECTION)
    ("Akt, RSK1/2, and GSK3" . SPARSER::COLLECTION) ("ER-" . SPARSER::PROTEIN)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("complex and the discrepancy" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("Wnt, BMP, and JAK-STAT" . SPARSER::COLLECTION)
    ("SOX2 , NANOG, CCND1 and ITGA6" . SPARSER::COLLECTION)
    ("Sox2 and its downstream targets" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN) ("PI3K/Akt/YB-1" . SPARSER::COLLECTION)
    ("SL0101 and CHIR99021" . SPARSER::COLLECTION)
    ("YB-1 or phospho-YB-1" . SPARSER::COLLECTION) ("SiRNA" . SPARSER::PROTEIN)
    ("parental MCF7" . SPARSER::PROTEIN)
    ("YB-1 and phospho-YB-1" . SPARSER::COLLECTION)
    ("Akt, RSK1/2 and GSK3" . SPARSER::COLLECTION)
    ("stem cell-associated proteins" . SPARSER::PROTEIN)
    ("-2, Cyclin D1, MDR-1, and p110α" . SPARSER::COLLECTION)
    ("protein-1" . SPARSER::PROTEIN)
    ("SOX2 and its downstream targets" . SPARSER::COLLECTION)
    ("Sox2 and YB-1" . SPARSER::COLLECTION)
    ("CCND1 and ITGA6" . SPARSER::COLLECTION) ("RR" . SPARSER::MOLECULE)
    ("YB-1 and Sox2" . SPARSER::COLLECTION) ("MK2206" . SPARSER::DRUG)
    ("JAK-STAT" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("CHIR99021" . SPARSER::MOLECULE) ("SL0101" . SPARSER::DRUG)
    ("RSK1" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("MDR-1" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN) ("Y-box binding protein-1" . SPARSER::PROTEIN)
    ("ITGA6" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("TIF, or p21" . SPARSER::COLLECTION)
    ("insufficient telomerase activity" . SPARSER::PROTEIN)
    ("TIF, and stathmin and EF1α" . SPARSER::COLLECTION)
    ("EF1α and stathmin" . SPARSER::COLLECTION)
    ("TIF, γ-H2AX, and p21" . SPARSER::COLLECTION)
    ("aminoacyl-tRNA" . SPARSER::PROTEIN)
    ("a translational cofactor" . SPARSER::MOLECULE)
    ("polypeptides" . SPARSER::PROTEIN) ("soluble tubulin" . SPARSER::PROTEIN)
    ("form dysplastic foci" . SPARSER::PROTEIN)
    ("dysplastic hepatocytes" . SPARSER::PROTEIN)
    ("dysplastic or transformed hepatocytes" . SPARSER::PROTEIN)
    ("Stathmin and EF1α" . SPARSER::COLLECTION)
    ("TIF, stathmin mRNA level, and EF1α histoscore (all, P  < 0.05)"
     . SPARSER::COLLECTION)
    ("Stathmin" . SPARSER::PROTEIN)
    ("stathmin, EF1α, γ-H2AX, and p21" . SPARSER::COLLECTION)
    ("telomere dysfunction-induced foci (TIF)" . SPARSER::PROTEIN)
    ("stathmin and EF1α" . SPARSER::COLLECTION)
    ("γ-H2AX, and p21" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("TIF" . SPARSER::PROTEIN)
    ("stathmin and elongation factor" . SPARSER::COLLECTION)
    ("stathmin" . SPARSER::PROTEIN) ("telomerase activity" . SPARSER::PROTEIN)
    ("6.3 " . SPARSER::PROTEIN) ("oncoprotein 18" . SPARSER::PROTEIN)
    ("STMN1" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("SSPs" . SPARSER::PROTEIN) ("Diamine" . SPARSER::MOLECULE)
    ("EDTA" . SPARSER::MOLECULE) ("allele and genotype" . SPARSER::COLLECTION)
    ("IBD" . SPARSER::PROTEIN)
    ("IFN
and IL-10"
     . SPARSER::COLLECTION)
    ("IL-12, IL- 23, Flt3 ligand, M-CSF, G-CSF, leptin and
growth hormone"
     . SPARSER::COLLECTION)
    ("IL-6/gp130" . SPARSER::COLLECTION) ("leptin" . SPARSER::PROTEIN)
    ("Han" . SPARSER::PROTEIN) ("allele " . SPARSER::ALLELE)
    ("CD-" . SPARSER::PROTEIN) ("dominant and recessive" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("Flt3 ligand" . SPARSER::PROTEIN)
    ("IL- 23" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("micropapillary-predominant subtypes" . SPARSER::PROTEIN)
    ("predominant subtype" . SPARSER::PROTEIN)
    ("acinar-predominant subtypes" . SPARSER::PROTEIN)
    ("MIA" . SPARSER::PROTEIN)
    ("the IASLC/ATS/ERS histologic subtypes" . SPARSER::PROTEIN)
    ("subtypes and EGFR" . SPARSER::COLLECTION)
    ("the micropapillary-predominant subtype and other subtypes ( P  = 0.0026)"
     . SPARSER::COLLECTION)
    ("different histologic subtypes" . SPARSER::PROTEIN)
    ("solid-predominant subtype" . SPARSER::PROTEIN)
    ("the predominant subtype" . SPARSER::PROTEIN)
    ("-tyrosine kinase" . SPARSER::COLLECTION)
    ("micropapillary-predominant subtype" . SPARSER::PROTEIN)
    ("The predominant subtype" . SPARSER::PROTEIN)
    ("the solid-predominant subtype" . SPARSER::PROTEIN)
    ("the micropapillary-predominant subtype" . SPARSER::PROTEIN)
    ("predominant subtypes" . SPARSER::PROTEIN)
    ("the prognostic subtypes" . SPARSER::PROTEIN)
    ("YL and XQ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("YL" . SPARSER::PROTEIN) ("exactly Cbl-b" . SPARSER::PROTEIN)
    ("Cbl-b and IGF-IR" . SPARSER::COLLECTION)
    ("all-trans retinoic acid and bufalin-induced cell adhesion in human promyelocytic cells [ xref ]"
     . SPARSER::COLLECTION)
    ("retinoic acid and bufalin-induced cell adhesion in human promyelocytic cells [ xref ]"
     . SPARSER::COLLECTION)
    ("bufalin" . SPARSER::DRUG)
    ("epidermal growth factor receptor-Vav2" . SPARSER::COLLECTION)
    ("ZEB2/E-cadherin" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("MEK/MAPK" . SPARSER::COLLECTION) ("IGF-I/IGF-IR" . SPARSER::COLLECTION)
    ("IGF-IR or Cbl-b" . SPARSER::COLLECTION)
    ("IGF-IR/Cbl-b" . SPARSER::COLLECTION)
    ("Vimentin and ZEB2" . SPARSER::COLLECTION) ("ShRNA" . SPARSER::PROTEIN)
    ("Cbl-b and non-silencing" . SPARSER::COLLECTION)
    ("LY294002 and PD98059" . SPARSER::COLLECTION)
    ("ERK or Akt" . SPARSER::COLLECTION)
    ("the PI3K/Akt inhibitor LY294002 (100 μM) and the ERK inhibitor PD98059 (20 μM)"
     . SPARSER::COLLECTION)
    ("EMT and ZEB2" . SPARSER::COLLECTION) ("IGF-IR/IR" . SPARSER::COLLECTION)
    ("IGF-IR, Akt, and ERK" . SPARSER::COLLECTION)
    ("Vimentin and transcription factor" . SPARSER::COLLECTION)
    ("mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("c-Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("Pyk2 and Paxillin" . SPARSER::COLLECTION) ("Paxillin" . SPARSER::PROTEIN)
    ("Cbl" . SPARSER::PROTEIN) ("IGF-IR and Cbl-b" . SPARSER::COLLECTION)
    ("Akt/ERK" . SPARSER::COLLECTION)
    ("ZEB2 and microRNA-200c" . SPARSER::COLLECTION)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin-like growth factor I receptor" . SPARSER::PROTEIN)
    ("Vav2" . SPARSER::PROTEIN) ("MiR-200c" . SPARSER::MOLECULE)
    ("PS341" . SPARSER::DRUG) ("ERK1" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("1–4 " . SPARSER::PROTEIN)
    ("S-P" . SPARSER::PROTEIN) ("Twist2" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("PS-341" . SPARSER::DRUG)
    ("PD98059" . SPARSER::MOLECULE) ("OSI-906" . SPARSER::DRUG)
    ("IRS-1" . SPARSER::PROTEIN) ("Pyk2" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN) ("Cbl-b" . SPARSER::PROTEIN)
    ("miR-200c" . SPARSER::MOLECULE) ("ZEB2" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN)
    ("Insulin-like growth factor I" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("Antibody" . SPARSER::PROTEIN) ("Biomarker" . SPARSER::MOLECULE)
    ("the pathological complete response group" . SPARSER::MOLECULE)
    ("PN" . SPARSER::PROTEIN) ("CB" . SPARSER::PROTEIN)
    ("HER2 and pHER2" . SPARSER::COLLECTION)
    ("HER2 or pHER2" . SPARSER::COLLECTION)
    ("University Oncology Group (BrUOG) and the Yale Cancer Center"
     . SPARSER::COLLECTION)
    ("ESR1 and HER2" . SPARSER::COLLECTION) ("receptor-" . SPARSER::RECEPTOR)
    ("docetaxel" . SPARSER::DRUG)
    ("anthracycline- and taxane" . SPARSER::COLLECTION)
    ("anthracycline-" . SPARSER::MOLECULE) ("taxane" . SPARSER::DRUG)
    ("anthracycline" . SPARSER::MOLECULE) ("Adjuvant" . SPARSER::DRUG)
    ("NeO" . SPARSER::PROTEIN)
    ("homodimers or HER2:HER3" . SPARSER::COLLECTION)
    ("HER2:HER3" . SPARSER::BIO-COMPLEX) ("HER2:HER2" . SPARSER::BIO-COMPLEX)
    ("larger cohorts" . SPARSER::MOLECULE) ("AQUA" . SPARSER::MOLECULE)
    ("trastuzumab or nab-paclitaxel" . SPARSER::COLLECTION)
    ("trastuzumab, nab-paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN) ("paclitaxel" . SPARSER::DRUG)
    ("HER2 or phospho-HER2" . SPARSER::COLLECTION)
    ("trastuzumab-" . SPARSER::DRUG) ("m2" . SPARSER::MOLECULE)
    ("ESR1" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("Rm" . SPARSER::MOLECULE) ("HY" . SPARSER::MOLECULE)
    ("YG" . SPARSER::MOLECULE) ("tissue type-" . SPARSER::PROTEIN)
    ("cell cycle-regulatory genes, and genes" . SPARSER::COLLECTION)
    ("genes, and genes" . SPARSER::COLLECTION)
    ("histological subtype" . SPARSER::PROTEIN)
    ("histological types and grades" . SPARSER::COLLECTION)
    ("types and grades" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("HGD" . SPARSER::PROTEIN) ("LGD" . SPARSER::PROTEIN)
    ("two major histologic subtypes" . SPARSER::PROTEIN)
    ("EAC" . SPARSER::PROTEIN) ("-deoxycytidine" . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE) ("Aza" . SPARSER::DRUG)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("Caveolin-1" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("ATC" . SPARSER::DRUG) ("AK" . SPARSER::PROTEIN) ("KN" . SPARSER::PROTEIN)
    ("Phosphatidylinositol" . SPARSER::PROTEIN)
    ("MSI, BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("/AKT" . SPARSER::COLLECTION) ("bisphosphonate" . SPARSER::MOLECULE)
    ("only one codon" . SPARSER::PROTEIN) ("Codon" . SPARSER::PROTEIN)
    ("HR " . SPARSER::PROTEIN) ("predictive biomarkers" . SPARSER::MOLECULE)
    ("RUNX3" . SPARSER::PROTEIN) ("NEUROG1" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("CRABP1" . SPARSER::PROTEIN)
    ("CACNA1G" . SPARSER::PROTEIN) ("PLP" . SPARSER::PROTEIN)
    ("DV" . SPARSER::MOLECULE) ("CMC" . SPARSER::PROTEIN-FAMILY)
    ("mutated alleles" . SPARSER::ALLELE) ("Fragment" . SPARSER::FRAGMENT)
    ("DEL19 or INS20" . SPARSER::COLLECTION) ("DEL19" . SPARSER::PROTEIN)
    ("mutated allele" . SPARSER::ALLELE)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("DEL19-CAST" . SPARSER::PROTEIN-PAIR) ("CAST" . SPARSER::PROTEIN)
    ("INS" . SPARSER::PROTEIN) ("INCa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EFGR-TKI" . SPARSER::COLLECTION)
    ("cysteine, alanine or serine" . SPARSER::COLLECTION)
    ("KRAS , EGFR , ALK , HER2 , PI3KCA and BRAF" . SPARSER::COLLECTION)
    ("the most frequent histological type" . TYPE) ("ADC" . SPARSER::PROTEIN)
    ("fragments" . SPARSER::FRAGMENT) ("Medicines" . SPARSER::DRUG)
    ("Tyrosine kinase" . SPARSER::PROTEIN) ("P27" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("WX" . SPARSER::PROTEIN) ("KE" . SPARSER::MOLECULE)
    ("Propidium" . SPARSER::MOLECULE) ("Dioxin" . SPARSER::MOLECULE)
    ("Doxycycline" . SPARSER::DRUG) ("Doxorubicin" . SPARSER::PROTEIN)
    ("PTEN and BRCA1" . SPARSER::COLLECTION)
    ("shown using senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("discrete foci" . SPARSER::PROTEIN)
    ("25nM AF and 250nM AF" . SPARSER::COLLECTION)
    ("poly-ADP" . SPARSER::PROTEIN) ("AF and BNF" . SPARSER::COLLECTION)
    ("blot and CYP1A1" . SPARSER::COLLECTION)
    ("AF or BNF" . SPARSER::COLLECTION)
    ("CYP1A2 and CYP1B1" . SPARSER::COLLECTION)
    ("a weak AhR agonist" . SPARSER::AGONIST)
    ("dimethyl sulfoxide (DMSO)" . SPARSER::MOLECULE)
    ("CYP1A1, CYP1B1, and luciferase" . SPARSER::COLLECTION)
    ("ERα and AhR" . SPARSER::COLLECTION)
    ("CYP1A1/1A2/1B1" . SPARSER::COLLECTION) ("dioxin" . SPARSER::MOLECULE)
    ("ARNT" . SPARSER::PROTEIN) ("dioxins" . SPARSER::MOLECULE)
    ("cytotoxic and DNA" . SPARSER::COLLECTION)
    ("CYP1A1 and SULT1A1" . SPARSER::COLLECTION)
    ("1A2 and 1B1" . SPARSER::COLLECTION) ("Ah" . SPARSER::MOLECULE)
    ("pyrene" . SPARSER::PROTEIN)
    ("the AhR and its target genes" . SPARSER::COLLECTION)
    ("vorinostat" . SPARSER::DRUG) ("MCF7" . SPARSER::PROTEIN)
    ("tamoxifen and trastuzumab" . SPARSER::COLLECTION)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION)
    ("AhR and AhR" . SPARSER::COLLECTION) ("1A1 and 1B1" . SPARSER::COLLECTION)
    ("Luciferase" . SPARSER::PROTEIN)
    ("Sulfotransferase 1A1" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("histone 2" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("Cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("Aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("Aryl hydrocarbon receptor" . SPARSER::PROTEIN) ("8B" . SPARSER::PROTEIN)
    ("S6B" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("C-E" . SPARSER::PROTEIN)
    ("CYP1A2" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("X-Gal" . SPARSER::MOLECULE) ("RPL13A" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("coat protein" . SPARSER::PROTEIN)
    ("K 2" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("CYP1A" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("Histone 2" . SPARSER::PROTEIN)
    ("SULT1A1" . SPARSER::PROTEIN) ("1A2" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("anti-angiogenic" . SPARSER::DRUG)
    ("H-1" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("CYP1A1" . SPARSER::PROTEIN) ("1B1" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("OM" . SPARSER::PROTEIN) ("MR" . SPARSER::PROTEIN)
    ("LCK" . SPARSER::PROTEIN) ("ACTB" . SPARSER::PROTEIN)
    ("a shorter AR allele" . SPARSER::ALLELE)
    ("androstenedione" . SPARSER::PROTEIN) ("dL" . SPARSER::MOLECULE)
    ("OHP" . SPARSER::PROTEIN) ("virilizing form" . SPARSER::FORM)
    ("ACTH and androgen" . SPARSER::COLLECTION)
    ("MC2R and/or AR" . SPARSER::COLLECTION)
    ("ACTH and AR" . SPARSER::COLLECTION)
    ("MC2R and androgen receptor" . SPARSER::COLLECTION)
    ("RM" . SPARSER::MOLECULE) ("MC2R or AR" . SPARSER::COLLECTION)
    ("a significantly shorter AR allele" . SPARSER::ALLELE)
    ("androgen and ACTH" . SPARSER::COLLECTION)
    ("MC2R and AR" . SPARSER::COLLECTION) ("AR and MC2R" . SPARSER::COLLECTION)
    ("LEP" . SPARSER::PROTEIN) ("Leptin" . SPARSER::PROTEIN)
    ("chronic adrenocorticotropic hormone (ACTH)" . SPARSER::PROTEIN)
    ("ACTH" . SPARSER::PROTEIN)
    ("Adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("CYP21A2" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Beta-actin" . SPARSER::PROTEIN)
    ("Steroidogenic factor 1" . SPARSER::PROTEIN)
    ("Androgen Receptor" . SPARSER::PROTEIN) ("MC2R" . SPARSER::PROTEIN)
    ("Melanocortin 2 receptor" . SPARSER::PROTEIN)
    ("adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("DSP and JNZ" . SPARSER::COLLECTION) ("DSP" . SPARSER::PROTEIN)
    ("these miR-34-induced metabolic targets" . SPARSER::TARGET-PROTEIN)
    ("SIRT1, LDHA and MYC" . SPARSER::COLLECTION)
    ("MYC and LDHA" . SPARSER::COLLECTION)
    ("MYC and HIF" . SPARSER::COLLECTION)
    ("LDHA, SIRT1 and MYC" . SPARSER::COLLECTION)
    ("LDHA and MYC" . SPARSER::COLLECTION) ("Lin28b" . SPARSER::PROTEIN)
    ("a collaborative form" . SPARSER::FORM)
    ("SIRT1, MYC and LDHA" . SPARSER::COLLECTION)
    ("LDHA, MYC and SIRT1" . SPARSER::COLLECTION)
    ("its essential partner MYC associated factor X" . SPARSER::PROTEIN)
    ("DBC1-SIRT1" . SPARSER::COLLECTION)
    ("MYC, and SIRT1" . SPARSER::COLLECTION) ("MYC-DBC1" . SPARSER::COLLECTION)
    ("SIRT1 deacetylase activity and the MYC-induced NAMPT"
     . SPARSER::COLLECTION)
    ("breast cancer 1 (DBC1) and SIRT1 [ xref ]" . SPARSER::COLLECTION)
    ("NAMPT" . SPARSER::PROTEIN) ("DBC1" . SPARSER::PROTEIN)
    ("SIRT1 and MYC" . SPARSER::COLLECTION)
    ("an essential part" . SPARSER::COMPONENT)
    ("pyruvate and NADH" . SPARSER::COLLECTION)
    ("SIRT1 and LDHA" . SPARSER::COLLECTION)
    ("p53 and miR-34 form" . SPARSER::COLLECTION)
    ("SIRT1, p53 and miR-34 form" . SPARSER::COLLECTION)
    ("MYC and HIFs" . SPARSER::COLLECTION) ("HIFs" . SPARSER::PROTEIN)
    ("the LDHA promoter and directly increase LDHA expression"
     . SPARSER::COLLECTION)
    ("GLUT1 and hexokinase 2" . SPARSER::COLLECTION)
    ("lactate" . SPARSER::LACTATE)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("MYC and SIRT1" . SPARSER::COLLECTION) ("LDHA" . SPARSER::PROTEIN)
    ("a tumor suppressive miRNA" . SPARSER::PROTEIN)
    ("p21, Puma and Noxa" . SPARSER::COLLECTION)
    ("miR-34-induced metabolic targets" . SPARSER::TARGET-PROTEIN)
    ("transcription factor 3 and cyclin E2" . SPARSER::COLLECTION)
    ("baculoviral IAP repeat containing 5 and silent information regulator"
     . SPARSER::COLLECTION)
    ("MiR" . SPARSER::PROTEIN) ("MicroRNA" . SPARSER::RNA)
    ("Lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("NAD + " . SPARSER::MOLECULE) ("HIF-1" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN) ("PANK1" . SPARSER::PROTEIN)
    ("pantothenate kinase 1" . SPARSER::PROTEIN)
    ("RNA-binding protein" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Let-7" . SPARSER::RNA)
    ("MYC associated factor X" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HK2" . SPARSER::PROTEIN)
    ("hexokinase 2" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN)
    ("transcription factor 3" . SPARSER::PROTEIN)
    ("v-myc avian myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("baculoviral IAP repeat containing 5" . SPARSER::PROTEIN)
    ("MiR-34a" . SPARSER::MOLECULE) ("HYH and DWW" . SPARSER::COLLECTION)
    ("HYH" . SPARSER::PROTEIN)
    ("Vascular epithelial growth factor" . SPARSER::GROWTH-FACTOR)
    ("Diarylpropionitrile" . SPARSER::DRUG)
    ("Bromodeoxyuridine" . SPARSER::DRUG) ("benzidine" . SPARSER::MOLECULE)
    ("DAB" . SPARSER::MOLECULE) ("subtype" . SPARSER::PROTEIN)
    ("P53, VEGF and ETE" . SPARSER::COLLECTION)
    ("PTC, and ERα" . SPARSER::COLLECTION) ("P53 and ER" . SPARSER::COLLECTION)
    ("ER-subtype" . SPARSER::PROTEIN-PAIR)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("triol" . SPARSER::MOLECULE)
    ("-diphenyl" . SPARSER::DRUG) ("trypan" . SPARSER::DRUG)
    ("transcription factor-1" . SPARSER::COLLECTION)
    ("ERβ1 and ERβ2" . SPARSER::COLLECTION)
    ("Postsurgical serum thyroglobulin" . SPARSER::PROTEIN)
    ("FTC" . SPARSER::DRUG) ("the last coding exon" . SPARSER::PROTEIN)
    ("ERβ1-ERβ5" . SPARSER::COLLECTION) ("ERα and ERβ" . SPARSER::COLLECTION)
    ("neither ERα nor ERβ1" . SPARSER::COLLECTION)
    ("P53 or VEGF" . SPARSER::COLLECTION)
    ("P53 and VEGF" . SPARSER::COLLECTION) ("ERα/ERβ1" . SPARSER::COLLECTION)
    ("PTC (26.7% with extranuclear expression) and NTG (no extranuclear expression)"
     . SPARSER::COLLECTION)
    ("ERα and ERβ1" . SPARSER::COLLECTION)
    ("two soluble intracellular receptors, ERα and ERβ" . SPARSER::COLLECTION)
    ("receptors, ERα and ERβ" . SPARSER::COLLECTION)
    ("Estrogen" . SPARSER::MOLECULE)
    ("sodium-iodide symporter and thyroglobulin" . SPARSER::COLLECTION)
    ("thyroglobulin" . SPARSER::PROTEIN) ("TSH" . SPARSER::PROTEIN)
    ("PTC and NTG" . SPARSER::COLLECTION) ("ERα or ERβ1" . SPARSER::COLLECTION)
    ("- 2" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("P63" . SPARSER::PROTEIN) ("ERβ2" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("SP6" . SPARSER::PROTEIN)
    ("sodium-iodide symporter" . SPARSER::PROTEIN) ("ERβ1" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("PS and JP" . SPARSER::COLLECTION) ("less severe form" . SPARSER::FORM)
    ("MICB and the viremia titer" . SPARSER::COLLECTION)
    ("stress-induced molecules" . SPARSER::MOLECULE)
    ("SF2/ASF" . SPARSER::COLLECTION) ("ASF" . SPARSER::PROTEIN)
    ("MICB and rs3765524" . SPARSER::COLLECTION)
    ("MHC class I polypeptide-related sequence B ( MICB ) and phospholipase C"
     . SPARSER::COLLECTION)
    ("The most severe form" . SPARSER::FORM)
    ("MICB and rs3765524-C" . SPARSER::COLLECTION)
    ("MICB and PLCE1" . SPARSER::COLLECTION)
    ("DSS and non-DSS" . SPARSER::COLLECTION) ("MICB" . SPARSER::PROTEIN)
    ("a severe life-threatening form" . SPARSER::FORM)
    ("DSS" . SPARSER::PROTEIN) ("NKG2D" . SPARSER::PROTEIN)
    ("member D" . SPARSER::PROTEIN) ("SRp40" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA)
    ("MHC class I polypeptide-related sequence B" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("epsilon 1" . SPARSER::PROTEIN)
    ("CS" . SPARSER::PROTEIN) ("YK" . SPARSER::MOLECULE)
    ("modifiers" . SPARSER::MOLECULE)
    ("potassium channel and CACNB3" . SPARSER::COLLECTION)
    ("KCTD8 and CACNB3" . SPARSER::COLLECTION) ("glycogen" . SPARSER::PROTEIN)
    ("lacritin" . SPARSER::PROTEIN) ("LACRT" . SPARSER::PROTEIN)
    ("functinal importance and breast cancer-related genes" . SPARSER::GENE)
    ("ZNF304 and ZNF674" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("Nonsynonymous variants" . SPARSER::VARIANT)
    ("mapping and variant" . SPARSER::COLLECTION)
    ("centrosomes" . SPARSER::PROTEIN)
    ("p53 and PTEN, and loss of heterozygosity" . SPARSER::COLLECTION)
    ("PTEN, and loss of heterozygosity" . SPARSER::COLLECTION)
    ("RB1, INPP4B, RAD17, RAD50 , and RAP80" . SPARSER::COLLECTION)
    ("BPTF and FOXP1" . SPARSER::COLLECTION) ("BPTF" . SPARSER::PROTEIN)
    ("a typical BRCA1 + breast cancer family" . SPARSER::PROTEIN-FAMILY)
    ("calcium channel" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN) ("CACNB3" . SPARSER::PROTEIN)
    ("KCTD8" . SPARSER::PROTEIN)
    ("glutathione S-transferase kappa 1" . SPARSER::PROTEIN)
    ("GSTK1" . SPARSER::PROTEIN)
    ("bromodomain PHD finger transcription factor" . SPARSER::PROTEIN)
    ("ZNF304" . SPARSER::PROTEIN) ("ZNF674" . SPARSER::PROTEIN)
    ("CLCN4" . SPARSER::PROTEIN) ("TMPRSS7" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("RAP80" . SPARSER::PROTEIN)
    ("RAD17" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("SRA1" . SPARSER::PROTEIN) ("PHKG2" . SPARSER::PROTEIN)
    ("phosphorylase kinase" . SPARSER::PROTEIN) ("CUL4B" . SPARSER::PROTEIN)
    ("FOXP1" . SPARSER::PROTEIN) ("RSR" . SPARSER::MOLECULE)
    ("PG" . SPARSER::PROTEIN) ("piperine and curcumin" . SPARSER::COLLECTION)
    ("curcumin" . SPARSER::DRUG) ("piperine" . SPARSER::DRUG)
    ("phytochemicals" . SPARSER::DRUG) ("homocysteine" . SPARSER::MOLECULE)
    ("focal cerebral ischemia" . SPARSER::PROTEIN)
    ("H2AX and Caspase-3" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("OGD" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("Da" . SPARSER::MOLECULE) ("rtPA" . SPARSER::DRUG)
    ("cerebral ischemia" . SPARSER::PROTEIN) ("Group III" . SPARSER::PROTEIN)
    ("Group I" . SPARSER::PROTEIN) ("PGP 9.5" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("sodium bicarbonate" . SPARSER::DRUG) ("-3 " . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("recombinant tissue plasminogen activator" . SPARSER::DRUG)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("bromodeoxyuridine" . SPARSER::DRUG) ("diphenyl" . SPARSER::DRUG)
    ("peroxidase" . SPARSER::PROTEIN) ("Streptavidin" . SPARSER::PROTEIN)
    ("the unique downstream effector" . SPARSER::EFFECTOR)
    ("c-Myc, Cyclin E, Notch1 and MCL-1" . SPARSER::COLLECTION)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("an ubiquitin western blot" . SPARSER::PROTEIN)
    ("c-Myc and Cyclin E" . SPARSER::COLLECTION)
    ("Fbxw7-shRNA" . SPARSER::COLLECTION)
    ("BrdU and MTT" . SPARSER::COLLECTION) ("Flag-Fbxw7" . SPARSER::COLLECTION)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("log-rank " . SPARSER::PROTEIN)
    ("rank " . SPARSER::PROTEIN) ("a retrospective cohort" . SPARSER::MOLECULE)
    ("driving oncogene" . SPARSER::ONCOGENE)
    ("p73 and TEAD" . SPARSER::COLLECTION) ("ErbB4" . SPARSER::PROTEIN)
    ("a well-conserved potent regulator" . SPARSER::REGULATOR)
    ("pS" . SPARSER::PROTEIN) ("CPD" . SPARSER::PROTEIN)
    ("Notch-1
[ xref ] and MCL-1 (Myeloid cell leukemia-1)"
     . SPARSER::COLLECTION)
    ("leukemia-1" . SPARSER::COLLECTION)
    ("element binding protein-1" . SPARSER::COLLECTION)
    ("Sterol" . SPARSER::PROTEIN) ("Fbw7" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("LSM 5" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("Runt-related transcription factor 2" . SPARSER::PROTEIN)
    ("Cdc4" . SPARSER::PROTEIN) ("MCL-1" . SPARSER::PROTEIN)
    ("Notch-1" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("WD repeat domain" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN) ("KW" . SPARSER::MOLECULE)
    ("Acyl-protein" . SPARSER::COLLECTION) ("Retinoid" . SPARSER::PROTEIN)
    ("Phospholipase" . SPARSER::PROTEIN) ("Guanidine" . SPARSER::MOLECULE)
    ("Arachidonyl" . SPARSER::MOLECULE) ("Metabolites" . SPARSER::PROTEIN)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("H-rev107, HRASLS2, and RIG1" . SPARSER::COLLECTION)
    ("H-rev107 and RIG1" . SPARSER::COLLECTION) ("PGDS" . SPARSER::PROTEIN)
    ("GEF/GAP" . SPARSER::COLLECTION) ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("PLA inhibitors and APT1 inhibitor" . SPARSER::COLLECTION)
    ("acceptors" . SPARSER::MOLECULE) ("β2-adrenergic" . SPARSER::COLLECTION)
    ("Acyl-H-rev107" . SPARSER::COLLECTION) ("Gs" . SPARSER::PROTEIN)
    ("Acyl" . SPARSER::PROTEIN) ("thioester" . SPARSER::MOLECULE)
    ("HRASLS2, H-REV107, and RIG1" . SPARSER::COLLECTION)
    ("glycerophospholipid" . SPARSER::MOLECULE)
    ("H-RAS and N-RAS" . SPARSER::COLLECTION)
    ("RIG1 or HRASLS2" . SPARSER::COLLECTION)
    ("APT1 or PLA/AT" . SPARSER::COLLECTION)
    ("AACOCF3 and MAFP increased acylated H-RAS by 6.4- and 3.8-fold"
     . SPARSER::COLLECTION)
    ("lipases" . SPARSER::PROTEIN) ("BEL" . SPARSER::PROTEIN)
    ("commercially available PLA2 inhibitors" . SPARSER::INHIBITOR)
    ("thioesterases" . SPARSER::PROTEIN-FAMILY) ("PATs" . SPARSER::PROTEIN)
    ("acyltransferases" . SPARSER::PROTEIN) ("acyl-RAS" . SPARSER::COLLECTION)
    ("Polyhistidine-tagged H-rev107 (FL) or H-rev107 (1–132) fusion proteins"
     . SPARSER::COLLECTION)
    ("H-rev107 (FL)" . SPARSER::PROTEIN) ("hydroxylamine" . SPARSER::MOLECULE)
    ("biotin" . SPARSER::PROTEIN) ("acyl-biotin" . SPARSER::PROTEIN-PAIR)
    ("acyl" . SPARSER::PROTEIN) ("GTP-GDP" . SPARSER::PROTEIN-PAIR)
    ("H-rev107-myc" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("guanidine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("guanidine" . SPARSER::MOLECULE)
    ("H-REV107 and RIG1" . SPARSER::COLLECTION)
    ("RIG1, HRASLS2, A-C1, and HRLP5" . SPARSER::COLLECTION)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("lysophospholipid" . SPARSER::MOLECULE)
    ("type I tissue transglutaminase or regulating tubulin"
     . SPARSER::COLLECTION)
    ("HRASLS" . SPARSER::PROTEIN) ("retinoid" . SPARSER::PROTEIN)
    ("H-REV107" . SPARSER::PROTEIN)
    ("HRASLS3 [ xref ] or PLA2G16 [ xref ]" . SPARSER::COLLECTION)
    ("acyl-protein" . SPARSER::COLLECTION) ("MAFP" . SPARSER::MOLECULE)
    ("the PLA/AT inhibitor arachidonyl trifluoromethyl ketone (AACOCF3) or methyl arachidonyl fluorophosphate (MAFP)"
     . SPARSER::COLLECTION)
    ("fluorophosphate (MAFP)" . SPARSER::MOLECULE)
    ("fluorophosphate" . SPARSER::MOLECULE) ("arachidonyl" . SPARSER::MOLECULE)
    ("HtTA" . SPARSER::PROTEIN) ("H-rev107" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN) ("phospholipase" . SPARSER::PROTEIN)
    ("HRASLS3 or PLA2G16" . SPARSER::COLLECTION) ("M-LC" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("phospholipase activity" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospholipase A2" . SPARSER::PROTEIN) ("PLA2" . SPARSER::PROTEIN)
    ("APT1" . SPARSER::PROTEIN) ("H-rev107 protein" . SPARSER::PROTEIN)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("RAF-1" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("O-acyltransferase activity" . SPARSER::PROTEIN)
    ("interferon-regulatory factor-1" . SPARSER::PROTEIN)
    ("tissue transglutaminase" . SPARSER::PROTEIN) ("A-C1" . SPARSER::PROTEIN)
    ("HRLP5" . SPARSER::PROTEIN) ("HRASLS2" . SPARSER::PROTEIN)
    ("RIG1" . SPARSER::PROTEIN) ("AACOCF3" . SPARSER::MOLECULE)
    ("ELK1" . SPARSER::PROTEIN) ("RAS-GTP" . SPARSER::PROTEIN)
    ("H-RAS" . SPARSER::PROTEIN) ("HREV107" . SPARSER::PROTEIN)
    ("PLA2G16" . SPARSER::PROTEIN) ("HRASLS3" . SPARSER::PROTEIN)
    ("extremely low-frequency mutant" . SPARSER::MUTANT)
    ("ARMS, and Scorpion-ARMS" . SPARSER::COLLECTION)
    ("LNA" . SPARSER::PROTEIN) ("PNA" . SPARSER::PROTEIN)
    ("KARS" . SPARSER::PROTEIN) ("potential variant" . SPARSER::VARIANT)
    ("melting (HRM)" . SPARSER::DRUG)
    ("epidermal growth factor receptor ( EGFR ) and KRAS"
     . SPARSER::COLLECTION)
    ("EGFR/KRAS" . SPARSER::COLLECTION) ("ADX-" . SPARSER::PROTEIN)
    ("ADX" . SPARSER::PROTEIN) ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("HS polymerase" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ddH 2" . SPARSER::PROTEIN)
    ("EGFR -TKI" . SPARSER::PROTEIN) ("Th2-cytokines" . SPARSER::COLLECTION)
    ("proangiogenic cytokines, IL-6, IL-8, and VEGF" . SPARSER::COLLECTION)
    ("cytokines, IL-6, IL-8, and VEGF" . SPARSER::COLLECTION)
    ("the entire cohort" . SPARSER::MOLECULE) ("LDH" . SPARSER::PROTEIN)
    ("VEGF and Ang2" . SPARSER::COLLECTION) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("VEGF and vascular hot" . SPARSER::COLLECTION)
    ("vascular hot" . SPARSER::PROTEIN)
    ("Ang2 and not VEGF correlated with MVD [ xref ]" . SPARSER::COLLECTION)
    ("many angiogenic molecules" . SPARSER::MOLECULE)
    ("SOCS-3 and FasL" . SPARSER::COLLECTION)
    ("IL-6 and SOCS-3" . SPARSER::COLLECTION)
    ("IL-10 and lipopolysaccharide" . SPARSER::COLLECTION)
    ("IL-6 and Ki-67" . SPARSER::COLLECTION)
    ("IL-8/CXCR2" . SPARSER::COLLECTION)
    ("functional chemokine receptor" . SPARSER::PROTEIN)
    ("MVD and TVA" . SPARSER::COLLECTION) ("rev" . SPARSER::PROTEIN-FAMILY)
    ("shorter TTP" . SPARSER::PROTEIN) ("longer TTP" . SPARSER::PROTEIN)
    ("Fas, FasL, and c-FLIP" . SPARSER::COLLECTION) ("Fas" . SPARSER::PROTEIN)
    ("FasL" . SPARSER::PROTEIN) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("signed-rank" . SPARSER::PROTEIN) ("TVA" . SPARSER::MOLECULE)
    ("MVD" . SPARSER::PROTEIN)
    ("these molecules and microvascular characteristics" . SPARSER::COLLECTION)
    ("TTP" . SPARSER::PROTEIN) ("TFT" . SPARSER::PROTEIN)
    ("chemokine (C-X-C motif) receptor 1 (CXCR1) and CXCR2"
     . SPARSER::COLLECTION)
    ("Glu-Leu-Arg" . SPARSER::COLLECTION) ("SOCS1–SOCS7" . SPARSER::COLLECTION)
    ("p-" . SPARSER::PROTEIN) ("pro-" . SPARSER::AMINO-ACID)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("cytokines and vascular endothelial" . SPARSER::COLLECTION)
    ("proangiogenic cytokines" . SPARSER::PROTEIN)
    ("p-STAT-3" . SPARSER::COLLECTION) ("IL-8 and CXCR2" . SPARSER::COLLECTION)
    ("IL-6, VEGF and SOCS-3" . SPARSER::COLLECTION) ("PCs" . SPARSER::PROTEIN)
    ("CXCR2, and tyrosine" . SPARSER::COLLECTION)
    ("p-STAT-3/SOCS-3" . SPARSER::COLLECTION)
    ("proangiogenic cytokines and microvessel" . SPARSER::COLLECTION)
    ("cytokines and microvessel" . SPARSER::COLLECTION)
    ("ZAP-70" . SPARSER::PROTEIN) ("β 2-microglobulin" . SPARSER::PROTEIN)
    ("VEGFR1" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("Ang2" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("CXCR1" . SPARSER::PROTEIN) ("SOCS7" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("SOCS-3" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("IL-8 receptor" . SPARSER::PROTEIN)
    ("metabotropic glutamate receptor" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases, extensive cancer genome sequencing"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gq/11 or NF2" . SPARSER::COLLECTION) ("Wine" . SPARSER::MOLECULE)
    ("Light" . SPARSER::PROTEIN) ("PBS" . SPARSER::PROTEIN)
    ("nanoparticles" . SPARSER::MOLECULE) ("OCT" . SPARSER::PROTEIN)
    ("Verteporfin" . SPARSER::DRUG)
    ("Forskolin and IBMX" . SPARSER::COLLECTION) ("IBMX" . SPARSER::MOLECULE)
    ("Forskolin" . SPARSER::PROTEIN) ("Gs-PKA" . SPARSER::PROTEIN-PAIR)
    ("shRNA or Gq" . SPARSER::COLLECTION)
    ("MAP-kinase (MAPK)" . SPARSER::PROTEIN)
    ("the extracellular-signal-regulated kinases (ERK)" . SPARSER::KINASE)
    ("indeed more active" . SPARSER::ACTIVE)
    ("Gq/11 and BRAF" . SPARSER::COLLECTION) ("Mel" . SPARSER::PROTEIN)
    ("the cancer-associated mutant Gq/11" . SPARSER::PROTEIN)
    ("heterotrimeric G-proteins" . SPARSER::PROTEIN)
    ("Gq and G11" . SPARSER::COLLECTION)
    ("GNAQ and GNA11" . SPARSER::COLLECTION) ("iris" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("Gq/11" . SPARSER::PROTEIN) ("verteporfin" . SPARSER::DRUG)
    ("cancer-associated Gq/11 mutants" . SPARSER::MUTANT)
    ("GNAQ or GNA11" . SPARSER::COLLECTION) ("Gq or G11" . SPARSER::COLLECTION)
    ("Gq" . SPARSER::DRUG) ("GNAQ" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN)
    ("neurofibromin 2" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN) ("phos-tag" . SPARSER::DRUG)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("G-proteins" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("UbE2K and K48-linked poly-Ub" . SPARSER::COLLECTION)
    ("both WT TRIM6 and its E3 ligase C15A mutant" . SPARSER::COLLECTION)
    ("an intact TRIM6" . SPARSER::PROTEIN)
    ("whereto other target proteins" . SPARSER::PROTEIN)
    ("TRIM6, IKKε and Ub" . SPARSER::COLLECTION)
    ("DCs and human cell lines" . SPARSER::COLLECTION)
    ("TLRs and RLRs" . SPARSER::COLLECTION) ("Ube2K" . SPARSER::PROTEIN)
    ("TRIM6 and UbE2K" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("a shorter form" . SPARSER::FORM)
    ("CCDs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM6 and poly-Ub" . SPARSER::COLLECTION)
    ("longer K48-linked poly-Ub" . SPARSER::PROTEIN)
    ("K48 poly-Ub-activated IKKε" . SPARSER::PROTEIN)
    ("UbE2K and TRIM6-" . SPARSER::COLLECTION) ("TRIM6-" . SPARSER::PROTEIN)
    ("ATP and the presence of UbE2K" . SPARSER::COLLECTION)
    ("CDC34 or UbE2G2" . SPARSER::COLLECTION) ("Ube2G2" . SPARSER::PROTEIN)
    ("E1 activating, E2 conjugating and E3 ligating enzymes"
     . SPARSER::COLLECTION)
    ("TRIM6 and the E2 conjugase UbE2K" . SPARSER::COLLECTION)
    ("tri-Ub" . SPARSER::COLLECTION)
    ("K63-linked poly-Ub (lane 11) or K48-K63 mixed-linkage tetra-Ub (lane 12)"
     . SPARSER::COLLECTION)
    ("tetra" . SPARSER::MOLECULE) ("Ifnar1" . SPARSER::PROTEIN)
    ("Crimean Congo hemorrhagic fever virus (CCHFV) large (L) protein"
     . SPARSER::PROTEIN)
    ("OTU" . SPARSER::PROTEIN-FAMILY) ("JAK1-associated Ub" . SPARSER::PROTEIN)
    ("multimeric Ub" . SPARSER::PROTEIN)
    ("TRIM6-synthesized multimeric Ub" . SPARSER::PROTEIN)
    ("isopeptidase T/USP5" . SPARSER::COLLECTION)
    ("diglycine" . SPARSER::MOLECULE) ("IsoT" . SPARSER::PROTEIN)
    ("his" . SPARSER::AMINO-ACID)
    ("pro-inflammatory cytokines TNFα and IL-6" . SPARSER::COLLECTION)
    ("TNFα and IL-6" . SPARSER::COLLECTION) ("DCs" . SPARSER::MOLECULE)
    ("ADAR1 and IFI44" . SPARSER::COLLECTION)
    ("viral nucleoprotein (NP) and NS1 protein ( xref , WCE)"
     . SPARSER::COLLECTION)
    ("viral nucleoprotein (NP)" . SPARSER::PROTEIN)
    ("viral M1 mRNA" . SPARSER::PROTEIN) ("nucleoprotein" . SPARSER::PROTEIN)
    ("TRIM6 and Ub" . SPARSER::COLLECTION)
    ("TRIM6, Ub and IKKε" . SPARSER::COLLECTION)
    ("TRIM6 and the IFN-stimulated gene ADAR1 ( xref )" . SPARSER::COLLECTION)
    ("IFNβ, TRIM6 and the IFN-stimulated gene ADAR1 ( xref )"
     . SPARSER::COLLECTION)
    ("M1 viral RNA" . SPARSER::RNA) ("PPMO" . SPARSER::PROTEIN)
    ("oligomers (PPMO)" . SPARSER::MOLECULE) ("oligomers" . SPARSER::PROTEIN)
    ("universal type I IFN" . SPARSER::DRUG) ("IKKε-Ub" . SPARSER::COLLECTION)
    ("TRIM6-IKKε" . SPARSER::COLLECTION)
    ("IKKε and different Ub lysine mutants" . SPARSER::COLLECTION)
    ("IKKε-associated Ub" . SPARSER::PROTEIN)
    ("an efficient antiviral state" . SPARSER::BIO-STATE)
    ("IKKε-STAT1" . SPARSER::COLLECTION) ("classic JAK1" . SPARSER::PROTEIN)
    ("IKKε-" . SPARSER::PROTEIN) ("STATs" . SPARSER::PROTEIN)
    ("ISG54 and OAS1" . SPARSER::COLLECTION)
    ("ISG15 and IRF7" . SPARSER::COLLECTION) ("Ddx58" . SPARSER::PROTEIN)
    ("Ikbke" . SPARSER::PROTEIN) ("IKKε-TRIM6" . SPARSER::COLLECTION)
    ("IKKε and TRIM6" . SPARSER::COLLECTION)
    ("TRIM6 and IKKε" . SPARSER::COLLECTION)
    ("the closely related kinase TBK-1 or the transcription factor IRF3"
     . SPARSER::COLLECTION)
    ("TBK-1, IKKε or IRF3" . SPARSER::COLLECTION) ("SPRY" . SPARSER::PROTEIN)
    ("an antiviral state" . SPARSER::BIO-STATE) ("gRNA" . SPARSER::RNA)
    ("MxA, OAS1 and ISG15" . SPARSER::COLLECTION)
    ("IRF3 and IKKε" . SPARSER::COLLECTION)
    ("efficient IFN and ISG induction" . SPARSER::COLLECTION)
    ("efficient IFN" . SPARSER::DRUG)
    ("RIG-I, OAS1, MxA and ISG54" . SPARSER::COLLECTION)
    ("MxA" . SPARSER::PROTEIN) ("SeV and IAV" . SPARSER::COLLECTION)
    ("cytokine and ISG" . SPARSER::COLLECTION)
    ("IFNβ and ISG54" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("IFNβ, ISG54, TNFα, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("TBK-1 and IKKε" . SPARSER::COLLECTION)
    ("MAVS/IPS-1" . SPARSER::COLLECTION) ("MAVS" . SPARSER::PROTEIN)
    ("SeV" . SPARSER::PROTEIN) ("IFN and NF-κB" . SPARSER::COLLECTION)
    ("IFNβ and ISGs" . SPARSER::COLLECTION)
    ("TRIMs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ubiquitin" . SPARSER::PROTEIN)
    ("an effective antiviral state" . SPARSER::BIO-STATE)
    ("JAK1 and TYK2" . SPARSER::COLLECTION) ("Interferon" . SPARSER::PROTEIN)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("the IκB (IKK) and IKK-related kinases ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("IκB (IKK)" . SPARSER::PROTEIN)
    ("Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs)"
     . SPARSER::COLLECTION)
    ("RLRs" . SPARSER::PROTEIN) ("PRRs" . SPARSER::PROTEIN)
    ("PAMPs" . SPARSER::PROTEIN)
    ("UbE2K-TRIM6-ubiquitin" . SPARSER::COLLECTION)
    ("TRIM6 and the E2-ubiquitin conjugase UbE2K" . SPARSER::COLLECTION)
    ("conjugase" . SPARSER::PROTEIN)
    ("the E3-ubiquitin ligase tripartite motif (TRIM) family"
     . SPARSER::PROTEIN-FAMILY)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antiviral cytokines" . SPARSER::PROTEIN) ("Type" . TYPE)
    ("UbE2G2" . SPARSER::PROTEIN) ("CDC34" . SPARSER::PROTEIN)
    ("USP5" . SPARSER::PROTEIN) ("isopeptidase T" . SPARSER::PROTEIN)
    ("IL-12p40" . SPARSER::PROTEIN) ("IFI44" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("ADAR1" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("IFNγ" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("ISG15" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("poly I:C" . SPARSER::MOLECULE)
    ("OAS1" . SPARSER::PROTEIN) ("ISG54" . SPARSER::PROTEIN)
    ("TBK-1" . SPARSER::PROTEIN) ("IPS-1" . SPARSER::PROTEIN)
    ("TRIM25" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("ISGF3" . SPARSER::PROTEIN)
    ("IRF9" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("anti-microbial" . SPARSER::DRUG)
    ("RIG-I" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("UbE2K" . SPARSER::PROTEIN)
    ("TRIM6" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("aa" . SPARSER::MOLECULE)
    ("this acetylation mimetic mutant" . SPARSER::MUTANT)
    ("an acetylation mimetic mutant" . SPARSER::MUTANT)
    ("A deacetylation mimetic mutant" . SPARSER::MUTANT)
    ("the HDAC6’s" . SPARSER::PROTEIN)
    ("deacetylase activity and Zn-UBP" . SPARSER::COLLECTION)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("Cdc20-APC" . SPARSER::COLLECTION) ("dynein" . SPARSER::PROTEIN)
    ("monomeric ubiquitin" . SPARSER::PROTEIN) ("SE" . SPARSER::PROTEIN)
    ("the resulting monomeric MSH2" . SPARSER::PROTEIN)
    ("cisplatin and doxorubicin" . SPARSER::COLLECTION)
    ("MSH2 or MSH6" . SPARSER::COLLECTION) ("monomer" . SPARSER::MONOMER)
    ("tubulin" . SPARSER::PROTEIN) ("MSH2 or MSH2" . SPARSER::COLLECTION)
    ("MEFs and HDAC6KD" . SPARSER::COLLECTION) ("MSH2(WT)" . SPARSER::PROTEIN)
    ("MSH6 and MSH3" . SPARSER::COLLECTION) ("HA-MSH2" . SPARSER::COLLECTION)
    ("Lysines" . SPARSER::AMINO-ACID) ("monomers" . SPARSER::MONOMER)
    ("trichostatin" . SPARSER::MOLECULE)
    ("both HDAC6’s deacetylase activity and DAC1’s" . SPARSER::COLLECTION)
    ("both HDAC6’s" . SPARSER::PROTEIN)
    ("deacetylase activity and DAC1" . SPARSER::COLLECTION)
    ("HDAC6 (F-HD6[H611A]) or DAC1-deficient HDAC6 (F-HD6 [439–1,215])"
     . SPARSER::COLLECTION)
    ("GST-MSH2" . SPARSER::COLLECTION)
    ("strong deacetylase activity" . SPARSER::PROTEIN)
    ("DAC1 efficiently polyubiquitinated MSH2" . SPARSER::PROTEIN)
    ("monomeric MSH2" . SPARSER::PROTEIN)
    ("the recombinant ubiquitin mutant K48R or K63R" . SPARSER::COLLECTION)
    ("that HDAC6’s" . SPARSER::PROTEIN)
    ("Ub, E1, and E2" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("GST-HDAC6" . SPARSER::COLLECTION)
    ("antibodies, and polyubiquitination" . SPARSER::COLLECTION)
    ("the treated HDAC6KO MEFs" . SPARSER::PROTEIN)
    ("ubiquitin-" . SPARSER::PROTEIN) ("Ligase" . SPARSER::LIGASE)
    ("MSH6KO MEFs MSH2’s" . SPARSER::PROTEIN)
    ("more monomeric MSH2" . SPARSER::PROTEIN)
    ("affecting MSH2’s" . SPARSER::PROTEIN)
    ("either HDAC6’s deacetylase activity or HDAC6’s" . SPARSER::COLLECTION)
    ("either HDAC6’s" . SPARSER::PROTEIN)
    ("HDAC6 (F-HD6DM, lanes 13–16) or the DAC1-deficient mutant"
     . SPARSER::COLLECTION)
    ("the HDAC6 catalytic dead mutant (F-HD6DM) or the DAC1-deficient mutant (F-HD6 [429–1,215])"
     . SPARSER::COLLECTION)
    ("deacetylase activity or HDAC6" . SPARSER::COLLECTION)
    ("C13-pRS (control) and C13-HD6KD" . SPARSER::COLLECTION)
    ("pRS" . SPARSER::PROTEIN) ("HD6" . SPARSER::PROTEIN)
    ("MSH6 and MLH1" . SPARSER::COLLECTION)
    ("a clinically relevant HDAC inhibitor" . SPARSER::INHIBITOR)
    ("SAHA" . SPARSER::DRUG) ("butyrate" . SPARSER::PROTEIN)
    ("tubacin" . SPARSER::DRUG) ("MSH6, MLH1, and NBS1" . SPARSER::COLLECTION)
    ("GST bead-bound MSH2 full-length and MSH2 deletion mutants"
     . SPARSER::MUTANT)
    ("full-length and MSH2" . SPARSER::COLLECTION)
    ("Flag-HDAC6" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("MSH2 and vice versa" . SPARSER::COLLECTION)
    ("MSH2 and HDAC6" . SPARSER::COLLECTION)
    ("HDAC6 and MSH2" . SPARSER::COLLECTION)
    ("HDAC6, MSH2, MSH6, MLH1, MSH3, MRE11 and RAD50" . SPARSER::COLLECTION)
    ("proteins, MSH2, MSH3, MSH6 and MLH1" . SPARSER::COLLECTION)
    ("MRE11 and RAD50" . SPARSER::COLLECTION)
    ("the control anti-IgG" . SPARSER::ANTIBODY)
    ("the anti-HDAC6" . SPARSER::ANTIBODY) ("PW" . SPARSER::MOLECULE)
    ("DEAE" . SPARSER::DRUG) ("phosphocellulose" . SPARSER::DRUG)
    ("cisplatin, carboplatin, doxorubicin, and etoposide"
     . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::DRUG) ("carboplatin" . SPARSER::DRUG)
    ("TG" . SPARSER::PROTEIN) ("thioguanine" . SPARSER::DRUG)
    ("MSH2 and MLH1" . SPARSER::COLLECTION) ("the parental DNA" . SPARSER::DNA)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("MLH1-PMS2" . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN) ("MSH6 or MSH3" . SPARSER::COLLECTION)
    ("α-tubulin, HSP90, and cortactin" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::PROTEIN) ("USPs" . SPARSER::PROTEIN)
    ("DAC" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("MSH2-MSH3" . SPARSER::COLLECTION) ("MSH2-MSH6" . SPARSER::COLLECTION)
    ("aa 1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("E2s" . SPARSER::MOLECULE)
    ("UbcH5a" . SPARSER::PROTEIN) ("AGK2" . SPARSER::PROTEIN)
    ("SirT2" . SPARSER::PROTEIN) ("P11" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN) ("exonuclease 1" . SPARSER::PROTEIN)
    ("MutLα" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("drug or gene" . SPARSER::COLLECTION)
    ("more cardiac-selective drug" . SPARSER::DRUG) ("EdU" . SPARSER::DRUG)
    ("Sav1 or Lats1/2" . SPARSER::COLLECTION) ("LAD" . SPARSER::PROTEIN)
    ("Xin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mst1" . SPARSER::PROTEIN)
    ("MST and LATS" . SPARSER::COLLECTION)
    ("TEAD, and perhaps" . SPARSER::COLLECTION) ("MCAT" . SPARSER::PROTEIN)
    ("our group and the Olson group" . SPARSER::COLLECTION)
    ("PKCα and ERK2" . SPARSER::COLLECTION)
    ("β-catenin/TCF" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("Tribbles" . SPARSER::PROTEIN-FAMILY)
    ("a vital transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Wnt/β-Catenin" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("Latrunculin B and Rho GTPase" . SPARSER::COLLECTION)
    ("NF2 and LATS" . SPARSER::COLLECTION) ("Actin" . SPARSER::PROTEIN)
    ("AMOT both a regulator" . SPARSER::REGULATOR)
    ("Angiomotin" . SPARSER::PROTEIN)
    ("calcium-dependent intercellular adhesion molecules" . SPARSER::MOLECULE)
    ("α-catenin and angiomotin" . SPARSER::COLLECTION)
    ("AMOT" . SPARSER::PROTEIN) ("angiomotin" . SPARSER::PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN) ("-adrenergic" . SPARSER::COLLECTION)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("adrenergic" . SPARSER::PROTEIN)
    ("epinephrine" . SPARSER::DRUG) ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF2 and SAV1" . SPARSER::COLLECTION)
    ("NF2 or SAV1" . SPARSER::COLLECTION)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("LATS" . SPARSER::PROTEIN) ("Yin" . SPARSER::PROTEIN)
    ("MST" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("Sav1" . SPARSER::PROTEIN) ("Sav" . SPARSER::PROTEIN)
    ("Sterile" . SPARSER::PROTEIN-FAMILY) ("Mats" . SPARSER::PROTEIN)
    ("Salvador" . SPARSER::PROTEIN)
    ("a membrane-associated cytoskeletal scaffolding protein"
     . SPARSER::PROTEIN)
    ("Merlin" . SPARSER::PROTEIN) ("mats" . SPARSER::PROTEIN)
    ("salvador" . SPARSER::PROTEIN) ("merlin" . SPARSER::PROTEIN)
    ("neuregulin" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("TEAD1" . SPARSER::PROTEIN)
    ("Lats2" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("TRIB2" . SPARSER::PROTEIN) ("homolog 2" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("Birc2" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("Latrunculin B" . SPARSER::DRUG) ("atrophin-1" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("PP2Ac" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sphingosine 1-phosphate" . SPARSER::DRUG)
    ("G-protein coupled" . SPARSER::PROTEIN) ("SAV1" . SPARSER::PROTEIN)
    ("Tead1" . SPARSER::PROTEIN) ("Mob1" . SPARSER::PROTEIN)
    ("Large Tumor Suppressor" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN) ("Ste-20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("Prp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Alcohol" . SPARSER::DRUG)
    ("Pro, or vice" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("Arg or Pro" . SPARSER::COLLECTION) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("alleles and genotypes" . SPARSER::COLLECTION)
    ("Arg and Pro" . SPARSER::COLLECTION) ("/Arg" . SPARSER::COLLECTION)
    ("/Pro" . SPARSER::COLLECTION) ("Arg/Pro" . SPARSER::COLLECTION)
    ("a key tumor suppressor gene" . SPARSER::PROTEIN)
    ("tobacco and/or alcohol" . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pro/Pro" . SPARSER::COLLECTION)
    ("Pro" . SPARSER::AMINO-ACID) ("ARMS" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("P 53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brca2-chek2-rad52" . SPARSER::COLLECTION) ("cigarette" . SPARSER::DRUG)
    ("TP63 and both isoforms" . SPARSER::COLLECTION)
    ("principal substrates" . SPARSER::SUBSTRATE) ("chek2" . SPARSER::PROTEIN)
    ("BRCA2-Chk2-Rad51" . SPARSER::COLLECTION) ("brca2" . SPARSER::PROTEIN)
    ("studied breast-ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("cryptic" . SPARSER::PROTEIN) ("Duo" . SPARSER::PROTEIN)
    ("CDKN2A/CDKN2B" . SPARSER::COLLECTION) ("SQ" . SPARSER::MOLECULE)
    ("BAT3-MSH5" . SPARSER::COLLECTION)
    ("CHRNA5-CHRNA3-CHRNB4" . SPARSER::COLLECTION) ("TERT" . SPARSER::PROTEIN)
    ("MaCH2" . SPARSER::DRUG) ("O-2" . SPARSER::PROTEIN)
    ("Alpha-Tocopherol" . SPARSER::MOLECULE) ("rad52" . SPARSER::PROTEIN)
    ("chk2" . SPARSER::PROTEIN) ("rad51" . SPARSER::PROTEIN)
    ("RAD52" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("MSH5" . SPARSER::PROTEIN) ("BAT3" . SPARSER::PROTEIN)
    ("CHRNB4" . SPARSER::PROTEIN) ("CHRNA3" . SPARSER::PROTEIN)
    ("CHRNA5" . SPARSER::PROTEIN) ("TP63" . SPARSER::PROTEIN)
    ("DNAs" . SPARSER::DNA) ("DNA and mRNA status" . SPARSER::COLLECTION)
    ("FISH and IHC" . SPARSER::COLLECTION)
    ("CagA and ROS" . SPARSER::COLLECTION) ("GCs" . SPARSER::PROTEIN)
    ("a potential diagnostic biomarker" . SPARSER::MOLECULE)
    ("Sigma-Aldrich" . SPARSER::PROTEIN-PAIR) ("TEMPOL" . SPARSER::DRUG)
    ("CagA and H 2 O 2" . SPARSER::COLLECTION)
    ("selectively targets HER-2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("RAS-mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("a 185-kD transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("HER-2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("RNA and protein" . SPARSER::COLLECTION) ("MMR" . SPARSER::PROTEIN)
    ("bacterial virulence factor cytotoxin-associated gene" . SPARSER::GENE)
    ("cytotoxin" . SPARSER::PROTEIN)
    ("HER-2 DNA and mRNA copy number" . SPARSER::COLLECTION)
    ("HFE" . SPARSER::PROTEIN) ("CagA and HER-2" . SPARSER::COLLECTION)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("HER -2" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("natural inducers" . SPARSER::MOLECULE) ("splenic APC" . SPARSER::PROTEIN)
    ("APCs" . SPARSER::PROTEIN)
    ("caspase 3 and caspase 9" . SPARSER::COLLECTION)
    ("Ly6C and CCR2" . SPARSER::COLLECTION)
    ("Ly6C and CD11b+" . SPARSER::COLLECTION) ("chemokine" . SPARSER::PROTEIN)
    ("mature forms" . SPARSER::FORM) ("Caspase" . SPARSER::PROTEIN)
    ("40 min warm ischemia" . SPARSER::PROTEIN) ("Ischemia" . SPARSER::PROTEIN)
    ("CD14 and IL-4" . SPARSER::COLLECTION)
    ("IL-10 and transforming growth factor-β" . SPARSER::COLLECTION)
    ("the proinflammatory cytokines" . SPARSER::PROTEIN)
    ("-2, tumor necrosis factor-α, and IL-1β" . SPARSER::COLLECTION)
    ("IL-4, IL-5, IL-10, and transforming growth factor-β"
     . SPARSER::COLLECTION)
    ("CD3 or CD8" . SPARSER::COLLECTION) ("CD3 and CD8" . SPARSER::COLLECTION)
    ("Polymerase" . SPARSER::PROTEIN) ("Enzyme" . SPARSER::ENZYME)
    ("SDC" . SPARSER::PROTEIN)
    ("anti-HA and anti–Hsp-25" . SPARSER::COLLECTION)
    ("HA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hemagglutinin (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("developed early CAV" . SPARSER::PROTEIN)
    ("significantly more Hsp-27" . SPARSER::PROTEIN) ("CAV" . SPARSER::PROTEIN)
    ("apoE" . SPARSER::PROTEIN)
    ("shock protein (Hsp)-27 (in humans) and Hsp-25 (in rodents)"
     . SPARSER::COLLECTION)
    ("calcineurin" . SPARSER::PROTEIN) ("ischemia" . SPARSER::PROTEIN)
    ("monocytes and cytokines" . SPARSER::COLLECTION) ("IL" . SPARSER::PROTEIN)
    ("interleukin" . SPARSER::PROTEIN) ("Mitomycin C" . SPARSER::DRUG)
    ("Asp-Glu" . SPARSER::MOLECULE) ("caspase3" . SPARSER::PROTEIN)
    ("CX 3 CR1" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("Gr1" . SPARSER::PROTEIN) ("Ly6C" . SPARSER::PROTEIN)
    ("T-Cell" . SPARSER::PROTEIN) ("caspase 1" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("Caspase1" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("caspase 9" . SPARSER::PROTEIN)
    ("Th-1" . SPARSER::PROTEIN) ("Interleukin-2" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("H-2 b" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("caspases 3" . SPARSER::PROTEIN)
    ("Heat shock protein-27" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("Hsp-27" . SPARSER::PROTEIN) ("platinum" . SPARSER::MOLECULE)
    ("camptothecin or cisplatin" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("CHEK2 or RPS6KA2" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("Epirubicin" . SPARSER::DRUG)
    ("CHEK2 and/or RPS6KA2 and/or MLL4 genes" . SPARSER::COLLECTION)
    ("RPS6KA2 and/or MLL4 genes" . SPARSER::COLLECTION)
    ("mutational biomarkers" . SPARSER::MOLECULE)
    ("enriched allelic variants" . SPARSER::VARIANT)
    ("GLI2 , MET and TNC" . SPARSER::COLLECTION) ("TNC" . SPARSER::PROTEIN)
    ("MLL4 and PPP1CC" . SPARSER::COLLECTION)
    ("CHEK2 , RPS6KA2, and MLL4" . SPARSER::COLLECTION)
    ("RPS6KA2 and MLL4" . SPARSER::COLLECTION)
    ("these 21 mutational prognostic genes" . SPARSER::GENE)
    ("CHEK2 , RPS6KA2 , MLL4 , ENAH , ADAMTSL3 , RSU1 , LRRN2 , MET , MAP3K6 , MAPK15 , GYPB , GLI2 , and PTK2B"
     . SPARSER::COLLECTION)
    ("ENAH" . SPARSER::PROTEIN) ("RPS6KA2 or MLL4" . SPARSER::COLLECTION)
    ("CHEK2 , RPS6KA2 , and MLL4" . SPARSER::COLLECTION)
    ("arg" . SPARSER::AMINO-ACID)
    ("the same TCGA patient cohort or a new patient cohort"
     . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("TS" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN) ("PSORT" . SPARSER::PROTEIN)
    ("hg" . SPARSER::MOLECULE)
    ("an early diagnostic biomarker" . SPARSER::MOLECULE)
    ("TP53, BRCA1 , or MUC16" . SPARSER::COLLECTION)
    ("allelic variants" . SPARSER::VARIANT)
    ("TBK1, PIK3C2B, MET, PRKCI, CHEK2, ALK, MAP3K6, PTK2B, RPS6KA2, MAPK15, PDGFRA, ROR2, TNK2 , and INSR"
     . SPARSER::COLLECTION)
    ("KIF4B, KIF3B, GCLC, TBK1, PIK3C2B, MET, PRKCI, TP53, CHEK2, ALK, ABCA3, MAP3K6, PTK2B, RPS6KA2, MAPK15, PDGFRA, ROR2, TNK2, CHD6, INSR, EP400 , and MYO5C"
     . SPARSER::COLLECTION)
    ("MAD1L1, HNF1A, GCLC, MET, TP53, ITGB2, CHEK2, GLI2, GLI3, ABCA3, ROR2, INSR, SPTB , and FN1"
     . SPARSER::COLLECTION)
    ("SPTB" . SPARSER::PROTEIN) ("ribonucleotide" . SPARSER::MOLECULE)
    ("purine" . SPARSER::DRUG) ("INSR" . SPARSER::PROTEIN)
    ("PDGFRA" . SPARSER::PROTEIN) ("PRKCI" . SPARSER::PROTEIN)
    ("BRCA1 and CHEK2" . SPARSER::COLLECTION)
    ("BRCA1 (12.0%, 40 out of 334) and CHEK2 (7.2%, 24 out of 334)"
     . SPARSER::COLLECTION)
    ("CHEK2 and BRCA1" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH6, PMS1 , and PMS2" . SPARSER::COLLECTION)
    ("BRCA1 (40 of 334 tumor samples) or BRCA2 (23 of 334 tumor samples) genes"
     . SPARSER::COLLECTION)
    ("potential target genes" . SPARSER::GENE)
    ("Nb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DNP" . SPARSER::DRUG)
    ("genes and patients" . SPARSER::COLLECTION) ("BI" . SPARSER::PROTEIN)
    ("BCM" . SPARSER::DRUG) ("Medicine" . SPARSER::DRUG)
    ("ABI" . SPARSER::PROTEIN-FAMILY) ("prognostic genes" . SPARSER::GENE)
    ("delC" . SPARSER::PROTEIN)
    ("ovarian cancer patient cohorts" . SPARSER::MOLECULE)
    ("p53, Cdc25, and BRCA1" . SPARSER::COLLECTION)
    ("TP53, NF1, RB1, FAT3, CSMD3, GABRA6, CDK12, BRCA1, BRCA2 , SMARCB1, KRAS, NRAS, CREBBP, and ERBB2"
     . SPARSER::COLLECTION)
    ("CHEK2, MRE11A, MSH6, NBN, PALB2, RAD50 , and RAD51C"
     . SPARSER::COLLECTION)
    ("NBN" . SPARSER::PROTEIN) ("CREBBP" . SPARSER::PROTEIN)
    ("CHEK2 , RPS6KA2 and MLL4" . SPARSER::COLLECTION)
    ("a major histologic type" . TYPE) ("TIP3" . SPARSER::PROTEIN)
    ("PDB2" . SPARSER::PROTEIN) ("Eq1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("dopamine receptor D2" . SPARSER::PROTEIN)
    ("PPP1CC" . SPARSER::PROTEIN) ("LRRN2" . SPARSER::PROTEIN)
    ("RSU1" . SPARSER::PROTEIN) ("ADAMTSL3" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("KPNA2" . SPARSER::PROTEIN)
    ("karyopherin-α" . SPARSER::PROTEIN) ("O96017" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("MUC16" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("GLI3" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("ITGB2" . SPARSER::PROTEIN)
    ("MAD1L1" . SPARSER::PROTEIN) ("MYO5C" . SPARSER::PROTEIN)
    ("EP400" . SPARSER::PROTEIN) ("CHD6" . SPARSER::PROTEIN)
    ("ABCA3" . SPARSER::PROTEIN) ("KIF3B" . SPARSER::PROTEIN)
    ("KIF4B" . SPARSER::PROTEIN) ("TNK2" . SPARSER::PROTEIN)
    ("ROR2" . SPARSER::PROTEIN) ("MAPK15" . SPARSER::PROTEIN)
    ("PTK2B" . SPARSER::PROTEIN) ("MAP3K6" . SPARSER::PROTEIN)
    ("PIK3C2B" . SPARSER::PROTEIN) ("PMS1" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("MRE11A" . SPARSER::PROTEIN)
    ("CDK12" . SPARSER::PROTEIN) ("GABRA6" . SPARSER::PROTEIN)
    ("FAT3" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("MLL4" . SPARSER::PROTEIN) ("RPS6KA2" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("metastatic CRCs" . SPARSER::PROTEIN)
    ("lapatinib or pertuzumab" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("lapatinib" . SPARSER::DRUG)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("capecitabine and oxaliplatin" . SPARSER::COLLECTION)
    ("CRT" . SPARSER::PROTEIN) ("capecitabine" . SPARSER::DRUG)
    ("consecutive CRCs" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN) ("Cohort" . SPARSER::MOLECULE)
    ("consecutive cohort" . SPARSER::MOLECULE) ("Trastuzumab" . SPARSER::DRUG)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("CRCs" . SPARSER::PROTEIN)
    ("two retrospective cohorts" . SPARSER::MOLECULE)
    ("chromosome 17" . SPARSER::PROTEIN) ("S2S" . SPARSER::MOLECULE)
    ("D5S346" . SPARSER::PROTEIN) ("Chromosome 17" . SPARSER::PROTEIN)
    ("or 2" . SPARSER::MOLECULE) ("messenger RNA" . SPARSER::RNA)
    ("modifying pathological protein" . SPARSER::PROTEIN)
    ("actin, MYOT and SQSTM1" . SPARSER::COLLECTION)
    ("KAT5/TIP60" . SPARSER::COLLECTION)
    ("ULK1 (unc-51 like autophagy activating kinase 1) and ATG13"
     . SPARSER::COLLECTION)
    ("HTT" . SPARSER::PROTEIN)
    ("the causative proteins APP (amyloid β [A4] precursor protein) and SNCA"
     . SPARSER::COLLECTION)
    ("the causative proteins APP" . SPARSER::PROTEIN)
    ("GSK3 and Huntington" . SPARSER::COLLECTION)
    ("SQSTM1, UB, and LC3B" . SPARSER::COLLECTION)
    ("the phosphomimetic form" . SPARSER::FORM)
    ("active GSK3 or phosphomimetic NBR1" . SPARSER::COLLECTION)
    ("inactive GSK3 or nonphosphorylable NBR1" . SPARSER::COLLECTION)
    ("ectopic NBR1 and endogenous ubiquitinated proteins"
     . SPARSER::COLLECTION)
    ("NBR1 or NBR1" . SPARSER::COLLECTION)
    ("SQSTM1, UB, LC3B, or GABARAP" . SPARSER::COLLECTION)
    ("SQSTM1, UB, LC3B, and GABARAP" . SPARSER::COLLECTION)
    ("GABA" . SPARSER::MOLECULE) ("GABARAP" . SPARSER::PROTEIN)
    ("SQSTM1 and total NBR1 (most probably nonphosphorylated)"
     . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("phosphomimetic NBR1" . SPARSER::PROTEIN)
    ("nonphosphorylable NBR1" . SPARSER::PROTEIN)
    ("inactive and active" . SPARSER::COLLECTION)
    ("systematically contained smaller SQSTM1" . SPARSER::PROTEIN)
    ("proteins and SQSTM1" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the detergent-insoluble fraction" . SPARSER::COMPONENT)
    ("GSK3A and GSK3A" . SPARSER::COLLECTION)
    ("a pathological mutant protein" . SPARSER::PROTEIN)
    ("the nonphosphorylable NBR1 mutant" . SPARSER::MUTANT)
    ("the phosphomimetic NBR1 mutant" . SPARSER::MUTANT)
    ("phosphomimetic T586E S590E (Thr586 and Ser590 replaced with glutamic acids mimicking serine and threonine phosphorylation) NBR1 mutants"
     . SPARSER::MUTANT)
    ("SQSTM1 and UB" . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("MAPT/tau" . SPARSER::COLLECTION) ("MAPT" . SPARSER::PROTEIN)
    ("DES or MYOT" . SPARSER::COLLECTION) ("myotilin" . SPARSER::PROTEIN)
    ("MYOT" . SPARSER::PROTEIN) ("SQSTM1, UB, and NBR1" . SPARSER::COLLECTION)
    ("Gsk3b  +/+ and gsk3b  −/− MEFs" . SPARSER::COLLECTION)
    ("gsk3b" . SPARSER::PROTEIN) ("Gsk3b" . SPARSER::PROTEIN)
    ("a detergent-insoluble fraction" . SPARSER::COMPONENT)
    ("detergent" . SPARSER::MOLECULE)
    ("inactive, or active" . SPARSER::COLLECTION)
    ("NBR1, SQSTM1, and UB" . SPARSER::COLLECTION)
    ("polyubiquitinated and form" . SPARSER::COLLECTION)
    ("NBR1, SQSTM1 and UB" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("elongation" . SPARSER::PROTEIN)
    ("Puromycin" . SPARSER::DRUG) ("GSK3 and NBR1" . SPARSER::COLLECTION)
    ("the nonphosphorylable DsRed-NBR1 T586A S590A double mutant"
     . SPARSER::MUTANT)
    ("DsRed-NBR1" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("a nonphosphorylable alanine" . SPARSER::AMINO-ACID)
    ("the longest isoform" . SPARSER::ISOFORM)
    ("bands around 150 kDa" . SPARSER::PROTEIN)
    ("Commercial antibody" . SPARSER::PROTEIN)
    ("GSK3 or another kinase" . SPARSER::COLLECTION)
    ("AXIN and CTNNB1" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AXIN" . SPARSER::PROTEIN)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("phox and bemp1" . SPARSER::COLLECTION)
    ("juxta-UBA" . SPARSER::COLLECTION) ("UBA" . SPARSER::PROTEIN)
    ("LIR" . SPARSER::PROTEIN) ("phox" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN)
    ("nonphosphorylable alanines" . SPARSER::AMINO-ACID)
    ("alanines" . SPARSER::AMINO-ACID)
    ("GSK3A and GSK3B" . SPARSER::COLLECTION)
    ("GSK3A and GSK3B interacting protein" . SPARSER::COLLECTION)
    ("PI3K-AKT-MTOR" . SPARSER::COLLECTION)
    ("pathological protein" . SPARSER::PROTEIN)
    ("NBR1 and GSK3" . SPARSER::COLLECTION)
    ("proteins, GSK3A and GSK3B" . SPARSER::COLLECTION)
    ("NBR1 and the kinase GSK3" . SPARSER::COLLECTION)
    ("SRF" . SPARSER::PROTEIN) ("titin" . SPARSER::PROTEIN)
    ("TTN" . SPARSER::PROTEIN) ("sprouty" . SPARSER::PROTEIN-FAMILY)
    ("pathological ubiquitinated protein" . SPARSER::PROTEIN)
    ("NBR1 and SQSTM1" . SPARSER::COLLECTION)
    ("Long-lived proteins" . SPARSER::PROTEIN)
    ("SQSTM1/p62" . SPARSER::COLLECTION) ("akt" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("Aggregates trap potentially toxic mutant proteins" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("DES/desmin" . SPARSER::COLLECTION)
    ("desmin" . SPARSER::PROTEIN) ("DES" . SPARSER::PROTEIN)
    ("puromycin" . SPARSER::DRUG) ("proteins and GSK3" . SPARSER::COLLECTION)
    ("ubiquitin and the autophagosome-conjugated MAP1LC3/LC3 (microtubule-associated protein 1 light chain 3) proteins"
     . SPARSER::COLLECTION)
    ("MAP1LC3/LC3" . SPARSER::COLLECTION)
    ("UB/ubiquitin" . SPARSER::COLLECTION) ("H2B" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("B-5" . SPARSER::PROTEIN)
    ("TUBA1A" . SPARSER::PROTEIN) ("PO 3" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("CCL-2" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("KAT5" . SPARSER::PROTEIN)
    ("ATG13" . SPARSER::PROTEIN)
    ("unc-51 like autophagy activating kinase 1" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("precursor protein" . SPARSER::PROTEIN)
    ("glycogen synthase1" . SPARSER::PROTEIN) ("GYS1" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("receptor-associated protein" . SPARSER::PROTEIN)
    ("bafilomycin A 1" . SPARSER::DRUG)
    ("glutamic acids" . SPARSER::AMINO-ACID)
    ("gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LIR2" . SPARSER::PROTEIN)
    ("cadherin-associated protein" . SPARSER::PROTEIN)
    ("T-X" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("GSK3B interacting protein" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("GSK3A" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("serum response factor" . SPARSER::PROTEIN)
    ("domain containing 2" . SPARSER::PROTEIN) ("SPRED2" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("TANK-binding kinase 1" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("superoxide dismutase 1, soluble" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN) ("sequestosome 1" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("MAP1LC3" . SPARSER::PROTEIN-FAMILY) ("NBR1" . SPARSER::PROTEIN)
    ("fibrosis-related genes and the excessive deposition"
     . SPARSER::COLLECTION)
    ("antibody and LY294002" . SPARSER::COLLECTION)
    ("IL-10, IL-10RB and LY294002" . SPARSER::COLLECTION)
    ("JAK1 and Tyk2" . SPARSER::COLLECTION)
    ("vimentin and IL-10Rα" . SPARSER::COLLECTION)
    ("CD31 and IL-10Rα" . SPARSER::COLLECTION)
    ("MMP1 and MMP8" . SPARSER::COLLECTION)
    ("HSFs, IL-10RB and LY294002" . SPARSER::COLLECTION)
    ("STAT3 or PI3K" . SPARSER::COLLECTION)
    ("STAT3 and PI3K" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION) ("STAT3 and AKT" . SPARSER::COLLECTION)
    ("The Western blot" . SPARSER::PROTEIN)
    ("AKT (p-AKT) and STAT3 (p-STAT3)" . SPARSER::COLLECTION)
    ("HSFs/NSFs" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("polypeptide" . SPARSER::PROTEIN)
    ("vimentin, CD31, and IL-10Rα" . SPARSER::COLLECTION)
    ("HSFs and NSFs" . SPARSER::COLLECTION) ("NSFs" . SPARSER::PROTEIN)
    ("IL-10-treated HSFs" . SPARSER::PROTEIN)
    ("particularly type I and type III collagen" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN)
    ("IL-10 receptor α-chain (IL-10Rα) and two molecules"
     . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("STAT3/AKT" . SPARSER::COLLECTION)
    ("type I and type III collagen (Col 1 and Col 3) and alpha-smooth muscle actin (α-SMA)"
     . SPARSER::COLLECTION)
    ("AKT and STAT" . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION)
    ("AKT and STAT3" . SPARSER::COLLECTION) ("primary HSFs" . SPARSER::PROTEIN)
    ("AKT and signal transducers and activators" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("a specific phosphatidylinositol 3 kinase (PI3K) inhibitor (LY294002) or a function-blocking antibody"
     . SPARSER::COLLECTION)
    ("Primary HSFs" . SPARSER::PROTEIN) ("HSFs" . SPARSER::PROTEIN)
    ("Tyk2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("STAT-3" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("IL-29" . SPARSER::PROTEIN) ("IL-28A" . SPARSER::PROTEIN)
    ("IL-26" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("IL-10R" . SPARSER::PROTEIN) ("α-chain" . SPARSER::PROTEIN)
    ("MMP8" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("Interleukin 10" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-10RB" . SPARSER::PROTEIN) ("IL-10 receptor" . SPARSER::PROTEIN)
    ("Interleukin-10" . SPARSER::PROTEIN) ("Fut8" . SPARSER::PROTEIN)
    ("glycosyltransferase" . SPARSER::PROTEIN) ("Guo" . SPARSER::MOLECULE)
    ("sugar" . SPARSER::MOLECULE) ("integrin-ECM" . SPARSER::COLLECTION)
    ("E-cadherin and α2β1 integrin" . SPARSER::COLLECTION)
    ("collagen, fibronectin and laminin" . SPARSER::COLLECTION)
    ("E-cadherin and integrins" . SPARSER::COLLECTION)
    ("α2 integrin subunit and SLe x" . SPARSER::COLLECTION)
    ("the typical pancreatic acinus" . SPARSER::PROTEIN)
    ("-sialic acid" . SPARSER::MOLECULE) ("lectins" . SPARSER::PROTEIN)
    ("MAL" . SPARSER::PROTEIN) ("E-cadherin and SLe x" . SPARSER::COLLECTION)
    ("E-cadherin and/or SLe x" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN)
    ("FAK/Src complex and the subsequent activation of different pathways"
     . SPARSER::COLLECTION)
    ("integrin-collagen" . SPARSER::COLLECTION) ("HRP" . SPARSER::PROTEIN)
    ("approximately 120 kDa" . SPARSER::PROTEIN) ("mAbs" . SPARSER::DRUG)
    ("function-blocking monoclonal antibodies" . SPARSER::ANTIBODY)
    ("mAb" . SPARSER::DRUG) ("TCL and Western blot" . SPARSER::COLLECTION)
    ("integrins or E-cadherin" . SPARSER::COLLECTION)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCL" . SPARSER::PROTEIN)
    ("the highest ST3Gal III and SLe x" . SPARSER::COLLECTION)
    ("E-cadherin and α2β1integrin" . SPARSER::COLLECTION)
    ("the correspondent glycosyltransferases" . SPARSER::PROTEIN)
    ("glycosyltransferases" . SPARSER::PROTEIN)
    ("pCAS, Crk or paxillin" . SPARSER::COLLECTION)
    ("FAK/Src" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("pCAS" . SPARSER::PROTEIN)
    ("the nonreceptor focal adhesion kinase (FAK) as well as a variety"
     . SPARSER::COLLECTION)
    ("transducers" . SPARSER::PROTEIN) ("Integrins" . SPARSER::PROTEIN)
    ("cadherins and integrins" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::PROTEIN)
    ("integrin and E-cadherin" . SPARSER::COLLECTION)
    ("collagen, and E-cadherin" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("GnT-III" . SPARSER::PROTEIN)
    ("N -acetylglucosaminyltransferase" . SPARSER::PROTEIN)
    ("MGAT5" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("N- glycans" . SPARSER::MOLECULE)
    ("ST3 Gal III" . SPARSER::PROTEIN) ("ST3GalIII" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("α1β1" . SPARSER::PROTEIN) ("ST6Gal I" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("sulfo-NHS" . SPARSER::DRUG)
    ("E- cadherin" . SPARSER::PROTEIN) ("sialic acids" . SPARSER::MOLECULE)
    ("Serum Albumin" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Penicillin G" . SPARSER::MOLECULE) ("N -glycans" . SPARSER::MOLECULE)
    ("sialic acid" . SPARSER::MOLECULE) ("ST3Gal III" . SPARSER::PROTEIN)
    ("pathological states" . SPARSER::BIO-STATE) ("DNA-repair" . SPARSER::DNA)
    ("many different pathologic states" . SPARSER::BIO-STATE)
    ("the major NADase" . SPARSER::PROTEIN) ("NADase" . SPARSER::PROTEIN)
    ("NR" . SPARSER::PROTEIN)
    ("proteins, SOD2 and catalase" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT6" . SPARSER::COLLECTION) ("IGF-AKT" . SPARSER::COLLECTION)
    ("IGF" . SPARSER::PROTEIN) ("serine-threonine" . SPARSER::COLLECTION)
    ("Sirt3 and Sirt6" . SPARSER::COLLECTION)
    ("PPARα and SIRT1" . SPARSER::COLLECTION)
    ("developmental genes" . SPARSER::GENE)
    ("Sod1 and Sod2" . SPARSER::COLLECTION) ("Sod2" . SPARSER::PROTEIN)
    ("Sod1" . SPARSER::PROTEIN) ("CaMKK" . SPARSER::PROTEIN)
    ("PS" . SPARSER::PROTEIN) ("glutamine" . SPARSER::AMINO-ACID)
    ("an oncogene or a tumor suppressor [ xref ]" . SPARSER::COLLECTION)
    ("type and stage" . SPARSER::COLLECTION)
    ("HIF-1α and c-MYC" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT3" . SPARSER::COLLECTION) ("LFS" . SPARSER::PROTEIN)
    ("complex (PDC)" . SPARSER::BIO-COMPLEX) ("PDC" . SPARSER::PROTEIN)
    ("pyruvate" . SPARSER::PROTEIN)
    ("SIRT1 and its substrates" . SPARSER::COLLECTION)
    ("particular HIF-1 α and c-MYC" . SPARSER::COLLECTION)
    ("HIF-1 α and c-MYC" . SPARSER::COLLECTION)
    ("c-MYC and SIRT1" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("survivin" . SPARSER::PROTEIN)
    ("the c-MYC oncoprotein and the tumor suppressor p53 [ xref ]"
     . SPARSER::COLLECTION)
    ("RELA/p65" . SPARSER::COLLECTION) ("RELA" . SPARSER::PROTEIN)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("subunit and FOXO" . SPARSER::COLLECTION)
    ("mTOR, and sirtuins" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("triglyceride and LDL" . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE)
    ("the lipogenic transcription factors SREBP1 and SREBP2"
     . SPARSER::COLLECTION)
    ("SREBP1 and SREBP2" . SPARSER::COLLECTION)
    ("lipogenic genes" . SPARSER::GENE) ("gluconeogenic genes" . SPARSER::GENE)
    ("mononucleotide (NMN)" . SPARSER::MOLECULE) ("NMN" . SPARSER::PROTEIN)
    ("mononucleotide" . SPARSER::MOLECULE)
    ("the nuclear mitochondrial transcription factor A (TFAM)"
     . SPARSER::PROTEIN)
    ("TFAM" . SPARSER::PROTEIN) ("NPY/AgRP" . SPARSER::COLLECTION)
    ("AgRP" . SPARSER::PROTEIN) ("NPY" . SPARSER::PROTEIN)
    ("POMC" . SPARSER::PROTEIN) ("mTOR and AMPK" . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("resveratrol" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("huntingtin" . SPARSER::PROTEIN) ("polyglutamine" . SPARSER::MOLECULE)
    ("presynaptic α-synuclein" . SPARSER::PROTEIN)
    ("amyloid" . SPARSER::PROTEIN)
    ("intracellular neurofibrillary tau protein" . SPARSER::PROTEIN)
    ("diverse age-sensitive traits" . SPARSER::PROTEIN)
    ("SIRT1 and SIRT6" . SPARSER::COLLECTION) ("Male" . SPARSER::MOLECULE)
    ("SIRT6 and its invertebrate homolog SIR-2" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN)
    ("Ectopically-expressed SIRT3" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY) ("Sv" . SPARSER::MOLECULE)
    ("orexin" . SPARSER::PROTEIN) ("DMH" . SPARSER::PROTEIN)
    ("several age-sensitive traits" . SPARSER::PROTEIN)
    ("age-sensitive traits" . SPARSER::PROTEIN)
    ("-O-acetyl-ADP-ribose" . SPARSER::MOLECULE)
    ("histones and many other proteins [ xref , xref – xref ]"
     . SPARSER::COLLECTION)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("acetyltransferase, and Sir2p" . SPARSER::COLLECTION)
    ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("proteins and mitochondria" . SPARSER::COLLECTION)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("self-replicating extrachromosomal rDNA" . SPARSER::PROTEIN)
    ("ribosomal DNA" . SPARSER::DNA) ("rDNA" . SPARSER::PROTEIN)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("SIRT1 or SIRT6" . SPARSER::COLLECTION)
    ("SIRT1, SIRT3, and SIRT6" . SPARSER::COLLECTION)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("apolipoprotein E" . SPARSER::PROTEIN)
    ("protein kinase kinase" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("K18" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("SREBP2" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("transcription factor A" . SPARSER::PROTEIN)
    ("agouti-related protein" . SPARSER::PROTEIN)
    ("pro-opiomelanocortin" . SPARSER::PROTEIN)
    ("coactivator 1" . SPARSER::PROTEIN) ("forkhead box O3" . SPARSER::PROTEIN)
    ("α -synuclein" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-synuclein" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("RAR β" . SPARSER::PROTEIN) ("β-amyloid" . SPARSER::MOLECULE)
    ("growth hormone" . SPARSER::PROTEIN) ("SIR-2" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("Sirt6" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN) ("OX2R" . SPARSER::PROTEIN)
    ("type 2 receptor" . SPARSER::PROTEIN)
    ("O-acetyl-ADP-ribose" . SPARSER::MOLECULE)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("Sas2" . SPARSER::PROTEIN) ("sir2" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IGF-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("a well-defined patient cohort" . SPARSER::MOLECULE)
    ("uPAR and uPA" . SPARSER::COLLECTION)
    ("uPA system components and clinicopathological parameters"
     . SPARSER::COLLECTION)
    ("uPA system components and other clinicopathological parameters"
     . SPARSER::COLLECTION)
    ("protein/protein" . SPARSER::COLLECTION)
    ("uPA and uPAR" . SPARSER::COLLECTION)
    ("macrophages, or neutrophils" . SPARSER::COLLECTION)
    ("uPAR or PAI-1" . SPARSER::COLLECTION)
    ("uPA and PAI-1 and suPAR and PAI-1" . SPARSER::COLLECTION)
    ("PAI-1 and suPAR and PAI-1" . SPARSER::COLLECTION)
    ("uPA, suPAR, and PAI-1" . SPARSER::COLLECTION)
    ("uPAR ( r  s = 0.550; P < 0.001) and PAI-1 ( r  s = 0.552; P < 0.001)"
     . SPARSER::COLLECTION)
    ("uPA and suPAR" . SPARSER::COLLECTION)
    ("uPA or suPAR" . SPARSER::COLLECTION)
    ("uPAR and PAI-1" . SPARSER::COLLECTION)
    ("uPA and PAI-1" . SPARSER::COLLECTION) ("uPA/PAI-1" . SPARSER::COLLECTION)
    ("uPA or PAI-1" . SPARSER::COLLECTION)
    ("strong uPA, uPAR, and PAI-1" . SPARSER::COLLECTION)
    ("uPA, uPAR, and PAI-1" . SPARSER::COLLECTION)
    ("strong PAI-1" . SPARSER::PROTEIN)
    ("uPA and/or uPAR" . SPARSER::COLLECTION)
    ("uPAR and/or PAI-1" . SPARSER::COLLECTION)
    ("soluble uPAR" . SPARSER::PROTEIN) ("uPAR" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("HIF1 α" . SPARSER::PROTEIN)
    ("TATA box binding protein" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN) ("heterodimer" . SPARSER::HETERODIMER)
    ("estradiol as well as other xenoestrogens [ xref ]" . SPARSER::COLLECTION)
    ("xenoestrogens" . SPARSER::MOLECULE)
    ("ERbeta1:beta2 and ERbeta1:beta5" . SPARSER::COLLECTION)
    ("ERbeta1:beta5" . SPARSER::BIO-COMPLEX)
    ("ERbeta1:beta2" . SPARSER::BIO-COMPLEX)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERbeta1, ERbeta2, or ERbeta5" . SPARSER::COLLECTION)
    ("-beta5" . SPARSER::COLLECTION) ("-beta2" . SPARSER::COLLECTION)
    ("ERbeta5" . SPARSER::PROTEIN) ("ERbeta2–ERbeta5" . SPARSER::PROTEIN-PAIR)
    ("p21 and PTEN" . SPARSER::COLLECTION)
    ("AR and ERalpha" . SPARSER::COLLECTION)
    ("ERbeta and AR" . SPARSER::COLLECTION)
    ("functional ARs" . SPARSER::PROTEIN) ("analogs" . SPARSER::ANALOG)
    ("the pure antiestrogen ICI 182,780" . SPARSER::DRUG)
    ("gene and protein" . SPARSER::COLLECTION)
    ("DPN [ xref ] and 8beta-VE2 [ xref ]" . SPARSER::COLLECTION)
    ("both the homo-dimer beta1:beta1 and the hetero-dimer beta1:beta2"
     . SPARSER::COLLECTION)
    ("beta1:beta2" . SPARSER::BIO-COMPLEX)
    ("beta1:beta1" . SPARSER::BIO-COMPLEX)
    ("beta1:beta5" . SPARSER::BIO-COMPLEX)
    ("neither DPN (not shown) nor 8beta-VE2" . SPARSER::COLLECTION)
    ("antiestrogen" . SPARSER::DRUG) ("AR and ERbeta" . SPARSER::COLLECTION)
    ("PTEN and p21" . SPARSER::COLLECTION)
    ("DPN and 8beta-VE2" . SPARSER::COLLECTION)
    ("both DPN and 8beta-VE2" . SPARSER::COLLECTION)
    ("AR-PC" . SPARSER::COLLECTION) ("SD" . SPARSER::PROTEIN)
    ("A representative Western blot" . SPARSER::PROTEIN)
    ("maps" . SPARSER::PROTEIN) ("ERs" . SPARSER::PROTEIN)
    ("androgen and estrogen" . SPARSER::COLLECTION)
    ("PTEN, p21 and cyclin E" . SPARSER::COLLECTION)
    ("the different available in vitro PC" . SPARSER::PROTEIN)
    ("androstane" . SPARSER::MOLECULE) ("-triene-3" . SPARSER::COLLECTION)
    ("diol" . SPARSER::MOLECULE) ("diarylpropionitrile" . SPARSER::DRUG)
    ("the optimal ERbeta agonist" . SPARSER::AGONIST)
    ("ERbeta2 or ERbeta5" . SPARSER::COLLECTION)
    ("estradiol or phytoestrogens" . SPARSER::COLLECTION)
    ("phytoestrogens" . SPARSER::MOLECULE)
    ("heterodimers" . SPARSER::HETERODIMER)
    ("ERbeta2 and ERbeta5" . SPARSER::COLLECTION)
    ("at least five ERbeta different isoforms" . SPARSER::ISOFORM)
    ("ERalpha and ERbeta" . SPARSER::COLLECTION) ("ERalpha" . SPARSER::PROTEIN)
    ("estrogens" . SPARSER::MOLECULE) ("Estrogens" . SPARSER::MOLECULE)
    ("CR-PC" . SPARSER::COLLECTION) ("agonists" . SPARSER::AGONIST)
    ("DPN" . SPARSER::MOLECULE) ("ERbeta" . SPARSER::PROTEIN)
    ("PC" . SPARSER::PROTEIN) ("beta2" . SPARSER::PROTEIN)
    ("beta5" . SPARSER::PROTEIN) ("beta1" . SPARSER::PROTEIN)
    ("nM 3" . SPARSER::DRUG) ("pgL 4" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("ERbeta2" . SPARSER::PROTEIN) ("ERbeta1" . SPARSER::PROTEIN)
    ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("a potential new target" . SPARSER::TARGET-PROTEIN)
    ("polo-like kinases (PLK) and aurora kinases" . SPARSER::COLLECTION)
    ("kinases (PLK)" . SPARSER::PROTEIN) ("PLK" . SPARSER::PROTEIN)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("GDS" . SPARSER::PROTEIN)
    ("PLK1 and MAP9" . SPARSER::COLLECTION)
    ("AURKA or PLK1" . SPARSER::COLLECTION) ("SBR" . SPARSER::PROTEIN)
    ("MAP9/PLK1" . SPARSER::COLLECTION) ("MAP9/AURKA" . SPARSER::COLLECTION)
    ("AURKA, PLK1, and MAP9" . SPARSER::COLLECTION) ("Map9" . SPARSER::PROTEIN)
    ("Map" . SPARSER::PROTEIN)
    ("microtubule-associated protein (MAP)" . SPARSER::PROTEIN)
    ("MAP" . SPARSER::PROTEIN) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("CGH" . SPARSER::PROTEIN) ("MAP9 and PLK1" . SPARSER::COLLECTION)
    ("MAP9, AURKA, and PLK1" . SPARSER::COLLECTION)
    ("AURKA and PLK1" . SPARSER::COLLECTION) ("AURKA" . SPARSER::PROTEIN)
    ("polo-like" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("hydroxymethylbilane synthase" . SPARSER::PROTEIN)
    ("IPO8" . SPARSER::PROTEIN) ("ribosomal protein S18" . SPARSER::PROTEIN)
    ("tryptophan 5-monooxygenase" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("Polo like kinase 1" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("C 20 " . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("MAP9" . SPARSER::PROTEIN) ("CHK1/CHK2" . SPARSER::COLLECTION)
    ("ATR/ATM" . SPARSER::COLLECTION) ("cyclinE/CDK" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY) ("cyclinD/CDK" . SPARSER::COLLECTION)
    ("cyclinD" . SPARSER::PROTEIN) ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p107 and p130" . SPARSER::COLLECTION) ("avid" . SPARSER::DRUG)
    ("dimers" . SPARSER::DIMER) ("Cdk4/Cdk6" . SPARSER::COLLECTION)
    ("Cdk4, and Cdk6" . SPARSER::COLLECTION)
    ("Mcm3 and Mcm5" . SPARSER::COLLECTION)
    ("promyelocytic" . SPARSER::PROTEIN) ("myogenin" . SPARSER::PROTEIN)
    ("media (FBS)" . SPARSER::PROTEIN)
    ("Asynchronous cycling C2C12 myoblasts" . SPARSER::PROTEIN)
    ("mitogen" . SPARSER::MITOGEN) ("myotube" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("myogenic" . SPARSER::PROTEIN)
    ("Un" . SPARSER::PROTEIN) ("parental MEFs" . SPARSER::PROTEIN)
    ("two strong E2F target genes" . SPARSER::GENE)
    ("DHFR and cdc6" . SPARSER::COLLECTION) ("DHFR" . SPARSER::PROTEIN)
    ("especially E2F target genes" . SPARSER::GENE)
    ("Parental MEFs" . SPARSER::PROTEIN)
    ("Parental homozygous LoxP Rb f/f MEFs" . SPARSER::PROTEIN)
    ("doxorubicin-treated MEFs" . SPARSER::PROTEIN)
    ("cyclin D1 and Cdk6" . SPARSER::COLLECTION)
    ("topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("a processive Rb kinase" . SPARSER::KINASE)
    ("a Cdk2 ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("roscovitine" . SPARSER::DRUG)
    ("active Cdk2 and active Cdk4/6 complexes" . SPARSER::BIO-COMPLEX)
    ("Cdk2 and active" . SPARSER::COLLECTION) ("−FBS" . SPARSER::COLLECTION)
    ("parental D1 + /D3 + MEFs" . SPARSER::PROTEIN)
    ("asynchronously cycling parental D1 + /D3 + MEFs" . SPARSER::PROTEIN)
    ("TKO" . SPARSER::PROTEIN) ("E2F2 and E2F3" . SPARSER::COLLECTION)
    ("E2F1 and E2F4" . SPARSER::COLLECTION) ("un" . SPARSER::PROTEIN)
    ("the associated Rb mono-phosphorylated isoforms" . SPARSER::ISOFORM)
    ("oncoprotein or E2F-1" . SPARSER::COLLECTION)
    ("un-phosphorylatable" . SPARSER::PROTEIN-PAIR)
    ("at least 8 individual mono-phosphorylated Rb isoforms"
     . SPARSER::ISOFORM)
    ("tryptic phospho-peptide mapping" . SPARSER::PROTEIN)
    ("active cyclin D:Cdk4/6 complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin:Cdk" . SPARSER::BIO-COMPLEX)
    ("hypo-phosphorylated Rb isoforms" . SPARSER::ISOFORM)
    ("HL60" . SPARSER::PROTEIN) ("Cdk4/6" . SPARSER::PROTEIN)
    ("basic isoform" . SPARSER::ISOFORM) ("tri" . SPARSER::PROTEIN)
    ("the putative hypo-phosphorylated Rb isoforms" . SPARSER::ISOFORM)
    ("constitutively active cyclin D:Cdk4/6 complexes" . SPARSER::BIO-COMPLEX)
    ("three generalized biochemical states" . SPARSER::BIO-STATE)
    ("triple cyclin D-deleted MEFs" . SPARSER::PROTEIN)
    ("cyclin E:Cdk2 complexes and the appearance" . SPARSER::COLLECTION)
    ("p16, p21, and p27" . SPARSER::COLLECTION)
    ("Ser/Thr" . SPARSER::COLLECTION)
    ("various cyclins (A, B, D, E) and Cdks (−1, −2, −4, −6)"
     . SPARSER::COLLECTION)
    ("Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("varieties" . SPARSER::VARIETY)
    ("just one phosphate group" . SPARSER::MOLECULE)
    ("the only Rb isoform" . SPARSER::ISOFORM)
    ("cyclin E:Cdk2" . SPARSER::BIO-COMPLEX)
    ("beta-2-microglobulin" . SPARSER::PROTEIN) ("β2M" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("OPA1" . SPARSER::PROTEIN)
    ("F10" . SPARSER::PROTEIN) ("pSM2" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("Mcm5" . SPARSER::PROTEIN)
    ("Mcm3" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("G 2 /M" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PD0332991" . SPARSER::DRUG) ("cyclin D2" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("E2F-4" . SPARSER::PROTEIN)
    ("E2F-3" . SPARSER::PROTEIN) ("E2F-2" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("s 15" . SPARSER::PROTEIN)
    ("cdc6" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("Rb 3" . SPARSER::PROTEIN) ("Rb 2" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("B-box" . SPARSER::PROTEIN)
    ("A'" . SPARSER::PROTEIN) ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("HCQ-treatment" . SPARSER::DRUG)
    ("a conditional Atg5 allele" . SPARSER::ALLELE)
    ("basal puncta" . SPARSER::PROTEIN) ("PDX" . SPARSER::PROTEIN)
    ("ATG" . SPARSER::DRUG) ("inp53" . SPARSER::PROTEIN)
    ("caspase-3, γH2AX, and Ki-67" . SPARSER::COLLECTION)
    ("Pdx1-cre" . SPARSER::COLLECTION) ("Atg5 and LC3" . SPARSER::COLLECTION)
    ("invasive PDAC" . SPARSER::MOLECULE)
    ("invasive and malignant PDAC" . SPARSER::MOLECULE)
    ("a Pdx1 promoter-driven Cre recombinase" . SPARSER::PROTEIN)
    ("HCQ" . SPARSER::DRUG)
    ("heterozygous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a conditional p53 deletion allele or a p53 mutant allele"
     . SPARSER::COLLECTION)
    ("a conditional p53 deletion allele" . SPARSER::ALLELE)
    ("p53 , CDKN2A , and SMAD4" . SPARSER::COLLECTION)
    ("Atg5 or Atg7" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("chloroquine" . SPARSER::PROTEIN) ("PDAC" . SPARSER::MOLECULE)
    ("hydroxychloroquine" . SPARSER::DRUG) ("Kras" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("NBP1" . SPARSER::PROTEIN) ("Caspase3" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("FOXA1-AR" . SPARSER::COLLECTION) ("FOXA1/AR" . SPARSER::COLLECTION)
    ("extensive AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a model wherein FOXA1 protein" . SPARSER::PROTEIN)
    ("previously reported androgen-repressed genes" . SPARSER::GENE)
    ("KLK3, TMPRSS2, FKBP5, and KLK2" . SPARSER::COLLECTION)
    ("FOXA1-KD" . SPARSER::COLLECTION)
    ("nuclear AR and chromatin-bound AR" . SPARSER::COLLECTION)
    ("total AR protein, nuclear AR and chromatin-bound AR"
     . SPARSER::COLLECTION)
    ("AR and KLK3 transcript and protein in PCa cells ( xref )"
     . SPARSER::PROTEIN)
    ("RV" . SPARSER::MOLECULE) ("AR and KLK3" . SPARSER::COLLECTION)
    ("ARE-only and ARE+FKHD" . SPARSER::COLLECTION)
    ("FAIRE" . SPARSER::PROTEIN) ("excessive FOXA1" . SPARSER::PROTEIN)
    ("FAIRE-seq" . SPARSER::COLLECTION)
    ("in general much weaker" . SPARSER::PROTEIN)
    ("ARE-only" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("FOXA1 and AR" . SPARSER::COLLECTION)
    ("DNA-binding-deficient AR mutants" . SPARSER::MUTANT)
    ("ARE and FKHD" . SPARSER::COLLECTION)
    ("authentic AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("androgen and pre-occupies" . SPARSER::COLLECTION)
    ("AR and ER" . SPARSER::COLLECTION) ("Gao" . SPARSER::PROTEIN)
    ("distal enhancers" . SPARSER::PROTEIN)
    ("other hormonal receptors" . SPARSER::PROTEIN)
    ("prostatic" . SPARSER::PROTEIN) ("Too much FOXA1" . SPARSER::PROTEIN)
    ("AR-chromatin" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("e7" . SPARSER::PROTEIN-FAMILY) ("GL2" . SPARSER::DRUG)
    ("anti-androgen" . SPARSER::DRUG) ("KLK3" . SPARSER::PROTEIN)
    ("HNF-3" . SPARSER::PROTEIN) ("DNA-binding protein" . SPARSER::PROTEIN)
    ("Rps19" . SPARSER::PROTEIN) ("Rps" . SPARSER::PROTEIN)
    ("fish" . SPARSER::PROTEIN)
    ("ROS, TOR, and S6 kinase" . SPARSER::COLLECTION)
    ("rpS6" . SPARSER::PROTEIN) ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pwp2h" . SPARSER::PROTEIN) ("SBDS" . SPARSER::PROTEIN)
    ("rpS3a and rpS7" . SPARSER::COLLECTION)
    ("rpS7 or rpS3a" . SPARSER::COLLECTION) ("rpS3a" . SPARSER::PROTEIN)
    ("Trolox" . SPARSER::MOLECULE) ("LC3-GFP" . SPARSER::COLLECTION)
    ("in turn targets IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a commercially available S6 kinase antibody" . SPARSER::ANTIBODY)
    ("rpS19 or rpS14" . SPARSER::COLLECTION) ("rpS14" . SPARSER::PROTEIN)
    ("rpS19" . SPARSER::PROTEIN) ("phospo-S6 kinase" . SPARSER::COLLECTION)
    ("the circular mitochondria" . SPARSER::PROTEIN)
    ("the previously reported mitochondria" . SPARSER::PROTEIN)
    ("dianisidine" . SPARSER::MOLECULE) ("hemoglobin" . SPARSER::MOLECULE)
    ("mildly condensed chromatin" . SPARSER::BIO-COMPLEX)
    ("rpS7" . SPARSER::PROTEIN) ("rpS" . SPARSER::PROTEIN)
    ("sequestosome-1/SQSTM1" . SPARSER::COLLECTION)
    ("very few puncta" . SPARSER::PROTEIN)
    ("distinct puncta" . SPARSER::PROTEIN)
    ("RPS17 , RPL11 , or RPS7" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("LC3-II/actin" . SPARSER::COLLECTION) ("gold" . SPARSER::MOLECULE)
    ("practically all the GFP-LC3" . SPARSER::PROTEIN)
    ("vacuolar H+ ATPase" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("bafA" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("phosphatidylethanolamine (PE)" . SPARSER::MOLECULE)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("adipocytes insulin-activated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adipocytes" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("the most vital carbohydrate" . SPARSER::MOLECULE)
    ("AKT and TOR" . SPARSER::COLLECTION)
    ("the translation machinery elements RPS6, eukaryotic initiation factor 4B (eIF4B), and eukaryotic elongation factor 2 kinase (eEF2K) xref"
     . SPARSER::COLLECTION)
    ("eukaryotic initiation factor 4B" . SPARSER::PROTEIN)
    ("whose substrates" . SPARSER::SUBSTRATE) ("Atg1" . SPARSER::PROTEIN)
    ("Atg13" . SPARSER::PROTEIN) ("TOR" . SPARSER::PROTEIN)
    ("Nix" . SPARSER::PROTEIN)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("SDS and very severe forms" . SPARSER::COLLECTION)
    ("very severe forms" . SPARSER::FORM) ("MDS" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia (DBA)" . SPARSER::PROTEIN)
    ("S6 kinase and p53" . SPARSER::COLLECTION) ("RPs" . SPARSER::PROTEIN)
    ("SDS" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("IL3" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("rpL11" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("sequestosome-1" . SPARSER::PROTEIN) ("RPS7" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("RPS17" . SPARSER::PROTEIN)
    ("18 kD" . SPARSER::PROTEIN) ("Atg6" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN) ("beclin-1" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("PIP 2" . SPARSER::PIP2)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("eEF2K" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor 2 kinase" . SPARSER::PROTEIN)
    ("initiation factor 4B" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("RPS19" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia" . SPARSER::PROTEIN) ("BMP" . SPARSER::PROTEIN)
    ("HEY1, MSX2, DLX5 and SOX9" . SPARSER::COLLECTION)
    ("EGFR1, FGFR1 and FGFR3" . SPARSER::COLLECTION)
    ("SOST, BMP7, BMP8A, WNT5B, WNT10B, and FGF21" . SPARSER::COLLECTION)
    ("SOST" . SPARSER::PROTEIN) ("IHH" . SPARSER::PROTEIN)
    ("mutant and non-mutant" . SPARSER::COLLECTION) ("Ext1" . SPARSER::PROTEIN)
    ("Ext" . SPARSER::PROTEIN)
    ("dysfunctional chondrocytes" . SPARSER::PROTEIN)
    ("otherwise normally functioning chondrocytes" . SPARSER::PROTEIN)
    ("EXT1 and EXT2" . SPARSER::COLLECTION)
    ("Gli2 or mutant" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("proliferative and hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("pre-hypertrophic and early-hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("Fsp1-cKO" . SPARSER::COLLECTION)
    ("stage-specific matrix components and signaling pathway components"
     . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("FRA1 and p-ERK1/2" . SPARSER::COLLECTION) ("Fosl1" . SPARSER::PROTEIN)
    ("both mature and immature chondrocytes" . SPARSER::PROTEIN)
    ("COLX" . SPARSER::PROTEIN) ("collagen (COLX)" . SPARSER::PROTEIN)
    ("mutant and wild-type chondrocytes" . SPARSER::COLLECTION)
    ("Mutant" . SPARSER::MUTANT) ("Mixtures" . SPARSER::MOLECULE)
    ("SHP2 and ERK1/2" . SPARSER::COLLECTION)
    ("Hmga" . SPARSER::PROTEIN-FAMILY)
    ("Egr1 and its target genes Spp1 and Hpse" . SPARSER::COLLECTION)
    ("whose known target genes" . SPARSER::GENE)
    ("Spp1 and Hpse" . SPARSER::COLLECTION) ("Egr1" . SPARSER::PROTEIN)
    ("Hpse" . SPARSER::PROTEIN) ("Tcf7" . SPARSER::PROTEIN)
    ("Mef2c" . SPARSER::PROTEIN) ("Rbpj" . SPARSER::PROTEIN)
    ("SHP2 and MEK1/2" . SPARSER::COLLECTION) ("Phospho1" . SPARSER::PROTEIN)
    ("Ihh and Panx3" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ihh" . SPARSER::PROTEIN)
    ("late stage hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("almost completely depleted SHP2" . SPARSER::PROTEIN)
    ("a conditional Ptpn11 allele" . SPARSER::ALLELE)
    ("EtOH" . SPARSER::MOLECULE) ("cKO" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN)
    ("proliferative or hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("terminally-differentiated chondrocytes" . SPARSER::PROTEIN)
    ("late-hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("proliferative chondrocytes" . SPARSER::PROTEIN)
    ("Col9a1" . SPARSER::PROTEIN) ("Sparc" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("hypertrophic state" . SPARSER::BIO-STATE)
    ("rapidly dividing chondrocytes" . SPARSER::PROTEIN)
    ("Chondrocytes" . SPARSER::PROTEIN) ("Erk1 and Erk2" . SPARSER::COLLECTION)
    ("ribs, and exostoses" . SPARSER::COLLECTION) ("ribs" . SPARSER::DRUG)
    ("EXT1 or EXT2" . SPARSER::COLLECTION)
    ("Families" . SPARSER::PROTEIN-FAMILY) ("mixtures" . SPARSER::MOLECULE)
    ("Fsp1-Cre" . SPARSER::COLLECTION)
    ("early-hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("Ptpn11" . SPARSER::PROTEIN) ("/SHP2" . SPARSER::COLLECTION)
    ("Reducing Agent" . SPARSER::MOLECULE) ("a 20 µ" . SPARSER::PROTEIN)
    ("Reverse-Transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD1" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN)
    ("Secreted phosphoprotein 1" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("SOX9" . SPARSER::PROTEIN)
    ("DLX5" . SPARSER::PROTEIN) ("MSX2" . SPARSER::PROTEIN)
    ("HEY1" . SPARSER::PROTEIN) ("FGF21" . SPARSER::PROTEIN)
    ("WNT10B" . SPARSER::PROTEIN) ("WNT5B" . SPARSER::PROTEIN)
    ("BMP8A" . SPARSER::PROTEIN) ("BMP7" . SPARSER::PROTEIN)
    ("PTHR1" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("FRA1" . SPARSER::PROTEIN) ("Foxp1" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("Hey1" . SPARSER::PROTEIN)
    ("Msx2" . SPARSER::PROTEIN) ("Dlx5" . SPARSER::PROTEIN)
    ("Spp1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Panx3" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("Shp2" . SPARSER::PROTEIN)
    ("Col2a1" . SPARSER::PROTEIN) ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1" . SPARSER::PROTEIN) ("EXT2" . SPARSER::PROTEIN)
    ("EXT1" . SPARSER::PROTEIN) ("Fsp1" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("cAMP-PKA" . SPARSER::COLLECTION)
    ("von" . SPARSER::PROTEIN)
    ("at least 12 mutated lysines" . SPARSER::AMINO-ACID)
    ("FOXA2 or SIRT1" . SPARSER::COLLECTION)
    ("FOXA2-SIRT1" . SPARSER::COLLECTION) ("ketone" . SPARSER::MOLECULE)
    ("glucagon" . SPARSER::PROTEIN) ("Von" . SPARSER::PROTEIN)
    ("at least part" . SPARSER::COMPONENT)
    ("the mutated lysines" . SPARSER::AMINO-ACID)
    ("at least twelve lysines" . SPARSER::AMINO-ACID)
    ("cofactor" . SPARSER::MOLECULE) ("Foxa2 and Sirt1" . SPARSER::COLLECTION)
    ("Sirt1" . SPARSER::PROTEIN) ("ST" . SPARSER::PROTEIN)
    ("Nutrient" . SPARSER::MOLECULE)
    ("ectopically-expressed wild type FOXA2" . SPARSER::PROTEIN)
    ("either wild type SIRT1 or the SIRT1-H363Y catalytically-impaired mutant"
     . SPARSER::COLLECTION)
    ("the SIRT1-H363Y catalytically-impaired mutant" . SPARSER::MUTANT)
    ("palmitoyltransferase" . SPARSER::PROTEIN)
    ("FLAG- and SIRT1-specific antibodies (data not shown)"
     . SPARSER::COLLECTION)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY) ("SIRT1-FOXA2" . SPARSER::COLLECTION)
    ("MYC-SIRT1" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("a pan-acetylation-specific antibody" . SPARSER::PROTEIN)
    ("acetyl" . SPARSER::MOLECULE)
    ("TSA (inhibitor of class I and II HDACs) and/or NAM (inhibitor of class III NAD + -dependent deacetylases, or sirtuins)"
     . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC) inhibitors nicotinamide (NAM) and Trichostatin"
     . SPARSER::COLLECTION)
    ("nicotinamide (NAM)" . SPARSER::MOLECULE) ("TSA" . SPARSER::PROTEIN)
    ("Trichostatin" . SPARSER::MOLECULE) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("nicotinamide" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("FLAG-FOXA2" . SPARSER::COLLECTION) ("proteases" . SPARSER::PROTEIN)
    ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("deacetylases, or sirtuins" . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("HDACs" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine TNFα" . SPARSER::PROTEIN)
    ("serines" . SPARSER::AMINO-ACID)
    ("Insulin-activated AKT2/PKB" . SPARSER::COLLECTION)
    ("AKT2/PKB" . SPARSER::COLLECTION) ("threonine" . SPARSER::AMINO-ACID)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("metazoan" . SPARSER::PROTEIN-FAMILY) ("FOXA" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN) ("post-natal life Foxa2" . SPARSER::PROTEIN)
    ("SIRT1 and FOXA2" . SPARSER::COLLECTION)
    ("FOXA2 and SIRT1" . SPARSER::COLLECTION) ("Foxa2" . SPARSER::PROTEIN)
    ("the FOXA2-driven G6pase and CPT1a promoters" . SPARSER::PROMOTER)
    ("G6pase and CPT1a" . SPARSER::COLLECTION) ("CPT1a" . SPARSER::PROTEIN)
    ("Forkhead" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("CRTC2" . SPARSER::PROTEIN) ("K-X" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("glucose-6-phosphatase" . SPARSER::PROTEIN) ("MS-MS" . SPARSER::PROTEIN)
    ("K-R" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("PHA-4" . SPARSER::PROTEIN)
    ("CPT1" . SPARSER::PROTEIN) ("G6pase" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("FOXA2" . SPARSER::PROTEIN)
    ("oncogene, or colon" . SPARSER::COLLECTION)
    ("BMAL1:CLOCK" . SPARSER::BIO-COMPLEX)
    ("Clock and CKIε" . SPARSER::COLLECTION)
    ("Bmal1 and Per1" . SPARSER::COLLECTION)
    ("output clock-associated genes" . SPARSER::GENE)
    ("the clock-associated genes" . SPARSER::GENE)
    ("33 clock-associated genes" . SPARSER::GENE)
    ("TGF-β, Jak-STAT and MAPK" . SPARSER::COLLECTION)
    ("discriminative genes" . SPARSER::GENE) ("RAS/PI3K" . SPARSER::COLLECTION)
    ("WASF3 and FOXA1" . SPARSER::COLLECTION)
    ("PPARD and PPARB" . SPARSER::COLLECTION)
    ("the heterotrimeric G-protein family" . SPARSER::PROTEIN-FAMILY)
    ("LOXL2 , SPARC and CTSB" . SPARSER::COLLECTION)
    ("FOXA1 and PDHX" . SPARSER::COLLECTION) ("PDHX" . SPARSER::PROTEIN)
    ("IFNGR" . SPARSER::PROTEIN)
    ("the ubiquitous epigenetic regulator and insulator protein CTCF"
     . SPARSER::PROTEIN)
    ("regulator and insulator" . SPARSER::COLLECTION)
    ("CTCF" . SPARSER::PROTEIN) ("CHD" . SPARSER::PROTEIN)
    ("the polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("molecules and transcriptional regulators" . SPARSER::COLLECTION)
    ("CLOCK/BMAL1" . SPARSER::COLLECTION)
    ("weakening BMAL1's" . SPARSER::PROTEIN) ("CLOCK" . SPARSER::PROTEIN)
    ("Cry1 and Clock" . SPARSER::COLLECTION)
    ("Bmal1 , Per2 , Cry1 and Clock" . SPARSER::COLLECTION)
    ("Per1 and Rev-Erbα" . SPARSER::COLLECTION)
    ("Cry1 , Bmal1 , Per2 , Rev-Erb α and Clock" . SPARSER::COLLECTION)
    ("a conditional KRASV12 oncogene" . SPARSER::ONCOGENE)
    ("Western Blot" . SPARSER::PROTEIN) ("IPTG" . SPARSER::MOLECULE)
    ("cue" . SPARSER::PROTEIN-FAMILY) ("monolayers" . SPARSER::PROTEIN)
    ("BLP" . SPARSER::PROTEIN) ("the immortal state" . SPARSER::BIO-STATE)
    ("derivatives" . SPARSER::DERIVATIVE) ("Jak/STAT" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("possible clock" . SPARSER::PROTEIN)
    ("these discriminative genes" . SPARSER::GENE)
    ("matrix (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("LOXL2 , PPARD and CTSB" . SPARSER::COLLECTION)
    ("MAPK/RAS" . SPARSER::COLLECTION) ("CTSB" . SPARSER::PROTEIN)
    ("PPARD" . SPARSER::PROTEIN) ("Discriminative genes" . SPARSER::GENE)
    ("bin" . SPARSER::PROTEIN)
    ("the discriminative genes and the clock/cancer genes"
     . SPARSER::COLLECTION)
    ("the discriminative genes" . SPARSER::GENE)
    ("genes and the genes" . SPARSER::COLLECTION)
    ("the core-clock genes ( xref ) and the 45 discriminative genes ( xref , xref )"
     . SPARSER::COLLECTION)
    ("known colon cancer-related genes ( xref , xref ) and the 45 discriminative genes"
     . SPARSER::COLLECTION)
    ("the 45 discriminative genes" . SPARSER::GENE)
    ("circadian regulators" . SPARSER::REGULATOR)
    ("discriminative genes links cancer genes" . SPARSER::GENE)
    ("DBP" . SPARSER::PROTEIN) ("BP" . SPARSER::PROTEIN)
    ("HLF" . SPARSER::PROTEIN) ("CAR" . SPARSER::PROTEIN)
    ("AhR" . SPARSER::PROTEIN) ("TEF" . SPARSER::PROTEIN)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PPAR" . SPARSER::PROTEIN)
    ("NONO" . SPARSER::PROTEIN) ("CBP" . SPARSER::PROTEIN)
    ("TRC" . SPARSER::PROTEIN) ("Examples" . SPARSER::EXAMPLE)
    ("core-clock and clock-controlled genes" . SPARSER::COLLECTION)
    ("Erb" . SPARSER::PROTEIN) ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("The mammalian circadian clock" . SPARSER::PROTEIN)
    ("circadian clock" . SPARSER::PROTEIN) ("p " . SPARSER::PROTEIN)
    ("of 45 discriminative genes" . SPARSER::GENE)
    ("mifepristone" . SPARSER::DRUG)
    ("of 45 best p-value discriminative genes" . SPARSER::GENE)
    ("Clock and Npas2" . SPARSER::COLLECTION) ("Cry2" . SPARSER::PROTEIN)
    ("Cry1" . SPARSER::PROTEIN) ("gene and cell line" . SPARSER::COLLECTION)
    ("The circadian clock" . SPARSER::PROTEIN)
    ("the circadian clock and proto-oncogenes" . SPARSER::COLLECTION)
    ("clock and proto-oncogenes" . SPARSER::COLLECTION)
    ("Npas2" . SPARSER::PROTEIN) ("Clock" . SPARSER::PROTEIN)
    ("Per1 and Per2" . SPARSER::COLLECTION)
    ("PER1 and Timeless" . SPARSER::COLLECTION)
    ("Timeless" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nocturnal light" . SPARSER::PROTEIN) ("/REV-ERBs" . SPARSER::COLLECTION)
    ("Bmal1" . SPARSER::PROTEIN) ("PERs" . SPARSER::PROTEIN)
    ("ERBs" . SPARSER::PROTEIN) ("REV" . SPARSER::PROTEIN-FAMILY)
    ("RORs" . SPARSER::PROTEIN-FAMILY) ("SCN" . SPARSER::MOLECULE)
    ("an internal circadian clock" . SPARSER::PROTEIN)
    ("conditionally active Ras oncogenes" . SPARSER::ONCOGENE)
    ("the mammalian circadian clock" . SPARSER::PROTEIN)
    ("the circadian clock" . SPARSER::PROTEIN)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("core-clock" . SPARSER::PROTEIN)
    ("IFNGR2, PITX2, RFWD2, PPARγ, LOXL2, Rab6 and SPARC"
     . SPARSER::COLLECTION)
    ("Rab6" . SPARSER::PROTEIN) ("SPARC" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN) ("UO126" . SPARSER::DRUG)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("phenol-red" . SPARSER::DRUG)
    ("pMD2" . SPARSER::MOLECULE) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-Ras" . SPARSER::PROTEIN) ("CKIε" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("GNG11" . SPARSER::PROTEIN) ("WASF3" . SPARSER::PROTEIN)
    ("INO80" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("PRC1" . SPARSER::PROTEIN) ("CBX7" . SPARSER::PROTEIN)
    ("Per3" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("U0126" . SPARSER::DRUG) ("ry1" . SPARSER::PROTEIN)
    ("H- Ras" . SPARSER::PROTEIN) ("IR4" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("e-5" . SPARSER::PROTEIN)
    ("DEC1" . SPARSER::PROTEIN) ("DEC2" . SPARSER::PROTEIN)
    ("ALAS1" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("Jak-STAT" . SPARSER::PROTEIN) ("Rorα" . SPARSER::PROTEIN)
    ("RT3" . SPARSER::MOLECULE) ("of 45" . SPARSER::PROTEIN)
    ("Per2" . SPARSER::PROTEIN) ("Per1" . SPARSER::PROTEIN)
    ("PER1" . SPARSER::PROTEIN) ("sirtuin 1" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("Wee1" . SPARSER::PROTEIN)
    ("BMAL1" . SPARSER::PROTEIN) ("LOXL2" . SPARSER::PROTEIN)
    ("RFWD2" . SPARSER::PROTEIN) ("PITX2" . SPARSER::PROTEIN)
    ("IFNGR2" . SPARSER::PROTEIN) ("lysines" . SPARSER::AMINO-ACID)
    ("a bulky benzimidazole group" . SPARSER::MOLECULE)
    ("benzimidazole" . SPARSER::DRUG)
    ("that galeterone and related compounds" . SPARSER::COLLECTION)
    ("a relatively pure direct AR antagonist" . SPARSER::MOLECULE)
    ("transcriptional coactivator or corepressor proteins"
     . SPARSER::COLLECTION)
    ("a direct AR competitive antagonist" . SPARSER::MOLECULE)
    ("enzalutamide or bicalutamide" . SPARSER::COLLECTION)
    ("hydroxyflutamide and nilutamide" . SPARSER::COLLECTION)
    ("hydroxyflutamide" . SPARSER::DRUG)
    ("AR and geneticin" . SPARSER::COLLECTION)
    ("geneticin" . SPARSER::MOLECULE) ("C4-2 and LNCaP" . SPARSER::COLLECTION)
    ("eIF2α" . SPARSER::PROTEIN)
    ("bicalutamide, enzalutamide or abiraterone" . SPARSER::COLLECTION)
    ("Rv" . SPARSER::MOLECULE) ("Abiraterone" . SPARSER::DRUG)
    ("CR" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("enzalutamide or vehicle" . SPARSER::COLLECTION)
    ("PSA , KLK2, NKX3.1 and TMPRSS2" . SPARSER::COLLECTION)
    ("ARE4" . SPARSER::PROTEIN) ("ARE4-LUC" . SPARSER::COLLECTION)
    ("bicalutamide and enzalutamide" . SPARSER::COLLECTION)
    ("bicalutamide, enzalutamide, or galeterone" . SPARSER::COLLECTION)
    ("LUC" . SPARSER::PROTEIN) ("Bicalutamide" . SPARSER::DRUG)
    ("galeterone or enzalutamide" . SPARSER::COLLECTION)
    ("Galeterone and enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide and bicalutamide" . SPARSER::COLLECTION)
    ("a competitive antagonist" . SPARSER::MOLECULE)
    ("galeterone, and AR" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN) ("VN" . SPARSER::PROTEIN)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE)
    ("flutamide, nilutamide, and bicalutamide" . SPARSER::COLLECTION)
    ("nilutamide" . SPARSER::DRUG) ("flutamide" . SPARSER::DRUG)
    ("residual androgens and precursor steroids" . SPARSER::COLLECTION)
    ("residual androgens" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("testosterone and dihydrotestosterone (DHT)" . SPARSER::COLLECTION)
    ("testosterone and dihydrotestosterone" . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN) ("dihydrotestosterone" . SPARSER::DRUG)
    ("androgens" . SPARSER::DRUG) ("DHEA" . SPARSER::DRUG)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("ARs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LNCaP and C4-2" . SPARSER::COLLECTION) ("bicalutamide" . SPARSER::DRUG)
    ("enzalutamide" . SPARSER::DRUG) ("PCa" . SPARSER::PROTEIN)
    ("galeterone" . SPARSER::DRUG) ("Galeterone" . SPARSER::DRUG)
    ("TORC1" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("KLK2" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("TOK-001" . SPARSER::DRUG) ("C4-2" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("CYP17A1" . SPARSER::PROTEIN)
    ("p53 and eIF2" . SPARSER::COLLECTION)
    ("promoter or suppressor" . SPARSER::COLLECTION)
    ("the ATF4 transcription factor and the promoters" . SPARSER::COLLECTION)
    ("PERK and IRE1 α" . SPARSER::COLLECTION)
    ("a noncanonical activator" . SPARSER::ACTIVATOR)
    ("inducer or inhibitor" . SPARSER::COLLECTION)
    ("acute myelogenous leukemia (AML) aims" . SPARSER::PROTEIN)
    ("p-p53" . SPARSER::COLLECTION) ("AFT" . SPARSER::PROTEIN)
    ("p62 and caspase 3" . SPARSER::COLLECTION)
    ("autophagy-associated LC3B and p62" . SPARSER::COLLECTION)
    ("LC3B and p62" . SPARSER::COLLECTION)
    ("CHOP and MAP1LC3B" . SPARSER::COLLECTION)
    ("p38 and p53" . SPARSER::COLLECTION)
    ("CHOP and MAP1LC3B and ATF4" . SPARSER::COLLECTION)
    ("MAP1LC3B and ATF4" . SPARSER::COLLECTION)
    ("ATF4 and the CHOP or MAP1LC3B promoters" . SPARSER::COLLECTION)
    ("CHOP or MAP1LC3B" . SPARSER::COLLECTION)
    ("ATF4 and the MAP1LC3B promoter ( xref )" . SPARSER::COLLECTION)
    ("salubrinal and the Mknk1 (MAP kinase interacting serine/threonine kinase 1) inhibitor"
     . SPARSER::COLLECTION)
    ("Mknk1" . SPARSER::PROTEIN) ("p-eIF4E" . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN)
    ("ATF4 and the CHOP promoter" . SPARSER::COLLECTION)
    ("-TGACCTCA-3" . SPARSER::COLLECTION)
    ("MAP1LC3B and CHOP" . SPARSER::COLLECTION)
    ("PERK and Hsp90" . SPARSER::COLLECTION)
    ("p-p38 and ATF4" . SPARSER::COLLECTION)
    ("Hsp90 and p38" . SPARSER::COLLECTION)
    ("p38 and Hsp90" . SPARSER::COLLECTION) ("-siRNA" . SPARSER::COLLECTION)
    ("salubrinal" . SPARSER::DRUG)
    ("a cell-permeable eIF2 α agonist" . SPARSER::AGONIST)
    ("Salubrinal" . SPARSER::DRUG) ("subunit-" . SPARSER::FRAGMENT)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARP and caspase 3" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("ATF4 (activating transcription factor 4) and CHOP (CCAAT/enhancer-binding protein homologous protein)"
     . SPARSER::COLLECTION)
    ("p-PERK" . SPARSER::PROTEIN-PAIR) ("scaffold" . SPARSER::SCAFFOLD)
    ("CHOP and LC3" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("PERK and eIF2" . SPARSER::COLLECTION) ("eIF2" . SPARSER::PROTEIN)
    ("/ATF4" . SPARSER::COLLECTION) ("eIF" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN) ("selenite" . SPARSER::MOLECULE)
    ("Selenite" . SPARSER::MOLECULE) ("CD33" . SPARSER::PROTEIN)
    ("MEK3" . SPARSER::PROTEIN) ("p38 α" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("IRE1 α" . SPARSER::PROTEIN)
    ("MAP kinase interacting serine/threonine kinase 1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN) ("α at" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("bafilomycin A1" . SPARSER::DRUG) ("SB203580" . SPARSER::DRUG)
    ("NB4" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("MAP1LC3B" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein homologous protein" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock protein 90" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("EB" . SPARSER::PROTEIN-FAMILY)
    ("M-CSF and GM-CSF" . SPARSER::COLLECTION)
    ("IL-34 and IL-32" . SPARSER::COLLECTION) ("op" . SPARSER::MOLECULE)
    ("amiloride" . SPARSER::DRUG) ("dynamin" . SPARSER::PROTEIN)
    ("Dynasore" . SPARSER::MOLECULE) ("p38 and JNK" . SPARSER::COLLECTION)
    ("Dominant-negative (DN) TAK1 mutant" . SPARSER::MUTANT)
    ("M2 and M1-M" . SPARSER::COLLECTION)
    ("IL-6, and IL-8" . SPARSER::COLLECTION)
    ("IFN- γ and IL-12" . SPARSER::COLLECTION)
    ("G2A and AxxA" . SPARSER::COLLECTION)
    ("p38 as well as TAK1" . SPARSER::COLLECTION)
    ("p38 and IKK α" . SPARSER::COLLECTION)
    ("Stat1 and Stat5" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("p-TAK1" . SPARSER::COLLECTION)
    ("The slowly migrating TAK1" . SPARSER::PROTEIN)
    ("p38, JNK, and ERK" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("M2-" . SPARSER::MOLECULE) ("Soluble Nef proteins" . SPARSER::PROTEIN)
    ("MAP kinases, NF- κ B, and Stat" . SPARSER::COLLECTION)
    ("IL-1 β , IL-6, TNF- α , MIP-1 α , and MIP-1 β" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("an essential component" . SPARSER::COMPONENT)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("EIPA" . SPARSER::DRUG)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("TAK1 or TRAF2" . SPARSER::COLLECTION)
    ("MAP kinases and NF- κ B" . SPARSER::COLLECTION)
    ("the pathogenetic protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble HIV-1 proteins" . SPARSER::PROTEIN)
    ("anti-inflammatory M2 and pro-inflammatory M1" . SPARSER::COLLECTION)
    ("p40)" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("C-2" . SPARSER::PROTEIN) ("C-21" . SPARSER::PROTEIN)
    ("I κ B- α" . SPARSER::PROTEIN) ("K-23" . SPARSER::PROTEIN)
    ("A-12" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("per 1 " . SPARSER::PROTEIN) ("TRIM5" . SPARSER::PROTEIN)
    ("BST2" . SPARSER::PROTEIN) ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("IL-34" . SPARSER::PROTEIN) ("Na + /H +" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 2" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("IL-1ra" . SPARSER::PROTEIN)
    ("GRO α" . SPARSER::PROTEIN) ("I-309" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("IFN- γ" . SPARSER::PROTEIN)
    ("IL-32" . SPARSER::PROTEIN) ("Stat5" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("G2A" . SPARSER::PROTEIN)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("I κ B" . SPARSER::PROTEIN) ("MAP3K7" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its receptor" . SPARSER::PROTEIN) ("CD163" . SPARSER::PROTEIN)
    ("MIP-1 β" . SPARSER::PROTEIN) ("MIP-1 α" . SPARSER::PROTEIN)
    ("IL-1 β" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF2" . SPARSER::PROTEIN) ("5Z-7-oxozeaenol" . SPARSER::DRUG)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("the pro-apoptotic proteins Bax and Bak" . SPARSER::COLLECTION)
    ("dihydroceramide" . SPARSER::MOLECULE) ("Ceramides" . SPARSER::MOLECULE)
    ("The extracellular S1P" . SPARSER::PROTEIN)
    ("Bioactive S1P" . SPARSER::PROTEIN) ("keratinocytes" . SPARSER::PROTEIN)
    ("ceramide and S1P" . SPARSER::COLLECTION)
    ("sphingolipids" . SPARSER::MOLECULE) ("Ceramide" . SPARSER::MOLECULE)
    ("proteins and ceramide" . SPARSER::COLLECTION) ("Bax-" . SPARSER::PROTEIN)
    ("ASMase" . SPARSER::PROTEIN) ("Bak and Bax" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION) ("ceramide" . SPARSER::MOLECULE)
    ("sphingoid" . SPARSER::MOLECULE) ("Sphingolipids" . SPARSER::MOLECULE)
    ("iPLA" . SPARSER::PROTEIN) ("extracellular PGE2" . SPARSER::DRUG)
    ("Bax and prostaglandins" . SPARSER::COLLECTION)
    ("protein and protein" . SPARSER::COLLECTION)
    ("solvent" . SPARSER::MOLECULE) ("tryptophan" . SPARSER::AMINO-ACID)
    ("PGE2 and Bid" . SPARSER::COLLECTION)
    ("PGE2 and PGD2" . SPARSER::COLLECTION)
    ("Bax and PGE2" . SPARSER::COLLECTION) ("cys" . SPARSER::AMINO-ACID)
    ("the microsomal PGES" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG) ("mPGES" . SPARSER::PROTEIN)
    ("PGES" . SPARSER::PROTEIN) ("EP" . SPARSER::PROTEIN)
    ("Cox-1 and Cox-2" . SPARSER::COLLECTION) ("Cox-1" . SPARSER::PROTEIN)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ligands" . SPARSER::LIGAND) ("Bid and Bax" . SPARSER::COLLECTION)
    ("Bax or tBid" . SPARSER::COLLECTION) ("tBid" . SPARSER::PROTEIN)
    ("cardiolipin" . SPARSER::MOLECULE) ("MIM" . SPARSER::PROTEIN)
    ("an anionic phospholipid" . SPARSER::PHOSPHOLIPID)
    ("Cardiolipin" . SPARSER::MOLECULE) ("lovastatin" . SPARSER::DRUG)
    ("ER and mitochondria" . SPARSER::COLLECTION) ("HDL" . SPARSER::PROTEIN)
    ("LDL" . SPARSER::PROTEIN)
    ("an essential cellular membrane component" . SPARSER::COMPONENT)
    ("Receptors" . SPARSER::RECEPTOR) ("protein–protein" . SPARSER::COLLECTION)
    ("Lipids and Bax" . SPARSER::COLLECTION) ("liposomes" . SPARSER::PROTEIN)
    ("MOMP and cytochrome c" . SPARSER::COLLECTION)
    ("healthy cells Bax" . SPARSER::PROTEIN)
    ("activator and sensitizer" . SPARSER::COLLECTION)
    ("-Sensitizers or de-repressor pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bad, Bik, BMF, HRK, Noxa and Puma" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("HRK" . SPARSER::PROTEIN) ("BMF" . SPARSER::PROTEIN)
    ("Bik" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("-Direct activator pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bid, Bim and Puma" . SPARSER::COLLECTION)
    ("run" . SPARSER::PROTEIN-FAMILY) ("MOMP" . SPARSER::PROTEIN)
    ("-Pro-apoptotic effector proteins" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION) ("shed new light" . SPARSER::PROTEIN)
    ("diacylglycerol or cholesterol" . SPARSER::COLLECTION)
    ("caspases or proteins" . SPARSER::COLLECTION)
    ("receptors or ligands" . SPARSER::COLLECTION) ("Lipids" . SPARSER::LIPID)
    ("S1P" . SPARSER::PROTEIN) ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("ABT-263" . SPARSER::DRUG) ("Promyelocytic leukemia" . SPARSER::PROTEIN)
    ("PGA2" . SPARSER::PROTEIN-FAMILY) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein-coupled" . SPARSER::PROTEIN) ("PGD2" . SPARSER::PROTEIN)
    ("PGE2" . SPARSER::DRUG) ("PGH2" . SPARSER::MOLECULE)
    ("prostaglandin H2" . SPARSER::MOLECULE) ("Cox-2" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("alpha 5" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID) ("HMG-CoA" . SPARSER::DRUG)
    ("translocator protein" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("BH2" . SPARSER::MOLECULE) ("BH1" . SPARSER::PROTEIN)
    ("Bcl-W" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("our findings collectively shed light" . SPARSER::PROTEIN)
    ("ElonginB" . SPARSER::PROTEIN)
    ("Skp2 ( xref ) and Cdc6 ( xref )" . SPARSER::COLLECTION)
    ("Skp2" . SPARSER::PROTEIN) ("Cdc20 and Bim" . SPARSER::COLLECTION)
    ("ΔD1D2" . SPARSER::PROTEIN) ("Bim and Cdc20" . SPARSER::COLLECTION)
    ("PKA" . SPARSER::PROTEIN) ("Taxol and MAPK" . SPARSER::COLLECTION)
    ("which targets both APC Cdc20 and APC Cdh1" . SPARSER::PROTEIN)
    ("an attractive therapeutic drug target" . SPARSER::TARGET-PROTEIN)
    ("Cdc20-Bim" . SPARSER::COLLECTION)
    ("free Bcl-2 or Bax/Bak" . SPARSER::COLLECTION)
    ("otherwise elevated Bim" . SPARSER::PROTEIN)
    ("directly binding Bax/Bak" . SPARSER::COLLECTION)
    ("Bax/Bak" . SPARSER::COLLECTION)
    ("Bid and a cohort" . SPARSER::COLLECTION)
    ("Puma, Bim, Bid and a cohort" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bim and Bcl-2" . SPARSER::COLLECTION)
    ("Bim or Puma" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Puma and Bid" . SPARSER::COLLECTION)
    ("Bim, Puma and Bid" . SPARSER::COLLECTION)
    ("Cdc20/Bim" . SPARSER::COLLECTION)
    ("Taxol, 5-FU and Etoposide" . SPARSER::COLLECTION)
    ("Etoposide" . SPARSER::PROTEIN)
    ("endogenous Cdc20 ( xref ) or other APC core components"
     . SPARSER::COLLECTION)
    ("APC6 ( xref ) and APC8 ( xref )" . SPARSER::COLLECTION)
    ("Cdc20 and Cdc27" . SPARSER::COLLECTION)
    ("Cdc20, Cdc27, APC4, APC6, APC8 and Cdc26" . SPARSER::COLLECTION)
    ("multiple chemotherapeutic drugs" . SPARSER::DRUG)
    ("Tax-negative Jurkat" . SPARSER::PROTEIN)
    ("Taxol ( xref ) and Nocodazole ( xref )" . SPARSER::COLLECTION)
    ("Nocodazole ( xref ) and Fluorouracil (5-FU)" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG) ("Jurkat" . SPARSER::PROTEIN)
    ("PL" . SPARSER::PROTEIN) ("SLB" . SPARSER::PROTEIN)
    ("Hyperactive Cdc20" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("BimEL" . SPARSER::PROTEIN) ("Cdh1 and Cdc20" . SPARSER::COLLECTION)
    ("Skp" . SPARSER::PROTEIN)
    ("endogenous Cdc20 and the APC core subunit Cdc27 ( xref )"
     . SPARSER::COLLECTION)
    ("GST-Bim" . SPARSER::COLLECTION) ("APC and SCF" . SPARSER::COLLECTION)
    ("Cdc20 and SCF" . SPARSER::COLLECTION)
    ("p-ERK and p-RSK" . SPARSER::COLLECTION) ("ERK/RSK" . SPARSER::COLLECTION)
    ("/Bax" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("lox/lox" . SPARSER::COLLECTION) ("Puma or Bid" . SPARSER::COLLECTION)
    ("Bid" . SPARSER::PROTEIN) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 ( xref ) and c-Jun ( xref )" . SPARSER::COLLECTION)
    ("ligases" . SPARSER::LIGASE) ("Ras/ERK/RSK" . SPARSER::COLLECTION)
    ("RSK" . SPARSER::PROTEIN) ("Taxol or Nocodazole" . SPARSER::COLLECTION)
    ("BMK" . SPARSER::PROTEIN)
    ("p21 ( xref ) and Securin ( xref )" . SPARSER::COLLECTION)
    ("a possible APC Cdc20 substrate" . SPARSER::SUBSTRATE)
    ("a potential APC Cdc20 substrate" . SPARSER::SUBSTRATE)
    ("homologues" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("Ile-Arg" . SPARSER::COLLECTION) ("TAME" . SPARSER::MOLECULE)
    ("Ile" . SPARSER::AMINO-ACID)
    ("Bim ( xref ; xref ) and Mcl-1 ( xref ; xref )" . SPARSER::COLLECTION)
    ("Securin and Cyclin" . SPARSER::COLLECTION) ("Securin" . SPARSER::PROTEIN)
    ("Cdc20 and APC" . SPARSER::COLLECTION)
    ("proteins, Cdc20 and Cdh1" . SPARSER::COLLECTION)
    ("Cdh1" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("ATL" . SPARSER::PROTEIN) ("Leukemia" . SPARSER::PROTEIN)
    ("Cdc20 and multiple APC-core components" . SPARSER::COLLECTION)
    ("the BH3-only pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("G Protein-Coupled" . SPARSER::PROTEIN) ("Cullin2" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("Cdc6" . SPARSER::PROTEIN)
    ("Cdc26" . SPARSER::PROTEIN) ("APC8" . SPARSER::PROTEIN)
    ("APC6" . SPARSER::PROTEIN) ("APC4" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("C91" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) ("Cdc27" . SPARSER::PROTEIN)
    ("p-RSK" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("4-Hydroxytamoxifen" . SPARSER::DRUG) ("z-VAD-fmk" . SPARSER::DRUG)
    ("Val-Ala" . SPARSER::MOLECULE) ("MAD2" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("anti-mitotic" . SPARSER::MOLECULE) ("Cdc20" . SPARSER::PROTEIN)
    ("The new SLE-associated genes" . SPARSER::GENE)
    ("immunologically active genes" . SPARSER::GENE)
    ("Classical MHC class I and class II genes" . SPARSER::GENE)
    ("MHC" . SPARSER::PROTEIN) ("the primary auto-antigens" . SPARSER::DRUG)
    ("SELP" . SPARSER::PROTEIN) ("ITGAM" . SPARSER::PROTEIN)
    ("IRF3 and NFκB" . SPARSER::COLLECTION) ("dsRNA" . SPARSER::RNA)
    ("PRKCB" . SPARSER::PROTEIN) ("Components" . SPARSER::COMPONENT)
    ("MAFB" . SPARSER::PROTEIN) ("TGFA" . SPARSER::PROTEIN)
    ("IFNs" . SPARSER::DRUG) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DQ" . SPARSER::MOLECULE) ("HLA-DQB1 or HLA-DRB1" . SPARSER::COLLECTION)
    ("HLA-DQB1 and HLA-DRB1" . SPARSER::COLLECTION) ("DR" . SPARSER::MOLECULE)
    ("HLA-DRB3 , DRB4 , and DRB5" . SPARSER::COLLECTION)
    ("DRB" . SPARSER::PROTEIN) ("DPB" . SPARSER::PROTEIN)
    ("allele and serotype" . SPARSER::COLLECTION)
    ("classical HLA" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("the classical HLA" . SPARSER::PROTEIN)
    ("ZNF184 and SNRPC" . SPARSER::COLLECTION) ("SNRPC" . SPARSER::PROTEIN)
    ("the classical HLA genes" . SPARSER::GENE)
    ("EDEM3 and LAMC1" . SPARSER::COLLECTION)
    ("EDEM3 , LAMC1 , and NCF2" . SPARSER::COLLECTION)
    ("SEC61G and EHF" . SPARSER::COLLECTION)
    ("at least two causal variants" . SPARSER::VARIANT)
    ("TNPO3 ( xref panel B) and rs4728142" . SPARSER::COLLECTION)
    ("IRF5/TNPO3" . SPARSER::COLLECTION)
    ("IRF5 and TNPO3" . SPARSER::COLLECTION)
    ("at least one relevant immune cell type" . TYPE)
    ("EHF and MED1" . SPARSER::COLLECTION)
    ("HLA alleles and serotypes" . SPARSER::COLLECTION)
    ("IMP" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("Systemic Lupus Erythematosus (SLE)" . SPARSER::PROTEIN)
    ("EHF , and MED1" . SPARSER::COLLECTION)
    ("RASSF2 and RNF114" . SPARSER::COLLECTION)
    ("BIN1 and SEC61G" . SPARSER::COLLECTION) ("EHF" . SPARSER::PROTEIN)
    ("HLA" . SPARSER::PROTEIN) ("lasso" . SPARSER::DRUG)
    ("Systemic Lupus Erythematosus" . SPARSER::PROTEIN)
    ("auto-antigens" . SPARSER::DRUG) ("ICAM1" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN) ("UBE2L3" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("IRAK1" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HLA-DRB1" . SPARSER::PROTEIN)
    ("HLA-DQB1" . SPARSER::PROTEIN) ("DQ2" . SPARSER::PROTEIN)
    ("HLADQB1" . SPARSER::PROTEIN) ("HLA-DQA1" . SPARSER::PROTEIN)
    ("HLA-DRB3" . SPARSER::PROTEIN) ("DQB1" . SPARSER::PROTEIN)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZNF184" . SPARSER::PROTEIN)
    ("LAMC1" . SPARSER::PROTEIN) ("EDEM3" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("NCF2" . SPARSER::PROTEIN)
    ("TYRO3" . SPARSER::PROTEIN) ("FAM98B" . SPARSER::PROTEIN)
    ("TNPO3" . SPARSER::PROTEIN) ("IRF5" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("SEC61G" . SPARSER::PROTEIN)
    ("BIN1" . SPARSER::PROTEIN) ("CNTN6" . SPARSER::PROTEIN)
    ("RNF114" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("MED1" . SPARSER::PROTEIN)
    ("recently described preleukemic HSCs" . SPARSER::PROTEIN)
    ("300 cancer-associated genes" . SPARSER::GENE)
    ("myeloid leukemic HSCs" . SPARSER::PROTEIN)
    ("T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Vemurafenib" . SPARSER::DRUG) ("PB" . SPARSER::PROTEIN)
    ("SRBCs" . SPARSER::PROTEIN)
    ("lymphoid and granulocyte/macrophage" . SPARSER::COLLECTION)
    ("methylcellulose-containing myeloid and erythroid cytokines [IL-3, IL-6, stem cell factor (SCF), and erythropoietin (EPO)] or the lymphopoietic cytokine IL-7"
     . SPARSER::COLLECTION)
    ("the lymphopoietic cytokine IL-7" . SPARSER::PROTEIN)
    ("EPO" . SPARSER::PROTEIN) ("erythropoietin" . SPARSER::PROTEIN)
    ("SCF" . SPARSER::PROTEIN) ("methylcellulose" . SPARSER::DRUG)
    ("LSK" . SPARSER::PROTEIN) ("sca-1" . SPARSER::PROTEIN)
    ("BRafV" . SPARSER::PROTEIN) ("Cd19-cre" . SPARSER::COLLECTION)
    ("betweenCre-ER" . SPARSER::COLLECTION) ("Cre-ER" . SPARSER::COLLECTION)
    ("Cd19" . SPARSER::PROTEIN)
    ("Mx1-cre , Vav-cre , and Cd19-cre transgenic mice" . SPARSER::COLLECTION)
    ("postnatal HSPCs" . SPARSER::PROTEIN) ("Vav-cre" . SPARSER::COLLECTION)
    ("Vav" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("lox-stop-lox" . SPARSER::COLLECTION) ("lox" . SPARSER::PROTEIN)
    ("immunophenotypic HSCs" . SPARSER::PROTEIN)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("MP and CD14" . SPARSER::COLLECTION)
    ("GMPs" . SPARSER::GMP) ("MPs" . SPARSER::PROTEIN) ("GMP" . SPARSER::GMP)
    ("CD10, CD19, CD103, and CD11c" . SPARSER::COLLECTION)
    ("fluorochromes" . SPARSER::MOLECULE) ("MP" . SPARSER::PROTEIN)
    ("BRAFV" . SPARSER::PROTEIN) ("CD103 and CD11c" . SPARSER::COLLECTION)
    ("aberrant HSCs" . SPARSER::PROTEIN)
    ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("erythroid" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("increased circulating soluble CD25" . SPARSER::PROTEIN)
    ("HSPCs" . SPARSER::PROTEIN) ("BRaf" . SPARSER::PROTEIN)
    ("HSPC" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("interferon-α" . SPARSER::DRUG) ("DNMT3A" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("Flk2" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("stem cell factor" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("PLX4720" . SPARSER::DRUG)
    ("sCD25" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("CD123" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("CD45RA" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("CD34" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("CD103" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("lysine and arginine" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("thyroid" . SPARSER::PROTEIN)
    ("a homozygous state" . SPARSER::BIO-STATE) ("HG" . SPARSER::MOLECULE)
    ("Normally both cytosolic IDH1 and mitochondrial IDH2"
     . SPARSER::COLLECTION)
    ("mitochondrial IDH2" . SPARSER::PROTEIN)
    ("Normally both cytosolic IDH1" . SPARSER::PROTEIN)
    ("homodimers" . SPARSER::HOMODIMER)
    ("IDH1, IDH2, and TP53" . SPARSER::COLLECTION)
    ("the favourable type" . TYPE) ("homozygous IDH1" . SPARSER::PROTEIN)
    ("GO" . SPARSER::PROTEIN) ("homozygous state" . SPARSER::BIO-STATE)
    ("histidine" . SPARSER::AMINO-ACID) ("ST2" . SPARSER::PROTEIN)
    ("IDH1, IDH2 , and TP53" . SPARSER::COLLECTION)
    ("glial" . SPARSER::PROTEIN)
    ("IDH1 , IDH2 , IDH3A , IDH3B , and IDH3G" . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("Isocitrate" . SPARSER::DRUG)
    ("IDH1 , IDH2 , and TP53" . SPARSER::COLLECTION)
    ("isocitrate" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("SF1" . SPARSER::PROTEIN) ("IDH3" . SPARSER::PROTEIN)
    ("NADP+" . SPARSER::MOLECULE) ("IDH3G" . SPARSER::PROTEIN)
    ("IDH3B" . SPARSER::PROTEIN) ("IDH3A" . SPARSER::PROTEIN)
    ("α -ketoglutarate" . SPARSER::MOLECULE)
    ("connexin and COX-2" . SPARSER::COLLECTION)
    ("MAPK or other kinases" . SPARSER::COLLECTION)
    ("structural proteins and other molecules ( xref )" . SPARSER::COLLECTION)
    ("other junctional proteins, enzymes, structural proteins and other molecules ( xref )"
     . SPARSER::COLLECTION)
    ("other junctional proteins" . SPARSER::PROTEIN)
    ("Connexins" . SPARSER::PROTEIN) ("aconitase" . SPARSER::PROTEIN)
    ("namely p38 MAPK and NF- κ B" . SPARSER::COLLECTION)
    ("cAMP and cGMP" . SPARSER::COLLECTION) ("p-NF- κ B" . SPARSER::COLLECTION)
    ("MAPK and NF- κ B" . SPARSER::COLLECTION)
    ("Cx26-MLTK" . SPARSER::COLLECTION) ("MLTK" . SPARSER::PROTEIN)
    ("COX-2 and gap" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase kinase kinase (MAPKKK)"
     . SPARSER::PROTEIN)
    ("normal COX-2" . SPARSER::PROTEIN) ("Calcein" . SPARSER::MOLECULE)
    ("CMTMR" . SPARSER::DRUG)
    ("the gap junction inhibitor AGA or the hemi-channel inhibitor La 3+ ( xref )"
     . SPARSER::COLLECTION)
    ("AGA" . SPARSER::PROTEIN) ("functional Cx26" . SPARSER::PROTEIN)
    ("sham" . SPARSER::DRUG) ("AG" . SPARSER::PROTEIN)
    ("Cx26 or Cx32" . SPARSER::COLLECTION)
    ("Cx32 or Cx26" . SPARSER::COLLECTION)
    ("COX-2 and Cx" . SPARSER::COLLECTION) ("-NF- κ B" . SPARSER::COLLECTION)
    ("IKK" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("ions" . SPARSER::MOLECULE) ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("RIBE" . SPARSER::PROTEIN)
    ("COX-2 and connexin" . SPARSER::COLLECTION) ("MAPKKK" . SPARSER::PROTEIN)
    ("connexin" . SPARSER::PROTEIN-FAMILY)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cx" . SPARSER::PROTEIN-FAMILY)
    ("connexins and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("connexins" . SPARSER::PROTEIN) ("p- p38" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("Cx43" . SPARSER::PROTEIN) ("connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NS-398" . SPARSER::DRUG) ("NF- κ B" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("Cx32" . SPARSER::PROTEIN)
    ("connexin32" . SPARSER::PROTEIN) ("Cx26" . SPARSER::PROTEIN)
    ("connexin26" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("immediate p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-" . SPARSER::PROTEIN)
    ("immediate direct p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("targets or p53" . SPARSER::COLLECTION)
    ("CDKN1A and miR-34a" . SPARSER::COLLECTION)
    ("the ‘repressed’ genes identified E2F4, RB and CDKN1A"
     . SPARSER::COLLECTION)
    ("E2F4, RB and CDKN1A" . SPARSER::COLLECTION)
    ("these novel genes ( xref ), which shows" . SPARSER::GENE)
    ("GRIN2C, PTCHD4 and RINL" . SPARSER::COLLECTION)
    ("GDF15 (a ‘basally activated’ gene) and PTP4A1 (a ‘basally repressed’ gene)"
     . SPARSER::COLLECTION)
    ("genotoxic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mature mRNA" . SPARSER::PROTEIN) ("Pol" . SPARSER::PROTEIN)
    ("p53 and/or MDM2" . SPARSER::COLLECTION) ("nutlin" . SPARSER::DRUG)
    ("some very valuable components" . SPARSER::COMPONENT)
    ("the editorial decision letter and author response" . SPARSER::COLLECTION)
    ("the editorial decision letter" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE) ("TNF" . SPARSER::PROTEIN)
    ("Nutlin or DNA damaging agents ( xref )" . SPARSER::COLLECTION)
    ("proliferating cells MDM2" . SPARSER::PROTEIN)
    ("TBP and TFIIE" . SPARSER::COLLECTION) ("TFIIE" . SPARSER::PROTEIN-FAMILY)
    ("TBP" . SPARSER::PROTEIN) ("Complex (PIC)" . SPARSER::BIO-COMPLEX)
    ("PIC" . SPARSER::BIO-COMPLEX)
    ("E2F4, p21, RB and miR-34a" . SPARSER::COLLECTION)
    ("only four repressed genes" . SPARSER::GENE)
    ("E2F4 repressive complexes" . SPARSER::BIO-COMPLEX)
    ("very few genes" . SPARSER::GENE)
    ("direct p53 target genes and those genes" . SPARSER::COLLECTION)
    ("the long intragenic ncRNA" . SPARSER::RNA) ("−1" . SPARSER::PROTEIN)
    ("A typical example" . SPARSER::EXAMPLE)
    ("the pro-apoptotic TRAIL receptors DR4 ( TNFRSF10A) and DR5/Killer ( TNFRSF10B )"
     . SPARSER::COLLECTION)
    ("the counteracting decoy receptors DCR1 ( TNFRSF10C) and DCR2 ( TNFRSF10D )"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic TRAIL receptors DR4" . SPARSER::PROTEIN)
    ("TRAIL" . SPARSER::PROTEIN)
    ("a bidirectional overlapping promoter" . SPARSER::PROMOTER)
    ("a non-overlapping bidirectional promoter" . SPARSER::PROMOTER)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("CDKN1A or DDB2" . SPARSER::COLLECTION)
    ("widespread divergent transcription at most active promoters"
     . SPARSER::PROMOTER)
    ("POLH" . SPARSER::PROTEIN) ("secondary response genes" . SPARSER::GENE)
    ("TP53I3 , TNFRSF10B , BBC3 and FAS" . SPARSER::COLLECTION)
    ("TP53I3 , PHLDA3 and FAS" . SPARSER::COLLECTION)
    ("CDKN1A and most pro-survival genes" . SPARSER::COLLECTION)
    ("the pro-apoptotic genes TRAF4 and AEN" . SPARSER::COLLECTION)
    ("TRAF4 and AEN" . SPARSER::COLLECTION) ("AEN" . SPARSER::PROTEIN)
    ("most pro-apoptotic genes" . SPARSER::GENE) ("classes" . CLASS)
    ("TP53I3 and FAS" . SPARSER::COLLECTION) ("FAS" . SPARSER::PROTEIN)
    ("PUMA" . SPARSER::PROTEIN)
    ("CDKN1A , GDF15 , BTG2 and MDM2" . SPARSER::COLLECTION)
    ("GSEA" . SPARSER::PROTEIN)
    ("CDKN1A , DDB2 and GDF15" . SPARSER::COLLECTION)
    ("PTP4A1 and HES2" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("MDM2-p53" . SPARSER::COLLECTION)
    ("GDF15 and PTP4A1" . SPARSER::COLLECTION)
    ("ADAMTS7 , TOB1 , ASS1 and CEP85L" . SPARSER::COLLECTION)
    ("CDC42BPG and LRP1" . SPARSER::COLLECTION)
    ("CDC42BPG , ADAMTS7 and LRP1" . SPARSER::COLLECTION)
    ("PTP4A1 and CCNG1" . SPARSER::COLLECTION)
    ("MDM2 , PTP4A1 , AMZ2 and CCNG1" . SPARSER::COLLECTION)
    ("robust p53 target genes" . SPARSER::GENE)
    ("CDKN1A and GDF15" . SPARSER::COLLECTION)
    ("CDKN1A (p=8.21e−62) and RB (p=8.12e−60)" . SPARSER::COLLECTION)
    ("E2F4 (p=1.02e−81, Fisher's Exact Test), CDKN1A (p=8.21e−62) and RB (p=8.12e−60)"
     . SPARSER::COLLECTION)
    ("p21 and E2F4" . SPARSER::COLLECTION) ("whose mRNAs" . SPARSER::PROTEIN)
    ("p53-MDM2" . SPARSER::COLLECTION) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("cellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GRIN2C, PTCDH4 and RINL" . SPARSER::COLLECTION)
    ("RINL" . SPARSER::PROTEIN) ("RELB" . SPARSER::PROTEIN)
    ("FLVCR" . SPARSER::PROTEIN) ("p53 or p21 protein" . SPARSER::COLLECTION)
    ("CDKN1A and TP53I3" . SPARSER::COLLECTION)
    ("CDKN1A ( p21 ) and TP53I3 ( PIG3 )" . SPARSER::COLLECTION)
    ("Typical GRO-seq" . SPARSER::COLLECTION)
    ("novel p53-regulated RNAs as well as gene-specific regulatory events"
     . SPARSER::COLLECTION)
    ("bidirectional promoters" . SPARSER::PROMOTER)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nutlin" . SPARSER::DRUG)
    ("seq" . SPARSER::PROTEIN) ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("p53 and its repressors" . SPARSER::COLLECTION)
    ("MDM2/MDM4" . SPARSER::COLLECTION) ("p53/MDM2/MDM4" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("masks" . SPARSER::PROTEIN)
    ("MDM2 and MDM4" . SPARSER::COLLECTION)
    ("Nearly 200 genes" . SPARSER::GENE)
    ("many uncharacterized p53 target genes and unexpected regulatory mechanisms"
     . SPARSER::COLLECTION)
    ("GRO-seq" . SPARSER::COLLECTION) ("GRO" . SPARSER::PROTEIN)
    ("Run" . SPARSER::PROTEIN-FAMILY) ("PTCHD4" . SPARSER::PROTEIN)
    ("D-7" . SPARSER::PROTEIN) ("Nutlin-3 as" . SPARSER::DRUG)
    ("C-15" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("S10" . SPARSER::PROTEIN) ("U20" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("t -v" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN) ("MnCl2" . SPARSER::DRUG)
    ("Exonuclease I" . SPARSER::PROTEIN) ("P-30" . SPARSER::PROTEIN)
    ("GAL4" . SPARSER::PROTEIN) ("e−12" . SPARSER::PROTEIN)
    ("pre-mRNAs" . SPARSER::RNA) ("DDIT4" . SPARSER::PROTEIN)
    ("MED12L" . SPARSER::PROTEIN) ("GPR87" . SPARSER::PROTEIN)
    ("TNFRSF10D" . SPARSER::PROTEIN) ("DCR2" . SPARSER::PROTEIN)
    ("TNFRSF10C" . SPARSER::PROTEIN) ("DCR1" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("TNFRSF10A" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("DRAM1" . SPARSER::PROTEIN)
    ("TNFRSF10B" . SPARSER::PROTEIN) ("PHLDA3" . SPARSER::PROTEIN)
    ("TRAF4" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("S2P" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("RBP1" . SPARSER::PROTEIN)
    ("Serine 2" . SPARSER::PROTEIN) ("GJB5" . SPARSER::PROTEIN)
    ("HES2" . SPARSER::PROTEIN) ("DDB2" . SPARSER::PROTEIN)
    ("ASS1" . SPARSER::PROTEIN) ("TOB1" . SPARSER::PROTEIN)
    ("LRP1" . SPARSER::PROTEIN) ("ADAMTS7" . SPARSER::PROTEIN)
    ("CDC42BPG" . SPARSER::PROTEIN) ("CCNG1" . SPARSER::PROTEIN)
    ("PTP4A1" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("BLIMP1" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("GRIN2C" . SPARSER::PROTEIN)
    ("EGR1" . SPARSER::PROTEIN) ("NR4A3" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("TP53I3" . SPARSER::PROTEIN) ("Nutlin-3a" . SPARSER::DRUG)
    ("ligase activity" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("innovative drugs" . SPARSER::DRUG)
    ("IDH1 and IDH2" . SPARSER::COLLECTION)
    ("ARID1A , BAP1 , and PBRM1" . SPARSER::COLLECTION)
    ("TGFBR2 and SMAD4" . SPARSER::COLLECTION)
    ("mTor and its downstream effectors" . SPARSER::COLLECTION)
    ("mTor" . SPARSER::PROTEIN) ("particular KRAS" . SPARSER::PROTEIN)
    ("receptors (TKR)" . SPARSER::RECEPTOR)
    ("mTOR, and TGF-" . SPARSER::COLLECTION)
    ("RAS/RAF/MAPK/ERK" . SPARSER::COLLECTION) ("TKR" . SPARSER::PROTEIN)
    ("novel MAPK/ERK Kinase (MEK) and mTOR inhibitors [ xref ]"
     . SPARSER::COLLECTION)
    ("Kinase (MEK)" . SPARSER::KINASE) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("cisplatin and gemcitabine" . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG)
    ("ARID1A , PBRM1 and BAP1" . SPARSER::COLLECTION)
    ("KRAS and TP53" . SPARSER::COLLECTION) ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("sharp" . SPARSER::PROTEIN) ("ph-4EBP1" . SPARSER::COLLECTION)
    ("ph-mTOR" . SPARSER::COLLECTION)
    ("mTOR and its effectors p70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("p70S6K and 4EBP1" . SPARSER::COLLECTION) ("Egfr" . SPARSER::PROTEIN)
    ("PIK3CA (7.7%) and PTEN (3.8%)" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN) ("ECCs" . SPARSER::MOLECULE)
    ("SMAD4 , and STK11" . SPARSER::COLLECTION)
    ("KDR/VEGFR2" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("BAP1 and IDH1" . SPARSER::COLLECTION)
    ("BAP1 (14.3%) and ARID1A (11.4%)" . SPARSER::COLLECTION)
    ("KRAS ( p =0.0019) and TP53 ( p =0.0019)" . SPARSER::COLLECTION)
    ("BRAF , KRAS , and TP53" . SPARSER::COLLECTION)
    ("IDH1/IDH2" . SPARSER::COLLECTION) ("cirrhosis" . SPARSER::PROTEIN)
    ("BAP1 , ARID1A and PBRM1" . SPARSER::COLLECTION)
    ("PIK3CA , PTEN , AKT1 , IDH1 and IDH2" . SPARSER::COLLECTION)
    ("KRAS , TP53 , CDKN2A and SMAD4" . SPARSER::COLLECTION)
    ("substance" . SPARSER::SUBSTANCE) ("ß/Smad" . SPARSER::COLLECTION)
    ("TGF-" . SPARSER::DRUG) ("KRAS/NRAS/BRAF" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF" . SPARSER::DRUG)
    ("KRAS (p=0.0019) and TP53 (p=0.0019)" . SPARSER::COLLECTION)
    ("At least one mutated gene" . SPARSER::GENE)
    ("EGFR and mTOR" . SPARSER::COLLECTION) ("ECC" . SPARSER::MOLECULE)
    ("1A" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("HNF1A" . SPARSER::PROTEIN) ("GNA11" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE) ("ph-p" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("TGFBR2" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("PIK3C2G" . SPARSER::PROTEIN) ("PIK3C2A" . SPARSER::PROTEIN)
    ("E −12" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("SMARCB1" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN) ("cis- or trans-" . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY) ("cis-" . SPARSER::PROTEIN)
    ("cis" . SPARSER::PROTEIN)
    ("the high-risk northwestern part" . SPARSER::COMPONENT)
    ("35 GCAs and 52 GNCAs (  xref  )" . SPARSER::COLLECTION)
    ("intestinal type" . TYPE) ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antigen-antibody" . SPARSER::COLLECTION) ("LV" . SPARSER::MOLECULE)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("xylene" . SPARSER::MOLECULE)
    ("GCAs" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("PSA" . SPARSER::PROTEIN)
    ("both formalin- and ethanol-fixed tissues" . SPARSER::COLLECTION)
    ("formalin-" . SPARSER::MOLECULE) ("ethanol-" . SPARSER::PROTEIN)
    ("70% ethanol (for GC cases, all tumor tissues were fixed in ethanol; for ESCC, 41 of 275 ESCC cases with paired tumor-normal tissues analyzed in relation to survival, and 249 of 489 cases with tumor tissue only analyzed in relation to survival were fixed in ethanol) or 10% neutral buffered formalin (all other ESCC tumor or normal tissues)"
     . SPARSER::COLLECTION)
    ("10% neutral buffered formalin" . SPARSER::MOLECULE)
    ("ethanol" . SPARSER::PROTEIN) ("streptavidin" . SPARSER::PROTEIN)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY) ("Trizol" . SPARSER::DRUG)
    ("nitrogen" . SPARSER::MOLECULE) ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Ras and Rho family GTPases and heterotrimeric G proteins"
     . SPARSER::COLLECTION)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("Ras and Rho family" . SPARSER::COLLECTION)
    ("second messenger inositol 1,4,5-triphosphate and the protein kinase C-activating second messenger diacylglycerol"
     . SPARSER::COLLECTION)
    ("diacylglycerol" . SPARSER::PROTEIN) ("epsilon" . SPARSER::PROTEIN)
    ("the predominant form" . SPARSER::FORM)
    ("two primary histologic types" . TYPE)
    ("GCA and GNCA" . SPARSER::COLLECTION)
    ("GCA (n=298) and GNCA (n=124)" . SPARSER::COLLECTION)
    ("GCA" . SPARSER::PROTEIN) ("PLCE 1" . SPARSER::PROTEIN)
    ("CS4" . SPARSER::PROTEIN) ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("Ca2 +" . SPARSER::CALCIUM-ION)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("phospholipase C" . SPARSER::PROTEIN) ("PLCE1" . SPARSER::PROTEIN)
    ("medicine" . SPARSER::DRUG) ("IIIB" . SPARSER::DRUG)
    ("acral-lentiginous type" . TYPE) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("NRA" . SPARSER::PROTEIN) ("BRAF , NRAS , and KIT" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION) ("MUPs" . SPARSER::PROTEIN)
    ("BRAF or NRAS" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("PI3K and PARP" . SPARSER::COLLECTION)
    ("Olaparib or BKM120" . SPARSER::COLLECTION) ("AP" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("the dual PI3K inhibitor BKM-120" . SPARSER::DRUG)
    ("dominant-negative p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LnCap" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("DLP" . SPARSER::PROTEIN) ("Probasin-Cre" . SPARSER::COLLECTION)
    ("Cre" . SPARSER::PROTEIN) ("Probasin" . SPARSER::PROTEIN)
    ("increased DNA-damage" . SPARSER::DNA) ("DNA-damage" . SPARSER::DNA)
    ("Blot" . SPARSER::PROTEIN) ("Olaparib" . SPARSER::DRUG)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("ADP" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("at least one allele" . SPARSER::ALLELE)
    ("PARP and PI3K" . SPARSER::COLLECTION) ("Pten/p53" . SPARSER::COLLECTION)
    ("Pten" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("β-Gal" . SPARSER::PROTEIN) ("BKM120" . SPARSER::DRUG)
    ("BKM-120" . SPARSER::DRUG) ("Akt1" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("Nrf2-antioxidant" . SPARSER::COLLECTION)
    ("cellular miRs" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("a miR153 and its target" . SPARSER::COLLECTION)
    ("neurotoxin" . SPARSER::PROTEIN) ("Drosha" . SPARSER::PROTEIN)
    ("the mature miR153" . SPARSER::PROTEIN)
    ("SNAP25 and SNCA" . SPARSER::COLLECTION) ("SNCA" . SPARSER::PROTEIN)
    ("redox and non-redox" . SPARSER::COLLECTION)
    ("a critical cytoprotective gene" . SPARSER::GENE)
    ("fix" . SPARSER::PROTEIN) ("RISC" . SPARSER::PROTEIN)
    ("a pivotal molecule" . SPARSER::MOLECULE)
    ("Nrf2 and its antioxidant" . SPARSER::COLLECTION)
    ("cellular H 2 O 2" . SPARSER::DRUG)
    ("PQ and H 2 O 2" . SPARSER::COLLECTION) ("Catalase" . SPARSER::PROTEIN)
    ("Nrf2-redox" . SPARSER::COLLECTION)
    ("the subsequent H 2 O 2 -dependent miR153" . SPARSER::PROTEIN)
    ("caspase 3 and caspase 7" . SPARSER::COLLECTION)
    ("glo" . SPARSER::PROTEIN) ("DCF" . SPARSER::PROTEIN)
    ("gal" . SPARSER::PROTEIN) ("GSSG" . SPARSER::DRUG) ("GSH" . SPARSER::DRUG)
    ("the basal miR153" . SPARSER::PROTEIN)
    ("the actual cellular ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("anti-miR or anti-miR153" . SPARSER::COLLECTION)
    ("PQ or H 2 O 2" . SPARSER::COLLECTION)
    ("specific anti-miR" . SPARSER::ANTIBODY)
    ("directly target Nrf2" . SPARSER::PROTEIN)
    ("antisense-miR" . SPARSER::COLLECTION)
    ("antisense-miR153" . SPARSER::COLLECTION) ("antisense" . SPARSER::PROTEIN)
    ("an artificial WT Nrf2" . SPARSER::PROTEIN)
    ("miR153 directly targets Nrf2" . SPARSER::PROTEIN)
    ("ROS ( xref ) and H 2 O 2" . SPARSER::COLLECTION)
    ("miR:mRNA" . SPARSER::BIO-COMPLEX) ("NQO1 and GCLC" . SPARSER::COLLECTION)
    ("both ∼100 kDA and 68 kDA" . SPARSER::COLLECTION)
    ("lamin" . SPARSER::PROTEIN) ("actin-Nrf2" . SPARSER::COLLECTION)
    ("dimer" . SPARSER::DIMER)
    ("its actual predicted molecular weight 68 kDA" . SPARSER::PROTEIN)
    ("kDA" . SPARSER::PROTEIN) ("miR153/Nrf2" . SPARSER::COLLECTION)
    ("dopaminergic toxin" . SPARSER::MOLECULE) ("toxin" . SPARSER::MOLECULE)
    ("basal Nrf2" . SPARSER::PROTEIN)
    ("miR144, miR153, miR27a and miR142-5p" . SPARSER::COLLECTION)
    ("miR153" . SPARSER::PROTEIN) ("microRNA's" . SPARSER::RNA)
    ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("the subsequent conformational change untethers Nrf2" . SPARSER::PROTEIN)
    ("cysteine" . SPARSER::AMINO-ACID) ("Keap-1-Cul3" . SPARSER::PROTEIN-PAIR)
    ("cytoprotective genes" . SPARSER::GENE)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("reactive oxygen species (ROS) mainly harmful H 2 O 2 and hydroxyl radical"
     . SPARSER::COLLECTION)
    ("H 2 O 2 and hydroxyl radical" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("its structural homology" . SPARSER::PROTEIN)
    ("barrier (BBB)" . SPARSER::PROTEIN) ("PQ" . SPARSER::MOLECULE)
    ("striatum" . SPARSER::PROTEIN)
    ("agricultural chemicals" . SPARSER::MOLECULE)
    ("dopamine" . SPARSER::PROTEIN)
    ("these environmental toxins" . SPARSER::MOLECULE)
    ("pesticides" . SPARSER::MOLECULE) ("miR153-Nrf2" . SPARSER::COLLECTION)
    ("oxidant" . SPARSER::PROTEIN) ("cCAT" . SPARSER::PROTEIN)
    ("GCLC and NQO1" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("redox" . SPARSER::PROTEIN) ("glutathione" . SPARSER::DRUG)
    ("miRs" . SPARSER::PROTEIN) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("environmental toxins" . SPARSER::MOLECULE)
    ("paraquat" . SPARSER::MOLECULE) ("SNAP25" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("caspase 7" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("caspases-3" . SPARSER::PROTEIN) ("green fluorescent" . SPARSER::PROTEIN)
    ("DCF-DA" . SPARSER::DRUG) ("small nuclear RNA" . SPARSER::RNA)
    ("dual-luciferase" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("Keap-1" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid-2 related factor 2" . SPARSER::PROTEIN)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("caspase 3" . SPARSER::PROTEIN)
    ("substances" . SPARSER::SUBSTANCE)
    ("tobacco and alcohol" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("UK, USA, Canada, and Australia" . SPARSER::COLLECTION)
    ("UK" . SPARSER::PROTEIN)
    ("acute-phase response factor (APRF)" . SPARSER::PROTEIN)
    ("APRF" . SPARSER::PROTEIN)
    ("IL-1, IL-6, IL-12, and TNF- α" . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("STAT3 and GC" . SPARSER::COLLECTION) ("CagA" . SPARSER::PROTEIN)
    ("IL-6, TNF- α , and VEGF" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("STAT" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("Janus" . SPARSER::PROTEIN-FAMILY) ("GC" . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN)
    ("activator of transcription protein 3 ( STAT3 ) and the risk"
     . SPARSER::COLLECTION)
    ("free-radical" . SPARSER::MOLECULE)
    ("acute-phase response factor" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("therapeutics" . SPARSER::THERAPEUTICS)
    ("the WT-ANXA7-induced PCD and G1-arrest" . SPARSER::COLLECTION)
    ("PCD and G1-arrest" . SPARSER::COLLECTION)
    ("inositol-1" . SPARSER::COLLECTION) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("inositol" . SPARSER::PROTEIN) ("annexin" . SPARSER::PROTEIN)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("the aberrant SGK1" . SPARSER::PROTEIN)
    ("p53 and WT-ANXA7" . SPARSER::COLLECTION)
    ("the exon11-lacking aberrant SGK1" . SPARSER::PROTEIN)
    ("the longer splice variants" . SPARSER::VARIANT)
    ("p53 and ANXA7" . SPARSER::COLLECTION)
    ("exporting FOXO3A" . SPARSER::PROTEIN)
    ("ANXA7 and p53" . SPARSER::COLLECTION) ("kDa-SGK1" . SPARSER::COLLECTION)
    ("a smaller extra-LMW-SGK1 protein form" . SPARSER::FORM)
    ("LMW" . SPARSER::PROTEIN)
    ("parental LNCaP and DU145" . SPARSER::COLLECTION)
    ("LNCaP and DU145" . SPARSER::COLLECTION)
    ("FOXO3A-S318" . SPARSER::PROTEIN-PAIR) ("LMW-SGK1" . SPARSER::COLLECTION)
    ("p53 and DN- (but not WT-) ANXA7" . SPARSER::COLLECTION)
    ("FOXO3A-Ser318/321" . SPARSER::PROTEIN-PAIR)
    ("RB-E2F" . SPARSER::COLLECTION) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("AnnexinV" . SPARSER::PROTEIN) ("BRDU" . SPARSER::DRUG)
    ("APO" . SPARSER::PROTEIN)
    ("the p53-responsive prosurvival SGK1" . SPARSER::PROTEIN)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen receptor-" . SPARSER::PROTEIN)
    ("the SGK1-inducing GR [ xref ] and TGF-beta [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN) ("p53 and FOXO3A" . SPARSER::COLLECTION)
    ("FOXO3A/FKHRL1" . SPARSER::COLLECTION)
    ("The RB-associated ANXA7" . SPARSER::PROTEIN) ("RB" . SPARSER::PROTEIN)
    ("NP" . SPARSER::PROTEIN) ("TSG" . SPARSER::PROTEIN)
    ("aberrant SGK1" . SPARSER::PROTEIN)
    ("SGK1-FOXO3A-Akt" . SPARSER::COLLECTION) ("PCD" . SPARSER::PROTEIN)
    ("SGK1 and FOXO3A" . SPARSER::COLLECTION) ("androgen" . SPARSER::PROTEIN)
    ("Anxa7" . SPARSER::PROTEIN) ("Annexin" . SPARSER::PROTEIN)
    ("ITPR3" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("S318" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("beta-actin" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("serum/glucocorticoid regulated kinase 1" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("ANXA7" . SPARSER::PROTEIN)
    ("glycine" . SPARSER::AMINO-ACID)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoinositide 3-kinase/AKT" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION) ("RFS" . SPARSER::PROTEIN)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("Ample growth factors" . SPARSER::GROWTH-FACTOR)
    ("MET" . SPARSER::PROTEIN)
    ("c-MET, KRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("primary CRC" . SPARSER::PROTEIN)
    ("KRAS , BRAF and PIK3CA" . SPARSER::COLLECTION) ("CC1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("TLR4 and NF-κB" . SPARSER::COLLECTION)
    ("interferon-γ and human leukocyte antigens (HLAs)" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN) ("CIS" . SPARSER::PROTEIN)
    ("anti-Ctrl or anti-" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("Western blot" . SPARSER::PROTEIN)
    ("Sirtuin 1 or NAD-dependent deacetylase sirtuin-1" . SPARSER::COLLECTION)
    ("TLR/NF-κB" . SPARSER::COLLECTION) ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("miRNAs" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("mask" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("Northern blot" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("IκBα" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("let7" . SPARSER::RNA)
    ("a 15" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("miR-200a" . SPARSER::MOLECULE) ("p65" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA)
    ("NAD-dependent deacetylase sirtuin-1" . SPARSER::PROTEIN)
    ("GM-CSF and M-CSF" . SPARSER::COLLECTION) ("IFN" . SPARSER::DRUG)
    ("CD16-monocytes" . SPARSER::COLLECTION)
    ("soluble Wnt ligands" . SPARSER::LIGAND) ("ligands" . SPARSER::LIGAND)
    ("viral DNA" . SPARSER::DNA) ("Vif" . SPARSER::PROTEIN)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral proteins" . SPARSER::PROTEIN)
    ("β-catenin and the NF-κB inhibitor IκB" . SPARSER::COLLECTION)
    ("an HIV-1 auxiliary protein" . SPARSER::PROTEIN)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("Vpu" . SPARSER::PROTEIN)
    ("β-catenin and E-cadherins" . SPARSER::COLLECTION)
    ("TCF-4, β-catenin, and SMAR-1" . SPARSER::COLLECTION)
    ("SMADH-1" . SPARSER::COLLECTION) ("SAM" . SPARSER::MOLECULE)
    ("APOBEC" . SPARSER::BIO-COMPLEX) ("MDM" . SPARSER::PROTEIN)
    ("GM-CSF or M-CSF" . SPARSER::COLLECTION)
    ("1 mM LiCl or left" . SPARSER::COLLECTION) ("env" . SPARSER::PROTEIN)
    ("pol" . SPARSER::PROTEIN) ("protein (GFP)" . SPARSER::PROTEIN)
    ("Monocytes and MDMs" . SPARSER::COLLECTION) ("FOP" . SPARSER::PROTEIN)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LiCl" . SPARSER::DRUG)
    ("monocytes and MDMs" . SPARSER::COLLECTION)
    ("a transcriptional co-factor" . SPARSER::MOLECULE)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("TCF" . SPARSER::PROTEIN) ("LRP" . SPARSER::PROTEIN)
    ("19 identified soluble secreted Wnts and at least 10 frizzled receptors"
     . SPARSER::COLLECTION)
    ("at least 10 frizzled receptors" . SPARSER::RECEPTOR)
    ("19 identified soluble secreted Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thymine" . SPARSER::MOLECULE)
    ("cyclin T1 and NFAT5" . SPARSER::COLLECTION) ("dTTP" . SPARSER::MOLECULE)
    ("deoxythymidine" . SPARSER::MOLECULE) ("CCR5/CXCR4" . SPARSER::COLLECTION)
    ("CD4/co-receptor" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("receptor and CCR5" . SPARSER::COLLECTION)
    ("IL-4, IL-13, or M-CSF" . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("β-catenin/TCF-4" . SPARSER::COLLECTION) ("MDMs" . SPARSER::PROTEIN)
    ("monocytes" . SPARSER::PROTEIN) ("Monocytes" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("NFκB" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("ubiquitin ligase" . SPARSER::PROTEIN)
    ("E3" . SPARSER::MOLECULE) ("Cdc53" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("SAMHD1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK3β" . SPARSER::PROTEIN) ("lithium chloride" . SPARSER::DRUG)
    ("FSC-H" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD86" . SPARSER::PROTEIN) ("CD80" . SPARSER::PROTEIN)
    ("CD16" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("Thymidine Kinase" . SPARSER::PROTEIN) ("Antigen-1" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN) ("colony stimulating factor" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony stimulating factor" . SPARSER::PROTEIN)
    ("E-cadherins" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN) ("NFAT5" . SPARSER::PROTEIN)
    ("cyclin T1" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("IL-13" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("M-1" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("TCF-4" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE) ("FGFRs" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the less common histological subtypes" . SPARSER::PROTEIN)
    ("the more rare histological variants" . SPARSER::VARIANT)
    ("The histological subtypes" . SPARSER::PROTEIN)
    ("male and 6 female" . SPARSER::COLLECTION)
    ("fibroblastic growth factor receptor 1" . SPARSER::PROTEIN)
    ("PI3/Akt" . SPARSER::COLLECTION)
    ("Ras/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("p12" . SPARSER::PROTEIN) ("all histological variants" . SPARSER::VARIANT)
    ("Neo" . SPARSER::PROTEIN) ("the histological variants" . SPARSER::VARIANT)
    ("the rarer histological variants" . SPARSER::VARIANT)
    ("S2" . SPARSER::MOLECULE) ("c-MYC" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("ADMA" . SPARSER::MOLECULE)
    ("radical" . SPARSER::MOLECULE)
    ("the cell membrane-associated eNOS" . SPARSER::PROTEIN)
    ("Leucyl-tRNA" . SPARSER::COLLECTION) ("tRNA" . SPARSER::PROTEIN)
    ("S6K1 or Arg-II" . SPARSER::COLLECTION)
    ("S6K1 and Arg-II" . SPARSER::COLLECTION) ("HEK" . SPARSER::PROTEIN)
    ("vascular stiffness and left ventricular ejection fraction"
     . SPARSER::COMPONENT)
    ("the vasoprotective molecule" . SPARSER::MOLECULE)
    ("DA" . SPARSER::MOLECULE) ("DHE" . SPARSER::DRUG)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("U6-shRNA" . SPARSER::PROTEIN-PAIR) ("mTORC1/S6K1" . SPARSER::COLLECTION)
    ("eNOS, VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)"
     . SPARSER::COLLECTION)
    ("nutritional components" . SPARSER::COMPONENT)
    ("Leucyl-tRNA synthetase-Rag" . SPARSER::COLLECTION)
    ("Rag" . SPARSER::PROTEIN)
    ("the important vasoprotective molecule nitric oxide (NO)"
     . SPARSER::MOLECULE)
    ("nitric oxide (NO)" . SPARSER::MOLECULE)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("a semi-essential amino acid" . SPARSER::AMINO-ACID)
    ("S6K1 and arginase-II" . SPARSER::COLLECTION)
    ("S6K1 or arginase-II" . SPARSER::COLLECTION)
    ("senescence-associated beta-galactosidase" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1 and intercellular adhesion molecule-1"
     . SPARSER::COLLECTION)
    ("mTORC1-S6K1" . SPARSER::COLLECTION) ("arginase" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("sodium chloride" . SPARSER::DRUG)
    ("Arginase activity" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("X-gal" . SPARSER::MOLECULE) ("K1" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("L-ornithine" . SPARSER::DRUG)
    ("DAF-2" . SPARSER::PROTEIN) ("L-NAME" . SPARSER::MOLECULE)
    ("superoxide anion" . SPARSER::MOLECULE) ("VCAM-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("Leucyl-tRNA synthetase" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE)
    ("protein and mRNA" . SPARSER::COLLECTION) ("HBx" . SPARSER::PROTEIN)
    ("suppressors" . SPARSER::SUPPRESSOR) ("TACE" . SPARSER::PROTEIN)
    ("pg" . SPARSER::MOLECULE) ("diagnostic biomarkers" . SPARSER::MOLECULE)
    ("TAZ ( P = 0.722, xref ) or AREG ( P = 0.583, xref )"
     . SPARSER::COLLECTION)
    ("TAZ and AREG" . SPARSER::COLLECTION) ("sera" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ)"
     . SPARSER::COLLECTION)
    ("Yki" . SPARSER::PROTEIN) ("a serological biomarker" . SPARSER::MOLECULE)
    ("AFP" . SPARSER::PROTEIN) ("AREG" . SPARSER::PROTEIN)
    ("Amphiregulin" . SPARSER::PROTEIN)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("TAZ" . SPARSER::PROTEIN) ("alpha-fetoprotein" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN)
    ("transcriptional coactivator with PDZ-binding motif" . SPARSER::PROTEIN)
    ("RAS family and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION) ("TCC" . SPARSER::PROTEIN)
    ("bad" . SPARSER::PROTEIN) ("type and amplicon" . SPARSER::COLLECTION)
    ("the genes involved in the RAS/RAF/MEK/ERK pathway" . SPARSER::GENE)
    ("NRAS and exon" . SPARSER::COLLECTION)
    ("an abnormal melting" . SPARSER::DRUG)
    ("a minimal fraction" . SPARSER::COMPONENT)
    ("2, 3 and 4 of the NRAS gene and exon" . SPARSER::COLLECTION)
    ("Two monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("highly homologous proteins" . SPARSER::PROTEIN)
    ("HRAS , KRAS and NRAS" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS , NRAS and BRAF" . SPARSER::COLLECTION)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("a bigger cohort" . SPARSER::MOLECULE) ("CRC" . SPARSER::PROTEIN)
    ("RH" . SPARSER::MOLECULE) ("CHT" . SPARSER::PROTEIN)
    ("oxaliplatin" . SPARSER::DRUG) ("miRNA" . SPARSER::PROTEIN)
    ("KRAS , BRAF, or NRAS" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("NRAS or BRAF" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("seven " . SPARSER::PROTEIN)
    ("SUR " . SPARSER::PROTEIN) ("SUR" . SPARSER::PROTEIN)
    ("PTC" . SPARSER::PROTEIN) ("Group (ECOG)" . SPARSER::MOLECULE)
    ("Group" . SPARSER::MOLECULE) ("mCRC" . SPARSER::PROTEIN)
    ("codon " . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("codons " . SPARSER::PROTEIN)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("cetuximab and irinotecan" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("irinotecan" . SPARSER::DRUG)
    ("exon " . SPARSER::PROTEIN)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("cetuximab" . SPARSER::DRUG) ("panitumumab" . SPARSER::DRUG)
    ("CpG" . SPARSER::PROTEIN) ("leucovorin" . SPARSER::DRUG)
    ("MLH1 , MSH2 , MSH6 or PMS2" . SPARSER::COLLECTION)
    ("mismatch" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("SRA" . SPARSER::PROTEIN)
    ("an immediately actionable drug target" . SPARSER::TARGET-PROTEIN)
    ("an accurate biomarker" . SPARSER::MOLECULE)
    ("SMO or MAPK–pathway" . SPARSER::COLLECTION) ("PTCH" . SPARSER::PROTEIN)
    ("IDH1 or IDH2" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("PTCH1 (30–40%) and SMO (6–13%)" . SPARSER::COLLECTION)
    ("keratins" . SPARSER::PROTEIN) ("SHH and FGFR" . SPARSER::COLLECTION)
    ("tip" . SPARSER::PROTEIN) ("SHH" . SPARSER::PROTEIN)
    ("FGFR-MAPK" . SPARSER::COLLECTION) ("map" . SPARSER::PROTEIN)
    ("Ptch1" . SPARSER::PROTEIN) ("GLI" . SPARSER::PROTEIN)
    ("Itraconazole" . SPARSER::DRUG)
    ("the divergent chemical" . SPARSER::MOLECULE)
    ("SMO, and itraconazole" . SPARSER::COLLECTION)
    ("itraconazole" . SPARSER::DRUG) ("vismodegib" . SPARSER::DRUG)
    ("cyclopamine" . SPARSER::DRUG) ("antagonists" . SPARSER::MOLECULE)
    ("Shh" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("Smo" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("BRAF , KRAS and FGFR2" . SPARSER::COLLECTION)
    ("KRAS and FGFR2" . SPARSER::COLLECTION)
    ("the presumptive upstream receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lys" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("Cys" . SPARSER::AMINO-ACID) ("a larger cohort" . SPARSER::MOLECULE)
    ("most follicular and desmoplastic variants" . SPARSER::VARIANT)
    ("SMO or BRAF" . SPARSER::COLLECTION)
    ("SMO and BRAF" . SPARSER::COLLECTION)
    ("an essential seven-transmembrane Hedgehog signal transduction component"
     . SPARSER::COMPONENT)
    ("gene or pathway" . SPARSER::COLLECTION) ("rRNA" . SPARSER::PROTEIN)
    ("well-expressed genes" . SPARSER::GENE) ("vemurafenib" . SPARSER::DRUG)
    ("Glu" . SPARSER::AMINO-ACID)
    ("Food and Drug Administration (FDA) that is currently in clinical trials for its Hedgehog-inhibitory activity"
     . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("ATO" . SPARSER::PROTEIN)
    ("Phe" . SPARSER::AMINO-ACID) ("Leu" . SPARSER::AMINO-ACID)
    ("BRAF" . SPARSER::PROTEIN) ("SMO" . SPARSER::PROTEIN)
    ("odontogenic" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("H3F3A" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("PTCH1" . SPARSER::PROTEIN) ("Sonic Hedgehog" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2" . SPARSER::PROTEIN) ("seven-transmembrane" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("PAK1 or Trio" . SPARSER::COLLECTION)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("Trio-Rac1-Pak1" . SPARSER::COLLECTION)
    ("RhoG-Rac1" . SPARSER::COLLECTION)
    ("different immediate downstream effectors" . SPARSER::EFFECTOR)
    ("Trio or PAK1" . SPARSER::COLLECTION)
    ("Rac1, PAK1 or Trio" . SPARSER::COLLECTION)
    ("3D-collagen" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("Trio, Rac1, or PAK1" . SPARSER::COLLECTION)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("An invadopodia-associated complex" . SPARSER::BIO-COMPLEX)
    ("cortactin, paxillin and PKC" . SPARSER::COLLECTION)
    ("GIT1-PIX-PAK" . SPARSER::COLLECTION) ("PIX" . SPARSER::PROTEIN)
    ("PKC" . SPARSER::PROTEIN) ("paxillin" . SPARSER::PROTEIN)
    ("Tiam1-GFP" . SPARSER::COLLECTION) ("Rac1-Tiam1" . SPARSER::COLLECTION)
    ("TKS5-GFP" . SPARSER::COLLECTION) ("Rac1-PAK1" . SPARSER::COLLECTION)
    ("serine" . SPARSER::AMINO-ACID)
    ("PAK1 and cortactin" . SPARSER::COLLECTION)
    ("cortactin and phospho-serine" . SPARSER::COLLECTION)
    ("PLA" . SPARSER::PROTEIN) ("Rac1 or PAK1" . SPARSER::COLLECTION)
    ("mTagRFP-cortactin" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("the immediate downstream target" . SPARSER::TARGET-PROTEIN)
    ("linking Rac1" . SPARSER::PROTEIN) ("Serine" . SPARSER::AMINO-ACID)
    ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("Two well-studied Rac1 effectors" . SPARSER::EFFECTOR)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("PAK1-cortactin" . SPARSER::COLLECTION)
    ("GFP-TKS5" . SPARSER::COLLECTION)
    ("mTag-RFP-cortactin" . SPARSER::COLLECTION)
    ("CFP-Rac1" . SPARSER::COLLECTION)
    ("monomeric Venus, and full-length Rac1" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("Rac1 and Rac3" . SPARSER::COLLECTION) ("Trio-Rac1" . SPARSER::COLLECTION)
    ("Trio" . SPARSER::PROTEIN)
    ("neuronal Wiskott-Aldrich Syndrome protein" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors (GEF), GTPase activating proteins (GAP), and guanine nucleotide dissociation inhibitors (GDI)  xref"
     . SPARSER::COLLECTION)
    ("proteins (GAP)" . SPARSER::PROTEIN) ("GDI" . SPARSER::PROTEIN)
    ("Regulators" . SPARSER::REGULATOR) ("states" . SPARSER::BIO-STATE)
    ("ON" . SPARSER::PROTEIN) ("Cdc42, RhoA, and RhoC" . SPARSER::COLLECTION)
    ("RhoC" . SPARSER::PROTEIN)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cortactin" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("SP5" . SPARSER::PROTEIN) ("L15" . SPARSER::PROTEIN)
    ("R-Y" . SPARSER::PROTEIN) ("c-Src-" . SPARSER::PROTEIN)
    ("Tiam-1" . SPARSER::PROTEIN) ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Pix" . SPARSER::PROTEIN) ("C-16" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("C-11" . SPARSER::PROTEIN)
    ("Tks5" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("DH-PH" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("k-Ras" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("β-PIX" . SPARSER::PROTEIN)
    ("GIT1" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("min-2" . SPARSER::PROTEIN)
    ("Tiam1" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("TKS5" . SPARSER::PROTEIN)
    ("Rap1GAP" . SPARSER::PROTEIN) ("p50RhoGAP" . SPARSER::PROTEIN)
    ("D-H" . SPARSER::PROTEIN) ("Rac 1" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("Rac3" . SPARSER::PROTEIN)
    ("NSC23766" . SPARSER::DRUG) ("p21 activated kinase 1" . SPARSER::PROTEIN)
    ("MT1-MMP" . SPARSER::PROTEIN) ("N-WASP" . SPARSER::PROTEIN)
    ("Wiskott-Aldrich Syndrome protein" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bazooka" . SPARSER::PROTEIN)
    ("disulphide" . SPARSER::MOLECULE) ("Mst4 and Ezrin" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN) ("alanine (RA)" . SPARSER::AMINO-ACID)
    ("alanine (KA)" . SPARSER::AMINO-ACID)
    ("alanine (KRA)" . SPARSER::AMINO-ACID) ("arginine" . SPARSER::AMINO-ACID)
    ("nitrocellulose" . SPARSER::MOLECULE) ("PLC" . SPARSER::PROTEIN)
    ("PtdIns" . SPARSER::PROTEIN) ("cAMP or cGMP" . SPARSER::COLLECTION)
    ("RA" . SPARSER::PROTEIN) ("cGMP" . SPARSER::PROTEIN)
    ("cAMP" . SPARSER::PROTEIN) ("CDC25-HD" . SPARSER::COLLECTION)
    ("HD" . SPARSER::PROTEIN)
    ("such Rap-specific exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("PLD" . SPARSER::PROTEIN) ("TNIK, Mst4 and Ezrin" . SPARSER::COLLECTION)
    ("Mst4" . SPARSER::PROTEIN) ("Ezrin" . SPARSER::PROTEIN)
    ("TNIK" . SPARSER::PROTEIN) ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Par-3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIP5K" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("PLD1" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("RapGEF6" . SPARSER::PROTEIN)
    ("PDZGEF2" . SPARSER::PROTEIN) ("RapGEF2" . SPARSER::PROTEIN)
    ("PDZGEF1" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("STRADα" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("Rap2a" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("herceptin" . SPARSER::DRUG) ("Herceptin" . SPARSER::DRUG)
    ("MCT-1/p190B/Src" . SPARSER::COLLECTION)
    ("p190B/MCT-1" . SPARSER::COLLECTION)
    ("PTEN and MCT-1" . SPARSER::COLLECTION)
    ("MCT-1 and Myc" . SPARSER::COLLECTION)
    ("PTEN and p53" . SPARSER::COLLECTION) ("astrocytes" . SPARSER::PROTEIN)
    ("AKT, EGFR and Src" . SPARSER::COLLECTION)
    ("MCT-1 and PTEN" . SPARSER::COLLECTION)
    ("p190B and PTEN" . SPARSER::COLLECTION)
    ("PTEN and p190B" . SPARSER::COLLECTION)
    ("p190B and active" . SPARSER::COLLECTION)
    ("a centromeric protein" . SPARSER::PROTEIN) ("toxins" . SPARSER::MOLECULE)
    ("nocodazole and taxol" . SPARSER::COLLECTION)
    ("Src-p190B" . SPARSER::COLLECTION)
    ("Src and active" . SPARSER::COLLECTION)
    ("Src (tyr416) and p190B (p-tyr)" . SPARSER::COLLECTION)
    ("MCT-1/p190B" . SPARSER::COLLECTION)
    ("MCT-1 and p190B" . SPARSER::COLLECTION)
    ("the active Src (try416) and p190B (p-tyr)" . SPARSER::COLLECTION)
    ("shMCT-1" . SPARSER::COLLECTION)
    ("the intrinsic and ectopic MCT-1" . SPARSER::PROTEIN)
    ("the tyrosine-phosphorylated p190B (p-tyr) and the active Src (tyr416)"
     . SPARSER::COLLECTION)
    ("p-tyr" . SPARSER::COLLECTION) ("Src and p190B" . SPARSER::COLLECTION)
    ("active Src (tyr416) and p190B" . SPARSER::COLLECTION)
    ("hyperactive p190A" . SPARSER::PROTEIN)
    ("p190A and p190B" . SPARSER::COLLECTION)
    ("MCT-1/−PTEN" . SPARSER::COLLECTION)
    ("The mitotic spindle asters and microtubule structure"
     . SPARSER::COLLECTION)
    ("NuMA (nuclear-mitotic apparatus) and α-tubulin Abs"
     . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN) ("NuMA" . SPARSER::PROTEIN)
    ("asters" . SPARSER::BIO-COMPLEX) ("PTEN " . SPARSER::PROTEIN)
    ("HA-ubiquitin " . SPARSER::PROTEIN-PAIR) ("ubiquitin " . SPARSER::PROTEIN)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src and PI3K" . SPARSER::COLLECTION)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("MCF-10A" . SPARSER::PROTEIN)
    ("PTEN and the interacting protein" . SPARSER::COLLECTION)
    ("Ras and AKT" . SPARSER::COLLECTION)
    ("p53 and MCT-1" . SPARSER::COLLECTION) ("thr" . SPARSER::AMINO-ACID)
    ("ser" . SPARSER::AMINO-ACID) ("tyr" . SPARSER::AMINO-ACID)
    ("PI3K and PTEN" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("a potential biomarker" . SPARSER::MOLECULE)
    ("Src/p190B" . SPARSER::COLLECTION) ("p190B and Src" . SPARSER::COLLECTION)
    ("phosphoinositide 3 kinase/AKT" . SPARSER::COLLECTION)
    ("ARHGAP5" . SPARSER::PROTEIN) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("MCT-1  " . SPARSER::PROTEIN) ("MCT-1 " . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("CENP-A" . SPARSER::PROTEIN)
    ("p190RhoGAP" . SPARSER::PROTEIN)
    ("growth factor " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MG132" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE) ("PP2" . SPARSER::DRUG)
    ("CK2" . SPARSER::PROTEIN) ("p110delta" . SPARSER::PROTEIN)
    ("p190A" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K " . SPARSER::HUMAN-PROTEIN-FAMILY) ("NEDD4-1" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("p190B" . SPARSER::PROTEIN)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("T -cell" . SPARSER::PROTEIN) ("MCT-1" . SPARSER::PROTEIN)
    ("Rac1 and FAK" . SPARSER::COLLECTION)
    ("VAV2 and VAV3" . SPARSER::COLLECTION)
    ("VAV2 and the family member VAV3" . SPARSER::COLLECTION)
    ("GEF, and active" . SPARSER::COLLECTION)
    ("FAK and vimentin" . SPARSER::COLLECTION)
    ("FAK and Rac1" . SPARSER::COLLECTION)
    ("VAV2 and Y397-FAK" . SPARSER::COLLECTION)
    ("actin and microtubules" . SPARSER::COLLECTION)
    ("VAV2-Rac1" . SPARSER::COLLECTION) ("trypsinized" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("Rac1 and/or cdc42" . SPARSER::COLLECTION)
    ("VAV2-GFP" . SPARSER::COLLECTION)
    ("a truncated GFP tagged dominant negative VAV2 mutant" . SPARSER::MUTANT)
    ("trypsin" . SPARSER::PROTEIN) ("FAK-GFP" . SPARSER::COLLECTION)
    ("trypsinization" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("calpain" . SPARSER::PROTEIN) ("calpains" . SPARSER::PROTEIN)
    ("CHX" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("vimentin and FAK" . SPARSER::COLLECTION)
    ("vimentin and pY418-Src" . SPARSER::COLLECTION)
    ("FAK and VAV2" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("vimentin and VAV2" . SPARSER::COLLECTION)
    ("Y142-VAV2 and Y172-VAV2" . SPARSER::COLLECTION)
    ("vimentin and pY142-VAV2" . SPARSER::COLLECTION)
    ("hVIM-GFP" . SPARSER::COLLECTION) ("tyrosines" . SPARSER::AMINO-ACID)
    ("Rac1 and cdc42" . SPARSER::COLLECTION)
    ("1,318 phospho-specific antibodies and their corresponding non-phosphorylated antibodies ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("β1 integrin and other proteins" . SPARSER::COLLECTION)
    ("Src" . SPARSER::PROTEIN) ("integrin" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("States" . SPARSER::BIO-STATE) ("vimentin or VAV2" . SPARSER::COLLECTION)
    ("VAV2 and FAK" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("vimentin and focal adhesion kinase (FAK)" . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a potential novel regulator" . SPARSER::REGULATOR)
    ("vimentin-VAV2" . SPARSER::COLLECTION) ("vimentin" . SPARSER::PROTEIN)
    ("Vimentin" . SPARSER::PROTEIN) ("rac1" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("LT1" . SPARSER::PROTEIN)
    ("PTK2" . SPARSER::PROTEIN) ("βPIX" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("Rho GTPase" . SPARSER::PROTEIN)
    ("VAV2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("AMPK and p38" . SPARSER::COLLECTION)
    ("Akt and ERK 1/2" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("Akt and ERKs" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK and JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("oxidants" . SPARSER::MOLECULE)
    ("other pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("Bax and adenine" . SPARSER::COLLECTION) ("adenine" . SPARSER::NUCLEOBASE)
    ("Bcl-2 and/or Bcl-xL" . SPARSER::COLLECTION) ("Mcl" . SPARSER::PROTEIN)
    ("p53 mRNA (TP53 gene) and p27 mRNA (CDKN1B gene)" . SPARSER::COLLECTION)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("cisplatin and p38α" . SPARSER::COLLECTION) ("cisplatin" . SPARSER::DRUG)
    ("stress resistance genes such as catalase and SOD xref"
     . SPARSER::COLLECTION)
    ("Drosophila" . SPARSER::PROTEIN)
    ("insulin receptor and insulin like growth factor I receptor"
     . SPARSER::COLLECTION)
    ("AMPK/p70S6K" . SPARSER::COLLECTION) ("p-p70S6K" . SPARSER::COLLECTION)
    ("electron" . SPARSER::MOLECULE) ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("caspase and poly-ADP-ribose" . SPARSER::COLLECTION)
    ("caspase" . SPARSER::PROTEIN)
    ("p53 (TP53 gene) and p27 (CDKN1B gene)" . SPARSER::COLLECTION)
    ("pRb (PRB1 gene), p53 (TP53 gene) and p27 (CDKN1B gene)"
     . SPARSER::COLLECTION)
    ("catalase and Mn-SOD" . SPARSER::COLLECTION)
    ("metformin and SOD or catalase" . SPARSER::COLLECTION)
    ("metformin and antioxidant" . SPARSER::COLLECTION)
    ("enzymes, apocynin, SOD and catalase" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("mTOR-p70S6K" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("p-Akt" . SPARSER::COLLECTION)
    ("IR/MEK/ERK1/2" . SPARSER::COLLECTION)
    ("IR/PI3K/Akt/mTOR" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("caspases" . SPARSER::PROTEIN) ("Trypan" . SPARSER::DRUG)
    ("superoxide" . SPARSER::MOLECULE) ("apocynin" . SPARSER::MOLECULE)
    ("antioxidant" . SPARSER::PROTEIN)
    ("FOXO3a and AMPK" . SPARSER::COLLECTION) ("antioxidants" . SPARSER::DRUG)
    ("cyclin D1 and p27" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3a, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("forkhead" . SPARSER::PROTEIN)
    ("LKB1/AMPK" . SPARSER::COLLECTION) ("MEK/ERK1/2" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION) ("Metformin" . SPARSER::DRUG)
    ("AMPK and FOXO3a" . SPARSER::COLLECTION)
    ("MAPK, catalase, MnSOD and Cu/Zn" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("metformin and H 2 O 2" . SPARSER::COLLECTION)
    ("p70S6K and Bcl-2" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("Bax" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("Gene and protein" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("metformin" . SPARSER::DRUG) ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-7" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("insulin like growth factor I receptor" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("PRB1" . SPARSER::PROTEIN) ("B–F" . SPARSER::PROTEIN)
    ("Mn-SOD" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("C–E" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("alpha subunit" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("D-F" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("mL -1" . SPARSER::PROTEIN) ("phenol red" . SPARSER::DRUG)
    ("CM-H" . SPARSER::MOLECULE) ("anti-β" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-ERK1" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("mL −1" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG) ("P53 and NF-kB" . SPARSER::COLLECTION)
    ("p53 and NF-kB" . SPARSER::COLLECTION)
    ("Ras, Myc and APC" . SPARSER::COLLECTION)
    ("p53, Ras, Myc, APC and DCC" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("DCC" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("c-Met and HER2" . SPARSER::COLLECTION)
    ("ETS-1 and MMPs" . SPARSER::COLLECTION)
    ("ETS-1 or MMPs" . SPARSER::COLLECTION)
    ("u-PA and MMPs" . SPARSER::COLLECTION)
    ("p19 ARF and MDM2" . SPARSER::COLLECTION)
    ("p53, ER and AR" . SPARSER::COLLECTION) ("repressor" . SPARSER::REPRESSOR)
    ("ARF or Rb" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("P53, FBI-1 and ETS-1" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("FBI-1/ETS-1" . SPARSER::COLLECTION) ("p21-luc" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN)
    ("FBI-1 or both p53 and FBI-1" . SPARSER::COLLECTION)
    ("EBS-luc" . SPARSER::PROTEIN-PAIR) ("siRNA or p53" . SPARSER::COLLECTION)
    ("A-B" . SPARSER::PROTEIN) ("ETS-1 and P53" . SPARSER::COLLECTION)
    ("MMP9 and c-Met" . SPARSER::COLLECTION)
    ("MMP9 (Fig. S2 in xref ) and c-Met promoter" . SPARSER::COLLECTION)
    ("ETS-1, FBI-1 and P53" . SPARSER::COLLECTION)
    ("fragment" . SPARSER::FRAGMENT)
    ("FBI-1, p53 and ETS-1" . SPARSER::COLLECTION)
    ("p53 and FBI-1" . SPARSER::COLLECTION)
    ("FLAG-ETS-1" . SPARSER::COLLECTION)
    ("p53 and ETS-1" . SPARSER::COLLECTION)
    ("FLAG-FBI-1" . SPARSER::COLLECTION)
    ("FBI-1, ETS-1 and p53" . SPARSER::COLLECTION)
    ("ETS-1 and p53" . SPARSER::COLLECTION)
    ("luciferase and IB" . SPARSER::COLLECTION)
    ("u-PA, c-Met, MMP1 and MMP9" . SPARSER::COLLECTION)
    ("FBI-1 or ETS-1" . SPARSER::COLLECTION)
    ("HGF/c-Met/ETS-1" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE) ("agonist" . SPARSER::AGONIST)
    ("ARG" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("EBS" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("SRC-1, AIB-1 and NCoR" . SPARSER::COLLECTION) ("NCoR" . SPARSER::PROTEIN)
    ("-GGAA/T-3" . SPARSER::COLLECTION) ("GGAA" . SPARSER::PROTEIN)
    ("MMP1, MMP9, u-PA and c-Met" . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN) ("FBI-1 and ETS-1" . SPARSER::COLLECTION)
    ("LNCaP" . SPARSER::PROTEIN) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HCC" . SPARSER::PROTEIN)
    ("Hdm2, Mdm2, and p19 ARF , p21 and Rb" . SPARSER::COLLECTION)
    ("p19 ARF , p21 and Rb" . SPARSER::COLLECTION)
    ("Pokemon" . SPARSER::PROTEIN) ("LRF" . SPARSER::PROTEIN)
    ("POK" . SPARSER::PROTEIN)
    ("a potential molecule target" . SPARSER::TARGET-PROTEIN)
    ("its target genes and increase ETS-1 accumulation" . SPARSER::COLLECTION)
    ("ETS-1 and FBI-1" . SPARSER::COLLECTION) ("NF-KB" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("Zbtb7a" . SPARSER::PROTEIN)
    ("C-D" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("β-galactosidase" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("AIB-1" . SPARSER::PROTEIN) ("SRC-1" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("u-PA" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("p19 ARF" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN)
    ("POK erythroid myeloid ontogenic factor" . SPARSER::PROTEIN)
    ("leukemia/lymphoma-related factor" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("ETS-1" . SPARSER::PROTEIN) ("FBI-1" . SPARSER::PROTEIN)
    ("LKB1 or AMPKα" . SPARSER::COLLECTION)
    ("LKB1 and AMPK" . SPARSER::COLLECTION)
    ("LKB1 and AMPKα2" . SPARSER::COLLECTION)
    ("LKB1 and AMPKα" . SPARSER::COLLECTION) ("fat" . SPARSER::PROTEIN)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("either transcriptional coactivators or transcriptional corepressors"
     . SPARSER::COLLECTION)
    ("transcriptional corepressors" . SPARSER::PROTEIN)
    ("either transcriptional coactivators" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("an excellent example" . SPARSER::EXAMPLE)
    ("mutp53s and wtp53" . SPARSER::COLLECTION) ("example" . SPARSER::EXAMPLE)
    ("wtp53 and pBabe" . SPARSER::COLLECTION)
    ("rosiglitazone, dexamethasone, and isobutylmethylxanthine"
     . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN) ("rosiglitazone" . SPARSER::DRUG)
    ("ACC and SREBP-1c" . SPARSER::COLLECTION)
    ("mutp53- and AMPKα1" . SPARSER::COLLECTION) ("mutp53-" . SPARSER::PROTEIN)
    ("RNA and Detroit" . SPARSER::COLLECTION)
    ("AMPKα and upstream kinases" . SPARSER::COLLECTION)
    ("wtp53 and mutp53s" . SPARSER::COLLECTION) ("LKB" . SPARSER::PROTEIN)
    ("Chromotek-GFP-Trap" . SPARSER::COLLECTION)
    ("HA-AMPKα2" . SPARSER::PROTEIN-PAIR) ("agarose" . SPARSER::MOLECULE)
    ("Trap" . SPARSER::PROTEIN)
    ("a heterotrimeric serine/threonine protein kinase complex"
     . SPARSER::BIO-COMPLEX)
    ("AMPKα-LKB1" . SPARSER::COLLECTION) ("p53-AMPKα" . SPARSER::COLLECTION)
    ("wtp53 and the mutants Δ161" . SPARSER::COLLECTION)
    ("Δ161" . SPARSER::PROTEIN) ("AMPKα2-LKB1" . SPARSER::COLLECTION)
    ("wtp53" . SPARSER::PROTEIN)
    ("an N-terminally intact p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GST-wtp53 and -Δ161" . SPARSER::COLLECTION)
    ("GST-wtp53" . SPARSER::PROTEIN-PAIR)
    ("LKB1 or TAK1, and AMPKα" . SPARSER::COLLECTION)
    ("TAK1, and AMPKα" . SPARSER::COLLECTION)
    ("LKB1 or TGF-β–activated kinase-1 (TAK1)" . SPARSER::COLLECTION)
    ("AMPKα1 or α2 substrates" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("AMPKα1 and AMPKα2" . SPARSER::COLLECTION)
    ("p53–AMPKα" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("mutp53s and AMPK" . SPARSER::COLLECTION)
    ("mutp53-AMPKα" . SPARSER::COLLECTION) ("holoenzyme" . SPARSER::PROTEIN)
    ("mutp53s" . SPARSER::PROTEIN) ("mutp53" . SPARSER::PROTEIN)
    ("AMPKα–mutp53s" . SPARSER::PROTEIN-PAIR)
    ("AMPKα and wtp53" . SPARSER::COLLECTION) ("AMPKα2" . SPARSER::PROTEIN)
    ("GFP-AMPKα2" . SPARSER::PROTEIN-PAIR)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("phosphorylated AMPK (pAMPK) and ACC (pACC)" . SPARSER::COLLECTION)
    ("pACC" . SPARSER::PROTEIN) ("Ctr" . SPARSER::PROTEIN)
    ("AMPK and ACC" . SPARSER::COLLECTION)
    ("AMPK and its upstream LKB1 kinase complexes (i.e., AMPKα/β/γ and LKB1/Mo25α/β/Stradα/β)"
     . SPARSER::COLLECTION)
    ("Strad" . SPARSER::PROTEIN) ("AMPKα as well as ACC" . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("AICAR" . SPARSER::PROTEIN)
    ("AKT and AMPK" . SPARSER::COLLECTION) ("/AMPK" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("low-glucose" . SPARSER::PROTEIN)
    ("glucose" . SPARSER::PROTEIN) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("MDM2 and p21" . SPARSER::COLLECTION) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("protein-protein" . SPARSER::COLLECTION)
    ("AMPK and wtp53" . SPARSER::COLLECTION)
    ("AMPK ( xref ) and sestrin ( xref )" . SPARSER::COLLECTION)
    ("sestrin" . SPARSER::PROTEIN-FAMILY) ("MDMX" . SPARSER::PROTEIN)
    ("carbohydrate" . SPARSER::MOLECULE) ("cofactors" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN)
    ("a catalytic α subunit and regulatory β and γ subunits"
     . SPARSER::COLLECTION)
    ("a highly conserved heterotrimeric serine/threonine protein kinase complex"
     . SPARSER::BIO-COMPLEX)
    ("subunits" . SPARSER::FRAGMENT)
    ("-activated protein kinase" . SPARSER::COLLECTION)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("catabolism" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("AMP" . SPARSER::AMP) ("some mutated forms" . SPARSER::FORM)
    ("AMPK" . SPARSER::PROTEIN) ("GOF" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY) ("1–2 µ" . SPARSER::PROTEIN)
    ("HIF1" . SPARSER::PROTEIN) ("hypoxia-induced factor 1" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAp63" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SREBP-1c" . SPARSER::PROTEIN)
    ("PP2C" . SPARSER::PROTEIN) ("AMPK β" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Mo25" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("5-FU" . SPARSER::PROTEIN)
    ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIRT1" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN)
    ("sterol regulatory element-binding protein 1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("homolog of" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("AMP-activated" . SPARSER::PROTEIN)
    ("the exocyst’s" . SPARSER::BIO-COMPLEX)
    ("localized exocyst complexes" . SPARSER::BIO-COMPLEX)
    ("human chorionic gonadotropin (CG)" . SPARSER::PROTEIN)
    ("CG" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("Mononuclear CTBs" . SPARSER::PROTEIN) ("mixture" . SPARSER::MOLECULE)
    ("secondary antibody" . SPARSER::PROTEIN)
    ("proteins and RAB11" . SPARSER::COLLECTION)
    ("CTBs and the STB" . SPARSER::COLLECTION)
    ("mononuclear CTBs" . SPARSER::PROTEIN) ("CTBs" . SPARSER::PROTEIN)
    ("homogenate" . SPARSER::PROTEIN) ("Proteins" . SPARSER::PROTEIN)
    ("Complex" . SPARSER::BIO-COMPLEX) ("complement" . SPARSER::PROTEIN)
    ("at least two unique peptides" . SPARSER::PEPTIDE)
    ("the eight exocyst complex proteins, EXOC1" . SPARSER::PROTEIN)
    ("STB" . SPARSER::PROTEIN) ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t-SNARE" . SPARSER::COLLECTION) ("SNARE" . SPARSER::PROTEIN)
    ("t" . SPARSER::PROTEIN)
    ("vesicle membrane Soluble NSF Attachment Receptor proteins (v-SNAREs) and the peripherally associated GTPase RAB11 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("the peripherally associated GTPase RAB11" . SPARSER::PROTEIN)
    ("vesicle membrane Soluble NSF Attachment Receptor proteins"
     . SPARSER::RECEPTOR-PROTEIN)
    ("target membrane Soluble NSF Attachment Receptor proteins"
     . SPARSER::RECEPTOR-PROTEIN)
    ("NSF" . SPARSER::PROTEIN)
    ("EXOC1, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC7, and EXOC8"
     . SPARSER::COLLECTION)
    ("these yeast secretory ( Sec ) mutants" . SPARSER::MUTANT)
    ("Sec3, Sec5, Sec6, Sec8, Sec10 and Sec15" . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec5" . SPARSER::PROTEIN)
    ("Sec3" . SPARSER::PROTEIN) ("alleles" . SPARSER::ALLELE)
    ("highly conserved octameric protein complex" . SPARSER::BIO-COMPLEX)
    ("PM" . SPARSER::PROTEIN) ("Saccharomyces" . SPARSER::PROTEIN)
    ("a principal regulator" . SPARSER::REGULATOR)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Exocyst" . SPARSER::BIO-COMPLEX)
    ("all exocyst complex components and effector proteins requisite"
     . SPARSER::COLLECTION)
    ("the octameric exocyst complex" . SPARSER::BIO-COMPLEX)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("m 2" . SPARSER::MOLECULE)
    ("of pregnancy" . SPARSER::PROTEIN) ("EXOC 1" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("g protein" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN) ("CHD1" . SPARSER::PROTEIN)
    ("N 2" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("CDH1" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("exocyst complex component 3" . SPARSER::PROTEIN)
    ("exocyst complex component 4" . SPARSER::PROTEIN)
    ("exocyst complex component 2" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t-SNAREs" . SPARSER::PROTEIN)
    ("Receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("EXOC8" . SPARSER::PROTEIN) ("EXOC7" . SPARSER::PROTEIN)
    ("EXOC6" . SPARSER::PROTEIN) ("EXOC5" . SPARSER::PROTEIN)
    ("EXOC4" . SPARSER::PROTEIN) ("EXOC3" . SPARSER::PROTEIN)
    ("EXOC2" . SPARSER::PROTEIN) ("Sec15" . SPARSER::PROTEIN-FAMILY)
    ("RAB11" . SPARSER::PROTEIN) ("EXOC1" . SPARSER::PROTEIN)
    ("XRCC1 Arg194Trp and PARP-1 Val762Ala genotypes" . SPARSER::COLLECTION)
    ("seven" . SPARSER::PROTEIN) ("PARP-1–" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION) ("PARP" . SPARSER::PROTEIN)
    ("t  " . SPARSER::PROTEIN) ("Arg/Arg" . SPARSER::COLLECTION)
    ("Val/Val" . SPARSER::COLLECTION) ("Gln/Gln" . SPARSER::COLLECTION)
    ("Ala/Ala" . SPARSER::COLLECTION) ("XRCC1-PARP1" . SPARSER::COLLECTION)
    ("PARP1 Val762Ala and XRCC1 Arg399Gln" . SPARSER::COLLECTION)
    ("NAD" . SPARSER::MOLECULE) ("COOH" . SPARSER::MOLECULE)
    ("alanine" . SPARSER::AMINO-ACID) ("valine" . SPARSER::AMINO-ACID)
    ("histones, P53, and PARP-1" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("nick" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::MOLECULE) ("reagents" . SPARSER::MOLECULE)
    ("rays" . SPARSER::PROTEIN) ("genotoxic chemicals" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("smoke" . SPARSER::MOLECULE)
    ("tobacco" . SPARSER::DRUG)
    ("PARP-1 Val762Ala and XRCC1 Arg399Gln" . SPARSER::COLLECTION)
    ("Gln" . SPARSER::AMINO-ACID) ("AA" . SPARSER::MOLECULE)
    ("VA" . SPARSER::MOLECULE) ("Ala" . SPARSER::AMINO-ACID)
    ("a nuclear chromatin-associated enzyme" . SPARSER::ENZYME)
    ("ERCC1" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("DNA-PK" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("PARP1" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE)
    ("these phosphatases as well as CDC25A" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("Phosphatases" . SPARSER::PHOSPHATASE) ("proteasomal" . SPARSER::PROTEIN)
    ("ATR-CHK1" . SPARSER::COLLECTION)
    ("ZM447439 and thymidine" . SPARSER::COLLECTION)
    ("kinase and RPA" . SPARSER::COLLECTION)
    ("IgG and FITC" . SPARSER::COLLECTION) ("FITC" . SPARSER::MOLECULE)
    ("goat" . SPARSER::PROTEIN) ("Phycoerythrin" . SPARSER::PROTEIN-FAMILY)
    ("Fluor" . SPARSER::MOLECULE) ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("ZM447439 and AZD1152" . SPARSER::COLLECTION)
    ("CDK1 and cyclin" . SPARSER::COLLECTION)
    ("CDK1 or cyclin" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("ATM-CHK2" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("CDKN1A/p21" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("cyclinB" . SPARSER::PROTEIN) ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("helicase" . SPARSER::PROTEIN)
    ("p53 and CHK1" . SPARSER::COLLECTION) ("Nocodazole" . SPARSER::DRUG)
    ("nocodazole" . SPARSER::DRUG) ("phospho-histone" . SPARSER::PROTEIN)
    ("siRNAs or thymidine" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("thymidine" . SPARSER::PROTEIN) ("ATR or CHK1" . SPARSER::COLLECTION)
    ("ATR and its downstream phosphorylation target CHK1"
     . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("Histone" . SPARSER::PROTEIN)
    ("RPA" . SPARSER::PROTEIN)
    ("premature chromosome condensation" . SPARSER::PROTEIN-FAMILY)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("RNAse A" . SPARSER::PROTEIN)
    ("T200" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("anti- β" . SPARSER::PROTEIN)
    ("RPA34" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN) ("MLN8237" . SPARSER::DRUG)
    ("AZD1152" . SPARSER::DRUG) ("ZM447439" . SPARSER::DRUG)
    ("Aurora Kinase B" . SPARSER::PROTEIN) ("AZD7762" . SPARSER::DRUG)
    ("Cyclin B1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("S-G2" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("histone-H3" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("γ H2AX" . SPARSER::PROTEIN) ("CDC45" . SPARSER::PROTEIN)
    ("RPA2" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("histoneH3" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("Aurora kinase B" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("taxol and mTOR" . SPARSER::COLLECTION)
    ("/mTOR" . SPARSER::COLLECTION) ("trastuzumab" . SPARSER::DRUG)
    ("raptor" . SPARSER::PROTEIN) ("polymers" . SPARSER::MOLECULE)
    ("Taxol" . SPARSER::DRUG) ("mTOR, S6K, or 4E-BP1" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("SPAG5 and taxol" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("Matrigel" . SPARSER::PROTEIN) ("ANT" . SPARSER::PROTEIN)
    ("p29, Aurora-A, and SNM1B" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN)
    ("a mitotic spindle-associated protein" . SPARSER::PROTEIN)
    ("SPAG5 or Astrin" . SPARSER::COLLECTION) ("Astrin" . SPARSER::PROTEIN)
    ("taxol" . SPARSER::DRUG) ("cytometry" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("annexin V" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("reducing agent" . SPARSER::MOLECULE)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("IB2" . SPARSER::PROTEIN)
    ("IB1" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC1" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("SNM1B" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("p29" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("SPAG5" . SPARSER::PROTEIN)
    ("sperm-associated antigen 5" . SPARSER::PROTEIN)
    ("lincRNA" . SPARSER::RNA) ("ncRNA" . SPARSER::RNA)
    ("Polycomb" . SPARSER::PROTEIN) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ke" . SPARSER::MOLECULE)
    ("WDR5/MLL" . SPARSER::COLLECTION) ("HOXA" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("exogenous RNAi TUG1" . SPARSER::PROTEIN)
    ("si-HOXB7" . SPARSER::COLLECTION)
    ("the key catalytic subunit" . SPARSER::PROTEIN)
    ("GAPDH and U6" . SPARSER::COLLECTION)
    ("TUG1 and HOTAIR" . SPARSER::COLLECTION)
    ("HOXD4, HOXD9 and HOXD10" . SPARSER::COLLECTION)
    ("HOXB7, HOXD4, HOXD9 and HOXD10" . SPARSER::COLLECTION)
    ("Hox" . SPARSER::PROTEIN) ("polycomb" . SPARSER::PROTEIN)
    ("si-NC" . SPARSER::PROTEIN-PAIR) ("NC" . SPARSER::PROTEIN)
    ("MTT" . SPARSER::MOLECULE) ("si-TUG1" . SPARSER::COLLECTION)
    ("siRNAs" . SPARSER::PROTEIN) ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("doxorubicin" . SPARSER::PROTEIN) ("p53 and p53" . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::PROTEIN) ("rank" . SPARSER::PROTEIN)
    ("HOTAIR" . SPARSER::PROTEIN)
    ("SUZ12 (suppressor of zeste 12) and embryonic ectoderm development"
     . SPARSER::COLLECTION)
    ("lysine" . SPARSER::AMINO-ACID) ("suppressor" . SPARSER::SUPPRESSOR)
    ("methyltransferase" . SPARSER::PROTEIN) ("microRNAs" . SPARSER::RNA)
    ("IV" . SPARSER::PROTEIN) ("scaffolds" . SPARSER::SCAFFOLD)
    ("LncRNAs" . SPARSER::RNA) ("arm" . SPARSER::PROTEIN)
    ("p53/TUG1/PRC2/HOXB7" . SPARSER::COLLECTION)
    ("regulator" . SPARSER::REGULATOR) ("AKT and MAPK" . SPARSER::COLLECTION)
    ("HOX" . SPARSER::PROTEIN)
    ("p53, and luciferase and chromatin" . SPARSER::COLLECTION)
    ("luciferase and chromatin" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("lncRNA" . SPARSER::RNA) ("taurine" . SPARSER::MOLECULE)
    ("lncRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("RNA-Binding Protein" . SPARSER::PROTEIN) ("p-F" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("WDR5" . SPARSER::PROTEIN) ("GSK3 β" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("HOXD10" . SPARSER::PROTEIN) ("HOXD4" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pGL3" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("p15 INK4B" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H3K27me3" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("embryonic ectoderm development" . SPARSER::PROTEIN)
    ("zeste 12" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("HOXB7" . SPARSER::PROTEIN)
    ("homeobox B7" . SPARSER::PROTEIN) ("PRC2" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("TUG1" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras–Raf–MEK–ERK" . SPARSER::COLLECTION) ("-Ras" . SPARSER::COLLECTION)
    ("p70S6k" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("a dual GEF" . SPARSER::GEF)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("RTKs" . SPARSER::PROTEIN) ("Sos1 and Sos2" . SPARSER::COLLECTION)
    ("Sos2" . SPARSER::PROTEIN) ("Ras-GAP or Grb2" . SPARSER::COLLECTION)
    ("Ras-GAP and Ras-GEF" . SPARSER::COLLECTION)
    ("the active Ras–GTP complex" . SPARSER::BIO-COMPLEX)
    ("Ras-GAPs" . SPARSER::COLLECTION)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("proteins and forms" . SPARSER::COLLECTION) ("ester" . SPARSER::MOLECULE)
    ("carboxymethyl" . SPARSER::MOLECULE) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("a unique class" . CLASS) ("-mutant" . SPARSER::MUTANT)
    ("p70s6k" . SPARSER::PROTEIN) ("p70S6K" . SPARSER::PROTEIN)
    ("c-RAF" . SPARSER::COLLECTION) ("Ros" . SPARSER::PROTEIN)
    ("mTOR" . SPARSER::PROTEIN) ("PKB" . SPARSER::PROTEIN)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FAK" . SPARSER::PROTEIN)
    ("Met" . SPARSER::AMINO-ACID)
    ("GEF (Grb2/Sos1 complex) and GAP" . SPARSER::COLLECTION)
    ("Grb2 or GAP" . SPARSER::COLLECTION) ("Grb2/Sos1" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION) ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("ERK–MAPK" . SPARSER::COLLECTION) ("MEK and ERK" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("its active-GTP-bound state" . SPARSER::BIO-STATE)
    ("c-Raf" . SPARSER::COLLECTION) ("Kinase" . SPARSER::KINASE)
    ("rasfonin and Ras" . SPARSER::COLLECTION) ("–1 " . SPARSER::PROTEIN)
    ("rasfonin and FTS" . SPARSER::COLLECTION)
    ("Even 10  μ M rasfonin" . SPARSER::DRUG)
    ("ras-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the membrane-associated guanine exchange factor (GEF)"
     . SPARSER::EXCHANGE-FACTOR)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("cytokines, growth factors or mitogens" . SPARSER::COLLECTION)
    ("/Son of sevenless" . SPARSER::COLLECTION)
    ("growth factors and mitogens" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION) ("mitogens" . SPARSER::MITOGEN)
    ("at least three genes" . SPARSER::GENE)
    ("H-ras, K-ras and N-ras" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("Gemcitabine" . SPARSER::DRUG)
    ("Ras–MAPK" . SPARSER::COLLECTION)
    ("a robust inhibitor" . SPARSER::INHIBITOR)
    ("GEF and GAP" . SPARSER::COLLECTION) ("Sos1" . SPARSER::PROTEIN)
    ("c-Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("rasfonin or Salirasib" . SPARSER::COLLECTION) ("FTS" . SPARSER::PROTEIN)
    ("Salirasib" . SPARSER::DRUG) ("CD1" . SPARSER::PROTEIN)
    ("-GDP" . SPARSER::NUCLEOTIDE) ("/GTPase-activating" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEF" . SPARSER::GEF)
    ("guanine" . SPARSER::PROTEIN)
    ("EGFR–Ras–Raf–MEK–ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("rasfonin" . SPARSER::DRUG)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derivative" . SPARSER::DERIVATIVE) ("pyrone" . SPARSER::MOLECULE)
    ("Rasfonin" . SPARSER::DRUG) ("18 h" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN) ("ras-binding" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DU145" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-GEF" . SPARSER::PROTEIN) ("Ras-GAP" . SPARSER::PROTEIN)
    ("Ras-GEFs" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("s6k" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN) ("IKK α" . SPARSER::PROTEIN)
    ("PKB γ" . SPARSER::PROTEIN) ("PKB α" . SPARSER::PROTEIN)
    ("PI3Kinase" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("Flt3" . SPARSER::PROTEIN) ("PDGFR β" . SPARSER::PROTEIN)
    ("PDGFR α" . SPARSER::PROTEIN) ("Ras family" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("Ras-Binding" . SPARSER::PROTEIN)
    ("MAP Kinase Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras–GTP" . SPARSER::PROTEIN) ("Ras–GDP" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN)
    ("growth factor receptor-binding protein" . SPARSER::PROTEIN)
    ("N-ras" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("H-ras" . SPARSER::PROTEIN) ("Son of sevenless" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("K- ras" . SPARSER::PROTEIN) ("K -ras" . SPARSER::PROTEIN)
    ("gefitinib" . SPARSER::DRUG)
    ("a possible new therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a well-defined patient group" . SPARSER::MOLECULE)
    ("neo" . SPARSER::PROTEIN) ("larger patient cohorts" . SPARSER::MOLECULE)
    ("cohorts" . SPARSER::MOLECULE) ("TMAs" . SPARSER::MOLECULE)
    ("trigger" . SPARSER::PROTEIN) ("MAPK" . SPARSER::PROTEIN)
    ("–1" . SPARSER::PROTEIN) ("HR" . SPARSER::PROTEIN)
    ("py" . SPARSER::MOLECULE) ("IA and IB" . SPARSER::COLLECTION)
    ("IIB" . SPARSER::PROTEIN) ("IB" . SPARSER::DRUG)
    ("IA" . SPARSER::MOLECULE)
    ("13% (3/23) LC and 2.2% (3/137) AC" . SPARSER::PROTEIN)
    ("EGFR-" . SPARSER::PROTEIN) ("ligand" . SPARSER::LIGAND)
    ("PTEN and fibroblast growth factor receptor 1" . SPARSER::COLLECTION)
    ("PIK3CA/AKT1" . SPARSER::COLLECTION) ("AC" . SPARSER::PROTEIN)
    ("targetable oncogenic protein kinases" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN) ("FGFR1-" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE) ("FISH" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transmembrane protein" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("Trp" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("acceptor" . SPARSER::MOLECULE) ("tyrosine" . SPARSER::AMINO-ACID)
    ("codons" . SPARSER::PROTEIN) ("phosphatase" . SPARSER::PHOSPHATASE)
    ("Ser or Gly" . SPARSER::COLLECTION) ("Asp" . SPARSER::AMINO-ACID)
    ("Gly" . SPARSER::AMINO-ACID) ("codon" . SPARSER::PROTEIN)
    ("non-converted DNA and water" . SPARSER::COLLECTION)
    ("water" . SPARSER::MOLECULE) ("melting" . SPARSER::DRUG)
    ("bisulphite" . SPARSER::MOLECULE)
    ("universal components" . SPARSER::COMPONENT)
    ("cyclophosphamide" . SPARSER::DRUG) ("epirubicin" . SPARSER::DRUG)
    ("adjuvant" . SPARSER::DRUG) ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("stop or indel" . SPARSER::COLLECTION)
    ("stop-codon, or frameshift" . SPARSER::COLLECTION)
    ("stop-codon" . SPARSER::PROTEIN-PAIR) ("Arg" . SPARSER::AMINO-ACID)
    ("TP53 , PTEN and K-RAS" . SPARSER::COLLECTION)
    ("K-RAS, PTEN and TP53" . SPARSER::COLLECTION)
    ("certain polymorphic variants" . SPARSER::VARIANT)
    ("cellular macromolecules" . SPARSER::MOLECULE)
    ("macromolecules" . SPARSER::MOLECULE) ("metabolites" . SPARSER::PROTEIN)
    ("E 1 S and E 2 S" . SPARSER::COLLECTION) ("sulphate" . SPARSER::MOLECULE)
    ("metabolite" . SPARSER::MOLECULE) ("male" . SPARSER::MOLECULE)
    ("receptor (ER)" . SPARSER::RECEPTOR)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("repressors" . SPARSER::REPRESSOR) ("TAM and EC" . SPARSER::COLLECTION)
    ("K-RAS, TP53 and PTEN" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("TAM" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("PTEN" . SPARSER::PROTEIN) ("MGMT" . SPARSER::PROTEIN)
    ("Tamoxifen" . SPARSER::MOLECULE) ("p16" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("l −1" . SPARSER::PROTEIN)
    ("E 2 S" . SPARSER::MOLECULE) ("E 1 S" . SPARSER::MOLECULE)
    ("OH-" . SPARSER::MOLECULE) ("alpha-" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("O6-methylguanine DNA methyltransferase" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("anti-oestrogenic" . SPARSER::DRUG)
    ("collagen and aggrecan" . SPARSER::COLLECTION)
    ("aggrecan" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("cytokines" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("KL, osteophyte and JSN" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("variant" . SPARSER::VARIANT)
    ("discs" . SPARSER::BIO-COMPLEX) ("allele" . SPARSER::ALLELE)
    ("KL" . SPARSER::PROTEIN) ("GOA" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–3" . SPARSER::PROTEIN) ("1–L" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("VEGF and uPA" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("VEGF" . SPARSER::PROTEIN)
    ("a multifunctional phospholipid" . SPARSER::PHOSPHOLIPID)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA) ("LPA" . SPARSER::LPA)
    ("lysophospholipids" . SPARSER::MOLECULE)
    ("ASPS and USCS2" . SPARSER::COLLECTION)
    ("residual matrigel" . SPARSER::PROTEIN) ("subtypes" . SPARSER::PROTEIN)
    ("KY" . SPARSER::PROTEIN) ("ASPS-KY" . SPARSER::COLLECTION)
    ("ASPS" . SPARSER::PROTEIN) ("matrigel" . SPARSER::PROTEIN)
    ("c-Jun and JunD" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("autotaxin" . SPARSER::PROTEIN) ("pyrophosphatase" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("Inhibin" . SPARSER::PROTEIN)
    ("western blot" . SPARSER::PROTEIN) ("c-Jun or RFP" . SPARSER::COLLECTION)
    ("LPS" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("MDM2 and CDK4" . SPARSER::COLLECTION) ("oncogenes" . SPARSER::ONCOGENE)
    ("INHBA" . SPARSER::PROTEIN) ("ERG" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CellTiter-Glo" . SPARSER::COLLECTION) ("Glo" . SPARSER::PROTEIN)
    ("CFD (adipsin) and CEBPA" . SPARSER::COLLECTION)
    ("PPARG2 , CFD (adipsin) and CEBPA" . SPARSER::COLLECTION)
    ("adipocytic genes" . SPARSER::GENE) ("CEBPA" . SPARSER::PROTEIN)
    ("adipsin" . SPARSER::PROTEIN) ("CFD" . SPARSER::PROTEIN)
    ("PPARγ and C/EBPα" . SPARSER::COLLECTION)
    ("only 12 genes" . SPARSER::GENE) ("Exon" . SPARSER::PROTEIN)
    ("exon" . SPARSER::PROTEIN)
    ("differentially expressed genes" . SPARSER::GENE)
    ("shRNAs" . SPARSER::RNA) ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("CDK4 , HMGA2 and MDM2" . SPARSER::COLLECTION)
    ("3 biological types" . TYPE)
    ("Jun (c-Jun, JunB and JunD) and Fos (c-Fos, FosB, Fra1 and Fra2) proteins"
     . SPARSER::COLLECTION)
    ("the viral oncoproteins v-Fos and v-Jun" . SPARSER::COLLECTION)
    ("c-Jun, JunB and JunD" . SPARSER::COLLECTION)
    ("c-Fos, FosB, Fra1 and Fra2" . SPARSER::COLLECTION)
    ("v-Fos and v-Jun" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN) ("FosB" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JunD" . SPARSER::PROTEIN)
    ("JunB" . SPARSER::PROTEIN) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("leucine" . SPARSER::AMINO-ACID)
    ("ATF and MAF protein families" . SPARSER::COLLECTION)
    ("the JUN, FOS, ATF and MAF protein families" . SPARSER::COLLECTION)
    ("a dimeric complex" . SPARSER::BIO-COMPLEX)
    ("families" . SPARSER::PROTEIN-FAMILY) ("ATF" . SPARSER::PROTEIN)
    ("FOS" . SPARSER::PROTEIN) ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AP1" . SPARSER::PROTEIN) ("Autotaxin" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("LPA2" . SPARSER::PROTEIN) ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("LPA1" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("phospholipase D" . SPARSER::PROTEIN) ("c- Jun" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN) ("TGFBR3" . SPARSER::PROTEIN)
    ("RCAN1" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PPARG2" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("F-12" . SPARSER::PROTEIN)
    ("p32" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("v-Jun" . SPARSER::PROTEIN) ("v-Fos" . SPARSER::PROTEIN)
    ("Fra2" . SPARSER::PROTEIN) ("Fra1" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN)
    ("Macrophages and neutrophils" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN) ("Macrophages" . SPARSER::PROTEIN)
    ("immune cells supply paracrine growth factors" . SPARSER::GROWTH-FACTOR)
    ("MMP2, MMP7, MMP9 and MMP14" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ROS" . SPARSER::PROTEIN)
    ("Rac1b, and MMP3" . SPARSER::COLLECTION) ("EGFR" . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("GTPase" . SPARSER::GTPASE) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inducer" . SPARSER::MOLECULE) ("IPA" . SPARSER::MOLECULE)
    ("refs" . SPARSER::PROTEIN) ("FC" . SPARSER::PROTEIN)
    ("detectible MMP3" . SPARSER::PROTEIN) ("MMP3/Rac1b" . SPARSER::COLLECTION)
    ("actin and collagen" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("acinus" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::PROTEIN) ("smooth muscle" . SPARSER::PROTEIN)
    ("transgene and Rac1b" . SPARSER::COLLECTION)
    ("KRAS/tet-MMP3" . SPARSER::COLLECTION) ("transgene" . SPARSER::PROTEIN)
    ("MMP3 and KRAS" . SPARSER::COLLECTION)
    ("tet-KRAS/tet-MMP3" . SPARSER::COLLECTION)
    ("MMP3, KRAS, and Rac1b" . SPARSER::COLLECTION)
    ("doxycycline" . SPARSER::DRUG)
    ("MMP3 and constitutively active KRAS G12V" . SPARSER::COLLECTION)
    ("tet-MMP3" . SPARSER::PROTEIN-PAIR) ("tet-KRAS" . SPARSER::COLLECTION)
    ("tet" . SPARSER::PROTEIN) ("elastase" . SPARSER::PROTEIN)
    ("tetracycline" . SPARSER::DRUG) ("macrophage" . SPARSER::PROTEIN)
    ("punctate" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("MMP3 or Rac1b" . SPARSER::COLLECTION)
    ("Collagen-I and αSMA" . SPARSER::COLLECTION)
    ("MMP3 and either Collagen-I or αSMA ( xref )" . SPARSER::COLLECTION)
    ("Rac1b and either Collagen-I or αSMA ( xref )" . SPARSER::COLLECTION)
    ("Collagen-I or αSMA" . SPARSER::COLLECTION)
    ("TMA-lab" . SPARSER::MOLECULE) ("biomarker" . SPARSER::MOLECULE)
    ("TMA" . SPARSER::MOLECULE) ("αSMA and Collagen-I" . SPARSER::COLLECTION)
    ("Rac1b and MMP3" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("ECM" . SPARSER::PROTEIN)
    ("variety" . SPARSER::VARIETY) ("oncogene" . SPARSER::ONCOGENE)
    ("MMP3 and Rac1b" . SPARSER::COLLECTION) ("cohort" . SPARSER::MOLECULE)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("KRAS" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("MMP14" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H2O2" . SPARSER::DRUG) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("2-4" . SPARSER::PROTEIN) ("Collagen-I" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("Rac1b" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-3" . SPARSER::PROTEIN)
    ("their causal genes and the mechanisms" . SPARSER::COLLECTION)
    ("AF" . SPARSER::PROTEIN) ("the northern parts" . SPARSER::COMPONENT)
    ("parts" . SPARSER::COMPONENT)
    ("the cardiac fast transient outward K+" . SPARSER::MOLECULE)
    ("subunit" . SPARSER::FRAGMENT) ("lipids" . SPARSER::PROTEIN)
    ("calcium" . SPARSER::CALCIUM) ("IL-6 and NF-κB" . SPARSER::COLLECTION)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("H3K27ac and H3K4" . SPARSER::COLLECTION)
    ("promoters" . SPARSER::PROMOTER) ("enhancers" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("KCND3 and FADS2" . SPARSER::COLLECTION)
    ("IL17D/N6AMT2" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("sub-traits" . SPARSER::PROTEIN) ("wave and PR" . SPARSER::COLLECTION)
    ("the AV-node" . SPARSER::MOLECULE)
    ("IL17D (−3.7kb) and N6AMT2 (+2.2kb)" . SPARSER::COLLECTION)
    ("N6AMT2 (lower expression) and ARHGAP24" . SPARSER::COLLECTION)
    ("Tbx3" . SPARSER::PROTEIN) ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("genes and gene" . SPARSER::COLLECTION) ("DNase" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("ARHGAP24 and TBX3" . SPARSER::COLLECTION)
    ("CAV1 and SOX5" . SPARSER::COLLECTION)
    ("SCN5A/SCN10A" . SPARSER::COLLECTION) ("aims" . SPARSER::PROTEIN)
    ("the previously identified PR-interval variants" . SPARSER::VARIANT)
    ("traits" . SPARSER::PROTEIN) ("ECG" . SPARSER::DRUG)
    ("variants" . SPARSER::VARIANT) ("AV-node" . SPARSER::MOLECULE)
    ("KCND3 ( P =8.3×10 −11 ) and FADS2 ( P =2.7×10 −8 )"
     . SPARSER::COLLECTION)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nodal" . SPARSER::PROTEIN)
    ("AV" . SPARSER::MOLECULE) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K+" . SPARSER::MOLECULE) ("Kv4.3" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("N6AMT2" . SPARSER::PROTEIN) ("TBX3" . SPARSER::PROTEIN)
    ("ARHGAP24" . SPARSER::PROTEIN) ("SOX5" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("SCN10A" . SPARSER::PROTEIN)
    ("SCN5A" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("Mef2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p300" . SPARSER::PROTEIN)
    ("Nkx2-5" . SPARSER::PROTEIN) ("Gata4" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("DNAse I" . SPARSER::PROTEIN)
    ("LRCH1" . SPARSER::PROTEIN) ("IL17D" . SPARSER::PROTEIN)
    ("FADS2" . SPARSER::PROTEIN) ("KCND3" . SPARSER::PROTEIN)
    ("a FLT3 kinase inhibitor (sorafenib) and an HSP90 inhibitor (geldanamycin or 17-AAG)"
     . SPARSER::COLLECTION)
    ("geldanamycin or 17-AAG" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN)
    ("geldanamycin and 17-AAG" . SPARSER::COLLECTION)
    ("Geldanamycin" . SPARSER::DRUG)
    ("geldanamycin, 17-AAG and 17-DMAG" . SPARSER::COLLECTION)
    ("STAT5 and ERK1/2" . SPARSER::COLLECTION) ("AAG" . SPARSER::PROTEIN)
    ("geldanamycin" . SPARSER::DRUG)
    ("HSP90 and the co-chaperone CDC37 ( xref )" . SPARSER::COLLECTION)
    ("TK1 or TK2" . SPARSER::COLLECTION)
    ("sunitinib and sorafenib" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("leukemia" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("HSP90 and secondary FLT3-ITD mutants" . SPARSER::COLLECTION)
    ("secondary FLT3-ITD mutants" . SPARSER::MUTANT)
    ("HSP90-FLT3-ITD" . SPARSER::COLLECTION)
    ("a client kinase" . SPARSER::KINASE) ("chaperone" . SPARSER::PROTEIN)
    ("ITD" . SPARSER::PROTEIN) ("TKI" . SPARSER::PROTEIN)
    ("inhibitor-resistant FLT3-ITD mutants and selectively induced toxicity"
     . SPARSER::COLLECTION)
    ("FLT3-ITD" . SPARSER::COLLECTION)
    ("an HSP90 client kinase" . SPARSER::KINASE)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDC37" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("TK2" . SPARSER::PROTEIN)
    ("TK1" . SPARSER::PROTEIN) ("AC220" . SPARSER::DRUG)
    ("PKC412" . SPARSER::DRUG) ("anti-ERK" . SPARSER::PROTEIN)
    ("ERK2" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("F-8" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("IL-3" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FLT3" . SPARSER::PROTEIN)
    ("highly-active PI3K-III kinase complexes" . SPARSER::BIO-COMPLEX)
    ("Beclin 1, Atg14L, Vps34 and Vps15" . SPARSER::COLLECTION)
    ("the autophagic substrate p62" . SPARSER::PROTEIN)
    ("Atg3 , Atg5 , or Atg7" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("Atg5" . SPARSER::PROTEIN) ("Atg3" . SPARSER::PROTEIN)
    ("perinatal" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("components" . SPARSER::COMPONENT) ("an essential gene" . SPARSER::GENE)
    ("Nrbf2" . SPARSER::PROTEIN) ("weaker" . SPARSER::PROTEIN)
    ("Vps15-Vps34" . SPARSER::COLLECTION) ("Atg38/NRBF2" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN)
    ("which shares sequence homology" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN)
    ("the Atg14L-associated PI3K-III complex" . SPARSER::BIO-COMPLEX)
    ("part" . SPARSER::COMPONENT)
    ("Beclin 1-Vps34-Vps15" . SPARSER::COLLECTION) ("SCOC" . SPARSER::PROTEIN)
    ("the Beclin 1-Vps34 complex and a critical modulator"
     . SPARSER::COLLECTION)
    ("Beclin 1, Atg14L, UVRAG or Rubicon" . SPARSER::COLLECTION)
    ("Vps15 and -Atg14L-bound" . SPARSER::COLLECTION)
    ("proteins and Vps34" . SPARSER::COLLECTION)
    ("Vps34-Vps15-Beclin 1-Atg14L" . SPARSER::COLLECTION)
    ("Vps34-associated UVRAG" . SPARSER::PROTEIN)
    ("less Vps15 (≈35% reduced) and Beclin 1 (≈40% reduced)"
     . SPARSER::COLLECTION)
    ("markedly less Atg14L" . SPARSER::PROTEIN)
    ("Vps34, Vps15, Beclin 1, UVRAG, and Atg14L" . SPARSER::COLLECTION)
    ("Beclin 1, Vps34 and Vps15" . SPARSER::COLLECTION)
    ("Vps34-Vps15-Beclin1-Atg14L" . SPARSER::COLLECTION)
    ("thapsigargin-treated NRBF2 KO MEFs" . SPARSER::PROTEIN)
    ("Caspase-8 and -3" . SPARSER::COLLECTION) ("Bip" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("thapsigargin or tunicamycin" . SPARSER::COLLECTION)
    ("tunicamycin" . SPARSER::MOLECULE) ("thapsigargin" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE)
    ("ubiquitin ( xref ) and NAD(P)H dehydrogenase" . SPARSER::COLLECTION)
    ("quinone" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("antibodies" . SPARSER::ANTIBODY) ("HMW" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("hepatocytes" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE) ("FLAG-UVRAG" . SPARSER::COLLECTION)
    ("NRBF2 and UVRAG" . SPARSER::COLLECTION) ("RFP-LC3" . SPARSER::COLLECTION)
    ("lysosomal" . SPARSER::PROTEIN) ("RFP" . SPARSER::PROTEIN)
    ("The dual color fluorescent LC3" . SPARSER::PROTEIN)
    ("NRBF2 or dCCD" . SPARSER::COLLECTION)
    ("NRBF2-CFP mutants or CFP" . SPARSER::COLLECTION)
    ("NRBF-CFP" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("LC3 and WIPI2" . SPARSER::COLLECTION)
    ("fluorescent puncta" . SPARSER::PROTEIN)
    ("AcGFP-NRBF2" . SPARSER::COLLECTION) ("II" . SPARSER::PROTEIN)
    ("p62/SQSTM1" . SPARSER::COLLECTION) ("rapamycin" . SPARSER::DRUG)
    ("Leucine" . SPARSER::AMINO-ACID) ("Beclin1-Myc" . SPARSER::COLLECTION)
    ("nutrient" . SPARSER::MOLECULE) ("Myc-Vps34" . SPARSER::COLLECTION)
    ("Atg14L-Vps34" . SPARSER::COLLECTION) ("His" . SPARSER::AMINO-ACID)
    ("Vps34-Beclin 1-Vps15-Atg14L" . SPARSER::COLLECTION)
    ("Vps34/Vps15" . SPARSER::COLLECTION) ("dCCD-CFP" . SPARSER::COLLECTION)
    ("dMIT-CFP" . SPARSER::COLLECTION) ("CCD" . SPARSER::PROTEIN)
    ("lipid" . SPARSER::LIPID) ("Vps34 and Vps15" . SPARSER::COLLECTION)
    ("MEFs" . SPARSER::PROTEIN)
    ("Atg14L, Vps34, Vps15 and Beclin 1" . SPARSER::COLLECTION)
    ("Atg14L, Beclin 1 and NRBF2" . SPARSER::COLLECTION)
    ("Beclin 1-Myc" . SPARSER::COLLECTION) ("NRBF2-GFP" . SPARSER::COLLECTION)
    ("puncta" . SPARSER::PROTEIN) ("Myc" . SPARSER::PROTEIN)
    ("NRBF2-CFP" . SPARSER::COLLECTION) ("CFP" . SPARSER::PROTEIN)
    ("NRBF2-Atg14L" . SPARSER::COLLECTION)
    ("Atg14L and NRBF2" . SPARSER::COLLECTION)
    ("GST-NRBF2" . SPARSER::COLLECTION) ("FLAG-Atg14L" . SPARSER::COLLECTION)
    ("Atg14L-NRBF2" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("Beclin 1-NRBF2" . SPARSER::COLLECTION)
    ("Beclin 1 and Atg14L" . SPARSER::COLLECTION)
    ("NRBF2-Beclin 1" . SPARSER::COLLECTION)
    ("NRBF2, Atg14L and Beclin 1" . SPARSER::COLLECTION)
    ("fractions" . SPARSER::COMPONENT)
    ("Vps34, Vps15, Atg14L, and UVRAG" . SPARSER::COLLECTION)
    ("Beclin 1 and NRBF2" . SPARSER::COLLECTION)
    ("anti-Beclin 1 or anti-NRBF2" . SPARSER::COLLECTION)
    ("kDa" . SPARSER::PROTEIN)
    ("Atg14L, UVRAG, Rubicon, and Vps15" . SPARSER::COLLECTION)
    ("Beclin 1-GFP" . SPARSER::COLLECTION)
    ("a highly active PI3K-III kinase complex" . SPARSER::BIO-COMPLEX)
    ("regulators" . SPARSER::REGULATOR)
    ("Beclin 1 or Vps34" . SPARSER::COLLECTION)
    ("UVRAG and Atg14L" . SPARSER::COLLECTION)
    ("Beclin 1-Atg14L" . SPARSER::COLLECTION)
    ("Beclin 1-UVRAG" . SPARSER::COLLECTION)
    ("our group and others" . SPARSER::COLLECTION)
    ("Atg14L/Barkor" . SPARSER::COLLECTION) ("Rubicon" . SPARSER::PROTEIN)
    ("Barkor" . SPARSER::PROTEIN) ("Beclin 1-Vps34" . SPARSER::COLLECTION)
    ("the only Class III phosphatidylinositol-3 kinase" . SPARSER::KINASE)
    ("phosphatidylinositol" . SPARSER::PROTEIN) ("Class" . CLASS)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("Atg14L-Beclin 1-Vps34-Vps15" . SPARSER::COLLECTION)
    ("re-introducing exogenous NRBF2" . SPARSER::PROTEIN)
    ("the specific PI3K-III complex and a modulator" . SPARSER::COLLECTION)
    ("Atg14L or UVRAG" . SPARSER::COLLECTION) ("Vps34" . SPARSER::PROTEIN)
    ("UVRAG" . SPARSER::PROTEIN) ("class" . CLASS) ("Vps" . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE) ("CH3" . SPARSER::MOLECULE)
    ("MnCl 2" . SPARSER::DRUG) ("NP40" . SPARSER::MOLECULE)
    ("T antigen" . SPARSER::MOLECULE) ("triton X-100" . SPARSER::MOLECULE)
    ("NaHCO 3" . SPARSER::DRUG) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P40" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("IP 1" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("M2" . SPARSER::MOLECULE) ("Bis-Tris" . SPARSER::MOLECULE)
    ("adaptor protein" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("Atg14" . SPARSER::PROTEIN)
    ("Atg38" . SPARSER::PROTEIN) ("p43" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("Caspase-8" . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("NQO1" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("Nrf2" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LAMP2" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("WIPI2" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("amino acid" . SPARSER::AMINO-ACID)
    ("CCD1" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("AMBRA1" . SPARSER::PROTEIN)
    ("Bif1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("Vps15" . SPARSER::PROTEIN) ("NRBF2" . SPARSER::PROTEIN)
    ("Atg14L" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("LA" . SPARSER::PROTEIN) ("DCP" . SPARSER::DRUG)
    ("neurotoxic Aβ peptides" . SPARSER::PEPTIDE)
    ("APP and presenilins" . SPARSER::COLLECTION)
    ("presenilins" . SPARSER::PROTEIN-FAMILY) ("APP" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HuD mRNA and HuD-associated mRNAs" . SPARSER::COLLECTION)
    ("HuD-associated mRNAs" . SPARSER::PROTEIN) ("group" . SPARSER::MOLECULE)
    ("oligomeric Aβ peptide" . SPARSER::PEPTIDE) ("FBS" . SPARSER::PROTEIN)
    ("media" . SPARSER::PROTEIN)
    ("HuD- or NEP-specific siRNA" . SPARSER::COLLECTION)
    ("HuD or NEP" . SPARSER::COLLECTION)
    ("PKCε inhibitor or NEP inhibitor" . SPARSER::COLLECTION)
    ("monomeric Aβ 1–42 peptides" . SPARSER::PEPTIDE)
    ("peptides" . SPARSER::PEPTIDE) ("Peptide" . SPARSER::PEPTIDE)
    ("HuD- or PKCε-specific siRNA" . SPARSER::COLLECTION)
    ("HuD and PKCε" . SPARSER::COLLECTION) ("HuD-" . SPARSER::PROTEIN)
    ("phosphoramidon" . SPARSER::MOLECULE)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a fluorometric peptide substrate" . SPARSER::SUBSTRATE)
    ("solution" . SPARSER::MOLECULE) ("Thr" . SPARSER::AMINO-ACID)
    ("Ser" . SPARSER::AMINO-ACID) ("PKCε and NEP" . SPARSER::COLLECTION)
    ("HuD and NEP" . SPARSER::COLLECTION) ("siRNA" . SPARSER::PROTEIN)
    ("HuD-mRNA" . SPARSER::COLLECTION)
    ("oligoribonucleotide" . SPARSER::MOLECULE)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("a sequence-specific inhibitory peptide" . SPARSER::PEPTIDE)
    ("GAPDH" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("RIP" . SPARSER::PROTEIN) ("PKCε, HuD, and NEP" . SPARSER::COLLECTION)
    ("PKCε and HuD" . SPARSER::COLLECTION)
    ("BDNF and NGF" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN) ("neprilysin (NEP)" . SPARSER::PROTEIN)
    ("insulin-degrading enzyme (IDE)" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme (ACE)" . SPARSER::PROTEIN)
    ("plasmin" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("IDE" . SPARSER::PROTEIN)
    ("ACE" . SPARSER::PROTEIN) ("the monomeric form" . SPARSER::FORM)
    ("Soluble oligomeric forms" . SPARSER::FORM)
    ("HuD-NEP" . SPARSER::COLLECTION) ("a monomeric form" . SPARSER::FORM)
    ("activator" . SPARSER::ACTIVATOR) ("HuD" . SPARSER::PROTEIN)
    ("NEP" . SPARSER::PROTEIN) ("neprilysin" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE) ("GSK-3β" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("Cell Membrane" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("CCK-8" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("N-hydroxysuccinimide" . SPARSER::DRUG)
    ("Membrane Protein" . SPARSER::PROTEIN) ("MgCl2" . SPARSER::MOLECULE)
    ("protein A" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("RNA Binding Protein" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("amino acids" . SPARSER::AMINO-ACID)
    ("insulin-degrading enzyme" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("amyloid-beta" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("cell membrane" . SPARSER::PROTEIN) ("PKCε" . SPARSER::PROTEIN)
    ("Amyloid-beta" . SPARSER::PROTEIN)
    ("PI(3,4,5)P 3 and the Rac1 downstream effector protein WAVE2"
     . SPARSER::COLLECTION)
    ("PI3K and Rac1" . SPARSER::COLLECTION) ("mediators" . SPARSER::PROTEIN)
    ("chemical" . SPARSER::MOLECULE)
    ("14-3-3 protein zeta) and several GEFs (VAV3, P-Rex1)"
     . SPARSER::COLLECTION)
    ("effectors" . SPARSER::EFFECTOR) ("phosphoinositide" . SPARSER::PROTEIN)
    ("WAVE2 and PI" . SPARSER::COLLECTION)
    ("GTP-bound Rac and acidic phospholipids" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("Rac1 and PI" . SPARSER::COLLECTION) ("complex" . SPARSER::BIO-COMPLEX)
    ("molecule" . SPARSER::MOLECULE) ("linker" . SPARSER::LINKER)
    ("substrate" . SPARSER::SUBSTRATE)
    ("WAVEs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heteropentameric protein complexes" . SPARSER::BIO-COMPLEX)
    ("Wiskott-Aldrich syndrome protein (WASP) and WASP-family verprolin-homologous protein (WAVE) family proteins"
     . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("WAVE" . SPARSER::PROTEIN)
    ("verprolin" . SPARSER::PROTEIN) ("receptors" . SPARSER::RECEPTOR)
    ("EGF" . SPARSER::PROTEIN) ("EGFP-WAVE2" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("mCitrine-AKT-PH" . SPARSER::COLLECTION)
    ("pmCitrine-AKT-PH" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DMSO" . SPARSER::MOLECULE)
    ("using 100 nM wortmannin or 1 µM ZSTK474" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("inhibitor" . SPARSER::INHIBITOR)
    ("PA-Rac1 T17N" . SPARSER::PROTEIN-PAIR) ("mutant" . SPARSER::MUTANT)
    ("macrophages" . SPARSER::PROTEIN)
    ("mCherry-PA-Rac1" . SPARSER::COLLECTION)
    ("mCherry-fused" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("mCherry" . SPARSER::PROTEIN) ("inhibitors" . SPARSER::INHIBITOR)
    ("P 3 and Rac" . SPARSER::COLLECTION) ("chemotaxis" . SPARSER::PROTEIN)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1 and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("effector" . SPARSER::EFFECTOR) ("flavin" . SPARSER::MOLECULE)
    ("carboxy" . SPARSER::MOLECULE) ("oxygen" . SPARSER::MOLECULE)
    ("light" . SPARSER::PROTEIN) ("active (CA)" . SPARSER::ACTIVE)
    ("mutants" . SPARSER::MUTANT) ("spike" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEFs" . SPARSER::GEF)
    ("GDP" . SPARSER::NUCLEOTIDE) ("inactive" . SPARSER::INACTIVE)
    ("GTP" . SPARSER::NUCLEOTIDE) ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("GTPases" . SPARSER::GTPASE) ("actin" . SPARSER::PROTEIN)
    ("adhesive foci" . SPARSER::PROTEIN) ("foci" . SPARSER::PROTEIN)
    ("P 3 and WAVE2" . SPARSER::COLLECTION) ("PI" . SPARSER::PROTEIN)
    ("PC-3" . SPARSER::PROTEIN) ("photoactivatable Rac1" . SPARSER::PROTEIN)
    ("PA-Rac1" . SPARSER::COLLECTION) ("PA" . SPARSER::PROTEIN)
    ("P-Rex1" . SPARSER::PROTEIN) ("VAV3" . SPARSER::PROTEIN)
    ("zeta)" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("IRSp53" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN)
    ("Wiskott-Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("PDGF receptor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1–4" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("ZSTK474" . SPARSER::DRUG) ("LY294002" . SPARSER::MOLECULE)
    ("CO 2" . SPARSER::PROTEIN) ("N1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3,4,5-triphosphate" . SPARSER::PIP3)
    ("phototropin 1" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Cdc42" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("WAVE2" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1" . SPARSER::PROTEIN) ("DNA and protein" . SPARSER::COLLECTION)
    ("DNA" . SPARSER::DNA) ("drugs" . SPARSER::DRUG)
    ("synthase" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("Jun/cdk" . SPARSER::COLLECTION) ("isoforms" . SPARSER::ISOFORM)
    ("estrone or 17β-estradiol" . SPARSER::COLLECTION)
    ("Type 1 and type 2" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::MOLECULE) ("progesterone" . SPARSER::PROTEIN)
    ("-androstene-3" . SPARSER::COLLECTION)
    ("testosterone" . SPARSER::MOLECULE) ("active" . SPARSER::ACTIVE)
    ("isoform" . SPARSER::ISOFORM) ("miR" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA) ("pregnenolone" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN)
    ("Cyclin D1 and cdk6" . SPARSER::COLLECTION)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION) ("ER" . SPARSER::PROTEIN)
    ("associated nuclear proteins" . SPARSER::PROTEIN)
    ("AP-1, and cdk6" . SPARSER::COLLECTION) ("component" . SPARSER::COMPONENT)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AP-1" . SPARSER::PROTEIN)
    ("cdk6-" . SPARSER::PROTEIN) ("oligonucleotide" . SPARSER::MOLECULE)
    ("-1" . SPARSER::PROTEIN)
    ("transfectants and 17β-HSD1" . SPARSER::COLLECTION)
    ("cdk10" . SPARSER::PROTEIN) ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Promoter" . SPARSER::PROMOTER)
    ("AKR1C1, AKR1C2, AKR1C3, or CYP19" . SPARSER::COLLECTION)
    ("cyclin D1-transfectant" . SPARSER::COLLECTION)
    ("cdk/cyclin D1" . SPARSER::COLLECTION)
    ("complexes" . SPARSER::BIO-COMPLEX) ("form" . SPARSER::FORM)
    ("Genes" . SPARSER::GENE) ("mRNA and protein" . SPARSER::COLLECTION)
    ("mRNA" . SPARSER::PROTEIN)
    ("cdk6, cdk4, and AKR1C3" . SPARSER::COLLECTION)
    ("Protein" . SPARSER::PROTEIN) ("drug" . SPARSER::DRUG)
    ("cdk4 or cdk6" . SPARSER::COLLECTION) ("kinase" . SPARSER::KINASE)
    ("transfectant" . SPARSER::PROTEIN)
    ("AKR1C1 and AKR1C3" . SPARSER::COLLECTION)
    ("cdk4-transfectant" . SPARSER::COLLECTION)
    ("Cdk4 and cdk6" . SPARSER::COLLECTION)
    ("cdk4-transfectants" . SPARSER::COLLECTION)
    ("3 clonally-derived cdk4" . SPARSER::PROTEIN)
    ("AKR1C1 and AKR1C2" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("CYP1B1 and 17β-HSD2" . SPARSER::COLLECTION) ("RNA" . SPARSER::RNA)
    ("AKR1C1, CYP1B1, and 17β-HSD2" . SPARSER::COLLECTION)
    ("family" . SPARSER::PROTEIN-FAMILY) ("AKR" . SPARSER::PROTEIN)
    ("cdk6-transfectants" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("AKR1C1, AKR1C2, AKR1C3, and 17β-HSD2" . SPARSER::COLLECTION)
    ("Gene" . SPARSER::GENE) ("fraction" . SPARSER::COMPONENT)
    ("genes" . SPARSER::GENE) ("cdk6 and cyclin D1" . SPARSER::COLLECTION)
    ("chondrocytes" . SPARSER::PROTEIN) ("endocrine" . SPARSER::PROTEIN)
    ("parkin" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("types" . TYPE) ("p130/Rb2" . SPARSER::COLLECTION)
    ("forms" . SPARSER::FORM) ("cyclins and CDKIs" . SPARSER::COLLECTION)
    ("type" . TYPE) ("kinases" . SPARSER::PROTEIN)
    ("substrates" . SPARSER::SUBSTRATE) ("pRb" . SPARSER::PROTEIN)
    ("CDKIs" . SPARSER::DRUG) ("proteins" . SPARSER::PROTEIN)
    ("cdks" . SPARSER::PROTEIN) ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("molecules" . SPARSER::MOLECULE) ("receptor" . SPARSER::RECEPTOR)
    ("hormone" . SPARSER::MOLECULE) ("cdk6 and cdk4" . SPARSER::COLLECTION)
    ("gene" . SPARSER::GENE) ("promoter" . SPARSER::PROMOTER)
    ("aromatase, 17β-HSD2, and CYP1B1" . SPARSER::COLLECTION)
    ("HSD" . SPARSER::PROTEIN) ("aromatase" . SPARSER::PROTEIN)
    ("CYP" . SPARSER::PROTEIN) ("a pro-estrogenic state" . SPARSER::BIO-STATE)
    ("state" . SPARSER::BIO-STATE) ("pro" . SPARSER::AMINO-ACID)
    ("estrone" . SPARSER::DRUG) ("enzyme" . SPARSER::ENZYME)
    ("aldo-keto reductase (AKR)1C1, AKR1C2 and AKR1C3" . SPARSER::COLLECTION)
    ("1C1, AKR1C2 and AKR1C3" . SPARSER::COLLECTION)
    ("HSDs" . SPARSER::PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("cdk6 or cdk4" . SPARSER::COLLECTION) ("estrogen" . SPARSER::MOLECULE)
    ("enzymes" . SPARSER::ENZYME) ("differentially" . SPARSER::PROTEIN)
    ("cyclin D1 or cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type 2" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("CYP11A1" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN) ("Ets2" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN) (NIL . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("HSD1" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("G418" . SPARSER::MOLECULE) ("Cdk6" . SPARSER::PROTEIN)
    ("AKR1C1" . SPARSER::PROTEIN) ("CYP19" . SPARSER::PROTEIN)
    ("Rb2" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYP1B1" . SPARSER::PROTEIN) ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("17β-estradiol" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE) ("AKR1C3" . SPARSER::PROTEIN)
    ("AKR1C2" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("aldo-keto reductase" . SPARSER::PROTEIN) ("cdk4" . SPARSER::PROTEIN)
    ("cdk6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1" . SPARSER::PROTEIN)))